data_2g2k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2g2k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.216 0.532 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.506 HD12 ' ND2' ' A' ' 38' ' ' ASN . 36.7 mt -109.74 128.4 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 138.95 51.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' HG13 ' A' ' 35' ' ' VAL . 22.7 mtpp -124.85 136.99 54.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 79' ' ' SER . 62.7 t -96.38 133.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 110.102 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.579 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.845 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HE3' HG23 ' A' ' 75' ' ' ILE . 33.1 pttt -128.47 152.66 47.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -97.16 128.55 44.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 75' ' ' ILE . 1.7 p -116.64 117.87 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.533 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 4.5 mt -95.49 110.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.91 -1.37 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' ND2' HD12 ' A' ' 22' ' ' ILE . 41.9 t30 -116.79 -1.18 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.533 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 20.6 ttm -64.3 -45.49 87.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.082 -1.011 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 45.5 t -70.4 -41.37 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.866 . . . . 0.0 110.258 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -62.12 -49.82 74.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.249 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 43' ' ' ALA . 6.3 m -68.36 -43.54 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.67 -44.44 77.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -67.68 -36.29 80.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.0 110.42 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -69.37 -25.82 64.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.9 . . . . 0.0 110.811 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 42' ' ' VAL . 2.5 pp -117.42 -9.19 10.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.051 . . . . 0.0 110.69 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ALA . 1.1 t-20 175.43 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -101.65 170.7 6.14 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.103 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.3 Cg_endo -72.57 128.88 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.962 1.506 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' OG1' ' A' ' 54' ' ' THR . 48.5 Cg_endo -74.58 48.83 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.912 1.48 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.642 ' CG2' ' CE1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -68.1 -23.94 64.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.56 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -75.49 -54.26 2.4 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.92 . . . . 0.0 110.814 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -71.17 -1.53 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.799 1.421 . . . . 0.0 110.819 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.522 HG23 ' CG2' ' A' ' 65' ' ' THR . 51.6 m -66.44 -21.58 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -42.54 64.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.531 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -49.5 77.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 0.0 110.302 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 5.5 m-30 -57.49 -43.89 84.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.924 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -59.64 -35.2 85.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.94 -37.23 71.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -1.228 . . . . 0.0 110.022 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.04 -47.8 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.651 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.567 HD12 ' CB ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.59 12.72 2.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.171 -0.956 . . . . 0.0 111.009 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 6.49 27.94 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASN . . . -117.65 163.95 15.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.338 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.9 mt-30 -105.4 -119.16 0.22 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.698 -1.252 . . . . 0.0 109.962 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.522 ' CG2' HG23 ' A' ' 54' ' ' THR . 7.7 p -149.42 170.42 18.61 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 111.228 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' ILE . 4.2 tp-100 -144.72 139.47 27.93 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.711 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 18.5 m-85 -126.81 143.97 51.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.743 -1.223 . . . . 0.0 113.066 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 1.7 t0 -124.63 117.28 23.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.778 -0.769 . . . . 0.0 108.982 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 7.7 m -89.13 -45.88 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.144 -0.973 . . . . 0.0 109.57 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.1 -6.84 42.34 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 108.516 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -118.21 -27.57 6.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.723 -0.611 . . . . 0.0 110.044 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.1 m-20 70.45 17.03 6.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.275 -0.891 . . . . 0.0 109.877 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.577 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -113.57 129.45 56.56 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.793 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.49 132.88 55.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 110.26 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 8.8 mm -120.5 148.68 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 21.0 t -114.04 126.04 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 68.5 m-80 -47.22 147.04 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 110.409 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 89.37 144.34 10.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.49 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 68.6 p -105.78 125.23 50.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -1.141 . . . . 0.0 110.136 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -139.51 155.4 47.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.08 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -90.86 156.84 17.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.29 -43.21 64.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 83' ' ' ASN . 1.6 m120 -59.65 -33.51 71.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -69.33 -39.69 78.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.276 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 80' ' ' HIS . 13.7 mt -60.4 -36.19 77.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -68.83 -36.22 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 110.134 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.901 -179.514 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 32.6 mt -107.88 120.32 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 110.076 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.15 135.9 54.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.414 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -117.38 137.96 52.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.1 t -93.35 122.98 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.227 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.8 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.194 -0.941 . . . . 0.0 110.448 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.621 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.376 0.607 . . . . 0.0 110.295 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -97.52 152.87 18.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 109.142 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.632 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 3.3 m -105.91 120.48 41.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.872 -1.142 . . . . 0.0 110.906 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 21.5 t -108.6 117.87 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.869 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 ' CG2' ' HG3' ' A' ' 39' ' ' MET . 5.2 mt -95.56 113.0 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 37' ' ' VAL . 7.4 p -99.76 -1.24 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.195 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 5.4 t-20 -97.64 -0.96 44.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.237 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' A' ' 36' ' ' ILE . 2.6 mtt -59.74 -43.41 94.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.459 HG21 ' OD1' ' A' ' 41' ' ' ASP . 34.4 m -60.6 -43.2 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD1' HG21 ' A' ' 40' ' ' VAL . 16.2 m-20 -66.98 -49.03 66.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.66 -42.73 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 39' ' ' MET . . . -63.27 -34.99 78.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.07 -46.85 87.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.27 -16.19 60.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 9.6 tt -103.27 -2.76 26.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 m-20 66.73 -58.34 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.14 132.95 69.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 46.3 Cg_endo -73.41 146.16 39.3 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.459 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.484 ' O ' ' HB ' ' A' ' 54' ' ' THR . 46.1 Cg_endo -73.19 -4.72 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.972 1.512 . . . . 0.0 110.499 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -60.53 -21.69 62.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.532 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.42 -58.29 0.8 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.719 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.9 Cg_endo -72.73 -3.13 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.958 1.504 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 51' ' ' THR . 13.9 t -72.97 -17.66 61.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.347 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -72.82 -45.41 58.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.467 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -66.92 -41.43 87.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 5.5 t80 -57.72 -42.06 83.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.49 -35.34 85.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.02 -37.27 79.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.239 . . . . 0.0 110.265 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.27 -28.73 68.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.905 . . . . 0.0 111.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.631 ' CD2' ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -105.42 12.96 30.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.053 -1.029 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 4.87 21.76 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.632 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -116.0 164.02 15.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -1.08 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' C ' ' CG2' ' A' ' 65' ' ' THR . 29.6 mt-30 -112.27 -120.13 0.29 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.71 -1.244 . . . . 0.0 110.245 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -149.49 170.62 18.17 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.414 -0.804 . . . . 0.0 111.158 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -146.68 139.67 25.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.737 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 23.7 m-85 -126.59 144.52 50.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.754 -1.216 . . . . 0.0 112.816 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.511 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -120.86 117.37 27.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.968 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 10.6 m -89.07 -45.13 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.694 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.513 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.64 -5.26 32.3 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.255 -0.903 . . . . 0.0 108.83 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.635 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 m120 -121.14 -24.64 5.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.517 -0.739 . . . . 0.0 110.345 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 69.55 17.5 7.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.67 129.65 56.53 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 109.436 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.737 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.2 m-30 -113.09 129.19 56.59 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.53 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.531 HG23 ' CB ' ' A' ' 66' ' ' GLN . 1.2 tt -125.29 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.552 -0.718 . . . . 0.0 109.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.541 ' CG1' HG23 ' A' ' 34' ' ' THR . 2.3 p -113.29 136.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.177 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.632 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -61.24 142.04 57.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.345 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 109.7 141.23 9.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 51.4 p -97.23 122.36 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -1.15 . . . . 0.0 110.025 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.632 ' ND1' ' OG1' ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.33 158.35 43.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 3.8 tt0 -103.99 158.15 16.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.09 -43.88 64.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.03 -33.49 76.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.87 -37.17 83.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.213 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.15 -44.46 94.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.89 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -66.99 -36.49 82.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.178 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.248 0.547 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' HD23 ' A' ' 21' ' ' LEU . 13.2 mm -100.74 136.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.61 141.2 52.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -124.19 138.08 54.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.998 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 79' ' ' SER . 3.3 p -93.26 134.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.209 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.7 mm . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.323 0.582 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -129.52 152.49 49.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.986 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.533 HG22 ' NE2' ' A' ' 80' ' ' HIS . 1.3 m -108.95 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 110.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 24' ' ' LYS . 3.0 p -102.85 117.73 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 3.3 mt -95.55 112.48 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.4 -21.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.222 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -91.79 11.46 24.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.515 ' CE ' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.98 -45.19 93.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.093 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 41' ' ' ASP . 14.5 m -67.43 -42.31 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 3.6 m-20 -64.96 -50.11 67.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.74 -43.66 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.95 75.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.21 93.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.48 -22.6 60.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -102.43 2.92 37.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.426 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 4.3 m120 65.43 -64.55 0.18 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.35 -0.843 . . . . 0.0 110.237 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -77.23 122.66 86.53 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.7 Cg_endo -73.06 144.84 38.54 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.974 1.512 . . . . 0.0 110.41 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HG2' ' CE ' ' A' ' 39' ' ' MET . 46.3 Cg_endo -72.99 -0.15 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.013 1.533 . . . . 0.0 110.22 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -57.21 -21.48 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.542 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.6 m-85 -82.1 -58.87 0.44 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.118 -0.988 . . . . 0.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 48.8 Cg_endo -74.76 -0.22 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.884 1.465 . . . . 0.0 111.049 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.495 ' HB ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -61.28 -23.51 65.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.03 -1.044 . . . . 0.0 110.376 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -42.09 64.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.982 . . . . 0.0 110.598 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.8 t80 -58.76 -51.29 70.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.246 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 15.5 m-30 -57.68 -43.26 84.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -61.22 -35.09 90.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -56.7 -37.26 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.257 . . . . 0.0 109.998 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.07 -47.59 76.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.739 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -83.07 12.92 4.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.162 -0.961 . . . . 0.0 110.91 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 4.87 26.93 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASN . . . -114.41 163.67 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.158 . . . . 0.0 109.397 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' C ' ' CG2' ' A' ' 65' ' ' THR . 12.5 tt0 -107.95 -119.07 0.26 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.958 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.495 HG23 ' HB ' ' A' ' 54' ' ' THR . 1.6 p -149.25 170.23 18.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.535 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.48 139.34 28.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.705 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 19.0 m-85 -126.83 143.77 51.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.864 -1.148 . . . . 0.0 112.844 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -122.99 117.47 25.55 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.731 -0.787 . . . . 0.0 108.943 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.48 -64.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.64 -17.52 5.85 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.184 -0.948 . . . . 0.0 108.682 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -103.92 -31.4 9.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.637 -0.665 . . . . 0.0 110.153 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.8 m-20 71.72 16.47 5.69 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -0.862 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.569 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.46 129.49 56.53 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.618 -0.676 . . . . 0.0 109.713 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.705 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.45 137.73 51.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 66' ' ' GLN . 10.8 tt -131.66 148.56 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 109.792 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 ' CG2' HG21 ' A' ' 34' ' ' THR . 3.6 m -114.21 137.84 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.094 -1.004 . . . . 0.0 109.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 98.4 m-20 -59.01 143.08 49.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.15 147.59 22.02 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 35.3 p -107.37 121.09 43.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -1.178 . . . . 0.0 110.462 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.21 167.23 22.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 110.004 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.483 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt-10 -101.25 158.14 16.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.937 . . . . 0.0 110.119 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 21' ' ' LEU . . . -52.85 -44.52 66.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.61 -34.98 79.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 109.845 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -59.41 -37.35 77.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 110.439 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 3.2 mp -61.79 -44.95 95.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -45.5 69.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.229 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 3.1 tm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.261 0.553 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -97.34 125.1 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.893 . . . . 0.0 110.175 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.7 138.08 47.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.522 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -116.67 137.97 51.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 25' ' ' VAL . 4.4 p -96.33 125.1 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.24 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 8.1 tt0 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.61 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 3.7 ttpt -97.62 153.08 18.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.551 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 1.2 m -98.63 118.37 35.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.942 -1.099 . . . . 0.0 110.507 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.536 ' CB ' HG12 ' A' ' 75' ' ' ILE . 2.3 p -107.76 117.4 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.093 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.567 ' CG2' ' O ' ' A' ' 36' ' ' ILE . 4.5 tp -96.05 119.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.4 t -100.77 -24.88 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.0 2.61 56.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.546 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 43.7 tpp -64.14 -44.91 90.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.9 p -59.55 -42.84 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.391 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -63.58 -49.4 73.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.205 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.77 -43.82 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.262 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -59.3 -35.54 73.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -50.12 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 109.968 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.15 60.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.543 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 8.3 tt -83.35 1.1 42.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 110.344 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.5 m120 73.89 -63.35 0.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.796 . . . . 0.0 110.514 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 3.9 mmt85 -77.13 155.17 82.5 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 110.262 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.1 Cg_endo -73.05 157.54 50.76 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.102 1.58 . . . . 0.0 110.528 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.64 -26.83 8.0 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.07 1.563 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 54' ' ' THR . 18.1 p -60.69 -21.83 63.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.528 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -58.29 0.59 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 110.653 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' O ' ' CD2' ' A' ' 57' ' ' PHE . 46.2 Cg_endo -72.99 -0.31 8.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.868 1.457 . . . . 0.0 110.892 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.8 -25.83 59.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -45.7 57.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -67.76 -48.86 65.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 11.5 m-85 -57.57 -41.37 80.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.499 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -58.83 -35.36 82.08 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -37.27 78.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.238 . . . . 0.0 109.932 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -48.38 71.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 110.651 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.606 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -77.79 11.46 2.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.169 -0.957 . . . . 0.0 111.046 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.97 11.26 36.99 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.693 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -118.05 164.31 15.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.508 -0.995 . . . . 0.0 109.274 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 65' ' ' THR . 11.8 mp0 -104.1 -121.38 0.2 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.63 -1.294 . . . . 0.0 110.001 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -149.86 170.12 19.53 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.458 -0.776 . . . . 0.0 111.82 -179.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -155.95 139.06 15.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 20.0 m-85 -127.31 146.1 50.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.741 -1.224 . . . . 0.0 112.967 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -117.9 117.17 28.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.667 177.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 14.0 m -90.21 -46.33 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.496 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 1.6 tptt -73.16 -3.62 27.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -118.92 -26.92 5.89 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.684 -0.635 . . . . 0.0 110.529 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.2 m-20 70.13 16.31 7.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.072 -1.017 . . . . 0.0 109.543 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.554 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 4.0 mmt85 -113.87 129.72 56.56 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.678 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.8 m-30 -109.06 128.97 55.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.825 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 84.4 mt -129.04 150.83 34.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.543 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 13.2 m -111.77 138.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.929 -1.107 . . . . 0.0 109.134 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 t30 -62.75 140.33 58.74 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.769 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 104.95 147.08 15.72 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.537 ' HB3' HD12 ' A' ' 32' ' ' ILE . 3.2 p -101.41 127.59 47.99 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.306 -1.114 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -141.92 156.69 45.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 1.4 pt-20 -104.01 143.4 32.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.758 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -53.49 -39.51 64.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.975 . . . . 0.0 110.268 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -34.71 66.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.173 -0.954 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 1.3 tppp? -73.03 -45.58 56.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -60.5 -44.19 96.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.354 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -68.66 -35.83 77.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.73 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.8 t0 . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 111.354 -178.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 39' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.279 0.562 . . . . 0.0 109.981 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.2 mt -115.61 123.52 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.258 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.99 132.53 53.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.07 136.18 53.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.518 HG12 ' CB ' ' A' ' 79' ' ' SER . 94.6 t -102.48 134.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.6 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.332 0.587 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HA ' ' N ' ' A' ' 78' ' ' GLY . 6.0 mtmm -126.76 152.55 46.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.0 OUTLIER -108.18 123.95 49.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.522 ' CG2' HG13 ' A' ' 75' ' ' ILE . 20.4 t -108.52 117.79 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -95.95 122.98 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -100.55 -43.56 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.774 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' O ' HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.23 -1.52 25.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.019 . . . . 0.0 110.75 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.569 ' HB3' ' HB ' ' A' ' 36' ' ' ILE . 1.5 tmt? -64.72 -45.6 85.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.019 . . . . 0.0 109.967 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 HG11 ' N ' ' A' ' 41' ' ' ASP . 14.3 p -70.68 -41.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 0.0 110.323 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' N ' HG11 ' A' ' 40' ' ' VAL . 40.1 t0 -62.17 -49.47 75.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.541 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 12.9 m -68.12 -43.57 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -61.53 -46.96 87.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -36.45 80.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.449 -0.782 . . . . 0.0 110.236 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -69.8 -31.96 70.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 42' ' ' VAL . 3.0 pp -108.94 -1.4 19.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -170.21 -154.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.291 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 1.8 mtt180 -93.47 174.49 3.84 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.274 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.94 128.57 13.31 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.359 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' O ' ' HB ' ' A' ' 54' ' ' THR . 47.9 Cg_endo -75.4 5.2 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.034 1.544 . . . . 0.0 110.657 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.605 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -56.46 -26.54 54.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.527 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -84.51 -55.94 0.43 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.964 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.9 Cg_endo -70.77 -23.66 25.95 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.824 1.434 . . . . 0.0 111.143 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 7.8 t -56.25 -16.31 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.992 -1.067 . . . . 0.0 110.208 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -45.4 68.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -62.11 -49.46 75.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -0.979 . . . . 0.0 110.11 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 8.9 m-30 -57.42 -36.8 71.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.921 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -39.25 94.91 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.2 m -57.45 -37.33 72.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -1.2 . . . . 0.0 109.924 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 -49.48 77.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.835 . . . . 0.0 110.723 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -83.42 12.98 4.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.109 -0.994 . . . . 0.0 110.697 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.05 6.29 31.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 77' ' ' ASN . . . -116.45 163.59 15.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -1.159 . . . . 0.0 109.609 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.488 ' C ' ' CG2' ' A' ' 65' ' ' THR . 24.6 tp60 -107.16 -118.42 0.25 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.936 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.18 170.25 18.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 111.022 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.561 ' CB ' HG23 ' A' ' 75' ' ' ILE . 3.3 mm100 -146.32 139.82 25.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.7 m-85 -126.54 142.59 51.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.819 -1.176 . . . . 0.0 112.849 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -120.28 117.48 27.92 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.015 178.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 70' ' ' LYS . 13.5 m -89.29 -45.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.645 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 69' ' ' VAL . 7.4 tptt -71.01 -5.95 35.15 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.198 -0.939 . . . . 0.0 108.722 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.7 m-20 -121.32 -25.27 5.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.591 -0.693 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.1 m-20 69.75 17.15 7.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 109.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -113.64 129.47 56.56 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.586 -0.696 . . . . 0.0 109.681 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.727 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-30 -113.18 138.02 50.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.555 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG23 ' CB ' ' A' ' 66' ' ' GLN . 1.6 tt -128.45 148.75 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.461 -0.774 . . . . 0.0 109.925 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t -113.89 130.03 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.688 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 67.6 m-80 -49.76 147.82 3.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 110.51 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.16 148.8 16.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.518 ' CB ' HG12 ' A' ' 25' ' ' VAL . 64.8 p -106.63 122.62 46.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -1.109 . . . . 0.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -142.09 145.45 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 109.975 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.3 tt0 -81.72 155.17 25.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.108 -0.995 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.25 -43.89 64.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.033 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -64.67 -33.55 76.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 109.797 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -36.87 85.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 110.082 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 80' ' ' HIS . 4.4 mp -59.95 -42.59 94.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.103 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -69.2 -35.93 76.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.535 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.476 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 3.4 tp . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.261 0.553 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -119.12 132.37 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.9 140.59 52.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -121.71 137.97 54.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 16.3 m -93.44 131.9 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.368 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 110.23 179.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.581 0.705 . . . . 0.0 110.028 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.77 153.27 18.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.832 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.563 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.3 m -97.16 124.97 41.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.088 -1.007 . . . . 0.0 110.834 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 5.7 t -118.02 117.65 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.923 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 3.6 mt -95.77 118.16 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.288 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 t -100.45 -16.92 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.286 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB2' HG23 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -99.01 14.47 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.54 ' HG2' ' CG ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -63.97 -41.95 97.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 58.4 t -61.37 -47.55 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -63.0 -50.2 71.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.28 -40.71 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.552 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -62.65 -48.4 79.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -62.11 -38.91 90.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 110.243 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.45 -15.89 60.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.382 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.602 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 7.2 tt -101.89 -9.33 20.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 110.387 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t30 78.26 -50.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.48 -0.762 . . . . 0.0 111.025 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.561 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 56.3 mtp180 -76.66 142.29 70.07 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.081 -1.012 . . . . 0.0 110.259 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.96 140.96 32.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.147 1.604 . . . . 0.0 110.637 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -75.73 -29.5 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 0.0 110.333 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.427 HG23 ' CE1' ' A' ' 67' ' ' PHE . 48.8 p -59.5 -22.8 62.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 110.316 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.554 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -77.52 -58.65 0.92 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 0.0 110.268 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 47.8 Cg_endo -73.68 -28.24 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.973 1.512 . . . . 0.0 110.702 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.509 ' CB ' ' O ' ' A' ' 50' ' ' PRO . 3.4 m -56.28 -19.74 15.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -72.77 -45.38 58.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.107 -0.995 . . . . 0.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 10.1 m-30 -64.6 -39.82 94.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.095 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -41.15 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.55 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -60.28 -35.33 87.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.0 m -56.99 -37.24 71.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 109.769 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.29 -44.0 93.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 110.722 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER -88.24 12.64 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.134 -0.979 . . . . 0.0 111.032 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.1 4.78 30.31 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -115.29 163.99 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 0.0 109.141 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' C ' ' CG2' ' A' ' 65' ' ' THR . 4.7 tt0 -106.2 -121.58 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.621 -1.3 . . . . 0.0 109.738 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.515 ' CG2' ' C ' ' A' ' 64' ' ' GLN . 1.3 p -149.84 170.43 18.79 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.45 -0.781 . . . . 0.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' HG21 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -142.41 139.43 31.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.82 144.17 51.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.759 -1.213 . . . . 0.0 113.13 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.3 t0 -126.34 117.38 22.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.165 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 16.9 t -86.58 -61.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -16.65 6.23 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.192 -0.942 . . . . 0.0 108.633 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.611 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.2 t30 -105.74 -30.02 9.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.584 -0.697 . . . . 0.0 110.152 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.7 m-20 71.05 16.67 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 tpt180 -113.62 128.98 56.63 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.503 -0.748 . . . . 0.0 109.865 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.682 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.44 138.2 50.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.469 -0.769 . . . . 0.0 110.022 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.531 HG21 ' CB ' ' A' ' 66' ' ' GLN . 1.0 OUTLIER -132.41 148.06 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.8 t -114.43 139.03 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.258 -0.901 . . . . 0.0 109.469 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.564 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 11.6 m-80 -64.05 141.72 58.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.085 -1.01 . . . . 0.0 110.469 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 99.64 142.12 12.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.523 ' HB3' HD13 ' A' ' 32' ' ' ILE . 4.9 p -80.6 127.3 32.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.096 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.563 ' CD2' ' OG1' ' A' ' 34' ' ' THR . 78.9 m-70 -142.2 141.03 32.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.801 . . . . 0.0 110.403 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 83' ' ' ASN . 4.6 tp10 -104.04 149.57 25.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.928 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.31 -43.91 64.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.426 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.421 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -64.15 -33.29 75.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.238 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -40.42 84.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 110.331 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 2.0 mp -60.58 -45.24 94.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.04 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -47.41 64.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.036 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.8 t0 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.54 -179.747 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.425 HD22 HD12 ' A' ' 85' ' ' LEU . 5.3 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.258 0.551 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 22' ' ' ILE . 25.9 mt -110.97 120.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.43 132.23 54.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.539 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.542 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.0 135.71 53.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.05 122.36 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.607 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.297 0.57 . . . . 0.0 110.381 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -97.43 153.12 18.31 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.929 -1.107 . . . . 0.0 109.213 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.555 ' CG2' ' O ' ' A' ' 34' ' ' THR . 1.3 t -117.94 121.72 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.771 -1.205 . . . . 0.0 110.877 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -107.27 117.63 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.723 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 19.0 mt -95.62 108.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.72 -4.9 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.364 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.513 ' OD1' ' CD1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -109.21 -1.19 18.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.546 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 34.9 ttm -64.22 -44.2 92.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 110.084 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 11.6 p -70.15 -39.46 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.865 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.443 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 23.8 t70 -62.51 -50.74 70.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.141 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 43' ' ' ALA . 12.4 p -68.5 -45.34 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.85 -35.13 78.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.355 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 2.4 tttp -67.4 -36.58 81.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.43 61.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 3.1 tt -117.47 -9.16 10.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ALA . 1.4 t-20 171.44 -148.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mtt85 -96.41 169.19 9.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.021 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.14 127.81 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.396 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 54' ' ' THR . 48.7 Cg_endo -75.03 46.92 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.927 1.488 . . . . 0.0 110.887 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.534 ' CG2' ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -68.05 -26.14 65.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -73.99 -54.31 3.61 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.722 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.4 Cg_endo -69.92 -19.85 34.84 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.812 1.428 . . . . 0.0 110.779 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 50' ' ' PRO . 6.3 m -56.25 -18.9 11.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.989 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -72.88 -40.82 65.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -58.66 -49.68 76.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.049 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 10.3 m-85 -57.27 -35.87 70.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -65.31 -35.14 91.14 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 67.0 m -56.69 -37.19 70.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.08 -1.247 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -49.3 69.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.644 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -79.9 11.94 3.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.113 -0.992 . . . . 0.0 111.115 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.2 4.66 30.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 77' ' ' ASN . . . -118.35 164.05 15.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.504 ' C ' ' CG2' ' A' ' 65' ' ' THR . 9.4 mt-30 -110.34 -120.53 0.28 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.594 -1.316 . . . . 0.0 109.875 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.504 ' CG2' ' C ' ' A' ' 64' ' ' GLN . 1.1 p -149.4 170.41 18.62 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.435 -0.791 . . . . 0.0 110.921 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.533 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 1.8 mm-40 -140.97 139.66 34.27 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.726 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.5 142.99 51.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.751 -1.218 . . . . 0.0 113.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -123.13 117.5 25.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.997 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.53 -64.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.599 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -16.91 6.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.134 -0.979 . . . . 0.0 108.656 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.75 -29.66 10.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.603 -0.686 . . . . 0.0 110.103 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.5 m-20 69.58 15.95 8.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.128 -0.982 . . . . 0.0 110.158 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 15.4 ttm180 -113.65 129.44 56.57 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.852 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.726 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.61 138.04 50.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.394 -0.816 . . . . 0.0 110.309 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 17.8 tt -130.6 148.41 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 34' ' ' THR . 4.2 t -114.73 139.21 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -0.958 . . . . 0.0 109.327 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 62.4 m-80 -67.86 140.03 56.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.346 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . 105.63 145.39 13.25 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -80.44 133.59 35.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -1.2 . . . . 0.0 110.179 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 34' ' ' THR . 99.1 m-70 -142.32 119.83 11.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.508 -0.745 . . . . 0.0 110.8 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -82.92 158.76 22.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.31 -43.74 61.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.997 -1.065 . . . . 0.0 109.559 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 2.4 t30 -64.71 -33.27 75.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.2 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.31 75.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.052 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.425 HD12 HD22 ' A' ' 21' ' ' LEU . 20.5 mt -58.85 -32.45 69.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.589 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 51.8 mm-40 -68.79 -35.08 76.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.442 -0.787 . . . . 0.0 111.585 -178.744 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 21' ' ' LEU . 5.1 tt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.449 HD11 ' OD1' ' A' ' 38' ' ' ASN . 4.7 mt -103.97 136.77 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.71 126.75 45.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.52 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 2.5 mmtp -116.12 138.05 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 25' ' ' VAL . 4.3 p -93.34 122.05 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.6 tt0 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.406 -0.809 . . . . 0.0 110.217 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -97.71 152.85 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.905 -1.122 . . . . 0.0 109.559 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.632 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 18.5 m -110.78 115.69 29.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.938 -1.101 . . . . 0.0 110.771 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 24' ' ' LYS . 14.3 p -107.14 117.42 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.2 mt -95.77 108.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 37' ' ' VAL . 7.6 p -100.6 -13.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' OD1' HD11 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -101.47 -1.32 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.415 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.552 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -64.5 -45.26 88.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 8.5 p -67.19 -38.58 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.0 110.422 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 16.2 t0 -61.93 -48.92 78.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -0.945 . . . . 0.0 110.353 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 46' ' ' LEU . 79.9 t -68.41 -40.7 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -66.43 -38.69 87.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -67.11 -36.45 81.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.052 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 46' ' ' LEU . . . -63.2 -30.27 71.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 6.1 mp -115.18 -9.31 12.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' ALA . 6.1 p30 171.37 -110.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.37 -0.831 . . . . 0.0 110.388 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.9 mtm-85 -137.32 167.35 21.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 44.9 Cg_endo -72.0 137.91 30.11 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.907 1.477 . . . . 0.0 110.571 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.531 ' O ' ' CG2' ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.11 52.08 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.066 1.561 . . . . 0.0 110.523 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -67.87 -21.69 65.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 m-85 -81.4 -54.2 0.71 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 111.081 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -72.47 2.49 5.08 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.796 1.419 . . . . 0.0 111.338 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.54 ' HB ' HG21 ' A' ' 65' ' ' THR . 1.9 p -66.35 -18.59 65.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -72.86 -42.3 63.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.878 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -58.72 -51.43 70.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.117 -0.99 . . . . 0.0 110.433 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.547 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 24.7 m-85 -57.82 -42.59 84.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.65 -35.52 89.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -37.28 70.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -1.208 . . . . 0.0 110.039 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.63 -48.88 70.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.14 12.45 3.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.066 -1.021 . . . . 0.0 111.097 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.85 4.85 22.28 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -117.71 163.87 15.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -1.139 . . . . 0.0 109.081 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.51 ' C ' ' CG2' ' A' ' 65' ' ' THR . 66.4 mt-30 -110.4 -123.07 0.27 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.643 -1.285 . . . . 0.0 109.929 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.54 HG21 ' HB ' ' A' ' 54' ' ' THR . 2.0 p -149.92 170.76 18.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.97 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.521 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.0 tm0? -144.27 139.4 28.59 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 30.8 m-85 -126.76 145.85 50.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.792 -1.193 . . . . 0.0 112.98 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 71' ' ' ASN . 10.5 m-20 -126.52 117.52 23.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.274 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.507 HG21 ' N ' ' A' ' 70' ' ' LYS . 14.9 m -87.29 -45.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.63 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.507 ' N ' HG21 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.38 -8.39 46.11 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.1 m120 -118.94 -24.69 6.49 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.695 -0.628 . . . . 0.0 110.147 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.1 m-20 68.45 15.71 9.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.958 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.587 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 5.6 mtp180 -113.82 129.43 56.59 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.566 -0.709 . . . . 0.0 109.788 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.702 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -113.79 130.91 56.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.484 -0.76 . . . . 0.0 110.316 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.521 HG23 ' CB ' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -111.39 148.04 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 3.0 t -120.31 132.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 109.22 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.601 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 82.5 m-20 -66.17 141.01 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 110.555 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 99.56 137.39 9.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.563 ' CB ' HD12 ' A' ' 32' ' ' ILE . 86.5 p -96.5 116.04 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.107 -1.231 . . . . 0.0 110.639 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.632 ' CE1' ' HB ' ' A' ' 34' ' ' THR . 3.1 p-80 -143.26 127.47 17.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.274 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.552 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -73.64 151.62 40.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.986 -1.071 . . . . 0.0 109.737 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.06 -44.59 64.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 110.208 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.56 -33.3 75.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.835 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -36.6 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.582 -0.699 . . . . 0.0 111.084 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 7.9 mp -59.22 -44.84 92.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.16 -0.963 . . . . 0.0 110.725 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.02 -36.42 83.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.037 -1.039 . . . . 0.0 109.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.2 t0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.475 -0.766 . . . . 0.0 111.426 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 tt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.261 0.553 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.62 133.82 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.239 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.05 147.18 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.099 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.525 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.22 137.17 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 110.3 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 25' ' ' VAL . 4.3 p -97.03 135.33 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.603 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.517 0.675 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HB3' HD13 ' A' ' 75' ' ' ILE . 7.7 mtmt -112.66 134.01 54.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.1 m -97.24 120.23 37.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 35' ' ' VAL . 3.2 m -101.53 118.78 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.609 ' CG2' ' O ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -95.22 111.95 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 ' CG2' ' HE2' ' A' ' 24' ' ' LYS . 13.9 t -101.1 -44.13 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.876 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -92.2 4.61 52.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.94 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.609 ' CB ' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.15 -33.38 75.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.0 110.242 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.42 -38.39 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -47.14 81.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.184 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.53 -48.32 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 50' ' ' PRO . . . -56.65 -34.93 67.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.72 -48.76 78.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.6 66.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.666 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 6.7 tt -85.34 -9.38 57.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 83.67 -35.72 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.706 -0.621 . . . . 0.0 110.621 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' H ' HD22 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -92.62 154.16 42.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.224 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.533 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.3 Cg_endo -73.18 150.57 47.89 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.021 1.537 . . . . 0.0 110.365 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 46.6 Cg_endo -73.24 -22.4 19.04 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.043 1.549 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.485 ' C ' ' OG1' ' A' ' 54' ' ' THR . 6.5 p -66.12 -21.66 66.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.497 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -79.79 -56.63 0.75 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.786 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 49' ' ' PRO . 46.3 Cg_endo -73.4 2.41 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.907 1.477 . . . . 0.0 111.054 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.51 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.44 -28.78 61.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.002 -1.062 . . . . 0.0 110.231 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -72.87 -45.56 57.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -0.923 . . . . 0.0 110.523 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.04 -51.18 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 110.414 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -44.01 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.887 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.06 -35.1 86.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -37.36 70.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -49.47 58.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.196 -0.94 . . . . 0.0 110.581 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -77.88 9.06 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 0.0 111.121 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.01 4.52 42.44 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -115.06 163.75 15.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -1.143 . . . . 0.0 109.129 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.501 ' C ' ' CG2' ' A' ' 65' ' ' THR . 7.5 pm0 -110.09 -120.78 0.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.582 -1.324 . . . . 0.0 109.964 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.5 p -149.4 170.53 18.34 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.447 -0.783 . . . . 0.0 110.966 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.538 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -143.82 139.53 29.37 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.695 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 18.4 m-85 -126.59 142.03 51.67 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.862 -1.135 . . . . 0.0 112.803 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 42.9 m-20 -121.33 117.47 27.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.083 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.09 -63.58 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -16.73 6.52 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.16 -0.962 . . . . 0.0 108.592 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.95 -29.88 10.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.656 -0.652 . . . . 0.0 110.051 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.5 m-20 69.66 15.48 8.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 109.986 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 2.6 ttm180 -113.89 129.86 56.55 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.669 -0.644 . . . . 0.0 109.581 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.695 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.5 m-30 -113.0 134.53 54.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -129.44 148.77 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.816 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.566 ' N ' ' CD1' ' A' ' 75' ' ' ILE . 25.5 t -113.6 138.0 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -0.985 . . . . 0.0 109.864 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 21.6 m-20 -59.88 141.08 56.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.855 . . . . 0.0 110.905 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.55 157.76 33.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.537 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 91.8 p -101.81 122.13 43.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.143 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -142.03 114.93 8.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HG2' ' CB ' ' A' ' 84' ' ' LYS . 2.2 pm0 -84.19 151.82 24.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.811 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' GLN . . . -52.46 -39.36 61.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.599 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 1.4 t-20 -64.54 -34.04 77.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 110.709 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.582 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -72.95 -48.27 38.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.635 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -0.957 . . . . 0.0 110.253 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.3 mt-30 -58.93 -36.99 75.67 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 1.1 m-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.426 0.631 . . . . 0.0 109.618 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 39' ' ' MET . 3.5 tm? . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.222 0.534 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.76 121.83 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.343 -0.848 . . . . 0.0 109.964 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.78 46.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.235 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.509 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.1 136.45 52.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.3 m -93.95 135.09 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.172 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.8 mm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -129.44 142.84 50.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.282 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.591 ' CG2' ' NE2' ' A' ' 80' ' ' HIS . 20.9 m -98.34 128.87 44.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.509 ' CG2' ' CB ' ' A' ' 24' ' ' LYS . 3.2 m -101.43 127.69 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 0.7 OUTLIER -93.82 121.12 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.914 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.84 -46.96 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 111.26 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.99 18.5 14.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.989 -1.069 . . . . 0.0 111.17 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.58 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.16 -45.26 89.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 110.236 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 23.5 m -70.28 -39.09 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -62.08 -48.9 78.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.459 ' O ' HD21 ' A' ' 46' ' ' LEU . 95.0 t -66.75 -48.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.498 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -63.72 -35.03 79.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -62.78 -36.48 83.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.22 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.895 . . . . 0.0 110.232 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 47' ' ' ASN . 3.2 pp -105.91 -1.24 24.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.8 OUTLIER 173.41 -151.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 110.243 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 8.4 mtt85 -89.31 174.95 4.34 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.6 Cg_endo -72.81 131.8 17.62 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.932 1.49 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 46.5 Cg_endo -73.72 1.25 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.547 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.598 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 88.1 m -56.46 -21.83 28.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 110.267 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -97.71 -54.9 0.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 111.277 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 52' ' ' TYR . 47.4 Cg_endo -74.99 -2.76 12.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.663 1.349 . . . . 0.0 111.151 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.506 ' OG1' ' CG2' ' A' ' 65' ' ' THR . 1.2 t -57.89 -14.41 6.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.298 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -72.77 -45.59 57.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.436 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -65.2 -51.17 62.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.026 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE1' HD23 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.36 -37.07 72.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 109.33 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -63.55 -35.21 91.73 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -37.15 70.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.2 . . . . 0.0 109.753 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 3.8 tp10 -64.5 -49.36 71.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -81.1 11.57 4.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.15 -0.969 . . . . 0.0 110.985 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.95 4.57 42.27 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . . . -116.11 163.15 16.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.145 -1.209 . . . . 0.0 109.257 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.522 ' C ' ' CG2' ' A' ' 65' ' ' THR . 2.2 tt0 -119.04 -123.33 0.29 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 0.0 109.813 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.9 p -149.98 170.63 18.4 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.641 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -149.59 139.48 21.91 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.714 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 23.8 m-85 -126.86 146.15 50.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.249 . . . . 0.0 113.024 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 3.6 t0 -121.34 117.45 26.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.922 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.14 -63.08 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.876 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -56.64 -15.22 4.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.139 -0.976 . . . . 0.0 108.957 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.628 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.8 t30 -106.0 -29.07 10.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.743 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 70.62 16.89 6.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.55 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -113.76 129.81 56.53 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.714 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.7 m-30 -111.16 129.03 56.07 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.752 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' CG2' ' HG2' ' A' ' 33' ' ' LYS . 13.8 mm -130.77 149.28 33.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 12.3 m -112.78 139.44 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 109.729 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.592 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 6.8 p-10 -69.32 137.0 52.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.258 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 108.1 129.61 6.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.486 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 63.1 p -92.07 121.77 33.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.005 -1.291 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.609 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 2.2 p-80 -142.02 114.86 8.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.416 -0.803 . . . . 0.0 110.04 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -58.72 157.13 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.067 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.555 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.11 -36.96 52.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 0.8 OUTLIER -55.91 -33.53 64.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.877 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -63.31 -39.52 94.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.551 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 85' ' ' LEU . 3.5 mm? -60.36 -32.99 71.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.24 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.477 ' CA ' ' OE1' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -62.74 -37.04 85.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 109.772 179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.497 ' HA ' HG11 ' A' ' 42' ' ' VAL . 9.3 tp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.291 0.567 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 mm -132.59 129.63 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB1' ' N ' ' A' ' 82' ' ' ALA . . . -125.86 149.24 48.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HB3' HG11 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -116.15 138.45 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 3.3 m -92.95 131.51 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 0.0 110.395 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.034 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.538 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' GLU . 3.6 ttpt -129.49 152.6 48.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.932 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.638 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -111.21 128.49 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 24' ' ' LYS . 2.2 p -117.8 117.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.517 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 1.6 mt -96.07 112.95 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.07 -14.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 110.417 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 31.1 m120 -111.01 11.38 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.546 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 1.2 ttt -61.74 -45.41 94.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 36.6 t -70.24 -47.62 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.68 -50.01 70.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.897 . . . . 0.0 110.534 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 21' ' ' LEU . 43.0 t -68.36 -45.33 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.464 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.13 -39.06 86.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -67.52 -41.14 84.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.47 -17.88 62.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 3.9 tt -117.48 -9.11 10.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 110.522 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER 167.68 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.34 170.47 10.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.61 135.21 19.55 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.876 1.461 . . . . 0.0 110.538 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.444 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 50.5 Cg_endo -78.18 20.33 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.995 1.524 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.59 -21.93 30.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.311 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -85.54 -58.54 0.33 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.0 110.877 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.8 Cg_endo -73.16 0.3 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.798 1.42 . . . . 0.0 110.943 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -56.52 -20.92 22.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.217 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.81 -39.97 66.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.958 . . . . 0.0 110.584 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.5 t80 -58.87 -51.18 71.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.309 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 32.3 m-85 -57.53 -43.37 84.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.6 -35.38 85.59 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 86.9 m -57.1 -37.24 71.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 110.028 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -66.19 -49.35 67.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 110.83 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -80.17 11.56 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 4.89 26.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 77' ' ' ASN . . . -116.47 163.77 15.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' C ' ' CG2' ' A' ' 65' ' ' THR . 3.3 mm100 -105.45 -120.44 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.598 -1.314 . . . . 0.0 109.754 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.52 170.24 19.07 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 75' ' ' ILE . 6.1 tt0 -143.47 139.33 29.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.3 m-85 -126.81 141.12 51.91 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.808 -1.182 . . . . 0.0 112.71 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -122.24 117.46 26.22 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.059 178.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -85.89 -63.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.656 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.3 ttmt -55.23 -17.49 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 108.872 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -105.4 -29.35 10.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.561 -0.712 . . . . 0.0 110.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.8 m-20 70.77 16.54 6.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 99.6 mtt180 -113.68 129.64 56.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.567 -0.708 . . . . 0.0 109.629 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.686 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.1 m-30 -113.29 137.94 50.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 110.337 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 34' ' ' THR . 44.3 mt -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 14.5 t -114.04 137.73 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 63' ' ' ALA . 67.9 m-80 -57.9 142.22 46.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 110.534 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 84.65 152.5 16.44 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.564 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 45.4 p -99.67 115.98 30.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.256 . . . . 0.0 110.687 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.638 ' CE1' ' HB ' ' A' ' 34' ' ' THR . 5.0 p-80 -143.32 117.05 9.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.158 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 3.2 tt0 -65.75 153.83 40.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.618 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' N ' ' HB1' ' A' ' 23' ' ' ALA . . . -52.31 -44.75 65.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.102 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.51 -33.47 76.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.055 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 81' ' ' GLU . 4.0 tttp -61.11 -36.48 79.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.749 -0.594 . . . . 0.0 110.145 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -59.4 -39.44 83.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.0 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -36.48 74.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.962 -1.086 . . . . 0.0 108.305 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.397 0.618 . . . . 0.0 109.938 178.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.18 0.514 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 21' ' ' LEU . 3.2 pt -109.99 120.89 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.13 136.77 54.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.6 mmmm -118.44 137.93 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.8 m -93.31 128.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.338 0.589 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' CD ' HG21 ' A' ' 75' ' ' ILE . 17.6 ttmm -97.58 152.91 18.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 109.29 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.8 m -99.28 115.81 30.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.832 -1.168 . . . . 0.0 110.914 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 ' CA ' HG23 ' A' ' 75' ' ' ILE . 2.2 p -112.36 117.42 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.84 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.53 HD13 ' CE ' ' A' ' 39' ' ' MET . 58.5 mt -95.88 109.75 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.66 -16.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.316 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 22' ' ' ILE . 6.2 p-10 -97.8 2.61 49.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 110.21 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.53 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -55.86 -33.64 64.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.195 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.49 -44.47 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 7.2 t0 -66.17 -48.35 71.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 43' ' ' ALA . 8.1 p -61.15 -41.37 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.525 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -61.35 -35.18 76.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.014 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.4 mmmt -59.41 -37.21 77.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.875 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' CB ' HD21 ' A' ' 46' ' ' LEU . . . -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.952 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.818 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -96.27 -9.05 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.889 . . . . 0.0 109.218 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 74.3 -50.18 0.68 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.634 . . . . 0.0 110.408 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.458 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 20.9 mtt85 -77.04 168.03 31.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.6 140.45 32.79 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.397 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 54' ' ' THR . 47.6 Cg_endo -73.51 -15.62 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.054 1.555 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 67' ' ' PHE . 73.8 p -64.07 -27.05 68.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -75.98 -54.91 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.19 -42.91 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.816 1.429 . . . . 0.0 110.829 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 6.9 t -56.36 -15.75 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 110.386 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -72.25 -45.36 60.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.349 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.66 79.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.6 -42.09 82.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.008 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.39 -35.43 85.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -37.12 74.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 110.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.72 -30.09 69.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.265 -0.897 . . . . 0.0 110.987 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -102.26 13.19 35.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.969 -1.082 . . . . 0.0 110.914 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.06 4.89 30.63 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -113.74 164.29 13.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.202 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.504 ' C ' ' CG2' ' A' ' 65' ' ' THR . 6.0 tt0 -109.92 -121.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.626 -1.296 . . . . 0.0 109.608 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.74 170.5 18.58 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.385 -0.822 . . . . 0.0 111.325 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.5 OUTLIER -139.82 139.92 36.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.693 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 21.1 m-85 -126.36 142.75 51.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.59 -1.244 . . . . 0.0 113.138 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 2.3 t0 -121.7 117.19 26.02 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.065 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -89.85 -45.1 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.0 -7.04 43.5 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -119.05 -27.19 5.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.749 -0.594 . . . . 0.0 110.186 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.0 m-20 70.19 16.98 7.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 12.4 mmm-85 -113.53 129.77 56.49 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.671 -0.643 . . . . 0.0 109.491 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.693 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.02 129.39 56.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 110.541 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.53 HG21 ' CD ' ' A' ' 33' ' ' LYS . 12.6 mt -123.22 149.8 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.618 -0.676 . . . . 0.0 109.792 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 75.3 t -112.84 139.19 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.981 -1.074 . . . . 0.0 109.19 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.63 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 35.2 m-80 -65.63 141.63 58.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.862 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 105.24 138.83 9.56 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.475 ' HB3' HD13 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -80.38 131.5 35.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 34' ' ' THR . 93.1 m-70 -141.7 126.34 17.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.645 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 82' ' ' ALA . 3.8 tp10 -100.89 151.07 22.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.583 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -52.1 -43.67 64.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 110.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -58.55 -38.25 77.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.955 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -39.55 78.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 21' ' ' LEU . 21.3 mt -60.4 -40.76 92.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -59.19 -36.36 75.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.918 . . . . 0.0 109.96 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 82' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.249 0.547 . . . . 0.0 110.24 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 23' ' ' ALA . 27.8 mm -121.97 143.82 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 81' ' ' GLU . . . -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.53 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 7.9 mttt -139.41 138.08 36.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 0.0 110.148 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 46.5 t -93.53 122.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.374 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.7 mm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.306 0.574 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.53 141.93 50.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.595 ' CG2' ' NE2' ' A' ' 80' ' ' HIS . 1.4 m -96.88 127.87 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 24' ' ' LYS . 3.5 p -117.04 118.02 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.956 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.529 ' CG2' ' HG2' ' A' ' 39' ' ' MET . 8.1 mt -95.39 138.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.329 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG21 ' NH1' ' A' ' 73' ' ' ARG . 28.8 t -100.31 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.48 12.25 37.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.529 ' HG2' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -53.35 -33.43 53.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -68.83 -38.41 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -50.21 72.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 43' ' ' ALA . 10.1 p -65.84 -40.82 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -64.98 -34.92 79.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.203 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.47 85.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.96 63.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.071 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 10.3 tt -92.57 -3.32 55.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.8 m-20 72.61 -62.41 0.47 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.815 . . . . 0.0 110.364 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 169.86 19.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.48 147.15 45.82 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 47.0 Cg_endo -73.92 -23.4 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.997 1.525 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.648 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 72.5 p -57.85 -21.81 44.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.0 m-30 -80.14 -58.37 0.6 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.893 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.27 -30.94 15.06 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.837 1.44 . . . . 0.0 111.045 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 9.7 t -57.99 -14.01 5.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.993 . . . . 0.0 110.3 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 13.1 tptm -64.25 -45.38 88.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.952 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -64.83 -38.77 92.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.304 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.57 -35.31 85.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -37.32 71.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 3.1 mm-40 -66.68 -49.54 65.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.23 -0.919 . . . . 0.0 110.622 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -79.92 12.87 2.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.189 -0.945 . . . . 0.0 110.961 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.25 9.38 29.48 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -118.74 163.95 16.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -1.122 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.5 ' C ' ' CG2' ' A' ' 65' ' ' THR . 31.4 mt-30 -105.36 -117.29 0.23 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.833 -1.167 . . . . 0.0 110.144 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.0 170.37 18.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 111.081 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.88 139.65 27.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.704 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 24.7 m-85 -126.67 143.46 51.22 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.001 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -123.69 117.37 24.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.969 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 HG21 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -88.11 -45.8 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -70.0 -7.6 42.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -118.32 -25.92 6.43 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.687 -0.633 . . . . 0.0 110.207 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.6 m-20 68.74 16.17 8.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.86 129.79 56.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.525 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.704 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.9 m-30 -112.89 129.2 56.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.524 HG12 ' CG2' ' A' ' 35' ' ' VAL . 52.8 mt -118.57 149.17 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.521 -0.737 . . . . 0.0 109.966 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 34' ' ' THR . 2.2 p -113.15 134.15 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 65.5 m-80 -50.63 143.4 9.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.772 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 94.44 131.28 6.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.524 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 59.4 p -97.3 120.29 37.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -1.152 . . . . 0.0 110.106 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.595 ' NE2' ' CG2' ' A' ' 34' ' ' THR . 1.8 p-80 -142.38 151.52 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.787 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.513 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 4.8 tt0 -93.0 157.69 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.951 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.3 -43.8 64.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.68 -33.47 76.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -37.33 86.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.191 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 85' ' ' LEU . 10.2 mp -60.09 -33.02 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -68.07 -36.22 79.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.846 . . . . 0.0 109.641 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.638 -179.905 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.451 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 5.7 tt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.235 0.54 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.2 mt -112.4 143.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 81' ' ' GLU . . . -125.37 123.98 40.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.898 . . . . 0.0 110.385 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 138.2 53.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 74.6 t -93.11 122.32 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.409 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' CB ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.389 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.547 HD13 ' HB3' ' A' ' 79' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -126.88 152.65 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -0.956 . . . . 0.0 110.502 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 80' ' ' HIS . 1.2 m -108.06 116.24 31.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.133 -0.98 . . . . 0.0 110.373 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG23 ' CB ' ' A' ' 26' ' ' GLU . 48.6 t -104.08 117.46 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.758 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 3.9 mm -96.02 108.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.41 -23.53 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' ND2' ' CG2' ' A' ' 42' ' ' VAL . 46.2 t30 -95.93 8.79 42.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.519 ' HG2' ' CG ' ' A' ' 50' ' ' PRO . 1.9 ttt -64.12 -45.29 89.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 17.9 t -67.24 -40.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -69.19 -45.26 70.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.661 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG2' ' ND2' ' A' ' 38' ' ' ASN . 80.4 t -68.29 -48.73 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 48' ' ' ARG . . . -67.45 -43.96 79.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.393 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 7.8 ttpt -59.54 -36.48 76.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.095 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -71.21 -16.5 62.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.632 ' C ' ' CD1' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -117.39 -11.17 10.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.149 -0.969 . . . . 0.0 110.078 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 13.6 t-20 167.02 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.237 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -137.67 172.07 7.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.08 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HA ' ' HB1' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -72.72 139.51 30.9 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.031 1.543 . . . . 0.0 110.629 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.563 ' CB ' ' HG2' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.76 60.34 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.042 1.548 . . . . 0.0 110.394 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -68.73 -50.53 50.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 111.332 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.733 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 p90 -87.33 -29.0 0.38 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.351 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.3 Cg_endo -71.29 -2.18 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.07 1.037 . . . . 0.0 110.755 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 2.9 p -76.46 -10.99 59.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.106 -0.996 . . . . 0.0 110.372 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -72.94 -45.42 58.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 0.0 110.58 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.53 -47.78 77.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 110.392 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.46 -42.8 83.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.859 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.52 -35.44 85.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -37.21 71.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -1.196 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -48.79 68.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.879 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.566 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -80.72 12.83 2.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.107 -0.995 . . . . 0.0 110.95 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.47 5.44 22.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -116.48 163.93 15.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -1.133 . . . . 0.0 109.213 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' C ' ' CG2' ' A' ' 65' ' ' THR . 19.6 mt-30 -102.87 -119.56 0.19 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.634 -1.292 . . . . 0.0 109.998 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -149.5 170.41 18.67 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 111.005 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.9 mt-30 -146.01 139.47 26.14 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.745 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.69 144.53 50.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.876 -1.14 . . . . 0.0 112.748 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.576 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 1.9 t0 -124.01 117.42 24.69 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.323 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 15.2 m -88.91 -46.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 2.5 tppt? -69.75 -8.73 50.52 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.636 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -117.17 -26.76 6.68 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.677 -0.639 . . . . 0.0 110.124 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 4.7 m-20 69.8 16.53 7.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HG3' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.87 129.66 56.57 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 109.643 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.18 129.18 56.59 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.417 -0.802 . . . . 0.0 110.5 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.535 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 2.3 tt -124.12 148.34 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.487 -0.758 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 11.0 m -114.35 139.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.7 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 70.6 m-20 -55.74 146.36 21.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.5 150.78 21.87 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 2.7 p -103.92 123.92 48.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -1.173 . . . . 0.0 110.202 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.56 ' N ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -142.19 114.84 8.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.569 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 4.9 tt0 -74.74 156.54 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.605 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.7 -44.19 63.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.077 -1.014 . . . . 0.0 109.74 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.09 -33.14 75.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.22 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 81' ' ' GLU . 29.8 mttt -71.35 -36.47 71.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.638 -0.663 . . . . 0.0 110.475 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 81' ' ' GLU . 1.2 mm? -59.37 -44.23 92.77 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.227 -0.921 . . . . 0.0 110.144 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -68.62 -36.12 78.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.948 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 111.297 -179.386 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.222 0.534 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' HG21 ' A' ' 22' ' ' ILE . 3.0 tt -128.5 136.1 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.8 135.44 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 110.23 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.16 137.47 52.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.27 135.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 110.267 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.547 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -98.35 142.14 30.36 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.683 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.491 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 1.9 m -96.97 115.93 28.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.636 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 24' ' ' LYS . 2.4 p -105.14 117.83 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.953 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.486 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 92.0 mt -95.66 112.87 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.52 -4.88 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.187 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.04 -0.29 47.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.275 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.486 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -53.32 -42.41 66.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.133 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.43 -40.4 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.24 -47.81 75.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HD21 ' A' ' 46' ' ' LEU . 84.1 t -62.77 -44.73 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . . . -56.4 -35.06 67.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -36.49 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.95 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.28 78.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.243 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -104.49 0.87 29.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER 73.17 -53.48 0.7 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.664 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.537 ' CB ' HD12 ' A' ' 46' ' ' LEU . 4.5 ttt-85 -76.93 147.83 77.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 47.4 Cg_endo -74.11 147.31 37.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.988 1.52 . . . . 0.0 110.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 48.8 Cg_endo -75.44 7.54 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.078 1.567 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.663 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -63.01 -37.97 89.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 110.421 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -69.85 -52.28 13.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 110.586 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.8 Cg_endo -70.37 -16.25 34.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.81 1.426 . . . . 0.0 110.462 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.517 HG22 ' CG2' ' A' ' 65' ' ' THR . 1.4 m -71.6 -19.42 62.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.104 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -73.0 -44.96 60.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.517 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 70.7 m-85 -66.84 -45.02 79.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.419 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 53' ' ' PRO . 23.4 m-85 -57.36 -43.97 83.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.801 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.44 -35.21 84.33 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 84.7 m -56.83 -37.38 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.25 . . . . 0.0 110.108 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.99 -48.21 66.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.867 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -77.8 10.84 2.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -0.992 . . . . 0.0 111.005 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.85 40.13 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -114.21 163.67 14.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -1.156 . . . . 0.0 109.503 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.7 tt0 -107.78 -118.49 0.26 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.777 -1.202 . . . . 0.0 109.915 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.517 ' CG2' HG22 ' A' ' 54' ' ' THR . 2.6 p -149.32 170.17 19.14 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 111.148 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -144.42 139.18 28.23 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.695 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 20.1 m-85 -127.19 142.48 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.712 -1.242 . . . . 0.0 113.032 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -125.24 117.38 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.908 178.151 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 t -84.78 -64.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -17.16 4.56 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.557 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.6 m-80 -102.12 -31.49 10.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 110.102 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.627 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.3 m-20 70.27 15.59 7.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -113.7 129.8 56.52 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.565 -0.709 . . . . 0.0 109.718 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.695 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.4 m-30 -112.86 129.29 56.51 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.521 HG12 ' CG2' ' A' ' 35' ' ' VAL . 17.8 mt -120.83 149.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 110.285 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 13.4 m -112.96 129.17 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 28.1 m-20 -48.25 144.51 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.884 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 97.71 146.4 20.7 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.547 ' OG ' ' CD1' ' A' ' 32' ' ' ILE . 0.6 OUTLIER -102.04 126.07 48.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -1.027 . . . . 0.0 109.889 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -141.94 156.68 45.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 2.3 tt0 -103.99 148.66 25.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 109.81 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.28 -39.74 60.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 1.6 t30 -64.28 -33.36 75.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -37.5 71.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 81' ' ' GLU . 17.3 mt -63.39 -44.66 94.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 12.3 pt20 -68.24 -36.15 79.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 7.8 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.406 -0.809 . . . . 0.0 110.218 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.502 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 1.8 tm? . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.166 0.507 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.48 ' N ' HD23 ' A' ' 21' ' ' LEU . 28.8 mt -103.25 133.52 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.53 131.08 52.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' HG11 ' A' ' 35' ' ' VAL . 5.2 tttt -116.57 138.21 51.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 79' ' ' SER . 17.9 m -93.24 135.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.468 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.8 mm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.557 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 1.2 tppt? -129.42 152.73 48.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 2.8 t -115.31 125.87 53.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 7.2 p -117.31 117.68 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.3 mp -95.67 143.16 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.52 -39.8 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.561 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -93.68 11.73 27.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.528 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.544 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.18 -45.52 88.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 41' ' ' ASP . 12.8 p -70.38 -43.99 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' N ' HG11 ' A' ' 40' ' ' VAL . 16.0 t0 -69.3 -47.95 63.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.583 ' O ' HD11 ' A' ' 46' ' ' LEU . 4.3 p -61.11 -44.92 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.481 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -68.19 -46.07 71.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.092 -1.005 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 1.3 mtpm? -67.6 -42.6 82.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.852 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 46' ' ' LEU . . . -59.6 -23.25 62.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.821 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.687 HD11 ' N ' ' A' ' 46' ' ' LEU . 6.5 mp -117.6 -9.26 10.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 110.464 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 43' ' ' ALA . 9.6 p30 -173.56 -146.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.783 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 11.8 mtm180 -90.2 175.47 3.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.79 . . . . 0.0 110.618 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 44.3 Cg_endo -70.64 137.07 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.019 1.536 . . . . 0.0 110.455 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.587 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.2 Cg_endo -76.94 0.23 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.114 1.586 . . . . 0.0 110.427 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.546 HG22 ' CE1' ' A' ' 67' ' ' PHE . 6.9 p -56.24 -21.87 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.89 . . . . 0.0 110.43 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -88.87 -57.78 0.27 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 111.006 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -72.73 -16.64 26.5 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.729 1.384 . . . . 0.0 111.052 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 4.9 t -56.37 -16.12 5.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 110.265 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 tptt -72.66 -45.48 58.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -50.04 75.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 110.152 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 m-85 -57.37 -38.55 74.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.913 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.37 -38.61 93.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -37.33 71.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -1.223 . . . . 0.0 109.94 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.78 -49.49 70.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -80.4 11.41 3.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.058 -1.026 . . . . 0.0 110.871 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.16 4.76 30.61 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 77' ' ' ASN . . . -118.8 163.4 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 25.1 mt-30 -105.52 -119.18 0.23 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.741 -1.225 . . . . 0.0 109.961 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.4 170.32 18.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -147.14 139.83 24.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.717 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.59 144.6 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.735 -1.228 . . . . 0.0 112.872 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -121.76 117.31 26.27 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.893 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 5.1 t -85.95 -64.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.564 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -16.51 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.14 -0.975 . . . . 0.0 108.62 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -103.69 -30.08 10.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.627 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.7 m-20 70.21 15.5 7.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.552 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.6 ttp180 -113.71 129.77 56.52 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.629 -0.67 . . . . 0.0 109.568 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.717 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.6 m-30 -112.16 136.89 50.99 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.339 -0.851 . . . . 0.0 110.311 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 3.1 tt -131.18 148.72 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.504 -0.747 . . . . 0.0 110.12 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 t -113.92 139.36 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.134 -0.979 . . . . 0.0 109.748 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.57 ' HB2' ' CB ' ' A' ' 63' ' ' ALA . 25.3 m-20 -55.54 143.94 27.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 91.52 147.03 19.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.457 ' HB2' HG12 ' A' ' 25' ' ' VAL . 72.2 p -89.73 125.33 35.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.117 . . . . 0.0 109.773 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.453 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . 74.8 m-70 -141.79 114.81 8.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -86.68 159.02 19.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.29 -44.6 61.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.882 -1.136 . . . . 0.0 109.311 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.86 -33.44 75.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 108.997 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.8 tptt -68.55 -35.71 77.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.716 -0.615 . . . . 0.0 110.539 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 80' ' ' HIS . 17.5 mt -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.97 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 33.1 tp60 -68.91 -35.98 77.48 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 108.883 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.707 . . . . 0.0 111.339 -179.768 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.257 0.551 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.9 mt -100.61 120.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.29 139.3 47.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.502 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HB2' HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -116.06 126.74 54.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.922 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 38.8 t -93.58 122.1 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.1 mm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.337 0.589 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -97.75 153.02 18.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.871 -1.143 . . . . 0.0 109.5 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.527 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 22.0 m -110.56 115.71 30.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.665 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -110.24 117.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.965 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.563 ' CG2' ' CG ' ' A' ' 39' ' ' MET . 21.3 mt -96.85 122.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.897 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 m -100.6 -8.41 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -116.71 6.99 13.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.021 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.563 ' CG ' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.03 -45.37 89.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 10.8 t -70.35 -42.33 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.461 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -62.22 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.401 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.501 ' O ' HD11 ' A' ' 46' ' ' LEU . 86.9 t -68.36 -44.97 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.467 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.72 -45.62 74.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.642 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -65.84 -36.15 82.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 46' ' ' LEU . . . -62.55 -34.47 77.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 5.5 mp -117.43 -9.17 10.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.951 -1.093 . . . . 0.0 110.917 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' ALA . 7.6 p-10 -162.28 -153.8 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.065 -1.022 . . . . 0.0 110.622 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.4 mtp180 -88.07 175.17 4.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.374 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.4 Cg_endo -72.5 138.23 29.33 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.086 1.572 . . . . 0.0 110.507 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.52 -7.19 17.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.059 1.557 . . . . 0.0 110.654 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.655 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.25 -21.91 26.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 0.0 110.175 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.489 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 6.4 m-85 -88.8 -57.39 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 111.155 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -71.3 -22.66 25.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.802 1.422 . . . . 0.0 111.352 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.497 HG21 ' CA ' ' A' ' 51' ' ' THR . 10.2 t -56.29 -14.4 2.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.101 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -45.43 66.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.398 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.68 -49.08 74.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.551 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 9.6 m-30 -57.3 -34.1 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.47 -41.86 97.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -37.09 70.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.088 -1.242 . . . . 0.0 109.731 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 5.2 mm-40 -63.26 -49.37 74.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.327 -0.858 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -81.65 12.93 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.99 -1.069 . . . . 0.0 110.812 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.73 4.87 28.23 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -121.33 163.48 18.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.183 -1.186 . . . . 0.0 109.397 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.499 ' C ' ' CG2' ' A' ' 65' ' ' THR . 3.7 mp0 -113.1 -120.9 0.3 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.653 -1.279 . . . . 0.0 109.676 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.5 170.26 19.01 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.447 -0.783 . . . . 0.0 111.042 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.589 ' CB ' HG13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.81 139.94 28.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.734 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 25.8 m-85 -126.09 144.19 50.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.688 -1.258 . . . . 0.0 113.055 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -126.08 117.37 23.04 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.11 178.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.01 -64.06 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.534 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -18.21 7.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -101.46 -31.57 10.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.654 -0.654 . . . . 0.0 110.073 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.4 m-20 70.79 15.52 6.87 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.2 -0.938 . . . . 0.0 110.357 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.558 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 25.5 ttm180 -113.64 129.54 56.55 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.734 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.0 m-30 -113.74 136.0 53.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.283 -0.886 . . . . 0.0 109.893 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -129.02 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.205 -0.934 . . . . 0.0 110.61 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 51.2 t -114.41 122.94 69.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 64.1 m-20 -50.02 142.69 8.98 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.6 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.96 140.0 9.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.545 ' HB3' HD12 ' A' ' 32' ' ' ILE . 95.6 p -99.09 123.93 43.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.863 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -142.09 134.83 28.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.574 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 4.0 tt0 -85.32 158.94 20.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 109.418 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.24 -44.01 61.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.79 -33.08 75.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.166 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.486 ' CE ' ' HB3' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -59.11 -35.79 74.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.669 -0.644 . . . . 0.0 110.324 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.518 ' N ' HD21 ' A' ' 85' ' ' LEU . 3.6 mm? -58.82 -38.78 79.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.924 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -68.57 -47.69 66.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.324 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.339 179.137 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.661 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.549 0.69 . . . . 0.0 110.649 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 19.9 mt -105.01 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 110.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.66 152.32 45.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 11.1 tttm -116.11 128.39 55.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 25' ' ' VAL . 15.5 m -105.59 135.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 35.5 tt0 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.539 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 2.1 mm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.327 0.584 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HE2' ' OE1' ' A' ' 26' ' ' GLU . 22.1 pttm -129.62 152.52 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.475 ' HB ' HG21 ' A' ' 76' ' ' VAL . 7.9 m -112.74 128.38 56.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 24' ' ' LYS . 4.0 m -109.82 132.29 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.542 HG21 ' CB ' ' A' ' 39' ' ' MET . 1.0 OUTLIER -80.56 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.57 -46.56 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.64 -1.04 12.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.776 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.542 ' CB ' HG21 ' A' ' 36' ' ' ILE . 2.7 tmm? -60.38 -33.54 72.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.089 -1.007 . . . . 0.0 110.036 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.84 -42.84 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.078 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -49.77 74.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.04 -40.73 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.056 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 50' ' ' PRO . . . -62.81 -35.0 78.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.82 -40.37 79.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -15.9 62.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.041 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 8.0 tt -82.56 1.02 40.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.847 . . . . 0.0 110.176 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.6 t30 71.57 -61.95 0.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 154.11 82.35 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.234 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.5 Cg_endo -72.72 141.59 34.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.002 1.527 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HG3' ' CB ' ' A' ' 43' ' ' ALA . 47.9 Cg_endo -73.55 -24.96 15.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.997 1.525 . . . . 0.0 110.393 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 33.2 p -56.44 -21.75 27.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.381 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -86.55 -57.46 0.33 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 111.141 -179.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.4 Cg_endo -70.83 -27.42 21.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.745 1.392 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.504 HG22 ' CA ' ' A' ' 51' ' ' THR . 15.2 t -56.72 -15.12 4.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.459 ' N ' HG21 ' A' ' 54' ' ' THR . 3.1 mmmt -72.81 -39.33 66.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.214 -0.929 . . . . 0.0 110.46 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -50.84 72.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.445 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 23.9 m-85 -67.53 -31.7 71.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 61' ' ' LEU . . . -59.27 -48.46 85.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 56.3 m -58.97 -46.26 88.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -1.213 . . . . 0.0 110.333 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -70.17 -28.72 65.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.95 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.577 ' CG ' ' HB1' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -91.92 12.99 19.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.932 -179.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.13 12.51 44.35 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 77' ' ' ASN . . . -131.59 163.2 28.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -1.17 . . . . 0.0 109.52 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.55 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -120.16 -125.31 0.27 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.722 -1.236 . . . . 0.0 109.187 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -150.8 170.36 19.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 111.985 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.0 139.53 20.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.68 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 19.3 m-85 -126.69 144.27 50.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.656 -1.278 . . . . 0.0 113.273 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -118.7 117.27 28.46 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.79 -64.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.773 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -15.11 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 108.642 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.622 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.68 -31.28 9.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.662 . . . . 0.0 110.271 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.9 m-20 72.15 15.32 5.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.222 -0.924 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.535 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 26.9 ttp180 -114.04 129.55 56.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.496 -0.752 . . . . 0.0 109.036 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.68 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 5.3 m-30 -108.91 128.93 55.35 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.608 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 10.5 mt -128.51 149.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 75' ' ' ILE . 7.4 m -112.24 139.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.919 -1.113 . . . . 0.0 109.753 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.58 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -68.33 135.88 52.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.2 158.42 22.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.502 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 91.8 p -97.22 123.78 41.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -1.224 . . . . 0.0 110.317 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.576 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -141.83 115.02 8.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 1.2 tt0 -89.92 155.32 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.139 -0.976 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.23 -43.59 64.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.15 -33.59 76.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.611 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.88 -36.98 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.505 -0.747 . . . . 0.0 109.762 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.15 -33.63 72.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.773 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.58 -37.12 79.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.994 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.224 0.535 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.52 40.2 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.205 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.69 -163.99 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.215 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -78.2 163.88 25.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 92.1 t -67.16 -39.87 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 33.3 m-20 54.03 29.01 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 -29.67 66.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.506 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.99 -0.91 43.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 8' ' ' SER . 29.5 m -156.37 150.72 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.248 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.433 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 176.8 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 110.16 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 12' ' ' GLN . 14.5 t0 -67.93 153.35 43.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.169 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -69.47 -21.16 63.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 12' ' ' GLN . 6.4 m-85 57.8 78.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 11.4 p90 -131.34 -28.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.361 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 16.2 tpt85 -178.59 -31.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -100.1 133.52 44.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 110.094 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 16' ' ' TYR . 11.5 mttt -129.48 157.0 43.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.259 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.47 94.53 26.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 110.127 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.57 83.11 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.026 1.54 . . . . 0.0 110.437 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -78.24 157.01 29.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 124.12 29.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.228 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 HD12 ' ND2' ' A' ' 38' ' ' ASN . 36.7 mt -109.74 128.4 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 138.95 51.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' HG13 ' A' ' 35' ' ' VAL . 22.7 mtpp -124.85 136.99 54.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG13 ' HB2' ' A' ' 79' ' ' SER . 62.7 t -96.38 133.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 110.102 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -123.39 167.95 13.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.99 59.19 0.49 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 173.68 11.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.15 . . . . 0.0 110.188 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.11 -124.74 6.55 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -85.2 2.47 43.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . 122.1 15.5 4.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.579 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.2 OUTLIER 168.46 105.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -1.141 . . . . 0.0 109.845 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HE3' HG23 ' A' ' 75' ' ' ILE . 33.1 pttt -128.47 152.66 47.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -97.16 128.55 44.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 75' ' ' ILE . 1.7 p -116.64 117.87 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.533 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 4.5 mt -95.49 110.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.91 -1.37 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' ND2' HD12 ' A' ' 22' ' ' ILE . 41.9 t30 -116.79 -1.18 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.533 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 20.6 ttm -64.3 -45.49 87.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.082 -1.011 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 45.5 t -70.4 -41.37 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.866 . . . . 0.0 110.258 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -62.12 -49.82 74.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.249 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG21 ' N ' ' A' ' 43' ' ' ALA . 6.3 m -68.36 -43.54 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.67 -44.44 77.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -67.68 -36.29 80.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.0 110.42 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -69.37 -25.82 64.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.9 . . . . 0.0 110.811 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 42' ' ' VAL . 2.5 pp -117.42 -9.19 10.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.051 . . . . 0.0 110.69 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ALA . 1.1 t-20 175.43 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -101.65 170.7 6.14 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.103 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.3 Cg_endo -72.57 128.88 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.962 1.506 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' O ' ' OG1' ' A' ' 54' ' ' THR . 48.5 Cg_endo -74.58 48.83 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.912 1.48 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.642 ' CG2' ' CE1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -68.1 -23.94 64.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.56 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -75.49 -54.26 2.4 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.92 . . . . 0.0 110.814 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -71.17 -1.53 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.799 1.421 . . . . 0.0 110.819 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.522 HG23 ' CG2' ' A' ' 65' ' ' THR . 51.6 m -66.44 -21.58 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -42.54 64.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.531 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -49.5 77.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 0.0 110.302 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 5.5 m-30 -57.49 -43.89 84.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.924 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -59.64 -35.2 85.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.94 -37.23 71.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -1.228 . . . . 0.0 110.022 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.04 -47.8 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.651 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.567 HD12 ' CB ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.59 12.72 2.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.171 -0.956 . . . . 0.0 111.009 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 6.49 27.94 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASN . . . -117.65 163.95 15.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.338 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.9 mt-30 -105.4 -119.16 0.22 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.698 -1.252 . . . . 0.0 109.962 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.522 ' CG2' HG23 ' A' ' 54' ' ' THR . 7.7 p -149.42 170.42 18.61 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 111.228 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' ILE . 4.2 tp-100 -144.72 139.47 27.93 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.711 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 18.5 m-85 -126.81 143.97 51.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.743 -1.223 . . . . 0.0 113.066 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 1.7 t0 -124.63 117.28 23.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.778 -0.769 . . . . 0.0 108.982 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 7.7 m -89.13 -45.88 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.144 -0.973 . . . . 0.0 109.57 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.1 -6.84 42.34 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 108.516 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.631 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -118.21 -27.57 6.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.723 -0.611 . . . . 0.0 110.044 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.631 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.1 m-20 70.45 17.03 6.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.275 -0.891 . . . . 0.0 109.877 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -113.57 129.45 56.56 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.793 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.49 132.88 55.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 110.26 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 35' ' ' VAL . 8.8 mm -120.5 148.68 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 21.0 t -114.04 126.04 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 68.5 m-80 -47.22 147.04 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 110.409 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 89.37 144.34 10.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.49 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 68.6 p -105.78 125.23 50.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -1.141 . . . . 0.0 110.136 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -139.51 155.4 47.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.08 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -90.86 156.84 17.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.29 -43.21 64.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 83' ' ' ASN . 1.6 m120 -59.65 -33.51 71.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.33 -39.69 78.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.276 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 88' ' ' MET . 13.7 mt -60.4 -36.19 77.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.541 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 25.3 mt-30 -68.83 -36.22 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 110.134 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.09 -46.66 88.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.901 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.52 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 4.3 ptm -71.4 -48.62 48.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.054 -1.029 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.5 OUTLIER -62.12 -32.95 73.58 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 7.4 t70 -63.88 -36.05 82.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 0.0 109.793 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -33.12 84.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -47.25 76.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -1.072 . . . . 0.0 109.58 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 3.2 mt -65.1 -33.93 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.73 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.648 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 7.8 mttt -55.39 -26.02 38.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.565 -0.709 . . . . 0.0 110.521 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.454 ' CD ' ' HD2' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -60.22 -32.26 70.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 112.144 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.57 ' CE1' HG12 ' A' ' 97' ' ' VAL . 17.2 p90 -115.3 -36.09 4.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.539 -1.35 . . . . 0.0 111.711 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.648 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 17.4 m -55.06 -49.65 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.89 -1.131 . . . . 0.0 110.301 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -73.14 66.48 0.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.769 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -69.54 155.31 93.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.224 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 44.5 Cg_endo -71.56 53.02 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.994 1.523 . . . . 0.0 110.333 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 0.6 OUTLIER 175.81 -29.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.875 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.527 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . 8.3 p -131.78 32.49 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 1.8 tm-20 -74.49 54.21 0.58 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.615 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -164.96 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.21 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.615 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.8 Cg_endo -71.96 149.96 54.08 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.853 1.449 . . . . 0.0 110.222 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -69.21 122.48 18.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.832 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -110.17 165.56 11.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.296 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.12 160.21 19.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.143 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.485 ' HB3' HD12 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -128.86 125.05 36.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' A' ' 110' ' ' HIS . 31.6 p80 -118.43 119.22 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 110.089 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 118' ' ' ILE . 13.7 t -97.55 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.303 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -97.03 127.79 37.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.215 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -29.21 12.29 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.988 1.52 . . . . 0.0 110.4 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.88 89.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 3.4 tptp -97.32 -3.8 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.1 49.53 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.136 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.448 ' O ' HG11 ' A' ' 111' ' ' VAL . 3.0 p -144.59 161.18 39.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.555 ' CG2' ' HB3' ' A' ' 131' ' ' LEU . 19.5 mt -103.37 135.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -102.52 156.98 18.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.536 ' HB2' ' CB ' ' A' ' 131' ' ' LEU . 11.1 t-20 -136.48 121.57 18.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -1.212 . . . . 0.0 109.665 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 22.8 t -126.9 139.06 53.35 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.569 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 102' ' ' CYS . 4.5 t -111.97 133.96 53.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -84.34 43.45 0.95 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.955 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.453 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -130.82 -33.71 1.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.307 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 4.0 t -137.23 1.45 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.67 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 91.08 -12.03 70.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.67 ' C ' ' O ' ' A' ' 126' ' ' GLY . 19.3 t80 -10.97 -64.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.8 -0.824 . . . . 0.0 111.151 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 5.9 ttt180 24.36 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.813 -0.554 . . . . 0.0 110.802 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.34 -114.96 0.84 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.546 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 2.5 mtp -120.89 150.06 41.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.522 -0.987 . . . . 0.0 110.973 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.555 ' HB3' ' CG2' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -114.03 108.53 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 109.839 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 133' ' ' THR . 0.3 OUTLIER -176.81 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 1.2 m 71.59 -54.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -177.93 -178.11 0.67 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.122 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.452 ' O ' ' HE3' ' A' ' 136' ' ' LYS . 2.8 m-70 -52.63 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.0 OUTLIER -139.08 -177.15 4.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.372 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 96' ' ' PHE . 2.5 pt? -42.72 -19.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.803 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.533 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 56.6 m -55.84 -38.9 70.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.361 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.0 m -68.62 -42.2 78.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.195 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 3.5 m-30 -57.21 -48.12 79.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 109.586 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 138' ' ' CYS . 22.6 pt -68.45 -41.34 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.403 -0.811 . . . . 0.0 109.761 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 21.7 tp -52.82 -17.47 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.509 ' HD2' ' ND2' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -70.2 -5.63 28.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.103 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.509 ' ND2' ' HD2' ' A' ' 143' ' ' LYS . 56.9 m-80 -118.17 83.31 19.65 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.147 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 133.04 18.99 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.059 1.558 . . . . 0.0 110.512 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.38 -170.87 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.002 1.527 . . . . 0.0 110.407 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.72 121.46 19.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.13 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -143.89 178.4 7.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.315 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -151.03 -153.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -107.15 12.0 28.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.7 t -176.27 170.79 2.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.26 41.09 5.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.0 p -65.52 94.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 110.237 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 155' ' ' LYS . . . 140.52 128.49 2.45 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 154' ' ' GLY . 2.0 ptpt 178.01 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -1.111 . . . . 0.0 110.36 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.164 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.215 0.531 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -148.4 63.55 1.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.872 . . . . 0.0 110.165 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 3' ' ' VAL . 12.6 t -138.21 9.62 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.173 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.74 133.05 36.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.42 -13.42 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.71 -1.58 58.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -57.19 -16.47 8.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.192 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 67.6 m -95.36 7.34 46.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 8' ' ' SER . 43.4 t 58.8 122.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 2.2 ttm 66.61 131.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -58.61 149.36 26.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.169 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -63.23 -26.41 68.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 46.47 72.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.171 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 15' ' ' ARG . 54.6 p90 -61.34 -43.91 98.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.258 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -158.29 22.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.126 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.449 ' OH ' ' SD ' ' A' ' 18' ' ' MET . 5.0 t80 -121.7 130.04 53.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 110.087 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.45 134.15 43.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.209 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.449 ' SD ' ' OH ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -116.09 105.38 51.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 110.236 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.8 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.962 1.506 . . . . 0.0 110.334 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -106.68 -67.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.7 tp -96.06 123.83 39.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 110.289 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 32.6 mt -107.88 120.32 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 110.076 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.15 135.9 54.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.414 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -117.38 137.96 52.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 31' ' ' GLY . 2.1 t -93.35 122.98 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.227 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.8 tt0 -141.09 163.74 32.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.194 -0.941 . . . . 0.0 110.448 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' HA2' ' A' ' 31' ' ' GLY . . . 156.05 -90.15 0.12 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 30' ' ' ASN . 12.1 ttpt -141.16 139.06 33.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -1.095 . . . . 0.0 109.895 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.04 -81.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -99.95 -18.52 17.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -1.103 . . . . 0.0 110.014 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.546 ' O ' ' CG1' ' A' ' 25' ' ' VAL . . . 78.31 104.04 0.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.621 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -100.59 9.55 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -1.14 . . . . 0.0 110.295 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 26' ' ' GLU . 0.9 OUTLIER -97.52 152.87 18.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 109.142 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.632 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 3.3 m -105.91 120.48 41.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.872 -1.142 . . . . 0.0 110.906 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 21.5 t -108.6 117.87 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.869 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 ' CG2' ' HG3' ' A' ' 39' ' ' MET . 5.2 mt -95.56 113.0 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 37' ' ' VAL . 7.4 p -99.76 -1.24 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.195 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 5.4 t-20 -97.64 -0.96 44.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.237 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' A' ' 36' ' ' ILE . 2.6 mtt -59.74 -43.41 94.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.459 HG21 ' OD1' ' A' ' 41' ' ' ASP . 34.4 m -60.6 -43.2 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' OD1' HG21 ' A' ' 40' ' ' VAL . 16.2 m-20 -66.98 -49.03 66.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.66 -42.73 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 39' ' ' MET . . . -63.27 -34.99 78.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.07 -46.85 87.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.27 -16.19 60.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 9.6 tt -103.27 -2.76 26.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 m-20 66.73 -58.34 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.503 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.14 132.95 69.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.472 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 46.3 Cg_endo -73.41 146.16 39.3 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.459 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' O ' ' HB ' ' A' ' 54' ' ' THR . 46.1 Cg_endo -73.19 -4.72 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.972 1.512 . . . . 0.0 110.499 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -60.53 -21.69 62.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.532 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.42 -58.29 0.8 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.719 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.9 Cg_endo -72.73 -3.13 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.958 1.504 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 51' ' ' THR . 13.9 t -72.97 -17.66 61.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.347 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -72.82 -45.41 58.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.467 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -66.92 -41.43 87.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 5.5 t80 -57.72 -42.06 83.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.49 -35.34 85.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.02 -37.27 79.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.239 . . . . 0.0 110.265 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.27 -28.73 68.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.905 . . . . 0.0 111.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.631 ' CD2' ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -105.42 12.96 30.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.053 -1.029 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 4.87 21.76 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.632 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -116.0 164.02 15.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -1.08 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' C ' ' CG2' ' A' ' 65' ' ' THR . 29.6 mt-30 -112.27 -120.13 0.29 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.71 -1.244 . . . . 0.0 110.245 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -149.49 170.62 18.17 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.414 -0.804 . . . . 0.0 111.158 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -146.68 139.67 25.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.737 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 23.7 m-85 -126.59 144.52 50.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.754 -1.216 . . . . 0.0 112.816 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -120.86 117.37 27.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.968 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.513 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 10.6 m -89.07 -45.13 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.694 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.513 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.64 -5.26 32.3 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.255 -0.903 . . . . 0.0 108.83 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.635 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 m120 -121.14 -24.64 5.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.517 -0.739 . . . . 0.0 110.345 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.635 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 69.55 17.5 7.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.67 129.65 56.53 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 109.436 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.737 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.2 m-30 -113.09 129.19 56.59 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.53 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.531 HG23 ' CB ' ' A' ' 66' ' ' GLN . 1.2 tt -125.29 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.552 -0.718 . . . . 0.0 109.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.541 ' CG1' HG23 ' A' ' 34' ' ' THR . 2.3 p -113.29 136.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.177 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.632 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -61.24 142.04 57.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.345 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 109.7 141.23 9.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 32' ' ' ILE . 51.4 p -97.23 122.36 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -1.15 . . . . 0.0 110.025 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.632 ' ND1' ' OG1' ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.33 158.35 43.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 3.8 tt0 -103.99 158.15 16.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.521 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.09 -43.88 64.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.03 -33.49 76.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.87 -37.17 83.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.213 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.15 -44.46 94.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.89 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -66.99 -36.49 82.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -63.74 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.178 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' A' ' 88' ' ' MET . 0.6 OUTLIER -60.24 -49.0 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' CD2' ' O ' ' A' ' 89' ' ' LEU . 2.1 tt -53.21 -29.94 34.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.3 t0 -63.94 -36.02 82.59 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.414 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -34.01 87.14 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.286 -1.925 . . . . 0.0 108.286 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.53 -40.31 82.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.413 -1.051 . . . . 0.0 109.11 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.67 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 28.0 mm -59.08 -46.77 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 109.637 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.514 ' CG ' ' OE1' ' A' ' 103' ' ' GLU . 7.1 ttmt -67.5 -27.12 66.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.472 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' O ' HD23 ' A' ' 98' ' ' LEU . 2.6 tptt -60.39 -35.93 76.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 111.014 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 25.5 p90 -115.34 -17.23 11.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 0.0 110.593 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.603 HG23 ' CE1' ' A' ' 96' ' ' PHE . 7.8 t -68.25 -60.16 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.045 . . . . 0.0 110.201 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.576 ' N ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? 33.51 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 110.35 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 103' ' ' GLU . 25.5 p -87.54 141.61 32.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.103 -0.998 . . . . 0.0 110.389 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 133' ' ' THR . 47.2 Cg_endo -73.79 50.62 2.13 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.056 1.556 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 1.3 tp10 -159.22 -36.73 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.971 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 3.4 p 175.01 62.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.546 ' N ' ' SG ' ' A' ' 99' ' ' CYS . 1.3 pp20? -74.61 -33.21 62.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.307 -0.871 . . . . 0.0 109.815 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.55 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.2 t-20 -29.09 -56.12 0.27 Allowed Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.986 -0.446 . . . . 0.0 110.776 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 43.0 Cg_endo -69.05 149.72 71.7 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.785 1.413 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.455 ' OE2' ' HB3' ' A' ' 90' ' ' ASP . 4.4 tp10 -69.46 131.61 45.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.029 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.463 HG23 ' SG ' ' A' ' 122' ' ' CYS . 1.5 p -125.19 165.3 18.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -114.09 148.81 36.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.92 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 109' ' ' LEU . 2.9 pp -123.95 120.2 31.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.542 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 9.7 p80 -124.01 125.73 45.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 111' ' ' VAL . 6.4 p -96.9 129.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -98.54 122.62 52.89 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 110.217 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.33 -31.44 9.21 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.994 1.523 . . . . 0.0 110.45 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -63.45 -37.62 87.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.286 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -106.59 -3.7 20.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.495 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER 52.5 43.9 30.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.473 ' HA ' HD11 ' A' ' 142' ' ' LEU . 0.2 OUTLIER -133.07 149.29 52.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.159 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.46 HG12 HD12 ' A' ' 142' ' ' LEU . 24.2 mm -92.68 126.21 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -117.24 148.25 18.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 28.9 t-20 -144.17 152.71 41.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.165 -1.197 . . . . 0.0 109.427 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.716 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -116.92 123.73 47.7 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.767 -1.208 . . . . 0.0 110.382 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.463 ' SG ' HG23 ' A' ' 107' ' ' THR . 0.1 OUTLIER -95.37 119.25 33.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.05 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -45.95 -36.16 5.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -73.6 -0.76 16.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.545 ' O ' ' C ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER 71.23 1.19 3.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.229 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.87 -70.63 0.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' A' ' 128' ' ' ARG . 5.7 p90 -122.17 -31.57 3.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -1.123 . . . . 0.0 110.359 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.716 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 29.48 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.889 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.38 -66.22 0.31 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.142 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.501 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.12 149.16 42.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -1.219 . . . . 0.0 110.999 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 120' ' ' ASN . 14.5 tp -113.64 107.48 15.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.809 . . . . 0.0 109.671 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 133' ' ' THR . 7.9 m-20 -107.25 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.543 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 1.5 m 69.87 -139.45 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.0 110.043 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' LYS . 37.8 m80 -121.96 178.6 4.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -42.72 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.107 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' HIS . 50.4 mmtt -136.63 -177.45 4.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.888 . . . . 0.0 110.345 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.552 HD22 ' CD1' ' A' ' 96' ' ' PHE . 2.7 pp -63.09 -6.11 3.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.538 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.513 ' O ' HG12 ' A' ' 141' ' ' ILE . 69.2 m -56.02 -43.4 77.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -42.25 77.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 110.018 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -47.87 79.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.639 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.528 HG13 ' N ' ' A' ' 142' ' ' LEU . 25.5 pt -68.35 -42.06 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.528 ' N ' HG13 ' A' ' 141' ' ' ILE . 12.9 tp -53.41 -28.99 32.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 1.3 tttt -85.03 -3.55 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.316 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.493 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 17.9 m-20 63.18 167.14 0.1 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.0 Cg_endo -72.33 174.63 11.21 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.919 1.484 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 145' ' ' PRO . 45.7 Cg_endo -72.45 116.35 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.969 1.51 . . . . 0.0 110.548 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -150.21 23.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.117 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 149' ' ' SER . 15.0 m-20 -63.6 -10.37 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.92 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 148' ' ' ASN . 1.0 OUTLIER 66.97 -59.75 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.274 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 148' ' ' ASN . 24.1 m-20 -69.22 171.12 8.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.208 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 t -103.98 127.92 51.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -105.82 -28.44 5.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -20.06 61.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -1.15 . . . . 0.0 110.174 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.03 -90.24 1.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mttm 52.77 -170.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 0.0 110.23 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.211 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 1' ' ' LEU . 19.9 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.202 0.525 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -92.71 16.63 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.46 133.36 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.18 156.73 38.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -52.03 -21.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.5 t30 54.79 26.24 7.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.08 -12.25 18.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 9' ' ' VAL . 2.7 t -82.85 8.04 13.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.481 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -42.61 -94.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.336 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 65.48 -179.27 0.19 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.01 . . . . 0.0 110.26 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 2.9 m-20 -82.48 143.01 31.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 -33.06 23.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 2.6 t80 -172.17 -68.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 1.5 t80 178.02 80.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -106.68 -16.91 14.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -129.28 151.04 50.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.385 -0.822 . . . . 0.0 110.311 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.509 ' NZ ' ' HG2' ' A' ' 86' ' ' GLN . 1.8 ttpt -112.74 130.7 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -138.31 103.93 7.92 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.498 ' HG3' ' NE2' ' A' ' 86' ' ' GLN . 48.3 Cg_endo -74.96 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.981 1.516 . . . . 0.0 110.276 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -149.13 20.43 0.97 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.188 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 2.0 tm? -89.2 122.46 32.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' N ' HD23 ' A' ' 21' ' ' LEU . 13.2 mm -100.74 136.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.61 141.2 52.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -124.19 138.08 54.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.998 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 79' ' ' SER . 3.3 p -93.26 134.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.85 159.56 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.209 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.65 68.62 0.47 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 30' ' ' ASN . 2.7 tttt -145.77 155.74 43.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.322 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.77 -81.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 28' ' ' LYS . 1.8 t30 -89.69 -15.28 32.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.153 . . . . 0.0 110.264 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 32' ' ' ILE . . . 84.86 -5.79 81.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.523 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.7 mm -153.67 88.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.141 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.43 ' HD2' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -129.52 152.49 49.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.986 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.533 HG22 ' NE2' ' A' ' 80' ' ' HIS . 1.3 m -108.95 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 110.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 24' ' ' LYS . 3.0 p -102.85 117.73 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 3.3 mt -95.55 112.48 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.8 m -89.4 -21.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.222 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -91.79 11.46 24.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.515 ' CE ' ' HG2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -59.98 -45.19 93.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.093 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 41' ' ' ASP . 14.5 m -67.43 -42.31 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' N ' ' CG2' ' A' ' 40' ' ' VAL . 3.6 m-20 -64.96 -50.11 67.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.74 -43.66 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.95 75.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.21 93.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.48 -22.6 60.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.704 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -102.43 2.92 37.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.426 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 4.3 m120 65.43 -64.55 0.18 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.35 -0.843 . . . . 0.0 110.237 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -77.23 122.66 86.53 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.7 Cg_endo -73.06 144.84 38.54 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.974 1.512 . . . . 0.0 110.41 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' HG2' ' CE ' ' A' ' 39' ' ' MET . 46.3 Cg_endo -72.99 -0.15 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.013 1.533 . . . . 0.0 110.22 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.497 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -57.21 -21.48 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.542 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.6 m-85 -82.1 -58.87 0.44 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.118 -0.988 . . . . 0.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 48.8 Cg_endo -74.76 -0.22 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.884 1.465 . . . . 0.0 111.049 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.495 ' HB ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -61.28 -23.51 65.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.03 -1.044 . . . . 0.0 110.376 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -42.09 64.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.982 . . . . 0.0 110.598 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.8 t80 -58.76 -51.29 70.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.246 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 15.5 m-30 -57.68 -43.26 84.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -61.22 -35.09 90.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -56.7 -37.26 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.257 . . . . 0.0 109.998 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' CG ' ' SD ' ' A' ' 88' ' ' MET . 13.4 mm-40 -65.07 -47.59 76.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.739 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -83.07 12.92 4.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.162 -0.961 . . . . 0.0 110.91 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 4.87 26.93 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 77' ' ' ASN . . . -114.41 163.67 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.158 . . . . 0.0 109.397 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' C ' ' CG2' ' A' ' 65' ' ' THR . 12.5 tt0 -107.95 -119.07 0.26 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.958 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.25 170.23 18.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.535 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.48 139.34 28.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.705 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 19.0 m-85 -126.83 143.77 51.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.864 -1.148 . . . . 0.0 112.844 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -122.99 117.47 25.55 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.731 -0.787 . . . . 0.0 108.943 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.48 -64.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.64 -17.52 5.85 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.184 -0.948 . . . . 0.0 108.682 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.613 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -103.92 -31.4 9.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.637 -0.665 . . . . 0.0 110.153 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.613 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.8 m-20 71.72 16.47 5.69 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -0.862 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.569 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.46 129.49 56.53 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.618 -0.676 . . . . 0.0 109.713 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.705 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.45 137.73 51.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 66' ' ' GLN . 10.8 tt -131.66 148.56 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 109.792 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 ' CG2' HG21 ' A' ' 34' ' ' THR . 3.6 m -114.21 137.84 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.094 -1.004 . . . . 0.0 109.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.572 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 98.4 m-20 -59.01 143.08 49.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.15 147.59 22.02 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 35.3 p -107.37 121.09 43.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -1.178 . . . . 0.0 110.462 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.21 167.23 22.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 110.004 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt-10 -101.25 158.14 16.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.937 . . . . 0.0 110.119 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 21' ' ' LEU . . . -52.85 -44.52 66.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.61 -34.98 79.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 109.845 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -59.41 -37.35 77.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 110.439 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 3.2 mp -61.79 -44.95 95.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.509 ' HG2' ' NZ ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -69.13 -45.5 69.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.229 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -64.65 -36.04 82.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.619 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.521 ' SD ' ' CG ' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -57.9 -49.61 76.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.076 -1.015 . . . . 0.0 110.379 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.72 -30.08 42.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.2 t0 -64.05 -35.99 82.53 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.253 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.48 ' O ' ' HG2' ' A' ' 95' ' ' LYS . . . -61.84 -48.14 85.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -56.09 -50.34 71.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.927 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.556 ' CG2' HG11 ' A' ' 97' ' ' VAL . 40.7 mm -65.26 -50.12 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.324 -0.86 . . . . 0.0 110.225 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.7 -27.09 66.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.423 -0.798 . . . . 0.0 110.865 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 1.4 mmpt? -60.6 -37.44 81.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 111.542 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.611 ' CE1' ' CG1' ' A' ' 97' ' ' VAL . 16.9 p90 -115.39 -18.58 10.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.75 -1.218 . . . . 0.0 111.359 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.611 ' CG1' ' CE1' ' A' ' 96' ' ' PHE . 4.7 m -85.2 -1.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.821 -1.174 . . . . 0.0 110.342 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.549 ' CD1' ' HG3' ' A' ' 103' ' ' GLU . 1.7 tp -40.33 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.897 . . . . 0.0 110.227 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 97' ' ' VAL . 41.2 t -84.75 139.91 37.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 101' ' ' GLU . 46.3 Cg_endo -73.75 50.62 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.044 1.55 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 9.1 tt0 173.06 -28.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 84.2 m -150.64 46.55 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.549 ' HG3' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -67.35 -30.89 70.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 110.005 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.5 m-20 -50.56 -59.17 7.83 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.0 Cg_endo -70.81 150.15 61.33 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.117 1.588 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -68.99 127.43 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.056 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.505 ' CG2' ' SG ' ' A' ' 122' ' ' CYS . 4.1 p -110.15 165.98 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 110.258 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.8 p30 -114.04 146.55 40.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.014 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 1.1 pp -107.79 122.51 46.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 110.366 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -109.25 119.59 39.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.079 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.513 HG11 ' CD1' ' A' ' 118' ' ' ILE . 4.4 m -96.75 125.06 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.923 . . . . 0.0 110.278 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.506 ' HB2' ' CG ' ' A' ' 115' ' ' LYS . 20.8 m120 -96.32 123.64 54.03 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.098 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.14 -36.28 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.952 1.501 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' HD2' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -59.63 -34.7 73.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 7.7 ptpt -110.87 -3.94 15.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.614 ' HG3' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER 51.99 37.95 22.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.521 -0.737 . . . . 0.0 110.541 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 130' ' ' MET . 0.2 OUTLIER -121.78 162.03 21.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.293 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.528 ' CB ' ' HB3' ' A' ' 138' ' ' CYS . 11.1 mm -101.2 135.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -115.2 163.8 12.18 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.553 ' HB2' ' CB ' ' A' ' 131' ' ' LEU . 2.3 t-20 -141.86 121.77 13.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.172 . . . . 0.0 109.785 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.629 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 43.2 t -124.45 127.24 47.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.505 ' SG ' ' CG2' ' A' ' 107' ' ' THR . 2.5 t -104.87 112.31 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.17 -12.71 9.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.04 97.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.853 . . . . 0.0 110.404 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 1.3 m -128.46 -11.47 5.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.669 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.658 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 101.05 -12.23 58.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.658 ' C ' ' O ' ' A' ' 126' ' ' GLY . 25.3 t80 -10.9 -63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.781 -0.835 . . . . 0.0 111.184 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.629 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 7.5 ttt-85 36.03 89.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -154.03 -112.25 0.46 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.482 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.67 151.77 39.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.464 -1.021 . . . . 0.0 110.734 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.581 ' O ' ' CB ' ' A' ' 132' ' ' ASP . 2.3 tt -103.09 139.51 38.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 131' ' ' LEU . 4.0 p30 160.76 115.93 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.435 -0.791 . . . . 0.0 109.72 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 98' ' ' LEU . 85.9 m -128.46 -66.45 0.84 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.285 0.564 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 135' ' ' HIS . 45.8 m170 -111.94 143.24 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.314 -0.866 . . . . 0.0 110.087 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 134' ' ' HIS . 19.7 m170 42.4 -135.43 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.981 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -135.68 81.69 1.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 96' ' ' PHE . 2.1 pp -82.55 -24.36 34.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.106 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.528 ' HB3' ' CB ' ' A' ' 118' ' ' ILE . 34.4 m -62.65 -40.33 96.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 110.367 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.3 m -64.49 -41.54 96.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -48.72 80.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.048 -1.032 . . . . 0.0 109.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.508 HG13 ' N ' ' A' ' 142' ' ' LEU . 26.2 pt -69.33 -42.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.552 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.508 ' N ' HG13 ' A' ' 141' ' ' ILE . 4.8 tp -53.54 -31.72 47.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 144' ' ' ASN . 14.8 mtmt -70.3 -36.42 74.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 0.7 OUTLIER 61.03 141.23 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 110.51 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.048 1.552 . . . . 0.0 110.505 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 46.7 Cg_endo -73.47 -42.79 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.02 1.537 . . . . 0.0 110.416 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 146' ' ' PRO . 51.1 mt-10 55.86 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 146' ' ' PRO . 6.6 m120 -144.84 122.1 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.59 70.16 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.223 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.93 60.51 1.28 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.91 62.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 61.32 95.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -51.4 68.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -1.141 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.15 -43.8 1.64 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -68.38 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -1.154 . . . . 0.0 110.136 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.1 mttm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.285 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 p -94.17 164.58 12.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.2 p -159.39 66.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.276 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -81.47 128.39 33.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.38 -19.33 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.4 154.21 24.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.7 tpt85 -67.82 -35.89 79.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.178 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 10' ' ' MET . 8.6 t -72.99 -13.46 61.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.202 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 10' ' ' MET . 46.4 t 55.1 -87.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.299 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.509 ' N ' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -43.44 -90.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 56.7 t0 -99.83 147.63 25.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 110.212 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 10.3 mp0 -70.3 -29.6 66.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.219 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 11' ' ' ASP . 2.8 m-30 57.64 83.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 5.3 p90 -177.82 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.353 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -84.11 -50.36 8.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.565 ' OH ' ' CE1' ' A' ' 13' ' ' PHE . 15.5 p90 -100.18 137.17 38.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.94 129.68 38.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 110.201 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.23 152.68 76.41 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -73.1 -45.38 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.007 1.53 . . . . 0.0 110.378 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HG2' ' NE2' ' A' ' 86' ' ' GLN . 1.4 ttt180 42.85 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.185 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 3.1 tm? -82.05 124.97 30.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -97.34 125.1 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.893 . . . . 0.0 110.175 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.7 138.08 47.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.522 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 0.1 OUTLIER -116.67 137.97 51.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 4.4 p -96.33 125.1 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.24 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 8.1 tt0 -140.96 161.37 37.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.15 -92.96 0.11 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -152.23 138.99 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.131 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.24 -81.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -99.83 -18.61 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -1.171 . . . . 0.0 110.207 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 25' ' ' VAL . . . 66.35 98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.61 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -106.13 9.74 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.217 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 26' ' ' GLU . 3.7 ttpt -97.62 153.08 18.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.551 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 1.2 m -98.63 118.37 35.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.942 -1.099 . . . . 0.0 110.507 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.536 ' CA ' HG23 ' A' ' 75' ' ' ILE . 2.3 p -107.76 117.4 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.093 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.567 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 4.5 tp -96.05 119.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.4 t -100.77 -24.88 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.0 2.61 56.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.546 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 43.7 tpp -64.14 -44.91 90.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' CG1' ' N ' ' A' ' 41' ' ' ASP . 5.9 p -59.55 -42.84 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.391 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -63.58 -49.4 73.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.205 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.77 -43.82 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.262 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -59.3 -35.54 73.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -50.12 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 109.968 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.15 60.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 8.3 tt -83.35 1.1 42.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 110.344 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.5 m120 73.89 -63.35 0.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.796 . . . . 0.0 110.514 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 3.9 mmt85 -77.13 155.17 82.5 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 110.262 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.1 Cg_endo -73.05 157.54 50.76 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.102 1.58 . . . . 0.0 110.528 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.64 -26.83 8.0 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.07 1.563 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.476 ' O ' ' OG1' ' A' ' 54' ' ' THR . 18.1 p -60.69 -21.83 63.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.528 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -58.29 0.59 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 110.653 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' O ' ' CD2' ' A' ' 57' ' ' PHE . 46.2 Cg_endo -72.99 -0.31 8.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.868 1.457 . . . . 0.0 110.892 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.8 -25.83 59.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -45.7 57.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -67.76 -48.86 65.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 11.5 m-85 -57.57 -41.37 80.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.499 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -58.83 -35.36 82.08 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -37.27 78.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.238 . . . . 0.0 109.932 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -48.38 71.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 110.651 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.606 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -77.79 11.46 2.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.169 -0.957 . . . . 0.0 111.046 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.97 11.26 36.99 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.693 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -118.05 164.31 15.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.508 -0.995 . . . . 0.0 109.274 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 65' ' ' THR . 11.8 mp0 -104.1 -121.38 0.2 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.63 -1.294 . . . . 0.0 110.001 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.7 OUTLIER -149.86 170.12 19.53 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.458 -0.776 . . . . 0.0 111.82 -179.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -155.95 139.06 15.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.678 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 20.0 m-85 -127.31 146.1 50.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.741 -1.224 . . . . 0.0 112.967 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -117.9 117.17 28.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.667 177.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 14.0 m -90.21 -46.33 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.496 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 1.6 tptt -73.16 -3.62 27.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -118.92 -26.92 5.89 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.684 -0.635 . . . . 0.0 110.529 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.626 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.2 m-20 70.13 16.31 7.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.072 -1.017 . . . . 0.0 109.543 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.554 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 4.0 mmt85 -113.87 129.72 56.56 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.678 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.8 m-30 -109.06 128.97 55.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.825 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.554 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 84.4 mt -129.04 150.83 34.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.543 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 13.2 m -111.77 138.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.929 -1.107 . . . . 0.0 109.134 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.693 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 8.9 t30 -62.75 140.33 58.74 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.769 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 104.95 147.08 15.72 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.537 ' HB3' HD12 ' A' ' 32' ' ' ILE . 3.2 p -101.41 127.59 47.99 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.306 -1.114 . . . . 0.0 110.074 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.588 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -141.92 156.69 45.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.4 pt-20 -104.01 143.4 32.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.758 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -53.49 -39.51 64.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.975 . . . . 0.0 110.268 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -34.71 66.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.173 -0.954 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.517 ' O ' ' HG2' ' A' ' 88' ' ' MET . 1.3 tppp? -73.03 -45.58 56.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -60.5 -44.19 96.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.354 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 23.4 mm100 -68.66 -35.83 77.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.73 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -58.94 -46.28 88.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 111.354 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 0.6 OUTLIER -70.62 -48.66 53.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.862 -1.149 . . . . 0.0 110.725 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 93' ' ' ILE . 1.3 mt -66.04 -32.61 74.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.107 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 8.2 t70 -63.66 -43.59 96.28 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.651 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.34 84.08 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' O ' ' CZ ' ' A' ' 96' ' ' PHE . 4.4 m-30 -68.56 -51.78 38.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -1.148 . . . . 0.0 110.356 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.646 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 13.0 mt -62.1 -33.41 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.499 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.575 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -57.98 -27.41 63.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.479 -0.763 . . . . 0.0 111.971 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HB2' HD22 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -94.28 -43.78 8.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.561 -1.337 . . . . 0.0 113.063 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.586 ' CZ ' ' O ' ' A' ' 92' ' ' PHE . 1.1 p90 -117.24 -36.99 3.62 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.313 -1.492 . . . . 0.0 112.599 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.646 ' CG2' ' HA ' ' A' ' 93' ' ' ILE . 48.4 t -66.77 -49.76 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.678 -1.264 . . . . 0.0 110.911 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' C ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -61.36 67.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.13 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 97' ' ' VAL . 42.5 t -64.06 140.38 97.87 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 110.032 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.488 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 41.1 Cg_endo -66.91 -12.98 38.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.081 1.569 . . . . 0.0 110.338 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 4.0 mm-40 -71.86 -32.48 67.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.35 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER 164.15 9.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.738 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.539 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 3.7 tm-20 37.92 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.524 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 t-20 -93.86 -49.67 0.27 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 110.907 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 46.6 Cg_endo -75.94 137.15 19.37 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.679 1.357 . . . . 0.0 110.517 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -69.88 156.11 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 110.177 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -118.33 160.45 21.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 99.6 m-20 -114.1 160.29 19.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 tp -105.96 104.3 13.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' NE2' ' HB2' ' A' ' 108' ' ' ASP . 65.1 m-70 -107.61 115.3 29.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.095 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG1' HG12 ' A' ' 118' ' ' ILE . 3.3 m -109.54 128.33 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.01 123.3 59.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.224 -0.923 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.32 -31.42 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.999 1.526 . . . . 0.0 110.315 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -67.46 -39.51 85.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 -3.72 29.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.228 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.28 50.07 18.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.165 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.53 ' HA ' ' CD2' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -135.21 166.68 22.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 110.223 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.528 HG12 ' CG1' ' A' ' 111' ' ' VAL . 87.3 mt -128.73 139.37 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.489 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -148.38 161.66 28.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 108' ' ' ASP . 1.9 p-10 -143.83 133.05 23.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 109.959 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -117.13 145.87 43.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -0.985 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 127' ' ' TYR . 17.1 p -88.69 133.79 34.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' ALA . 45.0 tptt -50.37 -20.32 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.449 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . . . -40.57 -49.46 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.898 . . . . 0.0 110.213 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.41 26.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 101.55 -67.09 0.44 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.554 ' HB3' ' O ' ' A' ' 126' ' ' GLY . 7.3 t80 61.65 -50.28 0.14 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.886 . . . . 0.0 111.12 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.3 OUTLIER 65.6 96.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -111.15 68.52 0.22 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.5 ' HE2' ' CG2' ' A' ' 117' ' ' THR . 0.5 OUTLIER -83.32 122.33 28.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 110.103 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.406 ' HB3' ' SG ' ' A' ' 138' ' ' CYS . 2.7 mt -86.3 133.18 33.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.124 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -132.78 1.28 3.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.3 t -60.6 -158.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.41 160.33 41.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 58.94 33.7 23.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 110.233 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -138.93 169.73 17.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.493 HD22 ' HB2' ' A' ' 95' ' ' LYS . 3.5 pp -42.57 -29.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 141' ' ' ILE . 58.3 m -58.02 -39.13 77.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 3.0 m -68.73 -40.42 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.463 ' O ' ' HG3' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -56.9 -48.73 77.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.096 -1.003 . . . . 0.0 109.428 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 138' ' ' CYS . 18.9 pt -69.26 -42.05 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.384 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -65.74 -43.1 90.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.505 -0.747 . . . . 0.0 110.265 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -79.27 6.84 8.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.378 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER -113.04 69.61 1.19 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.446 ' HD3' ' C ' ' A' ' 143' ' ' LYS . 46.2 Cg_endo -72.66 120.55 6.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 148' ' ' ASN . 45.9 Cg_endo -73.03 100.94 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.989 1.521 . . . . 0.0 110.37 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 12.3 tp10 -44.38 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 146' ' ' PRO . 9.1 m-80 -171.07 163.69 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.158 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.1 t -70.96 -42.17 70.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -137.86 -157.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.191 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 13.48 11.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.185 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 54.73 -134.62 46.85 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.46 91.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -1.134 . . . . 0.0 110.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 155' ' ' LYS . . . -83.45 -31.18 28.28 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 154' ' ' GLY . 0.1 OUTLIER -172.11 103.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -1.137 . . . . 0.0 110.208 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.23 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.23 0.538 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t -158.61 90.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.51 108.44 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -91.98 103.97 16.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' O ' HG21 ' A' ' 9' ' ' VAL . 10.8 p -56.4 -24.57 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.915 . . . . 0.0 110.142 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.83 -52.6 10.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 110.178 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -14.6 63.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -1.54 58.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.442 HG11 ' N ' ' A' ' 10' ' ' MET . 97.2 t -75.88 146.0 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.442 ' N ' HG11 ' A' ' 9' ' ' VAL . 1.3 tmm? -45.2 128.42 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.171 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.96 120.31 6.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -70.45 -15.24 62.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.617 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -84.35 -43.16 15.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.617 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER 64.82 -51.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.595 -0.691 . . . . 0.0 110.508 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 13' ' ' PHE . 6.8 ptp180 -66.98 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 110.382 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -137.22 133.25 34.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 110.232 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -112.57 161.25 17.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 0.0 110.237 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.4 mtm -111.9 99.11 44.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 46.9 Cg_endo -74.55 4.51 4.44 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.04 1.548 . . . . 0.0 110.448 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 64.2 mtt180 64.89 9.3 5.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 39' ' ' MET . 0.3 OUTLIER -95.17 122.61 38.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.981 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.2 mt -115.61 123.52 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.258 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.99 132.53 53.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.07 136.18 53.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.518 HG12 ' CB ' ' A' ' 79' ' ' SER . 94.6 t -102.48 134.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -128.22 144.76 51.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 48.19 0.99 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -120.12 152.35 37.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.177 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.73 -101.24 0.98 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.01 -18.65 61.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -1.157 . . . . 0.0 110.198 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.477 ' O ' HG12 ' A' ' 32' ' ' ILE . . . 97.33 -10.98 65.41 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.52 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.6 mm -154.74 88.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -1.163 . . . . 0.0 110.257 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HA ' ' N ' ' A' ' 78' ' ' GLY . 6.0 mtmm -126.76 152.55 46.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.0 OUTLIER -108.18 123.95 49.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' CG2' HG13 ' A' ' 75' ' ' ILE . 20.4 t -108.52 117.79 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -95.95 122.98 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -100.55 -43.56 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.774 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' O ' HG21 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.23 -1.52 25.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.019 . . . . 0.0 110.75 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.569 ' HB3' ' HB ' ' A' ' 36' ' ' ILE . 1.5 tmt? -64.72 -45.6 85.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.019 . . . . 0.0 109.967 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG11 ' N ' ' A' ' 41' ' ' ASP . 14.3 p -70.68 -41.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 0.0 110.323 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' N ' HG11 ' A' ' 40' ' ' VAL . 40.1 t0 -62.17 -49.47 75.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.541 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 12.9 m -68.12 -43.57 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -61.53 -46.96 87.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -36.45 80.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.449 -0.782 . . . . 0.0 110.236 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -69.8 -31.96 70.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.541 ' CD2' ' O ' ' A' ' 42' ' ' VAL . 3.0 pp -108.94 -1.4 19.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -170.21 -154.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.291 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 1.8 mtt180 -93.47 174.49 3.84 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.274 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.94 128.57 13.31 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.359 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' O ' ' HB ' ' A' ' 54' ' ' THR . 47.9 Cg_endo -75.4 5.2 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.034 1.544 . . . . 0.0 110.657 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.605 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -56.46 -26.54 54.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.527 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -84.51 -55.94 0.43 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.964 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.9 Cg_endo -70.77 -23.66 25.95 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.824 1.434 . . . . 0.0 111.143 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 7.8 t -56.25 -16.31 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.992 -1.067 . . . . 0.0 110.208 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -45.4 68.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -62.11 -49.46 75.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -0.979 . . . . 0.0 110.11 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 8.9 m-30 -57.42 -36.8 71.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.921 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -39.25 94.91 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.2 m -57.45 -37.33 72.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -1.2 . . . . 0.0 109.924 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 -49.48 77.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.835 . . . . 0.0 110.723 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -83.42 12.98 4.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.109 -0.994 . . . . 0.0 110.697 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.05 6.29 31.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 77' ' ' ASN . . . -116.45 163.59 15.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -1.159 . . . . 0.0 109.609 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.488 ' C ' ' CG2' ' A' ' 65' ' ' THR . 24.6 tp60 -107.16 -118.42 0.25 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.936 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.18 170.25 18.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 111.022 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.561 ' CB ' HG23 ' A' ' 75' ' ' ILE . 3.3 mm100 -146.32 139.82 25.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.7 m-85 -126.54 142.59 51.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.819 -1.176 . . . . 0.0 112.849 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -120.28 117.48 27.92 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.015 178.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 70' ' ' LYS . 13.5 m -89.29 -45.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.645 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' HG23 ' A' ' 69' ' ' VAL . 7.4 tptt -71.01 -5.95 35.15 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.198 -0.939 . . . . 0.0 108.722 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.7 m-20 -121.32 -25.27 5.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.591 -0.693 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.1 m-20 69.75 17.15 7.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 109.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -113.64 129.47 56.56 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.586 -0.696 . . . . 0.0 109.681 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.727 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-30 -113.18 138.02 50.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.555 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG23 ' CB ' ' A' ' 66' ' ' GLN . 1.6 tt -128.45 148.75 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.461 -0.774 . . . . 0.0 109.925 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t -113.89 130.03 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.688 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 67.6 m-80 -49.76 147.82 3.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 110.51 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.16 148.8 16.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.518 ' CB ' HG12 ' A' ' 25' ' ' VAL . 64.8 p -106.63 122.62 46.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -1.109 . . . . 0.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -142.09 145.45 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 109.975 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.3 tt0 -81.72 155.17 25.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.108 -0.995 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.25 -43.89 64.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.033 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -64.67 -33.55 76.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 109.797 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -64.64 -36.87 85.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 110.082 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.6 ' O ' ' HG3' ' A' ' 88' ' ' MET . 4.4 mp -59.95 -42.59 94.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.103 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 26.1 mt-30 -69.2 -35.93 76.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.535 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -46.61 88.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.476 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.6 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -64.46 -48.85 73.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.892 -1.13 . . . . 0.0 110.42 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' O ' ' CD1' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -68.69 -33.24 73.63 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.157 -0.964 . . . . 0.0 108.515 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 12.2 t0 -64.24 -39.01 93.07 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.3 0.572 . . . . 0.0 110.0 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.91 -35.3 91.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -64.96 -51.61 60.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -1.083 . . . . 0.0 109.775 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.631 ' HA ' ' CZ ' ' A' ' 96' ' ' PHE . 36.3 pt -65.15 -40.49 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.21 -26.47 39.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.458 -0.776 . . . . 0.0 110.909 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -60.31 -41.08 92.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.127 -0.983 . . . . 0.0 111.12 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 93' ' ' ILE . 1.7 p90 -115.3 -36.12 4.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.765 -1.209 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 93' ' ' ILE . 8.5 m -54.42 -29.94 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.914 -1.116 . . . . 0.0 110.047 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -70.8 51.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.924 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 4.0 m -64.66 148.68 96.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.987 -1.07 . . . . 0.0 110.269 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.89 2.88 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.061 1.558 . . . . 0.0 110.315 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 7.6 mm-40 -116.95 -7.07 11.42 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.758 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.616 ' O ' ' C ' ' A' ' 103' ' ' GLU . 54.3 m -153.03 -50.23 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 110.465 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' A' ' 102' ' ' CYS . 1.7 tm-20 24.06 68.26 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.599 -0.688 . . . . 0.0 110.671 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 8.2 m-20 -172.23 -61.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.28 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.1 Cg_endo -71.06 149.68 59.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.922 1.485 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.43 129.01 38.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 110.067 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.7 p -110.19 166.06 11.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 110.127 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.95 143.82 44.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 141' ' ' ILE . 9.8 tt -107.11 110.8 23.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.583 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 9.2 p80 -119.41 115.82 24.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG1' HG12 ' A' ' 118' ' ' ILE . 3.1 m -96.87 128.51 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.44 122.65 69.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.203 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.45 -37.26 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.986 1.519 . . . . 0.0 110.436 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -59.91 -42.08 93.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.309 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 8.9 tttp -100.59 -1.6 35.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 52.43 44.05 30.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.071 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -129.11 179.62 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.147 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 142' ' ' LEU . 10.6 mt -129.53 130.46 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.583 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -115.95 164.02 12.28 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' CD1' ' A' ' 131' ' ' LEU . 13.9 t30 -141.36 136.81 31.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.243 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -116.87 124.63 49.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.033 -1.042 . . . . 0.0 110.321 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.449 ' SG ' ' HG2' ' A' ' 105' ' ' PRO . 45.8 t -99.49 133.76 43.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.272 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.67 -19.99 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -74.07 -9.98 59.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 110.422 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -33.01 -71.42 0.1 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.627 ' O ' ' O ' ' A' ' 128' ' ' ARG . 58.8 t80 -60.79 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.082 . . . . 0.0 110.088 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.799 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 36.96 108.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.45 -0.781 . . . . 0.0 111.514 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.45 -94.29 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.503 ' O ' ' OH ' ' A' ' 127' ' ' TYR . 0.4 OUTLIER -119.69 150.85 39.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -1.101 . . . . 0.0 110.129 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 96' ' ' PHE . 2.8 tt -104.34 122.5 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.268 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 133' ' ' THR . 3.8 p30 -126.34 -54.19 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.217 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 0.8 OUTLIER 58.85 -143.44 0.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.258 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -96.58 -93.51 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.228 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -107.06 81.82 1.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.508 ' C ' ' CD1' ' A' ' 137' ' ' LEU . 2.1 tm? -82.31 -41.36 20.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.545 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 45.2 m -56.94 -42.05 79.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 110.219 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -63.7 -40.06 95.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 143' ' ' LYS . 2.1 t80 -61.85 -48.72 79.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.022 -1.049 . . . . 0.0 109.228 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 138' ' ' CYS . 28.7 pt -69.36 -42.15 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.36 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.532 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 25.6 tp -55.36 -22.92 21.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.296 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -70.28 -11.07 60.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.187 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.69 157.56 18.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 158.74 50.13 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.081 1.569 . . . . 0.0 110.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.411 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -73.57 -46.46 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.991 1.522 . . . . 0.0 110.418 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 149' ' ' SER . 0.0 OUTLIER -161.43 145.26 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 110.171 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 149' ' ' SER . 36.7 m-20 45.87 -92.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.079 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 147' ' ' GLU . 54.8 m 55.19 89.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.241 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.26 153.56 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 m -58.25 -45.56 87.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.24 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.22 108.47 3.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 m -69.49 -52.73 23.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -1.155 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' LYS . . . 61.38 61.88 6.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 154' ' ' GLY . 5.2 mmtm 53.3 173.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.246 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.231 0.539 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -68.77 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.147 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.77 158.92 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.91 123.56 28.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 7' ' ' ARG . 16.3 m -67.16 -8.75 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER 66.08 13.45 9.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.439 ' HB2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -67.18 -21.68 65.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.0 -5.43 34.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.3 95.2 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -168.22 119.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 123.0 9.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -64.5 -40.71 96.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.23 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.94 94.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -120.47 -89.65 0.6 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.208 -0.932 . . . . 0.0 110.211 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HG2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -174.44 -39.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 110.2 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -104.5 151.86 23.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 110.317 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -129.16 155.33 45.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -134.14 126.26 18.45 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 110.128 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 46.0 Cg_endo -73.28 -4.44 15.42 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.957 1.504 . . . . 0.0 110.5 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 1.5 ttt180 55.87 99.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.158 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' O ' ' CB ' ' A' ' 82' ' ' ALA . 3.4 tp -95.22 137.04 34.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.312 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 HG23 ' HB2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -119.12 132.37 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.9 140.59 52.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -121.71 137.97 54.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 16.3 m -93.44 131.9 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.368 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -141.17 139.99 33.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.73 -97.09 0.12 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -146.32 144.14 29.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -1.172 . . . . 0.0 110.177 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.97 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' LYS . 61.9 m-80 -99.87 -17.55 17.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.218 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . 63.22 96.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.69 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.14 20.65 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.495 ' HB3' HD12 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.77 153.27 18.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.832 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.563 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.3 m -97.16 124.97 41.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.088 -1.007 . . . . 0.0 110.834 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 24' ' ' LYS . 5.7 t -118.02 117.65 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.923 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 3.6 mt -95.77 118.16 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.288 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 t -100.45 -16.92 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.286 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' HB2' HG23 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -99.01 14.47 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.54 ' HG2' ' CG ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -63.97 -41.95 97.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 58.4 t -61.37 -47.55 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -63.0 -50.2 71.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.28 -40.71 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.552 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -62.65 -48.4 79.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -62.11 -38.91 90.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 110.243 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.45 -15.89 60.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.382 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.602 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 7.2 tt -101.89 -9.33 20.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 110.387 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t30 78.26 -50.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.48 -0.762 . . . . 0.0 111.025 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.561 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 56.3 mtp180 -76.66 142.29 70.07 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.081 -1.012 . . . . 0.0 110.259 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.96 140.96 32.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.147 1.604 . . . . 0.0 110.637 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -75.73 -29.5 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 0.0 110.333 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.427 HG23 ' CE1' ' A' ' 67' ' ' PHE . 48.8 p -59.5 -22.8 62.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 110.316 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.554 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -77.52 -58.65 0.92 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 0.0 110.268 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 47.8 Cg_endo -73.68 -28.24 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.973 1.512 . . . . 0.0 110.702 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.509 ' CB ' ' O ' ' A' ' 50' ' ' PRO . 3.4 m -56.28 -19.74 15.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' HD2' ' OG1' ' A' ' 153' ' ' THR . 18.4 ttpt -72.77 -45.38 58.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.107 -0.995 . . . . 0.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 10.1 m-30 -64.6 -39.82 94.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.095 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -41.15 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.55 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -60.28 -35.33 87.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.0 m -56.99 -37.24 71.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 109.769 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.29 -44.0 93.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 110.722 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.564 ' CD1' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER -88.24 12.64 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.134 -0.979 . . . . 0.0 111.032 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.1 4.78 30.31 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -115.29 163.99 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 0.0 109.141 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' C ' ' CG2' ' A' ' 65' ' ' THR . 4.7 tt0 -106.2 -121.58 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.621 -1.3 . . . . 0.0 109.738 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.515 ' CG2' ' C ' ' A' ' 64' ' ' GLN . 1.3 p -149.84 170.43 18.79 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.45 -0.781 . . . . 0.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' CB ' HG21 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -142.41 139.43 31.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.82 144.17 51.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.759 -1.213 . . . . 0.0 113.13 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.3 t0 -126.34 117.38 22.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.165 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 16.9 t -86.58 -61.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -16.65 6.23 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.192 -0.942 . . . . 0.0 108.633 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.611 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.2 t30 -105.74 -30.02 9.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.584 -0.697 . . . . 0.0 110.152 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.611 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.7 m-20 71.05 16.67 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 tpt180 -113.62 128.98 56.63 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.503 -0.748 . . . . 0.0 109.865 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.682 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.44 138.2 50.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.469 -0.769 . . . . 0.0 110.022 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.531 HG21 ' CB ' ' A' ' 66' ' ' GLN . 1.0 OUTLIER -132.41 148.06 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.8 t -114.43 139.03 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.258 -0.901 . . . . 0.0 109.469 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.564 ' O ' ' CD1' ' A' ' 61' ' ' LEU . 11.6 m-80 -64.05 141.72 58.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.085 -1.01 . . . . 0.0 110.469 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 99.64 142.12 12.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.523 ' HB3' HD13 ' A' ' 32' ' ' ILE . 4.9 p -80.6 127.3 32.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.096 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.563 ' CD2' ' OG1' ' A' ' 34' ' ' THR . 78.9 m-70 -142.2 141.03 32.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.801 . . . . 0.0 110.403 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 83' ' ' ASN . 4.6 tp10 -104.04 149.57 25.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.928 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.31 -43.91 64.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.426 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.421 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -64.15 -33.29 75.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.238 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -67.69 -40.42 84.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 110.331 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 2.0 mp -60.58 -45.24 94.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.04 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -69.32 -47.41 64.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.036 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 44.8 t0 -69.15 -46.3 67.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.54 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 84' ' ' LYS . 42.9 ttp -63.01 -49.75 73.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tp -54.36 -30.52 51.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.8 t70 -63.69 -35.77 81.65 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.646 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.47 -48.31 85.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.588 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -68.66 -51.54 40.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -1.22 . . . . 0.0 109.981 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 96' ' ' PHE . 1.3 mt -59.71 -50.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.132 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 22.4 ttpp -58.3 -27.94 64.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 110.633 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -42.61 99.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.068 -1.02 . . . . 0.0 111.067 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.621 ' CE1' ' CG2' ' A' ' 97' ' ' VAL . 47.9 p90 -115.87 -35.97 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.815 -1.178 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.621 ' CG2' ' CE1' ' A' ' 96' ' ' PHE . 96.2 t -56.21 -23.73 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.879 -1.138 . . . . 0.0 110.651 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.567 HD11 ' HG2' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -34.5 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.424 -0.798 . . . . 0.0 110.609 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' VAL . 94.4 m -87.45 154.91 54.19 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.823 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.29 -3.24 13.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.048 1.552 . . . . 0.0 110.408 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.89 8.59 1.12 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.866 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 99' ' ' CYS . 0.5 OUTLIER -155.47 16.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.002 -1.061 . . . . 0.0 110.625 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.567 ' HG2' HD11 ' A' ' 98' ' ' LEU . 1.6 tm-20 -69.26 -59.6 2.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.107 -0.996 . . . . 0.0 109.968 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.58 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -42.16 -52.08 9.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.447 -0.783 . . . . 0.0 110.623 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 45.2 Cg_endo -72.45 149.4 50.13 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.903 1.475 . . . . 0.0 110.607 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.07 150.44 46.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.368 -0.833 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.473 ' OG1' HG11 ' A' ' 97' ' ' VAL . 12.7 p -141.96 166.21 25.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 3.9 t70 -113.77 147.41 38.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.945 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.6 tt -106.46 132.15 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.587 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 56.3 m-70 -124.26 123.66 40.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.512 ' CG2' HG12 ' A' ' 118' ' ' ILE . 7.2 p -123.98 129.27 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -118.94 122.48 29.66 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.51 -39.96 1.75 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.993 1.523 . . . . 0.0 110.466 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -42.19 91.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.288 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 4.8 mmtt -94.24 -3.85 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 52.5 38.4 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.62 173.52 11.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.512 HG12 ' CG2' ' A' ' 111' ' ' VAL . 24.5 mt -141.61 141.6 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -127.06 163.95 20.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 10.9 t-20 -137.59 139.06 40.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -1.161 . . . . 0.0 109.519 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.703 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 13.5 t -116.83 124.67 50.1 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.056 -1.027 . . . . 0.0 110.338 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 102' ' ' CYS . 27.7 t -119.53 133.87 55.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.035 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -98.7 50.48 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.897 . . . . 0.0 109.988 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.533 ' HB2' ' CB ' ' A' ' 105' ' ' PRO . . . -133.82 -35.0 0.99 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 110.282 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 9.9 p -138.52 4.43 2.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 110.591 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 84.43 -12.49 55.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.661 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -36.82 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.476 -1.014 . . . . 0.0 110.426 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 22.2 ttp-105 -28.01 127.4 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.603 -0.686 . . . . 0.0 110.873 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.1 -91.51 0.11 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.1 151.6 38.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -1.195 . . . . 0.0 110.374 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.469 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 17.0 tp -112.06 107.65 16.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.075 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 133' ' ' THR . 0.2 OUTLIER -130.23 -70.11 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 132' ' ' ASP . 6.4 p 51.7 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 133' ' ' THR . 3.2 m-70 41.39 -97.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.453 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 132' ' ' ASP . 0.4 OUTLIER -66.18 150.38 48.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.314 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.443 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 0.9 OUTLIER -101.47 82.07 2.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.7 -9.93 56.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.108 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.508 ' O ' HG12 ' A' ' 141' ' ' ILE . 28.1 m -66.67 -41.92 87.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.302 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -40.24 81.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -57.79 -48.31 80.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.498 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.536 HG13 ' N ' ' A' ' 142' ' ' LEU . 28.8 pt -68.88 -41.91 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.536 ' N ' HG13 ' A' ' 141' ' ' ILE . 47.0 tp -55.84 -23.62 31.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.466 -0.771 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.488 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -78.06 4.06 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 110.41 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.554 ' C ' ' HD2' ' A' ' 146' ' ' PRO . 8.0 p30 36.29 92.95 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.417 -0.802 . . . . 0.0 110.517 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.674 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 41.9 Cg_endo -72.39 -29.11 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.055 1.555 . . . . 0.0 112.293 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 145' ' ' PRO . 47.3 Cg_endo -73.93 165.29 32.47 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 122.887 0.941 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.75 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 54.77 25.67 6.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.7 m -135.39 116.22 14.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.214 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 151' ' ' SER . 0.7 OUTLIER 60.32 166.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.275 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 150' ' ' ASP . 20.1 m 43.33 53.02 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.81 -81.63 1.1 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 18.0 m -125.07 -73.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.234 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.71 166.26 12.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -92.73 8.78 37.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -1.178 . . . . 0.0 110.252 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.165 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.25 0.548 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 3' ' ' VAL . 48.4 m -97.69 -19.26 18.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 2' ' ' SER . 24.5 t -146.74 149.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -76.01 151.49 37.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -59.34 -24.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.506 ' O ' ' CG2' ' A' ' 9' ' ' VAL . 5.3 m120 53.96 82.13 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -17.52 63.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.311 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -74.85 0.15 16.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 6' ' ' ASN . 70.5 t -57.83 -44.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 43.15 61.32 2.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.75 111.23 22.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 4.7 tp-100 -73.71 -13.57 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 56.9 m-85 -43.3 -31.09 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER 169.01 -23.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 0.0 110.304 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -75.1 49.52 0.45 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.073 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.26 132.49 33.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.352 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -112.72 129.54 56.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -148.21 96.71 3.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 45.4 Cg_endo -73.33 -89.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.277 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.8 ptt180 176.72 -46.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.425 HD22 HD12 ' A' ' 85' ' ' LEU . 5.3 tp -95.97 122.45 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 22' ' ' ILE . 25.9 mt -110.97 120.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.43 132.23 54.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.539 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.542 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.0 135.71 53.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 31' ' ' GLY . 10.1 t -99.05 122.36 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.36 136.21 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.48 -98.13 0.12 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -144.49 155.04 43.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -1.114 . . . . 0.0 110.018 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.0 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 28' ' ' LYS . 26.7 p-10 -99.98 -18.6 16.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.565 ' O ' ' CG1' ' A' ' 25' ' ' VAL . . . 80.14 105.19 0.27 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.607 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -103.99 8.36 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -1.232 . . . . 0.0 110.381 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -97.43 153.12 18.31 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.929 -1.107 . . . . 0.0 109.213 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.555 ' CG2' ' O ' ' A' ' 34' ' ' THR . 1.3 t -117.94 121.72 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.771 -1.205 . . . . 0.0 110.877 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.612 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -107.27 117.63 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.723 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 19.0 mt -95.62 108.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.72 -4.9 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.364 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.513 ' OD1' ' CD1' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -109.21 -1.19 18.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.546 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 34.9 ttm -64.22 -44.2 92.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 110.084 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 11.6 p -70.15 -39.46 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.865 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.443 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 23.8 t70 -62.51 -50.74 70.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.141 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 43' ' ' ALA . 12.4 p -68.5 -45.34 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.85 -35.13 78.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.355 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 2.4 tttp -67.4 -36.58 81.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.43 61.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 3.1 tt -117.47 -9.16 10.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ALA . 1.4 t-20 171.44 -148.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.53 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mtt85 -96.41 169.19 9.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.021 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.14 127.81 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.396 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 54' ' ' THR . 48.7 Cg_endo -75.03 46.92 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.927 1.488 . . . . 0.0 110.887 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.534 ' CG2' ' CE1' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -68.05 -26.14 65.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -73.99 -54.31 3.61 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.722 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.4 Cg_endo -69.92 -19.85 34.84 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.812 1.428 . . . . 0.0 110.779 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 50' ' ' PRO . 6.3 m -56.25 -18.9 11.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.989 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -72.88 -40.82 65.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -58.66 -49.68 76.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.049 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 88' ' ' MET . 10.3 m-85 -57.27 -35.87 70.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -65.31 -35.14 91.14 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 67.0 m -56.69 -37.19 70.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.08 -1.247 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -49.3 69.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.644 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -79.9 11.94 3.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.113 -0.992 . . . . 0.0 111.115 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.2 4.66 30.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 77' ' ' ASN . . . -118.35 164.05 15.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.504 ' C ' ' CG2' ' A' ' 65' ' ' THR . 9.4 mt-30 -110.34 -120.53 0.28 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.594 -1.316 . . . . 0.0 109.875 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.504 ' CG2' ' C ' ' A' ' 64' ' ' GLN . 1.1 p -149.4 170.41 18.62 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.435 -0.791 . . . . 0.0 110.921 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.533 ' HB2' ' CG2' ' A' ' 75' ' ' ILE . 1.8 mm-40 -140.97 139.66 34.27 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.726 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.5 142.99 51.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.751 -1.218 . . . . 0.0 113.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -123.13 117.5 25.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.997 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.53 -64.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.599 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -16.91 6.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.134 -0.979 . . . . 0.0 108.656 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.607 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.75 -29.66 10.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.603 -0.686 . . . . 0.0 110.103 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.607 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.5 m-20 69.58 15.95 8.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.128 -0.982 . . . . 0.0 110.158 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 15.4 ttm180 -113.65 129.44 56.57 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.852 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.726 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.61 138.04 50.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.394 -0.816 . . . . 0.0 110.309 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 17.8 tt -130.6 148.41 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 34' ' ' THR . 4.2 t -114.73 139.21 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -0.958 . . . . 0.0 109.327 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 62.4 m-80 -67.86 140.03 56.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.346 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . 105.63 145.39 13.25 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -80.44 133.59 35.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -1.2 . . . . 0.0 110.179 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 34' ' ' THR . 99.1 m-70 -142.32 119.83 11.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.508 -0.745 . . . . 0.0 110.8 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -82.92 158.76 22.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.31 -43.74 61.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.997 -1.065 . . . . 0.0 109.559 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 2.4 t30 -64.71 -33.27 75.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.2 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' O ' ' HE2' ' A' ' 88' ' ' MET . 0.1 OUTLIER -59.38 -36.31 75.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.052 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 88' ' ' MET . 20.5 mt -58.85 -32.45 69.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.589 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 51.8 mm-40 -68.79 -35.08 76.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 13.5 t70 -58.69 -46.67 86.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.442 -0.787 . . . . 0.0 111.585 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.641 ' HG2' ' O ' ' A' ' 85' ' ' LEU . 3.0 ptp -63.73 -44.91 92.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.561 -1.337 . . . . 0.0 109.259 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.516 ' O ' ' CD1' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -53.22 -31.29 42.47 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 11.3 t70 -63.65 -42.42 98.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -62.08 -33.39 85.59 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.573 ' CE2' ' HE2' ' A' ' 95' ' ' LYS . 46.1 t80 -56.29 -40.23 73.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.606 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 20.6 mt -54.78 -33.81 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 0.0 109.858 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.682 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 6.8 ttmt -55.23 -27.12 44.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.573 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 1.5 mtmt -61.24 -33.23 73.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 111.921 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 97' ' ' VAL . 8.4 p90 -115.31 -34.01 5.11 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.667 -1.271 . . . . 0.0 111.859 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.682 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 15.5 m -54.25 -16.25 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.735 -1.228 . . . . 0.0 110.376 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -40.99 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 97' ' ' VAL . 1.8 m -87.88 154.64 52.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 110.355 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.9 36.4 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.0 110.522 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.534 ' HB3' ' CG ' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -130.55 -53.81 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 110.236 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 176.27 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 104' ' ' ASN . 11.3 tp10 -77.55 -25.02 49.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.03 . . . . 0.0 109.732 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.614 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.6 t-20 -32.9 -54.33 0.61 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.342 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 40.4 Cg_endo -67.22 150.8 81.76 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.027 1.541 . . . . 0.0 110.225 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.22 113.61 5.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.951 . . . . 0.0 110.4 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.534 ' CG2' ' HB2' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -115.45 166.91 11.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.915 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 120' ' ' ASN . 1.4 m-20 -113.22 139.65 48.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.967 . . . . 0.0 109.938 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.503 HD22 ' CD1' ' A' ' 118' ' ' ILE . 8.6 tt -105.73 134.28 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 110' ' ' HIS . 1.7 m-70 -124.21 116.78 23.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG1' HD12 ' A' ' 118' ' ' ILE . 27.3 m -96.77 123.26 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.35 124.17 70.32 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.231 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.22 -37.18 3.54 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.942 1.496 . . . . 0.0 110.472 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.418 ' HG2' ' HD3' ' A' ' 115' ' ' LYS . 66.6 tttt -61.12 -41.91 97.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HD3' ' HG2' ' A' ' 114' ' ' LYS . 2.8 mmmt -96.39 -3.77 43.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 59.5 tt0 52.62 38.26 25.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.124 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.78 156.73 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 110.2 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.557 ' CD1' ' CD1' ' A' ' 141' ' ' ILE . 2.5 tt -119.29 134.62 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.304 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HG ' ' A' ' 109' ' ' LEU . . . -141.6 156.06 25.61 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 107' ' ' THR . 16.6 t30 -142.78 121.93 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.517 ' OG ' ' NE ' ' A' ' 128' ' ' ARG . 1.3 m -117.32 138.96 51.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.235 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.534 ' HB2' ' CG2' ' A' ' 107' ' ' THR . 43.0 t -105.5 133.81 49.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -60.37 -13.15 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.3 -51.76 51.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.852 . . . . 0.0 110.357 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.78 -27.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.791 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 101.21 -12.03 58.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 128' ' ' ARG . 4.2 p90 -29.29 -37.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.94 . . . . 0.0 111.188 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER 67.8 132.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.683 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.14 73.01 0.29 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 9.6 ttt -83.13 122.33 28.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -1.131 . . . . 0.0 110.111 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.452 HD11 ' SG ' ' A' ' 138' ' ' CYS . 13.5 mt -93.18 142.14 27.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 110.336 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -119.42 -41.38 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.0 p -45.44 139.04 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.401 ' C ' ' OG1' ' A' ' 139' ' ' THR . 38.5 m80 -109.49 23.55 14.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.453 ' O ' ' HD2' ' A' ' 136' ' ' LYS . 36.7 t60 -130.66 17.07 5.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 135' ' ' HIS . 4.7 mmmt -119.4 -178.24 3.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 110.262 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.579 HD13 ' CD1' ' A' ' 96' ' ' PHE . 1.7 pp -47.36 -23.86 0.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.262 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.516 ' O ' HG12 ' A' ' 141' ' ' ILE . 40.0 m -60.17 -42.28 94.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.883 . . . . 0.0 110.336 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.401 ' OG1' ' C ' ' A' ' 134' ' ' HIS . 20.1 m -68.86 -39.98 79.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -56.93 -48.43 78.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.106 -0.996 . . . . 0.0 109.732 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.557 ' CD1' ' CD1' ' A' ' 118' ' ' ILE . 23.8 pt -68.77 -42.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.519 ' N ' HG13 ' A' ' 141' ' ' ILE . 1.8 tm? -54.19 -37.26 64.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.838 . . . . 0.0 110.251 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 4.6 mmtt -91.67 -11.36 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 110.349 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 0.8 OUTLIER 61.02 175.03 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.191 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.1 Cg_endo -72.08 157.2 54.75 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.022 1.538 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.9 86.1 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.09 1.573 . . . . 0.0 110.503 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -169.21 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 110.138 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 147' ' ' GLU . 32.7 m-80 42.95 -158.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 150' ' ' ASP . 0.2 OUTLIER 177.96 -169.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 149' ' ' SER . 2.0 t70 54.65 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 m -103.15 172.97 6.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 110.244 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.7 24.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 153' ' ' THR . 7.9 m 51.79 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -1.168 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.29 -163.27 36.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -80.98 -84.71 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -1.157 . . . . 0.0 110.174 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.151 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.1 t -114.24 76.31 0.98 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.254 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 147.5 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.66 -174.97 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 72.7 t -62.27 -11.94 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER 65.51 8.97 5.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 110.182 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 8' ' ' SER . 9.5 ptt180 -70.26 -30.94 68.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 0.3 OUTLIER -78.26 -7.09 56.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 110.204 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -103.09 -29.95 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.908 . . . . 0.0 110.176 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.63 172.02 10.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.09 120.01 6.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 13' ' ' PHE . 18.1 pt20 -80.37 -21.98 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 6.8 t80 42.47 65.36 0.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.23 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 16' ' ' TYR . 49.9 t80 -177.77 -88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.13 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' O ' ' CG ' ' A' ' 15' ' ' ARG . 26.7 ttp180 42.18 26.76 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.329 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.8 m-85 -136.79 130.2 31.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -116.08 149.58 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 0.0 110.286 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.46 ' HB3' HG12 ' A' ' 22' ' ' ILE . 12.3 mmt -117.37 108.07 44.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' LEU . 46.4 Cg_endo -72.99 77.18 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 0.0 110.502 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.91 -78.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.283 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.1 tt -81.93 127.13 32.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.46 HG12 ' HB3' ' A' ' 18' ' ' MET . 4.7 mt -103.97 136.77 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.71 126.75 45.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.52 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . 2.5 mmtp -116.12 138.05 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 4.3 p -93.34 122.05 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.6 tt0 -141.58 133.31 27.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.406 -0.809 . . . . 0.0 110.217 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.8 -104.56 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' ASN . 1.1 mttt -152.55 139.15 18.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -1.043 . . . . 0.0 110.107 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.32 -84.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' LYS . 72.3 m-20 -90.28 -18.79 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 110.024 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.538 ' O ' ' CG2' ' A' ' 25' ' ' VAL . . . 46.37 88.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -107.83 22.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 110.301 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -97.71 152.85 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.905 -1.122 . . . . 0.0 109.559 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.632 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 18.5 m -110.78 115.69 29.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.938 -1.101 . . . . 0.0 110.771 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 24' ' ' LYS . 14.3 p -107.14 117.42 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.2 mt -95.77 108.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 37' ' ' VAL . 7.6 p -100.6 -13.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' OD1' HD11 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -101.47 -1.32 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.415 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.552 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -64.5 -45.26 88.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 8.5 p -67.19 -38.58 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.0 110.422 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 16.2 t0 -61.93 -48.92 78.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -0.945 . . . . 0.0 110.353 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 46' ' ' LEU . 79.9 t -68.41 -40.7 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -66.43 -38.69 87.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -67.11 -36.45 81.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.052 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HB3' ' CD1' ' A' ' 46' ' ' LEU . . . -63.2 -30.27 71.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 6.1 mp -115.18 -9.31 12.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' ALA . 6.1 p30 171.37 -110.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.37 -0.831 . . . . 0.0 110.388 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.9 mtm-85 -137.32 167.35 21.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 44.9 Cg_endo -72.0 137.91 30.11 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.907 1.477 . . . . 0.0 110.571 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.531 ' O ' ' CG2' ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.11 52.08 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.066 1.561 . . . . 0.0 110.523 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.502 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -67.87 -21.69 65.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 m-85 -81.4 -54.2 0.71 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 111.081 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -72.47 2.49 5.08 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.796 1.419 . . . . 0.0 111.338 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.54 ' HB ' HG21 ' A' ' 65' ' ' THR . 1.9 p -66.35 -18.59 65.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -72.86 -42.3 63.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.878 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -58.72 -51.43 70.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.117 -0.99 . . . . 0.0 110.433 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.547 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 24.7 m-85 -57.82 -42.59 84.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.65 -35.52 89.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -37.28 70.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -1.208 . . . . 0.0 110.039 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.63 -48.88 70.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.548 HD12 ' CB ' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.14 12.45 3.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.066 -1.021 . . . . 0.0 111.097 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.85 4.85 22.28 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.601 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -117.71 163.87 15.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -1.139 . . . . 0.0 109.081 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' C ' ' CG2' ' A' ' 65' ' ' THR . 66.4 mt-30 -110.4 -123.07 0.27 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.643 -1.285 . . . . 0.0 109.929 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.54 HG21 ' HB ' ' A' ' 54' ' ' THR . 2.0 p -149.92 170.76 18.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.97 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.521 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.0 tm0? -144.27 139.4 28.59 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 30.8 m-85 -126.76 145.85 50.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.792 -1.193 . . . . 0.0 112.98 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' CB ' ' HB2' ' A' ' 71' ' ' ASN . 10.5 m-20 -126.52 117.52 23.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.274 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.507 HG21 ' N ' ' A' ' 70' ' ' LYS . 14.9 m -87.29 -45.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.63 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.507 ' N ' HG21 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.38 -8.39 46.11 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.1 m120 -118.94 -24.69 6.49 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.695 -0.628 . . . . 0.0 110.147 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.1 m-20 68.45 15.71 9.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.958 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.587 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 5.6 mtp180 -113.82 129.43 56.59 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.566 -0.709 . . . . 0.0 109.788 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.702 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -113.79 130.91 56.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.484 -0.76 . . . . 0.0 110.316 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.521 HG23 ' CB ' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -111.39 148.04 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 3.0 t -120.31 132.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 109.22 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.601 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 82.5 m-20 -66.17 141.01 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 110.555 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 99.56 137.39 9.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.563 ' CB ' HD12 ' A' ' 32' ' ' ILE . 86.5 p -96.5 116.04 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.107 -1.231 . . . . 0.0 110.639 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.632 ' CE1' ' HB ' ' A' ' 34' ' ' THR . 3.1 p-80 -143.26 127.47 17.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.274 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -73.64 151.62 40.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.986 -1.071 . . . . 0.0 109.737 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.06 -44.59 64.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 110.208 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.56 -33.3 75.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.835 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.659 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -67.31 -36.6 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.582 -0.699 . . . . 0.0 111.084 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 7.9 mp -59.22 -44.84 92.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.16 -0.963 . . . . 0.0 110.725 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.02 -36.42 83.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.037 -1.039 . . . . 0.0 109.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -69.24 -38.12 78.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.475 -0.766 . . . . 0.0 111.426 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.659 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 2.3 ptm -71.17 -48.82 49.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.799 -1.188 . . . . 0.0 111.601 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.636 ' H ' ' HG3' ' A' ' 88' ' ' MET . 16.1 tp -57.89 -33.68 68.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.003 -1.06 . . . . 0.0 108.707 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.59 -47.53 75.42 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.441 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' CG ' ' A' ' 95' ' ' LYS . . . -68.6 -48.61 49.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.624 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 14.0 m-30 -62.13 -52.29 64.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -1.183 . . . . 0.0 110.787 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.593 ' O ' ' HB ' ' A' ' 97' ' ' VAL . 4.1 mt -54.0 -50.58 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.056 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' HG3' ' CD1' ' A' ' 98' ' ' LEU . 4.8 ttpm? -66.14 -27.95 68.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.848 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 91' ' ' GLY . 16.9 mmtt -65.92 -42.83 89.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 111.795 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.624 ' CE2' ' O ' ' A' ' 92' ' ' PHE . 2.5 p90 -115.99 -33.21 5.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.646 -1.284 . . . . 0.0 111.901 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.607 HG23 ' CD1' ' A' ' 96' ' ' PHE . 49.2 t -53.67 -21.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.617 -1.302 . . . . 0.0 109.879 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.541 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 12.1 mt -88.86 39.82 0.95 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.64 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -64.76 155.28 83.01 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.21 -2.32 10.3 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.034 1.544 . . . . 0.0 110.497 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.586 ' HG3' ' CD2' ' A' ' 127' ' ' TYR . 39.7 mm-40 -86.05 -12.08 51.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 103' ' ' GLU . 1.1 t 178.8 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 110.14 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.549 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER 33.39 63.48 0.35 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.576 -0.702 . . . . 0.0 110.359 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.602 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.8 m-20 -163.35 -62.7 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.7 Cg_endo -71.8 149.56 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.444 . . . . 0.0 110.299 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 11.4 pt-20 -69.62 121.99 18.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.17 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -110.27 165.83 11.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.17 150.37 34.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.84 142.72 50.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.244 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.499 ' NE2' ' HA3' ' A' ' 119' ' ' GLY . 23.5 p80 -123.0 129.78 51.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.118 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 118' ' ' ILE . 3.4 m -101.73 129.58 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.18 122.77 44.18 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.19 -30.9 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.075 1.566 . . . . 0.0 110.472 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -40.82 90.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.282 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.68 -0.05 17.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.007 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.49 ' O ' ' CD2' ' A' ' 142' ' ' LEU . 5.4 mt-30 52.6 37.98 24.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.017 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -117.06 149.96 39.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.519 HD13 ' CG1' ' A' ' 111' ' ' VAL . 11.3 mm -100.88 137.09 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.499 ' HA3' ' NE2' ' A' ' 110' ' ' HIS . . . -112.46 162.99 12.21 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' CG ' ' A' ' 131' ' ' LEU . 19.2 t-20 -143.76 128.02 17.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.87 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 t -116.87 124.71 50.17 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 110.53 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.1 t -115.09 124.4 51.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.79 26.14 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.452 ' HB1' ' SG ' ' A' ' 102' ' ' CYS . . . -94.3 -35.62 12.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 127' ' ' TYR . 9.5 p -136.72 2.25 2.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.425 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 87.49 -12.45 62.99 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.734 ' CG ' ' N ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -36.76 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -1.056 . . . . 0.0 110.266 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.87 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 2.2 tmm_? 45.95 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.21 -99.75 0.13 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.08 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.499 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -118.05 145.56 44.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -1.08 . . . . 0.0 110.525 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.525 ' CD1' ' CB ' ' A' ' 96' ' ' PHE . 2.1 tt -92.08 129.13 38.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.154 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.513 ' N ' HD22 ' A' ' 131' ' ' LEU . 1.4 t70 -131.7 -71.02 0.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.332 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.521 HG23 ' CD2' ' A' ' 134' ' ' HIS . 1.6 m 68.25 153.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.244 -0.91 . . . . 0.0 110.262 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.521 ' CD2' HG23 ' A' ' 133' ' ' THR . 7.7 p80 -42.77 -51.11 5.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' H ' ' CG ' ' A' ' 134' ' ' HIS . 48.0 t60 -97.03 140.44 31.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.983 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -75.59 81.65 2.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.935 . . . . 0.0 110.332 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 95' ' ' LYS . 2.4 pp -82.66 -19.19 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.482 ' HA ' HD11 ' A' ' 141' ' ' ILE . 40.0 m -56.31 -40.37 74.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 110.269 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -40.81 98.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 110.323 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -61.42 -49.4 77.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.41 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.551 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 16.9 pt -70.26 -41.89 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.543 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.49 ' CD2' ' O ' ' A' ' 116' ' ' GLN . 20.4 tp -56.02 -40.94 74.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 111.028 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 0.4 OUTLIER -108.99 -23.22 11.8 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.065 -1.022 . . . . 0.0 110.886 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 140' ' ' PHE . 13.4 m120 57.9 103.4 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.401 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 46.0 Cg_endo -73.0 172.48 15.38 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.979 1.515 . . . . 0.0 110.475 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.416 ' HG2' ' HA ' ' A' ' 149' ' ' SER . 45.2 Cg_endo -73.18 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.067 1.562 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 148' ' ' ASN . 1.3 mp0 -84.58 124.84 31.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 147' ' ' GLU . 5.1 m120 60.32 13.39 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 148' ' ' ASN . 1.3 m 42.75 74.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.92 155.67 32.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.4 m -72.52 57.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.38 90.53 1.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -169.15 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.41 -173.0 15.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.75 59.56 4.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -1.111 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.169 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.268 0.556 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -124.68 -179.2 4.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.251 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 9.8 p -47.57 127.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -92.15 177.35 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 41.2 t -45.03 -28.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 3.6 t-20 65.41 152.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -68.47 -13.74 62.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 9' ' ' VAL . 1.1 t -78.26 -7.68 57.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 8' ' ' SER . 41.0 t 46.23 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.3 ptm -151.81 28.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 14' ' ' TYR . 41.6 t0 -52.87 119.11 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.26 -21.79 31.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -114.95 25.73 10.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.584 ' CD2' ' N ' ' A' ' 15' ' ' ARG . 17.6 t80 -50.59 -78.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.584 ' N ' ' CD2' ' A' ' 14' ' ' TYR . 19.5 tpp85 -112.63 -30.98 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.04 130.21 46.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 110.234 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 18' ' ' MET . 1.4 ttpm? -128.71 162.17 28.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.228 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.401 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 8.5 ttt -141.77 109.95 6.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 46.3 Cg_endo -73.07 -57.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 179.76 -142.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.3 tt -84.84 133.92 34.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.62 133.82 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.239 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.05 147.18 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.099 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.22 137.17 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 110.3 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 25' ' ' VAL . 4.3 p -97.03 135.33 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.38 137.59 50.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.201 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 64.41 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -89.77 174.99 7.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.82 -3.85 44.65 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -72.84 -18.04 61.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -1.183 . . . . 0.0 110.218 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . 118.78 -44.58 1.38 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.603 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.2 OUTLIER 168.66 105.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -1.089 . . . . 0.0 109.581 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HB3' HD13 ' A' ' 75' ' ' ILE . 7.7 mtmt -112.66 134.01 54.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.537 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.1 m -97.24 120.23 37.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.532 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 3.2 m -101.53 118.78 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.609 ' CG2' ' CB ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -95.22 111.95 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 ' CG2' ' HE2' ' A' ' 24' ' ' LYS . 13.9 t -101.1 -44.13 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.876 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -92.2 4.61 52.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.94 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.609 ' CB ' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.15 -33.38 75.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.0 110.242 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.2 m -59.42 -38.39 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.05 -47.14 81.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.184 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.53 -48.32 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 50' ' ' PRO . . . -56.65 -34.93 67.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.72 -48.76 78.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.6 66.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.666 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 6.7 tt -85.34 -9.38 57.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 83.67 -35.72 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.706 -0.621 . . . . 0.0 110.621 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' H ' HD22 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -92.62 154.16 42.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.224 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.533 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.3 Cg_endo -73.18 150.57 47.89 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.021 1.537 . . . . 0.0 110.365 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HB3' ' HB3' ' A' ' 43' ' ' ALA . 46.6 Cg_endo -73.24 -22.4 19.04 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.043 1.549 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.485 ' C ' ' OG1' ' A' ' 54' ' ' THR . 6.5 p -66.12 -21.66 66.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.497 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -79.79 -56.63 0.75 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.786 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 49' ' ' PRO . 46.3 Cg_endo -73.4 2.41 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.907 1.477 . . . . 0.0 111.054 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.51 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.44 -28.78 61.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.002 -1.062 . . . . 0.0 110.231 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -72.87 -45.56 57.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -0.923 . . . . 0.0 110.523 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.04 -51.18 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 110.414 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -44.01 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.887 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.06 -35.1 86.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -37.36 70.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -49.47 58.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.196 -0.94 . . . . 0.0 110.581 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -77.88 9.06 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 0.0 111.121 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.01 4.52 42.44 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -115.06 163.75 15.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -1.143 . . . . 0.0 109.129 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.501 ' C ' ' CG2' ' A' ' 65' ' ' THR . 7.5 pm0 -110.09 -120.78 0.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.582 -1.324 . . . . 0.0 109.964 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.5 p -149.4 170.53 18.34 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.447 -0.783 . . . . 0.0 110.966 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.538 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -143.82 139.53 29.37 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.695 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 18.4 m-85 -126.59 142.03 51.67 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.862 -1.135 . . . . 0.0 112.803 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 42.9 m-20 -121.33 117.47 27.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.083 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.09 -63.58 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -16.73 6.52 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.16 -0.962 . . . . 0.0 108.592 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.605 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.95 -29.88 10.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.656 -0.652 . . . . 0.0 110.051 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.5 m-20 69.66 15.48 8.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 109.986 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 2.6 ttm180 -113.89 129.86 56.55 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.669 -0.644 . . . . 0.0 109.581 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.695 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.5 m-30 -113.0 134.53 54.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -129.44 148.77 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.816 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.566 ' N ' ' CD1' ' A' ' 75' ' ' ILE . 25.5 t -113.6 138.0 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -0.985 . . . . 0.0 109.864 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.561 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 21.6 m-20 -59.88 141.08 56.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.855 . . . . 0.0 110.905 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.55 157.76 33.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.537 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 91.8 p -101.81 122.13 43.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.143 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.586 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -142.03 114.93 8.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HG2' ' CB ' ' A' ' 84' ' ' LYS . 2.2 pm0 -84.19 151.82 24.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.811 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' GLN . . . -52.46 -39.36 61.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.599 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 1.4 t-20 -64.54 -34.04 77.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 110.709 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.582 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -72.95 -48.27 38.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.635 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -0.957 . . . . 0.0 110.253 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.3 mt-30 -58.93 -36.99 75.67 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.451 ' CA ' ' HB2' ' A' ' 90' ' ' ASP . 1.1 m-20 -69.82 -36.51 75.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.426 0.631 . . . . 0.0 109.618 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.465 ' HE3' ' HA ' ' A' ' 85' ' ' LEU . 33.6 ttp -68.7 -50.39 51.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 109.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 93' ' ' ILE . 0.4 OUTLIER -64.07 -30.47 71.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.55 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . 5.4 m-20 -63.45 -35.7 81.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.706 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.48 -45.66 95.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -68.4 -52.07 37.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.266 . . . . 0.0 110.279 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 96' ' ' PHE . 2.1 pp -65.43 -34.48 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.393 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.57 ' O ' ' CG ' ' A' ' 98' ' ' LEU . 1.2 ttmt -55.34 -27.65 48.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' CB ' HD12 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -61.9 -42.94 99.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.887 -1.133 . . . . 0.0 111.165 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 93' ' ' ILE . 3.5 p90 -116.61 -27.96 6.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.144 . . . . 0.0 111.683 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.647 ' O ' ' N ' ' A' ' 99' ' ' CYS . 41.8 t -53.79 -59.94 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.962 -1.087 . . . . 0.0 111.001 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.57 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -61.68 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.239 -0.913 . . . . 0.0 110.526 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -85.2 155.47 60.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 110.196 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 42.5 Cg_endo -69.27 -11.2 30.93 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.985 1.518 . . . . 0.0 110.027 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.452 ' OE1' ' HG2' ' A' ' 100' ' ' PRO . 0.6 OUTLIER -134.23 13.59 3.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.435 -0.79 . . . . 0.0 109.687 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 107' ' ' THR . 0.5 OUTLIER -144.9 -29.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 97' ' ' VAL . 2.7 tm-20 -37.7 -69.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 0.0 110.83 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.604 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 2.1 m-20 -39.84 -61.96 0.97 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 110.641 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 46.4 Cg_endo -71.35 150.03 57.88 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.032 1.543 . . . . 0.0 110.623 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 129.09 38.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.711 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.527 ' CG2' ' SG ' ' A' ' 102' ' ' CYS . 4.7 p -110.06 150.25 28.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.638 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 2.4 p30 -121.04 157.66 29.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 109.943 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 HD21 ' CD2' ' A' ' 131' ' ' LEU . 0.9 OUTLIER -129.32 111.35 12.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.111 -0.993 . . . . 0.0 110.567 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 110' ' ' HIS . 24.5 p80 -124.3 119.21 28.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.375 -0.828 . . . . 0.0 109.982 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 111' ' ' VAL . 3.1 p -104.74 129.67 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -98.95 122.88 51.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.221 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.12 -26.6 14.74 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.937 1.493 . . . . 0.0 110.496 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -63.59 -39.93 95.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' CD ' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -110.8 -3.75 15.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.422 ' C ' HD13 ' A' ' 142' ' ' LEU . 2.5 mt-30 52.54 53.46 12.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.522 ' OG1' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -134.01 152.85 52.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.444 ' CG1' ' HB2' ' A' ' 142' ' ' LEU . 13.8 mm -101.49 126.16 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.55 ' O ' ' CD2' ' A' ' 110' ' ' HIS . . . -126.08 146.71 16.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.564 ' CB ' ' HB2' ' A' ' 131' ' ' LEU . 15.2 t-20 -144.17 152.79 41.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.113 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.73 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -116.65 123.65 47.81 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.819 -1.176 . . . . 0.0 110.048 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.482 ' HA ' ' SG ' ' A' ' 102' ' ' CYS . 43.5 t -89.68 112.21 23.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 110.292 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.35 -22.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.549 ' CB ' ' HG3' ' A' ' 105' ' ' PRO . . . -94.19 7.33 45.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 4.9 m 71.16 -1.87 2.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.427 -0.796 . . . . 0.0 109.95 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.84 -62.15 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 128' ' ' ARG . 5.8 p90 -136.19 -31.74 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -1.144 . . . . 0.0 110.788 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.73 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 1.9 mtt180 29.01 94.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.737 . . . . 0.0 110.888 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 158.68 -80.49 0.16 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.128 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.496 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -119.93 143.32 48.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -1.156 . . . . 0.0 110.701 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' A' ' 132' ' ' ASP . 0.4 OUTLIER -113.75 110.85 20.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.37 -0.831 . . . . 0.0 110.203 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 131' ' ' LEU . 12.4 p-10 165.65 114.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.849 0.833 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -104.55 -14.07 15.78 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.268 0.556 . . . . 0.0 110.04 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER 172.36 -152.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.45 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.034 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' HIS . 1.1 mtmt -124.89 -179.29 4.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.507 HD12 ' CB ' ' A' ' 95' ' ' LYS . 1.8 pt? -70.31 -4.04 20.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 110.25 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.514 ' O ' HG12 ' A' ' 141' ' ' ILE . 94.4 m -56.12 -48.14 76.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.073 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -68.84 -39.13 80.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 110.062 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.35 -48.69 80.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.52 HG13 ' N ' ' A' ' 142' ' ' LEU . 24.7 pt -69.12 -42.28 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.405 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.52 ' N ' HG13 ' A' ' 141' ' ' ILE . 18.7 tp -53.54 -26.48 21.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.446 ' NZ ' ' HG3' ' A' ' 146' ' ' PRO . 10.0 tttm -87.79 -22.2 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 15.8 m-80 61.65 165.27 0.1 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.7 Cg_endo -72.72 113.39 3.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.393 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 45.7 Cg_endo -72.66 175.06 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.967 1.509 . . . . 0.0 110.453 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 146' ' ' PRO . 2.9 tt0 -178.77 141.81 0.2 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.48 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.67 93.31 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.21 -3.85 6.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.7 t -156.89 175.4 14.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 110.227 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 49.79 35.15 23.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 m -64.83 -60.97 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 110.218 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -150.57 57.72 0.45 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 111.47 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -1.175 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.17 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -121.32 89.83 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.423 ' O ' HG22 ' A' ' 3' ' ' VAL . 13.3 p -136.26 19.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.438 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . 11.8 t-20 -72.9 155.31 40.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.2 p -71.38 -10.4 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 7' ' ' ARG . 34.5 p-10 -62.43 -20.08 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.499 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 3.5 ptm180 -69.43 -31.45 69.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 110.227 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 2.5 m -91.33 -7.97 49.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -0.863 . . . . 0.0 110.222 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' MET . 14.6 t -111.32 106.77 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.451 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 172.86 54.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.27 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' OD1' ' HB2' ' A' ' 13' ' ' PHE . 13.8 t0 -107.86 110.66 22.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' PHE . 1.4 pp0? -84.38 -13.7 51.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 1.7 t80 -42.73 -54.85 3.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.95 . . . . 0.0 110.286 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER 68.23 87.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 2.5 tpt180 -122.59 -12.99 8.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -109.71 130.16 55.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.237 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' O ' ' SD ' ' A' ' 18' ' ' MET . 9.2 pttp -133.25 162.27 32.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.434 ' SD ' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -142.23 100.71 5.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.23 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 45.5 Cg_endo -73.12 74.28 3.03 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.014 1.534 . . . . 0.0 110.459 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 10.3 mtm180 -156.7 110.15 2.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.467 HD23 ' HB2' ' A' ' 39' ' ' MET . 3.5 tm? -94.29 122.38 36.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.76 121.83 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.343 -0.848 . . . . 0.0 109.964 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.78 46.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.235 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.509 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.1 136.45 52.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.3 m -93.95 135.09 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.172 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -112.63 156.6 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.11 64.74 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 139.1 25.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -1.112 . . . . 0.0 110.175 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.32 -90.83 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.0 m120 -99.63 -0.47 40.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -1.148 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 -0.43 76.35 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.8 mm -151.86 87.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -1.109 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -129.44 142.84 50.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.282 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.591 ' CG2' ' NE2' ' A' ' 80' ' ' HIS . 20.9 m -98.34 128.87 44.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.509 ' CG2' ' CB ' ' A' ' 24' ' ' LYS . 3.2 m -101.43 127.69 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 0.7 OUTLIER -93.82 121.12 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.914 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.84 -46.96 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 111.26 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.99 18.5 14.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.989 -1.069 . . . . 0.0 111.17 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.58 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.16 -45.26 89.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 110.236 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 23.5 m -70.28 -39.09 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -62.08 -48.9 78.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.459 ' O ' HD21 ' A' ' 46' ' ' LEU . 95.0 t -66.75 -48.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.498 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -63.72 -35.03 79.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -62.78 -36.48 83.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.22 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.895 . . . . 0.0 110.232 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' CD1' ' HB2' ' A' ' 47' ' ' ASN . 3.2 pp -105.91 -1.24 24.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.515 ' HB2' ' CD1' ' A' ' 46' ' ' LEU . 0.8 OUTLIER 173.41 -151.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 110.243 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 8.4 mtt85 -89.31 174.95 4.34 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.6 Cg_endo -72.81 131.8 17.62 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.932 1.49 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 46.5 Cg_endo -73.72 1.25 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.547 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.598 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 88.1 m -56.46 -21.83 28.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 110.267 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -97.71 -54.9 0.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 111.277 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 52' ' ' TYR . 47.4 Cg_endo -74.99 -2.76 12.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.663 1.349 . . . . 0.0 111.151 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.506 ' OG1' ' CG2' ' A' ' 65' ' ' THR . 1.2 t -57.89 -14.41 6.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.298 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -72.77 -45.59 57.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.436 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -65.2 -51.17 62.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.026 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.589 ' CE1' HD23 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.36 -37.07 72.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 109.33 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -63.55 -35.21 91.73 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -37.15 70.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.2 . . . . 0.0 109.753 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 3.8 tp10 -64.5 -49.36 71.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.589 HD23 ' CE1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -81.1 11.57 4.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.15 -0.969 . . . . 0.0 110.985 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.95 4.57 42.27 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' O ' ' C ' ' A' ' 58' ' ' GLY . . . -116.11 163.15 16.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.145 -1.209 . . . . 0.0 109.257 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.522 ' C ' ' CG2' ' A' ' 65' ' ' THR . 2.2 tt0 -119.04 -123.33 0.29 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 0.0 109.813 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.9 p -149.98 170.63 18.4 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.641 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -149.59 139.48 21.91 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.714 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 23.8 m-85 -126.86 146.15 50.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.249 . . . . 0.0 113.024 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 3.6 t0 -121.34 117.45 26.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.922 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.14 -63.08 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.876 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -56.64 -15.22 4.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.139 -0.976 . . . . 0.0 108.957 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.628 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.8 t30 -106.0 -29.07 10.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.743 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.628 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 70.62 16.89 6.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.55 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -113.76 129.81 56.53 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.714 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.7 m-30 -111.16 129.03 56.07 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.752 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' CG2' ' HG2' ' A' ' 33' ' ' LYS . 13.8 mm -130.77 149.28 33.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.556 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 12.3 m -112.78 139.44 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 109.729 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 6.8 p-10 -69.32 137.0 52.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.258 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 108.1 129.61 6.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.486 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 63.1 p -92.07 121.77 33.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.005 -1.291 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.609 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 2.2 p-80 -142.02 114.86 8.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.416 -0.803 . . . . 0.0 110.04 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -58.72 157.13 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.067 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.555 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.11 -36.96 52.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 0.8 OUTLIER -55.91 -33.53 64.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.877 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -63.31 -39.52 94.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.551 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' HD23 ' A' ' 85' ' ' LEU . 3.5 mm? -60.36 -32.99 71.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.24 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.477 ' CA ' ' OE1' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -62.74 -37.04 85.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 109.772 179.486 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -59.35 -46.78 87.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.586 ' HE1' ' CD1' ' A' ' 57' ' ' PHE . 1.1 tmm? -71.63 -30.83 66.2 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.856 0.836 . . . . 0.0 109.341 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -51.77 -27.21 11.47 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 15.2 t70 -55.12 -35.99 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.961 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.93 -32.65 82.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -38.58 91.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.615 -0.932 . . . . 0.0 109.996 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.653 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 38.3 mm -52.08 -33.57 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.599 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 10.2 ttpt -55.22 -26.76 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.947 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.578 ' O ' ' CD2' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -60.64 -29.8 69.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.522 -0.737 . . . . 0.0 111.724 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.653 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 5.7 p90 -115.88 -19.13 10.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.717 -1.239 . . . . 0.0 111.552 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.678 ' O ' ' C ' ' A' ' 98' ' ' LEU . 5.7 m -60.53 -46.82 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.758 -1.214 . . . . 0.0 110.24 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.678 ' C ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER 8.9 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.679 -0.638 . . . . 0.0 111.28 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -85.27 155.35 60.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.481 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 43.4 Cg_endo -71.06 -8.66 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.033 1.543 . . . . 0.0 110.307 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.481 ' OE1' ' HG2' ' A' ' 100' ' ' PRO . 1.6 pm0 -139.82 22.94 2.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 110.067 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 99' ' ' CYS . 67.1 m -152.38 -31.45 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.535 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.529 ' HG3' ' HB3' ' A' ' 98' ' ' LEU . 4.0 tm-20 -43.53 -65.09 0.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 110.443 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 4.8 m-20 -37.37 -62.62 0.57 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.488 -0.757 . . . . 0.0 110.443 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.2 Cg_endo -71.7 149.72 55.23 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.851 1.448 . . . . 0.0 110.26 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -69.65 135.42 49.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 102' ' ' CYS . 7.1 p -141.88 166.04 25.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 16.8 m-20 -114.16 136.93 52.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.8 tt -110.77 123.45 50.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 110.212 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -124.16 133.42 53.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 118' ' ' ILE . 2.3 p -121.04 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.78 122.66 41.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 110.269 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.18 -39.01 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.886 1.467 . . . . 0.0 110.401 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -59.89 -41.99 92.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 3.4 tttm -93.45 -3.78 52.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.933 . . . . 0.0 110.306 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.78 40.99 31.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -130.88 164.61 24.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.527 ' CD1' HD13 ' A' ' 141' ' ' ILE . 7.2 mt -141.38 127.14 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 110.026 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 129' ' ' GLY . . . -134.22 164.2 24.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 0.4 OUTLIER -138.99 153.11 48.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -1.122 . . . . 0.0 109.151 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 20.2 m -116.71 124.83 50.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.97 -1.081 . . . . 0.0 110.73 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.464 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . 17.8 t -118.0 134.0 55.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.958 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -98.17 49.01 1.0 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.989 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' ' CB ' ' A' ' 105' ' ' PRO . . . -128.3 -32.52 2.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.64 4.46 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 0.0 110.614 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.511 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . 84.06 -12.56 53.52 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.645 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -40.44 -30.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -1.131 . . . . 0.0 110.241 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -27.5 125.9 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.676 -0.64 . . . . 0.0 111.231 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.429 ' O ' ' HA3' ' A' ' 119' ' ' GLY . . . 156.52 -90.25 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.069 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtt -119.81 152.19 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -1.103 . . . . 0.0 110.372 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.442 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 0.3 OUTLIER -68.83 142.15 54.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.494 ' O ' ' CB ' ' A' ' 133' ' ' THR . 1.9 m-20 -43.17 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.29 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.494 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 169.94 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 135' ' ' HIS . 46.6 m80 55.61 -161.01 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 134' ' ' HIS . 28.5 m-70 -41.66 163.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.897 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 81.22 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.121 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 96' ' ' PHE . 19.8 tp -82.96 -54.27 5.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.547 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 56.9 m -57.0 -42.42 80.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.383 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.6 m -68.63 -44.81 73.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.336 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.05 -49.11 76.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 138' ' ' CYS . 7.4 pt -69.79 -42.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.24 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.458 ' CB ' ' O ' ' A' ' 138' ' ' CYS . 37.8 tp -68.56 -13.11 62.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.743 . . . . 0.0 110.258 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.552 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 19.1 tttt -109.0 -9.93 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.581 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 1.6 p30 47.9 179.91 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 45.5 Cg_endo -74.01 110.77 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.785 1.413 . . . . 0.0 110.325 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 45.9 Cg_endo -73.37 171.14 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 149' ' ' SER . 10.6 tp10 44.45 33.38 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.414 ' HB3' ' O ' ' A' ' 147' ' ' GLU . 34.2 t-20 54.62 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -167.5 170.14 11.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.183 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -146.91 -178.28 6.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.0 141.34 44.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 149.68 -34.91 1.04 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.1 p -48.27 158.17 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 155' ' ' LYS . . . -104.73 -25.28 6.95 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER 60.22 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -1.071 . . . . 0.0 110.176 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 154' ' ' GLY . 1.2 tttt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.157 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.243 0.545 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -98.89 1.17 45.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.198 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG13 ' N ' ' A' ' 4' ' ' ASN . 41.2 t 54.53 167.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.515 ' N ' HG13 ' A' ' 3' ' ' VAL . 3.9 m120 -93.43 117.78 30.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.5 -23.2 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.208 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.37 22.64 5.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.212 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -69.95 -14.49 62.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 t -93.42 4.28 54.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.176 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.38 144.07 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 tpp -98.53 -64.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 17.4 p-10 -87.38 111.53 21.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.47 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -80.79 -16.61 53.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 75.0 t80 -82.31 9.94 7.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -68.69 -21.94 64.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.567 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 4.8 ttp180 -172.62 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -136.63 132.19 34.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 110.101 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.96 154.49 29.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.425 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -125.59 163.19 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 18' ' ' MET . 45.8 Cg_endo -72.98 -90.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.101 1.579 . . . . 0.0 110.44 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.505 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 0.7 OUTLIER 62.83 171.84 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.28 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.497 ' HA ' HG11 ' A' ' 42' ' ' VAL . 9.3 tp -87.28 130.13 34.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.242 -0.911 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.2 mm -132.59 129.63 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.497 ' HB1' ' N ' ' A' ' 82' ' ' ALA . . . -125.86 149.24 48.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HB3' HG11 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -116.15 138.45 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' VAL . 3.3 m -92.95 131.51 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 0.0 110.395 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -137.34 169.48 17.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.034 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . 66.05 30.15 76.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -89.5 175.12 7.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -1.132 . . . . 0.0 110.192 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.99 -60.09 4.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -99.93 -15.49 18.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.107 . . . . 0.0 109.643 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.669 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . -154.49 -109.66 0.35 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.669 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.4 OUTLIER 152.79 101.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.943 -0.739 . . . . 0.0 109.371 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' GLU . 3.6 ttpt -129.49 152.6 48.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.932 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.638 ' HB ' ' CE1' ' A' ' 80' ' ' HIS . 0.9 OUTLIER -111.21 128.49 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 24' ' ' LYS . 2.2 p -117.8 117.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.517 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.546 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 1.6 mt -96.07 112.95 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.07 -14.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 110.417 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 31.1 m120 -111.01 11.38 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.546 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 1.2 ttt -61.74 -45.41 94.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 36.6 t -70.24 -47.62 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.68 -50.01 70.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.897 . . . . 0.0 110.534 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 20' ' ' ARG . 43.0 t -68.36 -45.33 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.464 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.13 -39.06 86.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -67.52 -41.14 84.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.47 -17.88 62.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 3.9 tt -117.48 -9.11 10.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 110.522 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER 167.68 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.34 170.47 10.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.61 135.21 19.55 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.876 1.461 . . . . 0.0 110.538 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.444 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 50.5 Cg_endo -78.18 20.33 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.995 1.524 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.59 -21.93 30.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.311 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -85.54 -58.54 0.33 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.0 110.877 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.8 Cg_endo -73.16 0.3 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.798 1.42 . . . . 0.0 110.943 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -56.52 -20.92 22.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.217 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.81 -39.97 66.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.958 . . . . 0.0 110.584 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.45 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.5 t80 -58.87 -51.18 71.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.309 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 32.3 m-85 -57.53 -43.37 84.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.6 -35.38 85.59 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 86.9 m -57.1 -37.24 71.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 110.028 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -66.19 -49.35 67.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 110.83 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.56 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -80.17 11.56 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 4.89 26.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.554 ' CB ' ' HB2' ' A' ' 77' ' ' ASN . . . -116.47 163.77 15.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' C ' ' CG2' ' A' ' 65' ' ' THR . 3.3 mm100 -105.45 -120.44 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.598 -1.314 . . . . 0.0 109.754 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.52 170.24 19.07 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 75' ' ' ILE . 6.1 tt0 -143.47 139.33 29.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.686 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.3 m-85 -126.81 141.12 51.91 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.808 -1.182 . . . . 0.0 112.71 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -122.24 117.46 26.22 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.059 178.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -85.89 -63.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.656 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.3 ttmt -55.23 -17.49 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 108.872 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.612 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.8 OUTLIER -105.4 -29.35 10.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.561 -0.712 . . . . 0.0 110.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.612 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.8 m-20 70.77 16.54 6.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 99.6 mtt180 -113.68 129.64 56.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.567 -0.708 . . . . 0.0 109.629 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.686 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.1 m-30 -113.29 137.94 50.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 110.337 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.533 ' CG2' ' O ' ' A' ' 34' ' ' THR . 44.3 mt -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 14.5 t -114.04 137.73 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.554 ' HB2' ' CB ' ' A' ' 63' ' ' ALA . 67.9 m-80 -57.9 142.22 46.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 110.534 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 84.65 152.5 16.44 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.564 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 45.4 p -99.67 115.98 30.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.256 . . . . 0.0 110.687 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.638 ' CE1' ' HB ' ' A' ' 34' ' ' THR . 5.0 p-80 -143.32 117.05 9.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.158 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.446 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 3.2 tt0 -65.75 153.83 40.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.618 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' N ' ' HB1' ' A' ' 23' ' ' ALA . . . -52.31 -44.75 65.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.102 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.51 -33.47 76.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.055 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 88' ' ' MET . 4.0 tttp -61.11 -36.48 79.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.749 -0.594 . . . . 0.0 110.145 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.717 ' HA ' ' CG ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -59.4 -39.44 83.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.0 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -36.48 74.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.962 -1.086 . . . . 0.0 108.305 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 6.3 t70 -68.83 -33.92 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.397 0.618 . . . . 0.0 109.938 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.717 ' CG ' ' HA ' ' A' ' 85' ' ' LEU . 9.8 mmm -55.98 -49.6 73.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.353 -0.842 . . . . 0.0 109.757 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.33 -31.32 67.46 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 0.6 OUTLIER -65.02 -46.49 81.13 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.767 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 95' ' ' LYS . . . -62.51 -48.56 81.01 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.476 ' O ' HD21 ' A' ' 137' ' ' LEU . 2.9 m-30 -61.21 -52.48 64.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.282 . . . . 0.0 110.495 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.597 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 3.0 tt -65.8 -45.61 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.571 ' N ' ' CG2' ' A' ' 93' ' ' ILE . 0.1 OUTLIER -68.09 -27.73 66.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.236 -0.915 . . . . 0.0 111.25 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.565 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -61.42 -41.94 97.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.965 -1.085 . . . . 0.0 111.383 -178.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.6 ' CE1' HG21 ' A' ' 97' ' ' VAL . 27.7 p90 -109.47 -32.26 7.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.849 -1.157 . . . . 0.0 111.387 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.6 HG21 ' CE1' ' A' ' 96' ' ' PHE . 77.4 t -57.98 -14.92 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.881 -1.137 . . . . 0.0 109.964 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.54 HD21 ' CG ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -78.11 44.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -76.48 155.59 83.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.892 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 42.2 Cg_endo -68.44 0.66 4.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.864 1.454 . . . . 0.0 110.435 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 2.5 mt-10 -124.23 0.89 8.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 124' ' ' ALA . 17.2 p -163.79 23.14 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 2.4 tm-20 -73.09 53.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.075 -1.015 . . . . 0.0 110.027 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.588 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.4 m-20 -167.53 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.588 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.5 Cg_endo -70.51 149.8 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.922 1.485 . . . . 0.0 110.486 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.52 127.59 33.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 110.182 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.465 ' CG2' ' CB ' ' A' ' 122' ' ' CYS . 9.9 p -112.97 166.53 11.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 0.0 110.09 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.7 160.36 18.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 110.078 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.531 HD13 ' CZ ' ' A' ' 96' ' ' PHE . 1.1 tp -121.71 123.13 41.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.873 . . . . 0.0 110.612 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.584 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 10.4 p80 -124.22 115.23 20.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.889 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.539 ' CG1' ' HD2' ' A' ' 146' ' ' PRO . 13.6 p -97.77 129.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.933 . . . . 0.0 110.545 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -92.06 125.2 57.64 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.78 -28.54 13.58 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.956 1.503 . . . . 0.0 110.333 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -41.94 78.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 7.9 mmtp -98.65 -2.53 38.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.625 ' HG2' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER 52.38 38.03 24.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 110.328 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.482 ' HA ' HD13 ' A' ' 142' ' ' LEU . 1.6 p -127.03 153.63 45.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.153 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' CD1' HD13 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -101.09 126.19 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 110.3 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -104.19 164.19 14.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 120' ' ' ASN . 20.2 p-10 -134.6 133.14 39.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.0 109.685 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 3.1 p -116.88 124.48 49.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 102' ' ' CYS . 30.3 p -134.32 133.83 41.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 110.142 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.28 5.24 10.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 102' ' ' CYS . . . -53.63 -41.17 66.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 22.0 p -164.11 20.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 0.0 110.549 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 84.95 -12.91 56.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.685 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.4 OUTLIER -37.83 -30.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 110.274 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.645 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -23.91 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.672 -0.643 . . . . 0.0 110.995 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 166.27 -91.75 0.1 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.353 -1.404 . . . . 0.0 110.174 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.475 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -119.9 151.79 38.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -1.165 . . . . 0.0 110.711 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.505 ' CD2' ' SG ' ' A' ' 138' ' ' CYS . 16.9 tp -109.1 118.1 35.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 133' ' ' THR . 0.9 OUTLIER -84.63 -104.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.531 ' CG2' ' HG3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER 40.63 80.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.317 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -71.53 173.91 7.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.885 . . . . 0.0 110.252 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER 42.92 48.9 5.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.129 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.531 ' HG3' ' CG2' ' A' ' 133' ' ' THR . 0.1 OUTLIER -139.01 -177.61 4.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.185 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.565 ' CD2' ' HB3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -56.56 -13.12 2.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 110.331 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 55.5 m -55.83 -38.6 70.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.01 -41.21 78.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.013 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.35 80.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.702 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 138' ' ' CYS . 15.1 pt -68.63 -41.81 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.554 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 116' ' ' GLN . 16.3 tp -53.03 -19.9 3.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -93.21 -12.41 30.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.468 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.3 m-80 -113.75 102.9 55.28 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.64 110.46 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.043 1.549 . . . . 0.0 110.456 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 111' ' ' VAL . 47.0 Cg_endo -74.11 -169.74 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.039 1.547 . . . . 0.0 110.376 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -93.76 113.41 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 149' ' ' SER . 0.9 OUTLIER -111.77 -161.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 148' ' ' ASN . 1.4 t 64.83 123.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 149' ' ' SER . 1.7 m-20 60.29 115.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 151' ' ' SER . 9.2 p 46.35 61.44 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.207 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' O ' ' OG1' ' A' ' 153' ' ' THR . . . -57.23 92.82 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 152' ' ' GLY . 63.3 p 43.43 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.82 50.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -147.54 64.07 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -1.189 . . . . 0.0 110.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.187 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.524 HD13 ' CG2' ' A' ' 3' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.1 141.59 31.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' CG2' HD13 ' A' ' 1' ' ' LEU . 14.6 t -139.04 158.04 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.218 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -90.64 172.73 8.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 110.234 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 6.5 p -69.56 -15.03 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 15.2 m120 54.66 71.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -14.05 61.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -87.61 -2.69 58.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.985 . . . . 0.0 110.155 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -132.62 143.65 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.148 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.429 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 5.2 ptp -46.56 147.62 1.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 21.4 t70 -94.38 121.06 35.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.536 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 13.1 pt20 -58.47 -23.08 56.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER 72.63 -52.47 0.7 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.556 ' CD2' ' HB3' ' A' ' 13' ' ' PHE . 3.1 p90 -143.74 -33.64 0.42 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 15.9 ttm180 -158.39 -57.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 7.1 p90 -137.16 129.83 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.065 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.531 ' CB ' ' O ' ' A' ' 11' ' ' ASP . 13.3 tmtt? -133.57 130.18 38.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.277 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mtp -108.32 126.69 29.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -72.09 -95.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 37.26 -149.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.0 110.32 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 3.4 tm? -84.66 136.58 33.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 21' ' ' LEU . 3.2 pt -109.99 120.89 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.13 136.77 54.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 35' ' ' VAL . 1.6 mmmm -118.44 137.93 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.8 m -93.31 128.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.16 167.69 21.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.67 -77.24 0.4 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 41.5 mmtt -100.38 175.17 5.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -1.111 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -38.56 -39.78 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -94.84 -18.66 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' LYS . . . 71.69 99.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -105.89 3.73 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -1.162 . . . . 0.0 110.049 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' CD ' HG21 ' A' ' 75' ' ' ILE . 17.6 ttmm -97.58 152.91 18.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 109.29 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.8 m -99.28 115.81 30.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.832 -1.168 . . . . 0.0 110.914 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' CA ' HG23 ' A' ' 75' ' ' ILE . 2.2 p -112.36 117.42 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.84 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.53 HD13 ' CE ' ' A' ' 39' ' ' MET . 58.5 mt -95.88 109.75 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.66 -16.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.316 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 22' ' ' ILE . 6.2 p-10 -97.8 2.61 49.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 110.21 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.53 ' CE ' HD13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -55.86 -33.64 64.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.195 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.49 -44.47 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 7.2 t0 -66.17 -48.35 71.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 43' ' ' ALA . 8.1 p -61.15 -41.37 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.525 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -61.35 -35.18 76.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.014 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.4 mmmt -59.41 -37.21 77.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.875 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' CB ' HD21 ' A' ' 46' ' ' LEU . . . -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.952 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.818 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -96.27 -9.05 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.889 . . . . 0.0 109.218 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 74.3 -50.18 0.68 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.634 . . . . 0.0 110.408 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.458 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 20.9 mtt85 -77.04 168.03 31.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.6 140.45 32.79 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.397 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.53 ' O ' ' CG2' ' A' ' 54' ' ' THR . 47.6 Cg_endo -73.51 -15.62 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.054 1.555 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.477 HG22 ' CE1' ' A' ' 67' ' ' PHE . 73.8 p -64.07 -27.05 68.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -75.98 -54.91 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.19 -42.91 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.816 1.429 . . . . 0.0 110.829 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 6.9 t -56.36 -15.75 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 110.386 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -72.25 -45.36 60.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.349 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.66 79.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.6 -42.09 82.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.008 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.544 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.39 -35.43 85.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -37.12 74.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 110.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.72 -30.09 69.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.265 -0.897 . . . . 0.0 110.987 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.571 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -102.26 13.19 35.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.969 -1.082 . . . . 0.0 110.914 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.06 4.89 30.63 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.63 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -113.74 164.29 13.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.202 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.504 ' C ' ' CG2' ' A' ' 65' ' ' THR . 6.0 tt0 -109.92 -121.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.626 -1.296 . . . . 0.0 109.608 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.74 170.5 18.58 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.385 -0.822 . . . . 0.0 111.325 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.5 OUTLIER -139.82 139.92 36.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.693 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 21.1 m-85 -126.36 142.75 51.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.59 -1.244 . . . . 0.0 113.138 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 2.3 t0 -121.7 117.19 26.02 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.065 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -89.85 -45.1 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.0 -7.04 43.5 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -119.05 -27.19 5.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.749 -0.594 . . . . 0.0 110.186 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.633 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.0 m-20 70.19 16.98 7.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 12.4 mmm-85 -113.53 129.77 56.49 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.671 -0.643 . . . . 0.0 109.491 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.693 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.02 129.39 56.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 110.541 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.53 HG21 ' CD ' ' A' ' 33' ' ' LYS . 12.6 mt -123.22 149.8 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.618 -0.676 . . . . 0.0 109.792 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 75.3 t -112.84 139.19 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.981 -1.074 . . . . 0.0 109.19 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.63 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 35.2 m-80 -65.63 141.63 58.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.862 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 105.24 138.83 9.56 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.475 ' HB3' HD13 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -80.38 131.5 35.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.516 ' CD2' ' OG1' ' A' ' 34' ' ' THR . 93.1 m-70 -141.7 126.34 17.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.645 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 82' ' ' ALA . 3.8 tp10 -100.89 151.07 22.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.583 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 21' ' ' LEU . . . -52.1 -43.67 64.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 110.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -58.55 -38.25 77.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.955 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -39.55 78.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 21' ' ' LEU . 21.3 mt -60.4 -40.76 92.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.474 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 1.6 tt0 -59.19 -36.36 75.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.541 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 2.6 m-20 -68.81 -46.61 68.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.918 . . . . 0.0 109.96 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.512 ' HE1' ' CD1' ' A' ' 57' ' ' PHE . 13.4 ttp -71.84 -41.0 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.401 -0.812 . . . . 0.0 110.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' O ' ' CD1' ' A' ' 93' ' ' ILE . 1.3 mt -51.96 -28.73 17.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 73.3 m-20 -56.17 -46.28 79.4 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.937 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.498 ' O ' ' CG ' ' A' ' 94' ' ' LYS . . . -66.92 -32.53 81.23 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -58.04 -40.05 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 110.24 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.655 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 1.4 mp -53.43 -33.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 98' ' ' LEU . 3.5 ptmt -54.91 -26.26 34.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 110.255 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.32 -28.05 67.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.389 -0.819 . . . . 0.0 111.687 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.655 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 5.9 p90 -115.18 -20.21 10.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.662 -1.274 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 5.3 m -55.76 -19.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.828 -1.17 . . . . 0.0 109.925 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -55.53 89.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' H ' ' CB ' ' A' ' 103' ' ' GLU . 75.2 m -82.64 155.11 68.6 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.11 39.86 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.988 1.52 . . . . 0.0 110.757 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -137.01 -53.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.116 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.494 ' HB2' ' CB ' ' A' ' 124' ' ' ALA . 4.5 p 175.05 54.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.592 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.554 ' O ' ' C ' ' A' ' 104' ' ' ASN . 8.5 tp10 -79.82 -19.42 48.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 0.0 109.947 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.571 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -30.36 -55.26 0.36 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.403 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 42.8 Cg_endo -70.02 150.52 66.74 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.967 1.509 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -68.49 111.19 4.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.97 . . . . 0.0 110.147 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.473 ' HB ' ' HA ' ' A' ' 122' ' ' CYS . 1.5 p -110.19 166.47 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.494 -0.754 . . . . 0.0 110.213 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.7 p30 -113.91 142.87 45.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.911 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 mp -106.08 145.42 31.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.364 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.526 ' CD2' ' HA3' ' A' ' 119' ' ' GLY . 11.6 p-80 -124.18 117.29 24.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CD2' ' A' ' 142' ' ' LEU . 5.8 p -118.02 129.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.529 ' HB2' ' CD ' ' A' ' 115' ' ' LYS . 7.8 m-80 -103.95 122.8 43.15 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 110.409 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.29 -33.92 6.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.039 1.547 . . . . 0.0 110.558 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.216 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CD ' ' HB2' ' A' ' 112' ' ' ASN . 1.9 ptpt -106.89 -1.71 22.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.948 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 53.64 53.37 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 146.31 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.515 ' CD1' ' HB ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -112.96 128.42 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.279 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.526 ' HA3' ' CD2' ' A' ' 110' ' ' HIS . . . -99.47 163.87 19.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.521 ' HB2' ' CA ' ' A' ' 131' ' ' LEU . 4.8 t30 -138.53 121.86 17.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -1.177 . . . . 0.0 109.756 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 30.0 t -125.27 130.57 52.31 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 110.702 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 74.0 m -113.06 133.0 55.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 109.903 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -84.16 44.32 1.01 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.494 ' CB ' ' HB2' ' A' ' 102' ' ' CYS . . . -129.19 -29.06 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 110.215 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 7.56 1.76 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 110.534 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.673 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.61 -12.3 59.49 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.673 ' C ' ' O ' ' A' ' 126' ' ' GLY . 7.4 t80 -12.13 -64.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.729 -0.866 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 7.7 tmm_? 21.75 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.882 -0.511 . . . . 0.0 111.193 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.32 -111.53 0.28 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.878 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.509 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -120.66 151.85 38.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.485 -1.009 . . . . 0.0 110.692 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.521 ' CA ' ' HB2' ' A' ' 120' ' ' ASN . 4.7 tt -97.83 107.55 20.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 109.823 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 133' ' ' THR . 9.3 m-20 -112.58 -84.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.514 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 0.8 OUTLIER 70.41 -175.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.036 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -70.88 155.29 40.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 63.3 m170 54.87 176.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -100.12 82.07 2.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.625 ' CD1' ' CG ' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -82.32 -5.62 58.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.51 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 57.9 m -62.69 -38.49 90.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 0.0 110.299 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.5 p -68.64 -40.32 80.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -59.02 -48.77 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.51 ' CD1' ' HA ' ' A' ' 138' ' ' CYS . 6.7 pt -69.17 -42.09 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.57 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.53 ' CD2' ' CG2' ' A' ' 111' ' ' VAL . 10.6 mt -53.26 -20.5 4.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.825 . . . . 0.0 110.32 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -86.07 -20.34 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.191 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.47 59.42 43.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.263 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.404 ' HB3' HG12 ' A' ' 111' ' ' VAL . 46.2 Cg_endo -72.96 169.56 21.87 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.041 1.548 . . . . 0.0 110.445 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' HB3' ' HD2' ' A' ' 155' ' ' LYS . 46.2 Cg_endo -72.94 -18.18 24.59 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.02 1.537 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 52.94 85.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 110.165 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.65 105.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.5 p -106.72 123.46 48.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -129.99 -160.86 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -90.53 137.74 32.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.127 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.93 -87.5 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 81.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -93.23 -49.76 2.55 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.4 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -109.63 -61.28 1.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 110.212 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.237 0.541 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t -128.6 -148.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.219 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -83.62 -43.12 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.458 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p30 -88.48 133.47 34.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 6' ' ' ASN . 39.4 t -71.69 -27.08 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 5' ' ' VAL . 1.5 m-20 60.38 121.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 8' ' ' SER . 8.1 ptp180 -69.94 -32.67 71.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.237 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 10' ' ' MET . 1.1 m -94.1 -13.77 26.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 110.115 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' C ' ' O ' ' A' ' 8' ' ' SER . 44.9 t 34.8 -94.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.483 -0.761 . . . . 0.0 110.568 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' SER . 8.6 ptt? -53.02 148.02 8.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.17 154.22 23.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.088 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -82.46 -13.57 56.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.893 . . . . 0.0 110.276 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -61.12 -22.82 65.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' ' N ' ' A' ' 15' ' ' ARG . 10.5 t80 -137.02 -91.57 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 0.0 110.236 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.55 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 12.1 ttt180 65.36 -63.12 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.511 ' N ' ' O ' ' A' ' 14' ' ' TYR . 51.5 p90 -104.79 151.77 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.314 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.469 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -132.8 162.08 32.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 110.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 1.3 mtt -144.48 150.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.198 -0.938 . . . . 0.0 110.205 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 46.4 Cg_endo -72.99 -29.88 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.538 . . . . 0.0 110.462 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 67.27 148.9 0.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.258 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.405 ' HB3' ' HB3' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -95.65 140.28 30.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.24 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 23' ' ' ALA . 27.8 mm -121.97 143.82 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' CB ' ' HA ' ' A' ' 81' ' ' GLU . . . -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.53 ' O ' ' CG1' ' A' ' 35' ' ' VAL . 7.9 mttt -139.41 138.08 36.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 0.0 110.148 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 46.5 t -93.53 122.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.33 133.24 27.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.374 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 148.52 -86.99 0.15 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.63 174.9 13.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -1.126 . . . . 0.0 110.231 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.42 -35.1 68.61 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -99.91 -18.63 17.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -1.162 . . . . 0.0 110.253 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -67.59 -50.57 42.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.7 mm 57.66 92.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -1.115 . . . . 0.0 110.293 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.53 141.93 50.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.595 ' CG2' ' NE2' ' A' ' 80' ' ' HIS . 1.4 m -96.88 127.87 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 24' ' ' LYS . 3.5 p -117.04 118.02 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.956 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.529 ' CG2' ' HG2' ' A' ' 39' ' ' MET . 8.1 mt -95.39 138.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.329 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG21 ' NH1' ' A' ' 73' ' ' ARG . 28.8 t -100.31 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.48 12.25 37.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.529 ' HG2' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -53.35 -33.43 53.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -68.83 -38.41 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -50.21 72.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 43' ' ' ALA . 10.1 p -65.84 -40.82 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -64.98 -34.92 79.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.203 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.47 85.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.96 63.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.071 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.538 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 10.3 tt -92.57 -3.32 55.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.8 m-20 72.61 -62.41 0.47 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.815 . . . . 0.0 110.364 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 169.86 19.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.48 147.15 45.82 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 47.0 Cg_endo -73.92 -23.4 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.997 1.525 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.648 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 72.5 p -57.85 -21.81 44.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.0 m-30 -80.14 -58.37 0.6 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.893 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.27 -30.94 15.06 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.837 1.44 . . . . 0.0 111.045 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.486 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 9.7 t -57.99 -14.01 5.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.993 . . . . 0.0 110.3 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.413 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 13.1 tptm -64.25 -45.38 88.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.952 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -64.83 -38.77 92.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.304 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.57 -35.31 85.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -37.32 71.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' OE2' ' CZ ' ' A' ' 92' ' ' PHE . 3.1 mm-40 -66.68 -49.54 65.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.23 -0.919 . . . . 0.0 110.622 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -79.92 12.87 2.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.189 -0.945 . . . . 0.0 110.961 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.25 9.38 29.48 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -118.74 163.95 16.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -1.122 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.5 ' C ' ' CG2' ' A' ' 65' ' ' THR . 31.4 mt-30 -105.36 -117.29 0.23 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.833 -1.167 . . . . 0.0 110.144 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.0 170.37 18.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 111.081 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.88 139.65 27.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.704 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 24.7 m-85 -126.67 143.46 51.22 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.001 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -123.69 117.37 24.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.969 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 HG21 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -88.11 -45.8 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.51 ' N ' HG21 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -70.0 -7.6 42.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.617 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -118.32 -25.92 6.43 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.687 -0.633 . . . . 0.0 110.207 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.6 m-20 68.74 16.17 8.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.86 129.79 56.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.525 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.704 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.9 m-30 -112.89 129.2 56.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.524 HG12 ' CG2' ' A' ' 35' ' ' VAL . 52.8 mt -118.57 149.17 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.521 -0.737 . . . . 0.0 109.966 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 34' ' ' THR . 2.2 p -113.15 134.15 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 65.5 m-80 -50.63 143.4 9.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.772 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 94.44 131.28 6.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.524 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 59.4 p -97.3 120.29 37.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -1.152 . . . . 0.0 110.106 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.595 ' NE2' ' CG2' ' A' ' 34' ' ' THR . 1.8 p-80 -142.38 151.52 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.787 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.513 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 4.8 tt0 -93.0 157.69 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.951 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.3 -43.8 64.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.68 -33.47 76.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.77 -37.33 86.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.191 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.2 mp -60.09 -33.02 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 16.9 tt0 -68.07 -36.22 79.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.846 . . . . 0.0 109.641 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.17 -46.4 74.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.638 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.584 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 3.4 ptm -69.9 -48.09 59.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.083 -1.011 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.9 OUTLIER -54.33 -32.57 56.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 108.613 179.131 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.462 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -63.68 -35.98 82.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.267 0.556 . . . . 0.0 110.091 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.78 -37.38 94.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.576 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 5.8 m-30 -63.87 -40.75 97.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.222 -1.164 . . . . 0.0 109.852 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 96' ' ' PHE . 0.1 OUTLIER -55.13 -44.14 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' N ' HG23 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -57.72 -28.02 63.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 110.62 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.491 ' O ' ' SG ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -61.74 -42.81 99.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.93 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 93' ' ' ILE . 8.7 p90 -116.46 -25.4 7.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.873 -1.142 . . . . 0.0 110.654 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.589 ' CG2' ' CE2' ' A' ' 96' ' ' PHE . 16.0 t -82.66 -55.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.73 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 98' ' ' LEU . 3.6 mm? -112.38 57.02 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.389 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.517 ' SG ' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -78.41 151.5 77.86 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.871 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 44.9 Cg_endo -72.3 1.17 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.91 1.479 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' C ' ' SG ' ' A' ' 102' ' ' CYS . 24.5 tt0 -75.39 -63.91 1.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.198 -0.939 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.473 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 62.8 m -148.55 4.95 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.593 ' OE2' ' CE2' ' A' ' 127' ' ' TYR . 24.2 mp0 -78.75 -14.85 59.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.575 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 3.0 m120 -29.43 -55.58 0.29 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.732 -0.605 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 42.5 Cg_endo -68.86 150.48 73.6 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.16 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 116.43 9.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.172 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.557 ' CG2' ' HA ' ' A' ' 122' ' ' CYS . 1.2 p -110.21 166.33 11.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.408 -0.808 . . . . 0.0 110.123 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.61 154.4 27.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 110.008 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 5.6 mp -105.96 138.15 42.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.471 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -124.09 115.26 20.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' HD11 ' A' ' 118' ' ' ILE . 4.0 p -97.19 124.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 110.309 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -90.01 122.68 67.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.34 -30.03 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.997 1.525 . . . . 0.0 110.477 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -66.83 -42.15 86.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -102.87 -3.92 25.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 52.53 38.1 24.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -118.06 179.6 4.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.536 HG23 ' CD1' ' A' ' 141' ' ' ILE . 12.7 mm -128.04 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.312 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.616 ' HA2' ' O ' ' A' ' 129' ' ' GLY . . . -147.66 123.88 1.81 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.517 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 3.7 p-10 -144.65 120.88 10.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.285 . . . . 0.0 108.967 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 128' ' ' ARG . 1.2 m -116.89 156.43 27.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.157 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 124' ' ' ALA . 25.8 p -87.64 134.64 33.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.435 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 122' ' ' CYS . 4.8 tttt -27.28 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.769 -0.582 . . . . 0.0 111.446 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 122' ' ' CYS . . . -61.75 -15.33 40.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.76 ' O ' ' N ' ' A' ' 127' ' ' TYR . 9.0 m 68.18 -48.21 0.54 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -0.976 . . . . 0.0 110.21 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' ALA . . . -34.6 -12.78 0.0 OUTLIER Glycine 0 N--CA 1.496 2.649 0 O-C-N 121.826 -0.546 . . . . 0.0 112.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.79 ' HD1' ' O ' ' A' ' 127' ' ' TYR . 0.7 OUTLIER -145.37 99.42 3.3 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.539 -1.565 . . . . 0.0 110.325 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.598 ' HA ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -86.65 123.86 32.29 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.616 ' O ' ' HA2' ' A' ' 119' ' ' GLY . . . -81.41 51.85 4.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.66 121.76 27.26 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.555 -0.968 . . . . 0.0 110.106 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 138' ' ' CYS . 2.4 mt -113.64 142.15 46.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.509 -0.745 . . . . 0.0 110.369 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.54 -24.38 4.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.7 p -57.66 -179.52 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' HIS . 86.8 m-70 -146.44 69.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 134' ' ' HIS . 11.3 p80 176.23 33.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.7 OUTLIER -138.94 -177.55 4.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.47 ' CD2' ' CE2' ' A' ' 96' ' ' PHE . 1.3 tt -42.05 -26.24 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 131' ' ' LEU . 53.0 m -56.3 -40.07 73.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.9 m -68.73 -41.51 78.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.441 ' CE2' ' CZ ' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -56.88 -48.05 79.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.663 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.536 ' CD1' HG23 ' A' ' 118' ' ' ILE . 18.4 pt -68.55 -42.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.488 ' N ' HG13 ' A' ' 141' ' ' ILE . 45.1 tp -53.4 -29.95 37.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.543 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.528 ' O ' ' CE ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -109.09 -1.48 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -51.79 143.89 20.67 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.932 . . . . 0.0 110.302 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 163.41 37.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.008 1.531 . . . . 0.0 110.341 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 -177.59 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.951 1.501 . . . . 0.0 110.456 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.11 23.08 8.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 149' ' ' SER . 1.0 OUTLIER 54.91 -172.47 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.23 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 148' ' ' ASN . 0.3 OUTLIER 59.48 162.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 149' ' ' SER . 5.1 t0 55.36 104.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 m 60.98 162.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 110.221 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 117.38 -10.34 14.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 64.0 p -76.24 82.97 3.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -1.122 . . . . 0.0 110.194 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -163.2 154.72 25.76 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -131.86 -51.91 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.205 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.164 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.277 0.561 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 155.43 17.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.242 -0.912 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 4' ' ' ASN . 8.6 p -133.95 -37.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.485 ' N ' HG12 ' A' ' 3' ' ' VAL . 73.3 m-80 -75.91 106.17 7.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -58.55 -22.54 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.66 91.05 8.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -69.11 -20.29 64.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.428 ' O ' ' SD ' ' A' ' 10' ' ' MET . 76.7 p -93.21 7.96 42.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 8' ' ' SER . 11.9 p -43.14 134.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 8' ' ' SER . 3.2 mpp? -112.14 -169.85 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 22.2 p-10 -86.96 114.31 23.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.551 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 14.1 mm100 -70.46 -20.26 62.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.89 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 12.9 t80 43.54 41.07 3.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.135 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -140.43 5.53 2.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 14' ' ' TYR . 1.8 ttt-85 -133.33 -49.88 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -100.03 139.22 36.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.219 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.37 159.19 32.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.435 ' O ' ' HG3' ' A' ' 18' ' ' MET . 2.1 ppp? -102.81 115.43 64.25 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.15 -155.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.971 1.511 . . . . 0.0 110.263 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mmt85 -91.78 -165.51 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.93 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.451 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 5.7 tt -65.03 133.85 52.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.19 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.2 mt -112.4 143.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 81' ' ' GLU . . . -125.37 123.98 40.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.898 . . . . 0.0 110.385 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 138.2 53.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 74.6 t -93.11 122.32 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.409 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' CB ' HG23 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.17 153.66 45.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.389 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.92 -81.07 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -152.61 153.23 32.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -1.088 . . . . 0.0 110.126 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.7 -5.56 89.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.02 -16.03 18.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.144 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . -109.59 -114.36 3.64 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.639 ' CB ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER 156.43 108.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.854 -0.792 . . . . 0.0 109.547 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -126.88 152.65 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -0.956 . . . . 0.0 110.502 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 80' ' ' HIS . 1.2 m -108.06 116.24 31.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.133 -0.98 . . . . 0.0 110.373 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG23 ' CB ' ' A' ' 26' ' ' GLU . 48.6 t -104.08 117.46 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.758 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 3.9 mm -96.02 108.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.41 -23.53 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 20' ' ' ARG . 46.2 t30 -95.93 8.79 42.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.519 ' HG2' ' CG ' ' A' ' 50' ' ' PRO . 1.9 ttt -64.12 -45.29 89.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 17.9 t -67.24 -40.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -69.19 -45.26 70.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.661 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.444 ' CG2' ' ND2' ' A' ' 38' ' ' ASN . 80.4 t -68.29 -48.73 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 48' ' ' ARG . . . -67.45 -43.96 79.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.393 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 7.8 ttpt -59.54 -36.48 76.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.095 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 41' ' ' ASP . . . -71.21 -16.5 62.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.632 ' C ' ' CD1' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -117.39 -11.17 10.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.149 -0.969 . . . . 0.0 110.078 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 13.6 t-20 167.02 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.237 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -137.67 172.07 7.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.08 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HA ' ' HB1' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -72.72 139.51 30.9 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.031 1.543 . . . . 0.0 110.629 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' CB ' ' HG2' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.76 60.34 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.042 1.548 . . . . 0.0 110.394 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -68.73 -50.53 50.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 111.332 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.733 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 p90 -87.33 -29.0 0.38 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.351 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.3 Cg_endo -71.29 -2.18 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.07 1.037 . . . . 0.0 110.755 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 50' ' ' PRO . 2.9 p -76.46 -10.99 59.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.106 -0.996 . . . . 0.0 110.372 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -72.94 -45.42 58.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 0.0 110.58 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.53 -47.78 77.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 110.392 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.46 -42.8 83.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.859 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.52 -35.44 85.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -37.21 71.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -1.196 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -48.79 68.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.879 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.566 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -80.72 12.83 2.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.107 -0.995 . . . . 0.0 110.95 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.47 5.44 22.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -116.48 163.93 15.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -1.133 . . . . 0.0 109.213 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' C ' ' CG2' ' A' ' 65' ' ' THR . 19.6 mt-30 -102.87 -119.56 0.19 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.634 -1.292 . . . . 0.0 109.998 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -149.5 170.41 18.67 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 111.005 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.9 mt-30 -146.01 139.47 26.14 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.745 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.69 144.53 50.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.876 -1.14 . . . . 0.0 112.748 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.576 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 1.9 t0 -124.01 117.42 24.69 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.323 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.5 ' CG2' ' N ' ' A' ' 70' ' ' LYS . 15.2 m -88.91 -46.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' N ' ' CG2' ' A' ' 69' ' ' VAL . 2.5 tppt? -69.75 -8.73 50.52 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.636 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -117.17 -26.76 6.68 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.677 -0.639 . . . . 0.0 110.124 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.636 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 4.7 m-20 69.8 16.53 7.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HG3' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.87 129.66 56.57 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 109.643 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.18 129.18 56.59 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.417 -0.802 . . . . 0.0 110.5 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.535 ' CD1' ' HG2' ' A' ' 33' ' ' LYS . 2.3 tt -124.12 148.34 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.487 -0.758 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' CG2' ' HB ' ' A' ' 34' ' ' THR . 11.0 m -114.35 139.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.7 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 70.6 m-20 -55.74 146.36 21.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.5 150.78 21.87 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.553 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 2.7 p -103.92 123.92 48.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -1.173 . . . . 0.0 110.202 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.56 ' N ' ' OG1' ' A' ' 34' ' ' THR . 0.1 OUTLIER -142.19 114.84 8.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.569 ' O ' ' CD2' ' A' ' 85' ' ' LEU . 4.9 tt0 -74.74 156.54 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.605 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.7 -44.19 63.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.077 -1.014 . . . . 0.0 109.74 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.09 -33.14 75.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.22 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 88' ' ' MET . 29.8 mttt -71.35 -36.47 71.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.638 -0.663 . . . . 0.0 110.475 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 81' ' ' GLU . 1.2 mm? -59.37 -44.23 92.77 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.227 -0.921 . . . . 0.0 110.144 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -68.62 -36.12 78.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.948 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 37.8 t0 -64.87 -46.12 83.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 111.297 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 3.2 ptm -57.94 -48.63 79.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.174 . . . . 0.0 110.681 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.579 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.7 OUTLIER -57.57 -33.06 67.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 0.0 108.554 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -64.33 -45.08 89.44 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.34 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 95' ' ' LYS . . . -61.89 -44.59 97.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -51.82 66.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -1.199 . . . . 0.0 110.013 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.581 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 17.1 mt -65.43 -50.6 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -61.32 -27.28 68.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 110.608 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 91' ' ' GLY . 9.9 mmtp -60.75 -37.26 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 111.381 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.644 ' CE1' ' CG1' ' A' ' 97' ' ' VAL . 18.7 p90 -115.34 -19.07 10.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 111.455 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.644 ' CG1' ' CE1' ' A' ' 96' ' ' PHE . 4.4 m -84.29 -8.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.813 -1.179 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' HG2' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -58.59 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.126 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.537 ' N ' ' O ' ' A' ' 97' ' ' VAL . 99.0 m -87.99 155.06 52.7 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.252 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.44 2.91 5.2 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.087 1.572 . . . . 0.0 110.207 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.627 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.1 mm-40 -98.25 18.24 16.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.1 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER 78.7 44.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.491 -0.755 . . . . 0.0 110.287 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.7 ' O ' ' N ' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -43.87 -24.14 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.753 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 2.6 m-20 16.93 -76.66 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 122.039 -0.413 . . . . 0.0 111.916 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.753 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 39.2 Cg_endo -64.93 150.17 88.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 110.507 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -68.66 129.47 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.08 -1.012 . . . . 0.0 110.261 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 121' ' ' SER . 1.3 p -110.2 166.17 11.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 110.161 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -114.07 151.83 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.893 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.585 HD22 ' CZ ' ' A' ' 96' ' ' PHE . 3.2 pp -119.36 149.54 41.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.595 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -124.11 119.48 29.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 109.993 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.542 HG12 ' CB ' ' A' ' 147' ' ' GLU . 8.2 p -101.75 129.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 116' ' ' GLN . 1.4 t-20 -101.2 124.88 39.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.17 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HG3' ' O ' ' A' ' 147' ' ' GLU . 46.2 Cg_endo -73.19 -31.62 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.974 1.513 . . . . 0.0 110.533 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.501 ' HB2' ' NZ ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -73.44 -33.76 65.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -108.67 -3.68 17.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.279 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER 52.56 38.52 25.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.883 . . . . 0.0 110.223 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -121.14 159.6 25.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.158 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.532 HD12 ' CA ' ' A' ' 142' ' ' LEU . 9.1 mt -126.51 126.25 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 109' ' ' LEU . . . -103.57 163.97 15.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.529 ' HB2' ' CD1' ' A' ' 131' ' ' LEU . 9.6 t-20 -143.62 129.56 19.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.257 . . . . 0.0 109.941 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 9.7 p -117.11 124.67 49.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -0.965 . . . . 0.0 110.272 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 125' ' ' CYS . 30.2 p -107.44 134.45 50.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.815 . . . . 0.0 109.934 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 122' ' ' CYS . 6.0 tttt -37.33 -28.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.596 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.553 ' O ' ' HB2' ' A' ' 125' ' ' CYS . . . -72.03 -27.84 62.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.232 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.553 ' HB2' ' O ' ' A' ' 124' ' ' ALA . 5.9 m 73.45 -46.08 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.62 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.638 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.9 OUTLIER -109.79 -33.14 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 110.547 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -28.29 125.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.623 -0.673 . . . . 0.0 110.866 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.53 -90.38 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.632 -1.271 . . . . 0.0 109.946 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.464 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -119.76 151.56 38.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -1.155 . . . . 0.0 110.523 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.551 ' CD2' ' HB3' ' A' ' 138' ' ' CYS . 0.9 OUTLIER -71.98 142.55 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.116 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -36.2 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 110.507 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -172.38 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 110.354 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.495 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 45.5 m170 -88.42 -135.42 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER 68.26 -60.38 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.109 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -68.87 -177.62 1.04 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 110.067 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 96' ' ' PHE . 1.1 pp -52.6 -14.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.393 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.565 ' O ' HG12 ' A' ' 141' ' ' ILE . 56.4 m -56.06 -42.41 76.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.984 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -69.1 -39.36 79.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.563 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 8.7 t80 -56.89 -48.45 78.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -0.936 . . . . 0.0 109.745 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.63 ' O ' ' HD2' ' A' ' 145' ' ' PRO . 9.4 pt -66.12 -41.48 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.532 ' CA ' HD12 ' A' ' 118' ' ' ILE . 2.9 tm? -54.25 -29.56 47.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.355 -0.841 . . . . 0.0 110.59 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -109.42 -36.86 5.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.442 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.746 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 0.9 OUTLIER -60.25 -76.1 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.921 -1.112 . . . . 0.0 110.573 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.746 ' CD ' ' CB ' ' A' ' 144' ' ' ASN . 43.1 Cg_endo -68.4 109.24 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.492 1.259 . . . . 0.0 110.515 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 49.1 Cg_endo -76.39 64.77 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.992 1.522 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.542 ' CB ' HG12 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -40.53 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.394 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 149' ' ' SER . 5.2 m-20 -148.19 155.6 41.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 148' ' ' ASN . 1.6 t 43.38 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.74 54.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.8 m -96.75 -79.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.44 -64.82 0.18 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.81 -88.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.154 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 118.42 115.85 2.68 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.24 179.1 6.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 110.225 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 30.2 mtmm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.212 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.286 0.565 . . . . 0.0 110.243 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER 67.12 -58.52 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.513 ' N ' ' OG ' ' A' ' 2' ' ' SER . 76.2 t -65.73 122.62 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -87.03 175.78 7.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 37.9 t -69.17 -33.89 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.7 m120 58.41 122.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -83.95 -13.37 53.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 53.9 t 54.65 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 110.233 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.424 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 0.7 OUTLIER 43.12 -150.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.176 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 128.41 36.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 6.8 mp0 -78.35 -40.86 35.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 12' ' ' GLN . 0.2 OUTLIER 69.75 99.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -144.55 -99.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.145 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.23 -37.18 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.8 p90 -101.15 130.55 47.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 7.0 tttp -123.24 162.32 22.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.332 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.44 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 36.5 mtm -106.36 91.44 5.76 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.205 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 46.3 Cg_endo -73.01 -52.24 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.922 1.485 . . . . 0.0 110.441 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 -73.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.91 122.65 38.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.913 . . . . 0.0 110.175 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.444 HG21 ' O ' ' A' ' 22' ' ' ILE . 3.0 tt -128.5 136.1 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.8 135.44 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 110.23 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.53 ' HB3' ' CG1' ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.16 137.47 52.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 m -100.27 135.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 110.267 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -112.62 164.47 13.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 61.99 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 4.6 tttt -152.41 160.38 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -1.146 . . . . 0.0 110.154 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.02 -118.06 4.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.55 -18.48 35.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.13 . . . . 0.0 110.439 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' C ' ' CG1' ' A' ' 32' ' ' ILE . . . 143.67 -21.46 2.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.547 ' CD1' ' OG ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -167.77 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -1.168 . . . . 0.0 110.59 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 6.2 mtmm -98.35 142.14 30.36 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.683 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.491 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 1.9 m -96.97 115.93 28.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.636 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.53 ' CG1' ' HB3' ' A' ' 24' ' ' LYS . 2.4 p -105.14 117.83 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.953 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.486 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 92.0 mt -95.66 112.87 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.6 m -83.52 -4.88 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.187 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.04 -0.29 47.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.275 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.486 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -53.32 -42.41 66.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.133 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.43 -40.4 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.24 -47.81 75.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.48 ' O ' HD21 ' A' ' 46' ' ' LEU . 84.1 t -62.77 -44.73 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . . . -56.4 -35.06 67.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -36.49 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.95 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.28 78.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.243 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.548 ' O ' ' CB ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -104.49 0.87 29.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER 73.17 -53.48 0.7 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.664 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.537 ' CB ' HD12 ' A' ' 46' ' ' LEU . 4.5 ttt-85 -76.93 147.83 77.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.463 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 47.4 Cg_endo -74.11 147.31 37.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.988 1.52 . . . . 0.0 110.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 48.8 Cg_endo -75.44 7.54 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.078 1.567 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.663 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -63.01 -37.97 89.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 110.421 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -69.85 -52.28 13.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 110.586 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.8 Cg_endo -70.37 -16.25 34.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.81 1.426 . . . . 0.0 110.462 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.517 HG22 ' CG2' ' A' ' 65' ' ' THR . 1.4 m -71.6 -19.42 62.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.104 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -73.0 -44.96 60.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.517 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 70.7 m-85 -66.84 -45.02 79.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.419 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 53' ' ' PRO . 23.4 m-85 -57.36 -43.97 83.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.801 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.44 -35.21 84.33 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 84.7 m -56.83 -37.38 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.25 . . . . 0.0 110.108 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.99 -48.21 66.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.867 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -77.8 10.84 2.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -0.992 . . . . 0.0 111.005 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.85 40.13 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -114.21 163.67 14.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -1.156 . . . . 0.0 109.503 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.7 tt0 -107.78 -118.49 0.26 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.777 -1.202 . . . . 0.0 109.915 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.517 ' CG2' HG22 ' A' ' 54' ' ' THR . 2.6 p -149.32 170.17 19.14 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 111.148 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -144.42 139.18 28.23 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.695 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 20.1 m-85 -127.19 142.48 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.712 -1.242 . . . . 0.0 113.032 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -125.24 117.38 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.908 178.151 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 t -84.78 -64.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -17.16 4.56 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.557 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.6 m-80 -102.12 -31.49 10.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 110.102 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.627 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.3 m-20 70.27 15.59 7.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.559 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -113.7 129.8 56.52 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.565 -0.709 . . . . 0.0 109.718 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.695 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.4 m-30 -112.86 129.29 56.51 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.521 HG12 ' CG2' ' A' ' 35' ' ' VAL . 17.8 mt -120.83 149.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 110.285 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 13.4 m -112.96 129.17 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.582 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 28.1 m-20 -48.25 144.51 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.884 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 97.71 146.4 20.7 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.547 ' OG ' ' CD1' ' A' ' 32' ' ' ILE . 0.6 OUTLIER -102.04 126.07 48.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -1.027 . . . . 0.0 109.889 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -141.94 156.68 45.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 2.3 tt0 -103.99 148.66 25.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 109.81 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.28 -39.74 60.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.461 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 1.6 t30 -64.28 -33.36 75.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -37.5 71.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 17.3 mt -63.39 -44.66 94.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 12.3 pt20 -68.24 -36.15 79.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 7.8 m-20 -68.8 -41.61 78.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -0.809 . . . . 0.0 110.218 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.449 ' HE3' ' HB3' ' A' ' 88' ' ' MET . 49.1 ttp -71.19 -50.01 37.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -54.69 -30.41 55.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.556 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . 0.4 OUTLIER -62.38 -35.84 80.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.68 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.86 -43.48 99.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -51.04 46.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -1.18 . . . . 0.0 110.556 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.602 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 2.8 pp -64.41 -36.64 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.63 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -54.98 -27.95 47.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.145 -0.972 . . . . 0.0 110.361 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.476 ' O ' HD21 ' A' ' 98' ' ' LEU . 22.5 mttm -62.72 -38.62 91.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 111.733 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.602 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 7.4 p90 -115.61 -17.48 11.13 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.8 -1.188 . . . . 0.0 112.129 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.63 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 20.0 m -68.81 -50.18 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.585 -1.322 . . . . 0.0 110.806 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 97' ' ' VAL . 1.3 mm? 33.43 100.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.348 -0.845 . . . . 0.0 110.78 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.469 ' HB2' HG22 ' A' ' 107' ' ' THR . 0.1 OUTLIER -64.79 152.22 90.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.939 . . . . 0.0 110.297 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 45.5 Cg_endo -72.48 -1.62 10.53 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -85.0 -58.17 2.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.478 ' O ' ' C ' ' A' ' 103' ' ' GLU . 3.0 p -176.35 23.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.593 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 8.6 tp10 38.41 35.34 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.618 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 3.4 m-20 -93.98 -64.47 0.13 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.026 -1.046 . . . . 0.0 110.622 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.618 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 46.8 Cg_endo -72.78 149.6 48.48 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.782 1.411 . . . . 0.0 110.546 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.86 114.81 8.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.0 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.489 ' O ' HD13 ' A' ' 93' ' ' ILE . 6.3 p -110.13 159.47 17.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -123.48 147.59 47.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.572 ' CD1' ' CD2' ' A' ' 131' ' ' LEU . 4.2 tt -105.95 128.81 54.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.561 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 7.3 p80 -124.28 115.55 21.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.251 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 111' ' ' VAL . 3.5 p -96.91 122.9 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -90.71 122.55 66.84 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.44 -39.49 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.085 1.571 . . . . 0.0 110.476 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -42.26 91.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -92.64 -3.82 54.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.46 42.12 31.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.412 ' O ' HG21 ' A' ' 111' ' ' VAL . 1.0 OUTLIER -139.79 175.94 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.53 ' CD1' HD11 ' A' ' 141' ' ' ILE . 3.3 mt -123.2 136.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.561 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -116.13 160.66 13.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.577 ' HB2' ' CA ' ' A' ' 131' ' ' LEU . 1.5 t30 -143.74 121.76 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -1.124 . . . . 0.0 109.724 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 88.8 p -118.6 133.5 55.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 110.425 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.455 ' HB2' ' SG ' ' A' ' 99' ' ' CYS . 5.1 t -110.25 133.83 52.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 110.201 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 123' ' ' LYS . 4.7 ptmt -83.36 42.19 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' CB ' ' HG3' ' A' ' 105' ' ' PRO . . . -124.51 -26.46 3.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 110.288 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.443 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 43.4 t -149.94 10.53 0.71 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.791 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.16 -12.24 58.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.65 ' C ' ' O ' ' A' ' 126' ' ' GLY . 9.2 t80 -11.05 -64.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.767 -0.843 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 19.6 ttt180 24.09 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.824 -0.547 . . . . 0.0 110.964 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -162.34 -108.32 0.22 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.07 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.498 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.06 151.65 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -1.052 . . . . 0.0 110.559 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.577 ' CA ' ' HB2' ' A' ' 120' ' ' ASN . 31.9 tp -91.25 107.45 19.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.545 ' O ' ' HB ' ' A' ' 133' ' ' THR . 14.6 m-20 61.11 5.47 1.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.546 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.605 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 48.6 m 60.32 -75.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 0.0 110.059 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 133' ' ' THR . 12.2 m80 -165.25 62.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.201 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -156.73 18.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.512 ' HB2' ' CB ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -139.06 -177.62 4.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.299 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.502 ' O ' HG12 ' A' ' 141' ' ' ILE . 5.5 tp -43.9 -24.11 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.574 ' O ' HG12 ' A' ' 141' ' ' ILE . 1.1 p -55.74 -50.86 69.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.446 ' CG2' ' HG3' ' A' ' 147' ' ' GLU . 3.4 m -64.32 -36.49 84.29 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.622 ' HA ' ' O ' ' A' ' 145' ' ' PRO . 5.4 t80 -62.52 -48.39 79.75 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.651 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 138' ' ' CYS . 29.9 pt -68.91 -40.74 81.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 109.535 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.514 ' N ' HG13 ' A' ' 141' ' ' ILE . 15.8 tp -52.55 -47.53 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.471 -0.768 . . . . 0.0 111.005 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.738 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -110.18 -38.61 5.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.8 -1.187 . . . . 0.0 110.737 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.738 ' CB ' ' O ' ' A' ' 143' ' ' LYS . 0.5 OUTLIER 142.21 -70.97 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 144' ' ' ASN . 48.9 Cg_endo -73.58 165.8 31.44 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.683 1.359 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.88 -161.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.994 1.523 . . . . 0.0 110.523 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.446 ' HG3' ' CG2' ' A' ' 139' ' ' THR . 1.4 tm-20 -129.7 -166.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.71 -166.04 2.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.24 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.0 p -97.44 108.57 21.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.25 -172.15 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 153' ' ' THR . 0.6 OUTLIER 59.85 104.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -45.61 99.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 151' ' ' SER . 9.8 t -64.38 -16.67 62.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.151 . . . . 0.0 110.224 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 153' ' ' THR . . . 103.18 161.77 25.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -136.8 -167.28 2.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -1.141 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.199 0.523 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 p -123.76 -161.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.34 -17.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -93.38 116.48 29.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.155 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.5 -40.93 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -129.41 82.24 2.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.27 -18.01 23.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 11' ' ' ASP . 0.2 OUTLIER -89.89 7.25 38.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 8' ' ' SER . 4.8 p -43.6 -34.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -114.17 -28.93 7.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.276 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.45 ' O ' ' OG ' ' A' ' 8' ' ' SER . 5.3 t0 -89.37 110.63 21.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -69.86 -40.46 75.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 12' ' ' GLN . 12.8 m-85 -147.78 -45.61 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.847 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 71.37 -5.66 1.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' TYR . 10.0 ptp180 -33.16 -21.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.15 -0.969 . . . . 0.0 111.833 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.726 ' N ' ' O ' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -137.0 132.39 34.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.942 -1.098 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -133.32 130.06 38.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.2 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.2 ttt -121.35 91.29 48.18 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 48.3 Cg_endo -76.17 -156.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.975 1.513 . . . . 0.0 110.363 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' PRO . 5.2 ttt85 70.29 94.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 1.8 tm? -95.81 125.24 40.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.029 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.48 ' N ' HD23 ' A' ' 21' ' ' LEU . 28.8 mt -103.25 133.52 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.53 131.08 52.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.46 ' O ' HG11 ' A' ' 35' ' ' VAL . 5.2 tttt -116.57 138.21 51.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 79' ' ' SER . 17.9 m -93.24 135.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -124.09 163.36 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . 43.82 65.63 1.52 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' HG2' HD13 ' A' ' 32' ' ' ILE . 3.5 tmtt? -91.46 140.62 29.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -1.143 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.02 -36.18 3.43 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -99.96 -12.86 19.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -1.159 . . . . 0.0 110.426 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -168.38 -30.62 0.02 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 27' ' ' GLY . 1.8 mm 59.71 91.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.177 . . . . 0.0 110.246 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' CD1' ' A' ' 75' ' ' ILE . 1.2 tppt? -129.42 152.73 48.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 2.8 t -115.31 125.87 53.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 7.2 p -117.31 117.68 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.3 mp -95.67 143.16 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.52 -39.8 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.561 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.473 ' O ' HG13 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -93.68 11.73 27.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.528 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.544 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.18 -45.52 88.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 41' ' ' ASP . 12.8 p -70.38 -43.99 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' N ' HG11 ' A' ' 40' ' ' VAL . 16.0 t0 -69.3 -47.95 63.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.583 ' O ' HD11 ' A' ' 46' ' ' LEU . 4.3 p -61.11 -44.92 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.481 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -68.19 -46.07 71.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.092 -1.005 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 1.3 mtpm? -67.6 -42.6 82.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.852 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HB3' ' CD1' ' A' ' 46' ' ' LEU . . . -59.6 -23.25 62.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.821 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.687 ' N ' HD11 ' A' ' 46' ' ' LEU . 6.5 mp -117.6 -9.26 10.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 110.464 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 43' ' ' ALA . 9.6 p30 -173.56 -146.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.783 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 11.8 mtm180 -90.2 175.47 3.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.79 . . . . 0.0 110.618 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 44.3 Cg_endo -70.64 137.07 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.019 1.536 . . . . 0.0 110.455 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.587 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.2 Cg_endo -76.94 0.23 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.114 1.586 . . . . 0.0 110.427 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.546 HG22 ' CE1' ' A' ' 67' ' ' PHE . 6.9 p -56.24 -21.87 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.89 . . . . 0.0 110.43 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -88.87 -57.78 0.27 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 111.006 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -72.73 -16.64 26.5 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.729 1.384 . . . . 0.0 111.052 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 4.9 t -56.37 -16.12 5.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 110.265 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 tptt -72.66 -45.48 58.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -50.04 75.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 110.152 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 m-85 -57.37 -38.55 74.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.913 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.37 -38.61 93.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -37.33 71.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -1.223 . . . . 0.0 109.94 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.78 -49.49 70.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.546 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -80.4 11.41 3.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.058 -1.026 . . . . 0.0 110.871 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.16 4.76 30.61 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.57 ' CB ' ' HB2' ' A' ' 77' ' ' ASN . . . -118.8 163.4 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 55' ' ' LYS . 25.1 mt-30 -105.52 -119.18 0.23 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.741 -1.225 . . . . 0.0 109.961 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.4 170.32 18.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HB3' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -147.14 139.83 24.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.717 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.59 144.6 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.735 -1.228 . . . . 0.0 112.872 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -121.76 117.31 26.27 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.893 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 5.1 t -85.95 -64.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.564 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -16.51 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.14 -0.975 . . . . 0.0 108.62 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.627 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -103.69 -30.08 10.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.627 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.7 m-20 70.21 15.5 7.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.552 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.6 ttp180 -113.71 129.77 56.52 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.629 -0.67 . . . . 0.0 109.568 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.717 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.6 m-30 -112.16 136.89 50.99 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.339 -0.851 . . . . 0.0 110.311 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 3.1 tt -131.18 148.72 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.504 -0.747 . . . . 0.0 110.12 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 42.6 t -113.92 139.36 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.134 -0.979 . . . . 0.0 109.748 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.57 ' HB2' ' CB ' ' A' ' 63' ' ' ALA . 25.3 m-20 -55.54 143.94 27.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.616 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 91.52 147.03 19.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.457 ' HB2' HG12 ' A' ' 25' ' ' VAL . 72.2 p -89.73 125.33 35.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.117 . . . . 0.0 109.773 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.453 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . 74.8 m-70 -141.79 114.81 8.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -86.68 159.02 19.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.531 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.29 -44.6 61.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.882 -1.136 . . . . 0.0 109.311 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.86 -33.44 75.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 108.997 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 88' ' ' MET . 28.8 tptt -68.55 -35.71 77.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.716 -0.615 . . . . 0.0 110.539 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' O ' ' CG ' ' A' ' 88' ' ' MET . 17.5 mt -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.97 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 33.1 tp60 -68.91 -35.98 77.48 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 108.883 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.24 -42.9 75.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.707 . . . . 0.0 111.339 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.581 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 6.0 ptm -57.68 -47.82 81.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.848 -1.157 . . . . 0.0 110.493 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.581 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.3 OUTLIER -54.08 -33.55 57.86 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.6 -35.83 82.28 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.574 0.702 . . . . 0.0 109.247 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 94' ' ' LYS . . . -61.4 -36.81 93.08 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -47.35 77.74 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.302 -1.117 . . . . 0.0 108.715 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.623 ' O ' ' CD1' ' A' ' 96' ' ' PHE . 15.5 mt -65.47 -33.44 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.793 0.806 . . . . 0.0 109.221 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -55.13 -25.44 31.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 110.838 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OH ' ' A' ' 127' ' ' TYR . 0.1 OUTLIER -59.29 -29.54 67.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 111.651 -178.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' CG2' ' A' ' 97' ' ' VAL . 10.1 p90 -115.67 -22.78 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.626 -1.296 . . . . 0.0 111.051 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.751 ' CG2' ' CE2' ' A' ' 96' ' ' PHE . 13.1 t -110.16 -60.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.219 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.696 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.9 OUTLIER -102.32 60.63 0.83 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.471 -0.768 . . . . 0.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 32.5 m -64.64 150.24 94.35 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.428 -0.795 . . . . 0.0 110.738 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.64 0.89 5.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.116 1.587 . . . . 0.0 110.465 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.02 -7.98 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.519 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.616 ' O ' ' C ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -175.22 -39.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.44 -0.788 . . . . 0.0 110.107 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.696 ' HG3' ' HB3' ' A' ' 98' ' ' LEU . 3.8 tm-20 23.64 70.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.488 0.661 . . . . 0.0 110.16 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.536 ' HB3' ' CD ' ' A' ' 105' ' ' PRO . 2.1 t-20 -173.94 -58.34 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.758 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.536 ' CD ' ' HB3' ' A' ' 104' ' ' ASN . 42.4 Cg_endo -68.45 145.62 65.53 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.75 1.395 . . . . 0.0 110.576 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.74 153.58 43.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.5 p -135.51 166.02 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.384 -0.823 . . . . 0.0 110.064 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -113.95 142.64 45.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 120' ' ' ASN . 2.0 mp -105.92 127.02 52.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 108' ' ' ASP . 3.3 m80 -117.45 115.25 24.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 0.0 110.08 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 111' ' ' VAL . 5.1 m -100.32 118.16 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -86.32 122.73 72.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -22.84 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.006 1.53 . . . . 0.0 110.456 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.45 -35.75 65.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.439 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.521 ' N ' ' HG3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -110.76 -4.1 15.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.335 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 52.27 51.4 16.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 147.39 50.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.513 ' CD1' HG13 ' A' ' 141' ' ' ILE . 2.3 mm -90.86 134.25 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -136.09 154.0 21.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 121' ' ' SER . 19.8 t-20 -143.46 154.26 43.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.288 -1.125 . . . . 0.0 108.926 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 120' ' ' ASN . 17.3 t -125.94 124.32 40.52 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.687 -1.258 . . . . 0.0 110.269 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.407 ' CB ' ' HB3' ' A' ' 127' ' ' TYR . 0.1 OUTLIER -90.87 129.53 36.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 38.67 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.05 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . . . -116.83 -27.6 6.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.303 -0.873 . . . . 0.0 110.281 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 124' ' ' ALA . 15.8 p -177.54 25.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 111.012 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 82.57 -12.19 48.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.592 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.8 t80 -19.53 -49.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.731 -0.864 . . . . 0.0 111.523 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER 64.72 128.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.411 -0.806 . . . . 0.0 109.572 -179.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -110.26 67.57 0.22 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.499 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 1.1 ttt -83.33 122.17 28.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.217 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD2' ' SG ' ' A' ' 138' ' ' CYS . 3.3 tp -113.9 135.42 54.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 110.097 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 133' ' ' THR . 1.3 m-20 -73.17 -92.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 132' ' ' ASP . 5.2 t 178.86 146.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 133' ' ' THR . 1.3 t-160 176.71 67.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.917 . . . . 0.0 110.269 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 134' ' ' HIS . 2.2 m-70 42.85 29.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 -177.62 3.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.293 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.508 HD11 ' CZ ' ' A' ' 96' ' ' PHE . 4.1 pp -62.16 -9.49 7.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.529 ' SG ' ' CD2' ' A' ' 131' ' ' LEU . 41.6 m -56.27 -41.95 76.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -42.68 77.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.324 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -56.98 -48.33 78.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.685 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.538 HG13 ' N ' ' A' ' 142' ' ' LEU . 25.5 pt -68.95 -42.24 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.553 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.538 ' N ' HG13 ' A' ' 141' ' ' ILE . 39.5 tp -54.04 -27.72 34.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.782 . . . . 0.0 110.385 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 143' ' ' LYS . 7.6 tttp -83.96 -18.84 35.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.375 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.458 ' O ' ' OD1' ' A' ' 144' ' ' ASN . 10.7 p30 -162.45 122.85 1.49 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.932 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.448 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 47.9 Cg_endo -73.24 174.16 12.54 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.917 1.482 . . . . 0.0 110.428 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 147' ' ' GLU . 46.2 Cg_endo -72.57 -92.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.91 1.479 . . . . 0.0 110.383 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER 171.78 34.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -72.74 119.76 17.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.0 m -63.4 176.51 0.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -121.67 -29.66 4.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 t -120.77 88.3 2.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 110.232 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -52.64 168.17 0.89 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.66 96.98 6.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -1.181 . . . . 0.0 110.184 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.58 50.17 1.6 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -154.47 112.8 3.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.208 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.219 0.533 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.552 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 17.1 m -86.91 -153.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 110.262 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 2' ' ' SER . 17.2 m 36.92 48.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 110.528 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.63 155.91 38.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.61 -20.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.08 13.25 21.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 2' ' ' SER . 14.2 ttt180 -68.37 -26.43 65.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.24 -7.09 58.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 110.234 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -170.65 135.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.136 -0.977 . . . . 0.0 110.196 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -8.41 38.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 110.176 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -84.49 148.65 26.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.97 -18.35 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CB ' ' O ' ' A' ' 12' ' ' GLN . 0.5 OUTLIER 73.28 -52.84 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 65.56 0.48 1.44 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.856 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.549 ' HB3' ' CD2' ' A' ' 13' ' ' PHE . 8.1 ttt180 -77.99 50.81 0.91 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.056 -1.028 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.1 134.9 36.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -130.93 135.88 48.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.306 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.431 ' HG3' HD13 ' A' ' 22' ' ' ILE . 2.5 mmt -139.59 119.05 9.06 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.86 . . . . 0.0 110.119 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.36 -4.89 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.964 1.508 . . . . 0.0 110.521 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.1 173.18 6.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -0.899 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' C ' ' CD1' ' A' ' 21' ' ' LEU . 3.4 tm? -90.52 122.49 33.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' A' ' 18' ' ' MET . 6.9 mt -100.61 120.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.29 139.3 47.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.502 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.448 ' HB2' HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -116.06 126.74 54.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.922 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 31' ' ' GLY . 38.8 t -93.58 122.1 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -141.53 169.43 17.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.418 ' CA ' ' HA2' ' A' ' 31' ' ' GLY . . . 162.16 -94.29 0.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 30' ' ' ASN . 3.9 ttpm? -152.62 139.0 18.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -1.068 . . . . 0.0 109.978 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.61 -78.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 28' ' ' LYS . 42.5 t30 -99.59 -18.73 17.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -1.132 . . . . 0.0 110.056 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' O ' ' CG1' ' A' ' 25' ' ' VAL . . . 68.21 100.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.1 mm -112.32 14.31 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.474 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -97.75 153.02 18.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.871 -1.143 . . . . 0.0 109.5 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.527 ' OG1' ' ND1' ' A' ' 80' ' ' HIS . 22.0 m -110.56 115.71 30.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.665 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.688 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -110.24 117.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.965 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.563 ' CG2' ' CG ' ' A' ' 39' ' ' MET . 21.3 mt -96.85 122.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.897 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.7 m -100.6 -8.41 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -116.71 6.99 13.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.021 . . . . 0.0 110.571 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.563 ' CG ' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.03 -45.37 89.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 10.8 t -70.35 -42.33 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.461 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.465 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -62.22 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.401 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.501 ' O ' HD11 ' A' ' 46' ' ' LEU . 86.9 t -68.36 -44.97 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.467 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.72 -45.62 74.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.642 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -65.84 -36.15 82.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 46' ' ' LEU . . . -62.55 -34.47 77.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 46' ' ' LEU . 5.5 mp -117.43 -9.17 10.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.951 -1.093 . . . . 0.0 110.917 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' ALA . 7.6 p-10 -162.28 -153.8 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.065 -1.022 . . . . 0.0 110.622 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.4 mtp180 -88.07 175.17 4.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.374 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.4 Cg_endo -72.5 138.23 29.33 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.086 1.572 . . . . 0.0 110.507 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.52 -7.19 17.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.059 1.557 . . . . 0.0 110.654 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.655 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.25 -21.91 26.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 0.0 110.175 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.489 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 6.4 m-85 -88.8 -57.39 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 111.155 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -71.3 -22.66 25.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.802 1.422 . . . . 0.0 111.352 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.497 HG21 ' CA ' ' A' ' 51' ' ' THR . 10.2 t -56.29 -14.4 2.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.101 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -45.43 66.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.398 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.68 -49.08 74.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.551 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 9.6 m-30 -57.3 -34.1 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.47 -41.86 97.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -37.09 70.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.088 -1.242 . . . . 0.0 109.731 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.579 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . 5.2 mm-40 -63.26 -49.37 74.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.327 -0.858 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.551 ' CD2' ' O ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -81.65 12.93 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.99 -1.069 . . . . 0.0 110.812 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.73 4.87 28.23 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 77' ' ' ASN . . . -121.33 163.48 18.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.183 -1.186 . . . . 0.0 109.397 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.499 ' C ' ' CG2' ' A' ' 65' ' ' THR . 3.7 mp0 -113.1 -120.9 0.3 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.653 -1.279 . . . . 0.0 109.676 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.5 170.26 19.01 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.447 -0.783 . . . . 0.0 111.042 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.589 ' CB ' HG13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.81 139.94 28.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.734 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 25.8 m-85 -126.09 144.19 50.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.688 -1.258 . . . . 0.0 113.055 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -126.08 117.37 23.04 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.11 178.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.01 -64.06 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.534 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -18.21 7.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.608 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -101.46 -31.57 10.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.654 -0.654 . . . . 0.0 110.073 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.4 m-20 70.79 15.52 6.87 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.2 -0.938 . . . . 0.0 110.357 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.558 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 25.5 ttm180 -113.64 129.54 56.55 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.734 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.0 m-30 -113.74 136.0 53.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.283 -0.886 . . . . 0.0 109.893 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 0.9 OUTLIER -129.02 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.205 -0.934 . . . . 0.0 110.61 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 51.2 t -114.41 122.94 69.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 64.1 m-20 -50.02 142.69 8.98 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.6 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.96 140.0 9.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.545 ' HB3' HD12 ' A' ' 32' ' ' ILE . 95.6 p -99.09 123.93 43.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.863 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -142.09 134.83 28.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.574 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 4.0 tt0 -85.32 158.94 20.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 109.418 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.523 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.24 -44.01 61.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.79 -33.08 75.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.166 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' CE ' ' HB3' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -59.11 -35.79 74.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.669 -0.644 . . . . 0.0 110.324 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 85' ' ' LEU . 3.6 mm? -58.82 -38.78 79.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.924 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -68.57 -47.69 66.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.324 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 35.5 t0 -67.69 -36.04 79.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.339 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.523 ' HE2' ' CE1' ' A' ' 92' ' ' PHE . 25.3 ttp -57.75 -48.28 80.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -53.04 -30.68 37.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 0.8 OUTLIER -64.3 -46.24 84.46 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' A' ' 95' ' ' LYS . . . -66.66 -32.03 80.23 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 60' ' ' GLU . 2.1 m-85 -55.17 -39.31 69.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.491 -1.005 . . . . 0.0 109.616 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.728 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mt -52.97 -47.94 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.733 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' O ' ' CD2' ' A' ' 98' ' ' LEU . 13.8 mptt -69.63 -25.17 63.8 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.534 -0.729 . . . . 0.0 110.755 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 18.6 mmtm -58.89 -29.42 67.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.421 -0.8 . . . . 0.0 111.985 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.728 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 4.6 p90 -100.87 -19.12 16.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.491 -1.381 . . . . 0.0 110.223 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.656 HG23 ' CE1' ' A' ' 96' ' ' PHE . 6.9 t -71.23 -7.99 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.064 . . . . 0.0 109.495 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.738 ' HA ' ' HB3' ' A' ' 103' ' ' GLU . 2.3 mm? -37.75 106.07 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.476 -0.765 . . . . 0.0 109.905 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.541 ' N ' ' HB3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -64.14 155.13 80.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.62 -14.21 33.16 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.081 1.569 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -66.68 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.59 ' O ' ' C ' ' A' ' 103' ' ' GLU . 14.3 p -160.38 10.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.847 . . . . 0.0 110.329 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER 23.55 59.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.629 -0.67 . . . . 0.0 110.726 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.623 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 9.4 m-20 -101.44 -65.19 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.261 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.3 Cg_endo -72.12 150.07 53.28 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.715 1.376 . . . . 0.0 110.164 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.11 118.15 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 110.073 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 121' ' ' SER . 4.0 p -110.13 166.06 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -113.92 159.4 19.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.123 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD2' HD12 ' A' ' 131' ' ' LEU . 0.8 OUTLIER -106.03 139.47 40.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.93 . . . . 0.0 110.384 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.542 ' CE1' ' C ' ' A' ' 119' ' ' GLY . 1.5 p80 -123.58 131.31 53.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.845 . . . . 0.0 110.07 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.509 HG23 ' CD2' ' A' ' 142' ' ' LEU . 2.0 p -117.95 129.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -98.27 122.48 53.82 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.48 -33.35 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.069 1.563 . . . . 0.0 110.456 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.525 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 4.1 pttp -59.34 -42.23 91.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.278 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -100.46 0.53 39.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.65 42.05 31.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -134.96 179.52 6.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.563 ' CD1' ' HG ' ' A' ' 142' ' ' LEU . 4.5 mt -137.1 139.91 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.038 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 110' ' ' HIS . . . -116.66 163.81 12.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.445 ' OD1' HD21 ' A' ' 109' ' ' LEU . 46.8 t30 -135.39 129.82 33.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -1.079 . . . . 0.0 109.681 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 1.1 p -117.44 152.7 34.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.47 ' HA ' HG23 ' A' ' 107' ' ' THR . 1.8 t -106.28 126.27 52.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 109.978 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -75.19 51.69 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.777 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' HB1' ' HG3' ' A' ' 105' ' ' PRO . . . -144.72 -34.38 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 110.012 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 14.0 p -137.83 2.16 2.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.689 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.44 -11.76 60.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.669 ' C ' ' O ' ' A' ' 126' ' ' GLY . 29.7 t80 -8.87 -64.16 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.83 -0.806 . . . . 0.0 111.237 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 9.9 ttt-85 35.88 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.589 -0.695 . . . . 0.0 110.578 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.27 -113.19 0.83 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.496 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.44 151.74 38.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.496 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.525 HD12 ' CD2' ' A' ' 109' ' ' LEU . 2.6 tt -80.94 121.23 25.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.024 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 133' ' ' THR . 10.4 m-20 -99.3 -97.24 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.348 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 96' ' ' PHE . 0.2 OUTLIER 66.52 -175.82 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.389 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -88.82 -91.49 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -51.41 173.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.59 81.96 2.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.645 ' CD1' ' CE1' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -82.23 -4.05 56.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.86 . . . . 0.0 110.012 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.56 ' O ' ' CG1' ' A' ' 141' ' ' ILE . 20.0 m -62.67 -45.33 93.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 110.392 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -40.1 96.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' O ' ' CD ' ' A' ' 143' ' ' LYS . 0.2 OUTLIER -58.3 -48.5 80.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.016 -1.053 . . . . 0.0 109.389 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.56 ' CG1' ' O ' ' A' ' 138' ' ' CYS . 16.8 pt -69.07 -41.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.489 -0.757 . . . . 0.0 109.545 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.563 ' HG ' ' CD1' ' A' ' 118' ' ' ILE . 1.3 mt -52.91 -16.16 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.364 -0.835 . . . . 0.0 110.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -69.68 -5.36 24.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.923 . . . . 0.0 110.23 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.527 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 0.4 OUTLIER -59.27 170.21 1.03 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 45.1 Cg_endo -72.99 156.96 51.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.872 1.459 . . . . 0.0 110.355 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.76 149.27 48.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.975 1.513 . . . . 0.0 110.433 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.51 65.55 0.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -140.6 122.06 15.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.0 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.251 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.58 123.39 7.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 110.222 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.3 t -174.41 154.55 2.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.25 89.4 1.58 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.414 ' CG2' ' O ' ' A' ' 153' ' ' THR . 11.3 t -137.09 64.04 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -1.145 . . . . 0.0 110.317 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 156' ' ' LYS . . . 67.33 -174.83 26.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.0 tttt 45.88 -96.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -1.125 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.253 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.165 0.507 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -170.63 147.95 2.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.54 -103.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.858 . . . . 0.0 110.22 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.29 105.85 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 110.219 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.98 -11.28 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.46 44.37 2.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.176 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 8' ' ' SER . 7.3 ptt180 -65.69 -17.72 64.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.433 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 4.1 p -85.35 4.09 36.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 8' ' ' SER . 30.0 t 55.29 85.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 9' ' ' VAL . 1.9 tpt 44.41 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.71 141.69 35.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -40.93 85.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.299 -0.876 . . . . 0.0 110.139 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.678 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -169.09 -103.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.222 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 61.0 t80 -177.29 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.042 -1.036 . . . . 0.0 110.163 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mtm105 41.06 27.46 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.184 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -137.06 138.91 40.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.37 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.462 ' HE3' ' OH ' ' A' ' 14' ' ' TYR . 8.9 mtpt -132.31 130.39 40.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.506 ' CE ' ' HB2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -138.43 121.87 11.21 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -73.24 -89.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.948 1.499 . . . . 0.0 110.395 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HB2' ' CE ' ' A' ' 18' ' ' MET . 12.0 tpt85 60.77 72.39 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.212 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.661 ' H ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.37 143.49 27.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.649 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 19.9 mt -105.01 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 110.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.66 152.32 45.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.502 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 11.1 tttm -116.11 128.39 55.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 25' ' ' VAL . 15.5 m -105.59 135.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 35.5 tt0 -112.67 134.42 54.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 32' ' ' ILE . . . -117.26 69.89 0.3 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.72 139.03 51.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 110.116 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -150.62 3.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.66 12.44 36.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -1.122 . . . . 0.0 110.209 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.435 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -70.01 -65.19 2.62 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 2.1 mm 56.93 88.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 110.107 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HE2' ' OE1' ' A' ' 26' ' ' GLU . 22.1 pttm -129.62 152.52 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.475 ' HB ' HG21 ' A' ' 76' ' ' VAL . 7.9 m -112.74 128.38 56.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.502 ' CG2' ' HB3' ' A' ' 24' ' ' LYS . 4.0 m -109.82 132.29 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.542 HG21 ' CB ' ' A' ' 39' ' ' MET . 1.0 OUTLIER -80.56 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.57 -46.56 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.64 -1.04 12.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.776 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.542 ' CB ' HG21 ' A' ' 36' ' ' ILE . 2.7 tmm? -60.38 -33.54 72.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.089 -1.007 . . . . 0.0 110.036 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.84 -42.84 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.078 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -49.77 74.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.04 -40.73 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.056 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' HG3' ' A' ' 50' ' ' PRO . . . -62.81 -35.0 78.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.82 -40.37 79.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -15.9 62.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.041 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 46' ' ' LEU . 8.0 tt -82.56 1.02 40.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.847 . . . . 0.0 110.176 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.6 t30 71.57 -61.95 0.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB2' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 154.11 82.35 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.234 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.5 Cg_endo -72.72 141.59 34.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.002 1.527 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HG3' ' CB ' ' A' ' 43' ' ' ALA . 47.9 Cg_endo -73.55 -24.96 15.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.997 1.525 . . . . 0.0 110.393 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 67' ' ' PHE . 33.2 p -56.44 -21.75 27.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.381 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -86.55 -57.46 0.33 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 111.141 -179.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.4 Cg_endo -70.83 -27.42 21.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.745 1.392 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.504 HG22 ' CA ' ' A' ' 51' ' ' THR . 15.2 t -56.72 -15.12 4.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.459 ' N ' HG21 ' A' ' 54' ' ' THR . 3.1 mmmt -72.81 -39.33 66.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.214 -0.929 . . . . 0.0 110.46 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -50.84 72.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.445 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 23.9 m-85 -67.53 -31.7 71.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 61' ' ' LEU . . . -59.27 -48.46 85.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 56.3 m -58.97 -46.26 88.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -1.213 . . . . 0.0 110.333 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -70.17 -28.72 65.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.95 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.577 ' CG ' ' HB1' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -91.92 12.99 19.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.932 -179.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.13 12.51 44.35 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 77' ' ' ASN . . . -131.59 163.2 28.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -1.17 . . . . 0.0 109.52 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.55 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -120.16 -125.31 0.27 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.722 -1.236 . . . . 0.0 109.187 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -150.8 170.36 19.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 111.985 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.0 139.53 20.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.302 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.68 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 19.3 m-85 -126.69 144.27 50.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.656 -1.278 . . . . 0.0 113.273 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -118.7 117.27 28.46 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.79 -64.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.773 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -15.11 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 108.642 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.622 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.68 -31.28 9.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.662 . . . . 0.0 110.271 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.622 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.9 m-20 72.15 15.32 5.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.222 -0.924 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.535 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 26.9 ttp180 -114.04 129.55 56.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.496 -0.752 . . . . 0.0 109.036 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.68 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 5.3 m-30 -108.91 128.93 55.35 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.608 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 66' ' ' GLN . 10.5 mt -128.51 149.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.497 ' N ' HG22 ' A' ' 75' ' ' ILE . 7.4 m -112.24 139.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.919 -1.113 . . . . 0.0 109.753 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.58 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -68.33 135.88 52.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.2 158.42 22.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.502 ' C ' ' CD2' ' A' ' 80' ' ' HIS . 91.8 p -97.22 123.78 41.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -1.224 . . . . 0.0 110.317 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.576 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -141.83 115.02 8.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 1.2 tt0 -89.92 155.32 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.139 -0.976 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.489 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.23 -43.59 64.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.15 -33.59 76.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.611 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.88 -36.98 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.505 -0.747 . . . . 0.0 109.762 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.15 -33.63 72.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.773 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.58 -37.12 79.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -61.62 -42.14 98.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.994 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 61' ' ' LEU . 48.7 ttp -66.61 -48.69 68.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' O ' HD11 ' A' ' 93' ' ' ILE . 0.3 OUTLIER -53.37 -29.73 36.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.3 t70 -56.13 -35.2 66.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.111 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -60.97 -32.59 80.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.77 -39.8 91.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -1.101 . . . . 0.0 109.346 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.656 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 1.4 mp -53.37 -32.84 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.446 -0.784 . . . . 0.0 110.056 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.705 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -54.13 -25.84 24.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.471 -0.768 . . . . 0.0 109.763 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 24.1 mmtm -60.44 -25.95 66.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.688 -0.632 . . . . 0.0 111.706 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.656 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 5.7 p90 -115.38 -19.72 10.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.537 -1.352 . . . . 0.0 111.725 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.619 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 30.1 m -62.24 -32.23 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.595 -1.315 . . . . 0.0 110.02 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.705 ' CD1' ' O ' ' A' ' 94' ' ' LYS . 1.2 mp -40.64 101.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.36 -0.837 . . . . 0.0 109.718 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 31.3 p -64.53 155.26 81.89 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.02 -0.68 8.33 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.112 1.585 . . . . 0.0 110.41 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.484 ' HG3' ' CB ' ' A' ' 127' ' ' TYR . 3.7 mm-40 -89.11 -11.29 44.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.353 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.614 ' O ' ' C ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -167.19 -38.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.547 -0.72 . . . . 0.0 109.795 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.614 ' C ' ' O ' ' A' ' 102' ' ' CYS . 0.8 OUTLIER 21.71 71.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.599 0.714 . . . . 0.0 110.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 6.1 m-80 -159.55 -64.02 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.651 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.4 Cg_endo -70.89 149.29 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.841 1.443 . . . . 0.0 110.547 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.81 107.88 3.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 122' ' ' CYS . 12.7 p -112.09 163.03 14.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -114.2 137.95 51.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' HB3' ' OD1' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -106.05 128.43 53.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 110.102 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -96.79 124.68 40.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 142' ' ' LEU . 2.2 p -108.47 117.9 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -0.853 . . . . 0.0 110.18 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -93.55 123.6 59.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 110.182 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 -31.88 9.03 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.058 1.557 . . . . 0.0 110.461 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -40.77 67.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.655 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 13.3 tttm -92.0 -3.73 55.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.655 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 2.0 pt20 51.53 37.94 20.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 110.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.448 HG21 ' HE2' ' A' ' 130' ' ' MET . 0.0 OUTLIER -134.11 174.06 10.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.109 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' A' ' 141' ' ' ILE . 13.7 mt -141.72 139.3 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 110.268 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -117.84 163.79 12.79 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.469 ' OD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -142.44 127.57 18.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -1.173 . . . . 0.0 109.775 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.697 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 1.3 p -117.0 124.7 49.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 110.355 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 107' ' ' THR . 69.1 m -91.57 128.36 37.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -23.33 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -83.88 -5.54 59.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER 70.54 2.79 4.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.67 -71.72 0.09 OUTLIER Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.707 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -135.55 1.68 2.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -1.135 . . . . 0.0 110.316 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.697 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -10.9 120.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.788 -0.57 . . . . 0.0 111.403 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.46 -93.52 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.52 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -116.71 151.63 35.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -1.117 . . . . 0.0 110.28 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 132' ' ' ASP . 1.2 tt -85.61 142.05 29.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.518 ' N ' HD21 ' A' ' 131' ' ' LEU . 75.2 m-20 -115.9 -91.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 132' ' ' ASP . 0.6 OUTLIER 56.93 161.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.188 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -75.68 -172.29 1.83 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' HIS . 15.6 m-70 42.54 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.111 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -131.91 81.99 2.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.248 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 138' ' ' CYS . 4.3 pp -82.29 -21.59 36.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.852 . . . . 0.0 110.101 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.518 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 56.5 m -56.69 -40.39 75.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 m -68.7 -42.64 77.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -57.08 -48.65 78.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 109.675 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.522 HD11 ' CD1' ' A' ' 118' ' ' ILE . 10.6 pt -69.17 -42.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.634 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.515 HD11 ' CG2' ' A' ' 111' ' ' VAL . 57.7 tp -54.41 -28.76 45.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 110.302 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.3 -6.33 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.418 ' CG ' ' O ' ' A' ' 141' ' ' ILE . 8.0 m120 -73.4 117.29 59.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 110.237 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.96 115.21 4.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.92 1.484 . . . . 0.0 110.384 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.904 1.476 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.48 113.9 9.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.37 -156.86 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 110.176 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 p -169.94 137.1 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.36 -45.28 6.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 m 45.95 -153.77 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.438 ' O ' ' OG1' ' A' ' 153' ' ' THR . . . 46.64 79.12 0.07 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 152' ' ' GLY . 44.8 p 43.83 56.67 4.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.136 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.31 152.08 29.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.52 -163.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.1 tttt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.214 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.216 0.532 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 ' ND2' ' A' ' 38' ' ' ASN . 36.7 mt -109.74 128.4 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 138.95 51.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.673 ' HB2' HG13 ' A' ' 35' ' ' VAL . 22.7 mtpp -124.85 136.99 54.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 79' ' ' SER . 62.7 t -96.38 133.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 110.102 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.845 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HE3' HG21 ' A' ' 75' ' ' ILE . 33.1 pttt -128.47 152.66 47.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -97.16 128.55 44.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 75' ' ' ILE . 1.7 p -116.64 117.87 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 39' ' ' MET . 4.5 mt -95.49 110.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.91 -1.37 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.788 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.9 t30 -116.79 -1.18 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB2' HG21 ' A' ' 36' ' ' ILE . 20.6 ttm -64.3 -45.49 87.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.082 -1.011 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 45.5 t -70.4 -41.37 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.866 . . . . 0.0 110.258 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -49.82 74.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -68.36 -43.54 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -67.67 -44.44 77.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -67.68 -36.29 80.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.0 110.42 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.82 64.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.9 . . . . 0.0 110.811 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.9 HD12 ' HB2' ' A' ' 47' ' ' ASN . 2.5 pp -117.42 -9.19 10.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.051 . . . . 0.0 110.69 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.9 ' HB2' HD12 ' A' ' 46' ' ' LEU . 1.1 t-20 175.43 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -101.65 170.7 6.14 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.103 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.3 Cg_endo -72.57 128.88 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.962 1.506 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 48.5 Cg_endo -74.58 48.83 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.912 1.48 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.103 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -68.1 -23.94 64.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -75.49 -54.26 2.4 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.92 . . . . 0.0 110.814 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -71.17 -1.53 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.799 1.421 . . . . 0.0 110.819 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.886 HG22 ' CG2' ' A' ' 65' ' ' THR . 51.6 m -66.44 -21.58 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -42.54 64.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.531 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -49.5 77.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 0.0 110.302 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 5.5 m-30 -57.49 -43.89 84.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.924 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -35.2 85.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.94 -37.23 71.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -1.228 . . . . 0.0 110.022 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.04 -47.8 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.651 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.055 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.59 12.72 2.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.171 -0.956 . . . . 0.0 111.009 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 6.49 27.94 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.081 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.65 163.95 15.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.338 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.9 mt-30 -105.4 -119.16 0.22 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.698 -1.252 . . . . 0.0 109.962 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.886 ' CG2' HG22 ' A' ' 54' ' ' THR . 7.7 p -149.42 170.42 18.61 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 111.228 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' ILE . 4.2 tp-100 -144.72 139.47 27.93 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.103 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.5 m-85 -126.81 143.97 51.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.743 -1.223 . . . . 0.0 113.066 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 1.7 t0 -124.63 117.28 23.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.778 -0.769 . . . . 0.0 108.982 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 70' ' ' LYS . 7.7 m -89.13 -45.88 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.144 -0.973 . . . . 0.0 109.57 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.608 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.1 -6.84 42.34 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 108.516 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -118.21 -27.57 6.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.723 -0.611 . . . . 0.0 110.044 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.1 m-20 70.45 17.03 6.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.275 -0.891 . . . . 0.0 109.877 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.577 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -113.57 129.45 56.56 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.793 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.719 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.49 132.88 55.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 110.26 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.855 ' CD1' HG23 ' A' ' 35' ' ' VAL . 8.8 mm -120.5 148.68 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 21.0 t -114.04 126.04 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.081 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 27.6 m120 -47.22 147.04 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 110.409 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 89.37 144.34 10.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.586 ' HB2' HG13 ' A' ' 25' ' ' VAL . 68.6 p -105.78 125.23 50.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -1.141 . . . . 0.0 110.136 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -139.51 155.4 47.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.08 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -90.86 156.84 17.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.29 -43.21 64.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 83' ' ' ASN . 1.6 m120 -59.65 -33.51 71.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -69.33 -39.69 78.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.276 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 80' ' ' HIS . 13.7 mt -60.4 -36.19 77.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -68.83 -36.22 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 110.134 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.901 -179.514 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 21' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 32.6 mt -107.88 120.32 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 110.076 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.15 135.9 54.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.414 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -117.38 137.96 52.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.1 t -93.35 122.98 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.227 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.8 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.194 -0.941 . . . . 0.0 110.448 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.714 HD13 ' CB ' ' A' ' 79' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.376 0.607 . . . . 0.0 110.295 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' CB ' HD11 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -97.52 152.87 18.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 109.142 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.742 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.3 m -105.91 120.48 41.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.872 -1.142 . . . . 0.0 110.906 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 75' ' ' ILE . 21.5 t -108.6 117.87 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.869 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 39' ' ' MET . 5.2 mt -95.56 113.0 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.76 -1.24 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.195 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 5.4 t-20 -97.64 -0.96 44.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.237 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.544 ' HG3' ' CG2' ' A' ' 36' ' ' ILE . 2.6 mtt -59.74 -43.41 94.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 41' ' ' ASP . 34.4 m -60.6 -43.2 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.587 ' N ' HG23 ' A' ' 40' ' ' VAL . 16.2 m-20 -66.98 -49.03 66.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.66 -42.73 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -63.27 -34.99 78.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.07 -46.85 87.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.27 -16.19 60.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 46' ' ' LEU . 9.6 tt -103.27 -2.76 26.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 m-20 66.73 -58.34 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.766 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.14 132.95 69.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 46.3 Cg_endo -73.41 146.16 39.3 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.459 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -73.19 -4.72 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.972 1.512 . . . . 0.0 110.499 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.176 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -60.53 -21.69 62.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.532 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.42 -58.29 0.8 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.719 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.9 Cg_endo -72.73 -3.13 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.958 1.504 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.849 HG22 ' O ' ' A' ' 51' ' ' THR . 13.9 t -72.97 -17.66 61.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.347 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -72.82 -45.41 58.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.467 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -66.92 -41.43 87.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 5.5 t80 -57.72 -42.06 83.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.49 -35.34 85.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.02 -37.27 79.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.239 . . . . 0.0 110.265 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.27 -28.73 68.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.905 . . . . 0.0 111.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.041 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -105.42 12.96 30.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.053 -1.029 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 4.87 21.76 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.041 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -116.0 164.02 15.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -1.08 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 mt-30 -112.27 -120.13 0.29 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.71 -1.244 . . . . 0.0 110.245 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -149.49 170.62 18.17 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.414 -0.804 . . . . 0.0 111.158 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.527 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -146.68 139.67 25.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.176 ' CZ ' HG22 ' A' ' 51' ' ' THR . 23.7 m-85 -126.59 144.52 50.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.754 -1.216 . . . . 0.0 112.816 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -120.86 117.37 27.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.968 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 70' ' ' LYS . 10.6 m -89.07 -45.13 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.694 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.64 -5.26 32.3 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.255 -0.903 . . . . 0.0 108.83 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 m120 -121.14 -24.64 5.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.517 -0.739 . . . . 0.0 110.345 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 69.55 17.5 7.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.67 129.65 56.53 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 109.436 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.2 m-30 -113.09 129.19 56.59 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.53 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.651 ' CG1' HG22 ' A' ' 35' ' ' VAL . 1.2 tt -125.29 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.552 -0.718 . . . . 0.0 109.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.3 p -113.29 136.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.177 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.787 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -61.24 142.04 57.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.345 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.668 ' HA3' ' HE2' ' A' ' 80' ' ' HIS . . . 109.7 141.23 9.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 32' ' ' ILE . 51.4 p -97.23 122.36 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -1.15 . . . . 0.0 110.025 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.668 ' HE2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -142.33 158.35 43.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 3.8 tt0 -103.99 158.15 16.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.54 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.09 -43.88 64.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.03 -33.49 76.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.87 -37.17 83.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.213 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.15 -44.46 94.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.89 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -66.99 -36.49 82.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.178 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 21' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.248 0.547 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.57 ' N ' HD22 ' A' ' 21' ' ' LEU . 13.2 mm -100.74 136.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.61 141.2 52.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.647 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -124.19 138.08 54.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.998 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.762 HG23 ' CB ' ' A' ' 79' ' ' SER . 3.3 p -93.26 134.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.209 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.7 mm . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.323 0.582 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -129.52 152.49 49.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.986 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.757 ' HB ' HG23 ' A' ' 76' ' ' VAL . 1.3 m -108.95 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 110.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 24' ' ' LYS . 3.0 p -102.85 117.73 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.3 mt -95.55 112.48 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.623 HG23 ' OD1' ' A' ' 38' ' ' ASN . 30.8 m -89.4 -21.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.623 ' OD1' HG23 ' A' ' 37' ' ' VAL . 11.6 m120 -91.79 11.46 24.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.685 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.98 -45.19 93.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.093 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 41' ' ' ASP . 14.5 m -67.43 -42.31 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 40' ' ' VAL . 3.6 m-20 -64.96 -50.11 67.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.74 -43.66 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.95 75.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.21 93.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.48 -22.6 60.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.857 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -102.43 2.92 37.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.426 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 4.3 m120 65.43 -64.55 0.18 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.35 -0.843 . . . . 0.0 110.237 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -77.23 122.66 86.53 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.7 Cg_endo -73.06 144.84 38.54 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.974 1.512 . . . . 0.0 110.41 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CE ' ' A' ' 39' ' ' MET . 46.3 Cg_endo -72.99 -0.15 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.013 1.533 . . . . 0.0 110.22 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.005 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -57.21 -21.48 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.551 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.6 m-85 -82.1 -58.87 0.44 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.118 -0.988 . . . . 0.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 52' ' ' TYR . 48.8 Cg_endo -74.76 -0.22 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.884 1.465 . . . . 0.0 111.049 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.568 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -61.28 -23.51 65.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.03 -1.044 . . . . 0.0 110.376 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -42.09 64.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.982 . . . . 0.0 110.598 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.8 t80 -58.76 -51.29 70.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.246 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 15.5 m-30 -57.68 -43.26 84.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -61.22 -35.09 90.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -56.7 -37.26 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.257 . . . . 0.0 109.998 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.07 -47.59 76.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.739 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.006 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -83.07 12.92 4.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.162 -0.961 . . . . 0.0 110.91 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 4.87 26.93 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.064 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -114.41 163.67 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.158 . . . . 0.0 109.397 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' C ' ' CG2' ' A' ' 65' ' ' THR . 12.5 tt0 -107.95 -119.07 0.26 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.958 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.568 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.6 p -149.25 170.23 18.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.563 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.48 139.34 28.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.005 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.0 m-85 -126.83 143.77 51.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.864 -1.148 . . . . 0.0 112.844 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -122.99 117.47 25.55 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.731 -0.787 . . . . 0.0 108.943 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.48 -64.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.64 -17.52 5.85 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.184 -0.948 . . . . 0.0 108.682 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -103.92 -31.4 9.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.637 -0.665 . . . . 0.0 110.153 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.8 m-20 71.72 16.47 5.69 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -0.862 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.569 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.46 129.49 56.53 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.618 -0.676 . . . . 0.0 109.713 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.45 137.73 51.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 66' ' ' GLN . 10.8 tt -131.66 148.56 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 109.792 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 34' ' ' THR . 3.6 m -114.21 137.84 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.094 -1.004 . . . . 0.0 109.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.064 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 98.4 m-20 -59.01 143.08 49.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.15 147.59 22.02 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.762 ' CB ' HG23 ' A' ' 25' ' ' VAL . 35.3 p -107.37 121.09 43.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -1.178 . . . . 0.0 110.462 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.21 167.23 22.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 110.004 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt-10 -101.25 158.14 16.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.937 . . . . 0.0 110.119 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.85 -44.52 66.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.61 -34.98 79.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 109.845 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -59.41 -37.35 77.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 110.439 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 3.2 mp -61.79 -44.95 95.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -45.5 69.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.229 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 3.1 tm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.261 0.553 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -97.34 125.1 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.893 . . . . 0.0 110.175 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.7 138.08 47.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -116.67 137.97 51.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 25' ' ' VAL . 4.4 p -96.33 125.1 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.24 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 8.1 tt0 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.61 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HG2' HG22 ' A' ' 75' ' ' ILE . 3.7 ttpt -97.62 153.08 18.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -98.63 118.37 35.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.942 -1.099 . . . . 0.0 110.507 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.76 117.4 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.093 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 4.5 tp -96.05 119.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.4 t -100.77 -24.88 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.0 2.61 56.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.571 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 43.7 tpp -64.14 -44.91 90.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 41' ' ' ASP . 5.9 p -59.55 -42.84 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.391 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -63.58 -49.4 73.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.205 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.77 -43.82 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.262 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.641 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -59.3 -35.54 73.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -50.12 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 109.968 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.15 60.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.859 ' O ' HD23 ' A' ' 46' ' ' LEU . 8.3 tt -83.35 1.1 42.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 110.344 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 3.7 m-20 73.89 -63.35 0.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.796 . . . . 0.0 110.514 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 46' ' ' LEU . 3.9 mmt85 -77.13 155.17 82.5 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 110.262 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.1 Cg_endo -73.05 157.54 50.76 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.102 1.58 . . . . 0.0 110.528 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.64 -26.83 8.0 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.07 1.563 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.731 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 18.1 p -60.69 -21.83 63.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.528 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -58.29 0.59 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 110.653 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' O ' ' CD2' ' A' ' 57' ' ' PHE . 46.2 Cg_endo -72.99 -0.31 8.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.868 1.457 . . . . 0.0 110.892 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.8 -25.83 59.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -45.7 57.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -67.76 -48.86 65.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 11.5 m-85 -57.57 -41.37 80.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -58.83 -35.36 82.08 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -37.27 78.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.238 . . . . 0.0 109.932 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -48.38 71.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 110.651 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.069 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.79 11.46 2.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.169 -0.957 . . . . 0.0 111.046 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.97 11.26 36.99 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.178 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -118.05 164.31 15.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.508 -0.995 . . . . 0.0 109.274 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.409 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 11.8 mp0 -104.1 -121.38 0.2 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.63 -1.294 . . . . 0.0 110.001 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.745 HG21 ' HB ' ' A' ' 54' ' ' THR . 0.7 OUTLIER -149.86 170.12 19.53 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.458 -0.776 . . . . 0.0 111.82 -179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -155.95 139.06 15.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.0 m-85 -127.31 146.1 50.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.741 -1.224 . . . . 0.0 112.967 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -117.9 117.17 28.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.667 177.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.623 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.0 m -90.21 -46.33 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' N ' HG23 ' A' ' 69' ' ' VAL . 1.6 tptt -73.16 -3.62 27.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -118.92 -26.92 5.89 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.684 -0.635 . . . . 0.0 110.529 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.2 m-20 70.13 16.31 7.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.072 -1.017 . . . . 0.0 109.543 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.554 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 4.0 mmt85 -113.87 129.72 56.56 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.8 m-30 -109.06 128.97 55.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.825 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 34' ' ' THR . 84.4 mt -129.04 150.83 34.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 34' ' ' THR . 13.2 m -111.77 138.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.929 -1.107 . . . . 0.0 109.134 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.178 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 8.9 t30 -62.75 140.33 58.74 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.769 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 104.95 147.08 15.72 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.2 p -101.41 127.59 47.99 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.306 -1.114 . . . . 0.0 110.074 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.688 ' NE2' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -141.92 156.69 45.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 1.4 pt-20 -104.01 143.4 32.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.758 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 21' ' ' LEU . . . -53.49 -39.51 64.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.975 . . . . 0.0 110.268 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -34.71 66.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.173 -0.954 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 1.3 tppp? -73.03 -45.58 56.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -60.5 -44.19 96.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.354 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -68.66 -35.83 77.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.73 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.8 t0 . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 111.354 -178.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.279 0.562 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.2 mt -115.61 123.52 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.258 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.99 132.53 53.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.07 136.18 53.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' HB2' ' A' ' 79' ' ' SER . 94.6 t -102.48 134.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.787 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.6 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.332 0.587 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HA ' ' N ' ' A' ' 78' ' ' GLY . 6.0 mtmm -126.76 152.55 46.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.0 OUTLIER -108.18 123.95 49.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' CD1' ' A' ' 75' ' ' ILE . 20.4 t -108.52 117.79 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.724 ' N ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -95.95 122.98 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -100.55 -43.56 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.774 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.716 ' O ' HG13 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -105.23 -1.52 25.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.019 . . . . 0.0 110.75 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.612 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.5 tmt? -64.72 -45.6 85.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.019 . . . . 0.0 109.967 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 74' ' ' TYR . 14.3 p -70.68 -41.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 0.0 110.323 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 40' ' ' VAL . 40.1 t0 -62.17 -49.47 75.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 38' ' ' ASN . 12.9 m -68.12 -43.57 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -61.53 -46.96 87.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -36.45 80.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.449 -0.782 . . . . 0.0 110.236 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.96 70.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 42' ' ' VAL . 3.0 pp -108.94 -1.4 19.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -170.21 -154.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.291 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.419 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 1.8 mtt180 -93.47 174.49 3.84 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.274 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.94 128.57 13.31 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.359 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 39' ' ' MET . 47.9 Cg_endo -75.4 5.2 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.034 1.544 . . . . 0.0 110.657 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.141 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -56.46 -26.54 54.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -84.51 -55.94 0.43 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.964 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.9 Cg_endo -70.77 -23.66 25.95 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.824 1.434 . . . . 0.0 111.143 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.536 HG22 ' C ' ' A' ' 51' ' ' THR . 7.8 t -56.25 -16.31 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.992 -1.067 . . . . 0.0 110.208 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -45.4 68.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -62.11 -49.46 75.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -0.979 . . . . 0.0 110.11 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 8.9 m-30 -57.42 -36.8 71.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.921 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -39.25 94.91 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.2 m -57.45 -37.33 72.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -1.2 . . . . 0.0 109.924 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 -49.48 77.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.835 . . . . 0.0 110.723 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.001 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -83.42 12.98 4.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.109 -0.994 . . . . 0.0 110.697 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.05 6.29 31.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.45 163.59 15.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -1.159 . . . . 0.0 109.609 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG13 ' A' ' 76' ' ' VAL . 24.6 tp60 -107.16 -118.42 0.25 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.936 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.18 170.25 18.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 111.022 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.796 ' HB2' HG23 ' A' ' 75' ' ' ILE . 3.3 mm100 -146.32 139.82 25.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.141 ' CZ ' HG22 ' A' ' 51' ' ' THR . 17.7 m-85 -126.54 142.59 51.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.819 -1.176 . . . . 0.0 112.849 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -120.28 117.48 27.92 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.015 178.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 70' ' ' LYS . 13.5 m -89.29 -45.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.645 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' N ' HG23 ' A' ' 69' ' ' VAL . 7.4 tptt -71.01 -5.95 35.15 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.198 -0.939 . . . . 0.0 108.722 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.7 m-20 -121.32 -25.27 5.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.591 -0.693 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.1 m-20 69.75 17.15 7.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 109.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -113.64 129.47 56.56 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.586 -0.696 . . . . 0.0 109.681 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.733 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-30 -113.18 138.02 50.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.555 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 66' ' ' GLN . 1.6 tt -128.45 148.75 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.461 -0.774 . . . . 0.0 109.925 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 64' ' ' GLN . 69.3 t -113.89 130.03 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.688 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.065 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 27.6 m120 -49.76 147.82 3.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 110.51 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 88.16 148.8 16.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 25' ' ' VAL . 64.8 p -106.63 122.62 46.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -1.109 . . . . 0.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.848 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.09 145.45 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 109.975 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.3 tt0 -81.72 155.17 25.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.108 -0.995 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.25 -43.89 64.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.033 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -64.67 -33.55 76.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 109.797 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -36.87 85.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 110.082 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 80' ' ' HIS . 4.4 mp -59.95 -42.59 94.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.103 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -69.2 -35.93 76.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.535 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.476 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.782 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 3.4 tp . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.261 0.553 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -119.12 132.37 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.9 140.59 52.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -121.71 137.97 54.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 16.3 m -93.44 131.9 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.368 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HB2' HG21 ' A' ' 35' ' ' VAL . 4.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.69 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.581 0.705 . . . . 0.0 110.028 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.708 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.77 153.27 18.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.832 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' A' ' 80' ' ' HIS . 2.3 m -97.16 124.97 41.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.088 -1.007 . . . . 0.0 110.834 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 26' ' ' GLU . 5.7 t -118.02 117.65 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.923 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.66 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.6 mt -95.77 118.16 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.288 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 t -100.45 -16.92 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.286 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.62 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -99.01 14.47 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.66 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -63.97 -41.95 97.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 58.4 t -61.37 -47.55 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -63.0 -50.2 71.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 21' ' ' LEU . 53.2 t -67.28 -40.71 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -62.65 -48.4 79.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -62.11 -38.91 90.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 110.243 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.45 -15.89 60.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.382 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.072 ' O ' HD23 ' A' ' 46' ' ' LEU . 7.2 tt -101.89 -9.33 20.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 110.387 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t30 78.26 -50.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.48 -0.762 . . . . 0.0 111.025 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.564 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 56.3 mtp180 -76.66 142.29 70.07 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.081 -1.012 . . . . 0.0 110.259 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.96 140.96 32.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.147 1.604 . . . . 0.0 110.637 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.727 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -75.73 -29.5 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 0.0 110.333 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.678 HG22 ' CE1' ' A' ' 67' ' ' PHE . 48.8 p -59.5 -22.8 62.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 110.316 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.554 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -77.52 -58.65 0.92 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 0.0 110.268 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 47.8 Cg_endo -73.68 -28.24 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.973 1.512 . . . . 0.0 110.702 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.567 HG22 HG21 ' A' ' 65' ' ' THR . 3.4 m -56.28 -19.74 15.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -72.77 -45.38 58.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.107 -0.995 . . . . 0.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 10.1 m-30 -64.6 -39.82 94.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.095 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -41.15 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -60.28 -35.33 87.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.0 m -56.99 -37.24 71.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 109.769 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.29 -44.0 93.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 110.722 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.216 HD13 ' CE1' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -88.24 12.64 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.134 -0.979 . . . . 0.0 111.032 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.1 4.78 30.31 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -115.29 163.99 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 0.0 109.141 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.736 ' O ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -106.2 -121.58 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.621 -1.3 . . . . 0.0 109.738 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 54' ' ' THR . 1.3 p -149.84 170.43 18.79 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.45 -0.781 . . . . 0.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.66 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -142.41 139.43 31.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.82 144.17 51.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.759 -1.213 . . . . 0.0 113.13 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.3 t0 -126.34 117.38 22.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.165 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 16.9 t -86.58 -61.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -56.47 -16.65 6.23 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.192 -0.942 . . . . 0.0 108.633 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.2 t30 -105.74 -30.02 9.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.584 -0.697 . . . . 0.0 110.152 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.7 m-20 71.05 16.67 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 tpt180 -113.62 128.98 56.63 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.503 -0.748 . . . . 0.0 109.865 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.688 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.44 138.2 50.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.469 -0.769 . . . . 0.0 110.022 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 ' HG2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -132.41 148.06 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 64' ' ' GLN . 59.8 t -114.43 139.03 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.258 -0.901 . . . . 0.0 109.469 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.003 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 11.6 m-80 -64.05 141.72 58.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.085 -1.01 . . . . 0.0 110.469 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 99.64 142.12 12.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 80' ' ' HIS . 4.9 p -80.6 127.3 32.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.096 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 1.216 ' CE1' HD13 ' A' ' 61' ' ' LEU . 28.3 m80 -142.2 141.03 32.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.801 . . . . 0.0 110.403 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 83' ' ' ASN . 4.6 tp10 -104.04 149.57 25.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.928 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -43.91 64.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.426 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -64.15 -33.29 75.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.238 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -40.42 84.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 110.331 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 2.0 mp -60.58 -45.24 94.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.04 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -47.41 64.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.036 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.8 t0 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.54 -179.747 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD23 ' CB ' ' A' ' 85' ' ' LEU . 5.3 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.258 0.551 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.558 HD12 ' OD1' ' A' ' 38' ' ' ASN . 25.9 mt -110.97 120.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.43 132.23 54.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.539 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.0 135.71 53.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.05 122.36 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.607 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.297 0.57 . . . . 0.0 110.381 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -97.43 153.12 18.31 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.929 -1.107 . . . . 0.0 109.213 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.555 ' O ' ' CG2' ' A' ' 34' ' ' THR . 1.3 t -117.94 121.72 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.771 -1.205 . . . . 0.0 110.877 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.27 117.63 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.723 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 39' ' ' MET . 19.0 mt -95.62 108.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.72 -4.9 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.364 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.652 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -109.21 -1.19 18.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 36' ' ' ILE . 34.9 ttm -64.22 -44.2 92.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 110.084 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 11.6 p -70.15 -39.46 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.865 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' N ' HG13 ' A' ' 40' ' ' VAL . 23.8 t70 -62.51 -50.74 70.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.141 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 38' ' ' ASN . 12.4 p -68.5 -45.34 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.619 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -67.85 -35.13 78.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.355 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 2.4 tttp -67.4 -36.58 81.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.43 61.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.1 tt -117.47 -9.16 10.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.914 ' HB2' HD23 ' A' ' 46' ' ' LEU . 1.4 t-20 171.44 -148.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mtt85 -96.41 169.19 9.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.021 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.14 127.81 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.396 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 48.7 Cg_endo -75.03 46.92 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.927 1.488 . . . . 0.0 110.887 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.995 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -68.05 -26.14 65.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.58 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -73.99 -54.31 3.61 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.722 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.4 Cg_endo -69.92 -19.85 34.84 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.812 1.428 . . . . 0.0 110.779 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 65' ' ' THR . 6.3 m -56.25 -18.9 11.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.989 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -72.88 -40.82 65.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -58.66 -49.68 76.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.049 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 10.3 m-85 -57.27 -35.87 70.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -65.31 -35.14 91.14 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 67.0 m -56.69 -37.19 70.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.08 -1.247 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -49.3 69.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.644 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.018 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.9 11.94 3.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.113 -0.992 . . . . 0.0 111.115 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.2 4.66 30.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -118.35 164.05 15.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.4 mt-30 -110.34 -120.53 0.28 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.594 -1.316 . . . . 0.0 109.875 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 54' ' ' THR . 1.1 p -149.4 170.41 18.62 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.435 -0.791 . . . . 0.0 110.921 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.801 ' HB2' HG23 ' A' ' 75' ' ' ILE . 1.8 mm-40 -140.97 139.66 34.27 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.995 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.6 m-85 -126.5 142.99 51.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.751 -1.218 . . . . 0.0 113.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -123.13 117.5 25.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.997 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.53 -64.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.599 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -16.91 6.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.134 -0.979 . . . . 0.0 108.656 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -103.75 -29.66 10.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.603 -0.686 . . . . 0.0 110.103 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.5 m-20 69.58 15.95 8.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.128 -0.982 . . . . 0.0 110.158 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 15.4 ttm180 -113.65 129.44 56.57 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.852 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.737 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.61 138.04 50.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.394 -0.816 . . . . 0.0 110.309 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.801 HG23 ' HB2' ' A' ' 66' ' ' GLN . 17.8 tt -130.6 148.41 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 64' ' ' GLN . 4.2 t -114.73 139.21 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -0.958 . . . . 0.0 109.327 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.836 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 62.4 m-80 -67.86 140.03 56.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.346 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . 105.63 145.39 13.25 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -80.44 133.59 35.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -1.2 . . . . 0.0 110.179 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.946 ' HE1' HD13 ' A' ' 61' ' ' LEU . 64.1 m80 -142.32 119.83 11.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.508 -0.745 . . . . 0.0 110.8 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -82.92 158.76 22.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.31 -43.74 61.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.997 -1.065 . . . . 0.0 109.559 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 2.4 t30 -64.71 -33.27 75.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.2 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.31 75.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.052 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' CB ' HD23 ' A' ' 21' ' ' LEU . 20.5 mt -58.85 -32.45 69.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.589 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 51.8 mm-40 -68.79 -35.08 76.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.442 -0.787 . . . . 0.0 111.585 -178.744 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 22' ' ' ILE . 5.1 tt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD23 ' A' ' 21' ' ' LEU . 4.7 mt -103.97 136.77 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.71 126.75 45.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.717 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 mmtp -116.12 138.05 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 25' ' ' VAL . 4.3 p -93.34 122.05 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.6 tt0 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.406 -0.809 . . . . 0.0 110.217 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -97.71 152.85 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.905 -1.122 . . . . 0.0 109.559 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.923 HG21 ' CD2' ' A' ' 80' ' ' HIS . 18.5 m -110.78 115.69 29.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.938 -1.101 . . . . 0.0 110.771 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 24' ' ' LYS . 14.3 p -107.14 117.42 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.2 mt -95.77 108.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 37' ' ' VAL . 7.6 p -100.6 -13.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.667 ' OD1' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -101.47 -1.32 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.415 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -64.5 -45.26 88.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 8.5 p -67.19 -38.58 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.0 110.422 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.519 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.2 t0 -61.93 -48.92 78.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -0.945 . . . . 0.0 110.353 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 38' ' ' ASN . 79.9 t -68.41 -40.7 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -66.43 -38.69 87.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -67.11 -36.45 81.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.052 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.762 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -63.2 -30.27 71.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.1 mp -115.18 -9.31 12.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' ALA . 6.1 p30 171.37 -110.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.37 -0.831 . . . . 0.0 110.388 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.916 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.9 mtm-85 -137.32 167.35 21.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 44.9 Cg_endo -72.0 137.91 30.11 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.907 1.477 . . . . 0.0 110.571 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 1.079 ' O ' HG23 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.11 52.08 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.066 1.561 . . . . 0.0 110.523 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.888 HG22 ' CE1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -67.87 -21.69 65.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.551 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 m-85 -81.4 -54.2 0.71 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 111.081 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -72.47 2.49 5.08 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.796 1.419 . . . . 0.0 111.338 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 1.079 HG23 ' O ' ' A' ' 50' ' ' PRO . 1.9 p -66.35 -18.59 65.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -72.86 -42.3 63.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.878 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -58.72 -51.43 70.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.117 -0.99 . . . . 0.0 110.433 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.547 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 24.7 m-85 -57.82 -42.59 84.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.65 -35.52 89.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -37.28 70.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -1.208 . . . . 0.0 110.039 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.63 -48.88 70.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.009 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.14 12.45 3.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.066 -1.021 . . . . 0.0 111.097 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.85 4.85 22.28 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.046 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.71 163.87 15.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -1.139 . . . . 0.0 109.081 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.51 ' C ' ' CG2' ' A' ' 65' ' ' THR . 66.4 mt-30 -110.4 -123.07 0.27 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.643 -1.285 . . . . 0.0 109.929 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.596 HG21 ' HB ' ' A' ' 54' ' ' THR . 2.0 p -149.92 170.76 18.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.97 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.647 ' CB ' HG22 ' A' ' 75' ' ' ILE . 2.0 tm0? -144.27 139.4 28.59 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.888 ' CE1' HG22 ' A' ' 51' ' ' THR . 30.8 m-85 -126.76 145.85 50.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.792 -1.193 . . . . 0.0 112.98 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 71' ' ' ASN . 10.5 m-20 -126.52 117.52 23.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.274 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.9 m -87.29 -45.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.63 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.604 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.38 -8.39 46.11 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.1 m120 -118.94 -24.69 6.49 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.695 -0.628 . . . . 0.0 110.147 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.1 m-20 68.45 15.71 9.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.958 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.587 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 5.6 mtp180 -113.82 129.43 56.59 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.566 -0.709 . . . . 0.0 109.788 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -113.79 130.91 56.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.484 -0.76 . . . . 0.0 110.316 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.647 HG22 ' CB ' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -111.39 148.04 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 3.0 t -120.31 132.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 109.22 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.046 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 82.5 m-20 -66.17 141.01 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 110.555 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 99.56 137.39 9.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 86.5 p -96.5 116.04 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.107 -1.231 . . . . 0.0 110.639 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CD2' HG21 ' A' ' 34' ' ' THR . 3.1 p-80 -143.26 127.47 17.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.274 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.552 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -73.64 151.62 40.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.986 -1.071 . . . . 0.0 109.737 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.06 -44.59 64.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 110.208 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.56 -33.3 75.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.835 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -36.6 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.582 -0.699 . . . . 0.0 111.084 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 7.9 mp -59.22 -44.84 92.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.16 -0.963 . . . . 0.0 110.725 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.02 -36.42 83.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.037 -1.039 . . . . 0.0 109.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.2 t0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.475 -0.766 . . . . 0.0 111.426 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 21' ' ' LEU . 10.3 tt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.261 0.553 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.62 133.82 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.239 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.05 147.18 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.099 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.22 137.17 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 110.3 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' H ' HG12 ' A' ' 25' ' ' VAL . 4.3 p -97.03 135.33 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 ' HB3' ' A' ' 79' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.517 0.675 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' ' 75' ' ' ILE . 7.7 mtmt -112.66 134.01 54.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.1 m -97.24 120.23 37.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.2 m -101.53 118.78 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.737 HG23 ' CB ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -95.22 111.95 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 24' ' ' LYS . 13.9 t -101.1 -44.13 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.876 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -92.2 4.61 52.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.94 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.737 ' CB ' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.15 -33.38 75.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.0 110.242 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 41' ' ' ASP . 35.2 m -59.42 -38.39 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -64.05 -47.14 81.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.184 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.53 -48.32 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . . . -56.65 -34.93 67.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 2.4 tmtt? -57.72 -48.76 78.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.6 66.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.084 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.7 tt -85.34 -9.38 57.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 83.67 -35.72 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.706 -0.621 . . . . 0.0 110.621 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HB2' HD22 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -92.62 154.16 42.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.224 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.533 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.3 Cg_endo -73.18 150.57 47.89 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.021 1.537 . . . . 0.0 110.365 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HB2' ' SD ' ' A' ' 39' ' ' MET . 46.6 Cg_endo -73.24 -22.4 19.04 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.043 1.549 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.783 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.5 p -66.12 -21.66 66.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -79.79 -56.63 0.75 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.786 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 49' ' ' PRO . 46.3 Cg_endo -73.4 2.41 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.907 1.477 . . . . 0.0 111.054 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.581 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.44 -28.78 61.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.002 -1.062 . . . . 0.0 110.231 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -72.87 -45.56 57.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -0.923 . . . . 0.0 110.523 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.04 -51.18 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 110.414 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -44.01 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.887 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.563 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -60.06 -35.1 86.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -37.36 70.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -49.47 58.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.196 -0.94 . . . . 0.0 110.581 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.065 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -77.88 9.06 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 0.0 111.121 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.01 4.52 42.44 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -115.06 163.75 15.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -1.143 . . . . 0.0 109.129 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.726 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.5 pm0 -110.09 -120.78 0.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.582 -1.324 . . . . 0.0 109.964 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.5 p -149.4 170.53 18.34 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.447 -0.783 . . . . 0.0 110.966 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -143.82 139.53 29.37 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.4 m-85 -126.59 142.03 51.67 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.862 -1.135 . . . . 0.0 112.803 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 42.9 m-20 -121.33 117.47 27.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.083 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.09 -63.58 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -16.73 6.52 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.16 -0.962 . . . . 0.0 108.592 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.95 -29.88 10.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.656 -0.652 . . . . 0.0 110.051 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.5 m-20 69.66 15.48 8.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 109.986 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 2.6 ttm180 -113.89 129.86 56.55 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.669 -0.644 . . . . 0.0 109.581 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.704 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.5 m-30 -113.0 134.53 54.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.102 HD13 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -129.44 148.77 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.816 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 1.102 ' N ' HD13 ' A' ' 75' ' ' ILE . 25.5 t -113.6 138.0 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -0.985 . . . . 0.0 109.864 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -59.88 141.08 56.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.855 . . . . 0.0 110.905 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.55 157.76 33.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.937 ' HB3' HD12 ' A' ' 32' ' ' ILE . 91.8 p -101.81 122.13 43.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.143 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.612 ' NE2' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.03 114.93 8.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 85' ' ' LEU . 2.2 pm0 -84.19 151.82 24.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.811 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLN . . . -52.46 -39.36 61.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.599 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 1.4 t-20 -64.54 -34.04 77.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 110.709 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.593 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -72.95 -48.27 38.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.635 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -0.957 . . . . 0.0 110.253 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.3 mt-30 -58.93 -36.99 75.67 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 1.1 m-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.426 0.631 . . . . 0.0 109.618 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.697 HD13 ' C ' ' A' ' 21' ' ' LEU . 3.5 tm? . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.222 0.534 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.61 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.1 mp -106.76 121.83 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.343 -0.848 . . . . 0.0 109.964 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.78 46.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.235 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.1 136.45 52.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.3 m -93.95 135.09 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.172 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.801 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.8 mm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -129.44 142.84 50.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.282 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.832 HG21 ' NE2' ' A' ' 80' ' ' HIS . 20.9 m -98.34 128.87 44.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.632 HG12 HG23 ' A' ' 75' ' ' ILE . 3.2 m -101.43 127.69 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.602 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 0.7 OUTLIER -93.82 121.12 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.914 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.84 -46.96 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 111.26 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.99 18.5 14.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.989 -1.069 . . . . 0.0 111.17 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.602 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.16 -45.26 89.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 110.236 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' ASP . 23.5 m -70.28 -39.09 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' ' 40' ' ' VAL . 58.7 t0 -62.08 -48.9 78.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.75 -48.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -63.72 -35.03 79.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -62.78 -36.48 83.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.22 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.895 . . . . 0.0 110.232 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.874 HD12 ' HB2' ' A' ' 47' ' ' ASN . 3.2 pp -105.91 -1.24 24.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.874 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER 173.41 -151.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 110.243 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.431 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 8.4 mtt85 -89.31 174.95 4.34 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.6 Cg_endo -72.81 131.8 17.62 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.932 1.49 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 39' ' ' MET . 46.5 Cg_endo -73.72 1.25 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.547 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.918 HG23 ' CE1' ' A' ' 67' ' ' PHE . 88.1 m -56.46 -21.83 28.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 110.267 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.576 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -97.71 -54.9 0.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 111.277 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 47.4 Cg_endo -74.99 -2.76 12.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.663 1.349 . . . . 0.0 111.151 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.58 HG23 HG21 ' A' ' 65' ' ' THR . 1.2 t -57.89 -14.41 6.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.298 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -72.77 -45.59 57.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.436 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -65.2 -51.17 62.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.026 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.36 -37.07 72.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 109.33 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -63.55 -35.21 91.73 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -37.15 70.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.2 . . . . 0.0 109.753 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 3.8 tp10 -64.5 -49.36 71.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.02 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -81.1 11.57 4.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.15 -0.969 . . . . 0.0 110.985 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.95 4.57 42.27 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.033 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -116.11 163.15 16.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.145 -1.209 . . . . 0.0 109.257 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.522 ' C ' ' CG2' ' A' ' 65' ' ' THR . 2.2 tt0 -119.04 -123.33 0.29 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 0.0 109.813 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.9 p -149.98 170.63 18.4 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.641 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -149.59 139.48 21.91 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.918 ' CE1' HG23 ' A' ' 51' ' ' THR . 23.8 m-85 -126.86 146.15 50.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.249 . . . . 0.0 113.024 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 3.6 t0 -121.34 117.45 26.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.922 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.14 -63.08 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.876 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -56.64 -15.22 4.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.139 -0.976 . . . . 0.0 108.957 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.8 t30 -106.0 -29.07 10.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.743 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 70.62 16.89 6.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.55 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -113.76 129.81 56.53 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.728 ' O ' HD13 ' A' ' 75' ' ' ILE . 3.7 m-30 -111.16 129.03 56.07 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.752 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 74' ' ' TYR . 13.8 mm -130.77 149.28 33.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 12.3 m -112.78 139.44 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 109.729 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.033 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 6.8 p-10 -69.32 137.0 52.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.258 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 108.1 129.61 6.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . 63.1 p -92.07 121.77 33.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.005 -1.291 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.832 ' NE2' HG21 ' A' ' 34' ' ' THR . 2.2 p-80 -142.02 114.86 8.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.416 -0.803 . . . . 0.0 110.04 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -58.72 157.13 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.067 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.572 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.11 -36.96 52.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -55.91 -33.53 64.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.877 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -63.31 -39.52 94.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.551 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 85' ' ' LEU . 3.5 mm? -60.36 -32.99 71.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.24 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.477 ' CA ' ' OE1' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -62.74 -37.04 85.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 109.772 179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 9.3 tp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.291 0.567 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 22' ' ' ILE . 14.2 mm -132.59 129.63 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.86 149.24 48.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -116.15 138.45 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.3 m -92.95 131.51 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 0.0 110.395 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.034 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.912 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' GLU . 3.6 ttpt -129.49 152.6 48.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.932 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.802 ' O ' HG23 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -111.21 128.49 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 75' ' ' ILE . 2.2 p -117.8 117.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.517 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.724 HD12 ' CE ' ' A' ' 39' ' ' MET . 1.6 mt -96.07 112.95 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.07 -14.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 110.417 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 31.1 m120 -111.01 11.38 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.724 ' CE ' HD12 ' A' ' 36' ' ' ILE . 1.2 ttt -61.74 -45.41 94.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 36.6 t -70.24 -47.62 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.68 -50.01 70.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.897 . . . . 0.0 110.534 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 38' ' ' ASN . 43.0 t -68.36 -45.33 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.464 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.13 -39.06 86.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -67.52 -41.14 84.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.47 -17.88 62.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.9 tt -117.48 -9.11 10.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 110.522 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.831 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.3 OUTLIER 167.68 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.34 170.47 10.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.61 135.21 19.55 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.876 1.461 . . . . 0.0 110.538 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 50.5 Cg_endo -78.18 20.33 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.995 1.524 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -56.59 -21.93 30.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.311 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -85.54 -58.54 0.33 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.0 110.877 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.8 Cg_endo -73.16 0.3 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.798 1.42 . . . . 0.0 110.943 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -56.52 -20.92 22.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.217 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.81 -39.97 66.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.958 . . . . 0.0 110.584 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.5 t80 -58.87 -51.18 71.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.309 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 32.3 m-85 -57.53 -43.37 84.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.6 -35.38 85.59 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 86.9 m -57.1 -37.24 71.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 110.028 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -66.19 -49.35 67.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 110.83 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.034 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.17 11.56 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 4.89 26.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.05 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.47 163.77 15.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.3 mm100 -105.45 -120.44 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.598 -1.314 . . . . 0.0 109.754 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.52 170.24 19.07 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 75' ' ' ILE . 6.1 tt0 -143.47 139.33 29.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.698 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.3 m-85 -126.81 141.12 51.91 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.808 -1.182 . . . . 0.0 112.71 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -122.24 117.46 26.22 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.059 178.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -85.89 -63.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.656 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.3 ttmt -55.23 -17.49 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 108.872 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -105.4 -29.35 10.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.561 -0.712 . . . . 0.0 110.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.8 m-20 70.77 16.54 6.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 99.6 mtt180 -113.68 129.64 56.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.567 -0.708 . . . . 0.0 109.629 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.1 m-30 -113.29 137.94 50.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 110.337 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 34' ' ' THR . 44.3 mt -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 64' ' ' GLN . 14.5 t -114.04 137.73 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.05 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 67.9 m-80 -57.9 142.22 46.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 110.534 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 84.65 152.5 16.44 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.912 ' OG ' HD12 ' A' ' 32' ' ' ILE . 45.4 p -99.67 115.98 30.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.256 . . . . 0.0 110.687 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.764 ' NE2' HG21 ' A' ' 34' ' ' THR . 5.0 p-80 -143.32 117.05 9.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.158 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 3.2 tt0 -65.75 153.83 40.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.618 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -44.75 65.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.102 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.51 -33.47 76.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.055 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 4.0 tttp -61.11 -36.48 79.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.749 -0.594 . . . . 0.0 110.145 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.673 HD21 ' HD2' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -59.4 -39.44 83.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.0 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.9 -36.48 74.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.962 -1.086 . . . . 0.0 108.305 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.397 0.618 . . . . 0.0 109.938 178.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 85' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.18 0.514 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.2 pt -109.99 120.89 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.13 136.77 54.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.722 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.6 mmmm -118.44 137.93 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.8 m -93.31 128.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.338 0.589 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.757 ' HD2' HG21 ' A' ' 75' ' ' ILE . 17.6 ttmm -97.58 152.91 18.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 109.29 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 80' ' ' HIS . 2.8 m -99.28 115.81 30.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.832 -1.168 . . . . 0.0 110.914 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.2 p -112.36 117.42 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.84 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 ' HE3' ' A' ' 39' ' ' MET . 58.5 mt -95.88 109.75 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.66 -16.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.316 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' HD11 ' A' ' 22' ' ' ILE . 6.2 p-10 -97.8 2.61 49.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 110.21 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.629 ' HE3' HG21 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -55.86 -33.64 64.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.195 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.49 -44.47 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 7.2 t0 -66.17 -48.35 71.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 43' ' ' ALA . 8.1 p -61.15 -41.37 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.778 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -61.35 -35.18 76.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.014 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.4 mmmt -59.41 -37.21 77.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.875 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.915 ' C ' HD23 ' A' ' 46' ' ' LEU . . . -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.952 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.012 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -96.27 -9.05 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.889 . . . . 0.0 109.218 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 74.3 -50.18 0.68 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.634 . . . . 0.0 110.408 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 20.9 mtt85 -77.04 168.03 31.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.6 140.45 32.79 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.397 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.778 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.6 Cg_endo -73.51 -15.62 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.054 1.555 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.707 HG22 ' CE1' ' A' ' 67' ' ' PHE . 73.8 p -64.07 -27.05 68.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -75.98 -54.91 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.19 -42.91 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.816 1.429 . . . . 0.0 110.829 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 50' ' ' PRO . 6.9 t -56.36 -15.75 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 110.386 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -72.25 -45.36 60.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.349 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.66 79.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.6 -42.09 82.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.008 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.557 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.39 -35.43 85.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -37.12 74.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 110.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.72 -30.09 69.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.265 -0.897 . . . . 0.0 110.987 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.087 HD13 ' CE1' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -102.26 13.19 35.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.969 -1.082 . . . . 0.0 110.914 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.06 4.89 30.63 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.023 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -113.74 164.29 13.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.202 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.926 ' O ' HG13 ' A' ' 76' ' ' VAL . 6.0 tt0 -109.92 -121.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.626 -1.296 . . . . 0.0 109.608 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.74 170.5 18.58 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.385 -0.822 . . . . 0.0 111.325 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.5 OUTLIER -139.82 139.92 36.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.707 ' CE1' HG22 ' A' ' 51' ' ' THR . 21.1 m-85 -126.36 142.75 51.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.59 -1.244 . . . . 0.0 113.138 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 2.3 t0 -121.7 117.19 26.02 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.065 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -89.85 -45.1 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.0 -7.04 43.5 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -119.05 -27.19 5.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.749 -0.594 . . . . 0.0 110.186 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.0 m-20 70.19 16.98 7.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 12.4 mmm-85 -113.53 129.77 56.49 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.671 -0.643 . . . . 0.0 109.491 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.7 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.02 129.39 56.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 110.541 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.757 HG21 ' HD2' ' A' ' 33' ' ' LYS . 12.6 mt -123.22 149.8 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.618 -0.676 . . . . 0.0 109.792 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 64' ' ' GLN . 75.3 t -112.84 139.19 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.981 -1.074 . . . . 0.0 109.19 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.653 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 17.5 m120 -65.63 141.63 58.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.862 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.24 138.83 9.56 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.38 131.5 35.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 1.087 ' CE1' HD13 ' A' ' 61' ' ' LEU . 39.8 m80 -141.7 126.34 17.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.645 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 82' ' ' ALA . 3.8 tp10 -100.89 151.07 22.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.583 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 81' ' ' GLU . . . -52.1 -43.67 64.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 110.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -58.55 -38.25 77.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.955 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -39.55 78.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 21' ' ' LEU . 21.3 mt -60.4 -40.76 92.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -59.19 -36.36 75.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.918 . . . . 0.0 109.96 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.249 0.547 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 22' ' ' ILE . 27.8 mm -121.97 143.82 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.975 ' O ' HG12 ' A' ' 35' ' ' VAL . 7.9 mttt -139.41 138.08 36.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 0.0 110.148 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 79' ' ' SER . 46.5 t -93.53 122.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.374 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.7 mm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.306 0.574 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.53 141.93 50.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' NE2' ' A' ' 80' ' ' HIS . 1.4 m -96.88 127.87 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 24' ' ' LYS . 3.5 p -117.04 118.02 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.956 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 39' ' ' MET . 8.1 mt -95.39 138.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.329 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.611 HG22 ' NH1' ' A' ' 73' ' ' ARG . 28.8 t -100.31 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.48 12.25 37.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -53.35 -33.43 53.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -68.83 -38.41 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -50.21 72.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 43' ' ' ALA . 10.1 p -65.84 -40.82 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.814 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -64.98 -34.92 79.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.203 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.47 85.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.96 63.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.071 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.912 ' O ' HD23 ' A' ' 46' ' ' LEU . 10.3 tt -92.57 -3.32 55.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.8 m-20 72.61 -62.41 0.47 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.815 . . . . 0.0 110.364 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.616 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 169.86 19.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.48 147.15 45.82 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.0 Cg_endo -73.92 -23.4 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.997 1.525 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.038 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 72.5 p -57.85 -21.81 44.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.0 m-30 -80.14 -58.37 0.6 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.893 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.27 -30.94 15.06 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.837 1.44 . . . . 0.0 111.045 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 51' ' ' THR . 9.7 t -57.99 -14.01 5.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.993 . . . . 0.0 110.3 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 13.1 tptm -64.25 -45.38 88.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.952 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -64.83 -38.77 92.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.304 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.57 -35.31 85.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -37.32 71.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' OE1' ' CA ' ' A' ' 60' ' ' GLU . 3.1 mm-40 -66.68 -49.54 65.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.23 -0.919 . . . . 0.0 110.622 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.061 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -79.92 12.87 2.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.189 -0.945 . . . . 0.0 110.961 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.25 9.38 29.48 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.061 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -118.74 163.95 16.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -1.122 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.4 mt-30 -105.36 -117.29 0.23 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.833 -1.167 . . . . 0.0 110.144 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.0 170.37 18.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 111.081 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HG3' ' HE3' ' A' ' 33' ' ' LYS . 1.1 mm-40 -144.88 139.65 27.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.038 ' CZ ' HG22 ' A' ' 51' ' ' THR . 24.7 m-85 -126.67 143.46 51.22 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.001 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -123.69 117.37 24.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.969 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -88.11 -45.8 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -70.0 -7.6 42.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -118.32 -25.92 6.43 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.687 -0.633 . . . . 0.0 110.207 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.6 m-20 68.74 16.17 8.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.611 ' NH1' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.86 129.79 56.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.525 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.9 m-30 -112.89 129.2 56.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.669 HG12 HG23 ' A' ' 35' ' ' VAL . 52.8 mt -118.57 149.17 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.521 -0.737 . . . . 0.0 109.966 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.2 p -113.15 134.15 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.061 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 65.5 m-80 -50.63 143.4 9.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.772 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 94.44 131.28 6.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.57 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 59.4 p -97.3 120.29 37.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -1.152 . . . . 0.0 110.106 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.886 ' NE2' HG21 ' A' ' 34' ' ' THR . 1.8 p-80 -142.38 151.52 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.787 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 4.8 tt0 -93.0 157.69 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.951 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.3 -43.8 64.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.68 -33.47 76.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -37.33 86.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.191 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.2 mp -60.09 -33.02 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -68.07 -36.22 79.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.846 . . . . 0.0 109.641 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.638 -179.905 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 5.7 tt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.235 0.54 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.2 mt -112.4 143.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.781 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.37 123.98 40.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.898 . . . . 0.0 110.385 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 138.2 53.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 74.6 t -93.11 122.32 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.409 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HB3' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.389 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 1.009 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -126.88 152.65 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -0.956 . . . . 0.0 110.502 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -108.06 116.24 31.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.133 -0.98 . . . . 0.0 110.373 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 HD12 ' A' ' 75' ' ' ILE . 48.6 t -104.08 117.46 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.758 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.9 mm -96.02 108.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.41 -23.53 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.663 ' OD1' HG23 ' A' ' 42' ' ' VAL . 46.2 t30 -95.93 8.79 42.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.545 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.9 ttt -64.12 -45.29 89.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 17.9 t -67.24 -40.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -45.26 70.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.661 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.663 HG23 ' OD1' ' A' ' 38' ' ' ASN . 80.4 t -68.29 -48.73 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -67.45 -43.96 79.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.393 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 7.8 ttpt -59.54 -36.48 76.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.095 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.21 -16.5 62.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.942 HD22 ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -117.39 -11.17 10.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.149 -0.969 . . . . 0.0 110.078 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.737 ' CB ' HD13 ' A' ' 46' ' ' LEU . 13.6 t-20 167.02 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.237 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.068 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -137.67 172.07 7.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.08 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -72.72 139.51 30.9 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.031 1.543 . . . . 0.0 110.629 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.932 ' O ' HG23 ' A' ' 54' ' ' THR . 47.2 Cg_endo -72.76 60.34 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.042 1.548 . . . . 0.0 110.394 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -68.73 -50.53 50.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 111.332 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.762 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 p90 -87.33 -29.0 0.38 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.351 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.3 Cg_endo -71.29 -2.18 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.07 1.037 . . . . 0.0 110.755 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.932 HG23 ' O ' ' A' ' 50' ' ' PRO . 2.9 p -76.46 -10.99 59.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.106 -0.996 . . . . 0.0 110.372 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -72.94 -45.42 58.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 0.0 110.58 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.53 -47.78 77.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 110.392 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.46 -42.8 83.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.859 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.52 -35.44 85.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -37.21 71.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -1.196 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -48.79 68.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.879 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.028 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -80.72 12.83 2.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.107 -0.995 . . . . 0.0 110.95 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.47 5.44 22.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.48 163.93 15.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -1.133 . . . . 0.0 109.213 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' C ' ' CG2' ' A' ' 65' ' ' THR . 19.6 mt-30 -102.87 -119.56 0.19 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.634 -1.292 . . . . 0.0 109.998 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -149.5 170.41 18.67 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 111.005 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.559 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.9 mt-30 -146.01 139.47 26.14 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.69 144.53 50.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.876 -1.14 . . . . 0.0 112.748 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.587 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 1.9 t0 -124.01 117.42 24.69 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.323 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 15.2 m -88.91 -46.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 2.5 tppt? -69.75 -8.73 50.52 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -117.17 -26.76 6.68 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.677 -0.639 . . . . 0.0 110.124 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 4.7 m-20 69.8 16.53 7.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.587 ' HG3' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.87 129.66 56.57 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 109.643 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.755 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.18 129.18 56.59 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.417 -0.802 . . . . 0.0 110.5 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.934 HD12 HG22 ' A' ' 35' ' ' VAL . 2.3 tt -124.12 148.34 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.487 -0.758 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 34' ' ' THR . 11.0 m -114.35 139.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.7 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.072 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 70.6 m-20 -55.74 146.36 21.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.5 150.78 21.87 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . 1.009 ' OG ' HD12 ' A' ' 32' ' ' ILE . 2.7 p -103.92 123.92 48.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -1.173 . . . . 0.0 110.202 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 1.019 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.19 114.84 8.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.781 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 4.9 tt0 -74.74 156.54 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.605 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.7 -44.19 63.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.077 -1.014 . . . . 0.0 109.74 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.09 -33.14 75.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.22 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 81' ' ' GLU . 29.8 mttt -71.35 -36.47 71.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.638 -0.663 . . . . 0.0 110.475 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 81' ' ' GLU . 1.2 mm? -59.37 -44.23 92.77 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.227 -0.921 . . . . 0.0 110.144 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -68.62 -36.12 78.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.948 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 111.297 -179.386 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.222 0.534 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 37' ' ' VAL . 3.0 tt -128.5 136.1 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 34' ' ' THR . . . -125.8 135.44 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 110.23 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.773 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.16 137.47 52.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.7 m -100.27 135.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.673 HD13 ' OG ' ' A' ' 79' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -98.35 142.14 30.36 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.683 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.572 ' C ' HG23 ' A' ' 75' ' ' ILE . 1.9 m -96.97 115.93 28.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.636 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.4 p -105.14 117.83 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.953 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 92.0 mt -95.66 112.87 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.644 HG22 HG23 ' A' ' 22' ' ' ILE . 28.6 m -83.52 -4.88 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.04 -0.29 47.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.275 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -53.32 -42.41 66.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.133 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.43 -40.4 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.24 -47.81 75.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' O ' HD23 ' A' ' 46' ' ' LEU . 84.1 t -62.77 -44.73 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -56.4 -35.06 67.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -36.49 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.95 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.28 78.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.243 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.848 HD11 ' O ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -104.49 0.87 29.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.0 t-20 73.17 -53.48 0.7 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.664 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.848 ' O ' HD11 ' A' ' 46' ' ' LEU . 4.5 ttt-85 -76.93 147.83 77.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.11 147.31 37.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.988 1.52 . . . . 0.0 110.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 48.8 Cg_endo -75.44 7.54 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.078 1.567 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.215 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -63.01 -37.97 89.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 110.421 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -69.85 -52.28 13.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 110.586 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.8 Cg_endo -70.37 -16.25 34.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.81 1.426 . . . . 0.0 110.462 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.692 HG22 ' CG2' ' A' ' 65' ' ' THR . 1.4 m -71.6 -19.42 62.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.104 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -73.0 -44.96 60.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.517 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 70.7 m-85 -66.84 -45.02 79.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.419 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 53' ' ' PRO . 23.4 m-85 -57.36 -43.97 83.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.801 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.44 -35.21 84.33 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 84.7 m -56.83 -37.38 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.25 . . . . 0.0 110.108 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.99 -48.21 66.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.867 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.014 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.8 10.84 2.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -0.992 . . . . 0.0 111.005 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.85 40.13 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.014 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -114.21 163.67 14.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -1.156 . . . . 0.0 109.503 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.7 tt0 -107.78 -118.49 0.26 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.777 -1.202 . . . . 0.0 109.915 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.692 ' CG2' HG22 ' A' ' 54' ' ' THR . 2.6 p -149.32 170.17 19.14 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 111.148 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -144.42 139.18 28.23 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.215 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.1 m-85 -127.19 142.48 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.712 -1.242 . . . . 0.0 113.032 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -125.24 117.38 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.908 178.151 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 t -84.78 -64.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -17.16 4.56 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.557 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.6 m-80 -102.12 -31.49 10.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 110.102 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.3 m-20 70.27 15.59 7.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -113.7 129.8 56.52 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.565 -0.709 . . . . 0.0 109.718 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.4 m-30 -112.86 129.29 56.51 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 35' ' ' VAL . 17.8 mt -120.83 149.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 110.285 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 13.4 m -112.96 129.17 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.755 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 28.1 m-20 -48.25 144.51 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.884 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 97.71 146.4 20.7 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.673 ' OG ' HD13 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -102.04 126.07 48.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -1.027 . . . . 0.0 109.889 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -141.94 156.68 45.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 2.3 tt0 -103.99 148.66 25.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 109.81 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.28 -39.74 60.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 1.6 t30 -64.28 -33.36 75.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -37.5 71.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' GLU . 17.3 mt -63.39 -44.66 94.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 3.8 pt20 -68.24 -36.15 79.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 7.8 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.406 -0.809 . . . . 0.0 110.218 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD13 ' C ' ' A' ' 21' ' ' LEU . 1.8 tm? . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.166 0.507 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.628 ' N ' HD22 ' A' ' 21' ' ' LEU . 28.8 mt -103.25 133.52 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -125.53 131.08 52.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' VAL . 5.2 tttt -116.57 138.21 51.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 25' ' ' VAL . 17.9 m -93.24 135.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.729 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.8 mm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.557 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' A' ' 75' ' ' ILE . 1.2 tppt? -129.42 152.73 48.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 2.8 t -115.31 125.87 53.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 35' ' ' VAL . 7.2 p -117.31 117.68 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.696 HD13 ' HG3' ' A' ' 39' ' ' MET . 2.3 mp -95.67 143.16 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.52 -39.8 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.561 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -93.68 11.73 27.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.528 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.696 ' HG3' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.18 -45.52 88.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 41' ' ' ASP . 12.8 p -70.38 -43.99 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.0 t0 -69.3 -47.95 63.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.765 ' O ' HD13 ' A' ' 46' ' ' LEU . 4.3 p -61.11 -44.92 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.481 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -68.19 -46.07 71.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.092 -1.005 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 1.3 mtpm? -67.6 -42.6 82.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.852 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.766 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -59.6 -23.25 62.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.821 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.789 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -117.6 -9.26 10.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 110.464 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 9.6 p30 -173.56 -146.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.783 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 11.8 mtm180 -90.2 175.47 3.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.79 . . . . 0.0 110.618 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 44.3 Cg_endo -70.64 137.07 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.019 1.536 . . . . 0.0 110.455 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.2 Cg_endo -76.94 0.23 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.114 1.586 . . . . 0.0 110.427 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.774 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.9 p -56.24 -21.87 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.89 . . . . 0.0 110.43 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.497 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -88.87 -57.78 0.27 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 111.006 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -72.73 -16.64 26.5 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.729 1.384 . . . . 0.0 111.052 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 4.9 t -56.37 -16.12 5.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 110.265 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 tptt -72.66 -45.48 58.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -50.04 75.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 110.152 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 m-85 -57.37 -38.55 74.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.913 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.37 -38.61 93.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -37.33 71.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -1.223 . . . . 0.0 109.94 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.78 -49.49 70.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.04 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.4 11.41 3.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.058 -1.026 . . . . 0.0 110.871 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.16 4.76 30.61 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.049 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -118.8 163.4 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.75 ' O ' HG13 ' A' ' 76' ' ' VAL . 25.1 mt-30 -105.52 -119.18 0.23 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.741 -1.225 . . . . 0.0 109.961 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.4 170.32 18.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.643 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -147.14 139.83 24.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.774 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.4 m-85 -126.59 144.6 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.735 -1.228 . . . . 0.0 112.872 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.576 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -121.76 117.31 26.27 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.893 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 5.1 t -85.95 -64.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.564 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -16.51 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.14 -0.975 . . . . 0.0 108.62 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -103.69 -30.08 10.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.7 m-20 70.21 15.5 7.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.552 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.6 ttp180 -113.71 129.77 56.52 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.629 -0.67 . . . . 0.0 109.568 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.725 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.6 m-30 -112.16 136.89 50.99 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.339 -0.851 . . . . 0.0 110.311 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG23 ' CB ' ' A' ' 66' ' ' GLN . 3.1 tt -131.18 148.72 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.504 -0.747 . . . . 0.0 110.12 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 64' ' ' GLN . 42.6 t -113.92 139.36 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.134 -0.979 . . . . 0.0 109.748 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 1.049 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 25.3 m-20 -55.54 143.94 27.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 91.52 147.03 19.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.411 ' HB2' ' CG1' ' A' ' 25' ' ' VAL . 72.2 p -89.73 125.33 35.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.117 . . . . 0.0 109.773 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . 74.8 m-70 -141.79 114.81 8.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -86.68 159.02 19.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.29 -44.6 61.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.882 -1.136 . . . . 0.0 109.311 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.86 -33.44 75.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 108.997 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 84' ' ' LYS . 28.8 tptt -68.55 -35.71 77.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.716 -0.615 . . . . 0.0 110.539 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 80' ' ' HIS . 17.5 mt -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.97 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 33.1 tp60 -68.91 -35.98 77.48 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 108.883 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.707 . . . . 0.0 111.339 -179.768 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 21' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.257 0.551 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 21' ' ' LEU . 6.9 mt -100.61 120.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.29 139.3 47.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.502 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -116.06 126.74 54.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.922 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 38.8 t -93.58 122.1 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.1 mm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.337 0.589 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.062 ' CD ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -97.75 153.02 18.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.871 -1.143 . . . . 0.0 109.5 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.59 ' HG1' ' CG ' ' A' ' 80' ' ' HIS . 22.0 m -110.56 115.71 30.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.665 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -110.24 117.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.965 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.946 HG21 ' CG ' ' A' ' 39' ' ' MET . 21.3 mt -96.85 122.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.897 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 37' ' ' VAL . 24.7 m -100.6 -8.41 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.741 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.646 HD21 HD22 ' A' ' 21' ' ' LEU . 15.1 p-10 -116.71 6.99 13.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.021 . . . . 0.0 110.571 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.946 ' CG ' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.03 -45.37 89.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 10.8 t -70.35 -42.33 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.461 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -62.22 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.401 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.9 t -68.36 -44.97 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.467 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . . . -67.72 -45.62 74.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.642 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -65.84 -36.15 82.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.722 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -62.55 -34.47 77.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.5 mp -117.43 -9.17 10.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.951 -1.093 . . . . 0.0 110.917 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' ALA . 7.6 p-10 -162.28 -153.8 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.065 -1.022 . . . . 0.0 110.622 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.4 mtp180 -88.07 175.17 4.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.374 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.4 Cg_endo -72.5 138.23 29.33 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.086 1.572 . . . . 0.0 110.507 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.52 -7.19 17.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.059 1.557 . . . . 0.0 110.654 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.173 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.25 -21.91 26.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 0.0 110.175 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.538 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 6.4 m-85 -88.8 -57.39 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 111.155 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -71.3 -22.66 25.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.802 1.422 . . . . 0.0 111.352 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 10.2 t -56.29 -14.4 2.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.101 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -45.43 66.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.398 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.68 -49.08 74.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' HD23 ' A' ' 61' ' ' LEU . 9.6 m-30 -57.3 -34.1 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.47 -41.86 97.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -37.09 70.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.088 -1.242 . . . . 0.0 109.731 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.26 -49.37 74.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.327 -0.858 . . . . 0.0 110.767 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.003 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.65 12.93 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.99 -1.069 . . . . 0.0 110.812 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.73 4.87 28.23 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -121.33 163.48 18.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.183 -1.186 . . . . 0.0 109.397 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.7 mp0 -113.1 -120.9 0.3 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.653 -1.279 . . . . 0.0 109.676 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.5 170.26 19.01 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.447 -0.783 . . . . 0.0 111.042 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.612 ' CB ' HG13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.81 139.94 28.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.173 ' CZ ' HG22 ' A' ' 51' ' ' THR . 25.8 m-85 -126.09 144.19 50.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.688 -1.258 . . . . 0.0 113.055 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -126.08 117.37 23.04 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.11 178.499 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.01 -64.06 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.534 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -18.21 7.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -101.46 -31.57 10.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.654 -0.654 . . . . 0.0 110.073 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.4 m-20 70.79 15.52 6.87 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.2 -0.938 . . . . 0.0 110.357 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 25.5 ttm180 -113.64 129.54 56.55 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.74 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.0 m-30 -113.74 136.0 53.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.283 -0.886 . . . . 0.0 109.893 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 1.062 HD13 ' CD ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -129.02 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.205 -0.934 . . . . 0.0 110.61 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 64' ' ' GLN . 51.2 t -114.41 122.94 69.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.707 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 64.1 m-20 -50.02 142.69 8.98 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.6 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.96 140.0 9.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 95.6 p -99.09 123.93 43.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.863 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -142.09 134.83 28.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.574 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 4.0 tt0 -85.32 158.94 20.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 109.418 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.24 -44.01 61.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.79 -33.08 75.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.166 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' CE ' ' HB3' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -59.11 -35.79 74.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.669 -0.644 . . . . 0.0 110.324 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 85' ' ' LEU . 3.6 mm? -58.82 -38.78 79.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.924 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -68.57 -47.69 66.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.324 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.339 179.137 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.816 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.549 0.69 . . . . 0.0 110.649 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 19.9 mt -105.01 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 110.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.66 152.32 45.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 11.1 tttm -116.11 128.39 55.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 80' ' ' HIS . 15.5 m -105.59 135.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 35.5 tt0 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.803 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.1 mm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.327 0.584 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE2' ' OE1' ' A' ' 26' ' ' GLU . 22.1 pttm -129.62 152.52 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.786 ' HB ' HG23 ' A' ' 76' ' ' VAL . 7.9 m -112.74 128.38 56.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.73 HG12 HD13 ' A' ' 75' ' ' ILE . 4.0 m -109.82 132.29 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 1.0 OUTLIER -80.56 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.57 -46.56 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.64 -1.04 12.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.776 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.554 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 2.7 tmm? -60.38 -33.54 72.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.089 -1.007 . . . . 0.0 110.036 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.84 -42.84 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.078 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -49.77 74.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.04 -40.73 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.056 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' HG3' ' A' ' 50' ' ' PRO . . . -62.81 -35.0 78.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.82 -40.37 79.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -15.9 62.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.041 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.832 ' O ' HD23 ' A' ' 46' ' ' LEU . 8.0 tt -82.56 1.02 40.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.847 . . . . 0.0 110.176 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.6 t30 71.57 -61.95 0.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.671 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 154.11 82.35 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.234 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.5 Cg_endo -72.72 141.59 34.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.002 1.527 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HG3' ' CB ' ' A' ' 43' ' ' ALA . 47.9 Cg_endo -73.55 -24.96 15.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.997 1.525 . . . . 0.0 110.393 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 1.026 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 33.2 p -56.44 -21.75 27.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.381 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.512 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -86.55 -57.46 0.33 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 111.141 -179.538 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 52' ' ' TYR . 44.4 Cg_endo -70.83 -27.42 21.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.745 1.392 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 15.2 t -56.72 -15.12 4.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -72.81 -39.33 66.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.214 -0.929 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -50.84 72.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 23.9 m-85 -67.53 -31.7 71.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.814 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . -59.27 -48.46 85.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 56.3 m -58.97 -46.26 88.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -1.213 . . . . 0.0 110.333 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -70.17 -28.72 65.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.95 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -91.92 12.99 19.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.932 -179.198 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.13 12.51 44.35 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -131.59 163.2 28.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -1.17 . . . . 0.0 109.52 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 6.1 tp60 -120.16 -125.31 0.27 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.722 -1.236 . . . . 0.0 109.187 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -150.8 170.36 19.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 111.985 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.0 139.53 20.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.302 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.026 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.3 m-85 -126.69 144.27 50.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.656 -1.278 . . . . 0.0 113.273 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -118.7 117.27 28.46 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.79 -64.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.773 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -15.11 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 108.642 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.68 -31.28 9.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.662 . . . . 0.0 110.271 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.9 m-20 72.15 15.32 5.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.222 -0.924 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.535 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 26.9 ttp180 -114.04 129.55 56.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.496 -0.752 . . . . 0.0 109.036 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 5.3 m-30 -108.91 128.93 55.35 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.608 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 35' ' ' VAL . 10.5 mt -128.51 149.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.786 HG23 ' HB ' ' A' ' 34' ' ' THR . 7.4 m -112.24 139.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.919 -1.113 . . . . 0.0 109.753 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -68.33 135.88 52.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.2 158.42 22.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.528 ' HB3' HG23 ' A' ' 32' ' ' ILE . 91.8 p -97.22 123.78 41.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -1.224 . . . . 0.0 110.317 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -141.83 115.02 8.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 1.2 tt0 -89.92 155.32 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.139 -0.976 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.23 -43.59 64.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -64.15 -33.59 76.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.611 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.88 -36.98 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.505 -0.747 . . . . 0.0 109.762 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 85' ' ' LEU . 0.5 OUTLIER -60.15 -33.63 72.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.773 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.58 -37.12 79.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.994 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.224 0.535 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.52 40.2 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.205 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.69 -163.99 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.215 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -78.2 163.88 25.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 7' ' ' ARG . 92.1 t -67.16 -39.87 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 33.3 m-20 54.03 29.01 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -70.25 -29.67 66.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.233 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.571 ' C ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.99 -0.91 43.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG13 ' C ' ' A' ' 8' ' ' SER . 29.5 m -156.37 150.72 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.248 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 176.8 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 110.16 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 12' ' ' GLN . 14.5 t0 -67.93 153.35 43.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.169 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -69.47 -21.16 63.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 12' ' ' GLN . 6.4 m-85 57.8 78.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 11.4 p90 -131.34 -28.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.361 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 16.2 tpt85 -178.59 -31.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -100.1 133.52 44.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 110.094 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 16' ' ' TYR . 11.5 mttt -129.48 157.0 43.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.259 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.47 94.53 26.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 110.127 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.57 83.11 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.026 1.54 . . . . 0.0 110.437 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -78.24 157.01 29.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 124.12 29.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.228 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 ' ND2' ' A' ' 38' ' ' ASN . 36.7 mt -109.74 128.4 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 138.95 51.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.673 ' HB2' HG13 ' A' ' 35' ' ' VAL . 22.7 mtpp -124.85 136.99 54.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 79' ' ' SER . 62.7 t -96.38 133.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 110.102 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -123.39 167.95 13.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.99 59.19 0.49 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 173.68 11.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.15 . . . . 0.0 110.188 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.11 -124.74 6.55 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -85.2 2.47 43.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . 122.1 15.5 4.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER 168.46 105.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -1.141 . . . . 0.0 109.845 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HE3' HG21 ' A' ' 75' ' ' ILE . 33.1 pttt -128.47 152.66 47.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -97.16 128.55 44.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 75' ' ' ILE . 1.7 p -116.64 117.87 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 39' ' ' MET . 4.5 mt -95.49 110.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.91 -1.37 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.788 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.9 t30 -116.79 -1.18 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB2' HG21 ' A' ' 36' ' ' ILE . 20.6 ttm -64.3 -45.49 87.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.082 -1.011 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 45.5 t -70.4 -41.37 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.866 . . . . 0.0 110.258 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -49.82 74.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -68.36 -43.54 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -67.67 -44.44 77.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -67.68 -36.29 80.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.0 110.42 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.82 64.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.9 . . . . 0.0 110.811 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.9 HD12 ' HB2' ' A' ' 47' ' ' ASN . 2.5 pp -117.42 -9.19 10.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.051 . . . . 0.0 110.69 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.9 ' HB2' HD12 ' A' ' 46' ' ' LEU . 1.1 t-20 175.43 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -101.65 170.7 6.14 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.103 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.3 Cg_endo -72.57 128.88 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.962 1.506 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 48.5 Cg_endo -74.58 48.83 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.912 1.48 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.103 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -68.1 -23.94 64.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -75.49 -54.26 2.4 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.92 . . . . 0.0 110.814 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -71.17 -1.53 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.799 1.421 . . . . 0.0 110.819 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.886 HG22 ' CG2' ' A' ' 65' ' ' THR . 51.6 m -66.44 -21.58 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -42.54 64.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.531 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -49.5 77.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 0.0 110.302 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 5.5 m-30 -57.49 -43.89 84.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.924 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -35.2 85.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.94 -37.23 71.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -1.228 . . . . 0.0 110.022 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.04 -47.8 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.651 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.055 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.59 12.72 2.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.171 -0.956 . . . . 0.0 111.009 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 6.49 27.94 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.081 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.65 163.95 15.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.338 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.9 mt-30 -105.4 -119.16 0.22 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.698 -1.252 . . . . 0.0 109.962 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.886 ' CG2' HG22 ' A' ' 54' ' ' THR . 7.7 p -149.42 170.42 18.61 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 111.228 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' ILE . 4.2 tp-100 -144.72 139.47 27.93 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.103 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.5 m-85 -126.81 143.97 51.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.743 -1.223 . . . . 0.0 113.066 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 1.7 t0 -124.63 117.28 23.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.778 -0.769 . . . . 0.0 108.982 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 70' ' ' LYS . 7.7 m -89.13 -45.88 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.144 -0.973 . . . . 0.0 109.57 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.1 -6.84 42.34 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 108.516 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -118.21 -27.57 6.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.723 -0.611 . . . . 0.0 110.044 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.1 m-20 70.45 17.03 6.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.275 -0.891 . . . . 0.0 109.877 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -113.57 129.45 56.56 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.793 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.719 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.49 132.88 55.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 110.26 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.855 ' CD1' HG23 ' A' ' 35' ' ' VAL . 8.8 mm -120.5 148.68 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 21.0 t -114.04 126.04 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.081 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 27.6 m120 -47.22 147.04 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 110.409 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 89.37 144.34 10.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.586 ' HB2' HG13 ' A' ' 25' ' ' VAL . 68.6 p -105.78 125.23 50.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -1.141 . . . . 0.0 110.136 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -139.51 155.4 47.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.08 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -90.86 156.84 17.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.29 -43.21 64.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 83' ' ' ASN . 1.6 m120 -59.65 -33.51 71.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.33 -39.69 78.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.276 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 88' ' ' MET . 13.7 mt -60.4 -36.19 77.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.541 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 25.3 mt-30 -68.83 -36.22 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 110.134 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.09 -46.66 88.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.901 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 4.3 ptm -71.4 -48.62 48.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.054 -1.029 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.5 OUTLIER -62.12 -32.95 73.58 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 7.4 t70 -63.88 -36.05 82.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 0.0 109.793 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -33.12 84.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -47.25 76.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -1.072 . . . . 0.0 109.58 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 97' ' ' VAL . 3.2 mt -65.1 -33.93 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.73 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 7.8 mttt -55.39 -26.02 38.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.565 -0.709 . . . . 0.0 110.521 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' CD ' ' HD2' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -60.22 -32.26 70.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 112.144 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.027 ' CD1' HD11 ' A' ' 137' ' ' LEU . 17.2 p90 -115.3 -36.09 4.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.539 -1.35 . . . . 0.0 111.711 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.954 HG23 HD22 ' A' ' 98' ' ' LEU . 17.4 m -55.06 -49.65 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.89 -1.131 . . . . 0.0 110.301 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.954 HD22 HG23 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -73.14 66.48 0.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.769 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -69.54 155.31 93.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.224 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 44.5 Cg_endo -71.56 53.02 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.994 1.523 . . . . 0.0 110.333 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 175.81 -29.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.527 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . 8.3 p -131.78 32.49 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 1.8 tm-20 -74.49 54.21 0.58 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.615 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -164.96 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.21 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.615 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.8 Cg_endo -71.96 149.96 54.08 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.853 1.449 . . . . 0.0 110.222 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -69.21 122.48 18.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.832 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -110.17 165.56 11.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.296 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.12 160.21 19.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.143 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.748 ' CB ' HD12 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -128.86 125.05 36.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.513 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 31.6 p80 -118.43 119.22 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 110.089 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.055 HG22 HG23 ' A' ' 118' ' ' ILE . 13.7 t -97.55 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.303 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -97.03 127.79 37.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.215 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -29.21 12.29 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.988 1.52 . . . . 0.0 110.4 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.88 89.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 3.4 tptp -97.32 -3.8 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.1 49.53 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.136 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 3.0 p -144.59 161.18 39.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.055 HG23 HG22 ' A' ' 111' ' ' VAL . 19.5 mt -103.37 135.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -102.52 156.98 18.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.547 ' HB2' ' CB ' ' A' ' 131' ' ' LEU . 11.1 t-20 -136.48 121.57 18.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -1.212 . . . . 0.0 109.665 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 22.8 t -126.9 139.06 53.35 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.569 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 4.5 t -111.97 133.96 53.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -84.34 43.45 0.95 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.955 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.672 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -130.82 -33.71 1.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.307 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 4.0 t -137.23 1.45 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.67 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 91.08 -12.03 70.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.67 ' C ' ' O ' ' A' ' 126' ' ' GLY . 19.3 t80 -10.97 -64.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.8 -0.824 . . . . 0.0 111.151 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 5.9 ttt180 24.36 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.813 -0.554 . . . . 0.0 110.802 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.34 -114.96 0.84 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.613 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 2.5 mtp -120.89 150.06 41.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.522 -0.987 . . . . 0.0 110.973 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.748 HD12 ' CB ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -114.03 108.53 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 109.839 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 133' ' ' THR . 0.3 OUTLIER -176.81 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 1.2 m 71.59 -54.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -177.93 -178.11 0.67 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.122 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' ' HE3' ' A' ' 136' ' ' LYS . 2.8 m-70 -52.63 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.697 ' HB3' HD23 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -139.08 -177.15 4.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.372 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.027 HD11 ' CD1' ' A' ' 96' ' ' PHE . 2.5 pt? -42.72 -19.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.803 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.716 ' HA ' HD11 ' A' ' 141' ' ' ILE . 56.6 m -55.84 -38.9 70.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.361 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.0 m -68.62 -42.2 78.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.195 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 3.5 m-30 -57.21 -48.12 79.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 109.586 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 138' ' ' CYS . 22.6 pt -68.45 -41.34 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.403 -0.811 . . . . 0.0 109.761 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.782 ' HB2' HD11 ' A' ' 118' ' ' ILE . 21.7 tp -52.82 -17.47 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -70.2 -5.63 28.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.103 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.444 ' CG ' ' HD2' ' A' ' 143' ' ' LYS . 18.3 m120 -118.17 83.31 19.65 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.147 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 133.04 18.99 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.059 1.558 . . . . 0.0 110.512 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.38 -170.87 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.002 1.527 . . . . 0.0 110.407 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.72 121.46 19.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.13 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -143.89 178.4 7.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.315 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -151.03 -153.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 151' ' ' SER . 3.8 t0 -107.15 12.0 28.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 42.7 t -176.27 170.79 2.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.26 41.09 5.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.0 p -65.52 94.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 110.237 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 155' ' ' LYS . . . 140.52 128.49 2.45 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 154' ' ' GLY . 2.0 ptpt 178.01 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -1.111 . . . . 0.0 110.36 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.164 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.215 0.531 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -148.4 63.55 1.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.872 . . . . 0.0 110.165 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -138.21 9.62 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.173 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.74 133.05 36.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.42 -13.42 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.71 -1.58 58.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -57.19 -16.47 8.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.192 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 67.6 m -95.36 7.34 46.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 8' ' ' SER . 43.4 t 58.8 122.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 2.2 ttm 66.61 131.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -58.61 149.36 26.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.169 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -63.23 -26.41 68.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 46.47 72.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.171 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 15' ' ' ARG . 54.6 p90 -61.34 -43.91 98.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.258 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -158.29 22.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.126 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -121.7 130.04 53.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 110.087 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.45 134.15 43.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.209 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.09 105.38 51.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 110.236 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.8 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.962 1.506 . . . . 0.0 110.334 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -106.68 -67.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 21' ' ' LEU . 6.7 tp -96.06 123.83 39.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 110.289 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 32.6 mt -107.88 120.32 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 110.076 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.15 135.9 54.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.414 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -117.38 137.96 52.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.035 HG12 ' O ' ' A' ' 31' ' ' GLY . 2.1 t -93.35 122.98 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.227 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.8 tt0 -141.09 163.74 32.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.194 -0.941 . . . . 0.0 110.448 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' N ' ' HA2' ' A' ' 31' ' ' GLY . . . 156.05 -90.15 0.12 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 30' ' ' ASN . 12.1 ttpt -141.16 139.06 33.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -1.095 . . . . 0.0 109.895 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.04 -81.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -99.95 -18.52 17.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -1.103 . . . . 0.0 110.014 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 1.035 ' O ' HG12 ' A' ' 25' ' ' VAL . . . 78.31 104.04 0.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.714 HD13 ' CB ' ' A' ' 79' ' ' SER . 0.7 OUTLIER -100.59 9.55 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -1.14 . . . . 0.0 110.295 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' CB ' HD11 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -97.52 152.87 18.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 109.142 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.742 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.3 m -105.91 120.48 41.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.872 -1.142 . . . . 0.0 110.906 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 75' ' ' ILE . 21.5 t -108.6 117.87 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.869 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 39' ' ' MET . 5.2 mt -95.56 113.0 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.76 -1.24 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.195 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 5.4 t-20 -97.64 -0.96 44.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.237 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.544 ' HG3' ' CG2' ' A' ' 36' ' ' ILE . 2.6 mtt -59.74 -43.41 94.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 41' ' ' ASP . 34.4 m -60.6 -43.2 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.587 ' N ' HG23 ' A' ' 40' ' ' VAL . 16.2 m-20 -66.98 -49.03 66.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.66 -42.73 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -63.27 -34.99 78.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.07 -46.85 87.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.27 -16.19 60.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 46' ' ' LEU . 9.6 tt -103.27 -2.76 26.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 m-20 66.73 -58.34 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.766 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.14 132.95 69.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 46.3 Cg_endo -73.41 146.16 39.3 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.459 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -73.19 -4.72 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.972 1.512 . . . . 0.0 110.499 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.176 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -60.53 -21.69 62.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.532 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.42 -58.29 0.8 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.719 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.9 Cg_endo -72.73 -3.13 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.958 1.504 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.849 HG22 ' O ' ' A' ' 51' ' ' THR . 13.9 t -72.97 -17.66 61.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.347 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -72.82 -45.41 58.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.467 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -66.92 -41.43 87.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 5.5 t80 -57.72 -42.06 83.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.49 -35.34 85.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.02 -37.27 79.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.239 . . . . 0.0 110.265 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.27 -28.73 68.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.905 . . . . 0.0 111.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.041 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -105.42 12.96 30.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.053 -1.029 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 4.87 21.76 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.041 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -116.0 164.02 15.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -1.08 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 mt-30 -112.27 -120.13 0.29 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.71 -1.244 . . . . 0.0 110.245 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -149.49 170.62 18.17 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.414 -0.804 . . . . 0.0 111.158 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.527 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -146.68 139.67 25.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.176 ' CZ ' HG22 ' A' ' 51' ' ' THR . 23.7 m-85 -126.59 144.52 50.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.754 -1.216 . . . . 0.0 112.816 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -120.86 117.37 27.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.968 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 70' ' ' LYS . 10.6 m -89.07 -45.13 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.694 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.64 -5.26 32.3 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.255 -0.903 . . . . 0.0 108.83 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 m120 -121.14 -24.64 5.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.517 -0.739 . . . . 0.0 110.345 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 69.55 17.5 7.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.67 129.65 56.53 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 109.436 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.2 m-30 -113.09 129.19 56.59 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.53 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.651 ' CG1' HG22 ' A' ' 35' ' ' VAL . 1.2 tt -125.29 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.552 -0.718 . . . . 0.0 109.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.3 p -113.29 136.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.177 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.787 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -61.24 142.04 57.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.345 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.668 ' HA3' ' HE2' ' A' ' 80' ' ' HIS . . . 109.7 141.23 9.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 32' ' ' ILE . 51.4 p -97.23 122.36 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -1.15 . . . . 0.0 110.025 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.668 ' HE2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -142.33 158.35 43.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 3.8 tt0 -103.99 158.15 16.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.54 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.09 -43.88 64.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.03 -33.49 76.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.87 -37.17 83.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.213 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.15 -44.46 94.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.89 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -66.99 -36.49 82.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -63.74 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.178 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.446 ' HE3' ' HB3' ' A' ' 88' ' ' MET . 0.6 OUTLIER -60.24 -49.0 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.793 ' O ' HD23 ' A' ' 89' ' ' LEU . 2.1 tt -53.21 -29.94 34.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.3 t0 -63.94 -36.02 82.59 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.414 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -34.01 87.14 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.286 -1.925 . . . . 0.0 108.286 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.53 -40.31 82.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.413 -1.051 . . . . 0.0 109.11 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.702 HD12 ' CD2' ' A' ' 109' ' ' LEU . 28.0 mm -59.08 -46.77 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 109.637 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.514 ' CG ' ' OE1' ' A' ' 103' ' ' GLU . 7.1 ttmt -67.5 -27.12 66.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.472 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' HD21 ' A' ' 98' ' ' LEU . 2.6 tptt -60.39 -35.93 76.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 111.014 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 137' ' ' LEU . 25.5 p90 -115.34 -17.23 11.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 0.0 110.593 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.619 HG21 HG22 ' A' ' 93' ' ' ILE . 7.8 t -68.25 -60.16 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.045 . . . . 0.0 110.201 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.566 ' N ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? 33.51 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 110.35 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 103' ' ' GLU . 25.5 p -87.54 141.61 32.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.103 -0.998 . . . . 0.0 110.389 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.585 ' HD3' HG23 ' A' ' 133' ' ' THR . 47.2 Cg_endo -73.79 50.62 2.13 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.056 1.556 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 1.3 tp10 -159.22 -36.73 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.971 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 3.4 p 175.01 62.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 1.3 pp20? -74.61 -33.21 62.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.307 -0.871 . . . . 0.0 109.815 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.2 t-20 -29.09 -56.12 0.27 Allowed Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.986 -0.446 . . . . 0.0 110.776 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 43.0 Cg_endo -69.05 149.72 71.7 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.785 1.413 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 90' ' ' ASP . 4.4 tp10 -69.46 131.61 45.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.029 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' SER . 1.5 p -125.19 165.3 18.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -114.09 148.81 36.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.92 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.702 ' CD2' HD12 ' A' ' 93' ' ' ILE . 2.9 pp -123.95 120.2 31.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.535 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 9.7 p80 -124.01 125.73 45.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 118' ' ' ILE . 6.4 p -96.9 129.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -98.54 122.62 52.89 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 110.217 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.33 -31.44 9.21 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.994 1.523 . . . . 0.0 110.45 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -63.45 -37.62 87.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.286 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.59 -3.7 20.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.786 ' O ' HD11 ' A' ' 142' ' ' LEU . 0.4 OUTLIER 52.5 43.9 30.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -133.07 149.29 52.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.159 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 111' ' ' VAL . 24.2 mm -92.68 126.21 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -117.24 148.25 18.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 28.9 t-20 -144.17 152.71 41.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.165 -1.197 . . . . 0.0 109.427 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.789 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -116.92 123.73 47.7 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.767 -1.208 . . . . 0.0 110.382 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 119.25 33.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.05 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -45.95 -36.16 5.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -73.6 -0.76 16.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.545 ' O ' ' C ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER 71.23 1.19 3.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.229 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.87 -70.63 0.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' A' ' 128' ' ' ARG . 5.7 p90 -122.17 -31.57 3.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -1.123 . . . . 0.0 110.359 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 29.48 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.889 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.38 -66.22 0.31 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.142 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.536 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.12 149.16 42.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -1.219 . . . . 0.0 110.999 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 120' ' ' ASN . 14.5 tp -113.64 107.48 15.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.809 . . . . 0.0 109.671 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 133' ' ' THR . 7.9 m-20 -107.25 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.543 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.585 HG23 ' HD3' ' A' ' 100' ' ' PRO . 1.5 m 69.87 -139.45 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.0 110.043 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' LYS . 37.8 m80 -121.96 178.6 4.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -42.72 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.107 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' HIS . 50.4 mmtt -136.63 -177.45 4.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.888 . . . . 0.0 110.345 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.756 HD21 ' CD1' ' A' ' 96' ' ' PHE . 2.7 pp -63.09 -6.11 3.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.538 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.644 ' HA ' HD11 ' A' ' 141' ' ' ILE . 69.2 m -56.02 -43.4 77.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -42.25 77.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 110.018 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -47.87 79.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.639 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 138' ' ' CYS . 25.5 pt -68.35 -42.06 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.786 HD11 ' O ' ' A' ' 116' ' ' GLN . 12.9 tp -53.41 -28.99 32.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 1.3 tttt -85.03 -3.55 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.316 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 17.9 m-20 63.18 167.14 0.1 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.0 Cg_endo -72.33 174.63 11.21 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.919 1.484 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 145' ' ' PRO . 45.7 Cg_endo -72.45 116.35 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.969 1.51 . . . . 0.0 110.548 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -150.21 23.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.117 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 150' ' ' ASP . 15.0 m-20 -63.6 -10.37 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.92 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 148' ' ' ASN . 1.0 OUTLIER 66.97 -59.75 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.274 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 148' ' ' ASN . 24.1 m-20 -69.22 171.12 8.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.208 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 t -103.98 127.92 51.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -105.82 -28.44 5.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -20.06 61.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -1.15 . . . . 0.0 110.174 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.03 -90.24 1.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mttm 52.77 -170.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 0.0 110.23 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.211 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 1' ' ' LEU . 19.9 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.202 0.525 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -92.71 16.63 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.46 133.36 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.18 156.73 38.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -52.03 -21.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' O ' HG13 ' A' ' 9' ' ' VAL . 65.5 t30 54.79 26.24 7.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.08 -12.25 18.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 9' ' ' VAL . 2.7 t -82.85 8.04 13.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -42.61 -94.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.336 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.527 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 65.48 -179.27 0.19 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.01 . . . . 0.0 110.26 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 2.9 m-20 -82.48 143.01 31.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 -33.06 23.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 2.6 t80 -172.17 -68.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 14' ' ' TYR . 1.5 t80 178.02 80.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -106.68 -16.91 14.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -129.28 151.04 50.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.385 -0.822 . . . . 0.0 110.311 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.511 ' NZ ' ' HG2' ' A' ' 86' ' ' GLN . 1.8 ttpt -112.74 130.7 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -138.31 103.93 7.92 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HD3' ' CE ' ' A' ' 17' ' ' LYS . 48.3 Cg_endo -74.96 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.981 1.516 . . . . 0.0 110.276 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' CD ' ' N ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -149.13 20.43 0.97 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.188 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.0 tm? -89.2 122.46 32.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.57 ' N ' HD22 ' A' ' 21' ' ' LEU . 13.2 mm -100.74 136.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.61 141.2 52.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.647 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -124.19 138.08 54.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.998 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.762 HG23 ' CB ' ' A' ' 79' ' ' SER . 3.3 p -93.26 134.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.85 159.56 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.209 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.65 68.62 0.47 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 30' ' ' ASN . 2.7 tttt -145.77 155.74 43.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.322 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.77 -81.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 28' ' ' LYS . 1.8 t30 -89.69 -15.28 32.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.153 . . . . 0.0 110.264 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 32' ' ' ILE . . . 84.86 -5.79 81.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.7 mm -153.67 88.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.141 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -129.52 152.49 49.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.986 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.757 ' HB ' HG23 ' A' ' 76' ' ' VAL . 1.3 m -108.95 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 110.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 24' ' ' LYS . 3.0 p -102.85 117.73 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.3 mt -95.55 112.48 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.623 HG23 ' OD1' ' A' ' 38' ' ' ASN . 30.8 m -89.4 -21.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.623 ' OD1' HG23 ' A' ' 37' ' ' VAL . 11.6 m120 -91.79 11.46 24.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.685 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.98 -45.19 93.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.093 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 41' ' ' ASP . 14.5 m -67.43 -42.31 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 40' ' ' VAL . 3.6 m-20 -64.96 -50.11 67.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.74 -43.66 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.95 75.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.21 93.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.48 -22.6 60.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -102.43 2.92 37.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.426 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 4.3 m120 65.43 -64.55 0.18 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.35 -0.843 . . . . 0.0 110.237 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -77.23 122.66 86.53 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.7 Cg_endo -73.06 144.84 38.54 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.974 1.512 . . . . 0.0 110.41 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CE ' ' A' ' 39' ' ' MET . 46.3 Cg_endo -72.99 -0.15 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.013 1.533 . . . . 0.0 110.22 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.005 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -57.21 -21.48 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.551 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.6 m-85 -82.1 -58.87 0.44 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.118 -0.988 . . . . 0.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 52' ' ' TYR . 48.8 Cg_endo -74.76 -0.22 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.884 1.465 . . . . 0.0 111.049 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.568 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -61.28 -23.51 65.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.03 -1.044 . . . . 0.0 110.376 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -42.09 64.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.982 . . . . 0.0 110.598 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.8 t80 -58.76 -51.29 70.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.246 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 15.5 m-30 -57.68 -43.26 84.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -61.22 -35.09 90.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -56.7 -37.26 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.257 . . . . 0.0 109.998 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' CG ' ' SD ' ' A' ' 88' ' ' MET . 13.4 mm-40 -65.07 -47.59 76.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.739 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.006 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -83.07 12.92 4.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.162 -0.961 . . . . 0.0 110.91 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 4.87 26.93 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.064 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -114.41 163.67 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.158 . . . . 0.0 109.397 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' C ' ' CG2' ' A' ' 65' ' ' THR . 12.5 tt0 -107.95 -119.07 0.26 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.958 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.568 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.6 p -149.25 170.23 18.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.563 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.48 139.34 28.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.005 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.0 m-85 -126.83 143.77 51.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.864 -1.148 . . . . 0.0 112.844 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -122.99 117.47 25.55 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.731 -0.787 . . . . 0.0 108.943 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.48 -64.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.64 -17.52 5.85 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.184 -0.948 . . . . 0.0 108.682 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -103.92 -31.4 9.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.637 -0.665 . . . . 0.0 110.153 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.8 m-20 71.72 16.47 5.69 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -0.862 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.569 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.46 129.49 56.53 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.618 -0.676 . . . . 0.0 109.713 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.45 137.73 51.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 66' ' ' GLN . 10.8 tt -131.66 148.56 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 109.792 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 34' ' ' THR . 3.6 m -114.21 137.84 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.094 -1.004 . . . . 0.0 109.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.064 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 98.4 m-20 -59.01 143.08 49.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.15 147.59 22.02 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.762 ' CB ' HG23 ' A' ' 25' ' ' VAL . 35.3 p -107.37 121.09 43.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -1.178 . . . . 0.0 110.462 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.21 167.23 22.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 110.004 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt-10 -101.25 158.14 16.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.937 . . . . 0.0 110.119 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.85 -44.52 66.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.61 -34.98 79.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 109.845 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -59.41 -37.35 77.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 110.439 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 3.2 mp -61.79 -44.95 95.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HG2' ' NZ ' ' A' ' 17' ' ' LYS . 0.2 OUTLIER -69.13 -45.5 69.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.229 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -64.65 -36.04 82.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.619 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.521 ' SD ' ' CG ' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -57.9 -49.61 76.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.076 -1.015 . . . . 0.0 110.379 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.72 -30.08 42.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.2 t0 -64.05 -35.99 82.53 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.253 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' LYS . . . -61.84 -48.14 85.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -56.09 -50.34 71.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.927 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.83 ' O ' HG22 ' A' ' 97' ' ' VAL . 40.7 mm -65.26 -50.12 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.324 -0.86 . . . . 0.0 110.225 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.684 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -59.7 -27.09 66.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.423 -0.798 . . . . 0.0 110.865 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 1.4 mmpt? -60.6 -37.44 81.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 111.542 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.891 ' HB2' HD13 ' A' ' 137' ' ' LEU . 16.9 p90 -115.39 -18.58 10.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.75 -1.218 . . . . 0.0 111.359 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.876 HG12 ' CE1' ' A' ' 96' ' ' PHE . 4.7 m -85.2 -1.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.821 -1.174 . . . . 0.0 110.342 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 94' ' ' LYS . 1.7 tp -40.33 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.897 . . . . 0.0 110.227 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 97' ' ' VAL . 41.2 t -84.75 139.91 37.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' GLU . 46.3 Cg_endo -73.75 50.62 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.044 1.55 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 9.1 tt0 173.06 -28.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 84.2 m -150.64 46.55 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.577 ' HG3' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -67.35 -30.89 70.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 110.005 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.5 m-20 -50.56 -59.17 7.83 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.0 Cg_endo -70.81 150.15 61.33 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.117 1.588 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -68.99 127.43 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.056 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.985 HG22 ' SG ' ' A' ' 122' ' ' CYS . 4.1 p -110.15 165.98 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 110.258 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.8 p30 -114.04 146.55 40.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.014 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.49 HD13 HD12 ' A' ' 141' ' ' ILE . 1.1 pp -107.79 122.51 46.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 110.366 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -109.25 119.59 39.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.079 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.964 HG12 HD13 ' A' ' 118' ' ' ILE . 4.4 m -96.75 125.06 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.923 . . . . 0.0 110.278 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.531 ' HB2' ' CG ' ' A' ' 115' ' ' LYS . 20.8 m120 -96.32 123.64 54.03 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.098 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.14 -36.28 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.952 1.501 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' HD2' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -59.63 -34.7 73.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.633 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 7.7 ptpt -110.87 -3.94 15.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER 51.99 37.95 22.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.521 -0.737 . . . . 0.0 110.541 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.78 162.03 21.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.293 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.964 HD13 HG12 ' A' ' 111' ' ' VAL . 11.1 mm -101.2 135.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -115.2 163.8 12.18 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.574 ' HB2' ' CB ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -141.86 121.77 13.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.172 . . . . 0.0 109.785 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 43.2 t -124.45 127.24 47.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.985 ' SG ' HG22 ' A' ' 107' ' ' THR . 2.5 t -104.87 112.31 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.17 -12.71 9.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.04 97.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.853 . . . . 0.0 110.404 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 1.3 m -128.46 -11.47 5.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.669 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.658 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 101.05 -12.23 58.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.658 ' C ' ' O ' ' A' ' 126' ' ' GLY . 25.3 t80 -10.9 -63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.781 -0.835 . . . . 0.0 111.184 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 7.5 ttt-85 36.03 89.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -154.03 -112.25 0.46 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.518 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.67 151.77 39.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.464 -1.021 . . . . 0.0 110.734 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.88 HD23 ' N ' ' A' ' 132' ' ' ASP . 2.3 tt -103.09 139.51 38.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.88 ' N ' HD23 ' A' ' 131' ' ' LEU . 4.0 p30 160.76 115.93 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.435 -0.791 . . . . 0.0 109.72 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 98' ' ' LEU . 85.9 m -128.46 -66.45 0.84 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.285 0.564 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 135' ' ' HIS . 2.5 m-70 -111.94 143.24 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.314 -0.866 . . . . 0.0 110.087 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 134' ' ' HIS . 19.7 m170 42.4 -135.43 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.981 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -135.68 81.69 1.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.891 HD13 ' HB2' ' A' ' 96' ' ' PHE . 2.1 pp -82.55 -24.36 34.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.106 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.577 ' HA ' HD11 ' A' ' 141' ' ' ILE . 34.4 m -62.65 -40.33 96.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 110.367 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.3 m -64.49 -41.54 96.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -48.72 80.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.048 -1.032 . . . . 0.0 109.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 138' ' ' CYS . 26.2 pt -69.33 -42.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.552 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.522 ' N ' HG13 ' A' ' 141' ' ' ILE . 4.8 tp -53.54 -31.72 47.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 144' ' ' ASN . 14.8 mtmt -70.3 -36.42 74.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 0.7 OUTLIER 61.03 141.23 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 110.51 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.048 1.552 . . . . 0.0 110.505 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 46.7 Cg_endo -73.47 -42.79 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.02 1.537 . . . . 0.0 110.416 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 146' ' ' PRO . 51.1 mt-10 55.86 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 146' ' ' PRO . 6.6 m120 -144.84 122.1 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.59 70.16 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.223 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.93 60.51 1.28 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.91 62.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 61.32 95.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -51.4 68.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -1.141 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.15 -43.8 1.64 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -68.38 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -1.154 . . . . 0.0 110.136 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.1 mttm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.285 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 1' ' ' LEU . 11.0 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 p -94.17 164.58 12.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 3' ' ' VAL . 12.2 p -159.39 66.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.276 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -81.47 128.39 33.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.38 -19.33 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.4 154.21 24.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.7 tpt85 -67.82 -35.89 79.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.178 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 10' ' ' MET . 8.6 t -72.99 -13.46 61.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.202 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG12 ' N ' ' A' ' 10' ' ' MET . 46.4 t 55.1 -87.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.299 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.611 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -43.44 -90.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 56.7 t0 -99.83 147.63 25.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 110.212 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 10.3 mp0 -70.3 -29.6 66.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.219 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 11' ' ' ASP . 2.8 m-30 57.64 83.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 5.3 p90 -177.82 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.353 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -84.11 -50.36 8.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' OH ' ' CE1' ' A' ' 13' ' ' PHE . 15.5 p90 -100.18 137.17 38.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.94 129.68 38.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 110.201 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.23 152.68 76.41 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -73.1 -45.38 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.007 1.53 . . . . 0.0 110.378 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HG2' ' NE2' ' A' ' 86' ' ' GLN . 1.4 ttt180 42.85 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.185 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 3.1 tm? -82.05 124.97 30.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -97.34 125.1 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.893 . . . . 0.0 110.175 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.7 138.08 47.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -116.67 137.97 51.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 31' ' ' GLY . 4.4 p -96.33 125.1 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.24 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 8.1 tt0 -140.96 161.37 37.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.15 -92.96 0.11 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -152.23 138.99 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.131 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.24 -81.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -99.83 -18.61 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -1.171 . . . . 0.0 110.207 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 25' ' ' VAL . . . 66.35 98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.61 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -106.13 9.74 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.217 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HG2' HG22 ' A' ' 75' ' ' ILE . 3.7 ttpt -97.62 153.08 18.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -98.63 118.37 35.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.942 -1.099 . . . . 0.0 110.507 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.76 117.4 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.093 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 4.5 tp -96.05 119.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.4 t -100.77 -24.88 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.0 2.61 56.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.571 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 43.7 tpp -64.14 -44.91 90.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 41' ' ' ASP . 5.9 p -59.55 -42.84 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.391 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -63.58 -49.4 73.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.205 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.77 -43.82 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.262 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.641 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -59.3 -35.54 73.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -50.12 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 109.968 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.15 60.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.859 ' O ' HD23 ' A' ' 46' ' ' LEU . 8.3 tt -83.35 1.1 42.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 110.344 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 3.7 m-20 73.89 -63.35 0.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.796 . . . . 0.0 110.514 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 46' ' ' LEU . 3.9 mmt85 -77.13 155.17 82.5 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 110.262 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.1 Cg_endo -73.05 157.54 50.76 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.102 1.58 . . . . 0.0 110.528 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.64 -26.83 8.0 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.07 1.563 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.731 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 18.1 p -60.69 -21.83 63.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.528 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -58.29 0.59 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 110.653 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' O ' ' CD2' ' A' ' 57' ' ' PHE . 46.2 Cg_endo -72.99 -0.31 8.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.868 1.457 . . . . 0.0 110.892 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.8 -25.83 59.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -45.7 57.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -67.76 -48.86 65.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 11.5 m-85 -57.57 -41.37 80.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -58.83 -35.36 82.08 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -37.27 78.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.238 . . . . 0.0 109.932 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -48.38 71.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 110.651 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.069 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.79 11.46 2.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.169 -0.957 . . . . 0.0 111.046 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.97 11.26 36.99 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.178 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -118.05 164.31 15.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.508 -0.995 . . . . 0.0 109.274 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.409 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 11.8 mp0 -104.1 -121.38 0.2 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.63 -1.294 . . . . 0.0 110.001 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.745 HG21 ' HB ' ' A' ' 54' ' ' THR . 0.7 OUTLIER -149.86 170.12 19.53 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.458 -0.776 . . . . 0.0 111.82 -179.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -155.95 139.06 15.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.0 m-85 -127.31 146.1 50.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.741 -1.224 . . . . 0.0 112.967 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -117.9 117.17 28.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.667 177.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.623 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.0 m -90.21 -46.33 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' N ' HG23 ' A' ' 69' ' ' VAL . 1.6 tptt -73.16 -3.62 27.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -118.92 -26.92 5.89 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.684 -0.635 . . . . 0.0 110.529 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.2 m-20 70.13 16.31 7.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.072 -1.017 . . . . 0.0 109.543 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.554 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 4.0 mmt85 -113.87 129.72 56.56 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.8 m-30 -109.06 128.97 55.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.825 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 34' ' ' THR . 84.4 mt -129.04 150.83 34.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 34' ' ' THR . 13.2 m -111.77 138.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.929 -1.107 . . . . 0.0 109.134 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.178 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 8.9 t30 -62.75 140.33 58.74 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.769 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 104.95 147.08 15.72 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.2 p -101.41 127.59 47.99 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.306 -1.114 . . . . 0.0 110.074 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.688 ' NE2' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -141.92 156.69 45.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 1.4 pt-20 -104.01 143.4 32.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.758 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 21' ' ' LEU . . . -53.49 -39.51 64.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.975 . . . . 0.0 110.268 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -34.71 66.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.173 -0.954 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 88' ' ' MET . 1.3 tppp? -73.03 -45.58 56.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -60.5 -44.19 96.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.354 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 23.4 mm100 -68.66 -35.83 77.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.73 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -58.94 -46.28 88.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 111.354 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.62 -48.66 53.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.862 -1.149 . . . . 0.0 110.725 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 93' ' ' ILE . 1.3 mt -66.04 -32.61 74.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.107 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 8.2 t70 -63.66 -43.59 96.28 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.651 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.34 84.08 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' O ' ' CZ ' ' A' ' 96' ' ' PHE . 4.4 m-30 -68.56 -51.78 38.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -1.148 . . . . 0.0 110.356 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.8 HG23 ' HB ' ' A' ' 97' ' ' VAL . 13.0 mt -62.1 -33.41 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.499 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -57.98 -27.41 63.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.479 -0.763 . . . . 0.0 111.971 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HB2' HD21 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -94.28 -43.78 8.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.561 -1.337 . . . . 0.0 113.063 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.622 ' CD2' HG23 ' A' ' 97' ' ' VAL . 1.1 p90 -117.24 -36.99 3.62 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.313 -1.492 . . . . 0.0 112.599 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.8 ' HB ' HG23 ' A' ' 93' ' ' ILE . 48.4 t -66.77 -49.76 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.678 -1.264 . . . . 0.0 110.911 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.12 HD22 ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -61.36 67.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.13 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 97' ' ' VAL . 42.5 t -64.06 140.38 97.87 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 110.032 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 41.1 Cg_endo -66.91 -12.98 38.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.081 1.569 . . . . 0.0 110.338 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 4.0 mm-40 -71.86 -32.48 67.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.35 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER 164.15 9.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.738 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.539 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 3.7 tm-20 37.92 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.55 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 t-20 -93.86 -49.67 0.27 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 110.907 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HD2' ' H ' ' A' ' 104' ' ' ASN . 46.6 Cg_endo -75.94 137.15 19.37 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.679 1.357 . . . . 0.0 110.517 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -69.88 156.11 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 110.177 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -118.33 160.45 21.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 99.6 m-20 -114.1 160.29 19.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 tp -105.96 104.3 13.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.472 ' NE2' ' HB2' ' A' ' 108' ' ' ASP . 65.1 m-70 -107.61 115.3 29.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.095 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.616 HG12 HG23 ' A' ' 118' ' ' ILE . 3.3 m -109.54 128.33 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.01 123.3 59.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.224 -0.923 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.32 -31.42 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.999 1.526 . . . . 0.0 110.315 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -67.46 -39.51 85.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 -3.72 29.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.228 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.28 50.07 18.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.165 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.9 ' HA ' HD21 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -135.21 166.68 22.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 110.223 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 HG13 ' A' ' 141' ' ' ILE . 87.3 mt -128.73 139.37 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -148.38 161.66 28.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 108' ' ' ASP . 1.9 p-10 -143.83 133.05 23.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 109.959 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -117.13 145.87 43.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -0.985 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 17.1 p -88.69 133.79 34.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' ALA . 45.0 tptt -50.37 -20.32 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -40.57 -49.46 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.898 . . . . 0.0 110.213 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.41 26.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 101.55 -67.09 0.44 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 126' ' ' GLY . 7.3 t80 61.65 -50.28 0.14 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.886 . . . . 0.0 111.12 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.3 OUTLIER 65.6 96.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -111.15 68.52 0.22 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.596 ' HE3' ' HB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -83.32 122.33 28.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 110.103 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.516 HD22 ' SG ' ' A' ' 138' ' ' CYS . 2.7 mt -86.3 133.18 33.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.124 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -132.78 1.28 3.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.3 t -60.6 -158.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.41 160.33 41.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 58.94 33.7 23.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 110.233 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -138.93 169.73 17.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.651 HD12 ' C ' ' A' ' 137' ' ' LEU . 3.5 pp -42.57 -29.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.564 ' HA ' HD11 ' A' ' 141' ' ' ILE . 58.3 m -58.02 -39.13 77.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 3.0 m -68.73 -40.42 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -56.9 -48.73 77.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.096 -1.003 . . . . 0.0 109.428 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.693 HG13 HD12 ' A' ' 118' ' ' ILE . 18.9 pt -69.26 -42.05 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.384 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.9 HD21 ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -65.74 -43.1 90.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.505 -0.747 . . . . 0.0 110.265 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -79.27 6.84 8.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.378 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 1.6 m120 -113.04 69.61 1.19 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 143' ' ' LYS . 46.2 Cg_endo -72.66 120.55 6.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 148' ' ' ASN . 45.9 Cg_endo -73.03 100.94 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.989 1.521 . . . . 0.0 110.37 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 12.3 tp10 -44.38 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 146' ' ' PRO . 9.1 m-80 -171.07 163.69 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.158 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.1 t -70.96 -42.17 70.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -137.86 -157.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.191 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 13.48 11.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.185 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 54.73 -134.62 46.85 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.46 91.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -1.134 . . . . 0.0 110.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.45 -31.18 28.28 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.11 103.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -1.137 . . . . 0.0 110.208 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.23 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.23 0.538 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t -158.61 90.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.51 108.44 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -91.98 103.97 16.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 9' ' ' VAL . 10.8 p -56.4 -24.57 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.915 . . . . 0.0 110.142 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.83 -52.6 10.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 110.178 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -14.6 63.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -1.54 58.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 5' ' ' VAL . 97.2 t -75.88 146.0 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -45.2 128.42 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.96 120.31 6.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -70.45 -15.24 62.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.616 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -84.35 -43.16 15.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.616 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER 64.82 -51.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.595 -0.691 . . . . 0.0 110.508 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 13' ' ' PHE . 6.8 ptp180 -66.98 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 110.382 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -137.22 133.25 34.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 110.232 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -112.57 161.25 17.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 0.0 110.237 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.4 mtm -111.9 99.11 44.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 46.9 Cg_endo -74.55 4.51 4.44 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.04 1.548 . . . . 0.0 110.448 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.653 ' O ' HG11 ' A' ' 42' ' ' VAL . 64.2 mtt180 64.89 9.3 5.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.17 122.61 38.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.981 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.2 mt -115.61 123.52 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.258 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.99 132.53 53.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.07 136.18 53.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' HB2' ' A' ' 79' ' ' SER . 94.6 t -102.48 134.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -128.22 144.76 51.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 48.19 0.99 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -120.12 152.35 37.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.177 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.73 -101.24 0.98 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -73.01 -18.65 61.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -1.157 . . . . 0.0 110.198 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 32' ' ' ILE . . . 97.33 -10.98 65.41 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.6 mm -154.74 88.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -1.163 . . . . 0.0 110.257 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HA ' ' N ' ' A' ' 78' ' ' GLY . 6.0 mtmm -126.76 152.55 46.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.0 OUTLIER -108.18 123.95 49.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' CD1' ' A' ' 75' ' ' ILE . 20.4 t -108.52 117.79 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.724 ' N ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -95.95 122.98 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -100.55 -43.56 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.774 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.716 ' O ' HG13 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -105.23 -1.52 25.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.019 . . . . 0.0 110.75 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.612 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.5 tmt? -64.72 -45.6 85.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.019 . . . . 0.0 109.967 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 74' ' ' TYR . 14.3 p -70.68 -41.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 0.0 110.323 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 40' ' ' VAL . 40.1 t0 -62.17 -49.47 75.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 38' ' ' ASN . 12.9 m -68.12 -43.57 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -61.53 -46.96 87.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -36.45 80.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.449 -0.782 . . . . 0.0 110.236 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.96 70.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 42' ' ' VAL . 3.0 pp -108.94 -1.4 19.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -170.21 -154.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.291 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.419 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 1.8 mtt180 -93.47 174.49 3.84 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.274 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.94 128.57 13.31 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.359 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 39' ' ' MET . 47.9 Cg_endo -75.4 5.2 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.034 1.544 . . . . 0.0 110.657 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.141 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -56.46 -26.54 54.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -84.51 -55.94 0.43 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.964 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.9 Cg_endo -70.77 -23.66 25.95 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.824 1.434 . . . . 0.0 111.143 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.536 HG22 ' C ' ' A' ' 51' ' ' THR . 7.8 t -56.25 -16.31 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.992 -1.067 . . . . 0.0 110.208 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -45.4 68.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -62.11 -49.46 75.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -0.979 . . . . 0.0 110.11 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 8.9 m-30 -57.42 -36.8 71.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.921 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -39.25 94.91 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.2 m -57.45 -37.33 72.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -1.2 . . . . 0.0 109.924 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 -49.48 77.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.835 . . . . 0.0 110.723 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.001 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -83.42 12.98 4.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.109 -0.994 . . . . 0.0 110.697 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.05 6.29 31.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.45 163.59 15.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -1.159 . . . . 0.0 109.609 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG13 ' A' ' 76' ' ' VAL . 24.6 tp60 -107.16 -118.42 0.25 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.936 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.18 170.25 18.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 111.022 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.796 ' HB2' HG23 ' A' ' 75' ' ' ILE . 3.3 mm100 -146.32 139.82 25.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.141 ' CZ ' HG22 ' A' ' 51' ' ' THR . 17.7 m-85 -126.54 142.59 51.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.819 -1.176 . . . . 0.0 112.849 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -120.28 117.48 27.92 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.015 178.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 70' ' ' LYS . 13.5 m -89.29 -45.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.645 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' N ' HG23 ' A' ' 69' ' ' VAL . 7.4 tptt -71.01 -5.95 35.15 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.198 -0.939 . . . . 0.0 108.722 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.7 m-20 -121.32 -25.27 5.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.591 -0.693 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.1 m-20 69.75 17.15 7.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 109.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -113.64 129.47 56.56 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.586 -0.696 . . . . 0.0 109.681 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.733 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-30 -113.18 138.02 50.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.555 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 66' ' ' GLN . 1.6 tt -128.45 148.75 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.461 -0.774 . . . . 0.0 109.925 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 64' ' ' GLN . 69.3 t -113.89 130.03 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.688 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.065 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 27.6 m120 -49.76 147.82 3.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 110.51 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 88.16 148.8 16.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 25' ' ' VAL . 64.8 p -106.63 122.62 46.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -1.109 . . . . 0.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.848 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.09 145.45 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 109.975 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.3 tt0 -81.72 155.17 25.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.108 -0.995 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.25 -43.89 64.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.033 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -64.67 -33.55 76.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 109.797 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -64.64 -36.87 85.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 110.082 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.624 ' O ' ' HG3' ' A' ' 88' ' ' MET . 4.4 mp -59.95 -42.59 94.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.103 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 26.1 mt-30 -69.2 -35.93 76.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.535 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -46.61 88.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.476 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -64.46 -48.85 73.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.892 -1.13 . . . . 0.0 110.42 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.794 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -68.69 -33.24 73.63 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.157 -0.964 . . . . 0.0 108.515 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 12.2 t0 -64.24 -39.01 93.07 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.3 0.572 . . . . 0.0 110.0 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.91 -35.3 91.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -64.96 -51.61 60.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -1.083 . . . . 0.0 109.775 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.87 ' O ' HG22 ' A' ' 97' ' ' VAL . 36.3 pt -65.15 -40.49 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.974 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.21 -26.47 39.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.458 -0.776 . . . . 0.0 110.909 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' O ' HG21 ' A' ' 133' ' ' THR . 1.4 tttt -60.31 -41.08 92.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.127 -0.983 . . . . 0.0 111.12 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.953 ' HB2' HD11 ' A' ' 131' ' ' LEU . 1.7 p90 -115.3 -36.12 4.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.765 -1.209 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 93' ' ' ILE . 8.5 m -54.42 -29.94 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.914 -1.116 . . . . 0.0 110.047 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -70.8 51.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.924 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 4.0 m -64.66 148.68 96.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.987 -1.07 . . . . 0.0 110.269 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.89 2.88 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.061 1.558 . . . . 0.0 110.315 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 7.6 mm-40 -116.95 -7.07 11.42 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.758 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.616 ' O ' ' C ' ' A' ' 103' ' ' GLU . 54.3 m -153.03 -50.23 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 110.465 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' A' ' 102' ' ' CYS . 1.7 tm-20 24.06 68.26 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.599 -0.688 . . . . 0.0 110.671 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 8.2 m-20 -172.23 -61.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.28 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.1 Cg_endo -71.06 149.68 59.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.922 1.485 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.43 129.01 38.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 110.067 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.7 p -110.19 166.06 11.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 110.127 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.95 143.82 44.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 141' ' ' ILE . 9.8 tt -107.11 110.8 23.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.573 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 9.2 p80 -119.41 115.82 24.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.76 HG12 HG12 ' A' ' 118' ' ' ILE . 3.1 m -96.87 128.51 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.44 122.65 69.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.203 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.45 -37.26 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.986 1.519 . . . . 0.0 110.436 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -59.91 -42.08 93.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.309 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 8.9 tttp -100.59 -1.6 35.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 52.43 44.05 30.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.071 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -129.11 179.62 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.147 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.765 HG13 HD13 ' A' ' 142' ' ' LEU . 10.6 mt -129.53 130.46 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.573 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -115.95 164.02 12.28 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.857 ' HB2' HD12 ' A' ' 131' ' ' LEU . 13.9 t30 -141.36 136.81 31.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.243 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -116.87 124.63 49.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.033 -1.042 . . . . 0.0 110.321 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 105' ' ' PRO . 45.8 t -99.49 133.76 43.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.272 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.67 -19.99 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -74.07 -9.98 59.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 110.422 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -33.01 -71.42 0.1 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.627 ' O ' ' O ' ' A' ' 128' ' ' ARG . 58.8 t80 -60.79 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.082 . . . . 0.0 110.088 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.841 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 36.96 108.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.45 -0.781 . . . . 0.0 111.514 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.45 -94.29 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.539 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -119.69 150.85 39.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -1.101 . . . . 0.0 110.129 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' A' ' 96' ' ' PHE . 2.8 tt -104.34 122.5 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.268 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 133' ' ' THR . 3.8 p30 -126.34 -54.19 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.217 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 0.8 OUTLIER 58.85 -143.44 0.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.258 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.465 ' H ' HG22 ' A' ' 133' ' ' THR . 17.8 m170 -96.58 -93.51 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.228 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -107.06 81.82 1.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 137' ' ' LEU . 2.1 tm? -82.31 -41.36 20.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.913 ' SG ' HD22 ' A' ' 131' ' ' LEU . 45.2 m -56.94 -42.05 79.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 110.219 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -63.7 -40.06 95.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 143' ' ' LYS . 2.1 t80 -61.85 -48.72 79.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.022 -1.049 . . . . 0.0 109.228 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 109' ' ' LEU . 28.7 pt -69.36 -42.15 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.36 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.765 HD13 HG13 ' A' ' 118' ' ' ILE . 25.6 tp -55.36 -22.92 21.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.296 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -70.28 -11.07 60.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.187 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -58.69 157.56 18.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 158.74 50.13 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.081 1.569 . . . . 0.0 110.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -73.57 -46.46 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.991 1.522 . . . . 0.0 110.418 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 149' ' ' SER . 0.0 OUTLIER -161.43 145.26 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 110.171 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 149' ' ' SER . 36.7 m-20 45.87 -92.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.079 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 147' ' ' GLU . 54.8 m 55.19 89.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.241 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.26 153.56 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 m -58.25 -45.56 87.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.24 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.22 108.47 3.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 m -69.49 -52.73 23.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -1.155 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' LYS . . . 61.38 61.88 6.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 154' ' ' GLY . 5.2 mmtm 53.3 173.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.246 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.231 0.539 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -68.77 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.147 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.77 158.92 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.91 123.56 28.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.669 HG23 ' H ' ' A' ' 7' ' ' ARG . 16.3 m -67.16 -8.75 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER 66.08 13.45 9.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -67.18 -21.68 65.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.0 -5.43 34.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.3 95.2 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -168.22 119.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 123.0 9.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -64.5 -40.71 96.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.23 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.94 94.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -120.47 -89.65 0.6 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.208 -0.932 . . . . 0.0 110.211 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -174.44 -39.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 110.2 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -104.5 151.86 23.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 110.317 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -129.16 155.33 45.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -134.14 126.26 18.45 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 110.128 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 46.0 Cg_endo -73.28 -4.44 15.42 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.957 1.504 . . . . 0.0 110.5 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 1.5 ttt180 55.87 99.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.158 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.782 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 3.4 tp -95.22 137.04 34.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.312 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -119.12 132.37 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.9 140.59 52.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -121.71 137.97 54.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 16.3 m -93.44 131.9 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.368 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HB2' HG21 ' A' ' 35' ' ' VAL . 4.1 tt0 -141.17 139.99 33.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 110.23 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.73 -97.09 0.12 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -146.32 144.14 29.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -1.172 . . . . 0.0 110.177 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.97 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' LYS . 61.9 m-80 -99.87 -17.55 17.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.218 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . 63.22 96.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.14 20.65 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.708 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.77 153.27 18.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.832 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.553 ' OG1' ' N ' ' A' ' 80' ' ' HIS . 2.3 m -97.16 124.97 41.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.088 -1.007 . . . . 0.0 110.834 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 26' ' ' GLU . 5.7 t -118.02 117.65 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.923 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.66 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.6 mt -95.77 118.16 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.288 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 t -100.45 -16.92 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.286 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.62 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -99.01 14.47 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.66 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -63.97 -41.95 97.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 58.4 t -61.37 -47.55 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -63.0 -50.2 71.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 21' ' ' LEU . 53.2 t -67.28 -40.71 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -62.65 -48.4 79.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -62.11 -38.91 90.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 110.243 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.45 -15.89 60.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.382 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.072 ' O ' HD23 ' A' ' 46' ' ' LEU . 7.2 tt -101.89 -9.33 20.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 110.387 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t30 78.26 -50.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.48 -0.762 . . . . 0.0 111.025 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.564 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 56.3 mtp180 -76.66 142.29 70.07 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.081 -1.012 . . . . 0.0 110.259 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.96 140.96 32.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.147 1.604 . . . . 0.0 110.637 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.727 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -75.73 -29.5 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 0.0 110.333 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.678 HG22 ' CE1' ' A' ' 67' ' ' PHE . 48.8 p -59.5 -22.8 62.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 110.316 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.554 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -77.52 -58.65 0.92 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 0.0 110.268 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 47.8 Cg_endo -73.68 -28.24 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.973 1.512 . . . . 0.0 110.702 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.567 HG22 HG21 ' A' ' 65' ' ' THR . 3.4 m -56.28 -19.74 15.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HD2' ' OG1' ' A' ' 153' ' ' THR . 18.4 ttpt -72.77 -45.38 58.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.107 -0.995 . . . . 0.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 10.1 m-30 -64.6 -39.82 94.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.095 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -41.15 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -60.28 -35.33 87.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.0 m -56.99 -37.24 71.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 109.769 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.29 -44.0 93.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 110.722 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.216 HD13 ' CE1' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -88.24 12.64 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.134 -0.979 . . . . 0.0 111.032 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.1 4.78 30.31 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -115.29 163.99 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 0.0 109.141 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.736 ' O ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -106.2 -121.58 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.621 -1.3 . . . . 0.0 109.738 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 54' ' ' THR . 1.3 p -149.84 170.43 18.79 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.45 -0.781 . . . . 0.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.66 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -142.41 139.43 31.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.82 144.17 51.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.759 -1.213 . . . . 0.0 113.13 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.3 t0 -126.34 117.38 22.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.165 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 16.9 t -86.58 -61.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -56.47 -16.65 6.23 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.192 -0.942 . . . . 0.0 108.633 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.2 t30 -105.74 -30.02 9.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.584 -0.697 . . . . 0.0 110.152 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.7 m-20 71.05 16.67 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 tpt180 -113.62 128.98 56.63 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.503 -0.748 . . . . 0.0 109.865 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.688 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.44 138.2 50.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.469 -0.769 . . . . 0.0 110.022 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 ' HG2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -132.41 148.06 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 64' ' ' GLN . 59.8 t -114.43 139.03 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.258 -0.901 . . . . 0.0 109.469 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.003 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 11.6 m-80 -64.05 141.72 58.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.085 -1.01 . . . . 0.0 110.469 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 80' ' ' HIS . . . 99.64 142.12 12.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 80' ' ' HIS . 4.9 p -80.6 127.3 32.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.096 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 1.216 ' CE1' HD13 ' A' ' 61' ' ' LEU . 28.3 m80 -142.2 141.03 32.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.801 . . . . 0.0 110.403 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 83' ' ' ASN . 4.6 tp10 -104.04 149.57 25.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.928 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -43.91 64.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.426 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -64.15 -33.29 75.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.238 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -67.69 -40.42 84.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 110.331 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 2.0 mp -60.58 -45.24 94.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.04 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -69.32 -47.41 64.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.036 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 44.8 t0 -69.15 -46.3 67.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.54 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 84' ' ' LYS . 42.9 ttp -63.01 -49.75 73.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD13 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 tp -54.36 -30.52 51.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.8 t70 -63.69 -35.77 81.65 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.646 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.47 -48.31 85.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.588 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -68.66 -51.54 40.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -1.22 . . . . 0.0 109.981 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.864 HG23 HG21 ' A' ' 97' ' ' VAL . 1.3 mt -59.71 -50.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.132 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.843 ' O ' HD13 ' A' ' 98' ' ' LEU . 22.4 ttpp -58.3 -27.94 64.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 110.633 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -42.61 99.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.068 -1.02 . . . . 0.0 111.067 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.787 ' CE1' HG23 ' A' ' 97' ' ' VAL . 47.9 p90 -115.87 -35.97 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.815 -1.178 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 HG23 ' A' ' 93' ' ' ILE . 96.2 t -56.21 -23.73 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.879 -1.138 . . . . 0.0 110.651 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -34.5 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.424 -0.798 . . . . 0.0 110.609 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' VAL . 94.4 m -87.45 154.91 54.19 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.823 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.29 -3.24 13.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.048 1.552 . . . . 0.0 110.408 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.89 8.59 1.12 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.866 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 99' ' ' CYS . 0.5 OUTLIER -155.47 16.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.002 -1.061 . . . . 0.0 110.625 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' HG3' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm-20 -69.26 -59.6 2.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.107 -0.996 . . . . 0.0 109.968 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -42.16 -52.08 9.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.447 -0.783 . . . . 0.0 110.623 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 45.2 Cg_endo -72.45 149.4 50.13 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.903 1.475 . . . . 0.0 110.607 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.07 150.44 46.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.368 -0.833 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.689 ' OG1' HG11 ' A' ' 97' ' ' VAL . 12.7 p -141.96 166.21 25.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 3.9 t70 -113.77 147.41 38.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.945 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.419 HD12 ' HE1' ' A' ' 96' ' ' PHE . 4.6 tt -106.46 132.15 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.587 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 56.3 m-70 -124.26 123.66 40.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.904 HG23 ' CG1' ' A' ' 118' ' ' ILE . 7.2 p -123.98 129.27 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -118.94 122.48 29.66 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.51 -39.96 1.75 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.993 1.523 . . . . 0.0 110.466 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -42.19 91.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.288 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -94.24 -3.85 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 52.5 38.4 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.62 173.52 11.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.904 ' CG1' HG23 ' A' ' 111' ' ' VAL . 24.5 mt -141.61 141.6 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -127.06 163.95 20.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 10.9 t-20 -137.59 139.06 40.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -1.161 . . . . 0.0 109.519 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 13.5 t -116.83 124.67 50.1 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.056 -1.027 . . . . 0.0 110.338 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 102' ' ' CYS . 27.7 t -119.53 133.87 55.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.035 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -98.7 50.48 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.897 . . . . 0.0 109.988 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' A' ' 105' ' ' PRO . . . -133.82 -35.0 0.99 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 110.282 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 9.9 p -138.52 4.43 2.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 110.591 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 84.43 -12.49 55.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.661 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -36.82 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.476 -1.014 . . . . 0.0 110.426 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.698 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 22.2 ttp-105 -28.01 127.4 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.603 -0.686 . . . . 0.0 110.873 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.1 -91.51 0.11 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.418 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.1 151.6 38.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -1.195 . . . . 0.0 110.374 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.963 HD21 HD11 ' A' ' 137' ' ' LEU . 17.0 tp -112.06 107.65 16.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.075 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -130.23 -70.11 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 135' ' ' HIS . 6.4 p 51.7 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 133' ' ' THR . 3.2 m-70 41.39 -97.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.453 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 132' ' ' ASP . 0.4 OUTLIER -66.18 150.38 48.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.314 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 0.9 OUTLIER -101.47 82.07 2.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.963 HD11 HD21 ' A' ' 131' ' ' LEU . 3.5 pp -69.7 -9.93 56.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.545 ' HA ' HD11 ' A' ' 141' ' ' ILE . 28.1 m -66.67 -41.92 87.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.302 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -40.24 81.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -57.79 -48.31 80.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.498 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 118' ' ' ILE . 28.8 pt -68.88 -41.91 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' N ' HG13 ' A' ' 141' ' ' ILE . 47.0 tp -55.84 -23.62 31.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.466 -0.771 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -78.06 4.06 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 110.41 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.628 ' ND2' ' O ' ' A' ' 144' ' ' ASN . 4.1 p-10 36.29 92.95 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.417 -0.802 . . . . 0.0 110.517 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.688 ' N ' ' HD2' ' A' ' 146' ' ' PRO . 41.9 Cg_endo -72.39 -29.11 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.055 1.555 . . . . 0.0 112.293 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 145' ' ' PRO . 47.3 Cg_endo -73.93 165.29 32.47 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 122.887 0.941 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.75 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 54.77 25.67 6.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.7 m -135.39 116.22 14.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.214 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 151' ' ' SER . 0.7 OUTLIER 60.32 166.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.275 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 150' ' ' ASP . 20.1 m 43.33 53.02 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.81 -81.63 1.1 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 18.0 m -125.07 -73.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.234 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.71 166.26 12.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -92.73 8.78 37.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -1.178 . . . . 0.0 110.252 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.165 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.25 0.548 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.452 ' C ' HG23 ' A' ' 3' ' ' VAL . 48.4 m -97.69 -19.26 18.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 2' ' ' SER . 24.5 t -146.74 149.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -76.01 151.49 37.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 5' ' ' VAL . 15.6 t -59.34 -24.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.841 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.3 m120 53.96 82.13 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -17.52 63.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.311 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -74.85 0.15 16.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 6' ' ' ASN . 70.5 t -57.83 -44.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 43.15 61.32 2.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.668 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -109.75 111.23 22.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 28.6 tp60 -73.71 -13.57 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 56.9 m-85 -43.3 -31.09 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 0.1 OUTLIER 169.01 -23.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 0.0 110.304 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -75.1 49.52 0.45 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.073 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.26 132.49 33.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.352 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -112.72 129.54 56.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -148.21 96.71 3.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 45.4 Cg_endo -73.33 -89.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.277 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.8 ptt180 176.72 -46.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD23 ' CB ' ' A' ' 85' ' ' LEU . 5.3 tp -95.97 122.45 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.558 HD12 ' OD1' ' A' ' 38' ' ' ASN . 25.9 mt -110.97 120.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.43 132.23 54.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.539 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.0 135.71 53.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 31' ' ' GLY . 10.1 t -99.05 122.36 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.36 136.21 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.48 -98.13 0.12 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -144.49 155.04 43.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -1.114 . . . . 0.0 110.018 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.0 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 28' ' ' LYS . 26.7 p-10 -99.98 -18.6 16.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.641 ' O ' HG13 ' A' ' 25' ' ' VAL . . . 80.14 105.19 0.27 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.607 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -103.99 8.36 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -1.232 . . . . 0.0 110.381 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -97.43 153.12 18.31 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.929 -1.107 . . . . 0.0 109.213 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.555 ' O ' ' CG2' ' A' ' 34' ' ' THR . 1.3 t -117.94 121.72 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.771 -1.205 . . . . 0.0 110.877 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.27 117.63 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.723 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 39' ' ' MET . 19.0 mt -95.62 108.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.72 -4.9 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.364 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.652 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -109.21 -1.19 18.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 36' ' ' ILE . 34.9 ttm -64.22 -44.2 92.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 110.084 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 11.6 p -70.15 -39.46 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.865 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' N ' HG13 ' A' ' 40' ' ' VAL . 23.8 t70 -62.51 -50.74 70.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.141 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 38' ' ' ASN . 12.4 p -68.5 -45.34 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.619 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -67.85 -35.13 78.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.355 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 2.4 tttp -67.4 -36.58 81.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.43 61.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.1 tt -117.47 -9.16 10.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.914 ' HB2' HD23 ' A' ' 46' ' ' LEU . 1.4 t-20 171.44 -148.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mtt85 -96.41 169.19 9.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.021 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.14 127.81 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.396 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 48.7 Cg_endo -75.03 46.92 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.927 1.488 . . . . 0.0 110.887 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.995 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -68.05 -26.14 65.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.58 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -73.99 -54.31 3.61 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.722 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.4 Cg_endo -69.92 -19.85 34.84 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.812 1.428 . . . . 0.0 110.779 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 65' ' ' THR . 6.3 m -56.25 -18.9 11.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.989 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -72.88 -40.82 65.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -58.66 -49.68 76.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.049 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 88' ' ' MET . 10.3 m-85 -57.27 -35.87 70.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -65.31 -35.14 91.14 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 67.0 m -56.69 -37.19 70.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.08 -1.247 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -49.3 69.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.644 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.018 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.9 11.94 3.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.113 -0.992 . . . . 0.0 111.115 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.2 4.66 30.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -118.35 164.05 15.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.4 mt-30 -110.34 -120.53 0.28 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.594 -1.316 . . . . 0.0 109.875 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 54' ' ' THR . 1.1 p -149.4 170.41 18.62 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.435 -0.791 . . . . 0.0 110.921 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.801 ' HB2' HG23 ' A' ' 75' ' ' ILE . 1.8 mm-40 -140.97 139.66 34.27 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.995 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.6 m-85 -126.5 142.99 51.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.751 -1.218 . . . . 0.0 113.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -123.13 117.5 25.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.997 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.53 -64.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.599 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -16.91 6.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.134 -0.979 . . . . 0.0 108.656 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -103.75 -29.66 10.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.603 -0.686 . . . . 0.0 110.103 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.5 m-20 69.58 15.95 8.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.128 -0.982 . . . . 0.0 110.158 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 15.4 ttm180 -113.65 129.44 56.57 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.852 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.737 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.61 138.04 50.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.394 -0.816 . . . . 0.0 110.309 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.801 HG23 ' HB2' ' A' ' 66' ' ' GLN . 17.8 tt -130.6 148.41 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 64' ' ' GLN . 4.2 t -114.73 139.21 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -0.958 . . . . 0.0 109.327 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.836 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 62.4 m-80 -67.86 140.03 56.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.346 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . 105.63 145.39 13.25 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -80.44 133.59 35.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -1.2 . . . . 0.0 110.179 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.946 ' HE1' HD13 ' A' ' 61' ' ' LEU . 64.1 m80 -142.32 119.83 11.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.508 -0.745 . . . . 0.0 110.8 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -82.92 158.76 22.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.31 -43.74 61.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.997 -1.065 . . . . 0.0 109.559 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 2.4 t30 -64.71 -33.27 75.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.2 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.509 ' O ' ' HE3' ' A' ' 88' ' ' MET . 0.1 OUTLIER -59.38 -36.31 75.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.052 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.655 ' O ' ' HG2' ' A' ' 88' ' ' MET . 20.5 mt -58.85 -32.45 69.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.589 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 51.8 mm-40 -68.79 -35.08 76.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 13.5 t70 -58.69 -46.67 86.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.442 -0.787 . . . . 0.0 111.585 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 85' ' ' LEU . 3.0 ptp -63.73 -44.91 92.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.561 -1.337 . . . . 0.0 109.259 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.88 ' O ' HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -53.22 -31.29 42.47 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 93' ' ' ILE . 11.3 t70 -63.65 -42.42 98.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -62.08 -33.39 85.59 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE2' ' HE2' ' A' ' 95' ' ' LYS . 46.1 t80 -56.29 -40.23 73.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.922 ' O ' HG22 ' A' ' 97' ' ' VAL . 20.6 mt -54.78 -33.81 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 0.0 109.858 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.89 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.8 ttmt -55.23 -27.12 44.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.6 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 1.5 mtmt -61.24 -33.23 73.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 111.921 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.041 ' HB2' HD22 ' A' ' 137' ' ' LEU . 8.4 p90 -115.31 -34.01 5.11 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.667 -1.271 . . . . 0.0 111.859 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 93' ' ' ILE . 15.5 m -54.25 -16.25 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.735 -1.228 . . . . 0.0 110.376 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -40.99 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 97' ' ' VAL . 1.8 m -87.88 154.64 52.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 110.355 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.9 36.4 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.0 110.522 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.556 ' HB3' ' CG ' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -130.55 -53.81 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 110.236 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 176.27 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.594 ' CG ' HD12 ' A' ' 98' ' ' LEU . 11.3 tp10 -77.55 -25.02 49.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.03 . . . . 0.0 109.732 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.624 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.6 t-20 -32.9 -54.33 0.61 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.342 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 40.4 Cg_endo -67.22 150.8 81.76 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.027 1.541 . . . . 0.0 110.225 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.22 113.61 5.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.951 . . . . 0.0 110.4 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.611 HG22 ' SG ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -115.45 166.91 11.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.915 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 120' ' ' ASN . 1.4 m-20 -113.22 139.65 48.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.967 . . . . 0.0 109.938 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.034 HD21 HG13 ' A' ' 118' ' ' ILE . 8.6 tt -105.73 134.28 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.457 ' N ' HD23 ' A' ' 109' ' ' LEU . 1.3 m80 -124.21 116.78 23.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.51 HG12 ' CG1' ' A' ' 118' ' ' ILE . 27.3 m -96.77 123.26 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.35 124.17 70.32 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.231 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.22 -37.18 3.54 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.942 1.496 . . . . 0.0 110.472 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HG2' ' HD3' ' A' ' 115' ' ' LYS . 66.6 tttt -61.12 -41.91 97.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 114' ' ' LYS . 2.8 mmmt -96.39 -3.77 43.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 116' ' ' GLN . 59.5 tt0 52.62 38.26 25.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.124 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.78 156.73 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 110.2 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.034 HG13 HD21 ' A' ' 109' ' ' LEU . 2.5 tt -119.29 134.62 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.304 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 109' ' ' LEU . . . -141.6 156.06 25.61 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 107' ' ' THR . 16.6 t30 -142.78 121.93 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.517 ' OG ' ' NE ' ' A' ' 128' ' ' ARG . 1.3 m -117.32 138.96 51.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.235 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.611 ' SG ' HG22 ' A' ' 107' ' ' THR . 43.0 t -105.5 133.81 49.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -60.37 -13.15 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.3 -51.76 51.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.852 . . . . 0.0 110.357 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.78 -27.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.791 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 101.21 -12.03 58.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 128' ' ' ARG . 4.2 p90 -29.29 -37.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.94 . . . . 0.0 111.188 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER 67.8 132.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.683 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.14 73.01 0.29 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 9.6 ttt -83.13 122.33 28.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -1.131 . . . . 0.0 110.111 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.887 HD13 ' SG ' ' A' ' 138' ' ' CYS . 13.5 mt -93.18 142.14 27.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 110.336 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -119.42 -41.38 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.0 p -45.44 139.04 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.403 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 38.5 m80 -109.49 23.55 14.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 136' ' ' LYS . 36.7 t60 -130.66 17.07 5.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 135' ' ' HIS . 4.7 mmmt -119.4 -178.24 3.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 110.262 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.041 HD22 ' HB2' ' A' ' 96' ' ' PHE . 1.7 pp -47.36 -23.86 0.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.262 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.887 ' SG ' HD13 ' A' ' 131' ' ' LEU . 40.0 m -60.17 -42.28 94.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.883 . . . . 0.0 110.336 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 134' ' ' HIS . 20.1 m -68.86 -39.98 79.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -56.93 -48.43 78.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.106 -0.996 . . . . 0.0 109.732 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.935 ' CD1' HD13 ' A' ' 118' ' ' ILE . 23.8 pt -68.77 -42.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.842 ' O ' HD13 ' A' ' 142' ' ' LEU . 1.8 tm? -54.19 -37.26 64.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.838 . . . . 0.0 110.251 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 4.6 mmtt -91.67 -11.36 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 110.349 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 143' ' ' LYS . 0.8 OUTLIER 61.02 175.03 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.191 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.1 Cg_endo -72.08 157.2 54.75 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.022 1.538 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.9 86.1 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.09 1.573 . . . . 0.0 110.503 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -169.21 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 110.138 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 147' ' ' GLU . 32.7 m-80 42.95 -158.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.2 OUTLIER 177.96 -169.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 149' ' ' SER . 2.0 t70 54.65 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 m -103.15 172.97 6.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 110.244 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.7 24.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.471 ' O ' HG22 ' A' ' 153' ' ' THR . 7.9 m 51.79 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -1.168 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.29 -163.27 36.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -80.98 -84.71 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -1.157 . . . . 0.0 110.174 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.151 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 1' ' ' LEU . 17.1 mt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.1 t -114.24 76.31 0.98 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.254 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 147.5 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.66 -174.97 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 72.7 t -62.27 -11.94 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER 65.51 8.97 5.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 110.182 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 8' ' ' SER . 9.5 ptt180 -70.26 -30.94 68.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.525 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 0.3 OUTLIER -78.26 -7.09 56.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 110.204 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -103.09 -29.95 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.908 . . . . 0.0 110.176 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.63 172.02 10.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.09 120.01 6.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG3' ' N ' ' A' ' 13' ' ' PHE . 18.1 pt20 -80.37 -21.98 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 6.8 t80 42.47 65.36 0.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.23 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 16' ' ' TYR . 49.9 t80 -177.77 -88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.13 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 26.7 ttp180 42.18 26.76 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.329 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.8 m-85 -136.79 130.2 31.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -116.08 149.58 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 0.0 110.286 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.468 ' HB3' HG12 ' A' ' 22' ' ' ILE . 12.3 mmt -117.37 108.07 44.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' LEU . 46.4 Cg_endo -72.99 77.18 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 0.0 110.502 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.91 -78.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.283 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 22' ' ' ILE . 5.1 tt -81.93 127.13 32.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD23 ' A' ' 21' ' ' LEU . 4.7 mt -103.97 136.77 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.71 126.75 45.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.717 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 mmtp -116.12 138.05 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 31' ' ' GLY . 4.3 p -93.34 122.05 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.6 tt0 -141.58 133.31 27.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.406 -0.809 . . . . 0.0 110.217 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.8 -104.56 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' ASN . 1.1 mttt -152.55 139.15 18.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -1.043 . . . . 0.0 110.107 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.32 -84.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' LYS . 72.3 m-20 -90.28 -18.79 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 110.024 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.752 ' O ' HG22 ' A' ' 25' ' ' VAL . . . 46.37 88.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -107.83 22.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 110.301 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -97.71 152.85 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.905 -1.122 . . . . 0.0 109.559 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.923 HG21 ' CD2' ' A' ' 80' ' ' HIS . 18.5 m -110.78 115.69 29.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.938 -1.101 . . . . 0.0 110.771 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 24' ' ' LYS . 14.3 p -107.14 117.42 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.2 mt -95.77 108.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 37' ' ' VAL . 7.6 p -100.6 -13.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.667 ' OD1' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -101.47 -1.32 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.415 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -64.5 -45.26 88.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 8.5 p -67.19 -38.58 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.0 110.422 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.519 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.2 t0 -61.93 -48.92 78.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -0.945 . . . . 0.0 110.353 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 38' ' ' ASN . 79.9 t -68.41 -40.7 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -66.43 -38.69 87.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -67.11 -36.45 81.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.052 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.762 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -63.2 -30.27 71.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.1 mp -115.18 -9.31 12.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' ALA . 6.1 p30 171.37 -110.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.37 -0.831 . . . . 0.0 110.388 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.916 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.9 mtm-85 -137.32 167.35 21.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 44.9 Cg_endo -72.0 137.91 30.11 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.907 1.477 . . . . 0.0 110.571 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 1.079 ' O ' HG23 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.11 52.08 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.066 1.561 . . . . 0.0 110.523 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.888 HG22 ' CE1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -67.87 -21.69 65.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.551 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 m-85 -81.4 -54.2 0.71 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 111.081 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -72.47 2.49 5.08 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.796 1.419 . . . . 0.0 111.338 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 1.079 HG23 ' O ' ' A' ' 50' ' ' PRO . 1.9 p -66.35 -18.59 65.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -72.86 -42.3 63.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.878 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -58.72 -51.43 70.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.117 -0.99 . . . . 0.0 110.433 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.547 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 24.7 m-85 -57.82 -42.59 84.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.65 -35.52 89.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -37.28 70.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -1.208 . . . . 0.0 110.039 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.63 -48.88 70.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.009 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.14 12.45 3.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.066 -1.021 . . . . 0.0 111.097 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.85 4.85 22.28 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.046 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.71 163.87 15.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -1.139 . . . . 0.0 109.081 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' C ' ' CG2' ' A' ' 65' ' ' THR . 66.4 mt-30 -110.4 -123.07 0.27 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.643 -1.285 . . . . 0.0 109.929 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.596 HG21 ' HB ' ' A' ' 54' ' ' THR . 2.0 p -149.92 170.76 18.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.97 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.647 ' CB ' HG22 ' A' ' 75' ' ' ILE . 2.0 tm0? -144.27 139.4 28.59 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.888 ' CE1' HG22 ' A' ' 51' ' ' THR . 30.8 m-85 -126.76 145.85 50.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.792 -1.193 . . . . 0.0 112.98 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 71' ' ' ASN . 10.5 m-20 -126.52 117.52 23.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.274 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.9 m -87.29 -45.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.63 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.604 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.38 -8.39 46.11 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.1 m120 -118.94 -24.69 6.49 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.695 -0.628 . . . . 0.0 110.147 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.1 m-20 68.45 15.71 9.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.958 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.587 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 5.6 mtp180 -113.82 129.43 56.59 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.566 -0.709 . . . . 0.0 109.788 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -113.79 130.91 56.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.484 -0.76 . . . . 0.0 110.316 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.647 HG22 ' CB ' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -111.39 148.04 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 3.0 t -120.31 132.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 109.22 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.046 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 82.5 m-20 -66.17 141.01 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 110.555 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 99.56 137.39 9.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 86.5 p -96.5 116.04 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.107 -1.231 . . . . 0.0 110.639 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CD2' HG21 ' A' ' 34' ' ' THR . 3.1 p-80 -143.26 127.47 17.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.274 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -73.64 151.62 40.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.986 -1.071 . . . . 0.0 109.737 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.06 -44.59 64.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 110.208 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.56 -33.3 75.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.835 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -67.31 -36.6 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.582 -0.699 . . . . 0.0 111.084 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 7.9 mp -59.22 -44.84 92.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.16 -0.963 . . . . 0.0 110.725 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.02 -36.42 83.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.037 -1.039 . . . . 0.0 109.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -69.24 -38.12 78.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.475 -0.766 . . . . 0.0 111.426 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 2.3 ptm -71.17 -48.82 49.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.799 -1.188 . . . . 0.0 111.601 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.643 ' H ' ' HG3' ' A' ' 88' ' ' MET . 16.1 tp -57.89 -33.68 68.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.003 -1.06 . . . . 0.0 108.707 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.59 -47.53 75.42 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.441 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' CG ' ' A' ' 95' ' ' LYS . . . -68.6 -48.61 49.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.624 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 14.0 m-30 -62.13 -52.29 64.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -1.183 . . . . 0.0 110.787 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.873 HG23 HG21 ' A' ' 97' ' ' VAL . 4.1 mt -54.0 -50.58 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.056 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.853 ' HG3' HD11 ' A' ' 98' ' ' LEU . 4.8 ttpm? -66.14 -27.95 68.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.848 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 137' ' ' LEU . 16.9 mmtt -65.92 -42.83 89.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 111.795 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.007 ' CB ' HD11 ' A' ' 131' ' ' LEU . 2.5 p90 -115.99 -33.21 5.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.646 -1.284 . . . . 0.0 111.901 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.873 HG21 HG23 ' A' ' 93' ' ' ILE . 49.2 t -53.67 -21.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.617 -1.302 . . . . 0.0 109.879 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.853 HD11 ' HG3' ' A' ' 94' ' ' LYS . 12.1 mt -88.86 39.82 0.95 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.64 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -64.76 155.28 83.01 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 43.2 Cg_endo -70.21 -2.32 10.3 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.034 1.544 . . . . 0.0 110.497 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG3' ' CD2' ' A' ' 127' ' ' TYR . 39.7 mm-40 -86.05 -12.08 51.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 103' ' ' GLU . 1.1 t 178.8 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 110.14 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.549 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER 33.39 63.48 0.35 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.576 -0.702 . . . . 0.0 110.359 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.602 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.8 m-20 -163.35 -62.7 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.7 Cg_endo -71.8 149.56 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.444 . . . . 0.0 110.299 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 11.4 pt-20 -69.62 121.99 18.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.17 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -110.27 165.83 11.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.17 150.37 34.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.84 142.72 50.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.244 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.509 ' NE2' ' HA3' ' A' ' 119' ' ' GLY . 23.5 p80 -123.0 129.78 51.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.118 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.664 HG12 HD13 ' A' ' 118' ' ' ILE . 3.4 m -101.73 129.58 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.18 122.77 44.18 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.19 -30.9 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.075 1.566 . . . . 0.0 110.472 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -40.82 90.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.282 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.68 -0.05 17.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.007 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.66 ' O ' HD21 ' A' ' 142' ' ' LEU . 5.4 mt-30 52.6 37.98 24.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.017 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -117.06 149.96 39.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.664 HD13 HG12 ' A' ' 111' ' ' VAL . 11.3 mm -100.88 137.09 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -112.46 162.99 12.21 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.479 ' HB2' ' CG ' ' A' ' 131' ' ' LEU . 19.2 t-20 -143.76 128.02 17.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 t -116.87 124.71 50.17 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 110.53 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.1 t -115.09 124.4 51.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.79 26.14 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.448 ' HB1' ' SG ' ' A' ' 102' ' ' CYS . . . -94.3 -35.62 12.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 127' ' ' TYR . 9.5 p -136.72 2.25 2.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.425 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 87.49 -12.45 62.99 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.734 ' CG ' ' N ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -36.76 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -1.056 . . . . 0.0 110.266 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.841 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 2.2 tmm_? 45.95 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.21 -99.75 0.13 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.08 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.551 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -118.05 145.56 44.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -1.08 . . . . 0.0 110.525 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.007 HD11 ' CB ' ' A' ' 96' ' ' PHE . 2.1 tt -92.08 129.13 38.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.154 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 133' ' ' THR . 1.4 t70 -131.7 -71.02 0.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.332 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.749 HG22 ' CD2' ' A' ' 134' ' ' HIS . 1.6 m 68.25 153.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.244 -0.91 . . . . 0.0 110.262 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.749 ' CD2' HG22 ' A' ' 133' ' ' THR . 7.7 p80 -42.77 -51.11 5.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -97.03 140.44 31.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.983 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -75.59 81.65 2.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.935 . . . . 0.0 110.332 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 2.4 pp -82.66 -19.19 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.581 ' HA ' HD11 ' A' ' 141' ' ' ILE . 40.0 m -56.31 -40.37 74.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 110.269 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -40.81 98.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 110.323 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -61.42 -49.4 77.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.41 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.581 HD11 ' HA ' ' A' ' 138' ' ' CYS . 16.9 pt -70.26 -41.89 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.543 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 116' ' ' GLN . 20.4 tp -56.02 -40.94 74.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 111.028 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 0.4 OUTLIER -108.99 -23.22 11.8 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.065 -1.022 . . . . 0.0 110.886 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 140' ' ' PHE . 77.6 m-20 57.9 103.4 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 46.0 Cg_endo -73.0 172.48 15.38 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.979 1.515 . . . . 0.0 110.475 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 149' ' ' SER . 45.2 Cg_endo -73.18 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.067 1.562 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 148' ' ' ASN . 1.3 mp0 -84.58 124.84 31.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 149' ' ' SER . 17.5 m-20 60.32 13.39 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 146' ' ' PRO . 1.3 m 42.75 74.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.92 155.67 32.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.4 m -72.52 57.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.38 90.53 1.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -169.15 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.41 -173.0 15.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.75 59.56 4.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -1.111 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.169 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.268 0.556 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -124.68 -179.2 4.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.251 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 3' ' ' VAL . 9.8 p -47.57 127.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -92.15 177.35 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 41.2 t -45.03 -28.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 3.6 t-20 65.41 152.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -68.47 -13.74 62.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 9' ' ' VAL . 1.1 t -78.26 -7.68 57.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 9' ' ' VAL . 41.0 t 46.23 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.3 ptm -151.81 28.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 14' ' ' TYR . 41.6 t0 -52.87 119.11 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.26 -21.79 31.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -114.95 25.73 10.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 15' ' ' ARG . 17.6 t80 -50.59 -78.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 19.5 tpp85 -112.63 -30.98 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.04 130.21 46.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 110.234 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 18' ' ' MET . 1.4 ttpm? -128.71 162.17 28.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.228 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.401 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 8.5 ttt -141.77 109.95 6.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 46.3 Cg_endo -73.07 -57.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 179.76 -142.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 21' ' ' LEU . 10.3 tt -84.84 133.92 34.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.206 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.62 133.82 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.239 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.05 147.18 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.099 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.22 137.17 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 110.3 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' H ' HG12 ' A' ' 25' ' ' VAL . 4.3 p -97.03 135.33 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.38 137.59 50.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.201 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 64.41 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -89.77 174.99 7.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.82 -3.85 44.65 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -72.84 -18.04 61.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -1.183 . . . . 0.0 110.218 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . 118.78 -44.58 1.38 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 ' HB3' ' A' ' 79' ' ' SER . 0.2 OUTLIER 168.66 105.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -1.089 . . . . 0.0 109.581 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' ' 75' ' ' ILE . 7.7 mtmt -112.66 134.01 54.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.1 m -97.24 120.23 37.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.2 m -101.53 118.78 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.737 HG23 ' CB ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -95.22 111.95 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 24' ' ' LYS . 13.9 t -101.1 -44.13 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.876 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -92.2 4.61 52.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.94 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.737 ' CB ' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.15 -33.38 75.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.0 110.242 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 41' ' ' ASP . 35.2 m -59.42 -38.39 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -64.05 -47.14 81.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.184 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.53 -48.32 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . . . -56.65 -34.93 67.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 2.4 tmtt? -57.72 -48.76 78.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.6 66.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.084 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.7 tt -85.34 -9.38 57.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 83.67 -35.72 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.706 -0.621 . . . . 0.0 110.621 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HB2' HD22 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -92.62 154.16 42.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.224 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.533 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.3 Cg_endo -73.18 150.57 47.89 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.021 1.537 . . . . 0.0 110.365 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HB2' ' SD ' ' A' ' 39' ' ' MET . 46.6 Cg_endo -73.24 -22.4 19.04 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.043 1.549 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.783 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.5 p -66.12 -21.66 66.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -79.79 -56.63 0.75 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.786 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 49' ' ' PRO . 46.3 Cg_endo -73.4 2.41 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.907 1.477 . . . . 0.0 111.054 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.581 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.44 -28.78 61.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.002 -1.062 . . . . 0.0 110.231 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -72.87 -45.56 57.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -0.923 . . . . 0.0 110.523 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.04 -51.18 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 110.414 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -44.01 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.887 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.563 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -60.06 -35.1 86.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -37.36 70.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -49.47 58.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.196 -0.94 . . . . 0.0 110.581 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.065 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -77.88 9.06 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 0.0 111.121 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.01 4.52 42.44 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -115.06 163.75 15.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -1.143 . . . . 0.0 109.129 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.726 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.5 pm0 -110.09 -120.78 0.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.582 -1.324 . . . . 0.0 109.964 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.5 p -149.4 170.53 18.34 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.447 -0.783 . . . . 0.0 110.966 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -143.82 139.53 29.37 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.4 m-85 -126.59 142.03 51.67 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.862 -1.135 . . . . 0.0 112.803 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 42.9 m-20 -121.33 117.47 27.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.083 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.09 -63.58 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -16.73 6.52 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.16 -0.962 . . . . 0.0 108.592 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.95 -29.88 10.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.656 -0.652 . . . . 0.0 110.051 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.5 m-20 69.66 15.48 8.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 109.986 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 2.6 ttm180 -113.89 129.86 56.55 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.669 -0.644 . . . . 0.0 109.581 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.704 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.5 m-30 -113.0 134.53 54.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.102 HD13 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -129.44 148.77 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.816 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 1.102 ' N ' HD13 ' A' ' 75' ' ' ILE . 25.5 t -113.6 138.0 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -0.985 . . . . 0.0 109.864 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -59.88 141.08 56.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.855 . . . . 0.0 110.905 -179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.55 157.76 33.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.937 ' HB3' HD12 ' A' ' 32' ' ' ILE . 91.8 p -101.81 122.13 43.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.143 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.612 ' NE2' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.03 114.93 8.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 85' ' ' LEU . 2.2 pm0 -84.19 151.82 24.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.811 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLN . . . -52.46 -39.36 61.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.599 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 1.4 t-20 -64.54 -34.04 77.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 110.709 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.593 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -72.95 -48.27 38.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.635 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -0.957 . . . . 0.0 110.253 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.3 mt-30 -58.93 -36.99 75.67 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 90' ' ' ASP . 1.1 m-20 -69.82 -36.51 75.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.426 0.631 . . . . 0.0 109.618 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 85' ' ' LEU . 33.6 ttp -68.7 -50.39 51.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 109.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -30.47 71.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . 5.4 m-20 -63.45 -35.7 81.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.706 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.48 -45.66 95.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -68.4 -52.07 37.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.266 . . . . 0.0 110.279 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.889 ' HB ' HG21 ' A' ' 97' ' ' VAL . 2.1 pp -65.43 -34.48 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.393 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.835 ' N ' HD12 ' A' ' 93' ' ' ILE . 1.2 ttmt -55.34 -27.65 48.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.69 ' HD3' HD13 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -61.9 -42.94 99.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.887 -1.133 . . . . 0.0 111.165 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.917 ' HB2' HD11 ' A' ' 131' ' ' LEU . 3.5 p90 -116.61 -27.96 6.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.144 . . . . 0.0 111.683 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 93' ' ' ILE . 41.8 t -53.79 -59.94 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.962 -1.087 . . . . 0.0 111.001 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.57 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -61.68 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.239 -0.913 . . . . 0.0 110.526 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -85.2 155.47 60.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 110.196 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 42.5 Cg_endo -69.27 -11.2 30.93 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.985 1.518 . . . . 0.0 110.027 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' OE1' ' HG2' ' A' ' 100' ' ' PRO . 0.6 OUTLIER -134.23 13.59 3.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.435 -0.79 . . . . 0.0 109.687 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.759 ' SG ' HG22 ' A' ' 107' ' ' THR . 0.5 OUTLIER -144.9 -29.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 98' ' ' LEU . 2.7 tm-20 -37.7 -69.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 0.0 110.83 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.604 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 2.1 m-20 -39.84 -61.96 0.97 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 110.641 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 46.4 Cg_endo -71.35 150.03 57.88 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.032 1.543 . . . . 0.0 110.623 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 129.09 38.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.711 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.759 HG22 ' SG ' ' A' ' 102' ' ' CYS . 4.7 p -110.06 150.25 28.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.638 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 2.4 p30 -121.04 157.66 29.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 109.943 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.841 ' CD2' HD22 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -129.32 111.35 12.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.111 -0.993 . . . . 0.0 110.567 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 110' ' ' HIS . 24.5 p80 -124.3 119.21 28.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.375 -0.828 . . . . 0.0 109.982 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 111' ' ' VAL . 3.1 p -104.74 129.67 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.494 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -98.95 122.88 51.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.221 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.12 -26.6 14.74 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.937 1.493 . . . . 0.0 110.496 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -63.59 -39.93 95.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' CD ' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -110.8 -3.75 15.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.524 ' C ' HD11 ' A' ' 142' ' ' LEU . 2.5 mt-30 52.54 53.46 12.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.522 ' OG1' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -134.01 152.85 52.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' CG1' ' HB2' ' A' ' 142' ' ' LEU . 13.8 mm -101.49 126.16 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.55 ' O ' ' CD2' ' A' ' 110' ' ' HIS . . . -126.08 146.71 16.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.582 ' CB ' ' HB2' ' A' ' 131' ' ' LEU . 15.2 t-20 -144.17 152.79 41.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.113 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -116.65 123.65 47.81 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.819 -1.176 . . . . 0.0 110.048 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 43.5 t -89.68 112.21 23.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 110.292 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -49.35 -22.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -94.19 7.33 45.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 126' ' ' GLY . 4.9 m 71.16 -1.87 2.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.427 -0.796 . . . . 0.0 109.95 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.84 -62.15 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 128' ' ' ARG . 5.8 p90 -136.19 -31.74 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -1.144 . . . . 0.0 110.788 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 1.9 mtt180 29.01 94.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.737 . . . . 0.0 110.888 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.403 ' O ' ' HA2' ' A' ' 119' ' ' GLY . . . 158.68 -80.49 0.16 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.128 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.527 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -119.93 143.32 48.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -1.156 . . . . 0.0 110.701 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.917 HD11 ' HB2' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -113.75 110.85 20.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.37 -0.831 . . . . 0.0 110.203 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 131' ' ' LEU . 12.4 p-10 165.65 114.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.849 0.833 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -104.55 -14.07 15.78 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.268 0.556 . . . . 0.0 110.04 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER 172.36 -152.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.45 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.034 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' HIS . 1.1 mtmt -124.89 -179.29 4.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.69 HD13 ' HD3' ' A' ' 95' ' ' LYS . 1.8 pt? -70.31 -4.04 20.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 110.25 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.567 ' SG ' HD23 ' A' ' 131' ' ' LEU . 94.4 m -56.12 -48.14 76.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.073 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -68.84 -39.13 80.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 110.062 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.35 -48.69 80.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.539 HG13 ' N ' ' A' ' 142' ' ' LEU . 24.7 pt -69.12 -42.28 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.405 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.539 ' N ' HG13 ' A' ' 141' ' ' ILE . 18.7 tp -53.54 -26.48 21.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.44 ' NZ ' ' HG3' ' A' ' 146' ' ' PRO . 10.0 tttm -87.79 -22.2 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 15.8 m-80 61.65 165.27 0.1 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.7 Cg_endo -72.72 113.39 3.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.393 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 45.7 Cg_endo -72.66 175.06 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.967 1.509 . . . . 0.0 110.453 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' PRO . 2.9 tt0 -178.77 141.81 0.2 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.48 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.67 93.31 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.21 -3.85 6.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.7 t -156.89 175.4 14.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 110.227 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 49.79 35.15 23.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 m -64.83 -60.97 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 110.218 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -150.57 57.72 0.45 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 111.47 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -1.175 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.17 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -121.32 89.83 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 3' ' ' VAL . 13.3 p -136.26 19.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.443 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . 11.8 t-20 -72.9 155.31 40.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 9' ' ' VAL . 8.2 p -71.38 -10.4 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 7' ' ' ARG . 34.5 p-10 -62.43 -20.08 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.499 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 3.5 ptm180 -69.43 -31.45 69.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 110.227 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.438 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 2.5 m -91.33 -7.97 49.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -0.863 . . . . 0.0 110.222 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' MET . 14.6 t -111.32 106.77 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.451 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 172.86 54.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.27 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 13' ' ' PHE . 13.8 t0 -107.86 110.66 22.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' PHE . 1.4 pp0? -84.38 -13.7 51.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 1.7 t80 -42.73 -54.85 3.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.95 . . . . 0.0 110.286 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER 68.23 87.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 2.5 tpt180 -122.59 -12.99 8.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -109.71 130.16 55.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.237 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' O ' ' SD ' ' A' ' 18' ' ' MET . 9.2 pttp -133.25 162.27 32.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.493 ' O ' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -142.23 100.71 5.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.23 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 45.5 Cg_endo -73.12 74.28 3.03 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.014 1.534 . . . . 0.0 110.459 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 10.3 mtm180 -156.7 110.15 2.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.697 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.5 tm? -94.29 122.38 36.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.61 HD12 ' N ' ' A' ' 22' ' ' ILE . 3.1 mp -106.76 121.83 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.343 -0.848 . . . . 0.0 109.964 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.78 46.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.235 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.509 ' O ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.1 136.45 52.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.3 m -93.95 135.09 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.172 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -112.63 156.6 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.11 64.74 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 139.1 25.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -1.112 . . . . 0.0 110.175 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.32 -90.83 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.0 m120 -99.63 -0.47 40.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -1.148 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 -0.43 76.35 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.8 mm -151.86 87.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -1.109 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -129.44 142.84 50.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.282 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.832 HG21 ' NE2' ' A' ' 80' ' ' HIS . 20.9 m -98.34 128.87 44.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.632 HG12 HG23 ' A' ' 75' ' ' ILE . 3.2 m -101.43 127.69 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.602 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 0.7 OUTLIER -93.82 121.12 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.914 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.84 -46.96 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 111.26 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.99 18.5 14.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.989 -1.069 . . . . 0.0 111.17 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.602 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.16 -45.26 89.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 110.236 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' ASP . 23.5 m -70.28 -39.09 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' ' 40' ' ' VAL . 58.7 t0 -62.08 -48.9 78.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 18' ' ' MET . 95.0 t -66.75 -48.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -63.72 -35.03 79.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -62.78 -36.48 83.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.22 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.895 . . . . 0.0 110.232 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.874 HD12 ' HB2' ' A' ' 47' ' ' ASN . 3.2 pp -105.91 -1.24 24.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.874 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.3 OUTLIER 173.41 -151.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 110.243 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 8.4 mtt85 -89.31 174.95 4.34 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.6 Cg_endo -72.81 131.8 17.62 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.932 1.49 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 39' ' ' MET . 46.5 Cg_endo -73.72 1.25 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.547 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.918 HG23 ' CE1' ' A' ' 67' ' ' PHE . 88.1 m -56.46 -21.83 28.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 110.267 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.576 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -97.71 -54.9 0.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 111.277 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 47.4 Cg_endo -74.99 -2.76 12.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.663 1.349 . . . . 0.0 111.151 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.58 HG23 HG21 ' A' ' 65' ' ' THR . 1.2 t -57.89 -14.41 6.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.298 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -72.77 -45.59 57.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.436 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -65.2 -51.17 62.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.026 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.36 -37.07 72.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 109.33 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -63.55 -35.21 91.73 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -37.15 70.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.2 . . . . 0.0 109.753 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' OE1' ' HA ' ' A' ' 60' ' ' GLU . 3.8 tp10 -64.5 -49.36 71.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.02 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -81.1 11.57 4.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.15 -0.969 . . . . 0.0 110.985 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.95 4.57 42.27 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.033 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -116.11 163.15 16.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.145 -1.209 . . . . 0.0 109.257 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.522 ' C ' ' CG2' ' A' ' 65' ' ' THR . 2.2 tt0 -119.04 -123.33 0.29 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 0.0 109.813 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.9 p -149.98 170.63 18.4 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.641 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -149.59 139.48 21.91 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.918 ' CE1' HG23 ' A' ' 51' ' ' THR . 23.8 m-85 -126.86 146.15 50.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.249 . . . . 0.0 113.024 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 3.6 t0 -121.34 117.45 26.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.922 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.14 -63.08 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.876 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -56.64 -15.22 4.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.139 -0.976 . . . . 0.0 108.957 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.8 t30 -106.0 -29.07 10.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.743 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 70.62 16.89 6.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.55 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -113.76 129.81 56.53 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.728 ' O ' HD13 ' A' ' 75' ' ' ILE . 3.7 m-30 -111.16 129.03 56.07 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.752 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 74' ' ' TYR . 13.8 mm -130.77 149.28 33.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 12.3 m -112.78 139.44 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 109.729 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.033 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 6.8 p-10 -69.32 137.0 52.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.258 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 108.1 129.61 6.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . 63.1 p -92.07 121.77 33.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.005 -1.291 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.832 ' NE2' HG21 ' A' ' 34' ' ' THR . 2.2 p-80 -142.02 114.86 8.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.416 -0.803 . . . . 0.0 110.04 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -58.72 157.13 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.067 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.572 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.11 -36.96 52.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -55.91 -33.53 64.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.877 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -63.31 -39.52 94.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.551 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.5 mm? -60.36 -32.99 71.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.24 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -62.74 -37.04 85.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 109.772 179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -59.35 -46.78 87.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.577 ' CE ' ' CD1' ' A' ' 57' ' ' PHE . 1.1 tmm? -71.63 -30.83 66.2 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.856 0.836 . . . . 0.0 109.341 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -51.77 -27.21 11.47 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 15.2 t70 -55.12 -35.99 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.961 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.93 -32.65 82.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -38.58 91.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.615 -0.932 . . . . 0.0 109.996 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.063 ' O ' HG13 ' A' ' 97' ' ' VAL . 38.3 mm -52.08 -33.57 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.639 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 10.2 ttpt -55.22 -26.76 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.947 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.607 ' O ' HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -60.64 -29.8 69.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.522 -0.737 . . . . 0.0 111.724 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.04 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 5.7 p90 -115.88 -19.13 10.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.717 -1.239 . . . . 0.0 111.552 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.063 HG13 ' O ' ' A' ' 93' ' ' ILE . 5.7 m -60.53 -46.82 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.758 -1.214 . . . . 0.0 110.24 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.678 ' C ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER 8.9 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.679 -0.638 . . . . 0.0 111.28 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -85.27 155.35 60.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.476 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 43.4 Cg_endo -71.06 -8.66 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.033 1.543 . . . . 0.0 110.307 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' OE2' ' CE2' ' A' ' 127' ' ' TYR . 1.6 pm0 -139.82 22.94 2.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 110.067 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.548 ' HB3' HG21 ' A' ' 107' ' ' THR . 67.1 m -152.38 -31.45 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.535 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.575 ' HG2' HD12 ' A' ' 98' ' ' LEU . 4.0 tm-20 -43.53 -65.09 0.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 110.443 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 4.8 m-20 -37.37 -62.62 0.57 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.488 -0.757 . . . . 0.0 110.443 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.633 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 45.2 Cg_endo -71.7 149.72 55.23 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.851 1.448 . . . . 0.0 110.26 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -69.65 135.42 49.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.548 HG21 ' HB3' ' A' ' 102' ' ' CYS . 7.1 p -141.88 166.04 25.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 16.8 m-20 -114.16 136.93 52.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.57 HD13 HG11 ' A' ' 97' ' ' VAL . 2.8 tt -110.77 123.45 50.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 110.212 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -124.16 133.42 53.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.903 HG23 HG12 ' A' ' 118' ' ' ILE . 2.3 p -121.04 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -105.78 122.66 41.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 110.269 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.18 -39.01 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.886 1.467 . . . . 0.0 110.401 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -59.89 -41.99 92.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 3.4 tttm -93.45 -3.78 52.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.933 . . . . 0.0 110.306 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.78 40.99 31.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -130.88 164.61 24.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.903 HG12 HG23 ' A' ' 111' ' ' VAL . 7.2 mt -141.38 127.14 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 110.026 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 129' ' ' GLY . . . -134.22 164.2 24.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 0.4 OUTLIER -138.99 153.11 48.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -1.122 . . . . 0.0 109.151 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 20.2 m -116.71 124.83 50.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.97 -1.081 . . . . 0.0 110.73 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.464 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . 17.8 t -118.0 134.0 55.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.958 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -98.17 49.01 1.0 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.989 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.633 ' HB2' ' CB ' ' A' ' 105' ' ' PRO . . . -128.3 -32.52 2.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.64 4.46 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 0.0 110.614 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . 84.06 -12.56 53.52 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.645 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -40.44 -30.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -1.131 . . . . 0.0 110.241 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -27.5 125.9 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.676 -0.64 . . . . 0.0 111.231 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' O ' ' HA3' ' A' ' 119' ' ' GLY . . . 156.52 -90.25 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.069 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtt -119.81 152.19 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -1.103 . . . . 0.0 110.372 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 0.3 OUTLIER -68.83 142.15 54.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.701 ' C ' HG22 ' A' ' 133' ' ' THR . 1.9 m-20 -43.17 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.29 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 169.94 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.485 ' H ' HG23 ' A' ' 133' ' ' THR . 46.6 m80 55.61 -161.01 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 134' ' ' HIS . 28.5 m-70 -41.66 163.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.897 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 81.22 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.121 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.907 HD11 ' CE1' ' A' ' 96' ' ' PHE . 19.8 tp -82.96 -54.27 5.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.775 ' HA ' HD11 ' A' ' 141' ' ' ILE . 56.9 m -57.0 -42.42 80.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.383 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.6 m -68.63 -44.81 73.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.336 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.05 -49.11 76.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.775 HD11 ' HA ' ' A' ' 138' ' ' CYS . 7.4 pt -69.79 -42.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.24 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' CYS . 37.8 tp -68.56 -13.11 62.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.743 . . . . 0.0 110.258 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.552 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 19.1 tttt -109.0 -9.93 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.591 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 1.6 p30 47.9 179.91 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 45.5 Cg_endo -74.01 110.77 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.785 1.413 . . . . 0.0 110.325 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 45.9 Cg_endo -73.37 171.14 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 149' ' ' SER . 10.6 tp10 44.45 33.38 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.412 ' C ' ' OD1' ' A' ' 148' ' ' ASN . 34.2 t-20 54.62 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -167.5 170.14 11.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.183 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -146.91 -178.28 6.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.0 141.34 44.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 149.68 -34.91 1.04 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.1 p -48.27 158.17 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 155' ' ' LYS . . . -104.73 -25.28 6.95 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER 60.22 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -1.071 . . . . 0.0 110.176 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 154' ' ' GLY . 1.2 tttt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.157 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.243 0.545 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -98.89 1.17 45.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.198 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 4' ' ' ASN . 41.2 t 54.53 167.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' HG12 ' A' ' 3' ' ' VAL . 3.9 m120 -93.43 117.78 30.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG13 ' OD1' ' A' ' 6' ' ' ASN . 11.7 p -61.5 -23.2 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.658 ' OD1' HG13 ' A' ' 5' ' ' VAL . 3.0 m120 -93.37 22.64 5.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 16.2 ttt180 -69.95 -14.49 62.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 t -93.42 4.28 54.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.176 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.38 144.07 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 tpp -98.53 -64.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 14' ' ' TYR . 17.4 p-10 -87.38 111.53 21.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 2.2 pp0? -80.79 -16.61 53.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 13' ' ' PHE . 75.0 t80 -82.31 9.94 7.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -68.69 -21.94 64.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.567 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 4.8 ttp180 -172.62 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -136.63 132.19 34.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 110.101 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.96 154.49 29.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.43 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -125.59 163.19 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 18' ' ' MET . 45.8 Cg_endo -72.98 -90.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.101 1.579 . . . . 0.0 110.44 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' O ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER 62.83 171.84 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.28 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 9.3 tp -87.28 130.13 34.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.242 -0.911 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 22' ' ' ILE . 14.2 mm -132.59 129.63 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.86 149.24 48.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -116.15 138.45 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.3 m -92.95 131.51 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 0.0 110.395 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -137.34 169.48 17.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.034 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . 66.05 30.15 76.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -89.5 175.12 7.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -1.132 . . . . 0.0 110.192 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.99 -60.09 4.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -99.93 -15.49 18.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.107 . . . . 0.0 109.643 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.669 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . -154.49 -109.66 0.35 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.912 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.4 OUTLIER 152.79 101.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.943 -0.739 . . . . 0.0 109.371 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' GLU . 3.6 ttpt -129.49 152.6 48.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.932 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.802 ' O ' HG23 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -111.21 128.49 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 75' ' ' ILE . 2.2 p -117.8 117.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.517 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.724 HD12 ' CE ' ' A' ' 39' ' ' MET . 1.6 mt -96.07 112.95 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.07 -14.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 110.417 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 31.1 m120 -111.01 11.38 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.724 ' CE ' HD12 ' A' ' 36' ' ' ILE . 1.2 ttt -61.74 -45.41 94.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 36.6 t -70.24 -47.62 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.68 -50.01 70.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.897 . . . . 0.0 110.534 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 20' ' ' ARG . 43.0 t -68.36 -45.33 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.464 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.13 -39.06 86.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -67.52 -41.14 84.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.47 -17.88 62.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.9 tt -117.48 -9.11 10.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 110.522 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.831 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.3 OUTLIER 167.68 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.34 170.47 10.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.61 135.21 19.55 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.876 1.461 . . . . 0.0 110.538 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 50.5 Cg_endo -78.18 20.33 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.995 1.524 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -56.59 -21.93 30.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.311 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -85.54 -58.54 0.33 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.0 110.877 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.8 Cg_endo -73.16 0.3 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.798 1.42 . . . . 0.0 110.943 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -56.52 -20.92 22.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.217 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.81 -39.97 66.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.958 . . . . 0.0 110.584 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.5 t80 -58.87 -51.18 71.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.309 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 32.3 m-85 -57.53 -43.37 84.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.6 -35.38 85.59 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 86.9 m -57.1 -37.24 71.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 110.028 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -66.19 -49.35 67.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 110.83 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.034 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.17 11.56 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 4.89 26.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.05 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.47 163.77 15.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.3 mm100 -105.45 -120.44 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.598 -1.314 . . . . 0.0 109.754 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.52 170.24 19.07 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 75' ' ' ILE . 6.1 tt0 -143.47 139.33 29.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.698 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.3 m-85 -126.81 141.12 51.91 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.808 -1.182 . . . . 0.0 112.71 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -122.24 117.46 26.22 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.059 178.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -85.89 -63.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.656 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 2.3 ttmt -55.23 -17.49 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 108.872 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -105.4 -29.35 10.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.561 -0.712 . . . . 0.0 110.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.8 m-20 70.77 16.54 6.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 99.6 mtt180 -113.68 129.64 56.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.567 -0.708 . . . . 0.0 109.629 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.1 m-30 -113.29 137.94 50.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 110.337 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 34' ' ' THR . 44.3 mt -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 64' ' ' GLN . 14.5 t -114.04 137.73 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.05 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 67.9 m-80 -57.9 142.22 46.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 110.534 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 84.65 152.5 16.44 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.912 ' OG ' HD12 ' A' ' 32' ' ' ILE . 45.4 p -99.67 115.98 30.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.256 . . . . 0.0 110.687 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.764 ' NE2' HG21 ' A' ' 34' ' ' THR . 5.0 p-80 -143.32 117.05 9.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.158 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 3.2 tt0 -65.75 153.83 40.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.618 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -44.75 65.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.102 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.51 -33.47 76.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.055 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 88' ' ' MET . 4.0 tttp -61.11 -36.48 79.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.749 -0.594 . . . . 0.0 110.145 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HA ' ' CG ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -59.4 -39.44 83.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.0 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.9 -36.48 74.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.962 -1.086 . . . . 0.0 108.305 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 6.3 t70 -68.83 -33.92 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.397 0.618 . . . . 0.0 109.938 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.76 ' CG ' ' HA ' ' A' ' 85' ' ' LEU . 9.8 mmm -55.98 -49.6 73.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.353 -0.842 . . . . 0.0 109.757 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.33 -31.32 67.46 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -65.02 -46.49 81.13 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.767 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 95' ' ' LYS . . . -62.51 -48.56 81.01 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.732 ' HA ' HD22 ' A' ' 137' ' ' LEU . 2.9 m-30 -61.21 -52.48 64.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.282 . . . . 0.0 110.495 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.625 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 3.0 tt -65.8 -45.61 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.036 ' O ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -68.09 -27.73 66.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.236 -0.915 . . . . 0.0 111.25 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -61.42 -41.94 97.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.965 -1.085 . . . . 0.0 111.383 -178.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 137' ' ' LEU . 27.7 p90 -109.47 -32.26 7.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.849 -1.157 . . . . 0.0 111.387 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 93' ' ' ILE . 77.4 t -57.98 -14.92 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.881 -1.137 . . . . 0.0 109.964 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.036 HD22 ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -78.11 44.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -76.48 155.59 83.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.892 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 42.2 Cg_endo -68.44 0.66 4.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.864 1.454 . . . . 0.0 110.435 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 2.5 mt-10 -124.23 0.89 8.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 17.2 p -163.79 23.14 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 99' ' ' CYS . 2.4 tm-20 -73.09 53.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.075 -1.015 . . . . 0.0 110.027 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.588 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.4 m-20 -167.53 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 124' ' ' ALA . 44.5 Cg_endo -70.51 149.8 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.922 1.485 . . . . 0.0 110.486 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.52 127.59 33.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 110.182 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.652 HG22 ' HB2' ' A' ' 122' ' ' CYS . 9.9 p -112.97 166.53 11.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 0.0 110.09 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.2 OUTLIER -113.7 160.36 18.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 110.078 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.506 HD23 HD12 ' A' ' 141' ' ' ILE . 1.1 tp -121.71 123.13 41.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.873 . . . . 0.0 110.612 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 110' ' ' HIS . 38.2 p-80 -124.22 115.23 20.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.889 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.556 ' CG1' ' HD2' ' A' ' 146' ' ' PRO . 13.6 p -97.77 129.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.933 . . . . 0.0 110.545 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -92.06 125.2 57.64 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.78 -28.54 13.58 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.956 1.503 . . . . 0.0 110.333 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -41.94 78.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 7.9 mmtp -98.65 -2.53 38.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.675 ' O ' HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 52.38 38.03 24.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 110.328 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.6 p -127.03 153.63 45.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.153 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.776 ' CD1' HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -101.09 126.19 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 110.3 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -104.19 164.19 14.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 120' ' ' ASN . 20.2 p-10 -134.6 133.14 39.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.0 109.685 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 3.1 p -116.88 124.48 49.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.652 ' HB2' HG22 ' A' ' 107' ' ' THR . 30.3 p -134.32 133.83 41.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 110.142 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.28 5.24 10.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . . . -53.63 -41.17 66.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 22.0 p -164.11 20.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 0.0 110.549 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 84.95 -12.91 56.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.685 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.4 OUTLIER -37.83 -30.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 110.274 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -23.91 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.672 -0.643 . . . . 0.0 110.995 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 166.27 -91.75 0.1 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.353 -1.404 . . . . 0.0 110.174 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.545 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -119.9 151.79 38.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -1.165 . . . . 0.0 110.711 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 96' ' ' PHE . 16.9 tp -109.1 118.1 35.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 133' ' ' THR . 0.9 OUTLIER -84.63 -104.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER 40.63 80.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.317 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -71.53 173.91 7.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.885 . . . . 0.0 110.252 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER 42.92 48.9 5.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.129 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.869 ' HG3' HG22 ' A' ' 133' ' ' THR . 0.1 OUTLIER -139.01 -177.61 4.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.185 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.969 HD11 ' CD2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -56.56 -13.12 2.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 110.331 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.701 ' HA ' HD11 ' A' ' 141' ' ' ILE . 55.5 m -55.83 -38.6 70.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.01 -41.21 78.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.013 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.35 80.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.702 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.776 HD12 ' CD1' ' A' ' 118' ' ' ILE . 15.1 pt -68.63 -41.81 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.554 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 116' ' ' GLN . 16.3 tp -53.03 -19.9 3.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -93.21 -12.41 30.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.47 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.3 m-80 -113.75 102.9 55.28 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.64 110.46 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.043 1.549 . . . . 0.0 110.456 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 111' ' ' VAL . 47.0 Cg_endo -74.11 -169.74 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.039 1.547 . . . . 0.0 110.376 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -93.76 113.41 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 149' ' ' SER . 0.9 OUTLIER -111.77 -161.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 150' ' ' ASP . 1.4 t 64.83 123.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 149' ' ' SER . 1.7 m-20 60.29 115.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 151' ' ' SER . 9.2 p 46.35 61.44 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.207 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.436 ' O ' ' OG1' ' A' ' 153' ' ' THR . . . -57.23 92.82 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 152' ' ' GLY . 63.3 p 43.43 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.82 50.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -147.54 64.07 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -1.189 . . . . 0.0 110.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.187 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.1 141.59 31.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -139.04 158.04 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.218 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -90.64 172.73 8.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 110.234 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 6.5 p -69.56 -15.03 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 55.6 m-20 54.66 71.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -14.05 61.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -87.61 -2.69 58.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.985 . . . . 0.0 110.155 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -132.62 143.65 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.148 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.452 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 5.2 ptp -46.56 147.62 1.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 21.4 t70 -94.38 121.06 35.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 13.1 pt20 -58.47 -23.08 56.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.55 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER 72.63 -52.47 0.7 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CD2' ' HB3' ' A' ' 13' ' ' PHE . 3.1 p90 -143.74 -33.64 0.42 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 15.9 ttm180 -158.39 -57.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 7.1 p90 -137.16 129.83 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.065 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 13.3 tmtt? -133.57 130.18 38.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.277 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mtp -108.32 126.69 29.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -72.09 -95.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 37.26 -149.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.0 110.32 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 85' ' ' LEU . 3.4 tm? -84.66 136.58 33.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.2 pt -109.99 120.89 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.13 136.77 54.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.722 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.6 mmmm -118.44 137.93 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.8 m -93.31 128.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.16 167.69 21.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.67 -77.24 0.4 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 41.5 mmtt -100.38 175.17 5.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -1.111 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -38.56 -39.78 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -94.84 -18.66 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' LYS . . . 71.69 99.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -105.89 3.73 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -1.162 . . . . 0.0 110.049 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.757 ' HD2' HG21 ' A' ' 75' ' ' ILE . 17.6 ttmm -97.58 152.91 18.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 109.29 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.404 ' OG1' ' HB2' ' A' ' 80' ' ' HIS . 2.8 m -99.28 115.81 30.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.832 -1.168 . . . . 0.0 110.914 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.2 p -112.36 117.42 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.84 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 ' HE3' ' A' ' 39' ' ' MET . 58.5 mt -95.88 109.75 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.66 -16.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.316 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' HD11 ' A' ' 22' ' ' ILE . 6.2 p-10 -97.8 2.61 49.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 110.21 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.629 ' HE3' HG21 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -55.86 -33.64 64.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.195 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.49 -44.47 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 7.2 t0 -66.17 -48.35 71.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 43' ' ' ALA . 8.1 p -61.15 -41.37 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.778 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -61.35 -35.18 76.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.014 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.4 mmmt -59.41 -37.21 77.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.875 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.915 ' C ' HD23 ' A' ' 46' ' ' LEU . . . -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.952 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.012 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -96.27 -9.05 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.889 . . . . 0.0 109.218 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 74.3 -50.18 0.68 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.634 . . . . 0.0 110.408 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 20.9 mtt85 -77.04 168.03 31.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.6 140.45 32.79 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.397 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.778 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.6 Cg_endo -73.51 -15.62 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.054 1.555 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.707 HG22 ' CE1' ' A' ' 67' ' ' PHE . 73.8 p -64.07 -27.05 68.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -75.98 -54.91 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.19 -42.91 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.816 1.429 . . . . 0.0 110.829 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 50' ' ' PRO . 6.9 t -56.36 -15.75 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 110.386 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -72.25 -45.36 60.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.349 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.66 79.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.6 -42.09 82.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.008 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.39 -35.43 85.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -37.12 74.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 110.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.72 -30.09 69.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.265 -0.897 . . . . 0.0 110.987 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.087 HD13 ' CE1' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -102.26 13.19 35.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.969 -1.082 . . . . 0.0 110.914 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.06 4.89 30.63 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.023 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -113.74 164.29 13.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.202 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.926 ' O ' HG13 ' A' ' 76' ' ' VAL . 6.0 tt0 -109.92 -121.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.626 -1.296 . . . . 0.0 109.608 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.74 170.5 18.58 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.385 -0.822 . . . . 0.0 111.325 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.5 OUTLIER -139.82 139.92 36.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.707 ' CE1' HG22 ' A' ' 51' ' ' THR . 21.1 m-85 -126.36 142.75 51.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.59 -1.244 . . . . 0.0 113.138 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 2.3 t0 -121.7 117.19 26.02 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.065 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -89.85 -45.1 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.0 -7.04 43.5 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -119.05 -27.19 5.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.749 -0.594 . . . . 0.0 110.186 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.0 m-20 70.19 16.98 7.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 12.4 mmm-85 -113.53 129.77 56.49 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.671 -0.643 . . . . 0.0 109.491 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.7 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.02 129.39 56.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 110.541 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.757 HG21 ' HD2' ' A' ' 33' ' ' LYS . 12.6 mt -123.22 149.8 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.618 -0.676 . . . . 0.0 109.792 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 64' ' ' GLN . 75.3 t -112.84 139.19 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.981 -1.074 . . . . 0.0 109.19 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.653 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 17.5 m120 -65.63 141.63 58.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.862 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.24 138.83 9.56 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.38 131.5 35.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 1.087 ' CE1' HD13 ' A' ' 61' ' ' LEU . 39.8 m80 -141.7 126.34 17.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.645 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 82' ' ' ALA . 3.8 tp10 -100.89 151.07 22.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.583 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 81' ' ' GLU . . . -52.1 -43.67 64.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 110.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -58.55 -38.25 77.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.955 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -39.55 78.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 21' ' ' LEU . 21.3 mt -60.4 -40.76 92.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.474 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 1.6 tt0 -59.19 -36.36 75.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 2.6 m-20 -68.81 -46.61 68.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.918 . . . . 0.0 109.96 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 13.4 ttp -71.84 -41.0 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.401 -0.812 . . . . 0.0 110.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.3 mt -51.96 -28.73 17.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 73.3 m-20 -56.17 -46.28 79.4 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.937 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.498 ' O ' ' CG ' ' A' ' 94' ' ' LYS . . . -66.92 -32.53 81.23 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 12.4 t80 -58.04 -40.05 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 110.24 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.006 ' O ' HG13 ' A' ' 97' ' ' VAL . 1.4 mp -53.43 -33.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.579 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.5 ptmt -54.91 -26.26 34.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 110.255 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.32 -28.05 67.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.389 -0.819 . . . . 0.0 111.687 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.932 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 5.9 p90 -115.18 -20.21 10.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.662 -1.274 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.006 HG13 ' O ' ' A' ' 93' ' ' ILE . 5.3 m -55.76 -19.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.828 -1.17 . . . . 0.0 109.925 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.684 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -55.53 89.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' H ' ' CB ' ' A' ' 103' ' ' GLU . 75.2 m -82.64 155.11 68.6 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.11 39.86 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.988 1.52 . . . . 0.0 110.757 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -137.01 -53.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.116 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.505 ' HB2' ' CB ' ' A' ' 124' ' ' ALA . 4.5 p 175.05 54.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.592 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' HG2' HG23 ' A' ' 97' ' ' VAL . 8.5 tp10 -79.82 -19.42 48.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 0.0 109.947 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.587 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -30.36 -55.26 0.36 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.403 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 42.8 Cg_endo -70.02 150.52 66.74 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.967 1.509 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -68.49 111.19 4.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.97 . . . . 0.0 110.147 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 105' ' ' PRO . 1.5 p -110.19 166.47 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.494 -0.754 . . . . 0.0 110.213 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.7 p30 -113.91 142.87 45.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.911 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.852 HD23 ' OD1' ' A' ' 120' ' ' ASN . 1.4 mp -106.08 145.42 31.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.364 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.518 ' NE2' ' HA3' ' A' ' 119' ' ' GLY . 11.6 p-80 -124.18 117.29 24.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.02 ' HB ' HD12 ' A' ' 118' ' ' ILE . 5.8 p -118.02 129.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.55 ' HB2' ' CD ' ' A' ' 115' ' ' LYS . 9.6 m120 -103.95 122.8 43.15 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 110.409 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.29 -33.92 6.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.039 1.547 . . . . 0.0 110.558 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.216 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 112' ' ' ASN . 1.9 ptpt -106.89 -1.71 22.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.948 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 53.64 53.37 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 146.31 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 1.02 HD12 ' HB ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -112.96 128.42 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.279 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -99.47 163.87 19.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.852 ' OD1' HD23 ' A' ' 109' ' ' LEU . 4.8 t30 -138.53 121.86 17.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -1.177 . . . . 0.0 109.756 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 30.0 t -125.27 130.57 52.31 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 110.702 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.492 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 74.0 m -113.06 133.0 55.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 109.903 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -84.16 44.32 1.01 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.552 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -129.19 -29.06 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 110.215 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 7.56 1.76 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 110.534 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.673 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.61 -12.3 59.49 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.673 ' C ' ' O ' ' A' ' 126' ' ' GLY . 7.4 t80 -12.13 -64.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.729 -0.866 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.612 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 7.7 tmm_? 21.75 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.882 -0.511 . . . . 0.0 111.193 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.32 -111.53 0.28 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.878 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.537 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -120.66 151.85 38.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.485 -1.009 . . . . 0.0 110.692 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.688 HD23 ' C ' ' A' ' 131' ' ' LEU . 4.7 tt -97.83 107.55 20.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 109.823 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 133' ' ' THR . 9.3 m-20 -112.58 -84.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.514 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 0.8 OUTLIER 70.41 -175.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.036 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.494 ' H ' HG22 ' A' ' 133' ' ' THR . 0.2 OUTLIER -70.88 155.29 40.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 63.3 m170 54.87 176.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -100.12 82.07 2.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.896 HD21 ' CE1' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -82.32 -5.62 58.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.729 ' HA ' HD11 ' A' ' 141' ' ' ILE . 57.9 m -62.69 -38.49 90.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 0.0 110.299 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.5 p -68.64 -40.32 80.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -59.02 -48.77 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.729 HD11 ' HA ' ' A' ' 138' ' ' CYS . 6.7 pt -69.17 -42.09 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.57 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD23 HG21 ' A' ' 111' ' ' VAL . 10.6 mt -53.26 -20.5 4.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.825 . . . . 0.0 110.32 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -86.07 -20.34 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.191 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.47 59.42 43.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.263 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.628 ' HB3' HG11 ' A' ' 111' ' ' VAL . 46.2 Cg_endo -72.96 169.56 21.87 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.041 1.548 . . . . 0.0 110.445 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.426 ' HB3' ' HD2' ' A' ' 155' ' ' LYS . 46.2 Cg_endo -72.94 -18.18 24.59 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.02 1.537 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 52.94 85.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 110.165 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.65 105.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.5 p -106.72 123.46 48.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -129.99 -160.86 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -90.53 137.74 32.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.127 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.93 -87.5 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 81.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -93.23 -49.76 2.55 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -109.63 -61.28 1.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 110.212 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.237 0.541 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t -128.6 -148.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.219 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -83.62 -43.12 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.458 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p30 -88.48 133.47 34.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 6' ' ' ASN . 39.4 t -71.69 -27.08 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.724 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.5 m-20 60.38 121.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.519 ' HG3' ' N ' ' A' ' 8' ' ' SER . 8.1 ptp180 -69.94 -32.67 71.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.237 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 10' ' ' MET . 1.1 m -94.1 -13.77 26.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 110.115 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.744 HG12 ' N ' ' A' ' 10' ' ' MET . 44.9 t 34.8 -94.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.483 -0.761 . . . . 0.0 110.568 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.744 ' N ' HG12 ' A' ' 9' ' ' VAL . 8.6 ptt? -53.02 148.02 8.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.17 154.22 23.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.088 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -82.46 -13.57 56.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.893 . . . . 0.0 110.276 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -61.12 -22.82 65.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' ' N ' ' A' ' 15' ' ' ARG . 10.5 t80 -137.02 -91.57 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 0.0 110.236 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.708 HH22 HG22 ' A' ' 153' ' ' THR . 12.1 ttt180 65.36 -63.12 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' TYR . 51.5 p90 -104.79 151.77 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.314 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -132.8 162.08 32.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 110.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 1.3 mtt -144.48 150.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.198 -0.938 . . . . 0.0 110.205 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 46.4 Cg_endo -72.99 -29.88 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.538 . . . . 0.0 110.462 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 67.27 148.9 0.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.258 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.65 140.28 30.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 22' ' ' ILE . 27.8 mm -121.97 143.82 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.975 ' O ' HG12 ' A' ' 35' ' ' VAL . 7.9 mttt -139.41 138.08 36.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 0.0 110.148 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 79' ' ' SER . 46.5 t -93.53 122.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.33 133.24 27.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.374 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . 148.52 -86.99 0.15 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -152.63 174.9 13.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -1.126 . . . . 0.0 110.231 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.42 -35.1 68.61 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -99.91 -18.63 17.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -1.162 . . . . 0.0 110.253 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -67.59 -50.57 42.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.7 mm 57.66 92.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -1.115 . . . . 0.0 110.293 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.53 141.93 50.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' NE2' ' A' ' 80' ' ' HIS . 1.4 m -96.88 127.87 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 24' ' ' LYS . 3.5 p -117.04 118.02 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.956 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 39' ' ' MET . 8.1 mt -95.39 138.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.329 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.611 HG22 ' NH1' ' A' ' 73' ' ' ARG . 28.8 t -100.31 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.48 12.25 37.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -53.35 -33.43 53.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -68.83 -38.41 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -50.21 72.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 43' ' ' ALA . 10.1 p -65.84 -40.82 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.814 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -64.98 -34.92 79.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.203 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.47 85.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.96 63.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.071 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.912 ' O ' HD23 ' A' ' 46' ' ' LEU . 10.3 tt -92.57 -3.32 55.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.8 m-20 72.61 -62.41 0.47 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.815 . . . . 0.0 110.364 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.616 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 169.86 19.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.48 147.15 45.82 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.0 Cg_endo -73.92 -23.4 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.997 1.525 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.038 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 72.5 p -57.85 -21.81 44.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.0 m-30 -80.14 -58.37 0.6 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.893 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.27 -30.94 15.06 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.837 1.44 . . . . 0.0 111.045 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 51' ' ' THR . 9.7 t -57.99 -14.01 5.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.993 . . . . 0.0 110.3 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 13.1 tptm -64.25 -45.38 88.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.952 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -64.83 -38.77 92.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.304 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.57 -35.31 85.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -37.32 71.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' OE2' ' CZ ' ' A' ' 92' ' ' PHE . 3.1 mm-40 -66.68 -49.54 65.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.23 -0.919 . . . . 0.0 110.622 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.061 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -79.92 12.87 2.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.189 -0.945 . . . . 0.0 110.961 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.25 9.38 29.48 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.061 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -118.74 163.95 16.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -1.122 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.4 mt-30 -105.36 -117.29 0.23 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.833 -1.167 . . . . 0.0 110.144 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.0 170.37 18.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 111.081 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HG3' ' HE3' ' A' ' 33' ' ' LYS . 1.1 mm-40 -144.88 139.65 27.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.038 ' CZ ' HG22 ' A' ' 51' ' ' THR . 24.7 m-85 -126.67 143.46 51.22 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.001 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -123.69 117.37 24.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.969 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -88.11 -45.8 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -70.0 -7.6 42.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -118.32 -25.92 6.43 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.687 -0.633 . . . . 0.0 110.207 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.6 m-20 68.74 16.17 8.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.611 ' NH1' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.86 129.79 56.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.525 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.9 m-30 -112.89 129.2 56.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.669 HG12 HG23 ' A' ' 35' ' ' VAL . 52.8 mt -118.57 149.17 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.521 -0.737 . . . . 0.0 109.966 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.2 p -113.15 134.15 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.061 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 65.5 m-80 -50.63 143.4 9.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.772 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 94.44 131.28 6.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.57 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 59.4 p -97.3 120.29 37.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -1.152 . . . . 0.0 110.106 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.886 ' NE2' HG21 ' A' ' 34' ' ' THR . 1.8 p-80 -142.38 151.52 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.787 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 4.8 tt0 -93.0 157.69 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.951 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.3 -43.8 64.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.68 -33.47 76.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.77 -37.33 86.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.191 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.2 mp -60.09 -33.02 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 16.9 tt0 -68.07 -36.22 79.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.846 . . . . 0.0 109.641 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.17 -46.4 74.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.638 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.598 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 3.4 ptm -69.9 -48.09 59.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.083 -1.011 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.604 ' HA ' ' CD2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -54.33 -32.57 56.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 108.613 179.131 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -63.68 -35.98 82.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.267 0.556 . . . . 0.0 110.091 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.78 -37.38 94.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 5.8 m-30 -63.87 -40.75 97.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.222 -1.164 . . . . 0.0 109.852 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.784 HG12 HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -55.13 -44.14 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.72 -28.02 63.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 110.62 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -61.74 -42.81 99.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.93 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.962 ' CE2' HD22 ' A' ' 137' ' ' LEU . 8.7 p90 -116.46 -25.4 7.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.873 -1.142 . . . . 0.0 110.654 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG12 ' CD2' ' A' ' 98' ' ' LEU . 16.0 t -82.66 -55.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.73 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.803 ' CD2' HG12 ' A' ' 97' ' ' VAL . 3.6 mm? -112.38 57.02 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.389 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -78.41 151.5 77.86 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.871 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.536 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 44.9 Cg_endo -72.3 1.17 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.91 1.479 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' C ' ' SG ' ' A' ' 102' ' ' CYS . 24.5 tt0 -75.39 -63.91 1.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.198 -0.939 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 62.8 m -148.55 4.95 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 24.2 mp0 -78.75 -14.85 59.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.587 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 3.0 m120 -29.43 -55.58 0.29 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.732 -0.605 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 42.5 Cg_endo -68.86 150.48 73.6 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.16 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 116.43 9.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.172 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 122' ' ' CYS . 1.2 p -110.21 166.33 11.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.408 -0.808 . . . . 0.0 110.123 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.485 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -113.61 154.4 27.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 110.008 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.791 ' N ' HD12 ' A' ' 109' ' ' LEU . 5.6 mp -105.96 138.15 42.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.471 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -124.09 115.26 20.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.798 HG23 ' CD1' ' A' ' 118' ' ' ILE . 4.0 p -97.19 124.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 110.309 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -90.01 122.68 67.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.34 -30.03 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.997 1.525 . . . . 0.0 110.477 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -66.83 -42.15 86.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -102.87 -3.92 25.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 52.53 38.1 24.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -118.06 179.6 4.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.798 ' CD1' HG23 ' A' ' 111' ' ' VAL . 12.7 mm -128.04 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.312 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 129' ' ' GLY . . . -147.66 123.88 1.81 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.7 p-10 -144.65 120.88 10.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.285 . . . . 0.0 108.967 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.604 ' CB ' ' HA ' ' A' ' 128' ' ' ARG . 1.2 m -116.89 156.43 27.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.157 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 124' ' ' ALA . 25.8 p -87.64 134.64 33.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.435 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 122' ' ' CYS . 4.8 tttt -27.28 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.769 -0.582 . . . . 0.0 111.446 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 122' ' ' CYS . . . -61.75 -15.33 40.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.76 ' O ' ' N ' ' A' ' 127' ' ' TYR . 9.0 m 68.18 -48.21 0.54 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -0.976 . . . . 0.0 110.21 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' ALA . . . -34.6 -12.78 0.0 OUTLIER Glycine 0 N--CA 1.496 2.649 0 O-C-N 121.826 -0.546 . . . . 0.0 112.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.802 ' O ' ' HD1' ' A' ' 127' ' ' TYR . 0.7 OUTLIER -145.37 99.42 3.3 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.539 -1.565 . . . . 0.0 110.325 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.604 ' HA ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -86.65 123.86 32.29 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.617 ' O ' ' HA2' ' A' ' 119' ' ' GLY . . . -81.41 51.85 4.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.66 121.76 27.26 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.555 -0.968 . . . . 0.0 110.106 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.92 HD13 ' SG ' ' A' ' 138' ' ' CYS . 2.4 mt -113.64 142.15 46.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.509 -0.745 . . . . 0.0 110.369 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.54 -24.38 4.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.7 p -57.66 -179.52 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' A' ' 135' ' ' HIS . 86.8 m-70 -146.44 69.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 134' ' ' HIS . 11.3 p80 176.23 33.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.7 OUTLIER -138.94 -177.55 4.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.962 HD22 ' CE2' ' A' ' 96' ' ' PHE . 1.3 tt -42.05 -26.24 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.92 ' SG ' HD13 ' A' ' 131' ' ' LEU . 53.0 m -56.3 -40.07 73.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.9 m -68.73 -41.51 78.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.441 ' CE2' ' CZ ' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -56.88 -48.05 79.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.663 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.664 HD11 HG21 ' A' ' 118' ' ' ILE . 18.4 pt -68.55 -42.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 111' ' ' VAL . 45.1 tp -53.4 -29.95 37.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.543 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -109.09 -1.48 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 141' ' ' ILE . 4.9 p-10 -51.79 143.89 20.67 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.932 . . . . 0.0 110.302 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 163.41 37.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.008 1.531 . . . . 0.0 110.341 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 -177.59 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.951 1.501 . . . . 0.0 110.456 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.11 23.08 8.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 149' ' ' SER . 1.0 OUTLIER 54.91 -172.47 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.23 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER 59.48 162.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 149' ' ' SER . 5.1 t0 55.36 104.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 m 60.98 162.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 110.221 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 117.38 -10.34 14.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.708 HG22 HH22 ' A' ' 15' ' ' ARG . 64.0 p -76.24 82.97 3.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -1.122 . . . . 0.0 110.194 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -163.2 154.72 25.76 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -131.86 -51.91 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.205 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.164 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.277 0.561 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 155.43 17.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.242 -0.912 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 4' ' ' ASN . 8.6 p -133.95 -37.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.498 ' N ' HG13 ' A' ' 3' ' ' VAL . 73.3 m-80 -75.91 106.17 7.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -58.55 -22.54 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.66 91.05 8.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -69.11 -20.29 64.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.428 ' O ' ' SD ' ' A' ' 10' ' ' MET . 76.7 p -93.21 7.96 42.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 9' ' ' VAL . 11.9 p -43.14 134.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 8' ' ' SER . 3.2 mpp? -112.14 -169.85 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 22.2 p-10 -86.96 114.31 23.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 14.1 mm100 -70.46 -20.26 62.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.89 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' CG ' ' O ' ' A' ' 13' ' ' PHE . 12.9 t80 43.54 41.07 3.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.135 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -140.43 5.53 2.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' HB2' ' CE1' ' A' ' 14' ' ' TYR . 1.8 ttt-85 -133.33 -49.88 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -100.03 139.22 36.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.219 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.37 159.19 32.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 18' ' ' MET . 2.1 ppp? -102.81 115.43 64.25 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.15 -155.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.971 1.511 . . . . 0.0 110.263 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mmt85 -91.78 -165.51 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.93 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 5.7 tt -65.03 133.85 52.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.19 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.2 mt -112.4 143.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.781 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.37 123.98 40.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.898 . . . . 0.0 110.385 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 138.2 53.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 74.6 t -93.11 122.32 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.409 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HB3' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.17 153.66 45.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.389 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.92 -81.07 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -152.61 153.23 32.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -1.088 . . . . 0.0 110.126 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.7 -5.56 89.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.02 -16.03 18.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.144 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . -109.59 -114.36 3.64 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.009 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER 156.43 108.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.854 -0.792 . . . . 0.0 109.547 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -126.88 152.65 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -0.956 . . . . 0.0 110.502 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -108.06 116.24 31.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.133 -0.98 . . . . 0.0 110.373 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 HD12 ' A' ' 75' ' ' ILE . 48.6 t -104.08 117.46 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.758 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.9 mm -96.02 108.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.41 -23.53 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.663 ' OD1' HG23 ' A' ' 42' ' ' VAL . 46.2 t30 -95.93 8.79 42.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.545 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.9 ttt -64.12 -45.29 89.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 17.9 t -67.24 -40.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -45.26 70.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.661 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.663 HG23 ' OD1' ' A' ' 38' ' ' ASN . 80.4 t -68.29 -48.73 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -67.45 -43.96 79.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.393 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 7.8 ttpt -59.54 -36.48 76.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.095 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.21 -16.5 62.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.942 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -117.39 -11.17 10.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.149 -0.969 . . . . 0.0 110.078 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.737 ' CB ' HD13 ' A' ' 46' ' ' LEU . 13.6 t-20 167.02 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.237 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.068 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -137.67 172.07 7.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.08 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -72.72 139.51 30.9 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.031 1.543 . . . . 0.0 110.629 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.932 ' O ' HG23 ' A' ' 54' ' ' THR . 47.2 Cg_endo -72.76 60.34 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.042 1.548 . . . . 0.0 110.394 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -68.73 -50.53 50.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 111.332 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.762 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 p90 -87.33 -29.0 0.38 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.351 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.3 Cg_endo -71.29 -2.18 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.07 1.037 . . . . 0.0 110.755 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.932 HG23 ' O ' ' A' ' 50' ' ' PRO . 2.9 p -76.46 -10.99 59.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.106 -0.996 . . . . 0.0 110.372 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -72.94 -45.42 58.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 0.0 110.58 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.53 -47.78 77.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 110.392 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.46 -42.8 83.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.859 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.52 -35.44 85.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -37.21 71.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -1.196 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -48.79 68.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.879 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.028 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -80.72 12.83 2.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.107 -0.995 . . . . 0.0 110.95 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.47 5.44 22.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.48 163.93 15.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -1.133 . . . . 0.0 109.213 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' C ' ' CG2' ' A' ' 65' ' ' THR . 19.6 mt-30 -102.87 -119.56 0.19 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.634 -1.292 . . . . 0.0 109.998 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -149.5 170.41 18.67 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 111.005 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.559 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.9 mt-30 -146.01 139.47 26.14 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.69 144.53 50.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.876 -1.14 . . . . 0.0 112.748 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.587 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 1.9 t0 -124.01 117.42 24.69 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.323 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 15.2 m -88.91 -46.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 2.5 tppt? -69.75 -8.73 50.52 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -117.17 -26.76 6.68 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.677 -0.639 . . . . 0.0 110.124 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 4.7 m-20 69.8 16.53 7.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.587 ' HG3' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.87 129.66 56.57 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 109.643 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.755 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.18 129.18 56.59 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.417 -0.802 . . . . 0.0 110.5 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.934 HD12 HG22 ' A' ' 35' ' ' VAL . 2.3 tt -124.12 148.34 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.487 -0.758 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 34' ' ' THR . 11.0 m -114.35 139.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.7 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.072 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 70.6 m-20 -55.74 146.36 21.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.5 150.78 21.87 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . 1.009 ' OG ' HD12 ' A' ' 32' ' ' ILE . 2.7 p -103.92 123.92 48.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -1.173 . . . . 0.0 110.202 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 1.019 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.19 114.84 8.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.781 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 4.9 tt0 -74.74 156.54 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.605 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.7 -44.19 63.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.077 -1.014 . . . . 0.0 109.74 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -65.09 -33.14 75.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.22 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 88' ' ' MET . 29.8 mttt -71.35 -36.47 71.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.638 -0.663 . . . . 0.0 110.475 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 81' ' ' GLU . 1.2 mm? -59.37 -44.23 92.77 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.227 -0.921 . . . . 0.0 110.144 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -68.62 -36.12 78.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.948 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 37.8 t0 -64.87 -46.12 83.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 111.297 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.601 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 3.2 ptm -57.94 -48.63 79.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.174 . . . . 0.0 110.681 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.601 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.7 OUTLIER -57.57 -33.06 67.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 0.0 108.554 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -64.33 -45.08 89.44 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.34 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 95' ' ' LYS . . . -61.89 -44.59 97.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -51.82 66.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -1.199 . . . . 0.0 110.013 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.842 ' O ' HG22 ' A' ' 97' ' ' VAL . 17.1 mt -65.43 -50.6 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -61.32 -27.28 68.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 110.608 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 91' ' ' GLY . 9.9 mmtp -60.75 -37.26 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 111.381 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.877 ' CE1' HG12 ' A' ' 97' ' ' VAL . 18.7 p90 -115.34 -19.07 10.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 111.455 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.877 HG12 ' CE1' ' A' ' 96' ' ' PHE . 4.4 m -84.29 -8.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.813 -1.179 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.854 HD12 ' CD ' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -58.59 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.126 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.563 ' H ' ' HB3' ' A' ' 103' ' ' GLU . 99.0 m -87.99 155.06 52.7 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.252 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.44 2.91 5.2 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.087 1.572 . . . . 0.0 110.207 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.627 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.1 mm-40 -98.25 18.24 16.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.1 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER 78.7 44.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.491 -0.755 . . . . 0.0 110.287 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.854 ' CD ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -43.87 -24.14 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.753 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 2.6 m-20 16.93 -76.66 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 122.039 -0.413 . . . . 0.0 111.916 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.753 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 39.2 Cg_endo -64.93 150.17 88.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 110.507 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -68.66 129.47 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.08 -1.012 . . . . 0.0 110.261 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 121' ' ' SER . 1.3 p -110.2 166.17 11.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 110.161 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -114.07 151.83 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.893 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.642 HD23 ' CZ ' ' A' ' 96' ' ' PHE . 3.2 pp -119.36 149.54 41.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.595 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 50.1 m-70 -124.11 119.48 29.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 109.993 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.867 HG23 HG12 ' A' ' 118' ' ' ILE . 8.2 p -101.75 129.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 116' ' ' GLN . 1.4 t-20 -101.2 124.88 39.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.17 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HG3' ' O ' ' A' ' 147' ' ' GLU . 46.2 Cg_endo -73.19 -31.62 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.974 1.513 . . . . 0.0 110.533 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.507 ' NZ ' ' HB2' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -73.44 -33.76 65.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 114' ' ' LYS . 6.6 tttm -108.67 -3.68 17.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.279 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER 52.56 38.52 25.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.883 . . . . 0.0 110.223 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -121.14 159.6 25.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.158 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.867 HG12 HG23 ' A' ' 111' ' ' VAL . 9.1 mt -126.51 126.25 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 109' ' ' LEU . . . -103.57 163.97 15.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.991 ' HB2' HD12 ' A' ' 131' ' ' LEU . 9.6 t-20 -143.62 129.56 19.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.257 . . . . 0.0 109.941 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 9.7 p -117.11 124.67 49.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -0.965 . . . . 0.0 110.272 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 125' ' ' CYS . 30.2 p -107.44 134.45 50.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.815 . . . . 0.0 109.934 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 122' ' ' CYS . 6.0 tttt -37.33 -28.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.596 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 125' ' ' CYS . . . -72.03 -27.84 62.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.232 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 122' ' ' CYS . 5.9 m 73.45 -46.08 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.62 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.638 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.9 OUTLIER -109.79 -33.14 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 110.547 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -28.29 125.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.623 -0.673 . . . . 0.0 110.866 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.53 -90.38 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.632 -1.271 . . . . 0.0 109.946 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.516 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -119.76 151.56 38.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -1.155 . . . . 0.0 110.523 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -71.98 142.55 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.116 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -36.2 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 110.507 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -172.38 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 110.354 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.495 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 45.5 m170 -88.42 -135.42 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER 68.26 -60.38 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.109 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -68.87 -177.62 1.04 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 110.067 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 96' ' ' PHE . 1.1 pp -52.6 -14.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.393 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' HD21 ' A' ' 131' ' ' LEU . 56.4 m -56.06 -42.41 76.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.984 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -69.1 -39.36 79.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.607 ' CE2' ' ND2' ' A' ' 144' ' ' ASN . 8.7 t80 -56.89 -48.45 78.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -0.936 . . . . 0.0 109.745 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 138' ' ' CYS . 9.4 pt -66.12 -41.48 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.785 ' C ' HD13 ' A' ' 142' ' ' LEU . 2.9 tm? -54.25 -29.56 47.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.355 -0.841 . . . . 0.0 110.59 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -109.42 -36.86 5.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.442 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.746 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 2.4 m-20 -60.25 -76.1 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.921 -1.112 . . . . 0.0 110.573 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.746 ' CD ' ' CB ' ' A' ' 144' ' ' ASN . 43.1 Cg_endo -68.4 109.24 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.492 1.259 . . . . 0.0 110.515 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 49.1 Cg_endo -76.39 64.77 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.992 1.522 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.53 ' CB ' HG13 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -40.53 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.394 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 149' ' ' SER . 5.2 m-20 -148.19 155.6 41.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 148' ' ' ASN . 1.6 t 43.38 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.74 54.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.8 m -96.75 -79.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.44 -64.82 0.18 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.81 -88.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.154 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 118.42 115.85 2.68 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.24 179.1 6.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 110.225 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 30.2 mtmm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.212 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.286 0.565 . . . . 0.0 110.243 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER 67.12 -58.52 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.579 ' O ' HD12 ' A' ' 1' ' ' LEU . 76.2 t -65.73 122.62 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -87.03 175.78 7.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 37.9 t -69.17 -33.89 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 6.5 m-80 58.41 122.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -83.95 -13.37 53.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 10' ' ' MET . 53.9 t 54.65 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 110.233 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.488 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER 43.12 -150.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.176 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 128.41 36.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.575 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 6.8 mp0 -78.35 -40.86 35.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 12' ' ' GLN . 0.2 OUTLIER 69.75 99.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -144.55 -99.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.145 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.23 -37.18 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.8 p90 -101.15 130.55 47.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 7.0 tttp -123.24 162.32 22.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.332 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 36.5 mtm -106.36 91.44 5.76 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.205 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 46.3 Cg_endo -73.01 -52.24 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.922 1.485 . . . . 0.0 110.441 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 -73.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.91 122.65 38.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.913 . . . . 0.0 110.175 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 37' ' ' VAL . 3.0 tt -128.5 136.1 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 34' ' ' THR . . . -125.8 135.44 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 110.23 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.773 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.16 137.47 52.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.7 m -100.27 135.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -112.62 164.47 13.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 61.99 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 4.6 tttt -152.41 160.38 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -1.146 . . . . 0.0 110.154 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.02 -118.06 4.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.55 -18.48 35.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.13 . . . . 0.0 110.439 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' C ' ' CG1' ' A' ' 32' ' ' ILE . . . 143.67 -21.46 2.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.673 HD13 ' OG ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -167.77 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -1.168 . . . . 0.0 110.59 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 6.2 mtmm -98.35 142.14 30.36 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.683 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.572 ' C ' HG23 ' A' ' 75' ' ' ILE . 1.9 m -96.97 115.93 28.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.636 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.4 p -105.14 117.83 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.953 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 92.0 mt -95.66 112.87 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.644 HG22 HG23 ' A' ' 22' ' ' ILE . 28.6 m -83.52 -4.88 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.04 -0.29 47.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.275 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -53.32 -42.41 66.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.133 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.43 -40.4 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.24 -47.81 75.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' O ' HD23 ' A' ' 46' ' ' LEU . 84.1 t -62.77 -44.73 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -56.4 -35.06 67.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -36.49 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.95 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.28 78.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.243 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.848 HD11 ' O ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -104.49 0.87 29.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.0 t-20 73.17 -53.48 0.7 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.664 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.848 ' O ' HD11 ' A' ' 46' ' ' LEU . 4.5 ttt-85 -76.93 147.83 77.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.11 147.31 37.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.988 1.52 . . . . 0.0 110.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 48.8 Cg_endo -75.44 7.54 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.078 1.567 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.215 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -63.01 -37.97 89.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 110.421 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -69.85 -52.28 13.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 110.586 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.8 Cg_endo -70.37 -16.25 34.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.81 1.426 . . . . 0.0 110.462 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.692 HG22 ' CG2' ' A' ' 65' ' ' THR . 1.4 m -71.6 -19.42 62.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.104 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -73.0 -44.96 60.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.517 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 70.7 m-85 -66.84 -45.02 79.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.419 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 53' ' ' PRO . 23.4 m-85 -57.36 -43.97 83.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.801 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.44 -35.21 84.33 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 84.7 m -56.83 -37.38 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.25 . . . . 0.0 110.108 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.99 -48.21 66.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.867 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.014 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.8 10.84 2.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -0.992 . . . . 0.0 111.005 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.85 40.13 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.014 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -114.21 163.67 14.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -1.156 . . . . 0.0 109.503 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.7 tt0 -107.78 -118.49 0.26 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.777 -1.202 . . . . 0.0 109.915 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.692 ' CG2' HG22 ' A' ' 54' ' ' THR . 2.6 p -149.32 170.17 19.14 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 111.148 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -144.42 139.18 28.23 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.215 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.1 m-85 -127.19 142.48 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.712 -1.242 . . . . 0.0 113.032 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -125.24 117.38 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.908 178.151 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 t -84.78 -64.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -17.16 4.56 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.557 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.6 m-80 -102.12 -31.49 10.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 110.102 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.3 m-20 70.27 15.59 7.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -113.7 129.8 56.52 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.565 -0.709 . . . . 0.0 109.718 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.4 m-30 -112.86 129.29 56.51 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 35' ' ' VAL . 17.8 mt -120.83 149.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 110.285 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 13.4 m -112.96 129.17 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.755 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 28.1 m-20 -48.25 144.51 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.884 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 97.71 146.4 20.7 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.673 ' OG ' HD13 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -102.04 126.07 48.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -1.027 . . . . 0.0 109.889 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -141.94 156.68 45.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 2.3 tt0 -103.99 148.66 25.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 109.81 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.28 -39.74 60.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 1.6 t30 -64.28 -33.36 75.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -37.5 71.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 17.3 mt -63.39 -44.66 94.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 3.8 pt20 -68.24 -36.15 79.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 7.8 m-20 -68.8 -41.61 78.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -0.809 . . . . 0.0 110.218 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.1 ttp -71.19 -50.01 37.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -54.69 -30.41 55.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.616 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . 0.4 OUTLIER -62.38 -35.84 80.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.68 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.86 -43.48 99.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -51.04 46.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -1.18 . . . . 0.0 110.556 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.904 ' O ' HG13 ' A' ' 97' ' ' VAL . 2.8 pp -64.41 -36.64 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.881 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -54.98 -27.95 47.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.145 -0.972 . . . . 0.0 110.361 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.692 ' O ' HD21 ' A' ' 98' ' ' LEU . 22.5 mttm -62.72 -38.62 91.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 111.733 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 7.4 p90 -115.61 -17.48 11.13 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.8 -1.188 . . . . 0.0 112.129 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 93' ' ' ILE . 20.0 m -68.81 -50.18 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.585 -1.322 . . . . 0.0 110.806 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 95' ' ' LYS . 1.3 mm? 33.43 100.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.348 -0.845 . . . . 0.0 110.78 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.523 ' SG ' HG21 ' A' ' 107' ' ' THR . 0.1 OUTLIER -64.79 152.22 90.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.939 . . . . 0.0 110.297 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HG2' ' CE2' ' A' ' 127' ' ' TYR . 45.5 Cg_endo -72.48 -1.62 10.53 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -85.0 -58.17 2.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 104' ' ' ASN . 3.0 p -176.35 23.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.622 ' HG2' HD12 ' A' ' 98' ' ' LEU . 8.6 tp10 38.41 35.34 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.618 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 3.4 m-20 -93.98 -64.47 0.13 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.026 -1.046 . . . . 0.0 110.622 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.919 ' HG3' ' HB2' ' A' ' 124' ' ' ALA . 46.8 Cg_endo -72.78 149.6 48.48 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.782 1.411 . . . . 0.0 110.546 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.86 114.81 8.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.0 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.523 HG21 ' SG ' ' A' ' 99' ' ' CYS . 6.3 p -110.13 159.47 17.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -123.48 147.59 47.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 110' ' ' HIS . 4.2 tt -105.95 128.81 54.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.84 ' N ' HD23 ' A' ' 109' ' ' LEU . 20.7 p-80 -124.28 115.55 21.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.251 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.877 HG23 HG12 ' A' ' 118' ' ' ILE . 3.5 p -96.91 122.9 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -90.71 122.55 66.84 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.44 -39.49 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.085 1.571 . . . . 0.0 110.476 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -42.26 91.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -92.64 -3.82 54.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.471 ' O ' HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 52.46 42.12 31.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.79 175.94 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.877 HG12 HG23 ' A' ' 111' ' ' VAL . 3.3 mt -123.2 136.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -116.13 160.66 13.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.748 ' ND2' HD13 ' A' ' 131' ' ' LEU . 1.5 t30 -143.74 121.76 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -1.124 . . . . 0.0 109.724 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 88.8 p -118.6 133.5 55.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 110.425 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 105' ' ' PRO . 5.1 t -110.25 133.83 52.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 110.201 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 123' ' ' LYS . 4.7 ptmt -83.36 42.19 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.919 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -124.51 -26.46 3.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 110.288 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 43.4 t -149.94 10.53 0.71 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.791 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.16 -12.24 58.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.65 ' C ' ' O ' ' A' ' 126' ' ' GLY . 9.2 t80 -11.05 -64.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.767 -0.843 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 19.6 ttt180 24.09 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.824 -0.547 . . . . 0.0 110.964 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -162.34 -108.32 0.22 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.07 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.535 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.06 151.65 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -1.052 . . . . 0.0 110.559 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.748 HD13 ' ND2' ' A' ' 120' ' ' ASN . 31.9 tp -91.25 107.45 19.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 133' ' ' THR . 14.6 m-20 61.11 5.47 1.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.546 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.605 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 48.6 m 60.32 -75.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 0.0 110.059 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 133' ' ' THR . 12.2 m80 -165.25 62.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.201 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -156.73 18.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -139.06 -177.62 4.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.299 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.496 ' O ' HG12 ' A' ' 141' ' ' ILE . 5.5 tp -43.9 -24.11 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.603 ' O ' HG12 ' A' ' 141' ' ' ILE . 1.1 p -55.74 -50.86 69.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.928 HG21 ' HG3' ' A' ' 147' ' ' GLU . 3.4 m -64.32 -36.49 84.29 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.634 ' HA ' ' O ' ' A' ' 145' ' ' PRO . 5.4 t80 -62.52 -48.39 79.75 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.651 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 138' ' ' CYS . 29.9 pt -68.91 -40.74 81.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 109.535 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' N ' HG13 ' A' ' 141' ' ' ILE . 15.8 tp -52.55 -47.53 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.471 -0.768 . . . . 0.0 111.005 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.738 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -110.18 -38.61 5.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.8 -1.187 . . . . 0.0 110.737 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.738 ' CB ' ' O ' ' A' ' 143' ' ' LYS . 4.1 m-20 142.21 -70.97 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 144' ' ' ASN . 48.9 Cg_endo -73.58 165.8 31.44 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.683 1.359 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.88 -161.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.994 1.523 . . . . 0.0 110.523 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.928 ' HG3' HG21 ' A' ' 139' ' ' THR . 1.4 tm-20 -129.7 -166.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.71 -166.04 2.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.24 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.0 p -97.44 108.57 21.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.25 -172.15 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 153' ' ' THR . 0.6 OUTLIER 59.85 104.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -45.61 99.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 151' ' ' SER . 9.8 t -64.38 -16.67 62.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.151 . . . . 0.0 110.224 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.18 161.77 25.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -136.8 -167.28 2.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -1.141 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.199 0.523 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 p -123.76 -161.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.34 -17.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -93.38 116.48 29.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.155 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.5 -40.93 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -129.41 82.24 2.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.27 -18.01 23.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -89.89 7.25 38.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 8' ' ' SER . 4.8 p -43.6 -34.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -114.17 -28.93 7.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.276 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 14' ' ' TYR . 5.3 t0 -89.37 110.63 21.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -69.86 -40.46 75.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 12' ' ' GLN . 12.8 m-85 -147.78 -45.61 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.847 ' O ' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 71.37 -5.66 1.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' TYR . 10.0 ptp180 -33.16 -21.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.15 -0.969 . . . . 0.0 111.833 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.726 ' N ' ' O ' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -137.0 132.39 34.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.942 -1.098 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -133.32 130.06 38.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.2 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.2 ttt -121.35 91.29 48.18 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 48.3 Cg_endo -76.17 -156.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.975 1.513 . . . . 0.0 110.363 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' PRO . 5.2 ttt85 70.29 94.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.8 tm? -95.81 125.24 40.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.029 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.628 ' N ' HD22 ' A' ' 21' ' ' LEU . 28.8 mt -103.25 133.52 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -125.53 131.08 52.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' VAL . 5.2 tttt -116.57 138.21 51.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 25' ' ' VAL . 17.9 m -93.24 135.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -124.09 163.36 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . 43.82 65.63 1.52 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HA ' HD13 ' A' ' 32' ' ' ILE . 3.5 tmtt? -91.46 140.62 29.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -1.143 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.02 -36.18 3.43 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -99.96 -12.86 19.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -1.159 . . . . 0.0 110.426 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -168.38 -30.62 0.02 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.8 mm 59.71 91.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.177 . . . . 0.0 110.246 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' A' ' 75' ' ' ILE . 1.2 tppt? -129.42 152.73 48.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 2.8 t -115.31 125.87 53.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -117.31 117.68 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.696 HD13 ' HG3' ' A' ' 39' ' ' MET . 2.3 mp -95.67 143.16 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.52 -39.8 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.561 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -93.68 11.73 27.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.528 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.696 ' HG3' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.18 -45.52 88.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 41' ' ' ASP . 12.8 p -70.38 -43.99 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.0 t0 -69.3 -47.95 63.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.765 ' O ' HD13 ' A' ' 46' ' ' LEU . 4.3 p -61.11 -44.92 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.481 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -68.19 -46.07 71.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.092 -1.005 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 1.3 mtpm? -67.6 -42.6 82.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.852 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.766 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -59.6 -23.25 62.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.821 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.789 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -117.6 -9.26 10.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 110.464 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 9.6 p30 -173.56 -146.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.783 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 11.8 mtm180 -90.2 175.47 3.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.79 . . . . 0.0 110.618 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 44.3 Cg_endo -70.64 137.07 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.019 1.536 . . . . 0.0 110.455 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.2 Cg_endo -76.94 0.23 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.114 1.586 . . . . 0.0 110.427 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.774 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.9 p -56.24 -21.87 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.89 . . . . 0.0 110.43 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.497 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -88.87 -57.78 0.27 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 111.006 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -72.73 -16.64 26.5 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.729 1.384 . . . . 0.0 111.052 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 4.9 t -56.37 -16.12 5.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 110.265 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 tptt -72.66 -45.48 58.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -50.04 75.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 110.152 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 m-85 -57.37 -38.55 74.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.913 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.37 -38.61 93.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -37.33 71.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -1.223 . . . . 0.0 109.94 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.78 -49.49 70.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.04 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.4 11.41 3.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.058 -1.026 . . . . 0.0 110.871 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.16 4.76 30.61 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.049 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -118.8 163.4 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.75 ' O ' HG13 ' A' ' 76' ' ' VAL . 25.1 mt-30 -105.52 -119.18 0.23 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.741 -1.225 . . . . 0.0 109.961 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.4 170.32 18.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.643 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -147.14 139.83 24.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.774 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.4 m-85 -126.59 144.6 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.735 -1.228 . . . . 0.0 112.872 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.576 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -121.76 117.31 26.27 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.893 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 5.1 t -85.95 -64.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.564 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -16.51 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.14 -0.975 . . . . 0.0 108.62 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -103.69 -30.08 10.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.7 m-20 70.21 15.5 7.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.552 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.6 ttp180 -113.71 129.77 56.52 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.629 -0.67 . . . . 0.0 109.568 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.725 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.6 m-30 -112.16 136.89 50.99 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.339 -0.851 . . . . 0.0 110.311 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG23 ' CB ' ' A' ' 66' ' ' GLN . 3.1 tt -131.18 148.72 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.504 -0.747 . . . . 0.0 110.12 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 64' ' ' GLN . 42.6 t -113.92 139.36 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.134 -0.979 . . . . 0.0 109.748 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 1.049 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 25.3 m-20 -55.54 143.94 27.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 91.52 147.03 19.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.411 ' HB2' ' CG1' ' A' ' 25' ' ' VAL . 72.2 p -89.73 125.33 35.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.117 . . . . 0.0 109.773 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . 74.8 m-70 -141.79 114.81 8.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -86.68 159.02 19.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.29 -44.6 61.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.882 -1.136 . . . . 0.0 109.311 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -65.86 -33.44 75.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 108.997 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 88' ' ' MET . 28.8 tptt -68.55 -35.71 77.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.716 -0.615 . . . . 0.0 110.539 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 88' ' ' MET . 17.5 mt -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.97 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' OE1' ' HA ' ' A' ' 86' ' ' GLN . 33.1 tp60 -68.91 -35.98 77.48 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 108.883 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.24 -42.9 75.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.707 . . . . 0.0 111.339 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.596 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 6.0 ptm -57.68 -47.82 81.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.848 -1.157 . . . . 0.0 110.493 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.596 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.3 OUTLIER -54.08 -33.55 57.86 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.6 -35.83 82.28 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.574 0.702 . . . . 0.0 109.247 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 94' ' ' LYS . . . -61.4 -36.81 93.08 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -47.35 77.74 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.302 -1.117 . . . . 0.0 108.715 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.646 HG23 ' CE1' ' A' ' 96' ' ' PHE . 15.5 mt -65.47 -33.44 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.793 0.806 . . . . 0.0 109.221 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -55.13 -25.44 31.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 110.838 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OH ' ' A' ' 127' ' ' TYR . 0.1 OUTLIER -59.29 -29.54 67.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 111.651 -178.045 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' CG2' ' A' ' 97' ' ' VAL . 10.1 p90 -115.67 -22.78 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.626 -1.296 . . . . 0.0 111.051 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.891 ' HB ' HD22 ' A' ' 98' ' ' LEU . 13.1 t -110.16 -60.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.219 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.891 HD22 ' HB ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -102.32 60.63 0.83 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.471 -0.768 . . . . 0.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 32.5 m -64.64 150.24 94.35 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.428 -0.795 . . . . 0.0 110.738 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.64 0.89 5.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.116 1.587 . . . . 0.0 110.465 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.02 -7.98 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.519 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.616 ' O ' ' C ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -175.22 -39.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.44 -0.788 . . . . 0.0 110.107 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.734 ' HG3' ' HB3' ' A' ' 98' ' ' LEU . 3.8 tm-20 23.64 70.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.488 0.661 . . . . 0.0 110.16 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 2.1 t-20 -173.94 -58.34 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.758 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 42.4 Cg_endo -68.45 145.62 65.53 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.75 1.395 . . . . 0.0 110.576 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.74 153.58 43.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.5 p -135.51 166.02 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.384 -0.823 . . . . 0.0 110.064 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -113.95 142.64 45.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 120' ' ' ASN . 2.0 mp -105.92 127.02 52.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 108' ' ' ASP . 3.3 m80 -117.45 115.25 24.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 0.0 110.08 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.953 HG12 HD13 ' A' ' 118' ' ' ILE . 5.1 m -100.32 118.16 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -86.32 122.73 72.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -22.84 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.006 1.53 . . . . 0.0 110.456 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.45 -35.75 65.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.439 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -110.76 -4.1 15.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.335 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 52.27 51.4 16.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 147.39 50.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.953 HD13 HG12 ' A' ' 111' ' ' VAL . 2.3 mm -90.86 134.25 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -136.09 154.0 21.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 19.8 t-20 -143.46 154.26 43.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.288 -1.125 . . . . 0.0 108.926 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 120' ' ' ASN . 17.3 t -125.94 124.32 40.52 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.687 -1.258 . . . . 0.0 110.269 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.412 ' CB ' ' HB3' ' A' ' 127' ' ' TYR . 0.1 OUTLIER -90.87 129.53 36.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 38.67 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.05 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . . . -116.83 -27.6 6.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.303 -0.873 . . . . 0.0 110.281 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 124' ' ' ALA . 15.8 p -177.54 25.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 111.012 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 82.57 -12.19 48.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.592 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.8 t80 -19.53 -49.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.731 -0.864 . . . . 0.0 111.523 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER 64.72 128.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.411 -0.806 . . . . 0.0 109.572 -179.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -110.26 67.57 0.22 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.519 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 1.1 ttt -83.33 122.17 28.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.217 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.975 HD23 ' SG ' ' A' ' 138' ' ' CYS . 3.3 tp -113.9 135.42 54.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 110.097 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 133' ' ' THR . 1.3 m-20 -73.17 -92.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 132' ' ' ASP . 5.2 t 178.86 146.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 133' ' ' THR . 1.3 t-160 176.71 67.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.917 . . . . 0.0 110.269 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 134' ' ' HIS . 2.2 m-70 42.85 29.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 -177.62 3.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.293 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.514 HD12 ' C ' ' A' ' 137' ' ' LEU . 4.1 pp -62.16 -9.49 7.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.975 ' SG ' HD23 ' A' ' 131' ' ' LEU . 41.6 m -56.27 -41.95 76.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -42.68 77.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.324 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' A' ' 140' ' ' PHE . 6.7 t80 -56.98 -48.33 78.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.685 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 138' ' ' CYS . 25.5 pt -68.95 -42.24 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.553 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.556 ' N ' HG13 ' A' ' 141' ' ' ILE . 39.5 tp -54.04 -27.72 34.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.782 . . . . 0.0 110.385 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 143' ' ' LYS . 7.6 tttp -83.96 -18.84 35.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.375 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.458 ' O ' ' OD1' ' A' ' 144' ' ' ASN . 10.7 p30 -162.45 122.85 1.49 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.932 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.462 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 47.9 Cg_endo -73.24 174.16 12.54 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.917 1.482 . . . . 0.0 110.428 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.466 ' O ' ' CB ' ' A' ' 147' ' ' GLU . 46.2 Cg_endo -72.57 -92.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.91 1.479 . . . . 0.0 110.383 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER 171.78 34.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -72.74 119.76 17.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.0 m -63.4 176.51 0.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -121.67 -29.66 4.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 t -120.77 88.3 2.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 110.232 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -52.64 168.17 0.89 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.66 96.98 6.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -1.181 . . . . 0.0 110.184 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.58 50.17 1.6 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -154.47 112.8 3.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.208 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.219 0.533 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.589 ' C ' HG22 ' A' ' 3' ' ' VAL . 17.1 m -86.91 -153.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 110.262 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.589 HG22 ' C ' ' A' ' 2' ' ' SER . 17.2 m 36.92 48.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 110.528 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.63 155.91 38.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.61 -20.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.08 13.25 21.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' NH1' ' HB3' ' A' ' 2' ' ' SER . 14.2 ttt180 -68.37 -26.43 65.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.24 -7.09 58.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 110.234 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 11' ' ' ASP . 10.0 p -170.65 135.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.136 -0.977 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -8.41 38.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 110.176 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 9' ' ' VAL . 30.2 m-20 -84.49 148.65 26.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.97 -18.35 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 15' ' ' ARG . 0.5 OUTLIER 73.28 -52.84 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' C ' ' CD1' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 65.56 0.48 1.44 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.856 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.571 ' HB3' ' CD2' ' A' ' 13' ' ' PHE . 8.1 ttt180 -77.99 50.81 0.91 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.056 -1.028 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.1 134.9 36.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -130.93 135.88 48.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.306 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.605 ' CG ' HD11 ' A' ' 22' ' ' ILE . 2.5 mmt -139.59 119.05 9.06 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.86 . . . . 0.0 110.119 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.36 -4.89 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.964 1.508 . . . . 0.0 110.521 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.1 173.18 6.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -0.899 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.4 tm? -90.52 122.49 33.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 18' ' ' MET . 6.9 mt -100.61 120.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.29 139.3 47.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.502 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -116.06 126.74 54.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.922 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 31' ' ' GLY . 38.8 t -93.58 122.1 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -141.53 169.43 17.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' CA ' ' HA2' ' A' ' 31' ' ' GLY . . . 162.16 -94.29 0.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 30' ' ' ASN . 3.9 ttpm? -152.62 139.0 18.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -1.068 . . . . 0.0 109.978 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.61 -78.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 28' ' ' LYS . 42.5 t30 -99.59 -18.73 17.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -1.132 . . . . 0.0 110.056 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 25' ' ' VAL . . . 68.21 100.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.1 mm -112.32 14.31 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.474 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.062 ' CD ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -97.75 153.02 18.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.871 -1.143 . . . . 0.0 109.5 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.59 ' HG1' ' CG ' ' A' ' 80' ' ' HIS . 22.0 m -110.56 115.71 30.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.665 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -110.24 117.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.965 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.946 HG21 ' CG ' ' A' ' 39' ' ' MET . 21.3 mt -96.85 122.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.897 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 37' ' ' VAL . 24.7 m -100.6 -8.41 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.741 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.646 HD21 HD22 ' A' ' 21' ' ' LEU . 15.1 p-10 -116.71 6.99 13.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.021 . . . . 0.0 110.571 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.946 ' CG ' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.03 -45.37 89.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 10.8 t -70.35 -42.33 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.461 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -62.22 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.401 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.9 t -68.36 -44.97 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.467 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . . . -67.72 -45.62 74.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.642 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -65.84 -36.15 82.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.722 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -62.55 -34.47 77.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.5 mp -117.43 -9.17 10.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.951 -1.093 . . . . 0.0 110.917 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' ALA . 7.6 p-10 -162.28 -153.8 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.065 -1.022 . . . . 0.0 110.622 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.4 mtp180 -88.07 175.17 4.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.374 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.4 Cg_endo -72.5 138.23 29.33 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.086 1.572 . . . . 0.0 110.507 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.52 -7.19 17.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.059 1.557 . . . . 0.0 110.654 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.173 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.25 -21.91 26.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 0.0 110.175 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.538 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 6.4 m-85 -88.8 -57.39 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 111.155 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -71.3 -22.66 25.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.802 1.422 . . . . 0.0 111.352 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 10.2 t -56.29 -14.4 2.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.101 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -45.43 66.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.398 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.68 -49.08 74.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' HD23 ' A' ' 61' ' ' LEU . 9.6 m-30 -57.3 -34.1 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.47 -41.86 97.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -37.09 70.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.088 -1.242 . . . . 0.0 109.731 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.579 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . 5.2 mm-40 -63.26 -49.37 74.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.327 -0.858 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.003 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.65 12.93 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.99 -1.069 . . . . 0.0 110.812 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.73 4.87 28.23 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -121.33 163.48 18.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.183 -1.186 . . . . 0.0 109.397 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.7 mp0 -113.1 -120.9 0.3 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.653 -1.279 . . . . 0.0 109.676 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.5 170.26 19.01 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.447 -0.783 . . . . 0.0 111.042 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.612 ' CB ' HG13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.81 139.94 28.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.173 ' CZ ' HG22 ' A' ' 51' ' ' THR . 25.8 m-85 -126.09 144.19 50.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.688 -1.258 . . . . 0.0 113.055 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -126.08 117.37 23.04 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.11 178.499 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.01 -64.06 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.534 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -18.21 7.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -101.46 -31.57 10.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.654 -0.654 . . . . 0.0 110.073 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.4 m-20 70.79 15.52 6.87 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.2 -0.938 . . . . 0.0 110.357 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 25.5 ttm180 -113.64 129.54 56.55 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.74 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.0 m-30 -113.74 136.0 53.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.283 -0.886 . . . . 0.0 109.893 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.062 HD13 ' CD ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -129.02 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.205 -0.934 . . . . 0.0 110.61 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 64' ' ' GLN . 51.2 t -114.41 122.94 69.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.707 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 64.1 m-20 -50.02 142.69 8.98 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.6 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.96 140.0 9.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 95.6 p -99.09 123.93 43.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.863 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -142.09 134.83 28.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.574 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 4.0 tt0 -85.32 158.94 20.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 109.418 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.24 -44.01 61.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.79 -33.08 75.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.166 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' CE ' ' HB3' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -59.11 -35.79 74.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.669 -0.644 . . . . 0.0 110.324 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.6 mm? -58.82 -38.78 79.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.924 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -68.57 -47.69 66.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.324 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 35.5 t0 -67.69 -36.04 79.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.339 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 25.3 ttp -57.75 -48.28 80.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -53.04 -30.68 37.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.666 ' HA ' HD12 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -64.3 -46.24 84.46 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 95' ' ' LYS . . . -66.66 -32.03 80.23 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 60' ' ' GLU . 2.1 m-85 -55.17 -39.31 69.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.491 -1.005 . . . . 0.0 109.616 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.781 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mt -52.97 -47.94 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.733 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' O ' ' CD2' ' A' ' 98' ' ' LEU . 13.8 mptt -69.63 -25.17 63.8 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.534 -0.729 . . . . 0.0 110.755 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 92' ' ' PHE . 18.6 mmtm -58.89 -29.42 67.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.421 -0.8 . . . . 0.0 111.985 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.818 ' HB2' HD22 ' A' ' 137' ' ' LEU . 4.6 p90 -100.87 -19.12 16.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.491 -1.381 . . . . 0.0 110.223 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.879 HG13 HD21 ' A' ' 109' ' ' LEU . 6.9 t -71.23 -7.99 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.064 . . . . 0.0 109.495 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.963 HD13 ' HB2' ' A' ' 103' ' ' GLU . 2.3 mm? -37.75 106.07 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.476 -0.765 . . . . 0.0 109.905 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.534 ' N ' ' HB3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -64.14 155.13 80.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.62 -14.21 33.16 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.081 1.569 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -66.68 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.59 ' O ' ' C ' ' A' ' 103' ' ' GLU . 14.3 p -160.38 10.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.847 . . . . 0.0 110.329 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.963 ' HB2' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 23.55 59.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.629 -0.67 . . . . 0.0 110.726 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.623 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 9.4 m-20 -101.44 -65.19 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.261 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.3 Cg_endo -72.12 150.07 53.28 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.715 1.376 . . . . 0.0 110.164 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.11 118.15 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 110.073 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 123' ' ' LYS . 4.0 p -110.13 166.06 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -113.92 159.4 19.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.123 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.879 HD21 HG13 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -106.03 139.47 40.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.93 . . . . 0.0 110.384 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.542 ' CE1' ' C ' ' A' ' 119' ' ' GLY . 1.5 p80 -123.58 131.31 53.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.845 . . . . 0.0 110.07 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG21 HD23 ' A' ' 142' ' ' LEU . 2.0 p -117.95 129.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -98.27 122.48 53.82 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.48 -33.35 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.069 1.563 . . . . 0.0 110.456 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.525 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 4.1 pttp -59.34 -42.23 91.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.278 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -100.46 0.53 39.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.65 42.05 31.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.474 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -134.96 179.52 6.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.709 HD11 ' HG ' ' A' ' 142' ' ' LEU . 4.5 mt -137.1 139.91 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.038 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 110' ' ' HIS . . . -116.66 163.81 12.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -135.39 129.82 33.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -1.079 . . . . 0.0 109.681 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.556 ' CA ' ' HA ' ' A' ' 128' ' ' ARG . 1.1 p -117.44 152.7 34.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.28 126.27 52.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 109.978 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.568 ' H ' HG22 ' A' ' 107' ' ' THR . 1.1 ttmt -75.19 51.69 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.777 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -144.72 -34.38 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 110.012 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 14.0 p -137.83 2.16 2.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.689 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.44 -11.76 60.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.669 ' C ' ' O ' ' A' ' 126' ' ' GLY . 29.7 t80 -8.87 -64.16 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.83 -0.806 . . . . 0.0 111.237 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 126' ' ' GLY . 9.9 ttt-85 35.88 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.589 -0.695 . . . . 0.0 110.578 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.27 -113.19 0.83 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.542 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.44 151.74 38.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.496 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.884 HD22 ' SG ' ' A' ' 138' ' ' CYS . 2.6 tt -80.94 121.23 25.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.024 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 133' ' ' THR . 10.4 m-20 -99.3 -97.24 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.348 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER 66.52 -175.82 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.389 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -88.82 -91.49 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -51.41 173.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.59 81.96 2.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.818 HD22 ' HB2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -82.23 -4.05 56.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.86 . . . . 0.0 110.012 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.884 ' SG ' HD22 ' A' ' 131' ' ' LEU . 20.0 m -62.67 -45.33 93.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 110.392 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -40.1 96.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' O ' ' CD ' ' A' ' 143' ' ' LYS . 0.2 OUTLIER -58.3 -48.5 80.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.016 -1.053 . . . . 0.0 109.389 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.737 HD11 ' HA ' ' A' ' 138' ' ' CYS . 16.8 pt -69.07 -41.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.489 -0.757 . . . . 0.0 109.545 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.709 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.3 mt -52.91 -16.16 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.364 -0.835 . . . . 0.0 110.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -69.68 -5.36 24.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.923 . . . . 0.0 110.23 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.533 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.7 p-10 -59.27 170.21 1.03 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.985 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 45.1 Cg_endo -72.99 156.96 51.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.872 1.459 . . . . 0.0 110.355 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.76 149.27 48.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.975 1.513 . . . . 0.0 110.433 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.51 65.55 0.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -140.6 122.06 15.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.0 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.251 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.58 123.39 7.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 110.222 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.3 t -174.41 154.55 2.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.25 89.4 1.58 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 153' ' ' THR . 11.3 t -137.09 64.04 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -1.145 . . . . 0.0 110.317 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 156' ' ' LYS . . . 67.33 -174.83 26.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.0 tttt 45.88 -96.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -1.125 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.253 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.165 0.507 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -170.63 147.95 2.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 4' ' ' ASN . 2.4 m -124.54 -103.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.858 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 3' ' ' VAL . 1.8 m-80 -73.29 105.85 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 110.219 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.98 -11.28 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.46 44.37 2.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.176 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HG3' ' N ' ' A' ' 8' ' ' SER . 7.3 ptt180 -65.69 -17.72 64.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 4.1 p -85.35 4.09 36.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' HG12 ' A' ' 9' ' ' VAL . 30.0 t 55.29 85.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 9' ' ' VAL . 1.9 tpt 44.41 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.71 141.69 35.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -40.93 85.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.299 -0.876 . . . . 0.0 110.139 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.678 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -169.09 -103.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.222 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.487 ' OH ' ' HE3' ' A' ' 17' ' ' LYS . 61.0 t80 -177.29 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.042 -1.036 . . . . 0.0 110.163 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mtm105 41.06 27.46 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.184 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -137.06 138.91 40.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.37 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HE3' ' OH ' ' A' ' 14' ' ' TYR . 8.9 mtpt -132.31 130.39 40.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.525 ' CE ' ' HB2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -138.43 121.87 11.21 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -73.24 -89.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.948 1.499 . . . . 0.0 110.395 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HB2' ' CE ' ' A' ' 18' ' ' MET . 12.0 tpt85 60.77 72.39 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.212 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.906 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.37 143.49 27.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.649 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 19.9 mt -105.01 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 110.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.66 152.32 45.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 11.1 tttm -116.11 128.39 55.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 80' ' ' HIS . 15.5 m -105.59 135.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 35.5 tt0 -112.67 134.42 54.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.26 69.89 0.3 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.72 139.03 51.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 110.116 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -150.62 3.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.66 12.44 36.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -1.122 . . . . 0.0 110.209 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -70.01 -65.19 2.62 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 32' ' ' ILE . 2.1 mm 56.93 88.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 110.107 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE2' ' OE1' ' A' ' 26' ' ' GLU . 22.1 pttm -129.62 152.52 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.786 ' HB ' HG23 ' A' ' 76' ' ' VAL . 7.9 m -112.74 128.38 56.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.73 HG12 HD13 ' A' ' 75' ' ' ILE . 4.0 m -109.82 132.29 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 1.0 OUTLIER -80.56 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.57 -46.56 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.64 -1.04 12.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.776 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.554 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 2.7 tmm? -60.38 -33.54 72.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.089 -1.007 . . . . 0.0 110.036 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.84 -42.84 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.078 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -49.77 74.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.04 -40.73 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.056 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' HG3' ' A' ' 50' ' ' PRO . . . -62.81 -35.0 78.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.82 -40.37 79.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -15.9 62.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.041 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.832 ' O ' HD23 ' A' ' 46' ' ' LEU . 8.0 tt -82.56 1.02 40.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.847 . . . . 0.0 110.176 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.6 t30 71.57 -61.95 0.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.671 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 154.11 82.35 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.234 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.5 Cg_endo -72.72 141.59 34.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.002 1.527 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HG3' ' CB ' ' A' ' 43' ' ' ALA . 47.9 Cg_endo -73.55 -24.96 15.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.997 1.525 . . . . 0.0 110.393 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 1.026 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 33.2 p -56.44 -21.75 27.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.381 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.512 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -86.55 -57.46 0.33 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 111.141 -179.538 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 52' ' ' TYR . 44.4 Cg_endo -70.83 -27.42 21.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.745 1.392 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 15.2 t -56.72 -15.12 4.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -72.81 -39.33 66.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.214 -0.929 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -50.84 72.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 23.9 m-85 -67.53 -31.7 71.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.814 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . -59.27 -48.46 85.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 56.3 m -58.97 -46.26 88.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -1.213 . . . . 0.0 110.333 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -70.17 -28.72 65.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.95 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -91.92 12.99 19.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.932 -179.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.13 12.51 44.35 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -131.59 163.2 28.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -1.17 . . . . 0.0 109.52 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 6.1 tp60 -120.16 -125.31 0.27 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.722 -1.236 . . . . 0.0 109.187 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -150.8 170.36 19.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 111.985 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.0 139.53 20.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.302 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.026 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.3 m-85 -126.69 144.27 50.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.656 -1.278 . . . . 0.0 113.273 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -118.7 117.27 28.46 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.79 -64.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.773 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -15.11 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 108.642 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.68 -31.28 9.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.662 . . . . 0.0 110.271 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.9 m-20 72.15 15.32 5.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.222 -0.924 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.535 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 26.9 ttp180 -114.04 129.55 56.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.496 -0.752 . . . . 0.0 109.036 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 5.3 m-30 -108.91 128.93 55.35 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.608 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 35' ' ' VAL . 10.5 mt -128.51 149.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.786 HG23 ' HB ' ' A' ' 34' ' ' THR . 7.4 m -112.24 139.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.919 -1.113 . . . . 0.0 109.753 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -68.33 135.88 52.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.2 158.42 22.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.528 ' HB3' HG23 ' A' ' 32' ' ' ILE . 91.8 p -97.22 123.78 41.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -1.224 . . . . 0.0 110.317 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -141.83 115.02 8.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 1.2 tt0 -89.92 155.32 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.139 -0.976 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.23 -43.59 64.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -64.15 -33.59 76.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.611 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.88 -36.98 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.505 -0.747 . . . . 0.0 109.762 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -60.15 -33.63 72.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.773 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.58 -37.12 79.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -61.62 -42.14 98.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.994 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 61' ' ' LEU . 48.7 ttp -66.61 -48.69 68.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -53.37 -29.73 36.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.3 t70 -56.13 -35.2 66.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.111 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -60.97 -32.59 80.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.77 -39.8 91.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -1.101 . . . . 0.0 109.346 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 1.116 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 mp -53.37 -32.84 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.446 -0.784 . . . . 0.0 110.056 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.816 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -54.13 -25.84 24.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.471 -0.768 . . . . 0.0 109.763 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 24.1 mmtm -60.44 -25.95 66.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.688 -0.632 . . . . 0.0 111.706 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 1.116 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 5.7 p90 -115.38 -19.72 10.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.537 -1.352 . . . . 0.0 111.725 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 30.1 m -62.24 -32.23 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.595 -1.315 . . . . 0.0 110.02 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.816 HD11 ' O ' ' A' ' 94' ' ' LYS . 1.2 mp -40.64 101.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.36 -0.837 . . . . 0.0 109.718 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 31.3 p -64.53 155.26 81.89 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.02 -0.68 8.33 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.112 1.585 . . . . 0.0 110.41 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.479 ' CB ' ' HB3' ' A' ' 127' ' ' TYR . 3.7 mm-40 -89.11 -11.29 44.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.353 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.614 ' O ' ' C ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -167.19 -38.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.547 -0.72 . . . . 0.0 109.795 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.617 ' CG ' ' HB3' ' A' ' 98' ' ' LEU . 0.8 OUTLIER 21.71 71.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.599 0.714 . . . . 0.0 110.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 6.1 m-80 -159.55 -64.02 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.651 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.4 Cg_endo -70.89 149.29 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.841 1.443 . . . . 0.0 110.547 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.81 107.88 3.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 105' ' ' PRO . 12.7 p -112.09 163.03 14.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -114.2 137.95 51.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.485 ' HB3' ' OD1' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -106.05 128.43 53.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 110.102 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -96.79 124.68 40.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 HG12 ' A' ' 118' ' ' ILE . 2.2 p -108.47 117.9 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -0.853 . . . . 0.0 110.18 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -93.55 123.6 59.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 110.182 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 -31.88 9.03 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.058 1.557 . . . . 0.0 110.461 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -40.77 67.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.655 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 13.3 tttm -92.0 -3.73 55.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.655 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 2.0 pt20 51.53 37.94 20.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 110.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.11 174.06 10.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.109 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.501 HG12 HG23 ' A' ' 111' ' ' VAL . 13.7 mt -141.72 139.3 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 110.268 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -117.84 163.79 12.79 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -142.44 127.57 18.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -1.173 . . . . 0.0 109.775 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 1.3 p -117.0 124.7 49.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 110.355 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 107' ' ' THR . 69.1 m -91.57 128.36 37.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -23.33 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -83.88 -5.54 59.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER 70.54 2.79 4.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.67 -71.72 0.09 OUTLIER Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.707 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -135.55 1.68 2.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -1.135 . . . . 0.0 110.316 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -10.9 120.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.788 -0.57 . . . . 0.0 111.403 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.46 -93.52 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.52 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -116.71 151.63 35.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -1.117 . . . . 0.0 110.28 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 132' ' ' ASP . 1.2 tt -85.61 142.05 29.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.524 ' N ' HD23 ' A' ' 131' ' ' LEU . 75.2 m-20 -115.9 -91.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 132' ' ' ASP . 0.6 OUTLIER 56.93 161.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.188 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -75.68 -172.29 1.83 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' HIS . 15.6 m-70 42.54 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.111 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -131.91 81.99 2.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.248 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.893 HD22 ' CD1' ' A' ' 96' ' ' PHE . 4.3 pp -82.29 -21.59 36.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.852 . . . . 0.0 110.101 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.73 ' HA ' HD11 ' A' ' 141' ' ' ILE . 56.5 m -56.69 -40.39 75.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 m -68.7 -42.64 77.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -57.08 -48.65 78.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 109.675 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.73 HD11 ' HA ' ' A' ' 138' ' ' CYS . 10.6 pt -69.17 -42.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.634 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.43 ' N ' HG13 ' A' ' 141' ' ' ILE . 57.7 tp -54.41 -28.76 45.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 110.302 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.3 -6.33 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 141' ' ' ILE . 8.0 m120 -73.4 117.29 59.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 110.237 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.96 115.21 4.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.92 1.484 . . . . 0.0 110.384 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.904 1.476 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.48 113.9 9.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.37 -156.86 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 110.176 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 p -169.94 137.1 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.36 -45.28 6.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 m 45.95 -153.77 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.43 ' O ' ' OG1' ' A' ' 153' ' ' THR . . . 46.64 79.12 0.07 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 152' ' ' GLY . 44.8 p 43.83 56.67 4.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.136 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.31 152.08 29.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.52 -163.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.1 tttt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.214 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.216 0.532 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 ' ND2' ' A' ' 38' ' ' ASN . 36.7 mt -109.74 128.4 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 138.95 51.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.673 ' HB2' HG13 ' A' ' 35' ' ' VAL . 22.7 mtpp -124.85 136.99 54.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 79' ' ' SER . 62.7 t -96.38 133.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 110.102 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 32' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.501 0.667 . . . . 0.0 109.845 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HE3' HG21 ' A' ' 75' ' ' ILE . 33.1 pttt -128.47 152.66 47.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -97.16 128.55 44.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 75' ' ' ILE . 1.7 p -116.64 117.87 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 39' ' ' MET . 4.5 mt -95.49 110.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.91 -1.37 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.788 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.9 t30 -116.79 -1.18 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB2' HG21 ' A' ' 36' ' ' ILE . 20.6 ttm -64.3 -45.49 87.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.082 -1.011 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 45.5 t -70.4 -41.37 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.866 . . . . 0.0 110.258 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -49.82 74.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -68.36 -43.54 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -67.67 -44.44 77.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -67.68 -36.29 80.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.0 110.42 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.82 64.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.9 . . . . 0.0 110.811 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.9 HD12 ' HB2' ' A' ' 47' ' ' ASN . 2.5 pp -117.42 -9.19 10.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.051 . . . . 0.0 110.69 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.9 ' HB2' HD12 ' A' ' 46' ' ' LEU . 1.1 t-20 175.43 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -101.65 170.7 6.14 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.103 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.3 Cg_endo -72.57 128.88 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.962 1.506 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 48.5 Cg_endo -74.58 48.83 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.912 1.48 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.103 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -68.1 -23.94 64.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -75.49 -54.26 2.4 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.92 . . . . 0.0 110.814 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -71.17 -1.53 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.799 1.421 . . . . 0.0 110.819 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.886 HG22 ' CG2' ' A' ' 65' ' ' THR . 51.6 m -66.44 -21.58 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -42.54 64.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.531 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -49.5 77.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 0.0 110.302 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 5.5 m-30 -57.49 -43.89 84.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.924 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -35.2 85.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.94 -37.23 71.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -1.228 . . . . 0.0 110.022 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.04 -47.8 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.651 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.055 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.59 12.72 2.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.171 -0.956 . . . . 0.0 111.009 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 6.49 27.94 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.081 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.65 163.95 15.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.338 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.9 mt-30 -105.4 -119.16 0.22 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.698 -1.252 . . . . 0.0 109.962 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.886 ' CG2' HG22 ' A' ' 54' ' ' THR . 7.7 p -149.42 170.42 18.61 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 111.228 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' ILE . 4.2 tp-100 -144.72 139.47 27.93 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.103 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.5 m-85 -126.81 143.97 51.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.743 -1.223 . . . . 0.0 113.066 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 1.7 t0 -124.63 117.28 23.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.778 -0.769 . . . . 0.0 108.982 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 70' ' ' LYS . 7.7 m -89.13 -45.88 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.144 -0.973 . . . . 0.0 109.57 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.608 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.1 -6.84 42.34 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 108.516 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -118.21 -27.57 6.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.723 -0.611 . . . . 0.0 110.044 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.1 m-20 70.45 17.03 6.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.275 -0.891 . . . . 0.0 109.877 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.577 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -113.57 129.45 56.56 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.793 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.719 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.49 132.88 55.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 110.26 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.855 ' CD1' HG23 ' A' ' 35' ' ' VAL . 8.8 mm -120.5 148.68 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 21.0 t -114.04 126.04 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.081 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 68.5 m-80 -47.22 147.04 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 110.409 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 89.37 144.34 10.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.586 ' HB2' HG13 ' A' ' 25' ' ' VAL . 68.6 p -105.78 125.23 50.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -1.141 . . . . 0.0 110.136 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -139.51 155.4 47.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.08 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -90.86 156.84 17.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.29 -43.21 64.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 83' ' ' ASN . 1.6 m120 -59.65 -33.51 71.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -69.33 -39.69 78.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.276 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 80' ' ' HIS . 13.7 mt -60.4 -36.19 77.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -68.83 -36.22 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 110.134 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.901 -179.514 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 21' ' ' LEU . 6.7 tp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 32.6 mt -107.88 120.32 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 110.076 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.15 135.9 54.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.414 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -117.38 137.96 52.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.1 t -93.35 122.98 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.227 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.8 tt0 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.194 -0.941 . . . . 0.0 110.448 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.714 HD13 ' CB ' ' A' ' 79' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.376 0.607 . . . . 0.0 110.295 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.564 ' CB ' HD11 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -97.52 152.87 18.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 109.142 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.742 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.3 m -105.91 120.48 41.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.872 -1.142 . . . . 0.0 110.906 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 75' ' ' ILE . 21.5 t -108.6 117.87 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.869 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 39' ' ' MET . 5.2 mt -95.56 113.0 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.76 -1.24 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.195 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 5.4 t-20 -97.64 -0.96 44.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.237 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.544 ' HG3' ' CG2' ' A' ' 36' ' ' ILE . 2.6 mtt -59.74 -43.41 94.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 41' ' ' ASP . 34.4 m -60.6 -43.2 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.587 ' N ' HG23 ' A' ' 40' ' ' VAL . 16.2 m-20 -66.98 -49.03 66.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.66 -42.73 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -63.27 -34.99 78.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.07 -46.85 87.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.27 -16.19 60.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.856 HD23 ' O ' ' A' ' 46' ' ' LEU . 9.6 tt -103.27 -2.76 26.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 m-20 66.73 -58.34 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.766 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.14 132.95 69.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 46.3 Cg_endo -73.41 146.16 39.3 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.459 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -73.19 -4.72 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.972 1.512 . . . . 0.0 110.499 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.176 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -60.53 -21.69 62.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.532 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.42 -58.29 0.8 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.719 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.9 Cg_endo -72.73 -3.13 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.958 1.504 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.849 HG22 ' O ' ' A' ' 51' ' ' THR . 13.9 t -72.97 -17.66 61.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.347 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -72.82 -45.41 58.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.467 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -66.92 -41.43 87.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 5.5 t80 -57.72 -42.06 83.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.49 -35.34 85.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.02 -37.27 79.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.239 . . . . 0.0 110.265 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.27 -28.73 68.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.905 . . . . 0.0 111.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.041 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -105.42 12.96 30.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.053 -1.029 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 4.87 21.76 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.041 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -116.0 164.02 15.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -1.08 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 mt-30 -112.27 -120.13 0.29 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.71 -1.244 . . . . 0.0 110.245 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -149.49 170.62 18.17 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.414 -0.804 . . . . 0.0 111.158 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.527 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -146.68 139.67 25.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.176 ' CZ ' HG22 ' A' ' 51' ' ' THR . 23.7 m-85 -126.59 144.52 50.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.754 -1.216 . . . . 0.0 112.816 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -120.86 117.37 27.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.968 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 70' ' ' LYS . 10.6 m -89.07 -45.13 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.694 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.64 -5.26 32.3 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.255 -0.903 . . . . 0.0 108.83 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 m120 -121.14 -24.64 5.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.517 -0.739 . . . . 0.0 110.345 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 69.55 17.5 7.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.67 129.65 56.53 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 109.436 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.2 m-30 -113.09 129.19 56.59 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.53 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.651 ' CG1' HG22 ' A' ' 35' ' ' VAL . 1.2 tt -125.29 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.552 -0.718 . . . . 0.0 109.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.3 p -113.29 136.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.177 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.787 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -61.24 142.04 57.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.345 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.668 ' HA3' ' HE2' ' A' ' 80' ' ' HIS . . . 109.7 141.23 9.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 32' ' ' ILE . 51.4 p -97.23 122.36 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -1.15 . . . . 0.0 110.025 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.668 ' HE2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -142.33 158.35 43.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 3.8 tt0 -103.99 158.15 16.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.54 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.09 -43.88 64.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.03 -33.49 76.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.87 -37.17 83.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.213 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.15 -44.46 94.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.89 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -66.99 -36.49 82.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.178 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.0 tm? . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.248 0.547 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.57 ' N ' HD22 ' A' ' 21' ' ' LEU . 13.2 mm -100.74 136.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.61 141.2 52.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.647 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -124.19 138.08 54.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.998 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.762 HG23 ' CB ' ' A' ' 79' ' ' SER . 3.3 p -93.26 134.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.209 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.7 mm . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.323 0.582 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -129.52 152.49 49.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.986 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.757 ' HB ' HG23 ' A' ' 76' ' ' VAL . 1.3 m -108.95 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 110.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 24' ' ' LYS . 3.0 p -102.85 117.73 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.3 mt -95.55 112.48 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.623 HG23 ' OD1' ' A' ' 38' ' ' ASN . 30.8 m -89.4 -21.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.623 ' OD1' HG23 ' A' ' 37' ' ' VAL . 11.6 m120 -91.79 11.46 24.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.685 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.98 -45.19 93.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.093 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 41' ' ' ASP . 14.5 m -67.43 -42.31 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 40' ' ' VAL . 3.6 m-20 -64.96 -50.11 67.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.74 -43.66 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.95 75.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.21 93.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.48 -22.6 60.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.857 HD12 ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -102.43 2.92 37.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.426 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 4.3 m120 65.43 -64.55 0.18 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.35 -0.843 . . . . 0.0 110.237 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -77.23 122.66 86.53 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.7 Cg_endo -73.06 144.84 38.54 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.974 1.512 . . . . 0.0 110.41 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CE ' ' A' ' 39' ' ' MET . 46.3 Cg_endo -72.99 -0.15 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.013 1.533 . . . . 0.0 110.22 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.005 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -57.21 -21.48 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.551 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.6 m-85 -82.1 -58.87 0.44 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.118 -0.988 . . . . 0.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 52' ' ' TYR . 48.8 Cg_endo -74.76 -0.22 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.884 1.465 . . . . 0.0 111.049 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.568 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -61.28 -23.51 65.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.03 -1.044 . . . . 0.0 110.376 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -42.09 64.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.982 . . . . 0.0 110.598 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.8 t80 -58.76 -51.29 70.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.246 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 15.5 m-30 -57.68 -43.26 84.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -61.22 -35.09 90.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -56.7 -37.26 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.257 . . . . 0.0 109.998 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -65.07 -47.59 76.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.739 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.006 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -83.07 12.92 4.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.162 -0.961 . . . . 0.0 110.91 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 4.87 26.93 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.064 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -114.41 163.67 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.158 . . . . 0.0 109.397 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.489 ' C ' ' CG2' ' A' ' 65' ' ' THR . 12.5 tt0 -107.95 -119.07 0.26 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.958 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.568 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.6 p -149.25 170.23 18.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.563 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.48 139.34 28.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.005 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.0 m-85 -126.83 143.77 51.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.864 -1.148 . . . . 0.0 112.844 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -122.99 117.47 25.55 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.731 -0.787 . . . . 0.0 108.943 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.48 -64.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.64 -17.52 5.85 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.184 -0.948 . . . . 0.0 108.682 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -103.92 -31.4 9.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.637 -0.665 . . . . 0.0 110.153 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.8 m-20 71.72 16.47 5.69 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -0.862 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.569 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.46 129.49 56.53 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.618 -0.676 . . . . 0.0 109.713 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.45 137.73 51.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 66' ' ' GLN . 10.8 tt -131.66 148.56 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 109.792 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 34' ' ' THR . 3.6 m -114.21 137.84 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.094 -1.004 . . . . 0.0 109.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.064 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 98.4 m-20 -59.01 143.08 49.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.15 147.59 22.02 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.762 ' CB ' HG23 ' A' ' 25' ' ' VAL . 35.3 p -107.37 121.09 43.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -1.178 . . . . 0.0 110.462 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.21 167.23 22.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 110.004 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.497 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt-10 -101.25 158.14 16.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.937 . . . . 0.0 110.119 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.85 -44.52 66.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.61 -34.98 79.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 109.845 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -59.41 -37.35 77.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 110.439 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 3.2 mp -61.79 -44.95 95.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.13 -45.5 69.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.229 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.619 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 3.1 tm? . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.261 0.553 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -97.34 125.1 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.893 . . . . 0.0 110.175 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.7 138.08 47.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -116.67 137.97 51.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 25' ' ' VAL . 4.4 p -96.33 125.1 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.24 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 8.1 tt0 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.61 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.292 0.568 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HG2' HG22 ' A' ' 75' ' ' ILE . 3.7 ttpt -97.62 153.08 18.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -98.63 118.37 35.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.942 -1.099 . . . . 0.0 110.507 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.76 117.4 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.093 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 4.5 tp -96.05 119.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.4 t -100.77 -24.88 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.0 2.61 56.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.571 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 43.7 tpp -64.14 -44.91 90.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 41' ' ' ASP . 5.9 p -59.55 -42.84 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.391 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -63.58 -49.4 73.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.205 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.77 -43.82 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.262 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.641 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -59.3 -35.54 73.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -50.12 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 109.968 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.15 60.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 46' ' ' LEU . 8.3 tt -83.35 1.1 42.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 110.344 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.5 m120 73.89 -63.35 0.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.796 . . . . 0.0 110.514 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 46' ' ' LEU . 3.9 mmt85 -77.13 155.17 82.5 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 110.262 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.1 Cg_endo -73.05 157.54 50.76 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.102 1.58 . . . . 0.0 110.528 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.64 -26.83 8.0 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.07 1.563 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.731 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 18.1 p -60.69 -21.83 63.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.528 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -58.29 0.59 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 110.653 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' O ' ' CD2' ' A' ' 57' ' ' PHE . 46.2 Cg_endo -72.99 -0.31 8.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.868 1.457 . . . . 0.0 110.892 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.8 -25.83 59.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -45.7 57.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -67.76 -48.86 65.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 11.5 m-85 -57.57 -41.37 80.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -58.83 -35.36 82.08 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -37.27 78.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.238 . . . . 0.0 109.932 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -48.38 71.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 110.651 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.069 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.79 11.46 2.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.169 -0.957 . . . . 0.0 111.046 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.97 11.26 36.99 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.178 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -118.05 164.31 15.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.508 -0.995 . . . . 0.0 109.274 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.409 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 11.8 mp0 -104.1 -121.38 0.2 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.63 -1.294 . . . . 0.0 110.001 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.745 HG21 ' HB ' ' A' ' 54' ' ' THR . 0.7 OUTLIER -149.86 170.12 19.53 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.458 -0.776 . . . . 0.0 111.82 -179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -155.95 139.06 15.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.0 m-85 -127.31 146.1 50.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.741 -1.224 . . . . 0.0 112.967 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -117.9 117.17 28.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.667 177.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.623 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.0 m -90.21 -46.33 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' N ' HG23 ' A' ' 69' ' ' VAL . 1.6 tptt -73.16 -3.62 27.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -118.92 -26.92 5.89 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.684 -0.635 . . . . 0.0 110.529 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.2 m-20 70.13 16.31 7.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.072 -1.017 . . . . 0.0 109.543 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.554 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 4.0 mmt85 -113.87 129.72 56.56 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.8 m-30 -109.06 128.97 55.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.825 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 34' ' ' THR . 84.4 mt -129.04 150.83 34.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 34' ' ' THR . 13.2 m -111.77 138.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.929 -1.107 . . . . 0.0 109.134 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.178 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 8.9 t30 -62.75 140.33 58.74 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.769 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 104.95 147.08 15.72 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.2 p -101.41 127.59 47.99 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.306 -1.114 . . . . 0.0 110.074 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.688 ' NE2' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -141.92 156.69 45.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 81' ' ' GLU . 1.4 pt-20 -104.01 143.4 32.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.758 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 21' ' ' LEU . . . -53.49 -39.51 64.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.975 . . . . 0.0 110.268 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -34.71 66.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.173 -0.954 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' A' ' 81' ' ' GLU . 1.3 tppp? -73.03 -45.58 56.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -60.5 -44.19 96.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.354 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.4 mm100 -68.66 -35.83 77.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.73 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.8 t0 . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 111.354 -178.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.279 0.562 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.2 mt -115.61 123.52 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.258 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.99 132.53 53.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.07 136.18 53.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' HB2' ' A' ' 79' ' ' SER . 94.6 t -102.48 134.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.787 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.6 mm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.332 0.587 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HA ' ' N ' ' A' ' 78' ' ' GLY . 6.0 mtmm -126.76 152.55 46.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.0 OUTLIER -108.18 123.95 49.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' CD1' ' A' ' 75' ' ' ILE . 20.4 t -108.52 117.79 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.724 HD13 ' N ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -95.95 122.98 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -100.55 -43.56 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.774 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.716 ' O ' HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.23 -1.52 25.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.019 . . . . 0.0 110.75 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.612 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.5 tmt? -64.72 -45.6 85.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.019 . . . . 0.0 109.967 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 74' ' ' TYR . 14.3 p -70.68 -41.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 0.0 110.323 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 40' ' ' VAL . 40.1 t0 -62.17 -49.47 75.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 38' ' ' ASN . 12.9 m -68.12 -43.57 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -61.53 -46.96 87.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -36.45 80.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.449 -0.782 . . . . 0.0 110.236 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.96 70.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 42' ' ' VAL . 3.0 pp -108.94 -1.4 19.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -170.21 -154.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.291 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.419 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 1.8 mtt180 -93.47 174.49 3.84 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.274 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.94 128.57 13.31 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.359 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 39' ' ' MET . 47.9 Cg_endo -75.4 5.2 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.034 1.544 . . . . 0.0 110.657 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.141 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -56.46 -26.54 54.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -84.51 -55.94 0.43 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.964 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.9 Cg_endo -70.77 -23.66 25.95 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.824 1.434 . . . . 0.0 111.143 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.536 HG22 ' C ' ' A' ' 51' ' ' THR . 7.8 t -56.25 -16.31 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.992 -1.067 . . . . 0.0 110.208 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -45.4 68.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -62.11 -49.46 75.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -0.979 . . . . 0.0 110.11 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 8.9 m-30 -57.42 -36.8 71.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.921 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -39.25 94.91 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.2 m -57.45 -37.33 72.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -1.2 . . . . 0.0 109.924 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 -49.48 77.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.835 . . . . 0.0 110.723 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.001 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -83.42 12.98 4.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.109 -0.994 . . . . 0.0 110.697 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.05 6.29 31.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.45 163.59 15.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -1.159 . . . . 0.0 109.609 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG13 ' A' ' 76' ' ' VAL . 24.6 tp60 -107.16 -118.42 0.25 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.936 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.18 170.25 18.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 111.022 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.796 ' HB2' HG23 ' A' ' 75' ' ' ILE . 3.3 mm100 -146.32 139.82 25.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.141 ' CZ ' HG22 ' A' ' 51' ' ' THR . 17.7 m-85 -126.54 142.59 51.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.819 -1.176 . . . . 0.0 112.849 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -120.28 117.48 27.92 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.015 178.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 70' ' ' LYS . 13.5 m -89.29 -45.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.645 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' N ' HG23 ' A' ' 69' ' ' VAL . 7.4 tptt -71.01 -5.95 35.15 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.198 -0.939 . . . . 0.0 108.722 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.7 m-20 -121.32 -25.27 5.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.591 -0.693 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.1 m-20 69.75 17.15 7.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 109.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -113.64 129.47 56.56 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.586 -0.696 . . . . 0.0 109.681 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.733 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-30 -113.18 138.02 50.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.555 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 66' ' ' GLN . 1.6 tt -128.45 148.75 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.461 -0.774 . . . . 0.0 109.925 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 64' ' ' GLN . 69.3 t -113.89 130.03 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.688 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.065 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 67.6 m-80 -49.76 147.82 3.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 110.51 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 88.16 148.8 16.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 25' ' ' VAL . 64.8 p -106.63 122.62 46.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -1.109 . . . . 0.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.848 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.09 145.45 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 109.975 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.3 tt0 -81.72 155.17 25.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.108 -0.995 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.25 -43.89 64.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.033 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -64.67 -33.55 76.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 109.797 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -36.87 85.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 110.082 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.48 ' CD1' ' HB2' ' A' ' 80' ' ' HIS . 4.4 mp -59.95 -42.59 94.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.103 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -69.2 -35.93 76.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.535 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.476 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.782 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 3.4 tp . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.261 0.553 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -119.12 132.37 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.9 140.59 52.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -121.71 137.97 54.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 16.3 m -93.44 131.9 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.368 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HB2' HG21 ' A' ' 35' ' ' VAL . 4.1 tt0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 110.23 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.69 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.581 0.705 . . . . 0.0 110.028 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.708 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.77 153.27 18.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.832 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.563 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.3 m -97.16 124.97 41.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.088 -1.007 . . . . 0.0 110.834 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 26' ' ' GLU . 5.7 t -118.02 117.65 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.923 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.66 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.6 mt -95.77 118.16 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.288 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 t -100.45 -16.92 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.286 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.62 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -99.01 14.47 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.66 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -63.97 -41.95 97.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 58.4 t -61.37 -47.55 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -63.0 -50.2 71.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 21' ' ' LEU . 53.2 t -67.28 -40.71 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -62.65 -48.4 79.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -62.11 -38.91 90.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 110.243 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.45 -15.89 60.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.382 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.072 HD23 ' O ' ' A' ' 46' ' ' LEU . 7.2 tt -101.89 -9.33 20.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 110.387 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t30 78.26 -50.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.48 -0.762 . . . . 0.0 111.025 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.564 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 56.3 mtp180 -76.66 142.29 70.07 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.081 -1.012 . . . . 0.0 110.259 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.96 140.96 32.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.147 1.604 . . . . 0.0 110.637 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.727 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -75.73 -29.5 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 0.0 110.333 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.678 HG22 ' CE1' ' A' ' 67' ' ' PHE . 48.8 p -59.5 -22.8 62.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 110.316 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.554 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -77.52 -58.65 0.92 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 0.0 110.268 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 47.8 Cg_endo -73.68 -28.24 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.973 1.512 . . . . 0.0 110.702 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.567 HG22 HG21 ' A' ' 65' ' ' THR . 3.4 m -56.28 -19.74 15.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -72.77 -45.38 58.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.107 -0.995 . . . . 0.0 110.346 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 10.1 m-30 -64.6 -39.82 94.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.095 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -41.15 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -60.28 -35.33 87.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.0 m -56.99 -37.24 71.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 109.769 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.29 -44.0 93.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 110.722 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.023 HD13 ' NE2' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -88.24 12.64 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.134 -0.979 . . . . 0.0 111.032 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.1 4.78 30.31 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -115.29 163.99 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 0.0 109.141 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.736 ' O ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -106.2 -121.58 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.621 -1.3 . . . . 0.0 109.738 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 54' ' ' THR . 1.3 p -149.84 170.43 18.79 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.45 -0.781 . . . . 0.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.66 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -142.41 139.43 31.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.82 144.17 51.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.759 -1.213 . . . . 0.0 113.13 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.3 t0 -126.34 117.38 22.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.165 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 16.9 t -86.58 -61.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -56.47 -16.65 6.23 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.192 -0.942 . . . . 0.0 108.633 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.2 t30 -105.74 -30.02 9.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.584 -0.697 . . . . 0.0 110.152 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.7 m-20 71.05 16.67 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 tpt180 -113.62 128.98 56.63 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.503 -0.748 . . . . 0.0 109.865 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.688 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.44 138.2 50.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.469 -0.769 . . . . 0.0 110.022 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 ' HG2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -132.41 148.06 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 64' ' ' GLN . 59.8 t -114.43 139.03 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.258 -0.901 . . . . 0.0 109.469 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.003 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 11.6 m-80 -64.05 141.72 58.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.085 -1.01 . . . . 0.0 110.469 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 99.64 142.12 12.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p -80.6 127.3 32.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 1.023 ' NE2' HD13 ' A' ' 61' ' ' LEU . 78.9 m-70 -142.2 141.03 32.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.801 . . . . 0.0 110.403 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 83' ' ' ASN . 4.6 tp10 -104.04 149.57 25.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.928 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -43.91 64.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.426 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -64.15 -33.29 75.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.238 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.69 -40.42 84.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 110.331 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 2.0 mp -60.58 -45.24 94.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.04 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -47.41 64.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.036 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.8 t0 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.54 -179.747 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD23 ' CB ' ' A' ' 85' ' ' LEU . 5.3 tp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.258 0.551 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.558 HD12 ' OD1' ' A' ' 38' ' ' ASN . 25.9 mt -110.97 120.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.43 132.23 54.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.539 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.0 135.71 53.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.1 t -99.05 122.36 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.607 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.297 0.57 . . . . 0.0 110.381 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -97.43 153.12 18.31 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.929 -1.107 . . . . 0.0 109.213 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.555 ' CG2' ' O ' ' A' ' 34' ' ' THR . 1.3 t -117.94 121.72 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.771 -1.205 . . . . 0.0 110.877 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.27 117.63 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.723 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 39' ' ' MET . 19.0 mt -95.62 108.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.72 -4.9 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.364 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.652 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -109.21 -1.19 18.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 36' ' ' ILE . 34.9 ttm -64.22 -44.2 92.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 110.084 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 11.6 p -70.15 -39.46 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.865 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' N ' HG13 ' A' ' 40' ' ' VAL . 23.8 t70 -62.51 -50.74 70.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.141 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 38' ' ' ASN . 12.4 p -68.5 -45.34 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.619 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -67.85 -35.13 78.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.355 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 2.4 tttp -67.4 -36.58 81.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.43 61.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.1 tt -117.47 -9.16 10.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.914 ' HB2' HD23 ' A' ' 46' ' ' LEU . 1.4 t-20 171.44 -148.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mtt85 -96.41 169.19 9.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.021 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.14 127.81 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.396 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.452 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 48.7 Cg_endo -75.03 46.92 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.927 1.488 . . . . 0.0 110.887 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.995 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -68.05 -26.14 65.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.58 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -73.99 -54.31 3.61 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.722 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.4 Cg_endo -69.92 -19.85 34.84 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.812 1.428 . . . . 0.0 110.779 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 65' ' ' THR . 6.3 m -56.25 -18.9 11.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.989 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -72.88 -40.82 65.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -58.66 -49.68 76.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.049 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 10.3 m-85 -57.27 -35.87 70.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -65.31 -35.14 91.14 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 67.0 m -56.69 -37.19 70.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.08 -1.247 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -49.3 69.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.644 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.018 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.9 11.94 3.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.113 -0.992 . . . . 0.0 111.115 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.2 4.66 30.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -118.35 164.05 15.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.4 mt-30 -110.34 -120.53 0.28 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.594 -1.316 . . . . 0.0 109.875 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 54' ' ' THR . 1.1 p -149.4 170.41 18.62 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.435 -0.791 . . . . 0.0 110.921 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.801 ' HB2' HG23 ' A' ' 75' ' ' ILE . 1.8 mm-40 -140.97 139.66 34.27 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.995 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.6 m-85 -126.5 142.99 51.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.751 -1.218 . . . . 0.0 113.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -123.13 117.5 25.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.997 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.53 -64.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.599 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -16.91 6.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.134 -0.979 . . . . 0.0 108.656 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -103.75 -29.66 10.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.603 -0.686 . . . . 0.0 110.103 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.5 m-20 69.58 15.95 8.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.128 -0.982 . . . . 0.0 110.158 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 15.4 ttm180 -113.65 129.44 56.57 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.852 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.737 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.61 138.04 50.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.394 -0.816 . . . . 0.0 110.309 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.801 HG23 ' HB2' ' A' ' 66' ' ' GLN . 17.8 tt -130.6 148.41 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 64' ' ' GLN . 4.2 t -114.73 139.21 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -0.958 . . . . 0.0 109.327 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.836 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 62.4 m-80 -67.86 140.03 56.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.346 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . 105.63 145.39 13.25 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -80.44 133.59 35.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -1.2 . . . . 0.0 110.179 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.67 ' NE2' HD13 ' A' ' 61' ' ' LEU . 99.1 m-70 -142.32 119.83 11.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.508 -0.745 . . . . 0.0 110.8 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -82.92 158.76 22.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.31 -43.74 61.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.997 -1.065 . . . . 0.0 109.559 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 2.4 t30 -64.71 -33.27 75.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.2 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -36.31 75.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.052 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' CB ' HD23 ' A' ' 21' ' ' LEU . 20.5 mt -58.85 -32.45 69.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.589 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 51.8 mm-40 -68.79 -35.08 76.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.5 t70 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.442 -0.787 . . . . 0.0 111.585 -178.744 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 22' ' ' ILE . 5.1 tt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.231 0.538 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD23 ' A' ' 21' ' ' LEU . 4.7 mt -103.97 136.77 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.71 126.75 45.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.717 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 mmtp -116.12 138.05 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 25' ' ' VAL . 4.3 p -93.34 122.05 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.6 tt0 . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.406 -0.809 . . . . 0.0 110.217 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.71 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.52 0.676 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -97.71 152.85 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.905 -1.122 . . . . 0.0 109.559 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.923 HG21 ' CD2' ' A' ' 80' ' ' HIS . 18.5 m -110.78 115.69 29.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.938 -1.101 . . . . 0.0 110.771 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 24' ' ' LYS . 14.3 p -107.14 117.42 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.2 mt -95.77 108.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 37' ' ' VAL . 7.6 p -100.6 -13.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.667 ' OD1' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -101.47 -1.32 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.415 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -64.5 -45.26 88.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 8.5 p -67.19 -38.58 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.0 110.422 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.519 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.2 t0 -61.93 -48.92 78.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -0.945 . . . . 0.0 110.353 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 38' ' ' ASN . 79.9 t -68.41 -40.7 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -66.43 -38.69 87.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -67.11 -36.45 81.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.052 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.762 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -63.2 -30.27 71.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.1 mp -115.18 -9.31 12.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' ALA . 6.1 p30 171.37 -110.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.37 -0.831 . . . . 0.0 110.388 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.916 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.9 mtm-85 -137.32 167.35 21.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 44.9 Cg_endo -72.0 137.91 30.11 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.907 1.477 . . . . 0.0 110.571 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 1.079 ' O ' HG23 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.11 52.08 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.066 1.561 . . . . 0.0 110.523 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.888 HG22 ' CE1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -67.87 -21.69 65.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.551 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 m-85 -81.4 -54.2 0.71 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 111.081 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -72.47 2.49 5.08 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.796 1.419 . . . . 0.0 111.338 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 1.079 HG23 ' O ' ' A' ' 50' ' ' PRO . 1.9 p -66.35 -18.59 65.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -72.86 -42.3 63.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.878 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -58.72 -51.43 70.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.117 -0.99 . . . . 0.0 110.433 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.547 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 24.7 m-85 -57.82 -42.59 84.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.65 -35.52 89.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -37.28 70.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -1.208 . . . . 0.0 110.039 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.63 -48.88 70.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.009 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.14 12.45 3.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.066 -1.021 . . . . 0.0 111.097 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.85 4.85 22.28 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.046 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.71 163.87 15.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -1.139 . . . . 0.0 109.081 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.51 ' C ' ' CG2' ' A' ' 65' ' ' THR . 66.4 mt-30 -110.4 -123.07 0.27 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.643 -1.285 . . . . 0.0 109.929 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.596 HG21 ' HB ' ' A' ' 54' ' ' THR . 2.0 p -149.92 170.76 18.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.97 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.647 ' CB ' HG22 ' A' ' 75' ' ' ILE . 2.0 tm0? -144.27 139.4 28.59 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.888 ' CE1' HG22 ' A' ' 51' ' ' THR . 30.8 m-85 -126.76 145.85 50.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.792 -1.193 . . . . 0.0 112.98 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 71' ' ' ASN . 10.5 m-20 -126.52 117.52 23.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.274 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.9 m -87.29 -45.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.63 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.604 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.38 -8.39 46.11 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.1 m120 -118.94 -24.69 6.49 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.695 -0.628 . . . . 0.0 110.147 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.1 m-20 68.45 15.71 9.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.958 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.587 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 5.6 mtp180 -113.82 129.43 56.59 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.566 -0.709 . . . . 0.0 109.788 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -113.79 130.91 56.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.484 -0.76 . . . . 0.0 110.316 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.647 HG22 ' CB ' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -111.39 148.04 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 3.0 t -120.31 132.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 109.22 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.046 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 82.5 m-20 -66.17 141.01 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 110.555 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 99.56 137.39 9.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 86.5 p -96.5 116.04 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.107 -1.231 . . . . 0.0 110.639 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CD2' HG21 ' A' ' 34' ' ' THR . 3.1 p-80 -143.26 127.47 17.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.274 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.552 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -73.64 151.62 40.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.986 -1.071 . . . . 0.0 109.737 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.06 -44.59 64.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 110.208 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.56 -33.3 75.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.835 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.31 -36.6 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.582 -0.699 . . . . 0.0 111.084 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 7.9 mp -59.22 -44.84 92.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.16 -0.963 . . . . 0.0 110.725 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.02 -36.42 83.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.037 -1.039 . . . . 0.0 109.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.2 t0 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.475 -0.766 . . . . 0.0 111.426 -179.573 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 21' ' ' LEU . 10.3 tt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.261 0.553 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.62 133.82 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.239 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.05 147.18 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.099 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.22 137.17 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 110.3 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' H ' HG12 ' A' ' 25' ' ' VAL . 4.3 p -97.03 135.33 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.201 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 ' HB3' ' A' ' 79' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.517 0.675 . . . . 0.0 109.581 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' ' 75' ' ' ILE . 7.7 mtmt -112.66 134.01 54.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.1 m -97.24 120.23 37.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.2 m -101.53 118.78 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.737 HG23 ' CB ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -95.22 111.95 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 24' ' ' LYS . 13.9 t -101.1 -44.13 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.876 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -92.2 4.61 52.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.94 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.737 ' CB ' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.15 -33.38 75.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.0 110.242 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 41' ' ' ASP . 35.2 m -59.42 -38.39 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -64.05 -47.14 81.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.184 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.53 -48.32 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . . . -56.65 -34.93 67.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 2.4 tmtt? -57.72 -48.76 78.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.6 66.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.084 HD23 ' O ' ' A' ' 46' ' ' LEU . 6.7 tt -85.34 -9.38 57.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 83.67 -35.72 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.706 -0.621 . . . . 0.0 110.621 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HB2' HD22 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -92.62 154.16 42.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.224 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.533 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.3 Cg_endo -73.18 150.57 47.89 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.021 1.537 . . . . 0.0 110.365 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HB2' ' SD ' ' A' ' 39' ' ' MET . 46.6 Cg_endo -73.24 -22.4 19.04 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.043 1.549 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.783 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.5 p -66.12 -21.66 66.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -79.79 -56.63 0.75 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.786 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 49' ' ' PRO . 46.3 Cg_endo -73.4 2.41 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.907 1.477 . . . . 0.0 111.054 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.581 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.44 -28.78 61.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.002 -1.062 . . . . 0.0 110.231 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -72.87 -45.56 57.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -0.923 . . . . 0.0 110.523 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.04 -51.18 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 110.414 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -44.01 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.887 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.563 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -60.06 -35.1 86.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -37.36 70.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -49.47 58.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.196 -0.94 . . . . 0.0 110.581 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.065 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -77.88 9.06 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 0.0 111.121 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.01 4.52 42.44 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -115.06 163.75 15.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -1.143 . . . . 0.0 109.129 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.726 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.5 pm0 -110.09 -120.78 0.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.582 -1.324 . . . . 0.0 109.964 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.5 p -149.4 170.53 18.34 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.447 -0.783 . . . . 0.0 110.966 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -143.82 139.53 29.37 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.4 m-85 -126.59 142.03 51.67 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.862 -1.135 . . . . 0.0 112.803 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 42.9 m-20 -121.33 117.47 27.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.083 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.09 -63.58 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -16.73 6.52 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.16 -0.962 . . . . 0.0 108.592 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.95 -29.88 10.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.656 -0.652 . . . . 0.0 110.051 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.5 m-20 69.66 15.48 8.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 109.986 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 2.6 ttm180 -113.89 129.86 56.55 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.669 -0.644 . . . . 0.0 109.581 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.704 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.5 m-30 -113.0 134.53 54.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.102 HD13 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -129.44 148.77 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.816 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 1.102 ' N ' HD13 ' A' ' 75' ' ' ILE . 25.5 t -113.6 138.0 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -0.985 . . . . 0.0 109.864 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 21.6 m-20 -59.88 141.08 56.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.855 . . . . 0.0 110.905 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.55 157.76 33.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.937 ' HB3' HD12 ' A' ' 32' ' ' ILE . 91.8 p -101.81 122.13 43.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.143 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.612 ' NE2' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.03 114.93 8.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 85' ' ' LEU . 2.2 pm0 -84.19 151.82 24.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.811 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLN . . . -52.46 -39.36 61.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.599 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 1.4 t-20 -64.54 -34.04 77.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 110.709 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.593 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -72.95 -48.27 38.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.635 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -0.957 . . . . 0.0 110.253 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.3 mt-30 -58.93 -36.99 75.67 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 1.1 m-20 . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.426 0.631 . . . . 0.0 109.618 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.697 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.5 tm? . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.222 0.534 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.61 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.1 mp -106.76 121.83 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.343 -0.848 . . . . 0.0 109.964 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.78 46.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.235 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.509 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.1 136.45 52.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.3 m -93.95 135.09 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.172 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.801 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.8 mm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.272 0.558 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -129.44 142.84 50.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.282 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.832 HG21 ' NE2' ' A' ' 80' ' ' HIS . 20.9 m -98.34 128.87 44.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.632 HG12 HG23 ' A' ' 75' ' ' ILE . 3.2 m -101.43 127.69 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.602 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 0.7 OUTLIER -93.82 121.12 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.914 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.84 -46.96 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 111.26 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.99 18.5 14.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.989 -1.069 . . . . 0.0 111.17 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.602 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.16 -45.26 89.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 110.236 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' ASP . 23.5 m -70.28 -39.09 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' ' 40' ' ' VAL . 58.7 t0 -62.08 -48.9 78.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.75 -48.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.216 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -63.72 -35.03 79.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -62.78 -36.48 83.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.22 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.895 . . . . 0.0 110.232 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.874 HD12 ' HB2' ' A' ' 47' ' ' ASN . 3.2 pp -105.91 -1.24 24.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.874 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.8 OUTLIER 173.41 -151.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 110.243 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.431 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 8.4 mtt85 -89.31 174.95 4.34 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.6 Cg_endo -72.81 131.8 17.62 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.932 1.49 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 39' ' ' MET . 46.5 Cg_endo -73.72 1.25 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.547 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.918 HG23 ' CE1' ' A' ' 67' ' ' PHE . 88.1 m -56.46 -21.83 28.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 110.267 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.576 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -97.71 -54.9 0.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 111.277 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 47.4 Cg_endo -74.99 -2.76 12.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.663 1.349 . . . . 0.0 111.151 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.58 HG23 HG21 ' A' ' 65' ' ' THR . 1.2 t -57.89 -14.41 6.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.298 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -72.77 -45.59 57.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.436 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -65.2 -51.17 62.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.026 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.36 -37.07 72.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 109.33 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -63.55 -35.21 91.73 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -37.15 70.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.2 . . . . 0.0 109.753 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 3.8 tp10 -64.5 -49.36 71.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.02 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -81.1 11.57 4.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.15 -0.969 . . . . 0.0 110.985 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.95 4.57 42.27 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.033 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -116.11 163.15 16.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.145 -1.209 . . . . 0.0 109.257 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.522 ' C ' ' CG2' ' A' ' 65' ' ' THR . 2.2 tt0 -119.04 -123.33 0.29 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 0.0 109.813 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.9 p -149.98 170.63 18.4 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.641 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -149.59 139.48 21.91 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.918 ' CE1' HG23 ' A' ' 51' ' ' THR . 23.8 m-85 -126.86 146.15 50.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.249 . . . . 0.0 113.024 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 3.6 t0 -121.34 117.45 26.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.922 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.14 -63.08 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.876 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -56.64 -15.22 4.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.139 -0.976 . . . . 0.0 108.957 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.8 t30 -106.0 -29.07 10.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.743 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 70.62 16.89 6.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.55 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -113.76 129.81 56.53 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.728 ' O ' HD13 ' A' ' 75' ' ' ILE . 3.7 m-30 -111.16 129.03 56.07 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.752 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 74' ' ' TYR . 13.8 mm -130.77 149.28 33.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 12.3 m -112.78 139.44 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 109.729 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.033 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 6.8 p-10 -69.32 137.0 52.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.258 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 108.1 129.61 6.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . 63.1 p -92.07 121.77 33.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.005 -1.291 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.832 ' NE2' HG21 ' A' ' 34' ' ' THR . 2.2 p-80 -142.02 114.86 8.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.416 -0.803 . . . . 0.0 110.04 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -58.72 157.13 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.067 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.572 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.11 -36.96 52.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -55.91 -33.53 64.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.877 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -63.31 -39.52 94.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.551 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.606 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.5 mm? -60.36 -32.99 71.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.24 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.477 ' CA ' ' OE1' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -62.74 -37.04 85.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 109.772 179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 9.3 tp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.291 0.567 . . . . 0.0 110.223 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 22' ' ' ILE . 14.2 mm -132.59 129.63 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.86 149.24 48.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -116.15 138.45 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 25' ' ' VAL . 3.3 m -92.95 131.51 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 0.0 110.395 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.034 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.912 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' GLU . 3.6 ttpt -129.49 152.6 48.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.932 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.802 ' O ' HG23 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -111.21 128.49 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 75' ' ' ILE . 2.2 p -117.8 117.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.517 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.724 HD12 ' CE ' ' A' ' 39' ' ' MET . 1.6 mt -96.07 112.95 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.07 -14.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 110.417 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 31.1 m120 -111.01 11.38 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.724 ' CE ' HD12 ' A' ' 36' ' ' ILE . 1.2 ttt -61.74 -45.41 94.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 36.6 t -70.24 -47.62 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.68 -50.01 70.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.897 . . . . 0.0 110.534 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 38' ' ' ASN . 43.0 t -68.36 -45.33 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.464 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.13 -39.06 86.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -67.52 -41.14 84.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.47 -17.88 62.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.9 tt -117.48 -9.11 10.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 110.522 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.831 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.7 OUTLIER 167.68 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.34 170.47 10.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.61 135.21 19.55 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.876 1.461 . . . . 0.0 110.538 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.439 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 50.5 Cg_endo -78.18 20.33 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.995 1.524 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -56.59 -21.93 30.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.311 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -85.54 -58.54 0.33 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.0 110.877 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.8 Cg_endo -73.16 0.3 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.798 1.42 . . . . 0.0 110.943 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -56.52 -20.92 22.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.217 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.81 -39.97 66.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.958 . . . . 0.0 110.584 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.5 t80 -58.87 -51.18 71.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.309 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 32.3 m-85 -57.53 -43.37 84.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.6 -35.38 85.59 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 86.9 m -57.1 -37.24 71.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 110.028 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -66.19 -49.35 67.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 110.83 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.034 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.17 11.56 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 4.89 26.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.05 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.47 163.77 15.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.3 mm100 -105.45 -120.44 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.598 -1.314 . . . . 0.0 109.754 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.52 170.24 19.07 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 75' ' ' ILE . 6.1 tt0 -143.47 139.33 29.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.698 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.3 m-85 -126.81 141.12 51.91 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.808 -1.182 . . . . 0.0 112.71 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -122.24 117.46 26.22 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.059 178.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -85.89 -63.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.656 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 2.3 ttmt -55.23 -17.49 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 108.872 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -105.4 -29.35 10.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.561 -0.712 . . . . 0.0 110.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.8 m-20 70.77 16.54 6.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 99.6 mtt180 -113.68 129.64 56.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.567 -0.708 . . . . 0.0 109.629 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.1 m-30 -113.29 137.94 50.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 110.337 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 34' ' ' THR . 44.3 mt -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 64' ' ' GLN . 14.5 t -114.04 137.73 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.05 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 67.9 m-80 -57.9 142.22 46.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 110.534 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 84.65 152.5 16.44 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.912 ' OG ' HD12 ' A' ' 32' ' ' ILE . 45.4 p -99.67 115.98 30.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.256 . . . . 0.0 110.687 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.764 ' NE2' HG21 ' A' ' 34' ' ' THR . 5.0 p-80 -143.32 117.05 9.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.158 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 3.2 tt0 -65.75 153.83 40.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.618 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -44.75 65.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.102 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.51 -33.47 76.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.055 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 80' ' ' HIS . 4.0 tttp -61.11 -36.48 79.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.749 -0.594 . . . . 0.0 110.145 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.673 HD21 ' HD2' ' A' ' 80' ' ' HIS . 0.3 OUTLIER -59.4 -39.44 83.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.0 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -36.48 74.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.962 -1.086 . . . . 0.0 108.305 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 t70 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.397 0.618 . . . . 0.0 109.938 178.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 85' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.18 0.514 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.2 pt -109.99 120.89 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.13 136.77 54.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.722 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.6 mmmm -118.44 137.93 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.8 m -93.31 128.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.338 0.589 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.757 ' HD2' HG21 ' A' ' 75' ' ' ILE . 17.6 ttmm -97.58 152.91 18.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 109.29 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.8 m -99.28 115.81 30.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.832 -1.168 . . . . 0.0 110.914 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.2 p -112.36 117.42 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.84 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 ' HE3' ' A' ' 39' ' ' MET . 58.5 mt -95.88 109.75 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.66 -16.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.316 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' HD11 ' A' ' 22' ' ' ILE . 6.2 p-10 -97.8 2.61 49.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 110.21 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.629 ' HE3' HG21 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -55.86 -33.64 64.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.195 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.49 -44.47 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 7.2 t0 -66.17 -48.35 71.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 43' ' ' ALA . 8.1 p -61.15 -41.37 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.778 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -61.35 -35.18 76.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.014 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.4 mmmt -59.41 -37.21 77.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.875 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.915 ' C ' HD23 ' A' ' 46' ' ' LEU . . . -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.952 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.012 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -96.27 -9.05 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.889 . . . . 0.0 109.218 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 74.3 -50.18 0.68 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.634 . . . . 0.0 110.408 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 20.9 mtt85 -77.04 168.03 31.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.6 140.45 32.79 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.397 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.778 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.6 Cg_endo -73.51 -15.62 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.054 1.555 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.707 HG22 ' CE1' ' A' ' 67' ' ' PHE . 73.8 p -64.07 -27.05 68.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -75.98 -54.91 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.19 -42.91 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.816 1.429 . . . . 0.0 110.829 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 50' ' ' PRO . 6.9 t -56.36 -15.75 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 110.386 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -72.25 -45.36 60.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.349 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.66 79.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.6 -42.09 82.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.008 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.557 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.39 -35.43 85.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -37.12 74.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 110.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.72 -30.09 69.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.265 -0.897 . . . . 0.0 110.987 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.023 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -102.26 13.19 35.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.969 -1.082 . . . . 0.0 110.914 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.06 4.89 30.63 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.023 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -113.74 164.29 13.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.202 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.926 ' O ' HG13 ' A' ' 76' ' ' VAL . 6.0 tt0 -109.92 -121.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.626 -1.296 . . . . 0.0 109.608 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.74 170.5 18.58 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.385 -0.822 . . . . 0.0 111.325 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.5 OUTLIER -139.82 139.92 36.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.707 ' CE1' HG22 ' A' ' 51' ' ' THR . 21.1 m-85 -126.36 142.75 51.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.59 -1.244 . . . . 0.0 113.138 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 2.3 t0 -121.7 117.19 26.02 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.065 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -89.85 -45.1 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.0 -7.04 43.5 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -119.05 -27.19 5.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.749 -0.594 . . . . 0.0 110.186 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.0 m-20 70.19 16.98 7.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 12.4 mmm-85 -113.53 129.77 56.49 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.671 -0.643 . . . . 0.0 109.491 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.7 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.02 129.39 56.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 110.541 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.757 HG21 ' HD2' ' A' ' 33' ' ' LYS . 12.6 mt -123.22 149.8 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.618 -0.676 . . . . 0.0 109.792 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 64' ' ' GLN . 75.3 t -112.84 139.19 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.981 -1.074 . . . . 0.0 109.19 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.653 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 35.2 m-80 -65.63 141.63 58.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.862 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 105.24 138.83 9.56 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.38 131.5 35.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.874 ' NE2' HD13 ' A' ' 61' ' ' LEU . 93.1 m-70 -141.7 126.34 17.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.645 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 82' ' ' ALA . 3.8 tp10 -100.89 151.07 22.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.583 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 81' ' ' GLU . . . -52.1 -43.67 64.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 110.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -58.55 -38.25 77.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.955 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -39.55 78.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 21' ' ' LEU . 21.3 mt -60.4 -40.76 92.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -59.19 -36.36 75.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.918 . . . . 0.0 109.96 179.891 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.249 0.547 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 22' ' ' ILE . 27.8 mm -121.97 143.82 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.975 ' O ' HG12 ' A' ' 35' ' ' VAL . 7.9 mttt -139.41 138.08 36.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 0.0 110.148 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 79' ' ' SER . 46.5 t -93.53 122.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.374 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.7 mm . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.306 0.574 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.53 141.93 50.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' NE2' ' A' ' 80' ' ' HIS . 1.4 m -96.88 127.87 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 24' ' ' LYS . 3.5 p -117.04 118.02 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.956 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 39' ' ' MET . 8.1 mt -95.39 138.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.329 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.611 HG22 ' NH1' ' A' ' 73' ' ' ARG . 28.8 t -100.31 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.48 12.25 37.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -53.35 -33.43 53.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -68.83 -38.41 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -50.21 72.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 43' ' ' ALA . 10.1 p -65.84 -40.82 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.814 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -64.98 -34.92 79.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.203 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.47 85.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.96 63.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.071 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.912 HD23 ' O ' ' A' ' 46' ' ' LEU . 10.3 tt -92.57 -3.32 55.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.8 m-20 72.61 -62.41 0.47 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.815 . . . . 0.0 110.364 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.616 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 169.86 19.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.48 147.15 45.82 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.0 Cg_endo -73.92 -23.4 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.997 1.525 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.038 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 72.5 p -57.85 -21.81 44.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.0 m-30 -80.14 -58.37 0.6 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.893 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.27 -30.94 15.06 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.837 1.44 . . . . 0.0 111.045 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 51' ' ' THR . 9.7 t -57.99 -14.01 5.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.993 . . . . 0.0 110.3 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 13.1 tptm -64.25 -45.38 88.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.952 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -64.83 -38.77 92.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.304 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.57 -35.31 85.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -37.32 71.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.407 ' OE1' ' CA ' ' A' ' 60' ' ' GLU . 3.1 mm-40 -66.68 -49.54 65.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.23 -0.919 . . . . 0.0 110.622 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.061 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -79.92 12.87 2.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.189 -0.945 . . . . 0.0 110.961 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.25 9.38 29.48 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.061 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -118.74 163.95 16.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -1.122 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.4 mt-30 -105.36 -117.29 0.23 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.833 -1.167 . . . . 0.0 110.144 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.0 170.37 18.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 111.081 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HG3' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -144.88 139.65 27.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.038 ' CZ ' HG22 ' A' ' 51' ' ' THR . 24.7 m-85 -126.67 143.46 51.22 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.001 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -123.69 117.37 24.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.969 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -88.11 -45.8 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -70.0 -7.6 42.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -118.32 -25.92 6.43 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.687 -0.633 . . . . 0.0 110.207 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.6 m-20 68.74 16.17 8.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.611 ' NH1' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.86 129.79 56.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.525 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.9 m-30 -112.89 129.2 56.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.669 HG12 HG23 ' A' ' 35' ' ' VAL . 52.8 mt -118.57 149.17 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.521 -0.737 . . . . 0.0 109.966 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.2 p -113.15 134.15 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.061 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 65.5 m-80 -50.63 143.4 9.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.772 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 94.44 131.28 6.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.57 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 59.4 p -97.3 120.29 37.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -1.152 . . . . 0.0 110.106 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.886 ' NE2' HG21 ' A' ' 34' ' ' THR . 1.8 p-80 -142.38 151.52 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.787 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 4.8 tt0 -93.0 157.69 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.951 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.3 -43.8 64.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.68 -33.47 76.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -37.33 86.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.191 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 85' ' ' LEU . 10.2 mp -60.09 -33.02 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -68.07 -36.22 79.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.846 . . . . 0.0 109.641 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 t70 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.638 -179.905 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 5.7 tt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.235 0.54 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.2 mt -112.4 143.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.781 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.37 123.98 40.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.898 . . . . 0.0 110.385 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 138.2 53.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 74.6 t -93.11 122.32 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.409 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HB3' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.389 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 1.009 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -126.88 152.65 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -0.956 . . . . 0.0 110.502 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -108.06 116.24 31.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.133 -0.98 . . . . 0.0 110.373 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 HD12 ' A' ' 75' ' ' ILE . 48.6 t -104.08 117.46 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.758 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.9 mm -96.02 108.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.41 -23.53 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.663 ' OD1' HG23 ' A' ' 42' ' ' VAL . 46.2 t30 -95.93 8.79 42.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.545 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.9 ttt -64.12 -45.29 89.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 17.9 t -67.24 -40.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -45.26 70.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.661 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.663 HG23 ' OD1' ' A' ' 38' ' ' ASN . 80.4 t -68.29 -48.73 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -67.45 -43.96 79.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.393 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 7.8 ttpt -59.54 -36.48 76.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.095 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.21 -16.5 62.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.942 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -117.39 -11.17 10.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.149 -0.969 . . . . 0.0 110.078 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.737 ' CB ' HD13 ' A' ' 46' ' ' LEU . 13.6 t-20 167.02 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.237 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.068 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -137.67 172.07 7.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.08 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -72.72 139.51 30.9 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.031 1.543 . . . . 0.0 110.629 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.932 ' O ' HG23 ' A' ' 54' ' ' THR . 47.2 Cg_endo -72.76 60.34 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.042 1.548 . . . . 0.0 110.394 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -68.73 -50.53 50.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 111.332 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.762 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 p90 -87.33 -29.0 0.38 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.351 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.3 Cg_endo -71.29 -2.18 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.07 1.037 . . . . 0.0 110.755 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.932 HG23 ' O ' ' A' ' 50' ' ' PRO . 2.9 p -76.46 -10.99 59.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.106 -0.996 . . . . 0.0 110.372 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -72.94 -45.42 58.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 0.0 110.58 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.53 -47.78 77.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 110.392 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.46 -42.8 83.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.859 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.52 -35.44 85.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -37.21 71.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -1.196 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -48.79 68.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.879 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.028 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -80.72 12.83 2.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.107 -0.995 . . . . 0.0 110.95 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.47 5.44 22.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.48 163.93 15.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -1.133 . . . . 0.0 109.213 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.484 ' C ' ' CG2' ' A' ' 65' ' ' THR . 19.6 mt-30 -102.87 -119.56 0.19 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.634 -1.292 . . . . 0.0 109.998 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -149.5 170.41 18.67 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 111.005 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.559 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.9 mt-30 -146.01 139.47 26.14 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.69 144.53 50.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.876 -1.14 . . . . 0.0 112.748 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.587 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 1.9 t0 -124.01 117.42 24.69 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.323 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 15.2 m -88.91 -46.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 2.5 tppt? -69.75 -8.73 50.52 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -117.17 -26.76 6.68 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.677 -0.639 . . . . 0.0 110.124 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 4.7 m-20 69.8 16.53 7.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.587 ' HG3' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.87 129.66 56.57 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 109.643 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.755 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.18 129.18 56.59 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.417 -0.802 . . . . 0.0 110.5 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.934 HD12 HG22 ' A' ' 35' ' ' VAL . 2.3 tt -124.12 148.34 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.487 -0.758 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 34' ' ' THR . 11.0 m -114.35 139.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.7 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.072 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 70.6 m-20 -55.74 146.36 21.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.5 150.78 21.87 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 1.009 ' OG ' HD12 ' A' ' 32' ' ' ILE . 2.7 p -103.92 123.92 48.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -1.173 . . . . 0.0 110.202 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 1.019 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.19 114.84 8.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.781 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 4.9 tt0 -74.74 156.54 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.605 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.7 -44.19 63.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.077 -1.014 . . . . 0.0 109.74 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.09 -33.14 75.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.22 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 81' ' ' GLU . 29.8 mttt -71.35 -36.47 71.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.638 -0.663 . . . . 0.0 110.475 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 81' ' ' GLU . 1.2 mm? -59.37 -44.23 92.77 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.227 -0.921 . . . . 0.0 110.144 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -68.62 -36.12 78.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.948 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.8 t0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 111.297 -179.386 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.222 0.534 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 37' ' ' VAL . 3.0 tt -128.5 136.1 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 34' ' ' THR . . . -125.8 135.44 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 110.23 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.773 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.16 137.47 52.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.7 m -100.27 135.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 179.933 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.673 HD13 ' OG ' ' A' ' 79' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.093 0.473 . . . . 0.0 110.59 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 mtmm -98.35 142.14 30.36 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.683 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.572 ' C ' HG23 ' A' ' 75' ' ' ILE . 1.9 m -96.97 115.93 28.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.636 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.4 p -105.14 117.83 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.953 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 92.0 mt -95.66 112.87 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.644 HG22 HG23 ' A' ' 22' ' ' ILE . 28.6 m -83.52 -4.88 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.04 -0.29 47.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.275 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -53.32 -42.41 66.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.133 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.43 -40.4 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.24 -47.81 75.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' O ' HD23 ' A' ' 46' ' ' LEU . 84.1 t -62.77 -44.73 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -56.4 -35.06 67.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -36.49 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.95 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.28 78.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.243 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.848 HD11 ' O ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -104.49 0.87 29.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER 73.17 -53.48 0.7 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.664 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.848 ' O ' HD11 ' A' ' 46' ' ' LEU . 4.5 ttt-85 -76.93 147.83 77.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.11 147.31 37.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.988 1.52 . . . . 0.0 110.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 48.8 Cg_endo -75.44 7.54 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.078 1.567 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.215 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -63.01 -37.97 89.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 110.421 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -69.85 -52.28 13.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 110.586 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.8 Cg_endo -70.37 -16.25 34.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.81 1.426 . . . . 0.0 110.462 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.692 HG22 ' CG2' ' A' ' 65' ' ' THR . 1.4 m -71.6 -19.42 62.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.104 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -73.0 -44.96 60.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.517 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 70.7 m-85 -66.84 -45.02 79.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.419 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 53' ' ' PRO . 23.4 m-85 -57.36 -43.97 83.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.801 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.44 -35.21 84.33 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 84.7 m -56.83 -37.38 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.25 . . . . 0.0 110.108 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.99 -48.21 66.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.867 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.014 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.8 10.84 2.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -0.992 . . . . 0.0 111.005 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.85 40.13 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.014 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -114.21 163.67 14.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -1.156 . . . . 0.0 109.503 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.7 tt0 -107.78 -118.49 0.26 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.777 -1.202 . . . . 0.0 109.915 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.692 ' CG2' HG22 ' A' ' 54' ' ' THR . 2.6 p -149.32 170.17 19.14 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 111.148 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -144.42 139.18 28.23 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.215 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.1 m-85 -127.19 142.48 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.712 -1.242 . . . . 0.0 113.032 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -125.24 117.38 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.908 178.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 t -84.78 -64.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -17.16 4.56 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.557 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.6 m-80 -102.12 -31.49 10.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 110.102 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.3 m-20 70.27 15.59 7.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -113.7 129.8 56.52 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.565 -0.709 . . . . 0.0 109.718 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.4 m-30 -112.86 129.29 56.51 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 35' ' ' VAL . 17.8 mt -120.83 149.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 110.285 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 13.4 m -112.96 129.17 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.755 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 28.1 m-20 -48.25 144.51 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.884 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 97.71 146.4 20.7 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.673 ' OG ' HD13 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -102.04 126.07 48.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -1.027 . . . . 0.0 109.889 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -141.94 156.68 45.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 2.3 tt0 -103.99 148.66 25.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 109.81 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.28 -39.74 60.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 1.6 t30 -64.28 -33.36 75.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -37.5 71.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 81' ' ' GLU . 17.3 mt -63.39 -44.66 94.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 12.3 pt20 -68.24 -36.15 79.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 7.8 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.406 -0.809 . . . . 0.0 110.218 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.8 tm? . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.166 0.507 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.628 ' N ' HD22 ' A' ' 21' ' ' LEU . 28.8 mt -103.25 133.52 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -125.53 131.08 52.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' VAL . 5.2 tttt -116.57 138.21 51.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 25' ' ' VAL . 17.9 m -93.24 135.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.729 ' O ' HG22 ' A' ' 32' ' ' ILE . 1.8 mm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.271 0.557 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' A' ' 75' ' ' ILE . 1.2 tppt? -129.42 152.73 48.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 2.8 t -115.31 125.87 53.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -117.31 117.68 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.696 HD13 ' HG3' ' A' ' 39' ' ' MET . 2.3 mp -95.67 143.16 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.52 -39.8 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.561 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -93.68 11.73 27.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.528 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.696 ' HG3' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.18 -45.52 88.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 41' ' ' ASP . 12.8 p -70.38 -43.99 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.0 t0 -69.3 -47.95 63.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.765 ' O ' HD13 ' A' ' 46' ' ' LEU . 4.3 p -61.11 -44.92 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.481 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -68.19 -46.07 71.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.092 -1.005 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 1.3 mtpm? -67.6 -42.6 82.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.852 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.766 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -59.6 -23.25 62.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.821 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.789 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -117.6 -9.26 10.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 110.464 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 9.6 p30 -173.56 -146.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.783 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 11.8 mtm180 -90.2 175.47 3.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.79 . . . . 0.0 110.618 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 44.3 Cg_endo -70.64 137.07 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.019 1.536 . . . . 0.0 110.455 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.2 Cg_endo -76.94 0.23 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.114 1.586 . . . . 0.0 110.427 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.774 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.9 p -56.24 -21.87 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.89 . . . . 0.0 110.43 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.497 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -88.87 -57.78 0.27 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 111.006 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -72.73 -16.64 26.5 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.729 1.384 . . . . 0.0 111.052 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 4.9 t -56.37 -16.12 5.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 110.265 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 tptt -72.66 -45.48 58.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -50.04 75.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 110.152 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 m-85 -57.37 -38.55 74.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.913 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.37 -38.61 93.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -37.33 71.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -1.223 . . . . 0.0 109.94 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.78 -49.49 70.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.04 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.4 11.41 3.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.058 -1.026 . . . . 0.0 110.871 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.16 4.76 30.61 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.049 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -118.8 163.4 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.75 ' O ' HG13 ' A' ' 76' ' ' VAL . 25.1 mt-30 -105.52 -119.18 0.23 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.741 -1.225 . . . . 0.0 109.961 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.4 170.32 18.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.643 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -147.14 139.83 24.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.774 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.4 m-85 -126.59 144.6 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.735 -1.228 . . . . 0.0 112.872 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.576 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -121.76 117.31 26.27 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.893 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 5.1 t -85.95 -64.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.564 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -16.51 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.14 -0.975 . . . . 0.0 108.62 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -103.69 -30.08 10.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.7 m-20 70.21 15.5 7.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.552 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.6 ttp180 -113.71 129.77 56.52 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.629 -0.67 . . . . 0.0 109.568 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.725 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.6 m-30 -112.16 136.89 50.99 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.339 -0.851 . . . . 0.0 110.311 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.643 HG23 ' CB ' ' A' ' 66' ' ' GLN . 3.1 tt -131.18 148.72 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.504 -0.747 . . . . 0.0 110.12 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 64' ' ' GLN . 42.6 t -113.92 139.36 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.134 -0.979 . . . . 0.0 109.748 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 1.049 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 25.3 m-20 -55.54 143.94 27.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 91.52 147.03 19.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.411 ' HB2' ' CG1' ' A' ' 25' ' ' VAL . 72.2 p -89.73 125.33 35.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.117 . . . . 0.0 109.773 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . 74.8 m-70 -141.79 114.81 8.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -86.68 159.02 19.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.29 -44.6 61.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.882 -1.136 . . . . 0.0 109.311 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.86 -33.44 75.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 108.997 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.423 ' HD2' ' HA ' ' A' ' 84' ' ' LYS . 28.8 tptt -68.55 -35.71 77.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.716 -0.615 . . . . 0.0 110.539 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 80' ' ' HIS . 17.5 mt -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.97 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 33.1 tp60 -68.91 -35.98 77.48 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 108.883 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.707 . . . . 0.0 111.339 -179.768 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.257 0.551 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 21' ' ' LEU . 6.9 mt -100.61 120.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.29 139.3 47.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.502 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -116.06 126.74 54.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.922 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 38.8 t -93.58 122.1 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.666 ' CG2' ' O ' ' A' ' 32' ' ' ILE . 1.1 mm . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.337 0.589 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.062 ' CD ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -97.75 153.02 18.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.871 -1.143 . . . . 0.0 109.5 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.59 ' HG1' ' CG ' ' A' ' 80' ' ' HIS . 22.0 m -110.56 115.71 30.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.665 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -110.24 117.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.965 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.946 HG21 ' CG ' ' A' ' 39' ' ' MET . 21.3 mt -96.85 122.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.897 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 37' ' ' VAL . 24.7 m -100.6 -8.41 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.741 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.646 HD21 HD22 ' A' ' 21' ' ' LEU . 15.1 p-10 -116.71 6.99 13.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.021 . . . . 0.0 110.571 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.946 ' CG ' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.03 -45.37 89.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 10.8 t -70.35 -42.33 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.461 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -62.22 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.401 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.9 t -68.36 -44.97 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.467 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . . . -67.72 -45.62 74.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.642 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -65.84 -36.15 82.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.722 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -62.55 -34.47 77.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.5 mp -117.43 -9.17 10.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.951 -1.093 . . . . 0.0 110.917 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' ALA . 7.6 p-10 -162.28 -153.8 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.065 -1.022 . . . . 0.0 110.622 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.4 mtp180 -88.07 175.17 4.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.374 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.4 Cg_endo -72.5 138.23 29.33 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.086 1.572 . . . . 0.0 110.507 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.52 -7.19 17.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.059 1.557 . . . . 0.0 110.654 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.173 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.25 -21.91 26.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 0.0 110.175 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.538 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 6.4 m-85 -88.8 -57.39 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 111.155 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -71.3 -22.66 25.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.802 1.422 . . . . 0.0 111.352 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 10.2 t -56.29 -14.4 2.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.101 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -45.43 66.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.398 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.68 -49.08 74.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' HD23 ' A' ' 61' ' ' LEU . 9.6 m-30 -57.3 -34.1 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.47 -41.86 97.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -37.09 70.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.088 -1.242 . . . . 0.0 109.731 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -63.26 -49.37 74.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.327 -0.858 . . . . 0.0 110.767 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.003 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.65 12.93 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.99 -1.069 . . . . 0.0 110.812 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.73 4.87 28.23 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -121.33 163.48 18.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.183 -1.186 . . . . 0.0 109.397 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.7 mp0 -113.1 -120.9 0.3 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.653 -1.279 . . . . 0.0 109.676 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.5 170.26 19.01 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.447 -0.783 . . . . 0.0 111.042 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.612 ' CB ' HG13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.81 139.94 28.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.173 ' CZ ' HG22 ' A' ' 51' ' ' THR . 25.8 m-85 -126.09 144.19 50.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.688 -1.258 . . . . 0.0 113.055 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -126.08 117.37 23.04 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.11 178.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.01 -64.06 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.534 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -18.21 7.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -101.46 -31.57 10.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.654 -0.654 . . . . 0.0 110.073 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.4 m-20 70.79 15.52 6.87 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.2 -0.938 . . . . 0.0 110.357 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 25.5 ttm180 -113.64 129.54 56.55 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.74 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.0 m-30 -113.74 136.0 53.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.283 -0.886 . . . . 0.0 109.893 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 1.062 HD13 ' CD ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -129.02 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.205 -0.934 . . . . 0.0 110.61 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 64' ' ' GLN . 51.2 t -114.41 122.94 69.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.707 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 64.1 m-20 -50.02 142.69 8.98 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.6 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.96 140.0 9.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 95.6 p -99.09 123.93 43.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.863 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -142.09 134.83 28.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.574 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 4.0 tt0 -85.32 158.94 20.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 109.418 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.24 -44.01 61.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.79 -33.08 75.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.166 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.496 ' CE ' ' HB3' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -59.11 -35.79 74.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.669 -0.644 . . . . 0.0 110.324 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 85' ' ' LEU . 3.6 mm? -58.82 -38.78 79.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.924 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -68.57 -47.69 66.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.324 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.339 179.137 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.816 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.549 0.69 . . . . 0.0 110.649 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 19.9 mt -105.01 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 110.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.66 152.32 45.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 11.1 tttm -116.11 128.39 55.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 80' ' ' HIS . 15.5 m -105.59 135.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 35.5 tt0 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.803 ' O ' HG22 ' A' ' 32' ' ' ILE . 2.1 mm . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.327 0.584 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE2' ' OE1' ' A' ' 26' ' ' GLU . 22.1 pttm -129.62 152.52 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.786 ' HB ' HG23 ' A' ' 76' ' ' VAL . 7.9 m -112.74 128.38 56.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.73 HG12 HD13 ' A' ' 75' ' ' ILE . 4.0 m -109.82 132.29 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 1.0 OUTLIER -80.56 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.57 -46.56 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.64 -1.04 12.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.776 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.554 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 2.7 tmm? -60.38 -33.54 72.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.089 -1.007 . . . . 0.0 110.036 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.84 -42.84 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.078 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -49.77 74.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.04 -40.73 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.056 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' HG3' ' A' ' 50' ' ' PRO . . . -62.81 -35.0 78.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.82 -40.37 79.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -15.9 62.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.041 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.832 HD23 ' O ' ' A' ' 46' ' ' LEU . 8.0 tt -82.56 1.02 40.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.847 . . . . 0.0 110.176 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.6 t30 71.57 -61.95 0.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.671 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 154.11 82.35 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.234 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.5 Cg_endo -72.72 141.59 34.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.002 1.527 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HG3' ' CB ' ' A' ' 43' ' ' ALA . 47.9 Cg_endo -73.55 -24.96 15.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.997 1.525 . . . . 0.0 110.393 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 1.026 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 33.2 p -56.44 -21.75 27.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.381 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.512 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -86.55 -57.46 0.33 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 111.141 -179.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 52' ' ' TYR . 44.4 Cg_endo -70.83 -27.42 21.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.745 1.392 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 15.2 t -56.72 -15.12 4.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -72.81 -39.33 66.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.214 -0.929 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -50.84 72.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 23.9 m-85 -67.53 -31.7 71.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.814 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . -59.27 -48.46 85.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 56.3 m -58.97 -46.26 88.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -1.213 . . . . 0.0 110.333 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -70.17 -28.72 65.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.95 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -91.92 12.99 19.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.932 -179.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.13 12.51 44.35 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -131.59 163.2 28.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -1.17 . . . . 0.0 109.52 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -120.16 -125.31 0.27 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.722 -1.236 . . . . 0.0 109.187 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -150.8 170.36 19.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 111.985 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.0 139.53 20.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.026 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.3 m-85 -126.69 144.27 50.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.656 -1.278 . . . . 0.0 113.273 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -118.7 117.27 28.46 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.79 -64.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.773 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -15.11 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 108.642 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.68 -31.28 9.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.662 . . . . 0.0 110.271 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.9 m-20 72.15 15.32 5.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.222 -0.924 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.535 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 26.9 ttp180 -114.04 129.55 56.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.496 -0.752 . . . . 0.0 109.036 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 5.3 m-30 -108.91 128.93 55.35 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.608 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 35' ' ' VAL . 10.5 mt -128.51 149.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.786 HG23 ' HB ' ' A' ' 34' ' ' THR . 7.4 m -112.24 139.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.919 -1.113 . . . . 0.0 109.753 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -68.33 135.88 52.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.2 158.42 22.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.528 ' HB3' HG23 ' A' ' 32' ' ' ILE . 91.8 p -97.22 123.78 41.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -1.224 . . . . 0.0 110.317 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -141.83 115.02 8.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 1.2 tt0 -89.92 155.32 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.139 -0.976 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.23 -43.59 64.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.15 -33.59 76.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.611 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.88 -36.98 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.505 -0.747 . . . . 0.0 109.762 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 85' ' ' LEU . 0.5 OUTLIER -60.15 -33.63 72.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.773 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.58 -37.12 79.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.994 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.224 0.535 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.52 40.2 3.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 110.205 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.4 m -130.69 -163.99 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 110.215 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -78.2 163.88 25.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 110.208 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 7' ' ' ARG . 92.1 t -67.16 -39.87 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.319 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 33.3 m-20 54.03 29.01 9.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.248 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -70.25 -29.67 66.52 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -0.876 . . . . 0.0 110.233 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.571 ' C ' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -97.99 -0.91 43.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.297 -0.877 . . . . 0.0 110.229 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.571 HG13 ' C ' ' A' ' 8' ' ' SER . 29.5 m -156.37 150.72 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.248 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 176.8 -30.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.351 -0.843 . . . . 0.0 110.16 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 12' ' ' GLN . 14.5 t0 -67.93 153.35 43.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 0.0 110.169 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -69.47 -21.16 63.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 110.274 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.445 ' HB2' ' O ' ' A' ' 12' ' ' GLN . 6.4 m-85 57.8 78.99 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 110.25 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 11.4 p90 -131.34 -28.61 1.87 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.361 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' TYR . 16.2 tpt85 -178.59 -31.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 110.166 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' CD1' ' C ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -100.1 133.52 44.38 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 110.094 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 16' ' ' TYR . 11.5 mttt -129.48 157.0 43.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.928 . . . . 0.0 110.259 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.47 94.53 26.12 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.311 -0.868 . . . . 0.0 110.127 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.57 83.11 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.026 1.54 . . . . 0.0 110.437 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.499 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -78.24 157.01 29.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.296 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 124.12 29.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.228 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 ' ND2' ' A' ' 38' ' ' ASN . 36.7 mt -109.74 128.4 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -116.55 138.95 51.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.205 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.673 ' HB2' HG13 ' A' ' 35' ' ' VAL . 22.7 mtpp -124.85 136.99 54.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 110.239 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' A' ' 79' ' ' SER . 62.7 t -96.38 133.77 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 0.0 110.102 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -123.39 167.95 13.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.99 59.19 0.49 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 173.68 11.39 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -1.15 . . . . 0.0 110.188 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.11 -124.74 6.55 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -85.2 2.47 43.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 110.286 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . 122.1 15.5 4.23 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 32' ' ' ILE . 0.2 OUTLIER 168.46 105.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.261 -1.141 . . . . 0.0 109.845 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HE3' HG21 ' A' ' 75' ' ' ILE . 33.1 pttt -128.47 152.66 47.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -97.16 128.55 44.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.292 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.855 HG23 ' CD1' ' A' ' 75' ' ' ILE . 1.7 p -116.64 117.87 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 109.946 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 39' ' ' MET . 4.5 mt -95.49 110.35 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.2 m -91.91 -1.37 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.788 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.9 t30 -116.79 -1.18 12.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 110.426 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.595 ' HB2' HG21 ' A' ' 36' ' ' ILE . 20.6 ttm -64.3 -45.49 87.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.082 -1.011 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 45.5 t -70.4 -41.37 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.315 -0.866 . . . . 0.0 110.258 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -49.82 74.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.249 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.788 HG13 ' O ' ' A' ' 38' ' ' ASN . 6.3 m -68.36 -43.54 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.0 110.156 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -67.67 -44.44 77.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -67.68 -36.29 80.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.42 -0.8 . . . . 0.0 110.42 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.82 64.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.9 . . . . 0.0 110.811 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.9 HD12 ' HB2' ' A' ' 47' ' ' ASN . 2.5 pp -117.42 -9.19 10.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.019 -1.051 . . . . 0.0 110.69 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.9 ' HB2' HD12 ' A' ' 46' ' ' LEU . 1.1 t-20 175.43 -142.28 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -101.65 170.7 6.14 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.897 . . . . 0.0 110.103 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.3 Cg_endo -72.57 128.88 13.96 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.962 1.506 . . . . 0.0 110.383 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 48.5 Cg_endo -74.58 48.83 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.912 1.48 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.103 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -68.1 -23.94 64.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.167 -0.958 . . . . 0.0 110.364 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.574 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -75.49 -54.26 2.4 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.227 -0.92 . . . . 0.0 110.814 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -71.17 -1.53 9.73 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.799 1.421 . . . . 0.0 110.819 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.886 HG22 ' CG2' ' A' ' 65' ' ' THR . 51.6 m -66.44 -21.58 66.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 110.138 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -42.54 64.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.234 -0.916 . . . . 0.0 110.531 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -49.5 77.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.939 . . . . 0.0 110.302 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.564 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 5.5 m-30 -57.49 -43.89 84.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 109.924 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -35.2 85.1 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.94 -37.23 71.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -1.228 . . . . 0.0 110.022 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.04 -47.8 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.651 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.055 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.59 12.72 2.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.171 -0.956 . . . . 0.0 111.009 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.39 6.49 27.94 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.081 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.65 163.95 15.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -1.143 . . . . 0.0 109.338 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.9 mt-30 -105.4 -119.16 0.22 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.698 -1.252 . . . . 0.0 109.962 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.886 ' CG2' HG22 ' A' ' 54' ' ' THR . 7.7 p -149.42 170.42 18.61 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.396 -0.815 . . . . 0.0 111.228 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' A' ' 75' ' ' ILE . 4.2 tp-100 -144.72 139.47 27.93 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.103 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.5 m-85 -126.81 143.97 51.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.743 -1.223 . . . . 0.0 113.066 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 1.7 t0 -124.63 117.28 23.92 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.778 -0.769 . . . . 0.0 108.982 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 70' ' ' LYS . 7.7 m -89.13 -45.88 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.144 -0.973 . . . . 0.0 109.57 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.1 -6.84 42.34 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.174 -0.954 . . . . 0.0 108.516 178.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.7 OUTLIER -118.21 -27.57 6.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.723 -0.611 . . . . 0.0 110.044 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.595 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.1 m-20 70.45 17.03 6.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.275 -0.891 . . . . 0.0 109.877 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.577 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.7 OUTLIER -113.57 129.45 56.56 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.793 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.719 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.49 132.88 55.51 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.416 -0.802 . . . . 0.0 110.26 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.855 ' CD1' HG23 ' A' ' 35' ' ' VAL . 8.8 mm -120.5 148.68 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 0.0 110.119 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 21.0 t -114.04 126.04 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.0 109.467 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.081 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 68.5 m-80 -47.22 147.04 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 110.409 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 89.37 144.34 10.75 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.586 ' HB2' HG13 ' A' ' 25' ' ' VAL . 68.6 p -105.78 125.23 50.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -1.141 . . . . 0.0 110.136 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.1 OUTLIER -139.51 155.4 47.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 0.0 110.08 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -90.86 156.84 17.72 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 110.11 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.29 -43.21 64.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.239 -0.913 . . . . 0.0 110.22 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 83' ' ' ASN . 1.6 m120 -59.65 -33.51 71.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.897 . . . . 0.0 110.09 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.3 OUTLIER -69.33 -39.69 78.05 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.276 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' HG3' ' A' ' 88' ' ' MET . 13.7 mt -60.4 -36.19 77.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.198 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.541 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 25.3 mt-30 -68.83 -36.22 77.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 110.134 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.09 -46.66 88.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.297 -0.877 . . . . 0.0 110.901 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 4.3 ptm -71.4 -48.62 48.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.054 -1.029 . . . . 0.0 110.376 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.5 OUTLIER -62.12 -32.95 73.58 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.541 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 7.4 t70 -63.88 -36.05 82.67 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 0.0 109.793 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -33.12 84.08 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -47.25 76.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.377 -1.072 . . . . 0.0 109.58 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.797 ' O ' HG22 ' A' ' 97' ' ' VAL . 3.2 mt -65.1 -33.93 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.334 -0.854 . . . . 0.0 109.73 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 7.8 mttt -55.39 -26.02 38.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.565 -0.709 . . . . 0.0 110.521 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' CD ' ' HD2' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -60.22 -32.26 70.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.294 -0.879 . . . . 0.0 112.144 -178.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.027 ' CD1' HD11 ' A' ' 137' ' ' LEU . 17.2 p90 -115.3 -36.09 4.45 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.539 -1.35 . . . . 0.0 111.711 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.954 HG23 HD22 ' A' ' 98' ' ' LEU . 17.4 m -55.06 -49.65 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.89 -1.131 . . . . 0.0 110.301 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.954 HD22 HG23 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -73.14 66.48 0.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.769 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -69.54 155.31 93.75 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.224 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 44.5 Cg_endo -71.56 53.02 1.72 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.994 1.523 . . . . 0.0 110.333 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 175.81 -29.37 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.875 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.527 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . 8.3 p -131.78 32.49 4.09 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -0.886 . . . . 0.0 110.231 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 1.8 tm-20 -74.49 54.21 0.58 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.923 . . . . 0.0 109.822 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.615 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -164.96 -63.06 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.197 -0.939 . . . . 0.0 110.21 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.615 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.8 Cg_endo -71.96 149.96 54.08 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.853 1.449 . . . . 0.0 110.222 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -69.21 122.48 18.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.161 -0.962 . . . . 0.0 109.832 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.1 p -110.17 165.56 11.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.296 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.12 160.21 19.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -0.889 . . . . 0.0 110.143 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.748 ' CB ' HD12 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -128.86 125.05 36.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.513 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 31.6 p80 -118.43 119.22 33.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -0.896 . . . . 0.0 110.089 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.055 HG22 HG23 ' A' ' 118' ' ' ILE . 13.7 t -97.55 129.62 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.303 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -97.03 127.79 37.6 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.928 . . . . 0.0 110.215 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -29.21 12.29 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.988 1.52 . . . . 0.0 110.4 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.88 89.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 110.229 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 3.4 tptp -97.32 -3.8 39.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.225 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 53.1 49.53 19.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.211 -0.93 . . . . 0.0 110.136 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 3.0 p -144.59 161.18 39.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.055 HG23 HG22 ' A' ' 111' ' ' VAL . 19.5 mt -103.37 135.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 110.409 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -102.52 156.98 18.33 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.547 ' HB2' ' CB ' ' A' ' 131' ' ' LEU . 11.1 t-20 -136.48 121.57 18.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.139 -1.212 . . . . 0.0 109.665 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 22.8 t -126.9 139.06 53.35 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.569 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 4.5 t -111.97 133.96 53.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.375 -0.828 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -84.34 43.45 0.95 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.316 -0.865 . . . . 0.0 109.955 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.672 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -130.82 -33.71 1.56 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.307 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 4.0 t -137.23 1.45 2.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.185 -0.947 . . . . 0.0 110.66 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.67 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 91.08 -12.03 70.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.67 ' C ' ' O ' ' A' ' 126' ' ' GLY . 19.3 t80 -10.97 -64.65 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.8 -0.824 . . . . 0.0 111.151 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 5.9 ttt180 24.36 92.81 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.813 -0.554 . . . . 0.0 110.802 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -147.34 -114.96 0.84 Allowed Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.122 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.613 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 2.5 mtp -120.89 150.06 41.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.522 -0.987 . . . . 0.0 110.973 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.748 HD12 ' CB ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -114.03 108.53 17.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 0.0 109.839 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 133' ' ' THR . 0.3 OUTLIER -176.81 -65.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.114 -0.991 . . . . 0.0 110.507 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 1.2 m 71.59 -54.46 0.67 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.209 -0.932 . . . . 0.0 110.118 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.521 ' O ' ' N ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -177.93 -178.11 0.67 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.928 . . . . 0.0 110.122 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' ' HE3' ' A' ' 136' ' ' LYS . 2.8 m-70 -52.63 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.269 -0.894 . . . . 0.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.697 ' HB3' HD23 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -139.08 -177.15 4.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 110.372 -179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.027 HD11 ' CD1' ' A' ' 96' ' ' PHE . 2.5 pt? -42.72 -19.17 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.803 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.716 ' HA ' HD11 ' A' ' 141' ' ' ILE . 56.6 m -55.84 -38.9 70.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.361 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.0 m -68.62 -42.2 78.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.195 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 3.5 m-30 -57.21 -48.12 79.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 109.586 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 138' ' ' CYS . 22.6 pt -68.45 -41.34 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.403 -0.811 . . . . 0.0 109.761 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.782 ' HB2' HD11 ' A' ' 118' ' ' ILE . 21.7 tp -52.82 -17.47 1.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.348 -0.845 . . . . 0.0 110.399 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -70.2 -5.63 28.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.103 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.49 ' ND2' ' HD2' ' A' ' 143' ' ' LYS . 56.9 m-80 -118.17 83.31 19.65 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.295 -0.878 . . . . 0.0 110.147 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.09 133.04 18.99 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.059 1.558 . . . . 0.0 110.512 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.38 -170.87 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.002 1.527 . . . . 0.0 110.407 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.72 121.46 19.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.13 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -143.89 178.4 7.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 110.315 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.5 t -151.03 -153.31 0.48 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 151' ' ' SER . 3.8 t0 -107.15 12.0 28.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' ASP . 42.7 t -176.27 170.79 2.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.187 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 90.26 41.09 5.6 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.0 p -65.52 94.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 0.0 110.237 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 155' ' ' LYS . . . 140.52 128.49 2.45 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 154' ' ' GLY . 2.0 ptpt 178.01 -28.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -1.111 . . . . 0.0 110.36 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.164 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.215 0.531 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -148.4 63.55 1.09 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.872 . . . . 0.0 110.165 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 t -138.21 9.62 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.194 -0.941 . . . . 0.0 110.173 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -92.74 133.05 36.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.224 -0.922 . . . . 0.0 110.195 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -63.42 -13.42 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 110.204 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.71 -1.58 58.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.2 tpt180 -57.19 -16.47 8.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.192 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 67.6 m -95.36 7.34 46.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.319 -0.863 . . . . 0.0 110.207 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 8' ' ' SER . 43.4 t 58.8 122.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.471 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 2.2 ttm 66.61 131.74 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.185 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -58.61 149.36 26.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.169 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -63.23 -26.41 68.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.288 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 46.47 72.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 110.171 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 15' ' ' ARG . 54.6 p90 -61.34 -43.91 98.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.906 . . . . 0.0 110.258 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.611 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -158.29 22.92 0.24 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.126 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -121.7 130.04 53.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.386 -0.821 . . . . 0.0 110.087 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.45 134.15 43.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.203 -0.936 . . . . 0.0 110.209 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -116.09 105.38 51.09 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 110.236 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.8 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.962 1.506 . . . . 0.0 110.334 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -106.68 -67.72 0.93 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -0.89 . . . . 0.0 110.21 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 21' ' ' LEU . 6.7 tp -96.06 123.83 39.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 110.289 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 32.6 mt -107.88 120.32 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.301 -0.874 . . . . 0.0 110.076 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.15 135.9 54.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 110.414 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -117.38 137.96 52.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.035 HG12 ' O ' ' A' ' 31' ' ' GLY . 2.1 t -93.35 122.98 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 110.227 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 33' ' ' LYS . 2.8 tt0 -141.09 163.74 32.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.194 -0.941 . . . . 0.0 110.448 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.533 ' N ' ' HA2' ' A' ' 31' ' ' GLY . . . 156.05 -90.15 0.12 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 30' ' ' ASN . 12.1 ttpt -141.16 139.06 33.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.339 -1.095 . . . . 0.0 109.895 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.04 -81.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -99.95 -18.52 17.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -1.103 . . . . 0.0 110.014 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 1.035 ' O ' HG12 ' A' ' 25' ' ' VAL . . . 78.31 104.04 0.2 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.714 HD13 ' CB ' ' A' ' 79' ' ' SER . 0.7 OUTLIER -100.59 9.55 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -1.14 . . . . 0.0 110.295 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.564 ' CB ' HD11 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -97.52 152.87 18.57 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.926 -1.109 . . . . 0.0 109.142 179.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.742 ' HB ' HG13 ' A' ' 76' ' ' VAL . 3.3 m -105.91 120.48 41.85 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.872 -1.142 . . . . 0.0 110.906 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.651 HG22 ' CG1' ' A' ' 75' ' ' ILE . 21.5 t -108.6 117.87 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.869 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 39' ' ' MET . 5.2 mt -95.56 113.0 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.212 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.76 -1.24 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 0.0 110.195 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.465 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 5.4 t-20 -97.64 -0.96 44.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 110.237 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.544 ' HG3' ' CG2' ' A' ' 36' ' ' ILE . 2.6 mtt -59.74 -43.41 94.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 110.113 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.587 HG23 ' N ' ' A' ' 41' ' ' ASP . 34.4 m -60.6 -43.2 94.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.587 ' N ' HG23 ' A' ' 40' ' ' VAL . 16.2 m-20 -66.98 -49.03 66.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.66 -42.73 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.205 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.773 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -63.27 -34.99 78.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.873 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -59.07 -46.85 87.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.27 -16.19 60.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 0.0 110.164 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.856 ' O ' HD23 ' A' ' 46' ' ' LEU . 9.6 tt -103.27 -2.76 26.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.215 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 6.3 m-20 66.73 -58.34 0.39 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.324 -0.86 . . . . 0.0 110.282 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.766 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.14 132.95 69.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.47 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 46.3 Cg_endo -73.41 146.16 39.3 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.871 1.459 . . . . 0.0 110.46 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -73.19 -4.72 15.91 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.972 1.512 . . . . 0.0 110.499 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.176 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -60.53 -21.69 62.78 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.214 -0.929 . . . . 0.0 110.383 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.532 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -78.42 -58.29 0.8 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.176 -0.953 . . . . 0.0 110.719 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.9 Cg_endo -72.73 -3.13 12.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.958 1.504 . . . . 0.0 110.908 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.849 HG22 ' O ' ' A' ' 51' ' ' THR . 13.9 t -72.97 -17.66 61.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.095 -1.003 . . . . 0.0 110.347 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -72.82 -45.41 58.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.953 . . . . 0.0 110.467 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -66.92 -41.43 87.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.254 -0.904 . . . . 0.0 110.213 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.631 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 5.5 t80 -57.72 -42.06 83.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.311 -0.868 . . . . 0.0 110.1 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.49 -35.34 85.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.02 -37.27 79.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.093 -1.239 . . . . 0.0 110.265 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -66.27 -28.73 68.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.905 . . . . 0.0 111.072 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.041 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -105.42 12.96 30.93 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.053 -1.029 . . . . 0.0 111.01 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.76 4.87 21.76 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.041 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -116.0 164.02 15.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -1.08 . . . . 0.0 109.033 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.953 ' O ' HG23 ' A' ' 76' ' ' VAL . 29.6 mt-30 -112.27 -120.13 0.29 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.71 -1.244 . . . . 0.0 110.245 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.8 OUTLIER -149.49 170.62 18.17 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.414 -0.804 . . . . 0.0 111.158 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.527 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -146.68 139.67 25.4 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.176 ' CZ ' HG22 ' A' ' 51' ' ' THR . 23.7 m-85 -126.59 144.52 50.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.754 -1.216 . . . . 0.0 112.816 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -120.86 117.37 27.21 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.522 -0.871 . . . . 0.0 108.968 178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 70' ' ' LYS . 10.6 m -89.07 -45.13 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 0.0 109.694 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.64 -5.26 32.3 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.255 -0.903 . . . . 0.0 108.83 178.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.6 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 7.0 m120 -121.14 -24.64 5.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.517 -0.739 . . . . 0.0 110.345 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 69.55 17.5 7.92 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.67 129.65 56.53 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.667 -0.646 . . . . 0.0 109.436 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.745 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.2 m-30 -113.09 129.19 56.59 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.53 -179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.651 ' CG1' HG22 ' A' ' 35' ' ' VAL . 1.2 tt -125.29 149.73 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.552 -0.718 . . . . 0.0 109.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.3 p -113.29 136.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.177 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.787 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.6 OUTLIER -61.24 142.04 57.1 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 110.345 -178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.668 ' HA3' ' HE2' ' A' ' 80' ' ' HIS . . . 109.7 141.23 9.07 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.714 ' CB ' HD13 ' A' ' 32' ' ' ILE . 51.4 p -97.23 122.36 40.16 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -1.15 . . . . 0.0 110.025 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.668 ' HE2' ' HA3' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -142.33 158.35 43.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 3.8 tt0 -103.99 158.15 16.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 109.571 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.54 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.09 -43.88 64.11 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.965 . . . . 0.0 109.802 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -65.03 -33.49 76.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.833 . . . . 0.0 109.718 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -61.87 -37.17 83.52 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.507 -0.746 . . . . 0.0 110.213 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.15 -44.46 94.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 109.89 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -66.99 -36.49 82.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.739 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 1.0 OUTLIER -63.74 -36.21 83.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 110.178 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.446 ' HE3' ' HB3' ' A' ' 88' ' ' MET . 0.6 OUTLIER -60.24 -49.0 79.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 110.093 179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 89' ' ' LEU . 2.1 tt -53.21 -29.94 34.96 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.3 t0 -63.94 -36.02 82.59 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.414 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.73 -34.01 87.14 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.286 -1.925 . . . . 0.0 108.286 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.53 -40.31 82.56 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.413 -1.051 . . . . 0.0 109.11 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.702 HD12 ' CD2' ' A' ' 109' ' ' LEU . 28.0 mm -59.08 -46.77 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 109.637 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.514 ' CG ' ' OE1' ' A' ' 103' ' ' GLU . 7.1 ttmt -67.5 -27.12 66.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.52 -0.738 . . . . 0.0 110.472 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.549 ' O ' HD21 ' A' ' 98' ' ' LEU . 2.6 tptt -60.39 -35.93 76.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.241 -0.912 . . . . 0.0 111.014 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.756 ' CD1' HD21 ' A' ' 137' ' ' LEU . 25.5 p90 -115.34 -17.23 11.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 0.0 110.593 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.619 HG21 HG22 ' A' ' 93' ' ' ILE . 7.8 t -68.25 -60.16 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.045 . . . . 0.0 110.201 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.566 ' N ' HD22 ' A' ' 98' ' ' LEU . 1.5 mm? 33.51 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 110.35 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.546 ' SG ' ' N ' ' A' ' 103' ' ' GLU . 25.5 p -87.54 141.61 32.34 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.103 -0.998 . . . . 0.0 110.389 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.585 ' HD3' HG23 ' A' ' 133' ' ' THR . 47.2 Cg_endo -73.79 50.62 2.13 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.056 1.556 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 1.3 tp10 -159.22 -36.73 0.06 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 109.971 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 3.4 p 175.01 62.62 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.356 -0.84 . . . . 0.0 110.083 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 1.3 pp20? -74.61 -33.21 62.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.307 -0.871 . . . . 0.0 109.815 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.561 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.2 t-20 -29.09 -56.12 0.27 Allowed Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.986 -0.446 . . . . 0.0 110.776 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 43.0 Cg_endo -69.05 149.72 71.7 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.785 1.413 . . . . 0.0 110.387 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 90' ' ' ASP . 4.4 tp10 -69.46 131.61 45.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.92 . . . . 0.0 110.029 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 121' ' ' SER . 1.5 p -125.19 165.3 18.51 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 110.366 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -114.09 148.81 36.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.328 -0.858 . . . . 0.0 109.92 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.702 ' CD2' HD12 ' A' ' 93' ' ' ILE . 2.9 pp -123.95 120.2 31.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 110.438 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.535 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 9.7 p80 -124.01 125.73 45.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.299 -0.876 . . . . 0.0 110.065 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 118' ' ' ILE . 6.4 p -96.9 129.64 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -98.54 122.62 52.89 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 110.217 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.33 -31.44 9.21 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.994 1.523 . . . . 0.0 110.45 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.9 mmmt -63.45 -37.62 87.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.334 -0.854 . . . . 0.0 110.286 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.59 -3.7 20.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 110.249 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.786 ' O ' HD11 ' A' ' 142' ' ' LEU . 0.4 OUTLIER 52.5 43.9 30.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 110.057 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.462 ' HA ' ' CD1' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -133.07 149.29 52.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 0.0 110.159 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 111' ' ' VAL . 24.2 mm -92.68 126.21 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 110.241 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -117.24 148.25 18.8 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.509 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 28.9 t-20 -144.17 152.71 41.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.165 -1.197 . . . . 0.0 109.427 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.789 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -116.92 123.73 47.7 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.767 -1.208 . . . . 0.0 110.382 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.37 119.25 33.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.05 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -45.95 -36.16 5.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 0.0 110.227 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.536 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -73.6 -0.76 16.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.281 -0.887 . . . . 0.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.545 ' O ' ' C ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER 71.23 1.19 3.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.327 -0.858 . . . . 0.0 110.229 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.87 -70.63 0.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.658 ' CD1' ' N ' ' A' ' 128' ' ' ARG . 5.7 p90 -122.17 -31.57 3.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -1.123 . . . . 0.0 110.359 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 29.48 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.716 -0.615 . . . . 0.0 110.889 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 155.38 -66.22 0.31 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.142 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.536 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.12 149.16 42.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -1.219 . . . . 0.0 110.999 -179.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 120' ' ' ASN . 14.5 tp -113.64 107.48 15.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.809 . . . . 0.0 109.671 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 133' ' ' THR . 7.9 m-20 -107.25 -78.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.0 110.543 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.585 HG23 ' HD3' ' A' ' 100' ' ' PRO . 1.5 m 69.87 -139.45 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.17 -0.956 . . . . 0.0 110.043 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.514 ' O ' ' N ' ' A' ' 136' ' ' LYS . 37.8 m80 -121.96 178.6 4.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.921 . . . . 0.0 110.124 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -42.72 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.266 -0.896 . . . . 0.0 110.107 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 134' ' ' HIS . 50.4 mmtt -136.63 -177.45 4.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.278 -0.888 . . . . 0.0 110.345 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.756 HD21 ' CD1' ' A' ' 96' ' ' PHE . 2.7 pp -63.09 -6.11 3.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.538 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.644 ' HA ' HD11 ' A' ' 141' ' ' ILE . 69.2 m -56.02 -43.4 77.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 110.169 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -42.25 77.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 110.018 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -47.87 79.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.639 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 138' ' ' CYS . 25.5 pt -68.35 -42.06 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 109.55 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.786 HD11 ' O ' ' A' ' 116' ' ' GLN . 12.9 tp -53.41 -28.99 32.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.371 -0.83 . . . . 0.0 110.162 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 1.3 tttt -85.03 -3.55 58.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.316 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.506 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 17.9 m-20 63.18 167.14 0.1 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.106 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.0 Cg_endo -72.33 174.63 11.21 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.919 1.484 . . . . 0.0 110.399 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 145' ' ' PRO . 45.7 Cg_endo -72.45 116.35 4.68 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.969 1.51 . . . . 0.0 110.548 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -150.21 23.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 110.117 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 150' ' ' ASP . 15.0 m-20 -63.6 -10.37 18.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.92 . . . . 0.0 110.326 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 148' ' ' ASN . 1.0 OUTLIER 66.97 -59.75 0.37 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.274 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' A' ' 148' ' ' ASN . 24.1 m-20 -69.22 171.12 8.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.208 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.4 t -103.98 127.92 51.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -105.82 -28.44 5.34 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -20.06 61.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.245 -1.15 . . . . 0.0 110.174 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 97.03 -90.24 1.11 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 24.6 mttm 52.77 -170.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -1.193 . . . . 0.0 110.23 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.211 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 1' ' ' LEU . 19.9 mt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.202 0.525 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.9 p -92.71 16.63 11.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.46 133.36 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.18 156.73 38.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.239 -0.913 . . . . 0.0 110.221 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.0 t -52.03 -21.19 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.245 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' O ' HG13 ' A' ' 9' ' ' VAL . 65.5 t30 54.79 26.24 7.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.901 . . . . 0.0 110.227 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.08 -12.25 18.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.182 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 9' ' ' VAL . 2.7 t -82.85 8.04 13.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 110.225 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 6' ' ' ASN . 0.9 OUTLIER -42.61 -94.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.326 -0.859 . . . . 0.0 110.336 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.527 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER 65.48 -179.27 0.19 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.01 . . . . 0.0 110.26 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 2.9 m-20 -82.48 143.01 31.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.234 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.38 -33.06 23.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.257 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 2.6 t80 -172.17 -68.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 1.5 t80 178.02 80.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.196 -0.94 . . . . 0.0 110.194 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -106.68 -16.91 14.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.245 -0.909 . . . . 0.0 110.087 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -129.28 151.04 50.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.385 -0.822 . . . . 0.0 110.311 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.511 ' NZ ' ' HG2' ' A' ' 86' ' ' GLN . 1.8 ttpt -112.74 130.7 55.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 110.241 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -138.31 103.93 7.92 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 0.0 110.216 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HG3' ' NE2' ' A' ' 86' ' ' GLN . 48.3 Cg_endo -74.96 -155.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.981 1.516 . . . . 0.0 110.276 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' N ' ' CD ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -149.13 20.43 0.97 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.188 -0.945 . . . . 0.0 110.188 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.0 tm? -89.2 122.46 32.5 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 110.222 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.57 ' N ' HD22 ' A' ' 21' ' ' LEU . 13.2 mm -100.74 136.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.232 -0.918 . . . . 0.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.61 141.2 52.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.647 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -124.19 138.08 54.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 109.998 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.762 HG23 ' CB ' ' A' ' 79' ' ' SER . 3.3 p -93.26 134.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.147 -0.971 . . . . 0.0 110.334 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.85 159.56 19.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.289 -0.882 . . . . 0.0 110.209 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.65 68.62 0.47 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 30' ' ' ASN . 2.7 tttt -145.77 155.74 43.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.143 . . . . 0.0 110.322 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.77 -81.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 28' ' ' LYS . 1.8 t30 -89.69 -15.28 32.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -1.153 . . . . 0.0 110.264 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 32' ' ' ILE . . . 84.86 -5.79 81.02 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.7 mm -153.67 88.14 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -1.141 . . . . 0.0 110.177 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -129.52 152.49 49.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.986 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.757 ' HB ' HG23 ' A' ' 76' ' ' VAL . 1.3 m -108.95 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.097 -1.002 . . . . 0.0 110.36 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 24' ' ' LYS . 3.0 p -102.85 117.73 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 109.859 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.685 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.3 mt -95.55 112.48 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.0 110.199 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.623 HG23 ' OD1' ' A' ' 38' ' ' ASN . 30.8 m -89.4 -21.9 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.222 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.623 ' OD1' HG23 ' A' ' 37' ' ' VAL . 11.6 m120 -91.79 11.46 24.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.215 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.685 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -59.98 -45.19 93.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 110.093 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.583 HG23 ' N ' ' A' ' 41' ' ' ASP . 14.5 m -67.43 -42.31 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.583 ' N ' HG23 ' A' ' 40' ' ' VAL . 3.6 m-20 -64.96 -50.11 67.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.214 -0.929 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.74 -43.66 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.09 -34.95 75.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 110.169 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.91 -39.21 93.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 0.0 110.148 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.48 -22.6 60.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.146 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.857 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.7 OUTLIER -102.43 2.92 37.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.426 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 4.3 m120 65.43 -64.55 0.18 Allowed 'General case' 0 C--N 1.292 -1.92 0 O-C-N 121.35 -0.843 . . . . 0.0 110.237 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -77.23 122.66 86.53 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.912 . . . . 0.0 110.19 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.7 Cg_endo -73.06 144.84 38.54 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.974 1.512 . . . . 0.0 110.41 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG2' ' CE ' ' A' ' 39' ' ' MET . 46.3 Cg_endo -72.99 -0.15 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.013 1.533 . . . . 0.0 110.22 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.005 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.8 OUTLIER -57.21 -21.48 33.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 110.46 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.551 ' CB ' ' HD3' ' A' ' 53' ' ' PRO . 2.6 m-85 -82.1 -58.87 0.44 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.118 -0.988 . . . . 0.0 110.658 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 52' ' ' TYR . 48.8 Cg_endo -74.76 -0.22 9.59 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.884 1.465 . . . . 0.0 111.049 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.568 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -61.28 -23.51 65.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.03 -1.044 . . . . 0.0 110.376 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.8 -42.09 64.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.13 -0.982 . . . . 0.0 110.598 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.8 t80 -58.76 -51.29 70.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 110.246 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 15.5 m-30 -57.68 -43.26 84.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.077 -1.014 . . . . 0.0 109.861 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -61.22 -35.09 90.35 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -56.7 -37.26 70.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.063 -1.257 . . . . 0.0 109.998 -179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.521 ' CG ' ' SD ' ' A' ' 88' ' ' MET . 13.4 mm-40 -65.07 -47.59 76.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 0.0 110.739 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.006 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -83.07 12.92 4.46 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.162 -0.961 . . . . 0.0 110.91 -179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 4.87 26.93 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.064 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -114.41 163.67 15.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -1.158 . . . . 0.0 109.397 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.489 ' C ' ' CG2' ' A' ' 65' ' ' THR . 12.5 tt0 -107.95 -119.07 0.26 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.712 -1.243 . . . . 0.0 109.958 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.568 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.6 p -149.25 170.23 18.96 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.835 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.563 ' HB3' ' CG2' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.48 139.34 28.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.005 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.0 m-85 -126.83 143.77 51.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.864 -1.148 . . . . 0.0 112.844 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.9 OUTLIER -122.99 117.47 25.55 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.731 -0.787 . . . . 0.0 108.943 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.48 -64.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.64 -17.52 5.85 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.184 -0.948 . . . . 0.0 108.682 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.626 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -103.92 -31.4 9.77 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.637 -0.665 . . . . 0.0 110.153 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.8 m-20 71.72 16.47 5.69 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.321 -0.862 . . . . 0.0 110.144 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.569 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -113.46 129.49 56.53 Favored 'General case' 0 C--N 1.293 -1.848 0 O-C-N 121.618 -0.676 . . . . 0.0 109.713 -179.608 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.45 137.73 51.12 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.389 -0.819 . . . . 0.0 110.552 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.563 ' CG2' ' HB3' ' A' ' 66' ' ' GLN . 10.8 tt -131.66 148.56 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.42 -0.8 . . . . 0.0 109.792 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.757 HG23 ' HB ' ' A' ' 34' ' ' THR . 3.6 m -114.21 137.84 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.094 -1.004 . . . . 0.0 109.855 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.064 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 98.4 m-20 -59.01 143.08 49.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.905 . . . . 0.0 110.468 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.15 147.59 22.02 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.762 ' CB ' HG23 ' A' ' 25' ' ' VAL . 35.3 p -107.37 121.09 43.88 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.197 -1.178 . . . . 0.0 110.462 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.531 ' NE2' HG21 ' A' ' 34' ' ' THR . 0.3 OUTLIER -142.21 167.23 22.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.452 -0.78 . . . . 0.0 110.004 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.497 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.3 mt-10 -101.25 158.14 16.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.937 . . . . 0.0 110.119 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.85 -44.52 66.84 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.418 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.61 -34.98 79.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 109.845 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.6 tptm -59.41 -37.35 77.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.532 -0.73 . . . . 0.0 110.439 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 3.2 mp -61.79 -44.95 95.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.126 -0.984 . . . . 0.0 110.258 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.52 ' NE2' ' HG3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -69.13 -45.5 69.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.229 179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.566 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.2 OUTLIER -64.65 -36.04 82.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.33 -0.856 . . . . 0.0 110.619 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.521 ' SD ' ' CG ' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -57.9 -49.61 76.15 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.076 -1.015 . . . . 0.0 110.379 -179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.72 -30.08 42.36 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.2 t0 -64.05 -35.99 82.53 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.253 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.495 ' O ' ' HG2' ' A' ' 95' ' ' LYS . . . -61.84 -48.14 85.78 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -56.09 -50.34 71.32 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.216 -1.167 . . . . 0.0 109.927 179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.83 ' O ' HG22 ' A' ' 97' ' ' VAL . 40.7 mm -65.26 -50.12 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.324 -0.86 . . . . 0.0 110.225 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.684 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -59.7 -27.09 66.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.423 -0.798 . . . . 0.0 110.865 -179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 1.4 mmpt? -60.6 -37.44 81.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.21 -0.931 . . . . 0.0 111.542 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.891 ' HB2' HD13 ' A' ' 137' ' ' LEU . 16.9 p90 -115.39 -18.58 10.98 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.75 -1.218 . . . . 0.0 111.359 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.876 HG12 ' CE1' ' A' ' 96' ' ' PHE . 4.7 m -85.2 -1.32 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.821 -1.174 . . . . 0.0 110.342 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD13 ' O ' ' A' ' 94' ' ' LYS . 1.7 tp -40.33 98.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.897 . . . . 0.0 110.227 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' N ' ' O ' ' A' ' 97' ' ' VAL . 41.2 t -84.75 139.91 37.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.303 -0.873 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 101' ' ' GLU . 46.3 Cg_endo -73.75 50.62 2.11 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.044 1.55 . . . . 0.0 110.415 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' PRO . 9.1 tt0 173.06 -28.45 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 110.043 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 84.2 m -150.64 46.55 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 110.312 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.577 ' HG3' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -67.35 -30.89 70.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.95 . . . . 0.0 110.005 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.5 m-20 -50.56 -59.17 7.83 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.367 -0.833 . . . . 0.0 110.145 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.0 Cg_endo -70.81 150.15 61.33 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.117 1.588 . . . . 0.0 110.243 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -68.99 127.43 33.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.056 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.985 HG22 ' SG ' ' A' ' 122' ' ' CYS . 4.1 p -110.15 165.98 11.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.347 -0.845 . . . . 0.0 110.258 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.461 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.8 p30 -114.04 146.55 40.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.306 -0.871 . . . . 0.0 110.014 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.49 HD13 HD12 ' A' ' 141' ' ' ILE . 1.1 pp -107.79 122.51 46.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.0 110.366 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -109.25 119.59 39.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.079 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.964 HG12 HD13 ' A' ' 118' ' ' ILE . 4.4 m -96.75 125.06 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.923 . . . . 0.0 110.278 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.531 ' HB2' ' CG ' ' A' ' 115' ' ' LYS . 20.8 m120 -96.32 123.64 54.03 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 110.098 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.14 -36.28 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.952 1.501 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' HD2' ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -59.63 -34.7 73.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.633 ' O ' ' HG3' ' A' ' 116' ' ' GLN . 7.7 ptpt -110.87 -3.94 15.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER 51.99 37.95 22.51 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.521 -0.737 . . . . 0.0 110.541 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.78 162.03 21.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.172 -0.955 . . . . 0.0 110.293 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.964 HD13 HG12 ' A' ' 111' ' ' VAL . 11.1 mm -101.2 135.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -115.2 163.8 12.18 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.574 ' HB2' ' CB ' ' A' ' 131' ' ' LEU . 2.3 t-20 -141.86 121.77 13.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.207 -1.172 . . . . 0.0 109.785 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 43.2 t -124.45 127.24 47.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.211 -0.931 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.985 ' SG ' HG22 ' A' ' 107' ' ' THR . 2.5 t -104.87 112.31 25.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.17 -12.71 9.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.63 -44.04 97.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.336 -0.853 . . . . 0.0 110.404 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 102' ' ' CYS . 1.3 m -128.46 -11.47 5.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 0.0 110.669 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.658 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 101.05 -12.23 58.89 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.658 ' C ' ' O ' ' A' ' 126' ' ' GLY . 25.3 t80 -10.9 -63.91 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.781 -0.835 . . . . 0.0 111.184 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.561 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 7.5 ttt-85 36.03 89.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -154.03 -112.25 0.46 Allowed Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.426 -1.369 . . . . 0.0 109.956 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.518 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.67 151.77 39.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.464 -1.021 . . . . 0.0 110.734 -179.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.88 HD23 ' N ' ' A' ' 132' ' ' ASP . 2.3 tt -103.09 139.51 38.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.285 -0.884 . . . . 0.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.88 ' N ' HD23 ' A' ' 131' ' ' LEU . 4.0 p30 160.76 115.93 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.435 -0.791 . . . . 0.0 109.72 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 98' ' ' LEU . 85.9 m -128.46 -66.45 0.84 Allowed 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.285 0.564 . . . . 0.0 110.152 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 135' ' ' HIS . 45.8 m170 -111.94 143.24 43.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.314 -0.866 . . . . 0.0 110.087 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 134' ' ' HIS . 19.7 m170 42.4 -135.43 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.195 -0.94 . . . . 0.0 109.981 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -135.68 81.69 1.9 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.284 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.891 HD13 ' HB2' ' A' ' 96' ' ' PHE . 2.1 pp -82.55 -24.36 34.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.34 -0.85 . . . . 0.0 110.106 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.577 ' HA ' HD11 ' A' ' 141' ' ' ILE . 34.4 m -62.65 -40.33 96.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 110.367 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.3 m -64.49 -41.54 96.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.901 . . . . 0.0 110.285 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -48.72 80.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.048 -1.032 . . . . 0.0 109.577 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 138' ' ' CYS . 26.2 pt -69.33 -42.09 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.893 . . . . 0.0 109.552 178.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.522 ' N ' HG13 ' A' ' 141' ' ' ILE . 4.8 tp -53.54 -31.72 47.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.455 -0.778 . . . . 0.0 110.213 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 144' ' ' ASN . 14.8 mtmt -70.3 -36.42 74.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.296 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 0.7 OUTLIER 61.03 141.23 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 110.51 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.048 1.552 . . . . 0.0 110.505 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 46.7 Cg_endo -73.47 -42.79 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.02 1.537 . . . . 0.0 110.416 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 146' ' ' PRO . 51.1 mt-10 55.86 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.214 -0.929 . . . . 0.0 110.256 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' A' ' 146' ' ' PRO . 6.6 m120 -144.84 122.1 11.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.59 70.16 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.223 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -125.93 60.51 1.28 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.91 62.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 61.32 95.26 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.59 -51.4 68.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -1.141 . . . . 0.0 110.23 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.15 -43.8 1.64 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.17 -68.38 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -1.154 . . . . 0.0 110.136 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 2.1 mttm . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.285 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 1' ' ' LEU . 11.0 mt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.257 0.551 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 p -94.17 164.58 12.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 110.165 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 3' ' ' VAL . 12.2 p -159.39 66.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.148 -0.97 . . . . 0.0 110.276 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -81.47 128.39 33.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 0.0 110.209 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -71.38 -19.33 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.4 154.21 24.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.187 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.7 tpt85 -67.82 -35.89 79.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.178 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 10' ' ' MET . 8.6 t -72.99 -13.46 61.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.202 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG12 ' N ' ' A' ' 10' ' ' MET . 46.4 t 55.1 -87.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.306 -0.871 . . . . 0.0 110.299 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.611 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -43.44 -90.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.29 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.58 ' HB3' ' CE1' ' A' ' 13' ' ' PHE . 56.7 t0 -99.83 147.63 25.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.922 . . . . 0.0 110.212 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' PHE . 10.3 mp0 -70.3 -29.6 66.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.219 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 11' ' ' ASP . 2.8 m-30 57.64 83.95 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.194 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 5.3 p90 -177.82 -31.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.353 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.416 ' N ' ' CG ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -84.11 -50.36 8.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.382 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' OH ' ' CE1' ' A' ' 13' ' ' PHE . 15.5 p90 -100.18 137.17 38.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.252 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.94 129.68 38.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.914 . . . . 0.0 110.201 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.23 152.68 76.41 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -73.1 -45.38 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.007 1.53 . . . . 0.0 110.378 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.452 ' HG2' ' NE2' ' A' ' 86' ' ' GLN . 1.4 ttt180 42.85 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.185 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.837 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 3.1 tm? -82.05 124.97 30.28 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.271 -0.893 . . . . 0.0 110.201 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -97.34 125.1 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -0.893 . . . . 0.0 110.175 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.7 138.08 47.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.767 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -116.67 137.97 51.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -0.901 . . . . 0.0 110.175 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 31' ' ' GLY . 4.4 p -96.33 125.1 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -0.888 . . . . 0.0 110.24 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 8.1 tt0 -140.96 161.37 37.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.262 -0.899 . . . . 0.0 110.273 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 162.15 -92.96 0.11 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -152.23 138.99 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -1.163 . . . . 0.0 110.131 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.24 -81.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -99.83 -18.61 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.209 -1.171 . . . . 0.0 110.207 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.87 ' O ' HG22 ' A' ' 25' ' ' VAL . . . 66.35 98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.61 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -106.13 9.74 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -1.126 . . . . 0.0 110.217 -179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' HG2' HG22 ' A' ' 75' ' ' ILE . 3.7 ttpt -97.62 153.08 18.43 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.053 -1.029 . . . . 0.0 109.556 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.746 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -98.63 118.37 35.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.942 -1.099 . . . . 0.0 110.507 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.76 117.4 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 110.093 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 4.5 tp -96.05 119.88 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 0.0 110.18 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.4 t -100.77 -24.88 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.988 . . . . 0.0 110.599 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.0 2.61 56.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 110.526 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.571 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 43.7 tpp -64.14 -44.91 90.71 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 0.0 110.499 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 41' ' ' ASP . 5.9 p -59.55 -42.84 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.391 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -63.58 -49.4 73.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 110.205 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 51.8 t -64.77 -43.82 96.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.262 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.641 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -59.3 -35.54 73.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.302 -0.874 . . . . 0.0 110.271 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.83 -50.12 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 0.0 109.968 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.57 -17.15 60.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.026 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.859 ' O ' HD23 ' A' ' 46' ' ' LEU . 8.3 tt -83.35 1.1 42.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 110.344 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.5 m120 73.89 -63.35 0.43 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.427 -0.796 . . . . 0.0 110.514 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.637 ' H ' HD23 ' A' ' 46' ' ' LEU . 3.9 mmt85 -77.13 155.17 82.5 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.095 -1.003 . . . . 0.0 110.262 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.48 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.1 Cg_endo -73.05 157.54 50.76 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.102 1.58 . . . . 0.0 110.528 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.798 ' O ' HG23 ' A' ' 54' ' ' THR . 48.9 Cg_endo -76.64 -26.83 8.0 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.07 1.563 . . . . 0.0 110.323 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.731 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 18.1 p -60.69 -21.83 63.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 110.465 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.528 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -80.24 -58.29 0.59 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 110.653 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' O ' ' CD2' ' A' ' 57' ' ' PHE . 46.2 Cg_endo -72.99 -0.31 8.87 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.868 1.457 . . . . 0.0 110.892 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -74.8 -25.83 59.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.054 -1.029 . . . . 0.0 110.356 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.71 -45.7 57.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 110.422 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -67.76 -48.86 65.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.202 -0.936 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 11.5 m-85 -57.57 -41.37 80.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.223 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -58.83 -35.36 82.08 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -37.27 78.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.238 . . . . 0.0 109.932 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -48.38 71.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.876 . . . . 0.0 110.651 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.069 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.79 11.46 2.14 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.169 -0.957 . . . . 0.0 111.046 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.97 11.26 36.99 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.178 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -118.05 164.31 15.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.508 -0.995 . . . . 0.0 109.274 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.409 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 11.8 mp0 -104.1 -121.38 0.2 Allowed 'General case' 0 C--N 1.307 -1.265 0 O-C-N 120.63 -1.294 . . . . 0.0 110.001 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.745 HG21 ' HB ' ' A' ' 54' ' ' THR . 0.7 OUTLIER -149.86 170.12 19.53 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.458 -0.776 . . . . 0.0 111.82 -179.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -155.95 139.06 15.51 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.0 m-85 -127.31 146.1 50.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.741 -1.224 . . . . 0.0 112.967 -178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -117.9 117.17 28.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.35 -0.94 . . . . 0.0 108.667 177.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.623 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.0 m -90.21 -46.33 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.535 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' N ' HG23 ' A' ' 69' ' ' VAL . 1.6 tptt -73.16 -3.62 27.73 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -118.92 -26.92 5.89 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.684 -0.635 . . . . 0.0 110.529 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.2 m-20 70.13 16.31 7.47 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.072 -1.017 . . . . 0.0 109.543 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.554 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 4.0 mmt85 -113.87 129.72 56.56 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 3.8 m-30 -109.06 128.97 55.43 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.825 -178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.695 HG23 ' O ' ' A' ' 34' ' ' THR . 84.4 mt -129.04 150.83 34.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.746 HG22 HG22 ' A' ' 34' ' ' THR . 13.2 m -111.77 138.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 120.929 -1.107 . . . . 0.0 109.134 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.178 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 8.9 t30 -62.75 140.33 58.74 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.769 -178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 104.95 147.08 15.72 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.2 p -101.41 127.59 47.99 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.306 -1.114 . . . . 0.0 110.074 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.688 ' NE2' ' HB2' ' A' ' 63' ' ' ALA . 0.8 OUTLIER -141.92 156.69 45.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.419 -0.801 . . . . 0.0 110.281 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 81' ' ' GLU . 1.4 pt-20 -104.01 143.4 32.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.758 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.837 ' HB1' ' O ' ' A' ' 21' ' ' LEU . . . -53.49 -39.51 64.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.141 -0.975 . . . . 0.0 110.268 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -34.71 66.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.173 -0.954 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 88' ' ' MET . 1.3 tppp? -73.03 -45.58 56.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 0.0 110.272 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 5.5 mp -60.5 -44.19 96.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.346 -0.846 . . . . 0.0 110.354 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.565 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 23.4 mm100 -68.66 -35.83 77.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 110.73 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -58.94 -46.28 88.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 111.354 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.541 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 0.6 OUTLIER -70.62 -48.66 53.97 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.862 -1.149 . . . . 0.0 110.725 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 93' ' ' ILE . 1.3 mt -66.04 -32.61 74.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.206 -0.934 . . . . 0.0 109.107 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 8.2 t70 -63.66 -43.59 96.28 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 120.159 -0.617 . . . . 0.0 110.651 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.99 -48.34 84.08 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' O ' ' CZ ' ' A' ' 96' ' ' PHE . 4.4 m-30 -68.56 -51.78 38.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -1.148 . . . . 0.0 110.356 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.8 HG23 ' HB ' ' A' ' 97' ' ' VAL . 13.0 mt -62.1 -33.41 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.317 -0.864 . . . . 0.0 110.499 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -57.98 -27.41 63.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.479 -0.763 . . . . 0.0 111.971 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.524 ' HB2' HD21 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -94.28 -43.78 8.26 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.561 -1.337 . . . . 0.0 113.063 -177.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.622 ' CD2' HG23 ' A' ' 97' ' ' VAL . 1.1 p90 -117.24 -36.99 3.62 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.313 -1.492 . . . . 0.0 112.599 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.8 ' HB ' HG23 ' A' ' 93' ' ' ILE . 48.4 t -66.77 -49.76 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.678 -1.264 . . . . 0.0 110.911 -178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.12 HD22 ' O ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -61.36 67.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.13 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.623 ' N ' ' O ' ' A' ' 97' ' ' VAL . 42.5 t -64.06 140.38 97.87 Favored Pre-proline 0 C--N 1.301 -1.519 0 O-C-N 121.063 -1.023 . . . . 0.0 110.032 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 41.1 Cg_endo -66.91 -12.98 38.21 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.081 1.569 . . . . 0.0 110.338 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 4.0 mm-40 -71.86 -32.48 67.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.35 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER 164.15 9.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.591 -0.693 . . . . 0.0 110.738 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.539 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 3.7 tm-20 37.92 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.108 -0.995 . . . . 0.0 110.172 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.55 ' H ' ' HD2' ' A' ' 105' ' ' PRO . 1.1 t-20 -93.86 -49.67 0.27 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.0 110.907 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.55 ' HD2' ' H ' ' A' ' 104' ' ' ASN . 46.6 Cg_endo -75.94 137.15 19.37 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.679 1.357 . . . . 0.0 110.517 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -69.88 156.11 39.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 110.177 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -118.33 160.45 21.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 110.236 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 120' ' ' ASN . 99.6 m-20 -114.1 160.29 19.09 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -0.85 . . . . 0.0 110.096 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 tp -105.96 104.3 13.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.472 ' NE2' ' HB2' ' A' ' 108' ' ' ASP . 65.1 m-70 -107.61 115.3 29.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.095 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.616 HG12 HG23 ' A' ' 118' ' ' ILE . 3.3 m -109.54 128.33 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.911 . . . . 0.0 110.176 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.01 123.3 59.71 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.224 -0.923 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.32 -31.42 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.999 1.526 . . . . 0.0 110.315 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -67.46 -39.51 85.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -100.81 -3.72 29.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.274 -0.891 . . . . 0.0 110.228 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 53.28 50.07 18.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.165 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.9 ' HA ' HD21 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -135.21 166.68 22.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 110.223 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.693 HD12 HG13 ' A' ' 141' ' ' ILE . 87.3 mt -128.73 139.37 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.912 . . . . 0.0 110.117 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -148.38 161.66 28.67 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 108' ' ' ASP . 1.9 p-10 -143.83 133.05 23.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -1.169 . . . . 0.0 109.959 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -117.13 145.87 43.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.124 -0.985 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 17.1 p -88.69 133.79 34.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.202 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 124' ' ' ALA . 45.0 tptt -50.37 -20.32 1.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -40.57 -49.46 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.898 . . . . 0.0 110.213 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.41 26.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 101.55 -67.09 0.44 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 126' ' ' GLY . 7.3 t80 61.65 -50.28 0.14 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.694 -0.886 . . . . 0.0 111.12 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.3 OUTLIER 65.6 96.58 0.05 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 -179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -111.15 68.52 0.22 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.596 ' HE3' ' HB ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -83.32 122.33 28.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -1.079 . . . . 0.0 110.103 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.516 HD22 ' SG ' ' A' ' 138' ' ' CYS . 2.7 mt -86.3 133.18 33.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.124 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -132.78 1.28 3.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.186 -0.946 . . . . 0.0 110.293 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 12.3 t -60.6 -158.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 110.181 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.41 160.33 41.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 58.94 33.7 23.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.92 . . . . 0.0 110.233 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -138.93 169.73 17.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.248 -0.908 . . . . 0.0 110.243 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.651 HD12 ' C ' ' A' ' 137' ' ' LEU . 3.5 pp -42.57 -29.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.299 -0.875 . . . . 0.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.564 ' HA ' HD11 ' A' ' 141' ' ' ILE . 58.3 m -58.02 -39.13 77.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.27 -0.894 . . . . 0.0 110.101 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.482 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 3.0 m -68.73 -40.42 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 110.241 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.482 ' O ' ' HG3' ' A' ' 143' ' ' LYS . 0.3 OUTLIER -56.9 -48.73 77.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.096 -1.003 . . . . 0.0 109.428 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.693 HG13 HD12 ' A' ' 118' ' ' ILE . 18.9 pt -69.26 -42.05 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.381 -0.824 . . . . 0.0 109.384 178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.9 HD21 ' HA ' ' A' ' 117' ' ' THR . 0.4 OUTLIER -65.74 -43.1 90.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.505 -0.747 . . . . 0.0 110.265 179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' A' ' 139' ' ' THR . 0.0 OUTLIER -79.27 6.84 8.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 110.378 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER -113.04 69.61 1.19 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 110.256 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.474 ' HD3' ' C ' ' A' ' 143' ' ' LYS . 46.2 Cg_endo -72.66 120.55 6.76 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.008 1.53 . . . . 0.0 110.38 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.518 ' O ' ' N ' ' A' ' 148' ' ' ASN . 45.9 Cg_endo -73.03 100.94 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.989 1.521 . . . . 0.0 110.37 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 148' ' ' ASN . 12.3 tp10 -44.38 93.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.17 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 146' ' ' PRO . 9.1 m-80 -171.07 163.69 7.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.158 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.1 t -70.96 -42.17 70.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.22 -0.925 . . . . 0.0 110.127 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -137.86 -157.16 0.75 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.23 -0.919 . . . . 0.0 110.191 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 13.48 11.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.295 -0.878 . . . . 0.0 110.185 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 54.73 -134.62 46.85 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 51.46 91.54 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -1.134 . . . . 0.0 110.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.45 -31.18 28.28 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.11 103.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -1.137 . . . . 0.0 110.208 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.6 mttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.23 -179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.23 0.538 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 t -158.61 90.43 1.01 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 49.2 t -135.51 108.44 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.323 -0.861 . . . . 0.0 110.189 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -91.98 103.97 16.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.23 -0.919 . . . . 0.0 110.27 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.687 ' O ' HG23 ' A' ' 9' ' ' VAL . 10.8 p -56.4 -24.57 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.915 . . . . 0.0 110.142 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -75.83 -52.6 10.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.216 -0.928 . . . . 0.0 110.178 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -14.6 63.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -1.54 58.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 110.198 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 5' ' ' VAL . 97.2 t -75.88 146.0 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.224 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.3 tmm? -45.2 128.42 7.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.96 120.31 6.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -70.45 -15.24 62.8 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -0.946 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.616 ' O ' ' HB3' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -84.35 -43.16 15.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.909 . . . . 0.0 110.175 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.616 ' HB3' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER 64.82 -51.42 0.32 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.595 -0.691 . . . . 0.0 110.508 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 13' ' ' PHE . 6.8 ptp180 -66.98 56.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 110.382 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -137.22 133.25 34.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.197 -0.939 . . . . 0.0 110.232 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -112.57 161.25 17.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.158 -0.964 . . . . 0.0 110.237 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 5.4 mtm -111.9 99.11 44.38 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 110.157 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 46.9 Cg_endo -74.55 4.51 4.44 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.04 1.548 . . . . 0.0 110.448 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.653 ' O ' HG11 ' A' ' 42' ' ' VAL . 64.2 mtt180 64.89 9.3 5.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -0.905 . . . . 0.0 110.145 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.17 122.61 38.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.278 -0.889 . . . . 0.0 109.981 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 55.2 mt -115.61 123.52 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.258 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.99 132.53 53.42 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 0.0 110.179 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -116.07 136.18 53.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.219 -0.926 . . . . 0.0 110.198 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.732 HG13 ' HB2' ' A' ' 79' ' ' SER . 94.6 t -102.48 134.41 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.19 -0.944 . . . . 0.0 110.339 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -128.22 144.76 51.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 110.138 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.95 48.19 0.99 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -120.12 152.35 37.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.177 . . . . 0.0 110.16 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.73 -101.24 0.98 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -73.01 -18.65 61.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -1.157 . . . . 0.0 110.198 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 32' ' ' ILE . . . 97.33 -10.98 65.41 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.6 mm -154.74 88.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -1.163 . . . . 0.0 110.257 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HA ' ' N ' ' A' ' 78' ' ' GLY . 6.0 mtmm -126.76 152.55 46.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 0.0 109.945 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.562 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.0 OUTLIER -108.18 123.95 49.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.26 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' CD1' ' A' ' 75' ' ' ILE . 20.4 t -108.52 117.79 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.724 ' N ' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -95.95 122.98 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.7 t -100.55 -43.56 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.774 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.716 ' O ' HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.23 -1.52 25.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.07 -1.019 . . . . 0.0 110.75 -179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.612 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.5 tmt? -64.72 -45.6 85.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.019 . . . . 0.0 109.967 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.717 HG21 ' CE2' ' A' ' 74' ' ' TYR . 14.3 p -70.68 -41.58 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.368 -0.832 . . . . 0.0 110.323 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' N ' HG13 ' A' ' 40' ' ' VAL . 40.1 t0 -62.17 -49.47 75.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 38' ' ' ASN . 12.9 m -68.12 -43.57 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.16 -0.962 . . . . 0.0 110.172 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -61.53 -46.96 87.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.908 . . . . 0.0 110.236 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -36.45 80.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.449 -0.782 . . . . 0.0 110.236 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.8 -31.96 70.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 42' ' ' VAL . 3.0 pp -108.94 -1.4 19.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.535 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -170.21 -154.24 0.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.291 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.419 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 1.8 mtt180 -93.47 174.49 3.84 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.274 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.94 128.57 13.31 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.057 1.556 . . . . 0.0 110.359 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' HG3' ' SD ' ' A' ' 39' ' ' MET . 47.9 Cg_endo -75.4 5.2 4.33 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.034 1.544 . . . . 0.0 110.657 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.141 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -56.46 -26.54 54.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.219 -0.926 . . . . 0.0 110.307 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -84.51 -55.94 0.43 Allowed Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 0.0 110.964 -179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.9 Cg_endo -70.77 -23.66 25.95 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.824 1.434 . . . . 0.0 111.143 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.536 HG22 ' C ' ' A' ' 51' ' ' THR . 7.8 t -56.25 -16.31 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.992 -1.067 . . . . 0.0 110.208 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.61 -45.4 68.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 0.0 110.36 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -62.11 -49.46 75.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.133 -0.979 . . . . 0.0 110.11 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.539 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 8.9 m-30 -57.42 -36.8 71.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.254 -0.904 . . . . 0.0 109.921 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.64 -39.25 94.91 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 1.2 m -57.45 -37.33 72.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -1.2 . . . . 0.0 109.924 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -60.44 -49.48 77.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.835 . . . . 0.0 110.723 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.001 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -83.42 12.98 4.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.109 -0.994 . . . . 0.0 110.697 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.05 6.29 31.18 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.45 163.59 15.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -1.159 . . . . 0.0 109.609 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.697 ' O ' HG13 ' A' ' 76' ' ' VAL . 24.6 tp60 -107.16 -118.42 0.25 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.814 -1.179 . . . . 0.0 109.936 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.18 170.25 18.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 0.0 111.022 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.796 ' HB2' HG23 ' A' ' 75' ' ' ILE . 3.3 mm100 -146.32 139.82 25.97 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.141 ' CZ ' HG22 ' A' ' 51' ' ' THR . 17.7 m-85 -126.54 142.59 51.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.819 -1.176 . . . . 0.0 112.849 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -120.28 117.48 27.92 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.015 178.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.594 HG23 ' N ' ' A' ' 70' ' ' LYS . 13.5 m -89.29 -45.21 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.268 -0.895 . . . . 0.0 109.645 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' N ' HG23 ' A' ' 69' ' ' VAL . 7.4 tptt -71.01 -5.95 35.15 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.198 -0.939 . . . . 0.0 108.722 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.7 m-20 -121.32 -25.27 5.26 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.591 -0.693 . . . . 0.0 110.174 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.1 m-20 69.75 17.15 7.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.153 -0.967 . . . . 0.0 109.876 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -113.64 129.47 56.56 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.586 -0.696 . . . . 0.0 109.681 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.733 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-30 -113.18 138.02 50.6 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.348 -0.845 . . . . 0.0 110.555 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 66' ' ' GLN . 1.6 tt -128.45 148.75 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.461 -0.774 . . . . 0.0 109.925 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.697 HG13 ' O ' ' A' ' 64' ' ' GLN . 69.3 t -113.89 130.03 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.688 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.065 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 67.6 m-80 -49.76 147.82 3.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 110.51 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.63 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 88.16 148.8 16.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.732 ' HB2' HG13 ' A' ' 25' ' ' VAL . 64.8 p -106.63 122.62 46.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -1.109 . . . . 0.0 110.242 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.848 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.09 145.45 34.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.384 -0.823 . . . . 0.0 109.975 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.3 tt0 -81.72 155.17 25.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.108 -0.995 . . . . 0.0 109.787 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.461 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.25 -43.89 64.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 110.033 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -64.67 -33.55 76.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.253 -0.904 . . . . 0.0 109.797 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.515 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -64.64 -36.87 85.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 110.082 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.624 ' O ' ' HG3' ' A' ' 88' ' ' MET . 4.4 mp -59.95 -42.59 94.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.103 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 26.1 mt-30 -69.2 -35.93 76.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 0.0 110.535 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.33 -46.61 88.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.476 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.624 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -64.46 -48.85 73.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.892 -1.13 . . . . 0.0 110.42 -179.317 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -68.69 -33.24 73.63 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.157 -0.964 . . . . 0.0 108.515 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 86' ' ' GLN . 12.2 t0 -64.24 -39.01 93.07 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.3 0.572 . . . . 0.0 110.0 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.91 -35.3 91.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.47 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -64.96 -51.61 60.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -1.083 . . . . 0.0 109.775 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.87 ' O ' HG22 ' A' ' 97' ' ' VAL . 36.3 pt -65.15 -40.49 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 109.998 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.974 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -55.21 -26.47 39.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.458 -0.776 . . . . 0.0 110.909 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' O ' HG21 ' A' ' 133' ' ' THR . 1.4 tttt -60.31 -41.08 92.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.127 -0.983 . . . . 0.0 111.12 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.953 ' HB2' HD11 ' A' ' 131' ' ' LEU . 1.7 p90 -115.3 -36.12 4.44 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.765 -1.209 . . . . 0.0 111.056 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.87 HG22 ' O ' ' A' ' 93' ' ' ILE . 8.5 m -54.42 -29.94 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.914 -1.116 . . . . 0.0 110.047 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -70.8 51.12 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.222 -0.924 . . . . 0.0 110.665 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 4.0 m -64.66 148.68 96.67 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.987 -1.07 . . . . 0.0 110.269 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.89 2.88 4.31 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.061 1.558 . . . . 0.0 110.315 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 7.6 mm-40 -116.95 -7.07 11.42 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.245 -0.909 . . . . 0.0 109.758 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.616 ' O ' ' C ' ' A' ' 103' ' ' GLU . 54.3 m -153.03 -50.23 0.1 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 110.465 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' A' ' 102' ' ' CYS . 1.7 tm-20 24.06 68.26 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.599 -0.688 . . . . 0.0 110.671 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.589 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 8.2 m-20 -172.23 -61.1 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.28 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.589 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.1 Cg_endo -71.06 149.68 59.05 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.922 1.485 . . . . 0.0 110.371 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.43 129.01 38.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 110.067 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.7 p -110.19 166.06 11.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 110.127 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -113.95 143.82 44.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.159 -0.963 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.777 HD11 ' CD1' ' A' ' 141' ' ' ILE . 9.8 tt -107.11 110.8 23.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.573 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 9.2 p80 -119.41 115.82 24.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 110.069 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.76 HG12 HG12 ' A' ' 118' ' ' ILE . 3.1 m -96.87 128.51 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 110.091 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.44 122.65 69.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 110.203 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.45 -37.26 3.31 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.986 1.519 . . . . 0.0 110.436 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -59.91 -42.08 93.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.254 -0.904 . . . . 0.0 110.309 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 8.9 tttp -100.59 -1.6 35.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.209 -0.932 . . . . 0.0 110.265 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 52.43 44.05 30.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.271 -0.893 . . . . 0.0 110.071 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.425 ' OG1' ' HB3' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -129.11 179.62 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 0.0 110.147 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.765 HG13 HD13 ' A' ' 142' ' ' LEU . 10.6 mt -129.53 130.46 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.949 . . . . 0.0 110.328 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.573 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -115.95 164.02 12.28 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.857 ' HB2' HD12 ' A' ' 131' ' ' LEU . 13.9 t30 -141.36 136.81 31.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.243 . . . . 0.0 109.608 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.8 OUTLIER -116.87 124.63 49.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.033 -1.042 . . . . 0.0 110.321 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 105' ' ' PRO . 45.8 t -99.49 133.76 43.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.272 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.67 -19.99 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.246 -0.909 . . . . 0.0 110.184 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.541 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -74.07 -9.98 59.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 110.072 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 124' ' ' ALA . 0.2 OUTLIER 72.52 -53.83 0.69 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.388 -0.82 . . . . 0.0 110.422 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -33.01 -71.42 0.1 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.627 ' O ' ' O ' ' A' ' 128' ' ' ARG . 58.8 t80 -60.79 -94.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.082 . . . . 0.0 110.088 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.841 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER 36.96 108.9 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.45 -0.781 . . . . 0.0 111.514 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.45 -94.29 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.539 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.4 OUTLIER -119.69 150.85 39.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.329 -1.101 . . . . 0.0 110.129 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.953 HD11 ' HB2' ' A' ' 96' ' ' PHE . 2.8 tt -104.34 122.5 45.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.268 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 133' ' ' THR . 3.8 p30 -126.34 -54.19 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 110.217 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.521 ' N ' ' OD1' ' A' ' 132' ' ' ASP . 0.8 OUTLIER 58.85 -143.44 0.61 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.242 -0.911 . . . . 0.0 110.258 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.465 ' H ' HG22 ' A' ' 133' ' ' THR . 17.8 m170 -96.58 -93.51 0.21 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.935 . . . . 0.0 110.228 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -163.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 110.131 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -107.06 81.82 1.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.158 -0.964 . . . . 0.0 110.322 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 137' ' ' LEU . 2.1 tm? -82.31 -41.36 20.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 110.014 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.913 ' SG ' HD22 ' A' ' 131' ' ' LEU . 45.2 m -56.94 -42.05 79.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -0.834 . . . . 0.0 110.219 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.5 m -63.7 -40.06 95.85 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.166 -0.959 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 143' ' ' LYS . 2.1 t80 -61.85 -48.72 79.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.022 -1.049 . . . . 0.0 109.228 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.777 ' CD1' HD11 ' A' ' 109' ' ' LEU . 28.7 pt -69.36 -42.15 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.413 -0.805 . . . . 0.0 109.36 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.765 HD13 HG13 ' A' ' 118' ' ' ILE . 25.6 tp -55.36 -22.92 21.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.442 -0.786 . . . . 0.0 110.296 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 140' ' ' PHE . 0.0 OUTLIER -70.28 -11.07 60.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.202 -0.936 . . . . 0.0 110.187 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -58.69 157.56 18.92 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.66 158.74 50.13 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.081 1.569 . . . . 0.0 110.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 46.1 Cg_endo -73.57 -46.46 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.991 1.522 . . . . 0.0 110.418 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 149' ' ' SER . 0.0 OUTLIER -161.43 145.26 12.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 110.171 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 149' ' ' SER . 36.7 m-20 45.87 -92.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.079 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.535 ' N ' ' O ' ' A' ' 147' ' ' GLU . 54.8 m 55.19 89.23 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.241 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -152.26 153.56 33.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.263 -0.898 . . . . 0.0 110.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 40.1 m -58.25 -45.56 87.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.228 -0.92 . . . . 0.0 110.24 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -85.22 108.47 3.2 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.0 m -69.49 -52.73 23.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.237 -1.155 . . . . 0.0 110.229 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 155' ' ' LYS . . . 61.38 61.88 6.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 154' ' ' GLY . 5.2 mmtm 53.3 173.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.265 -1.138 . . . . 0.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.246 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.231 0.539 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.57 -68.77 0.9 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.294 -0.879 . . . . 0.0 110.147 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.77 158.92 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 110.148 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -80.91 123.56 28.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.197 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.669 HG23 ' H ' ' A' ' 7' ' ' ARG . 16.3 m -67.16 -8.75 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER 66.08 13.45 9.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.191 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.669 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -67.18 -21.68 65.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.0 110.201 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.0 -5.43 34.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.162 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.2 t -127.3 95.2 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.3 tmm? -168.22 119.85 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 110.226 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.64 123.0 9.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.196 -0.94 . . . . 0.0 110.157 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' ' 14' ' ' TYR . 0.4 OUTLIER -64.5 -40.71 96.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.23 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.94 94.01 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 110.165 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 12' ' ' GLN . 0.1 OUTLIER -120.47 -89.65 0.6 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.208 -0.932 . . . . 0.0 110.211 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG2' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -174.44 -39.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 0.0 110.2 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' O ' ' CD1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -104.5 151.86 23.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 110.317 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -129.16 155.33 45.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.228 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -134.14 126.26 18.45 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 110.128 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 46.0 Cg_endo -73.28 -4.44 15.42 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.957 1.504 . . . . 0.0 110.5 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 1.5 ttt180 55.87 99.11 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.281 -0.887 . . . . 0.0 110.158 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.782 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 3.4 tp -95.22 137.04 34.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.0 110.312 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.62 HG22 ' HB2' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -119.12 132.37 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.144 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -124.9 140.59 52.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -0.902 . . . . 0.0 110.332 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.481 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -121.71 137.97 54.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.101 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 16.3 m -93.44 131.9 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.205 -0.934 . . . . 0.0 110.368 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HB2' HG21 ' A' ' 35' ' ' VAL . 4.1 tt0 -141.17 139.99 33.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 110.23 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.73 -97.09 0.12 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.4 OUTLIER -146.32 144.14 29.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -1.172 . . . . 0.0 110.177 -179.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.97 -87.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' LYS . 61.9 m-80 -99.87 -17.55 17.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -1.12 . . . . 0.0 110.218 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 25' ' ' VAL . . . 63.22 96.64 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.69 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -99.14 20.65 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 110.028 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.708 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -97.77 153.27 18.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.832 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.563 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.3 m -97.16 124.97 41.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.088 -1.007 . . . . 0.0 110.834 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 26' ' ' GLU . 5.7 t -118.02 117.65 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.134 -0.979 . . . . 0.0 109.923 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.66 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.6 mt -95.77 118.16 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 110.288 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 t -100.45 -16.92 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.237 -0.914 . . . . 0.0 110.286 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.62 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -99.01 14.47 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.278 -0.889 . . . . 0.0 110.138 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.66 ' HB2' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -63.97 -41.95 97.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 58.4 t -61.37 -47.55 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.284 -0.885 . . . . 0.0 110.263 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -63.0 -50.2 71.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 110.002 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 HD11 ' A' ' 21' ' ' LEU . 53.2 t -67.28 -40.71 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 0.0 110.054 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -62.65 -48.4 79.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 0.0 110.392 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -62.11 -38.91 90.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.414 -0.804 . . . . 0.0 110.243 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.45 -15.89 60.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 110.382 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.072 ' O ' HD23 ' A' ' 46' ' ' LEU . 7.2 tt -101.89 -9.33 20.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.976 . . . . 0.0 110.387 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 2.3 t30 78.26 -50.43 0.48 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.48 -0.762 . . . . 0.0 111.025 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.564 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 56.3 mtp180 -76.66 142.29 70.07 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.081 -1.012 . . . . 0.0 110.259 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 47.2 Cg_endo -72.96 140.96 32.42 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 124.147 1.604 . . . . 0.0 110.637 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.727 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 49.8 Cg_endo -75.73 -29.5 7.06 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 0.0 110.333 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.678 HG22 ' CE1' ' A' ' 67' ' ' PHE . 48.8 p -59.5 -22.8 62.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.884 . . . . 0.0 110.316 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.554 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -77.52 -58.65 0.92 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.958 . . . . 0.0 110.268 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 47.8 Cg_endo -73.68 -28.24 11.9 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.973 1.512 . . . . 0.0 110.702 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.567 HG22 HG21 ' A' ' 65' ' ' THR . 3.4 m -56.28 -19.74 15.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 110.389 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HD2' ' OG1' ' A' ' 153' ' ' THR . 18.4 ttpt -72.77 -45.38 58.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.107 -0.995 . . . . 0.0 110.346 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 56' ' ' TYR . 10.1 m-30 -64.6 -39.82 94.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.244 -0.91 . . . . 0.0 110.095 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -41.15 79.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.674 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.56 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -60.28 -35.33 87.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 59.0 m -56.99 -37.24 71.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 109.769 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -64.29 -44.0 93.02 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.325 -0.859 . . . . 0.0 110.722 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.023 HD13 ' NE2' ' A' ' 80' ' ' HIS . 0.2 OUTLIER -88.24 12.64 13.37 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.134 -0.979 . . . . 0.0 111.032 -179.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.1 4.78 30.31 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -115.29 163.99 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 0.0 109.141 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.736 ' O ' HG13 ' A' ' 76' ' ' VAL . 4.7 tt0 -106.2 -121.58 0.23 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.621 -1.3 . . . . 0.0 109.738 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 54' ' ' THR . 1.3 p -149.84 170.43 18.79 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.45 -0.781 . . . . 0.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.66 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -142.41 139.43 31.66 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.688 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.4 m-85 -126.82 144.17 51.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.759 -1.213 . . . . 0.0 113.13 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 1.3 t0 -126.34 117.38 22.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.729 -0.788 . . . . 0.0 109.165 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 16.9 t -86.58 -61.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -56.47 -16.65 6.23 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.192 -0.942 . . . . 0.0 108.633 178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.2 t30 -105.74 -30.02 9.7 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.584 -0.697 . . . . 0.0 110.152 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 9.7 m-20 71.05 16.67 6.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.217 -0.927 . . . . 0.0 110.225 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.0 tpt180 -113.62 128.98 56.63 Favored 'General case' 0 C--N 1.294 -1.842 0 O-C-N 121.503 -0.748 . . . . 0.0 109.865 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.688 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.44 138.2 50.43 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.469 -0.769 . . . . 0.0 110.022 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 ' HG2' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -132.41 148.06 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 64' ' ' GLN . 59.8 t -114.43 139.03 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.258 -0.901 . . . . 0.0 109.469 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.003 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 11.6 m-80 -64.05 141.72 58.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.085 -1.01 . . . . 0.0 110.469 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 99.64 142.12 12.87 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.9 p -80.6 127.3 32.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.255 -1.144 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 1.023 ' NE2' HD13 ' A' ' 61' ' ' LEU . 78.9 m-70 -142.2 141.03 32.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.419 -0.801 . . . . 0.0 110.403 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' HG3' ' N ' ' A' ' 83' ' ' ASN . 4.6 tp10 -104.04 149.57 25.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.928 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.782 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -43.91 64.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 110.426 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -64.15 -33.29 75.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.238 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -67.69 -40.42 84.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.384 -0.823 . . . . 0.0 110.331 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 85' ' ' LEU . 2.0 mp -60.58 -45.24 94.7 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.137 -0.977 . . . . 0.0 110.04 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -69.32 -47.41 64.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 110.036 179.65 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.441 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 44.8 t0 -69.15 -46.3 67.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 110.54 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.464 ' CB ' ' O ' ' A' ' 84' ' ' LYS . 42.9 ttp -63.01 -49.75 73.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 110.161 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.461 HD13 ' CZ ' ' A' ' 57' ' ' PHE . 3.0 tp -54.36 -30.52 51.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 1.8 t70 -63.69 -35.77 81.65 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.646 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.47 -48.31 85.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.588 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER -68.66 -51.54 40.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.125 -1.22 . . . . 0.0 109.981 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.864 HG23 HG21 ' A' ' 97' ' ' VAL . 1.3 mt -59.71 -50.26 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.132 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.843 ' O ' HD13 ' A' ' 98' ' ' LEU . 22.4 ttpp -58.3 -27.94 64.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.395 -0.815 . . . . 0.0 110.633 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.75 -42.61 99.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.068 -1.02 . . . . 0.0 111.067 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.787 ' CE1' HG23 ' A' ' 97' ' ' VAL . 47.9 p90 -115.87 -35.97 4.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.815 -1.178 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.864 HG21 HG23 ' A' ' 93' ' ' ILE . 96.2 t -56.21 -23.73 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.879 -1.138 . . . . 0.0 110.651 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -34.5 90.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.424 -0.798 . . . . 0.0 110.609 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.604 ' N ' ' O ' ' A' ' 97' ' ' VAL . 94.4 m -87.45 154.91 54.19 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.384 -0.823 . . . . 0.0 110.226 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.29 -3.24 13.51 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.048 1.552 . . . . 0.0 110.408 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.89 8.59 1.12 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.934 . . . . 0.0 110.866 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 99' ' ' CYS . 0.5 OUTLIER -155.47 16.06 0.39 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.002 -1.061 . . . . 0.0 110.625 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' HG3' ' HG ' ' A' ' 98' ' ' LEU . 1.6 tm-20 -69.26 -59.6 2.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.107 -0.996 . . . . 0.0 109.968 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.596 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -42.16 -52.08 9.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.447 -0.783 . . . . 0.0 110.623 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 45.2 Cg_endo -72.45 149.4 50.13 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.903 1.475 . . . . 0.0 110.607 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -70.07 150.44 46.59 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.368 -0.833 . . . . 0.0 110.314 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.689 ' OG1' HG11 ' A' ' 97' ' ' VAL . 12.7 p -141.96 166.21 25.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 110.13 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 3.9 t70 -113.77 147.41 38.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 109.945 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.419 HD12 ' HE1' ' A' ' 96' ' ' PHE . 4.6 tt -106.46 132.15 52.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.587 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.462 ' CD2' ' OD1' ' A' ' 108' ' ' ASP . 56.3 m-70 -124.26 123.66 40.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.289 -0.882 . . . . 0.0 110.092 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.904 HG23 ' CG1' ' A' ' 118' ' ' ILE . 7.2 p -123.98 129.27 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.176 -0.952 . . . . 0.0 110.314 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -118.94 122.48 29.66 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.192 -0.942 . . . . 0.0 110.298 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.51 -39.96 1.75 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.993 1.523 . . . . 0.0 110.466 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -42.19 91.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.288 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -94.24 -3.85 49.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 0.0 110.168 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 52.5 38.4 25.48 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 110.209 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.62 173.52 11.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.0 110.223 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.904 ' CG1' HG23 ' A' ' 111' ' ' VAL . 24.5 mt -141.61 141.6 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 110.152 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -127.06 163.95 20.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 10.9 t-20 -137.59 139.06 40.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.227 -1.161 . . . . 0.0 109.519 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 13.5 t -116.83 124.67 50.1 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.056 -1.027 . . . . 0.0 110.338 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 102' ' ' CYS . 27.7 t -119.53 133.87 55.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 110.035 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -98.7 50.48 0.98 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.897 . . . . 0.0 109.988 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' A' ' 105' ' ' PRO . . . -133.82 -35.0 0.99 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.892 . . . . 0.0 110.282 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 9.9 p -138.52 4.43 2.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.334 -0.854 . . . . 0.0 110.591 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 84.43 -12.49 55.35 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.661 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -36.82 -30.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.476 -1.014 . . . . 0.0 110.426 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.698 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 22.2 ttp-105 -28.01 127.4 0.08 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.603 -0.686 . . . . 0.0 110.873 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.1 -91.51 0.11 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.418 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.1 151.6 38.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.168 -1.195 . . . . 0.0 110.374 -179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.963 HD21 HD11 ' A' ' 137' ' ' LEU . 17.0 tp -112.06 107.65 16.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 110.075 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -130.23 -70.11 0.64 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.322 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 135' ' ' HIS . 6.4 p 51.7 96.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.358 -0.839 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 133' ' ' THR . 3.2 m-70 41.39 -97.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 110.453 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' ' O ' ' A' ' 132' ' ' ASP . 0.4 OUTLIER -66.18 150.38 48.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 0.0 110.314 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HG3' ' OD1' ' A' ' 132' ' ' ASP . 0.9 OUTLIER -101.47 82.07 2.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.963 HD11 HD21 ' A' ' 131' ' ' LEU . 3.5 pp -69.7 -9.93 56.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.545 ' HA ' HD11 ' A' ' 141' ' ' ILE . 28.1 m -66.67 -41.92 87.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.0 110.302 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -40.24 81.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -0.964 . . . . 0.0 110.147 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -57.79 -48.31 80.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.498 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 118' ' ' ILE . 28.8 pt -68.88 -41.91 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.609 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.554 ' N ' HG13 ' A' ' 141' ' ' ILE . 47.0 tp -55.84 -23.62 31.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.466 -0.771 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.488 ' C ' ' ND2' ' A' ' 144' ' ' ASN . 0.1 OUTLIER -78.06 4.06 13.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.976 . . . . 0.0 110.41 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.567 ' C ' ' HD2' ' A' ' 146' ' ' PRO . 8.0 p30 36.29 92.95 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.417 -0.802 . . . . 0.0 110.517 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.688 ' N ' ' HD2' ' A' ' 146' ' ' PRO . 41.9 Cg_endo -72.39 -29.11 14.14 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.055 1.555 . . . . 0.0 112.293 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.688 ' HD2' ' N ' ' A' ' 145' ' ' PRO . 47.3 Cg_endo -73.93 165.29 32.47 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 122.887 0.941 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.75 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.0 110.254 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 54.77 25.67 6.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 110.192 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.7 m -135.39 116.22 14.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.252 -0.905 . . . . 0.0 110.214 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 151' ' ' SER . 0.7 OUTLIER 60.32 166.57 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 110.275 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 150' ' ' ASP . 20.1 m 43.33 53.02 5.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.274 -0.891 . . . . 0.0 110.204 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.81 -81.63 1.1 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 18.0 m -125.07 -73.99 0.62 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -1.102 . . . . 0.0 110.234 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -115.71 166.26 12.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -92.73 8.78 37.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -1.178 . . . . 0.0 110.252 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.165 179.984 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.25 0.548 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.452 ' C ' HG23 ' A' ' 3' ' ' VAL . 48.4 m -97.69 -19.26 18.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 2' ' ' SER . 24.5 t -146.74 149.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 110.185 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -76.01 151.49 37.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.915 . . . . 0.0 110.175 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 ' H ' HG23 ' A' ' 5' ' ' VAL . 15.6 t -59.34 -24.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 110.282 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.841 ' O ' HG23 ' A' ' 9' ' ' VAL . 5.3 m120 53.96 82.13 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.06 -17.52 63.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 110.311 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.7 m -74.85 0.15 16.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 6' ' ' ASN . 70.5 t -57.83 -44.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.266 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 43.15 61.32 2.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.338 -0.851 . . . . 0.0 110.177 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.668 ' HB2' HG12 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -109.75 111.23 22.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 12' ' ' GLN . 4.7 tp-100 -73.71 -13.57 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.207 -0.933 . . . . 0.0 110.188 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.515 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 56.9 m-85 -43.3 -31.09 0.58 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 110.333 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER 169.01 -23.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 0.0 110.304 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -75.1 49.52 0.45 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.148 -0.97 . . . . 0.0 110.073 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.26 132.49 33.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.225 -0.922 . . . . 0.0 110.352 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -112.72 129.54 56.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -148.21 96.71 3.93 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.229 -0.919 . . . . 0.0 110.374 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 45.4 Cg_endo -73.33 -89.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.277 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 19' ' ' PRO . 2.8 ptt180 176.72 -46.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 0.0 110.227 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD23 ' CB ' ' A' ' 85' ' ' LEU . 5.3 tp -95.97 122.45 38.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.26 -0.9 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.558 HD12 ' OD1' ' A' ' 38' ' ' ASN . 25.9 mt -110.97 120.27 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.261 -0.899 . . . . 0.0 110.014 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -110.43 132.23 54.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.539 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.84 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.0 135.71 53.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 109.747 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 31' ' ' GLY . 10.1 t -99.05 122.36 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.538 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.36 136.21 31.23 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.271 -0.893 . . . . 0.0 110.173 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.48 -98.13 0.12 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -144.49 155.04 43.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -1.114 . . . . 0.0 110.018 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 49.0 -91.15 0.01 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 28' ' ' LYS . 26.7 p-10 -99.98 -18.6 16.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.231 -1.158 . . . . 0.0 110.103 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.641 ' O ' HG13 ' A' ' 25' ' ' VAL . . . 80.14 105.19 0.27 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.607 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.7 OUTLIER -103.99 8.36 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.105 -1.232 . . . . 0.0 110.381 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -97.43 153.12 18.31 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.929 -1.107 . . . . 0.0 109.213 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.555 ' CG2' ' O ' ' A' ' 34' ' ' THR . 1.3 t -117.94 121.72 41.4 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.771 -1.205 . . . . 0.0 110.877 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.3 p -107.27 117.63 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.723 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.596 HG21 ' HB2' ' A' ' 39' ' ' MET . 19.0 mt -95.62 108.07 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 110.171 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -100.72 -4.9 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 0.0 110.364 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.652 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -109.21 -1.19 18.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 110.364 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.596 ' HB2' HG21 ' A' ' 36' ' ' ILE . 34.9 ttm -64.22 -44.2 92.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.0 110.084 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 11.6 p -70.15 -39.46 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -0.865 . . . . 0.0 110.321 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' N ' HG13 ' A' ' 40' ' ' VAL . 23.8 t70 -62.51 -50.74 70.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 110.141 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 38' ' ' ASN . 12.4 p -68.5 -45.34 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 110.157 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.619 ' N ' HG13 ' A' ' 42' ' ' VAL . . . -67.85 -35.13 78.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.289 -0.882 . . . . 0.0 110.355 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 2.4 tttp -67.4 -36.58 81.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.359 -0.838 . . . . 0.0 110.44 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.04 -21.43 61.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.548 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.914 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.1 tt -117.47 -9.16 10.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.013 . . . . 0.0 110.579 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.914 ' HB2' HD23 ' A' ' 46' ' ' LEU . 1.4 t-20 171.44 -148.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.188 -0.945 . . . . 0.0 110.257 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.558 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 2.1 mtt85 -96.41 169.19 9.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.021 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.14 127.81 13.19 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.872 1.459 . . . . 0.0 110.396 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.452 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 48.7 Cg_endo -75.03 46.92 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.927 1.488 . . . . 0.0 110.887 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.995 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.7 OUTLIER -68.05 -26.14 65.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.155 -0.966 . . . . 0.0 110.037 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.58 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -73.99 -54.31 3.61 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.331 -0.855 . . . . 0.0 110.722 -179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.4 Cg_endo -69.92 -19.85 34.84 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.812 1.428 . . . . 0.0 110.779 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.801 HG22 HG21 ' A' ' 65' ' ' THR . 6.3 m -56.25 -18.9 11.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.989 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -72.88 -40.82 65.27 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.373 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER -58.66 -49.68 76.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.225 -0.922 . . . . 0.0 110.049 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 88' ' ' MET . 10.3 m-85 -57.27 -35.87 70.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.533 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -65.31 -35.14 91.14 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 67.0 m -56.69 -37.19 70.54 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.08 -1.247 . . . . 0.0 109.803 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.42 -49.3 69.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.644 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.018 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -79.9 11.94 3.01 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.113 -0.992 . . . . 0.0 111.115 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.2 4.66 30.4 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.018 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -118.35 164.05 15.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -1.195 . . . . 0.0 109.146 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.641 ' O ' HG13 ' A' ' 76' ' ' VAL . 9.4 mt-30 -110.34 -120.53 0.28 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.594 -1.316 . . . . 0.0 109.875 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.801 HG21 HG22 ' A' ' 54' ' ' THR . 1.1 p -149.4 170.41 18.62 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.435 -0.791 . . . . 0.0 110.921 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.801 ' HB2' HG23 ' A' ' 75' ' ' ILE . 1.8 mm-40 -140.97 139.66 34.27 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.995 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.6 m-85 -126.5 142.99 51.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.751 -1.218 . . . . 0.0 113.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.8 OUTLIER -123.13 117.5 25.52 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.997 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -85.53 -64.17 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.599 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -16.91 6.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.134 -0.979 . . . . 0.0 108.656 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.589 ' CB ' ' HB3' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -103.75 -29.66 10.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.603 -0.686 . . . . 0.0 110.103 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.5 m-20 69.58 15.95 8.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.128 -0.982 . . . . 0.0 110.158 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 15.4 ttm180 -113.65 129.44 56.57 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.852 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.737 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.6 m-85 -113.61 138.04 50.73 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.394 -0.816 . . . . 0.0 110.309 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.801 HG23 ' HB2' ' A' ' 66' ' ' GLN . 17.8 tt -130.6 148.41 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.131 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 64' ' ' GLN . 4.2 t -114.73 139.21 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -0.958 . . . . 0.0 109.327 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.836 ' HB2' ' HB1' ' A' ' 63' ' ' ALA . 62.4 m-80 -67.86 140.03 56.54 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.062 -1.024 . . . . 0.0 110.346 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' ILE . . . 105.63 145.39 13.25 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -80.44 133.59 35.89 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -1.2 . . . . 0.0 110.179 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.67 ' NE2' HD13 ' A' ' 61' ' ' LEU . 99.1 m-70 -142.32 119.83 11.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.508 -0.745 . . . . 0.0 110.8 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.8 tt0 -82.92 158.76 22.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.333 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.31 -43.74 61.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.997 -1.065 . . . . 0.0 109.559 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 86' ' ' GLN . 2.4 t30 -64.71 -33.27 75.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.2 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.509 ' O ' ' HE3' ' A' ' 88' ' ' MET . 0.1 OUTLIER -59.38 -36.31 75.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.612 -0.68 . . . . 0.0 110.052 179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.655 ' O ' ' HG2' ' A' ' 88' ' ' MET . 20.5 mt -58.85 -32.45 69.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.89 . . . . 0.0 109.589 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 83' ' ' ASN . 51.8 mm-40 -68.79 -35.08 76.59 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.766 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 13.5 t70 -58.69 -46.67 86.74 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.442 -0.787 . . . . 0.0 111.585 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.655 ' HG2' ' O ' ' A' ' 85' ' ' LEU . 3.0 ptp -63.73 -44.91 92.14 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.561 -1.337 . . . . 0.0 109.259 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.88 HD13 ' O ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -53.22 -31.29 42.47 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 93' ' ' ILE . 11.3 t70 -63.65 -42.42 98.11 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -62.08 -33.39 85.59 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE2' ' HE2' ' A' ' 95' ' ' LYS . 46.1 t80 -56.29 -40.23 73.96 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -1.086 . . . . 0.0 109.282 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.922 ' O ' HG22 ' A' ' 97' ' ' VAL . 20.6 mt -54.78 -33.81 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.416 -0.802 . . . . 0.0 109.858 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.89 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.8 ttmt -55.23 -27.12 44.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.6 ' HE2' ' CE2' ' A' ' 92' ' ' PHE . 1.5 mtmt -61.24 -33.23 73.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.322 -0.861 . . . . 0.0 111.921 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.041 ' HB2' HD22 ' A' ' 137' ' ' LEU . 8.4 p90 -115.31 -34.01 5.11 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.667 -1.271 . . . . 0.0 111.859 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.922 HG22 ' O ' ' A' ' 93' ' ' ILE . 15.5 m -54.25 -16.25 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.735 -1.228 . . . . 0.0 110.376 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.89 HD13 ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -40.99 91.72 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.186 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.57 ' N ' ' O ' ' A' ' 97' ' ' VAL . 1.8 m -87.88 154.64 52.84 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 110.355 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -77.9 36.4 0.56 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.0 110.522 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.556 ' HB3' ' CG ' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -130.55 -53.81 1.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 110.236 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER 176.27 52.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.95 . . . . 0.0 110.676 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.594 ' CG ' HD12 ' A' ' 98' ' ' LEU . 11.3 tp10 -77.55 -25.02 49.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.051 -1.03 . . . . 0.0 109.732 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.624 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 1.6 t-20 -32.9 -54.33 0.61 Allowed Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.598 -0.689 . . . . 0.0 110.342 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 40.4 Cg_endo -67.22 150.8 81.76 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.027 1.541 . . . . 0.0 110.225 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.22 113.61 5.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.951 . . . . 0.0 110.4 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.611 HG22 ' SG ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -115.45 166.91 11.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.647 -0.658 . . . . 0.0 109.915 -179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 120' ' ' ASN . 1.4 m-20 -113.22 139.65 48.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.967 . . . . 0.0 109.938 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.034 HD21 HG13 ' A' ' 118' ' ' ILE . 8.6 tt -105.73 134.28 49.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.605 ' N ' ' CD2' ' A' ' 110' ' ' HIS . 1.7 m-70 -124.21 116.78 23.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 110.061 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.51 HG12 ' CG1' ' A' ' 118' ' ' ILE . 27.3 m -96.77 123.26 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.183 -0.948 . . . . 0.0 110.201 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.35 124.17 70.32 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 0.0 110.231 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.22 -37.18 3.54 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.942 1.496 . . . . 0.0 110.472 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.437 ' HG2' ' HD3' ' A' ' 115' ' ' LYS . 66.6 tttt -61.12 -41.91 97.57 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.919 . . . . 0.0 110.222 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 114' ' ' LYS . 2.8 mmmt -96.39 -3.77 43.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.922 . . . . 0.0 110.236 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 59.5 tt0 52.62 38.26 25.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.124 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.78 156.73 37.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 110.2 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.034 HG13 HD21 ' A' ' 109' ' ' LEU . 2.5 tt -119.29 134.62 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.217 -0.927 . . . . 0.0 110.304 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.478 ' O ' ' HG ' ' A' ' 109' ' ' LEU . . . -141.6 156.06 25.61 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' ND2' ' OG1' ' A' ' 107' ' ' THR . 16.6 t30 -142.78 121.93 12.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -1.194 . . . . 0.0 110.197 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.517 ' OG ' ' NE ' ' A' ' 128' ' ' ARG . 1.3 m -117.32 138.96 51.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.235 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.611 ' SG ' HG22 ' A' ' 107' ' ' THR . 43.0 t -105.5 133.81 49.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -60.37 -13.15 11.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 109.755 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.3 -51.76 51.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.852 . . . . 0.0 110.357 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.78 -27.03 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 0.0 110.791 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 101.21 -12.03 58.62 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 128' ' ' ARG . 4.2 p90 -29.29 -37.2 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.602 -0.94 . . . . 0.0 111.188 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.575 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER 67.8 132.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.39 -0.819 . . . . 0.0 109.683 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.14 73.01 0.29 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 9.6 ttt -83.13 122.33 28.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.278 -1.131 . . . . 0.0 110.111 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.887 HD13 ' SG ' ' A' ' 138' ' ' CYS . 13.5 mt -93.18 142.14 27.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.367 -0.833 . . . . 0.0 110.336 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -119.42 -41.38 2.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.0 p -45.44 139.04 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.918 . . . . 0.0 110.198 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.403 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 38.5 m80 -109.49 23.55 14.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 136' ' ' LYS . 36.7 t60 -130.66 17.07 5.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.213 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 135' ' ' HIS . 4.7 mmmt -119.4 -178.24 3.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.278 -0.889 . . . . 0.0 110.262 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.041 HD22 ' HB2' ' A' ' 96' ' ' PHE . 1.7 pp -47.36 -23.86 0.66 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.262 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.887 ' SG ' HD13 ' A' ' 131' ' ' LEU . 40.0 m -60.17 -42.28 94.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.286 -0.883 . . . . 0.0 110.336 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.403 ' OG1' ' HA ' ' A' ' 134' ' ' HIS . 20.1 m -68.86 -39.98 79.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -0.886 . . . . 0.0 110.46 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -56.93 -48.43 78.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.106 -0.996 . . . . 0.0 109.732 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.935 ' CD1' HD13 ' A' ' 118' ' ' ILE . 23.8 pt -68.77 -42.34 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 142' ' ' LEU . 1.8 tm? -54.19 -37.26 64.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.838 . . . . 0.0 110.251 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 4.6 mmtt -91.67 -11.36 37.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.899 . . . . 0.0 110.349 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 143' ' ' LYS . 0.8 OUTLIER 61.02 175.03 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.191 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.1 Cg_endo -72.08 157.2 54.75 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.022 1.538 . . . . 0.0 110.515 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.9 86.1 1.11 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.09 1.573 . . . . 0.0 110.503 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 148' ' ' ASN . 0.4 OUTLIER -169.21 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 110.138 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 147' ' ' GLU . 32.7 m-80 42.95 -158.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -0.848 . . . . 0.0 110.224 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.2 OUTLIER 177.96 -169.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.222 -0.924 . . . . 0.0 110.237 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.434 ' O ' ' O ' ' A' ' 149' ' ' SER . 2.0 t70 54.65 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.223 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.1 m -103.15 172.97 6.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.252 -0.905 . . . . 0.0 110.244 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.7 24.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 153' ' ' THR . 7.9 m 51.79 92.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.215 -1.168 . . . . 0.0 110.176 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.29 -163.27 36.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 mmtt -80.98 -84.71 0.1 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -1.157 . . . . 0.0 110.174 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.151 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 1' ' ' LEU . 17.1 mt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.257 0.551 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.1 t -114.24 76.31 0.98 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.254 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.71 147.5 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -86.66 -174.97 5.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 0.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 72.7 t -62.27 -11.94 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.203 -0.935 . . . . 0.0 110.196 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.448 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER 65.51 8.97 5.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 110.182 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.525 ' HG3' ' N ' ' A' ' 8' ' ' SER . 9.5 ptt180 -70.26 -30.94 68.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.244 -0.91 . . . . 0.0 110.245 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.525 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 0.3 OUTLIER -78.26 -7.09 56.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.312 -0.867 . . . . 0.0 110.204 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 t -103.09 -29.95 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -0.908 . . . . 0.0 110.176 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.63 172.02 10.42 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.286 -0.884 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.09 120.01 6.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 0.0 110.222 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HG3' ' N ' ' A' ' 13' ' ' PHE . 18.1 pt20 -80.37 -21.98 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.244 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 14' ' ' TYR . 6.8 t80 42.47 65.36 0.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.23 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 16' ' ' TYR . 49.9 t80 -177.77 -88.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.293 -0.879 . . . . 0.0 110.13 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 15' ' ' ARG . 26.7 ttp180 42.18 26.76 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.329 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 2.8 m-85 -136.79 130.2 31.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -0.936 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -116.08 149.58 38.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.916 . . . . 0.0 110.286 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.468 ' HB3' HG12 ' A' ' 22' ' ' ILE . 12.3 mmt -117.37 108.07 44.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.159 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 21' ' ' LEU . 46.4 Cg_endo -72.99 77.18 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 0.0 110.502 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.91 -78.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.283 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.762 HD23 ' N ' ' A' ' 22' ' ' ILE . 5.1 tt -81.93 127.13 32.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.242 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.762 ' N ' HD23 ' A' ' 21' ' ' LEU . 4.7 mt -103.97 136.77 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.918 . . . . 0.0 110.067 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.71 126.75 45.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.247 -0.908 . . . . 0.0 110.425 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.717 ' O ' HG12 ' A' ' 35' ' ' VAL . 2.5 mmtp -116.12 138.05 51.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.378 -0.826 . . . . 0.0 109.802 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 31' ' ' GLY . 4.3 p -93.34 122.05 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.521 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 3.6 tt0 -141.58 133.31 27.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.406 -0.809 . . . . 0.0 110.217 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -172.8 -104.56 0.18 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 30' ' ' ASN . 1.1 mttt -152.55 139.15 18.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -1.043 . . . . 0.0 110.107 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.32 -84.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 28' ' ' LYS . 72.3 m-20 -90.28 -18.79 24.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 110.024 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.752 ' O ' HG22 ' A' ' 25' ' ' VAL . . . 46.37 88.37 0.01 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.71 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.0 OUTLIER -107.83 22.46 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -1.181 . . . . 0.0 110.301 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -97.71 152.85 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.905 -1.122 . . . . 0.0 109.559 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.923 HG21 ' CD2' ' A' ' 80' ' ' HIS . 18.5 m -110.78 115.69 29.99 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.938 -1.101 . . . . 0.0 110.771 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 24' ' ' LYS . 14.3 p -107.14 117.42 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.906 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.574 ' CG2' ' HB2' ' A' ' 39' ' ' MET . 2.2 mt -95.77 108.27 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 37' ' ' VAL . 7.6 p -100.6 -13.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.213 -0.93 . . . . 0.0 110.454 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.667 ' OD1' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -101.47 -1.32 33.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.415 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.574 ' HB2' ' CG2' ' A' ' 36' ' ' ILE . 0.5 OUTLIER -64.5 -45.26 88.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 8.5 p -67.19 -38.58 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.19 -0.943 . . . . 0.0 110.422 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.519 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.2 t0 -61.93 -48.92 78.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.187 -0.945 . . . . 0.0 110.353 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG23 HD22 ' A' ' 38' ' ' ASN . 79.9 t -68.41 -40.7 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -66.43 -38.69 87.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -67.11 -36.45 81.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.052 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.762 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -63.2 -30.27 71.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 110.404 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.1 mp -115.18 -9.31 12.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.215 -0.928 . . . . 0.0 110.345 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.577 ' N ' ' O ' ' A' ' 43' ' ' ALA . 6.1 p30 171.37 -110.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.37 -0.831 . . . . 0.0 110.388 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.916 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.9 mtm-85 -137.32 167.35 21.13 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.0 110.207 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 44.9 Cg_endo -72.0 137.91 30.11 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.907 1.477 . . . . 0.0 110.571 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 1.079 ' O ' HG23 ' A' ' 54' ' ' THR . 47.8 Cg_endo -74.11 52.08 2.6 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.066 1.561 . . . . 0.0 110.523 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.888 HG22 ' CE1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -67.87 -21.69 65.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.271 -0.893 . . . . 0.0 110.488 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.551 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 m-85 -81.4 -54.2 0.71 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.0 111.081 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -72.47 2.49 5.08 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.796 1.419 . . . . 0.0 111.338 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 1.079 HG23 ' O ' ' A' ' 50' ' ' PRO . 1.9 p -66.35 -18.59 65.45 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.993 -1.067 . . . . 0.0 110.147 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.2 ttmt -72.86 -42.3 63.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 0.0 110.878 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -58.72 -51.43 70.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.117 -0.99 . . . . 0.0 110.433 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.547 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 24.7 m-85 -57.82 -42.59 84.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -60.65 -35.52 89.68 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -37.28 70.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -1.208 . . . . 0.0 110.039 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.63 -48.88 70.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.286 -0.884 . . . . 0.0 110.871 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.009 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.14 12.45 3.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.066 -1.021 . . . . 0.0 111.097 -179.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.85 4.85 22.28 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.046 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -117.71 163.87 15.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.264 -1.139 . . . . 0.0 109.081 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.51 ' C ' ' CG2' ' A' ' 65' ' ' THR . 66.4 mt-30 -110.4 -123.07 0.27 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.643 -1.285 . . . . 0.0 109.929 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.596 HG21 ' HB ' ' A' ' 54' ' ' THR . 2.0 p -149.92 170.76 18.06 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.601 -0.687 . . . . 0.0 110.97 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.647 ' CB ' HG22 ' A' ' 75' ' ' ILE . 2.0 tm0? -144.27 139.4 28.59 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.888 ' CE1' HG22 ' A' ' 51' ' ' THR . 30.8 m-85 -126.76 145.85 50.46 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.792 -1.193 . . . . 0.0 112.98 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 71' ' ' ASN . 10.5 m-20 -126.52 117.52 23.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.274 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.9 m -87.29 -45.99 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.63 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.604 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.38 -8.39 46.11 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 178.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 4.1 m120 -118.94 -24.69 6.49 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.695 -0.628 . . . . 0.0 110.147 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.1 m-20 68.45 15.71 9.19 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.153 -0.967 . . . . 0.0 109.958 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.587 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 5.6 mtp180 -113.82 129.43 56.59 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.566 -0.709 . . . . 0.0 109.788 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.711 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -113.79 130.91 56.4 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.484 -0.76 . . . . 0.0 110.316 -179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.647 HG22 ' CB ' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -111.39 148.04 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 110.011 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 3.0 t -120.31 132.14 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 109.22 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.046 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 82.5 m-20 -66.17 141.01 58.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 110.555 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 99.56 137.39 9.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.536 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 86.5 p -96.5 116.04 28.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.107 -1.231 . . . . 0.0 110.639 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.923 ' CD2' HG21 ' A' ' 34' ' ' THR . 3.1 p-80 -143.26 127.47 17.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.609 -0.682 . . . . 0.0 110.274 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.552 ' O ' ' CD1' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -73.64 151.62 40.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.986 -1.071 . . . . 0.0 109.737 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 21' ' ' LEU . . . -52.06 -44.59 64.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.237 -0.915 . . . . 0.0 110.208 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -65.56 -33.3 75.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.17 -0.956 . . . . 0.0 109.835 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -67.31 -36.6 81.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.582 -0.699 . . . . 0.0 111.084 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.552 ' CD1' ' O ' ' A' ' 81' ' ' GLU . 7.9 mp -59.22 -44.84 92.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.16 -0.963 . . . . 0.0 110.725 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.02 -36.42 83.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.037 -1.039 . . . . 0.0 109.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -69.24 -38.12 78.32 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.475 -0.766 . . . . 0.0 111.426 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 2.3 ptm -71.17 -48.82 49.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.799 -1.188 . . . . 0.0 111.601 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.643 ' H ' ' HG3' ' A' ' 88' ' ' MET . 16.1 tp -57.89 -33.68 68.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.003 -1.06 . . . . 0.0 108.707 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.59 -47.53 75.42 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.441 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.551 ' O ' ' CG ' ' A' ' 95' ' ' LYS . . . -68.6 -48.61 49.22 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.624 ' O ' ' CE2' ' A' ' 96' ' ' PHE . 14.0 m-30 -62.13 -52.29 64.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -1.183 . . . . 0.0 110.787 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.873 HG23 HG21 ' A' ' 97' ' ' VAL . 4.1 mt -54.0 -50.58 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.106 -0.996 . . . . 0.0 110.056 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.853 ' HG3' HD11 ' A' ' 98' ' ' LEU . 4.8 ttpm? -66.14 -27.95 68.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 0.0 110.848 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 137' ' ' LEU . 16.9 mmtt -65.92 -42.83 89.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.177 -0.952 . . . . 0.0 111.795 -178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.007 ' CB ' HD11 ' A' ' 131' ' ' LEU . 2.5 p90 -115.99 -33.21 5.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.646 -1.284 . . . . 0.0 111.901 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.873 HG21 HG23 ' A' ' 93' ' ' ILE . 49.2 t -53.67 -21.0 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.617 -1.302 . . . . 0.0 109.879 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.853 HD11 ' HG3' ' A' ' 94' ' ' LYS . 12.1 mt -88.86 39.82 0.95 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.64 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -64.76 155.28 83.01 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.42 -0.8 . . . . 0.0 110.21 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.407 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 43.2 Cg_endo -70.21 -2.32 10.3 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.034 1.544 . . . . 0.0 110.497 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG3' ' CD2' ' A' ' 127' ' ' TYR . 39.7 mm-40 -86.05 -12.08 51.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 103' ' ' GLU . 1.1 t 178.8 -32.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.369 -0.832 . . . . 0.0 110.14 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.549 ' O ' ' CG ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER 33.39 63.48 0.35 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.576 -0.702 . . . . 0.0 110.359 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.602 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.8 m-20 -163.35 -62.7 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 110.198 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.7 Cg_endo -71.8 149.56 54.35 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.843 1.444 . . . . 0.0 110.299 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 106' ' ' GLU . 11.4 pt-20 -69.62 121.99 18.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 110.17 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.5 p -110.27 165.83 11.45 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.17 150.37 34.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 110.144 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.84 142.72 50.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.175 -0.953 . . . . 0.0 110.244 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.509 ' NE2' ' HA3' ' A' ' 119' ' ' GLY . 23.5 p80 -123.0 129.78 51.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.118 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.664 HG12 HD13 ' A' ' 118' ' ' ILE . 3.4 m -101.73 129.58 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.877 . . . . 0.0 110.218 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.18 122.77 44.18 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 0.0 110.193 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.19 -30.9 10.04 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.075 1.566 . . . . 0.0 110.472 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -40.82 90.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.282 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.68 -0.05 17.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.927 . . . . 0.0 110.007 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.66 ' O ' HD21 ' A' ' 142' ' ' LEU . 5.4 mt-30 52.6 37.98 24.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.017 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 2.7 p -117.06 149.96 39.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.664 HD13 HG12 ' A' ' 111' ' ' VAL . 11.3 mm -100.88 137.09 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.286 -0.884 . . . . 0.0 110.191 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -112.46 162.99 12.21 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.479 ' HB2' ' CG ' ' A' ' 131' ' ' LEU . 19.2 t-20 -143.76 128.02 17.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.366 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.841 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 t -116.87 124.71 50.17 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.001 -1.062 . . . . 0.0 110.53 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 42.1 t -115.09 124.4 51.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.79 26.14 1.17 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.448 ' HB1' ' SG ' ' A' ' 102' ' ' CYS . . . -94.3 -35.62 12.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 110.208 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 127' ' ' TYR . 9.5 p -136.72 2.25 2.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.234 -0.916 . . . . 0.0 110.425 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 87.49 -12.45 62.99 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.734 ' CG ' ' N ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -36.76 -80.89 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.404 -1.056 . . . . 0.0 110.266 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.841 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 2.2 tmm_? 45.95 122.41 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.505 -0.747 . . . . 0.0 110.985 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.21 -99.75 0.13 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.08 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.551 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -118.05 145.56 44.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.363 -1.08 . . . . 0.0 110.525 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.007 HD11 ' CB ' ' A' ' 96' ' ' PHE . 2.1 tt -92.08 129.13 38.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.154 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 133' ' ' THR . 1.4 t70 -131.7 -71.02 0.56 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.207 -0.933 . . . . 0.0 110.332 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.749 HG22 ' CD2' ' A' ' 134' ' ' HIS . 1.6 m 68.25 153.65 0.1 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.244 -0.91 . . . . 0.0 110.262 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.749 ' CD2' HG22 ' A' ' 133' ' ' THR . 7.7 p80 -42.77 -51.11 5.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -97.03 140.44 31.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.983 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -75.59 81.65 2.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.205 -0.935 . . . . 0.0 110.332 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.555 ' HB2' ' HD2' ' A' ' 95' ' ' LYS . 2.4 pp -82.66 -19.19 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.877 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.581 ' HA ' HD11 ' A' ' 141' ' ' ILE . 40.0 m -56.31 -40.37 74.24 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.414 -0.804 . . . . 0.0 110.269 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.08 -40.81 98.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.912 . . . . 0.0 110.323 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 144' ' ' ASN . 0.8 OUTLIER -61.42 -49.4 77.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 0.0 109.41 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.581 HD11 ' HA ' ' A' ' 138' ' ' CYS . 16.9 pt -70.26 -41.89 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.543 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 116' ' ' GLN . 20.4 tp -56.02 -40.94 74.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.486 -0.759 . . . . 0.0 111.028 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 0.4 OUTLIER -108.99 -23.22 11.8 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.065 -1.022 . . . . 0.0 110.886 -179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 140' ' ' PHE . 13.4 m120 57.9 103.4 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 110.193 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.408 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 46.0 Cg_endo -73.0 172.48 15.38 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.979 1.515 . . . . 0.0 110.475 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.443 ' HG2' ' HA ' ' A' ' 149' ' ' SER . 45.2 Cg_endo -73.18 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.067 1.562 . . . . 0.0 110.421 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 148' ' ' ASN . 1.3 mp0 -84.58 124.84 31.87 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.178 -0.951 . . . . 0.0 110.215 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 149' ' ' SER . 5.1 m120 60.32 13.39 3.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 146' ' ' PRO . 1.3 m 42.75 74.42 0.11 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.28 -0.887 . . . . 0.0 110.243 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -76.92 155.67 32.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 110.189 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.4 m -72.52 57.81 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.927 . . . . 0.0 110.203 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.38 90.53 1.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -169.15 0.2 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 120.41 -173.0 15.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 53.75 59.56 4.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -1.111 . . . . 0.0 110.2 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.169 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.268 0.556 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -124.68 -179.2 4.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 0.0 110.251 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 3' ' ' VAL . 9.8 p -47.57 127.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.274 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -92.15 177.35 6.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.2 -0.938 . . . . 0.0 110.217 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' ASN . 41.2 t -45.03 -28.49 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 3.6 t-20 65.41 152.49 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.203 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -68.47 -13.74 62.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 0.0 110.193 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 9' ' ' VAL . 1.1 t -78.26 -7.68 57.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.175 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 9' ' ' VAL . 41.0 t 46.23 92.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.308 -0.87 . . . . 0.0 110.221 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 15.3 ptm -151.81 28.13 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.195 -0.94 . . . . 0.0 110.202 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 14' ' ' TYR . 41.6 t0 -52.87 119.11 4.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 110.237 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -84.26 -21.79 31.0 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 0.0 110.227 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -114.95 25.73 10.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.254 -0.904 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.591 ' CE2' ' HB2' ' A' ' 15' ' ' ARG . 17.6 t80 -50.59 -78.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 110.14 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.591 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 19.5 tpp85 -112.63 -30.98 6.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 110.146 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -100.04 130.21 46.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 0.0 110.234 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 18' ' ' MET . 1.4 ttpm? -128.71 162.17 28.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.228 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.401 ' N ' ' CG ' ' A' ' 17' ' ' LYS . 8.5 ttt -141.77 109.95 6.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 0.0 110.244 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 20' ' ' ARG . 46.3 Cg_endo -73.07 -57.45 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 179.76 -142.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 110.263 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 21' ' ' LEU . 10.3 tt -84.84 133.92 34.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.206 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.1 mt -131.62 133.82 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 110.239 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -123.05 147.18 46.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.099 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.22 137.17 52.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.163 -0.961 . . . . 0.0 110.3 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' H ' HG12 ' A' ' 25' ' ' VAL . 4.3 p -97.03 135.33 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.38 137.59 50.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.201 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.87 64.41 0.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.4 tttm -89.77 174.99 7.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.82 -3.85 44.65 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -72.84 -18.04 61.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.189 -1.183 . . . . 0.0 110.218 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . 118.78 -44.58 1.38 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.937 HD12 ' HB3' ' A' ' 79' ' ' SER . 0.2 OUTLIER 168.66 105.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -1.089 . . . . 0.0 109.581 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.403 ' HD2' HD12 ' A' ' 75' ' ' ILE . 7.7 mtmt -112.66 134.01 54.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 79' ' ' SER . 1.1 m -97.24 120.23 37.22 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 35' ' ' VAL . 3.2 m -101.53 118.78 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.737 HG23 ' CB ' ' A' ' 39' ' ' MET . 0.4 OUTLIER -95.22 111.95 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.357 -0.84 . . . . 0.0 110.118 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG21 ' HE2' ' A' ' 24' ' ' LYS . 13.9 t -101.1 -44.13 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 110.876 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 38' ' ' ASN . 1.0 OUTLIER -92.2 4.61 52.87 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.197 -0.94 . . . . 0.0 110.991 -179.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.737 ' CB ' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.15 -33.38 75.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 0.0 110.242 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 41' ' ' ASP . 35.2 m -59.42 -38.39 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 110.17 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' N ' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -64.05 -47.14 81.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.184 -0.947 . . . . 0.0 110.184 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.2 t -61.53 -48.32 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . . . -56.65 -34.93 67.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.251 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 41' ' ' ASP . 2.4 tmtt? -57.72 -48.76 78.69 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.416 -0.802 . . . . 0.0 110.196 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.72 -21.6 66.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 110.082 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.084 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.7 tt -85.34 -9.38 57.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 110.075 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.666 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 83.67 -35.72 0.07 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.706 -0.621 . . . . 0.0 110.621 179.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.444 ' HB2' HD22 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -92.62 154.16 42.41 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 110.224 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.533 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.3 Cg_endo -73.18 150.57 47.89 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.021 1.537 . . . . 0.0 110.365 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.47 ' HB2' ' SD ' ' A' ' 39' ' ' MET . 46.6 Cg_endo -73.24 -22.4 19.04 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.043 1.549 . . . . 0.0 110.507 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.783 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.5 p -66.12 -21.66 66.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 110.285 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -79.79 -56.63 0.75 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 0.0 110.786 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' O ' ' A' ' 49' ' ' PRO . 46.3 Cg_endo -73.4 2.41 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.907 1.477 . . . . 0.0 111.054 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.581 ' HB ' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -74.44 -28.78 61.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.002 -1.062 . . . . 0.0 110.231 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -72.87 -45.56 57.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.223 -0.923 . . . . 0.0 110.523 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -59.04 -51.18 71.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 110.414 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.43 -44.01 84.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.151 -0.968 . . . . 0.0 109.887 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.563 ' HA2' HD11 ' A' ' 61' ' ' LEU . . . -60.06 -35.1 86.4 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -37.36 70.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.237 -1.155 . . . . 0.0 110.111 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -49.47 58.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.196 -0.94 . . . . 0.0 110.581 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.065 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -77.88 9.06 3.85 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 0.0 111.121 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.01 4.52 42.44 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.065 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -115.06 163.75 15.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -1.143 . . . . 0.0 109.129 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.726 ' O ' HG13 ' A' ' 76' ' ' VAL . 7.5 pm0 -110.09 -120.78 0.27 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.582 -1.324 . . . . 0.0 109.964 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.581 HG21 ' HB ' ' A' ' 54' ' ' THR . 1.5 p -149.4 170.53 18.34 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.447 -0.783 . . . . 0.0 110.966 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.672 ' HB3' HG22 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -143.82 139.53 29.37 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.783 ' CZ ' HG22 ' A' ' 51' ' ' THR . 18.4 m-85 -126.59 142.03 51.67 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.862 -1.135 . . . . 0.0 112.803 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 42.9 m-20 -121.33 117.47 27.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.083 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 t -86.09 -63.58 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.893 . . . . 0.0 109.523 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -16.73 6.52 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.16 -0.962 . . . . 0.0 108.592 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.95 -29.88 10.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.656 -0.652 . . . . 0.0 110.051 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.5 m-20 69.66 15.48 8.11 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 109.986 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.562 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 2.6 ttm180 -113.89 129.86 56.55 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.669 -0.644 . . . . 0.0 109.581 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.704 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.5 m-30 -113.0 134.53 54.46 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.374 -0.829 . . . . 0.0 110.421 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.102 HD13 ' N ' ' A' ' 76' ' ' VAL . 0.0 OUTLIER -129.44 148.77 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.816 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 1.102 ' N ' HD13 ' A' ' 75' ' ' ILE . 25.5 t -113.6 138.0 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.123 -0.985 . . . . 0.0 109.864 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 21.6 m-20 -59.88 141.08 56.11 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.333 -0.855 . . . . 0.0 110.905 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.586 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 93.55 157.76 33.48 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.937 ' HB3' HD12 ' A' ' 32' ' ' ILE . 91.8 p -101.81 122.13 43.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -1.143 . . . . 0.0 110.031 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.612 ' NE2' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.03 114.93 8.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 110.168 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.725 ' O ' HD12 ' A' ' 85' ' ' LEU . 2.2 pm0 -84.19 151.82 24.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 109.811 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 86' ' ' GLN . . . -52.46 -39.36 61.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -0.948 . . . . 0.0 110.599 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' ASP . 1.4 t-20 -64.54 -34.04 77.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.214 -0.929 . . . . 0.0 110.709 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.593 ' CB ' ' HG2' ' A' ' 81' ' ' GLU . 0.1 OUTLIER -72.95 -48.27 38.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 110.635 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.725 HD12 ' O ' ' A' ' 81' ' ' GLU . 0.9 OUTLIER -65.74 -44.99 84.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.169 -0.957 . . . . 0.0 110.253 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 82' ' ' ALA . 1.3 mt-30 -58.93 -36.99 75.67 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 90' ' ' ASP . 1.1 m-20 -69.82 -36.51 75.67 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.426 0.631 . . . . 0.0 109.618 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.46 ' HE2' ' HA ' ' A' ' 85' ' ' LEU . 33.6 ttp -68.7 -50.39 51.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.342 -0.849 . . . . 0.0 109.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.07 -30.47 71.53 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.601 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . 5.4 m-20 -63.45 -35.7 81.32 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.706 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.48 -45.66 95.92 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' O ' ' CE1' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -68.4 -52.07 37.01 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.048 -1.266 . . . . 0.0 110.279 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.889 ' HB ' HG21 ' A' ' 97' ' ' VAL . 2.1 pp -65.43 -34.48 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.227 -0.921 . . . . 0.0 110.393 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.835 ' N ' HD12 ' A' ' 93' ' ' ILE . 1.2 ttmt -55.34 -27.65 48.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.285 -0.884 . . . . 0.0 110.955 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.69 ' HD3' HD13 ' A' ' 137' ' ' LEU . 0.1 OUTLIER -61.9 -42.94 99.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.887 -1.133 . . . . 0.0 111.165 -178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.917 ' HB2' HD11 ' A' ' 131' ' ' LEU . 3.5 p90 -116.61 -27.96 6.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.87 -1.144 . . . . 0.0 111.683 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 93' ' ' ILE . 41.8 t -53.79 -59.94 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.962 -1.087 . . . . 0.0 111.001 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.57 ' CG ' ' O ' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -61.68 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.239 -0.913 . . . . 0.0 110.526 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.647 ' N ' ' O ' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -85.2 155.47 60.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.0 110.196 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 42.5 Cg_endo -69.27 -11.2 30.93 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.985 1.518 . . . . 0.0 110.027 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.461 ' OE1' ' HG2' ' A' ' 100' ' ' PRO . 0.6 OUTLIER -134.23 13.59 3.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.435 -0.79 . . . . 0.0 109.687 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.759 ' SG ' HG22 ' A' ' 107' ' ' THR . 0.5 OUTLIER -144.9 -29.44 0.46 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.391 -0.818 . . . . 0.0 110.529 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 98' ' ' LEU . 2.7 tm-20 -37.7 -69.23 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 0.0 110.83 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.604 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 2.1 m-20 -39.84 -61.96 0.97 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 110.641 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.604 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 46.4 Cg_endo -71.35 150.03 57.88 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.032 1.543 . . . . 0.0 110.623 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 129.09 38.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.057 -1.027 . . . . 0.0 109.711 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.759 HG22 ' SG ' ' A' ' 102' ' ' CYS . 4.7 p -110.06 150.25 28.84 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 110.638 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 2.4 p30 -121.04 157.66 29.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.312 -0.868 . . . . 0.0 109.943 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.841 ' CD2' HD22 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -129.32 111.35 12.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.111 -0.993 . . . . 0.0 110.567 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.573 ' CG ' ' O ' ' A' ' 110' ' ' HIS . 24.5 p80 -124.3 119.21 28.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.375 -0.828 . . . . 0.0 109.982 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.42 ' H ' HG12 ' A' ' 111' ' ' VAL . 3.1 p -104.74 129.67 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 110.347 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.494 ' HB3' ' HG2' ' A' ' 115' ' ' LYS . 0.7 OUTLIER -98.95 122.88 51.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.89 . . . . 0.0 110.221 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.12 -26.6 14.74 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.937 1.493 . . . . 0.0 110.496 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.8 tttp -63.59 -39.93 95.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.185 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.522 ' CD ' ' OG1' ' A' ' 117' ' ' THR . 0.3 OUTLIER -110.8 -3.75 15.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -0.918 . . . . 0.0 110.23 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.524 ' C ' HD11 ' A' ' 142' ' ' LEU . 2.5 mt-30 52.54 53.46 12.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.522 ' OG1' ' CD ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -134.01 152.85 52.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.223 -0.923 . . . . 0.0 110.268 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.448 ' CG1' ' HB2' ' A' ' 142' ' ' LEU . 13.8 mm -101.49 126.16 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.981 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.55 ' O ' ' CD2' ' A' ' 110' ' ' HIS . . . -126.08 146.71 16.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.582 ' CB ' ' HB2' ' A' ' 131' ' ' LEU . 15.2 t-20 -144.17 152.79 41.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.233 -1.157 . . . . 0.0 109.113 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.779 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -116.65 123.65 47.81 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.819 -1.176 . . . . 0.0 110.048 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 43.5 t -89.68 112.21 23.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 110.292 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -49.35 -22.07 1.03 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 109.897 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.596 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -94.19 7.33 45.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.375 -0.828 . . . . 0.0 110.139 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.529 ' O ' ' C ' ' A' ' 126' ' ' GLY . 4.9 m 71.16 -1.87 2.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.427 -0.796 . . . . 0.0 109.95 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.84 -62.15 0.35 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.718 ' CD1' ' N ' ' A' ' 128' ' ' ARG . 5.8 p90 -136.19 -31.74 0.89 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -1.144 . . . . 0.0 110.788 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 1.9 mtt180 29.01 94.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.52 -0.737 . . . . 0.0 110.888 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.403 ' O ' ' HA2' ' A' ' 119' ' ' GLY . . . 158.68 -80.49 0.16 Allowed Glycine 0 N--CA 1.49 2.267 0 C-N-CA 119.58 -1.295 . . . . 0.0 110.128 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.527 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -119.93 143.32 48.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.235 -1.156 . . . . 0.0 110.701 -179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.917 HD11 ' HB2' ' A' ' 96' ' ' PHE . 0.4 OUTLIER -113.75 110.85 20.83 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.37 -0.831 . . . . 0.0 110.203 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.631 ' HB3' ' O ' ' A' ' 131' ' ' LEU . 12.4 p-10 165.65 114.82 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.849 0.833 . . . . 0.0 109.783 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 134' ' ' HIS . 0.2 OUTLIER -104.55 -14.07 15.78 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.268 0.556 . . . . 0.0 110.04 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.451 ' O ' ' N ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER 172.36 -152.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.014 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.45 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 110.034 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' N ' ' O ' ' A' ' 134' ' ' HIS . 1.1 mtmt -124.89 -179.29 4.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.31 -0.869 . . . . 0.0 110.161 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.69 HD13 ' HD3' ' A' ' 95' ' ' LYS . 1.8 pt? -70.31 -4.04 20.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 110.25 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.567 ' SG ' HD23 ' A' ' 131' ' ' LEU . 94.4 m -56.12 -48.14 76.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.073 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 p -68.84 -39.13 80.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 110.062 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.35 -48.69 80.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.173 -0.954 . . . . 0.0 109.779 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.539 HG13 ' N ' ' A' ' 142' ' ' LEU . 24.7 pt -69.12 -42.28 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.405 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.539 ' N ' HG13 ' A' ' 141' ' ' ILE . 18.7 tp -53.54 -26.48 21.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 110.081 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.44 ' NZ ' ' HG3' ' A' ' 146' ' ' PRO . 10.0 tttm -87.79 -22.2 24.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.0 110.27 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.475 ' HB3' ' HD2' ' A' ' 145' ' ' PRO . 15.8 m-80 61.65 165.27 0.1 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.22 -0.925 . . . . 0.0 110.131 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 144' ' ' ASN . 45.7 Cg_endo -72.72 113.39 3.73 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.012 1.532 . . . . 0.0 110.393 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.452 ' O ' ' HB2' ' A' ' 147' ' ' GLU . 45.7 Cg_endo -72.66 175.06 10.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.967 1.509 . . . . 0.0 110.453 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 146' ' ' PRO . 2.9 tt0 -178.77 141.81 0.2 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.221 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.48 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.937 . . . . 0.0 110.225 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.67 93.31 1.66 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -0.936 . . . . 0.0 110.204 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -126.21 -3.85 6.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.198 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.7 t -156.89 175.4 14.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 110.227 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 49.79 35.15 23.4 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.5 m -64.83 -60.97 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 110.218 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -150.57 57.72 0.45 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 111.47 8.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -1.175 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.8 mttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.17 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.243 0.544 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -121.32 89.83 3.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.231 -0.918 . . . . 0.0 110.166 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.554 ' O ' HG22 ' A' ' 3' ' ' VAL . 13.3 p -136.26 19.43 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.228 -0.92 . . . . 0.0 110.23 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.443 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . 11.8 t-20 -72.9 155.31 40.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.216 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 9' ' ' VAL . 8.2 p -71.38 -10.4 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 110.208 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 7' ' ' ARG . 34.5 p-10 -62.43 -20.08 64.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.173 -0.954 . . . . 0.0 110.202 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.499 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 3.5 ptm180 -69.43 -31.45 69.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 110.227 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.438 ' N ' ' HG3' ' A' ' 7' ' ' ARG . 2.5 m -91.33 -7.97 49.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.319 -0.863 . . . . 0.0 110.222 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' MET . 14.6 t -111.32 106.77 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.451 ' CB ' ' O ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER 172.86 54.34 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.27 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 13' ' ' PHE . 13.8 t0 -107.86 110.66 22.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.291 -0.88 . . . . 0.0 110.209 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 13' ' ' PHE . 1.4 pp0? -84.38 -13.7 51.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 1.7 t80 -42.73 -54.85 3.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.181 -0.95 . . . . 0.0 110.286 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER 68.23 87.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.176 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 15' ' ' ARG . 2.5 tpt180 -122.59 -12.99 8.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.322 -0.861 . . . . 0.0 110.123 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -109.71 130.16 55.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.237 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.434 ' O ' ' SD ' ' A' ' 18' ' ' MET . 9.2 pttp -133.25 162.27 32.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 0.0 110.258 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.493 ' O ' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -142.23 100.71 5.78 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.238 -0.914 . . . . 0.0 110.23 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.478 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 45.5 Cg_endo -73.12 74.28 3.03 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.014 1.534 . . . . 0.0 110.459 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' PRO . 10.3 mtm180 -156.7 110.15 2.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.289 -0.882 . . . . 0.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.697 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.5 tm? -94.29 122.38 36.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 110.217 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.61 ' N ' HD12 ' A' ' 22' ' ' ILE . 3.1 mp -106.76 121.83 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.343 -0.848 . . . . 0.0 109.964 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.17 122.78 46.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.969 . . . . 0.0 110.235 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.509 ' CB ' ' CG2' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -117.1 136.45 52.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 4.3 m -93.95 135.09 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 110.172 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -112.63 156.6 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.253 -0.905 . . . . 0.0 110.242 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.11 64.74 0.3 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.51 139.1 25.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -1.112 . . . . 0.0 110.175 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.32 -90.83 1.69 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 2.0 m120 -99.63 -0.47 40.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -1.148 . . . . 0.0 110.33 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 78.58 -0.43 76.35 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.8 mm -151.86 87.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -1.109 . . . . 0.0 110.094 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.548 ' HG2' ' CG2' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -129.44 142.84 50.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.282 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.832 HG21 ' NE2' ' A' ' 80' ' ' HIS . 20.9 m -98.34 128.87 44.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.632 HG12 HG23 ' A' ' 75' ' ' ILE . 3.2 m -101.43 127.69 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.288 -0.883 . . . . 0.0 110.285 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.602 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 0.7 OUTLIER -93.82 121.12 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.914 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -100.84 -46.96 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 111.26 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.99 18.5 14.66 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.989 -1.069 . . . . 0.0 111.17 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.602 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.16 -45.26 89.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 0.0 110.236 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 41' ' ' ASP . 23.5 m -70.28 -39.09 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 0.0 110.274 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' ' 40' ' ' VAL . 58.7 t0 -62.08 -48.9 78.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 110.225 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 18' ' ' MET . 95.0 t -66.75 -48.63 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -0.891 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -63.72 -35.03 79.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -62.78 -36.48 83.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 0.0 110.22 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.02 -29.53 64.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.269 -0.895 . . . . 0.0 110.232 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.874 HD12 ' HB2' ' A' ' 47' ' ' ASN . 3.2 pp -105.91 -1.24 24.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.874 ' HB2' HD12 ' A' ' 46' ' ' LEU . 0.8 OUTLIER 173.41 -151.31 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 110.243 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.431 ' CB ' ' HD2' ' A' ' 49' ' ' PRO . 8.4 mtt85 -89.31 174.95 4.34 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 110.231 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 45.6 Cg_endo -72.81 131.8 17.62 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.932 1.49 . . . . 0.0 110.408 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' HG2' ' HG2' ' A' ' 39' ' ' MET . 46.5 Cg_endo -73.72 1.25 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.047 1.551 . . . . 0.0 110.547 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.918 HG23 ' CE1' ' A' ' 67' ' ' PHE . 88.1 m -56.46 -21.83 28.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 110.267 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.576 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -97.71 -54.9 0.2 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.105 -0.997 . . . . 0.0 111.277 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 47.4 Cg_endo -74.99 -2.76 12.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.663 1.349 . . . . 0.0 111.151 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.58 HG23 HG21 ' A' ' 65' ' ' THR . 1.2 t -57.89 -14.41 6.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.039 -1.038 . . . . 0.0 110.298 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -72.77 -45.59 57.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.147 -0.971 . . . . 0.0 110.436 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -65.2 -51.17 62.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.19 -0.944 . . . . 0.0 110.026 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CE1' HD22 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.36 -37.07 72.03 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.248 -0.907 . . . . 0.0 109.33 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' C ' ' O ' ' A' ' 63' ' ' ALA . . . -63.55 -35.21 91.73 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.64 -37.15 70.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -1.2 . . . . 0.0 109.753 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 60' ' ' GLU . 3.8 tp10 -64.5 -49.36 71.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.0 110.681 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.02 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -81.1 11.57 4.04 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.15 -0.969 . . . . 0.0 110.985 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.95 4.57 42.27 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.033 ' HB1' ' O ' ' A' ' 77' ' ' ASN . . . -116.11 163.15 16.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.145 -1.209 . . . . 0.0 109.257 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.522 ' C ' ' CG2' ' A' ' 65' ' ' THR . 2.2 tt0 -119.04 -123.33 0.29 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 0.0 109.813 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.9 p -149.98 170.63 18.4 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 119.716 -0.793 . . . . 0.0 111.641 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -149.59 139.48 21.91 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.918 ' CE1' HG23 ' A' ' 51' ' ' THR . 23.8 m-85 -126.86 146.15 50.39 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.702 -1.249 . . . . 0.0 113.024 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 3.6 t0 -121.34 117.45 26.99 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.922 178.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.14 -63.08 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.221 -0.925 . . . . 0.0 109.876 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -56.64 -15.22 4.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.139 -0.976 . . . . 0.0 108.957 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.59 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.8 t30 -106.0 -29.07 10.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.512 -0.743 . . . . 0.0 110.404 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.2 m-20 70.62 16.89 6.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.157 -0.964 . . . . 0.0 109.912 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.55 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -113.76 129.81 56.53 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.728 ' O ' HD13 ' A' ' 75' ' ' ILE . 3.7 m-30 -111.16 129.03 56.07 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.131 -0.98 . . . . 0.0 110.752 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 74' ' ' TYR . 13.8 mm -130.77 149.28 33.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 12.3 m -112.78 139.44 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.983 -1.073 . . . . 0.0 109.729 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.033 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 6.8 p-10 -69.32 137.0 52.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 110.258 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.609 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 108.1 129.61 6.06 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 32' ' ' ILE . 63.1 p -92.07 121.77 33.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.005 -1.291 . . . . 0.0 110.559 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.832 ' NE2' HG21 ' A' ' 34' ' ' THR . 2.2 p-80 -142.02 114.86 8.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.416 -0.803 . . . . 0.0 110.04 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.572 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -58.72 157.13 9.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.067 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.572 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.11 -36.96 52.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.897 . . . . 0.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.44 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 0.8 OUTLIER -55.91 -33.53 64.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.877 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -63.31 -39.52 94.79 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.551 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.606 HD22 ' N ' ' A' ' 85' ' ' LEU . 3.5 mm? -60.36 -32.99 71.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.385 -0.822 . . . . 0.0 109.24 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -62.74 -37.04 85.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.414 -0.804 . . . . 0.0 109.772 179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -59.35 -46.78 87.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.577 ' CE ' ' CD1' ' A' ' 57' ' ' PHE . 1.1 tmm? -71.63 -30.83 66.2 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.856 0.836 . . . . 0.0 109.341 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 86' ' ' GLN . 0.0 OUTLIER -51.77 -27.21 11.47 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 15.2 t70 -55.12 -35.99 65.25 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.961 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.93 -32.65 82.79 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -38.58 91.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.615 -0.932 . . . . 0.0 109.996 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.063 ' O ' HG13 ' A' ' 97' ' ' VAL . 38.3 mm -52.08 -33.57 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 110.198 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.639 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 10.2 ttpt -55.22 -26.76 41.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.947 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.607 ' O ' HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -60.64 -29.8 69.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.522 -0.737 . . . . 0.0 111.724 -178.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.04 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 5.7 p90 -115.88 -19.13 10.55 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.717 -1.239 . . . . 0.0 111.552 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.063 HG13 ' O ' ' A' ' 93' ' ' ILE . 5.7 m -60.53 -46.82 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.758 -1.214 . . . . 0.0 110.24 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.678 ' C ' ' O ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER 8.9 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.679 -0.638 . . . . 0.0 111.28 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -85.27 155.35 60.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.405 -0.81 . . . . 0.0 110.147 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.476 ' HG2' ' OE1' ' A' ' 101' ' ' GLU . 43.4 Cg_endo -71.06 -8.66 24.06 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.033 1.543 . . . . 0.0 110.307 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' OE2' ' CE2' ' A' ' 127' ' ' TYR . 1.6 pm0 -139.82 22.94 2.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.0 110.067 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.548 ' HB3' HG21 ' A' ' 107' ' ' THR . 67.1 m -152.38 -31.45 0.14 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.535 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.575 ' HG2' HD12 ' A' ' 98' ' ' LEU . 4.0 tm-20 -43.53 -65.09 0.54 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.231 -0.918 . . . . 0.0 110.443 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 4.8 m-20 -37.37 -62.62 0.57 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.488 -0.757 . . . . 0.0 110.443 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.633 ' CB ' ' HB2' ' A' ' 124' ' ' ALA . 45.2 Cg_endo -71.7 149.72 55.23 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.851 1.448 . . . . 0.0 110.26 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 123' ' ' LYS . 0.5 OUTLIER -69.65 135.42 49.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.97 . . . . 0.0 110.205 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.548 HG21 ' HB3' ' A' ' 102' ' ' CYS . 7.1 p -141.88 166.04 25.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 16.8 m-20 -114.16 136.93 52.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.146 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.57 HD13 HG11 ' A' ' 97' ' ' VAL . 2.8 tt -110.77 123.45 50.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 110.212 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -124.16 133.42 53.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.903 HG23 HG12 ' A' ' 118' ' ' ILE . 2.3 p -121.04 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.889 . . . . 0.0 110.198 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.78 122.66 41.8 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.302 -0.874 . . . . 0.0 110.269 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.18 -39.01 2.36 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.886 1.467 . . . . 0.0 110.401 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -59.89 -41.99 92.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.402 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 3.4 tttm -93.45 -3.78 52.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.208 -0.933 . . . . 0.0 110.306 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.78 40.99 31.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 110.2 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -130.88 164.61 24.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 0.0 110.158 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.903 HG12 HG23 ' A' ' 111' ' ' VAL . 7.2 mt -141.38 127.14 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.098 -1.001 . . . . 0.0 110.026 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 129' ' ' GLY . . . -134.22 164.2 24.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 0.4 OUTLIER -138.99 153.11 48.12 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.293 -1.122 . . . . 0.0 109.151 179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.626 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 20.2 m -116.71 124.83 50.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.97 -1.081 . . . . 0.0 110.73 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.464 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . 17.8 t -118.0 134.0 55.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 109.958 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 106' ' ' GLU . 0.0 OUTLIER -98.17 49.01 1.0 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.273 -0.892 . . . . 0.0 109.989 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.633 ' HB2' ' CB ' ' A' ' 105' ' ' PRO . . . -128.3 -32.52 2.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.337 -0.852 . . . . 0.0 110.198 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 12.6 p -142.64 4.46 1.53 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.89 . . . . 0.0 110.614 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . 84.06 -12.56 53.52 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.645 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.6 OUTLIER -40.44 -30.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.277 -1.131 . . . . 0.0 110.241 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -27.5 125.9 0.08 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.676 -0.64 . . . . 0.0 111.231 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' O ' ' HA3' ' A' ' 119' ' ' GLY . . . 156.52 -90.25 0.12 Allowed Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.614 -1.279 . . . . 0.0 110.069 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mtt -119.81 152.19 37.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.325 -1.103 . . . . 0.0 110.372 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 0.3 OUTLIER -68.83 142.15 54.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.701 ' C ' HG22 ' A' ' 133' ' ' THR . 1.9 m-20 -43.17 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 110.29 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.701 HG22 ' C ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER 169.94 -97.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.0 110.309 -179.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.485 ' H ' HG23 ' A' ' 133' ' ' THR . 46.6 m80 55.61 -161.01 0.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.072 -1.018 . . . . 0.0 110.035 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.468 ' O ' ' O ' ' A' ' 134' ' ' HIS . 28.5 m-70 -41.66 163.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.897 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.77 81.22 0.29 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.093 -1.004 . . . . 0.0 110.121 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.907 HD11 ' CE1' ' A' ' 96' ' ' PHE . 19.8 tp -82.96 -54.27 5.2 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.359 -0.838 . . . . 0.0 110.024 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.775 ' HA ' HD11 ' A' ' 141' ' ' ILE . 56.9 m -57.0 -42.42 80.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.485 -0.76 . . . . 0.0 110.383 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.6 m -68.63 -44.81 73.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 110.336 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.05 -49.11 76.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.024 -1.048 . . . . 0.0 109.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.775 HD11 ' HA ' ' A' ' 138' ' ' CYS . 7.4 pt -69.79 -42.12 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 0.0 109.24 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 138' ' ' CYS . 37.8 tp -68.56 -13.11 62.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.512 -0.743 . . . . 0.0 110.258 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.552 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 19.1 tttt -109.0 -9.93 15.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.591 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 1.6 p30 47.9 179.91 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 45.5 Cg_endo -74.01 110.77 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.785 1.413 . . . . 0.0 110.325 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 45.9 Cg_endo -73.37 171.14 18.28 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.027 1.54 . . . . 0.0 110.545 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 149' ' ' SER . 10.6 tp10 44.45 33.38 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.22 -0.925 . . . . 0.0 110.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.412 ' OD1' ' C ' ' A' ' 148' ' ' ASN . 34.2 t-20 54.62 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.245 -0.909 . . . . 0.0 110.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -167.5 170.14 11.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 110.183 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -146.91 -178.28 6.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.939 . . . . 0.0 110.31 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.0 141.34 44.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 110.132 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 149.68 -34.91 1.04 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.1 p -48.27 158.17 0.28 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -1.138 . . . . 0.0 110.121 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 155' ' ' LYS . . . -104.73 -25.28 6.95 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER 60.22 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -1.071 . . . . 0.0 110.176 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 154' ' ' GLY . 1.2 tttt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.157 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.243 0.545 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' VAL . 0.1 OUTLIER -98.89 1.17 45.45 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 110.198 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 4' ' ' ASN . 41.2 t 54.53 167.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.275 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.526 ' N ' HG12 ' A' ' 3' ' ' VAL . 3.9 m120 -93.43 117.78 30.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 110.235 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.658 HG13 ' OD1' ' A' ' 6' ' ' ASN . 11.7 p -61.5 -23.2 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.895 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.658 ' OD1' HG13 ' A' ' 5' ' ' VAL . 3.0 m120 -93.37 22.64 5.07 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 0.0 110.212 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 16.2 ttt180 -69.95 -14.49 62.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.92 . . . . 0.0 110.183 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 t -93.42 4.28 54.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.264 -0.897 . . . . 0.0 110.176 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.3 p -145.38 144.07 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.9 tpp -98.53 -64.46 1.04 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 14' ' ' TYR . 17.4 p-10 -87.38 111.53 21.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -0.891 . . . . 0.0 110.221 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -80.79 -16.61 53.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 0.0 110.242 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 75.0 t80 -82.31 9.94 7.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -68.69 -21.94 64.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.257 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.567 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 4.8 ttp180 -172.62 31.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.163 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' GLN . 0.5 OUTLIER -136.63 132.19 34.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.0 110.101 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.96 154.49 29.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.291 -0.881 . . . . 0.0 110.153 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.43 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -125.59 163.19 40.31 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.256 -0.902 . . . . 0.0 110.221 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 18' ' ' MET . 45.8 Cg_endo -72.98 -90.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.101 1.579 . . . . 0.0 110.44 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' O ' HG11 ' A' ' 42' ' ' VAL . 0.7 OUTLIER 62.83 171.84 0.14 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.211 -0.93 . . . . 0.0 110.28 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 82' ' ' ALA . 9.3 tp -87.28 130.13 34.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.242 -0.911 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 22' ' ' ILE . 14.2 mm -132.59 129.63 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.86 149.24 48.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 110.342 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.531 ' HB3' HG13 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -116.15 138.45 51.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.308 -0.87 . . . . 0.0 109.885 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 25' ' ' VAL . 3.3 m -92.95 131.51 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -0.984 . . . . 0.0 110.395 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' O ' ' N ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -137.34 169.48 17.71 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 110.034 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . 66.05 30.15 76.39 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -89.5 175.12 7.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -1.132 . . . . 0.0 110.192 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.99 -60.09 4.88 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -99.93 -15.49 18.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.319 -1.107 . . . . 0.0 109.643 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.669 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . -154.49 -109.66 0.35 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.912 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.4 OUTLIER 152.79 101.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.943 -0.739 . . . . 0.0 109.371 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 26' ' ' GLU . 3.6 ttpt -129.49 152.6 48.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.932 . . . . 0.0 110.252 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.802 ' O ' HG23 ' A' ' 75' ' ' ILE . 0.9 OUTLIER -111.21 128.49 55.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.174 -0.953 . . . . 0.0 110.494 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.578 HG23 HG12 ' A' ' 75' ' ' ILE . 2.2 p -117.8 117.16 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.958 . . . . 0.0 109.517 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.724 HD12 ' CE ' ' A' ' 39' ' ' MET . 1.6 mt -96.07 112.95 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.897 . . . . 0.0 110.192 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.3 p -100.07 -14.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.313 -0.867 . . . . 0.0 110.417 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 31.1 m120 -111.01 11.38 22.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.267 -0.896 . . . . 0.0 110.247 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.724 ' CE ' HD12 ' A' ' 36' ' ' ILE . 1.2 ttt -61.74 -45.41 94.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.194 -0.941 . . . . 0.0 110.271 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 36.6 t -70.24 -47.62 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -63.68 -50.01 70.92 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.266 -0.897 . . . . 0.0 110.534 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.557 HG11 ' O ' ' A' ' 20' ' ' ARG . 43.0 t -68.36 -45.33 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.283 -0.885 . . . . 0.0 110.464 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' A' ' 47' ' ' ASN . . . -67.13 -39.06 86.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.485 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -67.52 -41.14 84.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.348 -0.845 . . . . 0.0 110.294 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.47 -17.88 62.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -0.868 . . . . 0.0 110.387 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.831 HD23 ' HB2' ' A' ' 47' ' ' ASN . 3.9 tt -117.48 -9.11 10.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.136 -0.978 . . . . 0.0 110.522 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.831 ' HB2' HD23 ' A' ' 46' ' ' LEU . 0.7 OUTLIER 167.68 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -89.34 170.47 10.7 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.113 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.61 135.21 19.55 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.876 1.461 . . . . 0.0 110.538 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.439 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 50.5 Cg_endo -78.18 20.33 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.995 1.524 . . . . 0.0 110.838 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -56.59 -21.93 30.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.027 -1.046 . . . . 0.0 110.311 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -85.54 -58.54 0.33 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.0 110.877 -179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 45.8 Cg_endo -73.16 0.3 8.09 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.798 1.42 . . . . 0.0 110.943 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -56.52 -20.92 22.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.145 -0.972 . . . . 0.0 110.217 179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -72.81 -39.97 66.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.168 -0.958 . . . . 0.0 110.584 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 1.5 t80 -58.87 -51.18 71.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.193 -0.942 . . . . 0.0 110.309 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.56 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 32.3 m-85 -57.53 -43.37 84.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.919 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.6 -35.38 85.59 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 86.9 m -57.1 -37.24 71.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -1.187 . . . . 0.0 110.028 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -66.19 -49.35 67.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.283 -0.886 . . . . 0.0 110.83 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.034 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.17 11.56 3.41 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.113 -0.992 . . . . 0.0 110.988 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 4.89 26.78 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.05 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.47 163.77 15.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -1.086 . . . . 0.0 109.177 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.684 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.3 mm100 -105.45 -120.44 0.22 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.598 -1.314 . . . . 0.0 109.754 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.52 170.24 19.07 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.41 -0.806 . . . . 0.0 111.056 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HB3' ' O ' ' A' ' 75' ' ' ILE . 6.1 tt0 -143.47 139.33 29.81 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.698 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 17.3 m-85 -126.81 141.12 51.91 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.808 -1.182 . . . . 0.0 112.71 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -122.24 117.46 26.22 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.059 178.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.2 t -85.89 -63.02 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.656 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 70' ' ' LYS . 2.3 ttmt -55.23 -17.49 4.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 108.872 178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.59 ' HB2' ' HB3' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -105.4 -29.35 10.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.561 -0.712 . . . . 0.0 110.202 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.8 m-20 70.77 16.54 6.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 0.0 110.04 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.568 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 99.6 mtt180 -113.68 129.64 56.54 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.567 -0.708 . . . . 0.0 109.629 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.1 m-30 -113.29 137.94 50.76 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 110.337 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 34' ' ' THR . 44.3 mt -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 110.048 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 64' ' ' GLN . 14.5 t -114.04 137.73 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.135 -0.978 . . . . 0.0 109.689 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.05 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 67.9 m-80 -57.9 142.22 46.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 110.534 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' HG22 ' A' ' 32' ' ' ILE . . . 84.65 152.5 16.44 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.912 ' OG ' HD12 ' A' ' 32' ' ' ILE . 45.4 p -99.67 115.98 30.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.064 -1.256 . . . . 0.0 110.687 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.764 ' NE2' HG21 ' A' ' 34' ' ' THR . 5.0 p-80 -143.32 117.05 9.26 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.755 -0.591 . . . . 0.0 110.158 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.582 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 3.2 tt0 -65.75 153.83 40.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.021 . . . . 0.0 109.618 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 21' ' ' LEU . . . -52.31 -44.75 65.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.982 . . . . 0.0 110.102 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -65.51 -33.47 76.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.055 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 88' ' ' MET . 4.0 tttp -61.11 -36.48 79.83 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.749 -0.594 . . . . 0.0 110.145 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HA ' ' CG ' ' A' ' 88' ' ' MET . 0.3 OUTLIER -59.4 -39.44 83.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.0 -179.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -36.48 74.77 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.962 -1.086 . . . . 0.0 108.305 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 6.3 t70 -68.83 -33.92 74.64 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.397 0.618 . . . . 0.0 109.938 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.76 ' CG ' ' HA ' ' A' ' 85' ' ' LEU . 9.8 mmm -55.98 -49.6 73.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.353 -0.842 . . . . 0.0 109.757 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 tp -58.33 -31.32 67.46 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -65.02 -46.49 81.13 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.767 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 95' ' ' LYS . . . -62.51 -48.56 81.01 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.732 ' HA ' HD22 ' A' ' 137' ' ' LEU . 2.9 m-30 -61.21 -52.48 64.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.02 -1.282 . . . . 0.0 110.495 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.625 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 3.0 tt -65.8 -45.61 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 110.633 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.036 ' O ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -68.09 -27.73 66.73 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.236 -0.915 . . . . 0.0 111.25 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.594 ' HB3' ' CD2' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -61.42 -41.94 97.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.965 -1.085 . . . . 0.0 111.383 -178.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 137' ' ' LEU . 27.7 p90 -109.47 -32.26 7.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.849 -1.157 . . . . 0.0 111.387 -179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 93' ' ' ILE . 77.4 t -57.98 -14.92 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.881 -1.137 . . . . 0.0 109.964 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.036 HD22 ' O ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER -78.11 44.73 0.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 110.32 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -76.48 155.59 83.63 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.892 179.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.435 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 42.2 Cg_endo -68.44 0.66 4.42 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.864 1.454 . . . . 0.0 110.435 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 124' ' ' ALA . 2.5 mt-10 -124.23 0.89 8.44 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 110.014 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . 17.2 p -163.79 23.14 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 0.0 110.591 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 99' ' ' CYS . 2.4 tm-20 -73.09 53.73 0.37 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.075 -1.015 . . . . 0.0 110.027 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.588 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 1.4 m-20 -167.53 -61.49 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.271 -0.893 . . . . 0.0 110.307 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.633 ' HG2' ' HB2' ' A' ' 124' ' ' ALA . 44.5 Cg_endo -70.51 149.8 62.69 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.922 1.485 . . . . 0.0 110.486 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.52 127.59 33.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 110.182 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.652 HG22 ' HB2' ' A' ' 122' ' ' CYS . 9.9 p -112.97 166.53 11.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -0.824 . . . . 0.0 110.09 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' SER . 0.2 OUTLIER -113.7 160.36 18.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 110.078 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.506 HD23 HD12 ' A' ' 141' ' ' ILE . 1.1 tp -121.71 123.13 41.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.873 . . . . 0.0 110.612 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.584 ' CE1' ' HA3' ' A' ' 119' ' ' GLY . 10.4 p80 -124.22 115.23 20.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.889 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.556 ' CG1' ' HD2' ' A' ' 146' ' ' PRO . 13.6 p -97.77 129.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.208 -0.933 . . . . 0.0 110.545 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -92.06 125.2 57.64 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.894 . . . . 0.0 110.166 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.78 -28.54 13.58 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.956 1.503 . . . . 0.0 110.333 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.71 -41.94 78.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 110.132 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 116' ' ' GLN . 7.9 mmtp -98.65 -2.53 38.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.255 -0.903 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.675 ' O ' HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 52.38 38.03 24.09 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 0.0 110.328 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.6 p -127.03 153.63 45.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 0.0 110.153 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.776 ' CD1' HD12 ' A' ' 141' ' ' ILE . 0.7 OUTLIER -101.09 126.19 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.209 -0.932 . . . . 0.0 110.3 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.584 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -104.19 164.19 14.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 120' ' ' ASN . 20.2 p-10 -134.6 133.14 39.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.123 -1.222 . . . . 0.0 109.685 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.641 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 3.1 p -116.88 124.48 49.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.045 -1.034 . . . . 0.0 110.216 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.652 ' HB2' HG22 ' A' ' 107' ' ' THR . 30.3 p -134.32 133.83 41.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.209 -0.932 . . . . 0.0 110.142 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.28 5.24 10.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.059 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.633 ' HB2' ' HG2' ' A' ' 105' ' ' PRO . . . -53.63 -41.17 66.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.236 -0.915 . . . . 0.0 110.317 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 22.0 p -164.11 20.9 0.07 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -0.914 . . . . 0.0 110.549 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 128' ' ' ARG . . . 84.95 -12.91 56.51 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.685 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.4 OUTLIER -37.83 -30.63 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.28 -1.129 . . . . 0.0 110.274 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -23.91 131.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.672 -0.643 . . . . 0.0 110.995 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 166.27 -91.75 0.1 Allowed Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.353 -1.404 . . . . 0.0 110.174 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.545 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -119.9 151.79 38.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.22 -1.165 . . . . 0.0 110.711 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 96' ' ' PHE . 16.9 tp -109.1 118.1 35.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.377 -0.827 . . . . 0.0 110.037 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 133' ' ' THR . 0.9 OUTLIER -84.63 -104.78 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -0.919 . . . . 0.0 110.198 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.869 HG22 ' HG3' ' A' ' 136' ' ' LYS . 0.2 OUTLIER 40.63 80.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.317 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -71.53 173.91 7.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.283 -0.885 . . . . 0.0 110.252 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.427 ' C ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER 42.92 48.9 5.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.274 -0.891 . . . . 0.0 110.129 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.869 ' HG3' HG22 ' A' ' 133' ' ' THR . 0.1 OUTLIER -139.01 -177.61 4.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 0.0 110.185 -179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.969 HD11 ' CD2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -56.56 -13.12 2.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.954 . . . . 0.0 110.331 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.701 ' HA ' HD11 ' A' ' 141' ' ' ILE . 55.5 m -55.83 -38.6 70.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.01 -41.21 78.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.21 -0.931 . . . . 0.0 110.013 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.39 -48.35 80.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.702 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.776 HD12 ' CD1' ' A' ' 118' ' ' ILE . 15.1 pt -68.63 -41.81 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.361 -0.837 . . . . 0.0 109.554 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 116' ' ' GLN . 16.3 tp -53.03 -19.9 3.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.431 -0.793 . . . . 0.0 110.31 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -93.21 -12.41 30.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.266 -0.896 . . . . 0.0 110.257 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.47 ' O ' ' HD3' ' A' ' 146' ' ' PRO . 2.3 m-80 -113.75 102.9 55.28 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.221 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.64 110.46 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.043 1.549 . . . . 0.0 110.456 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.556 ' HD2' ' CG1' ' A' ' 111' ' ' VAL . 47.0 Cg_endo -74.11 -169.74 0.62 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.039 1.547 . . . . 0.0 110.376 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -93.76 113.41 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 149' ' ' SER . 0.9 OUTLIER -111.77 -161.87 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 150' ' ' ASP . 1.4 t 64.83 123.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 149' ' ' SER . 1.7 m-20 60.29 115.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 151' ' ' SER . 9.2 p 46.35 61.44 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.207 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.436 ' O ' ' OG1' ' A' ' 153' ' ' THR . . . -57.23 92.82 0.03 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 152' ' ' GLY . 63.3 p 43.43 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 0.0 110.232 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.82 50.42 0.06 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -147.54 64.07 1.14 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.179 -1.189 . . . . 0.0 110.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.187 -179.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.1 141.59 31.0 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.259 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 t -139.04 158.04 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 110.218 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -90.64 172.73 8.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 110.234 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 6.5 p -69.56 -15.03 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.183 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 15.2 m120 54.66 71.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.317 -0.865 . . . . 0.0 110.197 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.37 -14.05 61.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -0.915 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 m -87.61 -2.69 58.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.985 . . . . 0.0 110.155 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 63.8 t -132.62 143.65 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.236 -0.915 . . . . 0.0 110.148 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.452 ' SD ' ' HD3' ' A' ' 19' ' ' PRO . 5.2 ptp -46.56 147.62 1.17 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 110.161 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 17' ' ' LYS . 21.4 t70 -94.38 121.06 35.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.22 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.556 ' HA ' ' HB2' ' A' ' 17' ' ' LYS . 13.1 pt20 -58.47 -23.08 56.79 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.55 ' HB3' ' CD2' ' A' ' 14' ' ' TYR . 0.3 OUTLIER 72.63 -52.47 0.7 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.341 -0.85 . . . . 0.0 110.234 -179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CD2' ' HB3' ' A' ' 13' ' ' PHE . 3.1 p90 -143.74 -33.64 0.42 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.234 -0.916 . . . . 0.0 110.124 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.481 ' N ' ' CD1' ' A' ' 14' ' ' TYR . 15.9 ttm180 -158.39 -57.16 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 110.05 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.482 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 7.1 p90 -137.16 129.83 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.34 -0.85 . . . . 0.0 110.065 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 12' ' ' GLN . 13.3 tmtt? -133.57 130.18 38.05 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.277 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.4 mtp -108.32 126.69 29.05 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -72.09 -95.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.026 1.54 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' C ' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 37.26 -149.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.0 110.32 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 85' ' ' LEU . 3.4 tm? -84.66 136.58 33.69 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 110.175 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.799 ' N ' HD13 ' A' ' 21' ' ' LEU . 3.2 pt -109.99 120.89 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 0.0 110.128 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -120.13 136.77 54.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 110.381 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.722 ' O ' HG12 ' A' ' 35' ' ' VAL . 1.6 mmmm -118.44 137.93 52.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.103 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 2.8 m -93.31 128.41 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.207 -0.933 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.16 167.69 21.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.67 -77.24 0.4 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 31' ' ' GLY . 41.5 mmtt -100.38 175.17 5.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -1.111 . . . . 0.0 110.119 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 28' ' ' LYS . . . -38.56 -39.78 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -94.84 -18.66 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 109.896 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 28' ' ' LYS . . . 71.69 99.87 0.06 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.553 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 0.9 OUTLIER -105.89 3.73 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -1.162 . . . . 0.0 110.049 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.757 ' HD2' HG21 ' A' ' 75' ' ' ILE . 17.6 ttmm -97.58 152.91 18.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.146 -0.971 . . . . 0.0 109.29 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.516 ' OG1' ' CD2' ' A' ' 80' ' ' HIS . 2.8 m -99.28 115.81 30.02 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.832 -1.168 . . . . 0.0 110.914 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.722 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.2 p -112.36 117.42 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 109.84 179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 ' HE3' ' A' ' 39' ' ' MET . 58.5 mt -95.88 109.75 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.2 p -81.66 -16.11 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.262 -0.899 . . . . 0.0 110.316 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' HB3' HD11 ' A' ' 22' ' ' ILE . 6.2 p-10 -97.8 2.61 49.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.173 -0.955 . . . . 0.0 110.21 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.629 ' HE3' HG21 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -55.86 -33.64 64.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.886 . . . . 0.0 110.195 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -68.49 -44.47 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 110.239 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 7.2 t0 -66.17 -48.35 71.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 43' ' ' ALA . 8.1 p -61.15 -41.37 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.778 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -61.35 -35.18 76.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 110.014 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 5.4 mmmt -59.41 -37.21 77.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.377 -0.827 . . . . 0.0 109.875 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.915 ' C ' HD23 ' A' ' 46' ' ' LEU . . . -70.23 -19.76 63.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 0.0 109.952 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.012 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -96.27 -9.05 31.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.278 -0.889 . . . . 0.0 109.218 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER 74.3 -50.18 0.68 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.685 -0.634 . . . . 0.0 110.408 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 20.9 mtt85 -77.04 168.03 31.6 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.205 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 48' ' ' ARG . 45.2 Cg_endo -72.6 140.45 32.79 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.96 1.505 . . . . 0.0 110.397 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.778 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.6 Cg_endo -73.51 -15.62 24.64 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.054 1.555 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.707 HG22 ' CE1' ' A' ' 67' ' ' PHE . 73.8 p -64.07 -27.05 68.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.156 -0.965 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -75.98 -54.91 1.99 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.204 -0.935 . . . . 0.0 110.646 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.19 -42.91 1.76 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.816 1.429 . . . . 0.0 110.829 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 50' ' ' PRO . 6.9 t -56.36 -15.75 4.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 110.386 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 52' ' ' TYR . 0.1 OUTLIER -72.25 -45.36 60.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.912 . . . . 0.0 110.349 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.66 79.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.21 -0.931 . . . . 0.0 110.087 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.571 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.6 -42.09 82.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 110.008 179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.39 -35.43 85.05 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -37.12 74.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.176 -1.191 . . . . 0.0 110.099 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -67.72 -30.09 69.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.265 -0.897 . . . . 0.0 110.987 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.023 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -102.26 13.19 35.3 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.969 -1.082 . . . . 0.0 110.914 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.06 4.89 30.63 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.023 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -113.74 164.29 13.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -1.129 . . . . 0.0 109.202 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.926 ' O ' HG13 ' A' ' 76' ' ' VAL . 6.0 tt0 -109.92 -121.24 0.27 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.626 -1.296 . . . . 0.0 109.608 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.74 170.5 18.58 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.385 -0.822 . . . . 0.0 111.325 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.5 OUTLIER -139.82 139.92 36.48 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.707 ' CE1' HG22 ' A' ' 51' ' ' THR . 21.1 m-85 -126.36 142.75 51.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.59 -1.244 . . . . 0.0 113.138 -178.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 2.3 t0 -121.7 117.19 26.02 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.065 178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -89.85 -45.1 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -71.0 -7.04 43.5 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.598 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.5 OUTLIER -119.05 -27.19 5.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.749 -0.594 . . . . 0.0 110.186 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.598 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.0 m-20 70.19 16.98 7.28 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.266 -0.896 . . . . 0.0 109.94 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.572 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 12.4 mmm-85 -113.53 129.77 56.49 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.671 -0.643 . . . . 0.0 109.491 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.7 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.8 m-30 -113.02 129.39 56.51 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 110.541 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.757 HG21 ' HD2' ' A' ' 33' ' ' LYS . 12.6 mt -123.22 149.8 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.618 -0.676 . . . . 0.0 109.792 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 64' ' ' GLN . 75.3 t -112.84 139.19 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 120.981 -1.074 . . . . 0.0 109.19 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.653 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 35.2 m-80 -65.63 141.63 58.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.862 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 80' ' ' HIS . . . 105.24 138.83 9.56 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -80.38 131.5 35.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.286 -1.126 . . . . 0.0 109.573 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.874 ' NE2' HD13 ' A' ' 61' ' ' LEU . 93.1 m-70 -141.7 126.34 17.93 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.645 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 82' ' ' ALA . 3.8 tp10 -100.89 151.07 22.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.319 -0.863 . . . . 0.0 109.583 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.445 ' N ' ' CD ' ' A' ' 81' ' ' GLU . . . -52.1 -43.67 64.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 110.214 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 81' ' ' GLU . 0.3 OUTLIER -58.55 -38.25 77.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 109.955 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -39.55 78.19 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.934 HD12 HD12 ' A' ' 21' ' ' LEU . 21.3 mt -60.4 -40.76 92.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.906 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.474 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 1.6 tt0 -59.19 -36.36 75.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 2.6 m-20 -68.81 -46.61 68.18 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.232 -0.918 . . . . 0.0 109.96 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.49 ' HE2' ' HB3' ' A' ' 88' ' ' MET . 13.4 ttp -71.84 -41.0 68.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.401 -0.812 . . . . 0.0 110.392 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.58 ' O ' HD12 ' A' ' 93' ' ' ILE . 1.3 mt -51.96 -28.73 17.72 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 73.3 m-20 -56.17 -46.28 79.4 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.937 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.498 ' O ' ' CG ' ' A' ' 94' ' ' LYS . . . -66.92 -32.53 81.23 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 12.4 t80 -58.04 -40.05 79.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.981 . . . . 0.0 110.24 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.006 ' O ' HG13 ' A' ' 97' ' ' VAL . 1.4 mp -53.43 -33.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.21 -0.931 . . . . 0.0 110.143 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.579 ' HA ' ' CG2' ' A' ' 97' ' ' VAL . 3.5 ptmt -54.91 -26.26 34.7 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 110.255 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -60.32 -28.05 67.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.389 -0.819 . . . . 0.0 111.687 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.932 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 5.9 p90 -115.18 -20.21 10.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.662 -1.274 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.006 HG13 ' O ' ' A' ' 93' ' ' ILE . 5.3 m -55.76 -19.81 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.828 -1.17 . . . . 0.0 109.925 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -55.53 89.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.889 . . . . 0.0 109.975 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' H ' ' CB ' ' A' ' 103' ' ' GLU . 75.2 m -82.64 155.11 68.6 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.34 -0.85 . . . . 0.0 110.142 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.11 39.86 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.988 1.52 . . . . 0.0 110.757 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 102' ' ' CYS . 0.0 OUTLIER -137.01 -53.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.116 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.505 ' HB2' ' CB ' ' A' ' 124' ' ' ALA . 4.5 p 175.05 54.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 110.592 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' HG2' HG23 ' A' ' 97' ' ' VAL . 8.5 tp10 -79.82 -19.42 48.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 0.0 109.947 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.587 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -30.36 -55.26 0.36 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.636 -0.665 . . . . 0.0 110.403 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 42.8 Cg_endo -70.02 150.52 66.74 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.967 1.509 . . . . 0.0 109.957 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -68.49 111.19 4.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.147 -0.97 . . . . 0.0 110.147 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 105' ' ' PRO . 1.5 p -110.19 166.47 10.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.494 -0.754 . . . . 0.0 110.213 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.7 p30 -113.91 142.87 45.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.905 . . . . 0.0 109.911 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.852 HD23 ' OD1' ' A' ' 120' ' ' ASN . 1.4 mp -106.08 145.42 31.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.318 -0.864 . . . . 0.0 110.364 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.518 ' NE2' ' HA3' ' A' ' 119' ' ' GLY . 11.6 p-80 -124.18 117.29 24.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.208 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.02 ' HB ' HD12 ' A' ' 118' ' ' ILE . 5.8 p -118.02 129.74 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.153 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.55 ' HB2' ' CD ' ' A' ' 115' ' ' LYS . 7.8 m-80 -103.95 122.8 43.15 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 110.409 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.29 -33.92 6.62 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.039 1.547 . . . . 0.0 110.558 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 tptp -59.48 -33.85 71.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.226 -0.921 . . . . 0.0 110.216 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 112' ' ' ASN . 1.9 ptpt -106.89 -1.71 22.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.182 -0.948 . . . . 0.0 110.141 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 53.64 53.37 11.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.332 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 146.31 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.936 . . . . 0.0 110.173 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 1.02 HD12 ' HB ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -112.96 128.42 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.903 . . . . 0.0 110.279 -179.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -99.47 163.87 19.93 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.852 ' OD1' HD23 ' A' ' 109' ' ' LEU . 4.8 t30 -138.53 121.86 17.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -1.177 . . . . 0.0 109.756 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.612 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 30.0 t -125.27 130.57 52.31 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.172 -0.955 . . . . 0.0 110.702 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.492 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 74.0 m -113.06 133.0 55.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 109.903 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.9 tttt -84.16 44.32 1.01 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.314 -0.866 . . . . 0.0 110.042 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.552 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -129.19 -29.06 2.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.861 . . . . 0.0 110.215 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.32 7.56 1.76 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 110.534 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.673 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.61 -12.3 59.49 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.673 ' C ' ' O ' ' A' ' 126' ' ' GLY . 7.4 t80 -12.13 -64.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.729 -0.866 . . . . 0.0 110.978 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.612 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 7.7 tmm_? 21.75 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.882 -0.511 . . . . 0.0 111.193 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -160.32 -111.53 0.28 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.878 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.537 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.5 OUTLIER -120.66 151.85 38.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.485 -1.009 . . . . 0.0 110.692 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.688 ' C ' HD23 ' A' ' 131' ' ' LEU . 4.7 tt -97.83 107.55 20.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.335 -0.853 . . . . 0.0 109.823 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.508 ' O ' ' CB ' ' A' ' 133' ' ' THR . 9.3 m-20 -112.58 -84.86 0.58 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.514 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 132' ' ' ASP . 0.8 OUTLIER 70.41 -175.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.036 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.494 ' H ' HG22 ' A' ' 133' ' ' THR . 0.2 OUTLIER -70.88 155.29 40.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 134' ' ' HIS . 63.3 m170 54.87 176.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 110.252 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -100.12 82.07 2.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.896 HD21 ' CE1' ' A' ' 96' ' ' PHE . 1.0 OUTLIER -82.32 -5.62 58.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 0.0 110.172 179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.729 ' HA ' HD11 ' A' ' 141' ' ' ILE . 57.9 m -62.69 -38.49 90.58 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 0.0 110.299 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 35.5 p -68.64 -40.32 80.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.156 -0.965 . . . . 0.0 110.288 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -59.02 -48.77 80.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.072 -1.017 . . . . 0.0 109.679 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.729 HD11 ' HA ' ' A' ' 138' ' ' CYS . 6.7 pt -69.17 -42.09 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.344 -0.848 . . . . 0.0 109.57 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD23 HG21 ' A' ' 111' ' ' VAL . 10.6 mt -53.26 -20.5 4.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.379 -0.825 . . . . 0.0 110.32 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -86.07 -20.34 28.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.177 -0.952 . . . . 0.0 110.191 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -132.47 59.42 43.48 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.263 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.628 ' HB3' HG11 ' A' ' 111' ' ' VAL . 46.2 Cg_endo -72.96 169.56 21.87 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.041 1.548 . . . . 0.0 110.445 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.426 ' HB3' ' HD2' ' A' ' 155' ' ' LYS . 46.2 Cg_endo -72.94 -18.18 24.59 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.02 1.537 . . . . 0.0 110.395 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 52.94 85.69 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.948 . . . . 0.0 110.165 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.65 105.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 110.107 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 88.5 p -106.72 123.46 48.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 110.287 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -129.99 -160.86 1.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.914 . . . . 0.0 110.222 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -90.53 137.74 32.11 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.902 . . . . 0.0 110.127 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 123.93 -87.5 0.38 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.04 81.68 1.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 110.191 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -93.23 -49.76 2.55 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.426 ' HD2' ' HB3' ' A' ' 146' ' ' PRO . 0.3 OUTLIER -109.63 -61.28 1.66 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.174 -1.192 . . . . 0.0 110.212 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.176 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.237 0.541 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 t -128.6 -148.88 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 110.219 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.3 t -83.62 -43.12 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.458 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 31.9 p30 -88.48 133.47 34.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 110.214 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' A' ' 6' ' ' ASN . 39.4 t -71.69 -27.08 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.724 ' O ' HG23 ' A' ' 9' ' ' VAL . 1.5 m-20 60.38 121.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.229 -0.92 . . . . 0.0 110.148 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.519 ' HG3' ' N ' ' A' ' 8' ' ' SER . 8.1 ptp180 -69.94 -32.67 71.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 110.237 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 10' ' ' MET . 1.1 m -94.1 -13.77 26.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 110.115 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.744 HG12 ' N ' ' A' ' 10' ' ' MET . 44.9 t 34.8 -94.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.483 -0.761 . . . . 0.0 110.568 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.744 ' N ' HG12 ' A' ' 9' ' ' VAL . 8.6 ptt? -53.02 148.02 8.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 110.341 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.17 154.22 23.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.322 -0.861 . . . . 0.0 110.088 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -82.46 -13.57 56.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.893 . . . . 0.0 110.276 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -61.12 -22.82 65.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 0.0 110.242 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.55 ' CG ' ' N ' ' A' ' 15' ' ' ARG . 10.5 t80 -137.02 -91.57 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 0.0 110.236 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.708 HH22 HG22 ' A' ' 153' ' ' THR . 12.1 ttt180 65.36 -63.12 0.21 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.302 -0.874 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.522 ' N ' ' O ' ' A' ' 14' ' ' TYR . 51.5 p90 -104.79 151.77 23.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 0.0 110.314 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HB2' ' OH ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER -132.8 162.08 32.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 110.129 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.456 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 1.3 mtt -144.48 150.5 47.84 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.198 -0.938 . . . . 0.0 110.205 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 46.4 Cg_endo -72.99 -29.88 11.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.538 . . . . 0.0 110.462 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 67.27 148.9 0.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.203 -0.935 . . . . 0.0 110.258 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.65 140.28 30.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.24 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 22' ' ' ILE . 27.8 mm -121.97 143.82 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.279 -0.888 . . . . 0.0 110.154 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.636 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.239 -0.913 . . . . 0.0 110.277 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.975 ' O ' HG12 ' A' ' 35' ' ' VAL . 7.9 mttt -139.41 138.08 36.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 0.0 110.148 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 79' ' ' SER . 46.5 t -93.53 122.3 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.974 . . . . 0.0 110.198 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -141.33 133.24 27.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.172 -0.955 . . . . 0.0 110.374 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 28' ' ' LYS . . . 148.52 -86.99 0.15 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -152.63 174.9 13.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -1.126 . . . . 0.0 110.231 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.42 -35.1 68.61 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -99.91 -18.63 17.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -1.162 . . . . 0.0 110.253 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -67.59 -50.57 42.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.741 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.7 mm 57.66 92.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.304 -1.115 . . . . 0.0 110.293 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.53 141.93 50.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 110.062 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.886 HG21 ' NE2' ' A' ' 80' ' ' HIS . 1.4 m -96.88 127.87 43.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.071 -1.018 . . . . 0.0 110.341 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.975 HG12 ' O ' ' A' ' 24' ' ' LYS . 3.5 p -117.04 118.02 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.892 . . . . 0.0 109.956 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.68 HG21 ' HG2' ' A' ' 39' ' ' MET . 8.1 mt -95.39 138.0 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.329 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.611 HG22 ' NH1' ' A' ' 73' ' ' ARG . 28.8 t -100.31 -22.47 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -100.48 12.25 37.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.148 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.68 ' HG2' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -53.35 -33.43 53.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.209 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.8 t -68.83 -38.41 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.273 -0.892 . . . . 0.0 110.204 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -50.21 72.72 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.173 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.544 HG13 ' N ' ' A' ' 43' ' ' ALA . 10.1 p -65.84 -40.82 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 0.0 110.077 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.814 ' HB1' ' HD3' ' A' ' 50' ' ' PRO . . . -64.98 -34.92 79.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 0.0 110.203 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -43.47 85.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 110.032 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.96 63.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.248 -0.908 . . . . 0.0 110.071 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.912 ' O ' HD23 ' A' ' 46' ' ' LEU . 10.3 tt -92.57 -3.32 55.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.538 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.8 m-20 72.61 -62.41 0.47 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -0.815 . . . . 0.0 110.364 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.616 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 169.86 19.12 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.162 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.471 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 45.5 Cg_endo -72.48 147.15 45.82 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.011 1.532 . . . . 0.0 110.466 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.814 ' HD3' ' HB1' ' A' ' 43' ' ' ALA . 47.0 Cg_endo -73.92 -23.4 16.33 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.997 1.525 . . . . 0.0 110.383 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.038 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 72.5 p -57.85 -21.81 44.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.888 . . . . 0.0 110.469 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 2.0 m-30 -80.14 -58.37 0.6 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.923 . . . . 0.0 110.893 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 52' ' ' TYR . 44.2 Cg_endo -71.27 -30.94 15.06 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.837 1.44 . . . . 0.0 111.045 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 51' ' ' THR . 9.7 t -57.99 -14.01 5.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.112 -0.993 . . . . 0.0 110.3 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 55' ' ' LYS . 13.1 tptm -64.25 -45.38 88.41 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.952 . . . . 0.0 110.344 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -64.83 -38.77 92.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.971 . . . . 0.0 110.304 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.57 -35.31 85.24 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -37.32 71.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -1.197 . . . . 0.0 110.06 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.531 ' OE2' ' CZ ' ' A' ' 92' ' ' PHE . 3.1 mm-40 -66.68 -49.54 65.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.23 -0.919 . . . . 0.0 110.622 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.061 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -79.92 12.87 2.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.189 -0.945 . . . . 0.0 110.961 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.25 9.38 29.48 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.656 -1.377 . . . . 0.0 109.656 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.061 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -118.74 163.95 16.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -1.122 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.693 ' O ' HG23 ' A' ' 76' ' ' VAL . 31.4 mt-30 -105.36 -117.29 0.23 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 120.833 -1.167 . . . . 0.0 110.144 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.6 p -149.0 170.37 18.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 111.081 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HG3' ' HE3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -144.88 139.65 27.8 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.038 ' CZ ' HG22 ' A' ' 51' ' ' THR . 24.7 m-85 -126.67 143.46 51.22 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 118.745 -1.182 . . . . 0.0 113.001 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -123.69 117.37 24.81 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.547 -0.861 . . . . 0.0 108.969 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 14.8 m -88.11 -45.8 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -70.0 -7.6 42.24 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.3 OUTLIER -118.32 -25.92 6.43 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.687 -0.633 . . . . 0.0 110.207 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 7.6 m-20 68.74 16.17 8.96 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.212 -0.93 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.611 ' NH1' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.86 129.79 56.55 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.592 -0.693 . . . . 0.0 109.525 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.9 m-30 -112.89 129.2 56.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 110.364 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.669 HG12 HG23 ' A' ' 35' ' ' VAL . 52.8 mt -118.57 149.17 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.521 -0.737 . . . . 0.0 109.966 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 64' ' ' GLN . 2.2 p -113.15 134.15 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.091 -1.005 . . . . 0.0 109.642 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.061 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 65.5 m-80 -50.63 143.4 9.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.335 -0.853 . . . . 0.0 110.772 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 94.44 131.28 6.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.57 ' HA ' ' OG1' ' A' ' 34' ' ' THR . 59.4 p -97.3 120.29 37.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -1.152 . . . . 0.0 110.106 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.886 ' NE2' HG21 ' A' ' 34' ' ' THR . 1.8 p-80 -142.38 151.52 41.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.787 . . . . 0.0 110.274 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' HA ' ' CB ' ' A' ' 23' ' ' ALA . 4.8 tt0 -93.0 157.69 16.18 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.266 -0.896 . . . . 0.0 109.951 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.527 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.3 -43.8 64.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.182 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.68 -33.47 76.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.954 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 88' ' ' MET . 0.0 OUTLIER -62.77 -37.33 86.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.438 -0.789 . . . . 0.0 110.191 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 85' ' ' LEU . 10.2 mp -60.09 -33.02 71.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.921 . . . . 0.0 109.901 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 16.9 tt0 -68.07 -36.22 79.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.346 -0.846 . . . . 0.0 109.641 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -67.17 -46.4 74.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.367 -0.833 . . . . 0.0 110.638 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.598 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 3.4 ptm -69.9 -48.09 59.98 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.083 -1.011 . . . . 0.0 110.353 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.604 ' HA ' ' CD2' ' A' ' 92' ' ' PHE . 0.9 OUTLIER -54.33 -32.57 56.97 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.176 -0.953 . . . . 0.0 108.613 179.131 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -63.68 -35.98 82.34 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.267 0.556 . . . . 0.0 110.091 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.78 -37.38 94.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.604 ' CD2' ' HA ' ' A' ' 89' ' ' LEU . 5.8 m-30 -63.87 -40.75 97.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.222 -1.164 . . . . 0.0 109.852 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.784 HG12 HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -55.13 -44.14 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 0.0 109.91 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -57.72 -28.02 63.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 110.62 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -61.74 -42.81 99.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.141 -0.974 . . . . 0.0 110.93 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.962 ' CE2' HD22 ' A' ' 137' ' ' LEU . 8.7 p90 -116.46 -25.4 7.48 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.873 -1.142 . . . . 0.0 110.654 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG12 ' CD2' ' A' ' 98' ' ' LEU . 16.0 t -82.66 -55.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.206 -0.934 . . . . 0.0 110.73 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.803 ' CD2' HG12 ' A' ' 97' ' ' VAL . 3.6 mm? -112.38 57.02 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 110.389 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.536 ' SG ' ' HD2' ' A' ' 100' ' ' PRO . 0.1 OUTLIER -78.41 151.5 77.86 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.452 -0.78 . . . . 0.0 109.871 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.536 ' HD2' ' SG ' ' A' ' 99' ' ' CYS . 44.9 Cg_endo -72.3 1.17 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.91 1.479 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' C ' ' SG ' ' A' ' 102' ' ' CYS . 24.5 tt0 -75.39 -63.91 1.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.198 -0.939 . . . . 0.0 109.992 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 62.8 m -148.55 4.95 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.307 -0.871 . . . . 0.0 110.641 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 24.2 mp0 -78.75 -14.85 59.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.032 -1.043 . . . . 0.0 109.826 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.587 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 3.0 m120 -29.43 -55.58 0.29 Allowed Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.732 -0.605 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 104' ' ' ASN . 42.5 Cg_endo -68.86 150.48 73.6 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.899 1.473 . . . . 0.0 110.16 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.56 116.43 9.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 110.172 -179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 122' ' ' CYS . 1.2 p -110.21 166.33 11.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.408 -0.808 . . . . 0.0 110.123 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.485 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -113.61 154.4 27.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.897 . . . . 0.0 110.008 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.791 ' N ' HD12 ' A' ' 109' ' ' LEU . 5.6 mp -105.96 138.15 42.65 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 110.471 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -124.09 115.26 20.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.338 -0.851 . . . . 0.0 109.952 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.798 HG23 ' CD1' ' A' ' 118' ' ' ILE . 4.0 p -97.19 124.79 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.155 -0.966 . . . . 0.0 110.309 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -90.01 122.68 67.51 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.34 -30.03 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.997 1.525 . . . . 0.0 110.477 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -66.83 -42.15 86.28 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.338 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -102.87 -3.92 25.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.146 -0.971 . . . . 0.0 110.227 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 52.53 38.1 24.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.265 -0.897 . . . . 0.0 110.134 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -118.06 179.6 4.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.324 -0.86 . . . . 0.0 110.154 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.798 ' CD1' HG23 ' A' ' 111' ' ' VAL . 12.7 mm -128.04 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 0.0 110.312 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 129' ' ' GLY . . . -147.66 123.88 1.81 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.7 p-10 -144.65 120.88 10.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.285 . . . . 0.0 108.967 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.604 ' CB ' ' HA ' ' A' ' 128' ' ' ARG . 1.2 m -116.89 156.43 27.37 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.05 -1.031 . . . . 0.0 111.157 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.673 ' O ' ' N ' ' A' ' 124' ' ' ALA . 25.8 p -87.64 134.64 33.61 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.435 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 122' ' ' CYS . 4.8 tttt -27.28 -33.75 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.769 -0.582 . . . . 0.0 111.446 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 122' ' ' CYS . . . -61.75 -15.33 40.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 0.0 110.503 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.76 ' O ' ' N ' ' A' ' 127' ' ' TYR . 9.0 m 68.18 -48.21 0.54 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.138 -0.976 . . . . 0.0 110.21 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' ALA . . . -34.6 -12.78 0.0 OUTLIER Glycine 0 N--CA 1.496 2.649 0 O-C-N 121.826 -0.546 . . . . 0.0 112.186 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.802 ' HD1' ' O ' ' A' ' 127' ' ' TYR . 0.7 OUTLIER -145.37 99.42 3.3 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 120.539 -1.565 . . . . 0.0 110.325 -179.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.604 ' HA ' ' CB ' ' A' ' 121' ' ' SER . 0.1 OUTLIER -86.65 123.86 32.29 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.617 ' O ' ' HA2' ' A' ' 119' ' ' GLY . . . -81.41 51.85 4.45 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.66 121.76 27.26 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.555 -0.968 . . . . 0.0 110.106 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.92 HD13 ' SG ' ' A' ' 138' ' ' CYS . 2.4 mt -113.64 142.15 46.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.509 -0.745 . . . . 0.0 110.369 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.54 -24.38 4.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 110.136 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 2.7 p -57.66 -179.52 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 110.207 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' A' ' 135' ' ' HIS . 86.8 m-70 -146.44 69.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 134' ' ' HIS . 11.3 p80 176.23 33.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.887 . . . . 0.0 110.197 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.7 OUTLIER -138.94 -177.55 4.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.138 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.962 HD22 ' CE2' ' A' ' 96' ' ' PHE . 1.3 tt -42.05 -26.24 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.916 . . . . 0.0 110.169 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.92 ' SG ' HD13 ' A' ' 131' ' ' LEU . 53.0 m -56.3 -40.07 73.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.235 -0.916 . . . . 0.0 110.277 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.9 m -68.73 -41.51 78.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.203 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.441 ' CE2' ' CZ ' ' A' ' 57' ' ' PHE . 0.5 OUTLIER -56.88 -48.05 79.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 0.0 109.663 179.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.664 HD11 HG21 ' A' ' 118' ' ' ILE . 18.4 pt -68.55 -42.14 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.694 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.523 ' HA ' HG21 ' A' ' 111' ' ' VAL . 45.1 tp -53.4 -29.95 37.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 110.543 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.528 ' O ' ' CE ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -109.09 -1.48 18.8 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -0.991 . . . . 0.0 110.455 -179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -51.79 143.89 20.67 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.932 . . . . 0.0 110.302 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.67 163.41 37.39 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.008 1.531 . . . . 0.0 110.341 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.93 -177.59 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.951 1.501 . . . . 0.0 110.456 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -98.11 23.08 8.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.937 . . . . 0.0 110.257 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 149' ' ' SER . 1.0 OUTLIER 54.91 -172.47 0.05 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.23 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.415 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.3 OUTLIER 59.48 162.73 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 149' ' ' SER . 5.1 t0 55.36 104.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.2 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.4 m 60.98 162.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 0.0 110.221 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 117.38 -10.34 14.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.708 HG22 HH22 ' A' ' 15' ' ' ARG . 64.0 p -76.24 82.97 3.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.292 -1.122 . . . . 0.0 110.194 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -163.2 154.72 25.76 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -131.86 -51.91 0.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.3 -1.118 . . . . 0.0 110.205 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.108 -0.949 . . . . 0.0 110.164 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.277 0.561 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.2 155.43 17.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.242 -0.912 . . . . 0.0 110.207 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 4' ' ' ASN . 8.6 p -133.95 -37.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 110.219 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.498 ' N ' HG13 ' A' ' 3' ' ' VAL . 73.3 m-80 -75.91 106.17 7.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 110.191 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -58.55 -22.54 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 110.23 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -88.66 91.05 8.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.3 mtt180 -69.11 -20.29 64.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.428 ' O ' ' SD ' ' A' ' 10' ' ' MET . 76.7 p -93.21 7.96 42.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 9' ' ' VAL . 11.9 p -43.14 134.36 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.167 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 8' ' ' SER . 3.2 mpp? -112.14 -169.85 1.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.33 -0.856 . . . . 0.0 110.244 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 22.2 p-10 -86.96 114.31 23.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.882 . . . . 0.0 110.191 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.576 ' HB3' ' CD1' ' A' ' 14' ' ' TYR . 14.1 mm100 -70.46 -20.26 62.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.89 . . . . 0.0 110.251 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' O ' ' CG ' ' A' ' 13' ' ' PHE . 12.9 t80 43.54 41.07 3.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 110.135 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.576 ' CD1' ' HB3' ' A' ' 12' ' ' GLN . 0.3 OUTLIER -140.43 5.53 2.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' HB2' ' CE1' ' A' ' 14' ' ' TYR . 1.8 ttt-85 -133.33 -49.88 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -100.03 139.22 36.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.303 -0.873 . . . . 0.0 110.219 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.37 159.19 32.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.432 ' O ' ' CG ' ' A' ' 18' ' ' MET . 2.1 ppp? -102.81 115.43 64.25 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.115 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -75.15 -155.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.971 1.511 . . . . 0.0 110.263 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' O ' ' ND2' ' A' ' 38' ' ' ASN . 1.1 mmt85 -91.78 -165.51 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.213 -0.93 . . . . 0.0 110.179 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 5.7 tt -65.03 133.85 52.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.19 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.2 mt -112.4 143.99 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.228 -0.92 . . . . 0.0 110.264 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.781 ' HB3' ' HA ' ' A' ' 81' ' ' GLU . . . -125.37 123.98 40.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.262 -0.898 . . . . 0.0 110.385 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.25 138.2 53.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.277 -0.889 . . . . 0.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 33' ' ' LYS . 74.6 t -93.11 122.32 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.945 . . . . 0.0 110.409 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HB3' HG21 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -141.17 153.66 45.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.389 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 135.92 -81.07 0.3 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -152.61 153.23 32.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.35 -1.088 . . . . 0.0 110.126 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.7 -5.56 89.34 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.02 -16.03 18.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.254 -1.144 . . . . 0.0 110.429 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 32' ' ' ILE . . . -109.59 -114.36 3.64 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.009 HD12 ' OG ' ' A' ' 79' ' ' SER . 0.3 OUTLIER 156.43 108.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.854 -0.792 . . . . 0.0 109.547 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.686 ' HG2' HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -126.88 152.65 46.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.171 -0.956 . . . . 0.0 110.502 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.66 HG22 HG22 ' A' ' 76' ' ' VAL . 1.2 m -108.06 116.24 31.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.133 -0.98 . . . . 0.0 110.373 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 HD12 ' A' ' 75' ' ' ILE . 48.6 t -104.08 117.46 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.942 . . . . 0.0 109.758 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 ' HB2' ' A' ' 39' ' ' MET . 3.9 mm -96.02 108.46 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 110.086 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.41 -23.53 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.663 ' OD1' HG23 ' A' ' 42' ' ' VAL . 46.2 t30 -95.93 8.79 42.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 0.0 110.286 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.545 ' HB2' HG22 ' A' ' 36' ' ' ILE . 1.9 ttt -64.12 -45.29 89.26 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 0.0 110.306 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 17.9 t -67.24 -40.7 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.928 . . . . 0.0 110.423 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -45.26 70.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 0.0 110.661 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.663 HG23 ' OD1' ' A' ' 38' ' ' ASN . 80.4 t -68.29 -48.73 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.175 -0.953 . . . . 0.0 110.569 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.068 ' HB1' ' O ' ' A' ' 48' ' ' ARG . . . -67.45 -43.96 79.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.916 . . . . 0.0 110.393 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 40' ' ' VAL . 7.8 ttpt -59.54 -36.48 76.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 110.095 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.21 -16.5 62.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.287 -0.883 . . . . 0.0 110.382 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.942 HD22 ' O ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -117.39 -11.17 10.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.149 -0.969 . . . . 0.0 110.078 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.737 ' CB ' HD13 ' A' ' 46' ' ' LEU . 13.6 t-20 167.02 -96.02 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.42 -0.8 . . . . 0.0 110.237 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.068 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -137.67 172.07 7.42 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -0.949 . . . . 0.0 110.08 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 46.1 Cg_endo -72.72 139.51 30.9 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.031 1.543 . . . . 0.0 110.629 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.932 ' O ' HG23 ' A' ' 54' ' ' THR . 47.2 Cg_endo -72.76 60.34 3.56 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.042 1.548 . . . . 0.0 110.394 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.45 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -68.73 -50.53 50.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 111.332 -179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.762 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 2.8 p90 -87.33 -29.0 0.38 Allowed Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.994 -1.066 . . . . 0.0 112.351 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.762 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 45.3 Cg_endo -71.29 -2.18 10.81 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.07 1.037 . . . . 0.0 110.755 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.932 HG23 ' O ' ' A' ' 50' ' ' PRO . 2.9 p -76.46 -10.99 59.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.106 -0.996 . . . . 0.0 110.372 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.1 mttp -72.94 -45.42 58.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 0.0 110.58 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -64.53 -47.78 77.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.172 -0.955 . . . . 0.0 110.392 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.566 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -57.46 -42.8 83.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.155 -0.966 . . . . 0.0 109.859 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.52 -35.44 85.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -56.93 -37.21 71.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.168 -1.196 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -48.79 68.5 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.293 -0.879 . . . . 0.0 110.765 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.028 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -80.72 12.83 2.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.107 -0.995 . . . . 0.0 110.95 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.47 5.44 22.76 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.072 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -116.48 163.93 15.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -1.133 . . . . 0.0 109.213 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.484 ' C ' ' CG2' ' A' ' 65' ' ' THR . 19.6 mt-30 -102.87 -119.56 0.19 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.634 -1.292 . . . . 0.0 109.998 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.3 OUTLIER -149.5 170.41 18.67 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.373 -0.83 . . . . 0.0 111.005 -179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.559 ' CB ' HG23 ' A' ' 75' ' ' ILE . 2.9 mt-30 -146.01 139.47 26.14 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.755 ' CE1' ' HB3' ' A' ' 74' ' ' TYR . 22.6 m-85 -126.69 144.53 50.9 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.876 -1.14 . . . . 0.0 112.748 -178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.587 ' CB ' ' HG3' ' A' ' 73' ' ' ARG . 1.9 t0 -124.01 117.42 24.69 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.323 178.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 70' ' ' LYS . 15.2 m -88.91 -46.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 0.0 109.455 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' N ' HG23 ' A' ' 69' ' ' VAL . 2.5 tppt? -69.75 -8.73 50.52 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.601 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.1 OUTLIER -117.17 -26.76 6.68 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.677 -0.639 . . . . 0.0 110.124 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 4.7 m-20 69.8 16.53 7.81 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.28 -0.887 . . . . 0.0 109.962 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.587 ' HG3' ' CB ' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.87 129.66 56.57 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 109.643 -179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.755 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 1.8 m-85 -113.18 129.18 56.59 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.417 -0.802 . . . . 0.0 110.5 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.934 HD12 HG22 ' A' ' 35' ' ' VAL . 2.3 tt -124.12 148.34 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.487 -0.758 . . . . 0.0 109.872 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.66 HG22 HG22 ' A' ' 34' ' ' THR . 11.0 m -114.35 139.34 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.981 . . . . 0.0 109.7 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.072 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 70.6 m-20 -55.74 146.36 21.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.516 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.549 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 88.5 150.78 21.87 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 1.009 ' OG ' HD12 ' A' ' 32' ' ' ILE . 2.7 p -103.92 123.92 48.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -1.173 . . . . 0.0 110.202 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 1.019 ' CE1' HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -142.19 114.84 8.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.781 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 4.9 tt0 -74.74 156.54 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.952 . . . . 0.0 109.605 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.7 -44.19 63.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.077 -1.014 . . . . 0.0 109.74 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -65.09 -33.14 75.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.22 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 88' ' ' MET . 29.8 mttt -71.35 -36.47 71.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.638 -0.663 . . . . 0.0 110.475 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' CD2' ' O ' ' A' ' 81' ' ' GLU . 1.2 mm? -59.37 -44.23 92.77 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.227 -0.921 . . . . 0.0 110.144 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -68.62 -36.12 78.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.948 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 90' ' ' ASP . 37.8 t0 -64.87 -46.12 83.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.421 -0.799 . . . . 0.0 111.297 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.601 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 3.2 ptm -57.94 -48.63 79.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.821 -1.174 . . . . 0.0 110.681 -179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.601 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.7 OUTLIER -57.57 -33.06 67.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 0.0 108.554 179.387 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 0.6 OUTLIER -64.33 -45.08 89.44 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.265 0.555 . . . . 0.0 110.34 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 95' ' ' LYS . . . -61.89 -44.59 97.63 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -55.73 -51.82 66.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -1.199 . . . . 0.0 110.013 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.842 ' O ' HG22 ' A' ' 97' ' ' VAL . 17.1 mt -65.43 -50.6 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.232 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -61.32 -27.28 68.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.433 -0.792 . . . . 0.0 110.608 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' CG ' ' O ' ' A' ' 91' ' ' GLY . 9.9 mmtp -60.75 -37.26 81.22 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 111.381 -178.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.877 ' CE1' HG12 ' A' ' 97' ' ' VAL . 18.7 p90 -115.34 -19.07 10.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.837 -1.164 . . . . 0.0 111.455 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.877 HG12 ' CE1' ' A' ' 96' ' ' PHE . 4.4 m -84.29 -8.07 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.813 -1.179 . . . . 0.0 110.123 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.854 HD12 ' CD ' ' A' ' 103' ' ' GLU . 0.8 OUTLIER -58.59 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.126 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.563 ' H ' ' HB3' ' A' ' 103' ' ' GLU . 99.0 m -87.99 155.06 52.7 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.865 . . . . 0.0 110.252 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.44 2.91 5.2 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.087 1.572 . . . . 0.0 110.207 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.627 ' O ' ' CB ' ' A' ' 102' ' ' CYS . 40.1 mm-40 -98.25 18.24 16.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 110.1 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.627 ' CB ' ' O ' ' A' ' 101' ' ' GLU . 0.5 OUTLIER 78.7 44.21 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.491 -0.755 . . . . 0.0 110.287 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.854 ' CD ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -43.87 -24.14 0.12 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.281 -0.887 . . . . 0.0 110.175 179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.753 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 2.6 m-20 16.93 -76.66 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 122.039 -0.413 . . . . 0.0 111.916 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.753 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 39.2 Cg_endo -64.93 150.17 88.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 110.507 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -68.66 129.47 40.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.08 -1.012 . . . . 0.0 110.261 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 121' ' ' SER . 1.3 p -110.2 166.17 11.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.485 -0.759 . . . . 0.0 110.161 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -114.07 151.83 31.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.893 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.642 HD23 ' CZ ' ' A' ' 96' ' ' PHE . 3.2 pp -119.36 149.54 41.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 110.595 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 118' ' ' ILE . 50.1 m-70 -124.11 119.48 29.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 109.993 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.867 HG23 HG12 ' A' ' 118' ' ' ILE . 8.2 p -101.75 129.63 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 110.451 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.437 ' O ' ' N ' ' A' ' 116' ' ' GLN . 1.4 t-20 -101.2 124.88 39.82 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.346 -0.846 . . . . 0.0 110.17 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.443 ' HG3' ' O ' ' A' ' 147' ' ' GLU . 46.2 Cg_endo -73.19 -31.62 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.974 1.513 . . . . 0.0 110.533 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.507 ' HB2' ' NZ ' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -73.44 -33.76 65.07 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.252 -0.905 . . . . 0.0 110.29 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 114' ' ' LYS . 6.6 tttm -108.67 -3.68 17.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.272 -0.893 . . . . 0.0 110.279 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.437 ' N ' ' O ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER 52.56 38.52 25.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.883 . . . . 0.0 110.223 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 0.5 OUTLIER -121.14 159.6 25.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.158 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.867 HG12 HG23 ' A' ' 111' ' ' VAL . 9.1 mt -126.51 126.25 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 0.0 110.296 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 109' ' ' LEU . . . -103.57 163.97 15.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.991 ' HB2' HD12 ' A' ' 131' ' ' LEU . 9.6 t-20 -143.62 129.56 19.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.063 -1.257 . . . . 0.0 109.941 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 9.7 p -117.11 124.67 49.78 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.156 -0.965 . . . . 0.0 110.272 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.54 ' O ' ' N ' ' A' ' 125' ' ' CYS . 30.2 p -107.44 134.45 50.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.815 . . . . 0.0 109.934 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.479 ' C ' ' O ' ' A' ' 122' ' ' CYS . 6.0 tttt -37.33 -28.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.29 -0.881 . . . . 0.0 110.596 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.54 ' O ' ' HB2' ' A' ' 125' ' ' CYS . . . -72.03 -27.84 62.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.232 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 122' ' ' CYS . 5.9 m 73.45 -46.08 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.519 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.62 -36.58 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.638 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.9 OUTLIER -109.79 -33.14 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -1.233 . . . . 0.0 110.547 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -28.29 125.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.623 -0.673 . . . . 0.0 110.866 -179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.53 -90.38 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.632 -1.271 . . . . 0.0 109.946 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.516 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -119.76 151.56 38.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.236 -1.155 . . . . 0.0 110.523 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 120' ' ' ASN . 0.9 OUTLIER -71.98 142.55 49.38 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.116 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.481 ' C ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -36.2 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.359 -0.838 . . . . 0.0 110.507 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -172.38 3.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 110.354 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.495 ' O ' ' CB ' ' A' ' 135' ' ' HIS . 45.5 m170 -88.42 -135.42 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -0.896 . . . . 0.0 110.291 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.495 ' CB ' ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER 68.26 -60.38 0.42 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.251 -0.906 . . . . 0.0 110.109 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -68.87 -177.62 1.04 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 110.067 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.768 HD11 ' HB3' ' A' ' 96' ' ' PHE . 1.1 pp -52.6 -14.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.393 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.711 ' SG ' HD21 ' A' ' 131' ' ' LEU . 56.4 m -56.06 -42.41 76.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.984 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -69.1 -39.36 79.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.557 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 8.7 t80 -56.89 -48.45 78.13 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.203 -0.936 . . . . 0.0 109.745 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.67 HD11 ' HA ' ' A' ' 138' ' ' CYS . 9.4 pt -66.12 -41.48 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.336 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.785 ' C ' HD13 ' A' ' 142' ' ' LEU . 2.9 tm? -54.25 -29.56 47.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.355 -0.841 . . . . 0.0 110.59 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -109.42 -36.86 5.88 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.442 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.746 ' CB ' ' CD ' ' A' ' 145' ' ' PRO . 0.9 OUTLIER -60.25 -76.1 0.1 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.921 -1.112 . . . . 0.0 110.573 -179.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.746 ' CD ' ' CB ' ' A' ' 144' ' ' ASN . 43.1 Cg_endo -68.4 109.24 1.98 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.492 1.259 . . . . 0.0 110.515 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 144' ' ' ASN . 49.1 Cg_endo -76.39 64.77 7.27 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.992 1.522 . . . . 0.0 110.247 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.53 ' CB ' HG13 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -40.53 105.22 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 110.394 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 149' ' ' SER . 5.2 m-20 -148.19 155.6 41.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.11 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 148' ' ' ASN . 1.6 t 43.38 -149.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.16 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -156.74 54.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.8 m -96.75 -79.71 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.286 -0.884 . . . . 0.0 110.176 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 169.44 -64.82 0.18 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.81 -88.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.213 -1.169 . . . . 0.0 110.154 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 118.42 115.85 2.68 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -138.24 179.1 6.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 110.225 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 155' ' ' LYS . 30.2 mtmm . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.212 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.286 0.565 . . . . 0.0 110.243 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER 67.12 -58.52 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.579 ' O ' HD12 ' A' ' 1' ' ' LEU . 76.2 t -65.73 122.62 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.187 -0.946 . . . . 0.0 110.201 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -87.03 175.78 7.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 6' ' ' ASN . 37.9 t -69.17 -33.89 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.181 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.7 m120 58.41 122.82 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.292 -0.88 . . . . 0.0 110.313 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -37.99 87.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -83.95 -13.37 53.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.173 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.488 HG12 ' N ' ' A' ' 10' ' ' MET . 53.9 t 54.65 165.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 110.233 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.488 ' N ' HG12 ' A' ' 9' ' ' VAL . 0.7 OUTLIER 43.12 -150.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.325 -0.859 . . . . 0.0 110.176 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.67 128.41 36.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.292 -0.88 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.575 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 6.8 mp0 -78.35 -40.86 35.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.0 110.214 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' CB ' ' O ' ' A' ' 12' ' ' GLN . 0.2 OUTLIER 69.75 99.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.587 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -144.55 -99.93 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.363 -0.836 . . . . 0.0 110.145 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -144.23 -37.18 0.32 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 0.0 110.287 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' O ' ' CE1' ' A' ' 14' ' ' TYR . 6.8 p90 -101.15 130.55 47.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.374 -0.829 . . . . 0.0 110.291 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 7.0 tttp -123.24 162.32 22.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 110.332 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.435 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 36.5 mtm -106.36 91.44 5.76 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.248 -0.907 . . . . 0.0 110.205 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 17' ' ' LYS . 46.3 Cg_endo -73.01 -52.24 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.922 1.485 . . . . 0.0 110.441 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 -73.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 110.172 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.91 122.65 38.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.913 . . . . 0.0 110.175 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.644 HG23 HG22 ' A' ' 37' ' ' VAL . 3.0 tt -128.5 136.1 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 110.237 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 34' ' ' THR . . . -125.8 135.44 52.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 110.23 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.773 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.5 OUTLIER -116.16 137.47 52.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.188 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.7 m -100.27 135.2 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.275 -0.89 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -112.62 164.47 13.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.219 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 61.99 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.5 ' O ' ' HG3' ' A' ' 33' ' ' LYS . 4.6 tttt -152.41 160.38 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.251 -1.146 . . . . 0.0 110.154 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.02 -118.06 4.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.55 -18.48 35.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -1.13 . . . . 0.0 110.439 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' C ' ' CG1' ' A' ' 32' ' ' ILE . . . 143.67 -21.46 2.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.673 HD13 ' OG ' ' A' ' 79' ' ' SER . 0.0 OUTLIER -167.77 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -1.168 . . . . 0.0 110.59 179.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 28' ' ' LYS . 6.2 mtmm -98.35 142.14 30.36 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.683 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.572 ' C ' HG23 ' A' ' 75' ' ' ILE . 1.9 m -96.97 115.93 28.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.636 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.773 HG12 ' O ' ' A' ' 24' ' ' LYS . 2.4 p -105.14 117.83 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 109.953 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HG3' ' A' ' 39' ' ' MET . 92.0 mt -95.66 112.87 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 110.211 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.644 HG22 HG23 ' A' ' 22' ' ' ILE . 28.6 m -83.52 -4.88 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 110.187 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -97.04 -0.29 47.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -0.879 . . . . 0.0 110.275 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.515 ' HG3' ' HB ' ' A' ' 36' ' ' ILE . 0.3 OUTLIER -53.32 -42.41 66.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.244 -0.91 . . . . 0.0 110.133 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -64.43 -40.4 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 110.12 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -65.24 -47.81 75.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' O ' HD23 ' A' ' 46' ' ' LEU . 84.1 t -62.77 -44.73 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . . . -56.4 -35.06 67.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 110.124 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -36.49 82.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.95 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.96 -35.28 78.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.243 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.848 HD11 ' O ' ' A' ' 48' ' ' ARG . 0.5 OUTLIER -104.49 0.87 29.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.159 -0.963 . . . . 0.0 110.203 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER 73.17 -53.48 0.7 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -0.872 . . . . 0.0 110.664 179.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.848 ' O ' HD11 ' A' ' 46' ' ' LEU . 4.5 ttt-85 -76.93 147.83 77.92 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.0 110.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 48' ' ' ARG . 47.4 Cg_endo -74.11 147.31 37.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.988 1.52 . . . . 0.0 110.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 43' ' ' ALA . 48.8 Cg_endo -75.44 7.54 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.078 1.567 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.215 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 1.0 OUTLIER -63.01 -37.97 89.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.106 -0.996 . . . . 0.0 110.421 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.609 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -69.85 -52.28 13.69 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.181 -0.95 . . . . 0.0 110.586 -179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 52' ' ' TYR . 43.8 Cg_endo -70.37 -16.25 34.94 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.81 1.426 . . . . 0.0 110.462 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.692 HG22 ' CG2' ' A' ' 65' ' ' THR . 1.4 m -71.6 -19.42 62.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.104 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -73.0 -44.96 60.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 110.517 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' CYS . 70.7 m-85 -66.84 -45.02 79.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 0.0 110.419 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.579 ' CD2' ' O ' ' A' ' 53' ' ' PRO . 23.4 m-85 -57.36 -43.97 83.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 109.801 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 61' ' ' LEU . . . -59.44 -35.21 84.33 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' TYR . 84.7 m -56.83 -37.38 71.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.076 -1.25 . . . . 0.0 110.108 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.99 -48.21 66.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.312 -0.867 . . . . 0.0 110.686 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.014 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -77.8 10.84 2.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.113 -0.992 . . . . 0.0 111.005 -179.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.85 40.13 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.014 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . . . -114.21 163.67 14.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -1.156 . . . . 0.0 109.503 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' C ' ' CG2' ' A' ' 65' ' ' THR . 1.7 tt0 -107.78 -118.49 0.26 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 120.777 -1.202 . . . . 0.0 109.915 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.692 ' CG2' HG22 ' A' ' 54' ' ' THR . 2.6 p -149.32 170.17 19.14 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 111.148 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -144.42 139.18 28.23 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.215 ' CZ ' HG22 ' A' ' 51' ' ' THR . 20.1 m-85 -127.19 142.48 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.712 -1.242 . . . . 0.0 113.032 -178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -125.24 117.38 23.7 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.635 -0.826 . . . . 0.0 108.908 178.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 t -84.78 -64.21 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.616 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.43 -17.16 4.56 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.557 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 1.6 m-80 -102.12 -31.49 10.58 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.612 -0.68 . . . . 0.0 110.102 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.3 m-20 70.27 15.59 7.42 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.211 -0.931 . . . . 0.0 110.061 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -113.7 129.8 56.52 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.565 -0.709 . . . . 0.0 109.718 -179.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.698 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.4 m-30 -112.86 129.29 56.51 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.29 -0.881 . . . . 0.0 110.32 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 35' ' ' VAL . 17.8 mt -120.83 149.79 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.553 -0.717 . . . . 0.0 110.285 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 13.4 m -112.96 129.17 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.105 -0.997 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.755 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 28.1 m-20 -48.25 144.51 3.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.884 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.559 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 97.71 146.4 20.7 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.673 ' OG ' HD13 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -102.04 126.07 48.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.454 -1.027 . . . . 0.0 109.889 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.559 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.9 OUTLIER -141.94 156.68 45.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.262 -0.899 . . . . 0.0 110.189 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 2.3 tt0 -103.99 148.66 25.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.237 -0.914 . . . . 0.0 109.81 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.28 -39.74 60.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 110.128 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 1.6 t30 -64.28 -33.36 75.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 -37.5 71.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 17.3 mt -63.39 -44.66 94.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.531 ' HG3' ' N ' ' A' ' 87' ' ' ASP . 12.3 pt20 -68.24 -36.15 79.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.656 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.531 ' N ' ' HG3' ' A' ' 86' ' ' GLN . 7.8 m-20 -68.8 -41.61 78.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.406 -0.809 . . . . 0.0 110.218 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 49.1 ttp -71.19 -50.01 37.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.282 -0.886 . . . . 0.0 110.11 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 85' ' ' LEU . 0.4 OUTLIER -54.69 -30.41 55.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.616 ' HA ' ' CG1' ' A' ' 93' ' ' ILE . 0.4 OUTLIER -62.38 -35.84 80.43 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.68 -179.674 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.86 -43.48 99.15 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.59 -51.04 46.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -1.18 . . . . 0.0 110.556 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.904 ' O ' HG13 ' A' ' 97' ' ' VAL . 2.8 pp -64.41 -36.64 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.18 -0.95 . . . . 0.0 110.602 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.881 ' N ' HD12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -54.98 -27.95 47.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.145 -0.972 . . . . 0.0 110.361 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.692 ' O ' HD21 ' A' ' 98' ' ' LEU . 22.5 mttm -62.72 -38.62 91.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -0.827 . . . . 0.0 111.733 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.623 ' CE2' ' HA ' ' A' ' 93' ' ' ILE . 7.4 p90 -115.61 -17.48 11.13 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.8 -1.188 . . . . 0.0 112.129 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 93' ' ' ILE . 20.0 m -68.81 -50.18 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.585 -1.322 . . . . 0.0 110.806 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 95' ' ' LYS . 1.3 mm? 33.43 100.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.348 -0.845 . . . . 0.0 110.78 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.523 ' SG ' HG21 ' A' ' 107' ' ' THR . 0.1 OUTLIER -64.79 152.22 90.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.198 -0.939 . . . . 0.0 110.297 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.468 ' HG2' ' CE2' ' A' ' 127' ' ' TYR . 45.5 Cg_endo -72.48 -1.62 10.53 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.123 1.591 . . . . 0.0 110.41 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -85.0 -58.17 2.8 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.954 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 104' ' ' ASN . 3.0 p -176.35 23.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.622 ' HG2' HD12 ' A' ' 98' ' ' LEU . 8.6 tp10 38.41 35.34 0.09 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.167 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.618 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 3.4 m-20 -93.98 -64.47 0.13 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.026 -1.046 . . . . 0.0 110.622 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.919 ' HG3' ' HB2' ' A' ' 124' ' ' ALA . 46.8 Cg_endo -72.78 149.6 48.48 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.782 1.411 . . . . 0.0 110.546 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.86 114.81 8.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.0 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.523 HG21 ' SG ' ' A' ' 99' ' ' CYS . 6.3 p -110.13 159.47 17.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.213 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -123.48 147.59 47.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.84 HD23 ' N ' ' A' ' 110' ' ' HIS . 4.2 tt -105.95 128.81 54.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.84 ' N ' HD23 ' A' ' 109' ' ' LEU . 7.3 p80 -124.28 115.55 21.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.251 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.877 HG23 HG12 ' A' ' 118' ' ' ILE . 3.5 p -96.91 122.9 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 109.881 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -90.71 122.55 66.84 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 110.449 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.44 -39.49 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 124.085 1.571 . . . . 0.0 110.476 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -42.26 91.44 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -92.64 -3.82 54.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -0.888 . . . . 0.0 110.098 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.471 ' O ' HD11 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 52.46 42.12 31.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.881 . . . . 0.0 110.164 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.79 175.94 9.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.318 -0.864 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.877 HG12 HG23 ' A' ' 111' ' ' VAL . 3.3 mt -123.2 136.08 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.97 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.552 ' HA3' ' CE1' ' A' ' 110' ' ' HIS . . . -116.13 160.66 13.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.748 ' ND2' HD13 ' A' ' 131' ' ' LEU . 1.5 t30 -143.74 121.76 12.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -1.124 . . . . 0.0 109.724 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 88.8 p -118.6 133.5 55.81 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 110.425 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.473 ' SG ' ' HG2' ' A' ' 105' ' ' PRO . 5.1 t -110.25 133.83 52.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.352 -0.843 . . . . 0.0 110.201 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 123' ' ' LYS . 4.7 ptmt -83.36 42.19 0.81 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.316 -0.865 . . . . 0.0 110.013 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.919 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -124.51 -26.46 3.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.864 . . . . 0.0 110.288 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 43.4 t -149.94 10.53 0.71 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -0.938 . . . . 0.0 110.791 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.65 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.16 -12.24 58.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.65 ' C ' ' O ' ' A' ' 126' ' ' GLY . 9.2 t80 -11.05 -64.76 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.767 -0.843 . . . . 0.0 111.037 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.585 ' C ' ' O ' ' A' ' 127' ' ' TYR . 19.6 ttt180 24.09 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.824 -0.547 . . . . 0.0 110.964 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -162.34 -108.32 0.22 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.411 -1.376 . . . . 0.0 110.07 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.535 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.06 151.65 38.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.412 -1.052 . . . . 0.0 110.559 -179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.748 HD13 ' ND2' ' A' ' 120' ' ' ASN . 31.9 tp -91.25 107.45 19.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 0.0 110.264 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 133' ' ' THR . 14.6 m-20 61.11 5.47 1.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.27 -0.894 . . . . 0.0 110.546 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.605 ' O ' ' CG ' ' A' ' 134' ' ' HIS . 48.6 m 60.32 -75.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 0.0 110.059 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.605 ' CG ' ' O ' ' A' ' 133' ' ' THR . 12.2 m80 -165.25 62.87 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.212 -0.93 . . . . 0.0 110.201 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -156.73 18.04 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 0.0 110.368 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -139.06 -177.62 4.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.299 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.496 ' O ' HG12 ' A' ' 141' ' ' ILE . 5.5 tp -43.9 -24.11 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.34 -0.85 . . . . 0.0 110.373 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.603 ' O ' HG12 ' A' ' 141' ' ' ILE . 1.1 p -55.74 -50.86 69.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.19 -0.944 . . . . 0.0 110.505 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.928 HG21 ' HG3' ' A' ' 147' ' ' GLU . 3.4 m -64.32 -36.49 84.29 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 108.658 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.634 ' HA ' ' O ' ' A' ' 145' ' ' PRO . 5.4 t80 -62.52 -48.39 79.75 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.651 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 138' ' ' CYS . 29.9 pt -68.91 -40.74 81.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.489 -0.757 . . . . 0.0 109.535 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.529 ' N ' HG13 ' A' ' 141' ' ' ILE . 15.8 tp -52.55 -47.53 66.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.471 -0.768 . . . . 0.0 111.005 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.738 ' O ' ' CB ' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -110.18 -38.61 5.24 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.8 -1.187 . . . . 0.0 110.737 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.738 ' CB ' ' O ' ' A' ' 143' ' ' LYS . 0.5 OUTLIER 142.21 -70.97 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 144' ' ' ASN . 48.9 Cg_endo -73.58 165.8 31.44 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.683 1.359 . . . . 0.0 110.276 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.88 -161.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.994 1.523 . . . . 0.0 110.523 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.928 ' HG3' HG21 ' A' ' 139' ' ' THR . 1.4 tm-20 -129.7 -166.31 1.64 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -143.71 -166.04 2.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -0.933 . . . . 0.0 110.24 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 22.0 p -97.44 108.57 21.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.152 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.25 -172.15 3.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -0.894 . . . . 0.0 110.306 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 153' ' ' THR . 0.6 OUTLIER 59.85 104.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.265 -0.897 . . . . 0.0 110.266 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -45.61 99.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.415 ' N ' ' O ' ' A' ' 151' ' ' SER . 9.8 t -64.38 -16.67 62.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.244 -1.151 . . . . 0.0 110.224 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 103.18 161.77 25.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -136.8 -167.28 2.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -1.141 . . . . 0.0 110.202 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.183 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.199 0.523 . . . . 0.0 110.169 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 p -123.76 -161.99 1.02 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.226 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.1 m -120.34 -17.0 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.267 -0.896 . . . . 0.0 110.211 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -93.38 116.48 29.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.297 -0.877 . . . . 0.0 110.155 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.7 t -61.5 -40.93 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.296 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -129.41 82.24 2.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.27 -18.01 23.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -89.89 7.25 38.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 8' ' ' SER . 4.8 p -43.6 -34.75 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.918 . . . . 0.0 110.253 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.462 ' SD ' ' HA ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -114.17 -28.93 7.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.276 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 14' ' ' TYR . 5.3 t0 -89.37 110.63 21.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.148 -0.97 . . . . 0.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' O ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -69.86 -40.46 75.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 12' ' ' GLN . 12.8 m-85 -147.78 -45.61 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.304 -0.873 . . . . 0.0 110.117 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.847 ' CD1' ' O ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 71.37 -5.66 1.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' A' ' 14' ' ' TYR . 10.0 ptp180 -33.16 -21.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.15 -0.969 . . . . 0.0 111.833 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.726 ' N ' ' O ' ' A' ' 14' ' ' TYR . 1.0 OUTLIER -137.0 132.39 34.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.942 -1.098 . . . . 0.0 110.287 -179.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -133.32 130.06 38.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.908 . . . . 0.0 110.2 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.2 ttt -121.35 91.29 48.18 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 20' ' ' ARG . 48.3 Cg_endo -76.17 -156.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.975 1.513 . . . . 0.0 110.363 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' PRO . 5.2 ttt85 70.29 94.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.277 -0.889 . . . . 0.0 110.404 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.778 ' C ' HD13 ' A' ' 21' ' ' LEU . 1.8 tm? -95.81 125.24 40.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.029 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.628 ' N ' HD22 ' A' ' 21' ' ' LEU . 28.8 mt -103.25 133.52 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 110.4 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 80' ' ' HIS . . . -125.53 131.08 52.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.475 ' O ' HG12 ' A' ' 35' ' ' VAL . 5.2 tttt -116.57 138.21 51.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.212 -0.93 . . . . 0.0 110.185 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 25' ' ' VAL . 17.9 m -93.24 135.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.257 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.408 ' O ' ' C ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -124.09 163.36 21.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.0 110.223 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 32' ' ' ILE . . . 43.82 65.63 1.52 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HA ' HD13 ' A' ' 32' ' ' ILE . 3.5 tmtt? -91.46 140.62 29.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.257 -1.143 . . . . 0.0 110.15 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.02 -36.18 3.43 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 -99.96 -12.86 19.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -1.159 . . . . 0.0 110.426 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.518 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -168.38 -30.62 0.02 OUTLIER Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 32' ' ' ILE . 1.8 mm 59.71 91.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.198 -1.177 . . . . 0.0 110.246 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' A' ' 75' ' ' ILE . 1.2 tppt? -129.42 152.73 48.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.846 . . . . 0.0 110.092 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 2.8 t -115.31 125.87 53.79 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.027 -1.046 . . . . 0.0 110.474 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 35' ' ' VAL . 7.2 p -117.31 117.68 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.229 -0.919 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.696 HD13 ' HG3' ' A' ' 39' ' ' MET . 2.3 mp -95.67 143.16 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.52 -39.8 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.222 -0.924 . . . . 0.0 110.561 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.506 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -93.68 11.73 27.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.528 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.696 ' HG3' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.18 -45.52 88.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 -179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.609 HG13 ' N ' ' A' ' 41' ' ' ASP . 12.8 p -70.38 -43.99 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.389 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' N ' HG13 ' A' ' 40' ' ' VAL . 16.0 t0 -69.3 -47.95 63.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 110.492 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.765 ' O ' HD13 ' A' ' 46' ' ' LEU . 4.3 p -61.11 -44.92 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.161 -0.962 . . . . 0.0 110.481 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' CB ' ' HD3' ' A' ' 50' ' ' PRO . . . -68.19 -46.07 71.66 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.092 -1.005 . . . . 0.0 110.648 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 1.3 mtpm? -67.6 -42.6 82.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.41 -0.806 . . . . 0.0 110.852 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.766 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -59.6 -23.25 62.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 110.821 -179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.789 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.5 mp -117.6 -9.26 10.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 110.464 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 44' ' ' LYS . 9.6 p30 -173.56 -146.6 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 0.0 110.783 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.505 ' N ' ' OD1' ' A' ' 47' ' ' ASN . 11.8 mtm180 -90.2 175.47 3.74 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.435 -0.79 . . . . 0.0 110.618 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 48' ' ' ARG . 44.3 Cg_endo -70.64 137.07 32.11 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.019 1.536 . . . . 0.0 110.455 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 43' ' ' ALA . 48.2 Cg_endo -76.94 0.23 9.89 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.114 1.586 . . . . 0.0 110.427 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.774 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 6.9 p -56.24 -21.87 26.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.277 -0.89 . . . . 0.0 110.43 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.497 ' H ' ' HD2' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -88.87 -57.78 0.27 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.21 -0.931 . . . . 0.0 111.006 -179.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' A' ' 52' ' ' TYR . 44.3 Cg_endo -72.73 -16.64 26.5 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.729 1.384 . . . . 0.0 111.052 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 4.9 t -56.37 -16.12 5.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.015 -1.053 . . . . 0.0 110.265 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 tptt -72.66 -45.48 58.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.208 -0.932 . . . . 0.0 110.391 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -59.7 -50.04 75.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.208 -0.933 . . . . 0.0 110.152 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.546 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 6.6 m-85 -57.37 -38.55 74.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.21 -0.931 . . . . 0.0 109.913 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.37 -38.61 93.65 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -37.33 71.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -1.223 . . . . 0.0 109.94 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.78 -49.49 70.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.776 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.04 ' CD1' ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -80.4 11.41 3.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.058 -1.026 . . . . 0.0 110.871 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.16 4.76 30.61 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.049 ' HB1' ' CB ' ' A' ' 77' ' ' ASN . . . -118.8 163.4 16.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -1.12 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.75 ' O ' HG13 ' A' ' 76' ' ' VAL . 25.1 mt-30 -105.52 -119.18 0.23 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.741 -1.225 . . . . 0.0 109.961 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 3.2 p -149.4 170.32 18.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.496 -0.753 . . . . 0.0 111.113 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.643 ' CB ' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -147.14 139.83 24.92 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.774 ' CZ ' HG22 ' A' ' 51' ' ' THR . 22.4 m-85 -126.59 144.6 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.735 -1.228 . . . . 0.0 112.872 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.576 ' HB3' ' CB ' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -121.76 117.31 26.27 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.893 178.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 5.1 t -85.95 -64.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.564 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -16.51 5.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.14 -0.975 . . . . 0.0 108.62 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.592 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -103.69 -30.08 10.66 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.572 -0.705 . . . . 0.0 110.296 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.592 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 8.7 m-20 70.21 15.5 7.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.123 -0.986 . . . . 0.0 109.939 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.552 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 3.6 ttp180 -113.71 129.77 56.52 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.629 -0.67 . . . . 0.0 109.568 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.725 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.6 m-30 -112.16 136.89 50.99 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.339 -0.851 . . . . 0.0 110.311 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.643 HG23 ' CB ' ' A' ' 66' ' ' GLN . 3.1 tt -131.18 148.72 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.504 -0.747 . . . . 0.0 110.12 -179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 64' ' ' GLN . 42.6 t -113.92 139.36 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.134 -0.979 . . . . 0.0 109.748 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 1.049 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 25.3 m-20 -55.54 143.94 27.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 110.611 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.631 ' O ' ' HB ' ' A' ' 34' ' ' THR . . . 91.52 147.03 19.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.411 ' HB2' ' CG1' ' A' ' 25' ' ' VAL . 72.2 p -89.73 125.33 35.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -1.117 . . . . 0.0 109.773 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.476 ' HB3' ' CD2' ' A' ' 85' ' ' LEU . 74.8 m-70 -141.79 114.81 8.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.223 -0.923 . . . . 0.0 110.932 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 2.6 tt0 -86.68 159.02 19.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.313 -0.867 . . . . 0.0 109.108 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.29 -44.6 61.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.882 -1.136 . . . . 0.0 109.311 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.86 -33.44 75.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 108.997 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 88' ' ' MET . 28.8 tptt -68.55 -35.71 77.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.716 -0.615 . . . . 0.0 110.539 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.578 ' O ' ' HG3' ' A' ' 88' ' ' MET . 17.5 mt -58.61 -39.43 80.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.97 -179.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 33.1 tp60 -68.91 -35.98 77.48 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.062 -1.024 . . . . 0.0 108.883 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.24 -42.9 75.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.707 . . . . 0.0 111.339 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.596 ' HG3' ' H ' ' A' ' 89' ' ' LEU . 6.0 ptm -57.68 -47.82 81.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.848 -1.157 . . . . 0.0 110.493 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.596 ' H ' ' HG3' ' A' ' 88' ' ' MET . 0.3 OUTLIER -54.08 -33.55 57.86 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -64.6 -35.83 82.28 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.574 0.702 . . . . 0.0 109.247 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 94' ' ' LYS . . . -61.4 -36.81 93.08 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -47.35 77.74 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.302 -1.117 . . . . 0.0 108.715 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.646 HG23 ' CE1' ' A' ' 96' ' ' PHE . 15.5 mt -65.47 -33.44 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.793 0.806 . . . . 0.0 109.221 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -55.13 -25.44 31.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.623 -0.673 . . . . 0.0 110.838 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.463 ' O ' ' OH ' ' A' ' 127' ' ' TYR . 0.1 OUTLIER -59.29 -29.54 67.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.165 -0.959 . . . . 0.0 111.651 -178.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.751 ' CE2' ' CG2' ' A' ' 97' ' ' VAL . 10.1 p90 -115.67 -22.78 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.626 -1.296 . . . . 0.0 111.051 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.891 ' HB ' HD22 ' A' ' 98' ' ' LEU . 13.1 t -110.16 -60.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 120.749 -1.219 . . . . 0.0 110.117 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.891 HD22 ' HB ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -102.32 60.63 0.83 Allowed 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.471 -0.768 . . . . 0.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.59 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 32.5 m -64.64 150.24 94.35 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.428 -0.795 . . . . 0.0 110.738 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.64 0.89 5.62 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.116 1.587 . . . . 0.0 110.465 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -92.02 -7.98 47.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.251 -0.905 . . . . 0.0 109.519 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.616 ' O ' ' C ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -175.22 -39.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.44 -0.788 . . . . 0.0 110.107 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.734 ' HG3' ' HB3' ' A' ' 98' ' ' LEU . 3.8 tm-20 23.64 70.37 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.488 0.661 . . . . 0.0 110.16 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.541 ' HB3' ' HD3' ' A' ' 105' ' ' PRO . 2.1 t-20 -173.94 -58.34 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.044 -1.035 . . . . 0.0 110.758 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 104' ' ' ASN . 42.4 Cg_endo -68.45 145.62 65.53 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.75 1.395 . . . . 0.0 110.576 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.74 153.58 43.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.286 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.5 p -135.51 166.02 24.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.384 -0.823 . . . . 0.0 110.064 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -113.95 142.64 45.89 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 120' ' ' ASN . 2.0 mp -105.92 127.02 52.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.275 -0.891 . . . . 0.0 110.338 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 108' ' ' ASP . 3.3 m80 -117.45 115.25 24.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.213 -0.929 . . . . 0.0 110.08 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.953 HG12 HD13 ' A' ' 118' ' ' ILE . 5.1 m -100.32 118.16 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 110.151 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -86.32 122.73 72.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 110.229 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.37 -22.84 18.24 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.006 1.53 . . . . 0.0 110.456 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -73.45 -35.75 65.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 110.439 -179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -110.76 -4.1 15.47 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.335 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 52.27 51.4 16.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.213 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.14 147.39 50.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.34 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.953 HD13 HG12 ' A' ' 111' ' ' VAL . 2.3 mm -90.86 134.25 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -136.09 154.0 21.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 108' ' ' ASP . 19.8 t-20 -143.46 154.26 43.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.288 -1.125 . . . . 0.0 108.926 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 120' ' ' ASN . 17.3 t -125.94 124.32 40.52 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.687 -1.258 . . . . 0.0 110.269 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.412 ' CB ' ' HB3' ' A' ' 127' ' ' TYR . 0.1 OUTLIER -90.87 129.53 36.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 0.0 110.045 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.76 38.67 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 110.05 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.531 ' CB ' ' SG ' ' A' ' 102' ' ' CYS . . . -116.83 -27.6 6.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.303 -0.873 . . . . 0.0 110.281 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 124' ' ' ALA . 15.8 p -177.54 25.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.118 -0.989 . . . . 0.0 111.012 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 82.57 -12.19 48.05 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.592 ' C ' ' O ' ' A' ' 126' ' ' GLY . 1.8 t80 -19.53 -49.73 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.731 -0.864 . . . . 0.0 111.523 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER 64.72 128.55 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.411 -0.806 . . . . 0.0 109.572 -179.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 120' ' ' ASN . . . -110.26 67.57 0.22 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.519 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 1.1 ttt -83.33 122.17 28.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -1.103 . . . . 0.0 110.217 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.975 HD23 ' SG ' ' A' ' 138' ' ' CYS . 3.3 tp -113.9 135.42 54.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.369 -0.832 . . . . 0.0 110.097 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.497 ' O ' ' HB ' ' A' ' 133' ' ' THR . 1.3 m-20 -73.17 -92.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 0.0 110.213 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 132' ' ' ASP . 5.2 t 178.86 146.17 0.16 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 110.147 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 133' ' ' THR . 1.3 t-160 176.71 67.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.234 -0.917 . . . . 0.0 110.269 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 134' ' ' HIS . 2.2 m-70 42.85 29.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 -177.62 3.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.293 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.514 HD12 ' C ' ' A' ' 137' ' ' LEU . 4.1 pp -62.16 -9.49 7.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.975 ' SG ' HD23 ' A' ' 131' ' ' LEU . 41.6 m -56.27 -41.95 76.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.191 -0.943 . . . . 0.0 110.186 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -42.68 77.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.184 -0.947 . . . . 0.0 110.324 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' A' ' 140' ' ' PHE . 6.7 t80 -56.98 -48.33 78.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.107 -0.996 . . . . 0.0 109.685 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 138' ' ' CYS . 25.5 pt -68.95 -42.24 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.553 179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.556 ' N ' HG13 ' A' ' 141' ' ' ILE . 39.5 tp -54.04 -27.72 34.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.45 -0.782 . . . . 0.0 110.385 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 143' ' ' LYS . 7.6 tttp -83.96 -18.84 35.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.907 . . . . 0.0 110.375 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.458 ' O ' ' OD1' ' A' ' 144' ' ' ASN . 10.7 p30 -162.45 122.85 1.49 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.932 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.462 ' HB2' ' HD2' ' A' ' 146' ' ' PRO . 47.9 Cg_endo -73.24 174.16 12.54 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.917 1.482 . . . . 0.0 110.428 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.466 ' O ' ' CB ' ' A' ' 147' ' ' GLU . 46.2 Cg_endo -72.57 -92.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.91 1.479 . . . . 0.0 110.383 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER 171.78 34.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.193 -0.942 . . . . 0.0 110.319 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -72.74 119.76 17.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.234 -0.916 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 39.0 m -63.4 176.51 0.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 110.237 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -121.67 -29.66 4.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.207 -0.933 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.6 t -120.77 88.3 2.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.259 -0.9 . . . . 0.0 110.232 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -52.64 168.17 0.89 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.66 96.98 6.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.192 -1.181 . . . . 0.0 110.184 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -96.58 50.17 1.6 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -154.47 112.8 3.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -1.153 . . . . 0.0 110.208 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.219 0.533 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.589 ' C ' HG22 ' A' ' 3' ' ' VAL . 17.1 m -86.91 -153.36 0.21 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 0.0 110.262 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.589 HG22 ' C ' ' A' ' 2' ' ' SER . 17.2 m 36.92 48.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.425 -0.797 . . . . 0.0 110.528 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.63 155.91 38.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.61 -20.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -111.08 13.25 21.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 110.197 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' NH1' ' HB3' ' A' ' 2' ' ' SER . 14.2 ttt180 -68.37 -26.43 65.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.227 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.24 -7.09 58.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.277 -0.89 . . . . 0.0 110.234 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 11' ' ' ASP . 10.0 p -170.65 135.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.136 -0.977 . . . . 0.0 110.196 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -8.41 38.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.237 -0.915 . . . . 0.0 110.176 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' H ' HG22 ' A' ' 9' ' ' VAL . 30.2 m-20 -84.49 148.65 26.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.937 . . . . 0.0 110.174 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -63.97 -18.35 64.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.281 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD2' ' HB3' ' A' ' 15' ' ' ARG . 0.5 OUTLIER 73.28 -52.84 0.7 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 110.264 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' CD1' ' C ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER 65.56 0.48 1.44 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.856 . . . . 0.0 110.645 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.571 ' HB3' ' CD2' ' A' ' 13' ' ' PHE . 8.1 ttt180 -77.99 50.81 0.91 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.056 -1.028 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.1 134.9 36.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 110.248 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 17' ' ' LYS . 0.1 OUTLIER -130.93 135.88 48.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.317 -0.864 . . . . 0.0 110.306 -179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.605 ' CG ' HD11 ' A' ' 22' ' ' ILE . 2.5 mmt -139.59 119.05 9.06 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.86 . . . . 0.0 110.119 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.36 -4.89 16.2 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.964 1.508 . . . . 0.0 110.521 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.1 173.18 6.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.261 -0.899 . . . . 0.0 110.215 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.783 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.4 tm? -90.52 122.49 33.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 18' ' ' MET . 6.9 mt -100.61 120.35 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 109.916 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -112.29 139.3 47.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 0.0 110.502 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.64 ' HB2' HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -116.06 126.74 54.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.277 -0.89 . . . . 0.0 109.922 179.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.571 HG12 ' O ' ' A' ' 31' ' ' GLY . 38.8 t -93.58 122.1 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HB3' ' NZ ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -141.53 169.43 17.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.327 -0.858 . . . . 0.0 110.168 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' CA ' ' HA2' ' A' ' 31' ' ' GLY . . . 162.16 -94.29 0.12 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' A' ' 30' ' ' ASN . 3.9 ttpm? -152.62 139.0 18.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.385 -1.068 . . . . 0.0 109.978 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.61 -78.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 28' ' ' LYS . 42.5 t30 -99.59 -18.73 17.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -1.132 . . . . 0.0 110.056 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 25' ' ' VAL . . . 68.21 100.81 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.666 ' O ' ' CG2' ' A' ' 32' ' ' ILE . 1.1 mm -112.32 14.31 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.474 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.062 ' CD ' HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -97.75 153.02 18.54 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.871 -1.143 . . . . 0.0 109.5 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.59 ' HG1' ' CG ' ' A' ' 80' ' ' HIS . 22.0 m -110.56 115.71 30.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.048 -1.033 . . . . 0.0 110.665 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' ' HA ' ' A' ' 75' ' ' ILE . 2.3 p -110.24 117.25 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.155 -0.965 . . . . 0.0 110.417 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.946 HG21 ' CG ' ' A' ' 39' ' ' MET . 21.3 mt -96.85 122.17 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.367 -0.833 . . . . 0.0 109.897 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 37' ' ' VAL . 24.7 m -100.6 -8.41 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.184 -0.948 . . . . 0.0 110.741 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.646 HD21 HD22 ' A' ' 21' ' ' LEU . 15.1 p-10 -116.71 6.99 13.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.067 -1.021 . . . . 0.0 110.571 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.946 ' CG ' HG21 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -64.03 -45.37 89.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -0.96 . . . . 0.0 110.373 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 10.8 t -70.35 -42.33 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.276 -0.89 . . . . 0.0 110.461 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -62.22 -49.42 75.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 0.0 110.401 -179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.9 t -68.36 -44.97 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.927 . . . . 0.0 110.467 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 50' ' ' PRO . . . -67.72 -45.62 74.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -0.926 . . . . 0.0 110.642 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -65.84 -36.15 82.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.385 -179.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.722 ' C ' HD12 ' A' ' 46' ' ' LEU . . . -62.55 -34.47 77.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.5 mp -117.43 -9.17 10.92 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.951 -1.093 . . . . 0.0 110.917 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.559 ' N ' ' O ' ' A' ' 43' ' ' ALA . 7.6 p-10 -162.28 -153.8 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.065 -1.022 . . . . 0.0 110.622 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' HD2' ' A' ' 49' ' ' PRO . 5.4 mtp180 -88.07 175.17 4.39 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.303 -0.873 . . . . 0.0 110.374 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HB2' ' OG1' ' A' ' 51' ' ' THR . 45.4 Cg_endo -72.5 138.23 29.33 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.086 1.572 . . . . 0.0 110.507 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 48.9 Cg_endo -76.52 -7.19 17.64 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.059 1.557 . . . . 0.0 110.654 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.173 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -56.25 -21.91 26.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 0.0 110.175 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.538 ' HB2' ' HD3' ' A' ' 53' ' ' PRO . 6.4 m-85 -88.8 -57.39 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.0 111.155 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 52' ' ' TYR . 45.0 Cg_endo -71.3 -22.66 25.09 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.802 1.422 . . . . 0.0 111.352 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 10.2 t -56.29 -14.4 2.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.938 -1.101 . . . . 0.0 110.267 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.35 -45.43 66.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 110.398 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.68 -49.08 74.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 0.0 110.327 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' O ' HD23 ' A' ' 61' ' ' LEU . 9.6 m-30 -57.3 -34.1 68.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 63' ' ' ALA . . . -59.47 -41.86 97.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -37.09 70.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.088 -1.242 . . . . 0.0 109.731 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.579 ' CB ' ' CE1' ' A' ' 92' ' ' PHE . 5.2 mm-40 -63.26 -49.37 74.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.327 -0.858 . . . . 0.0 110.767 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.003 HD12 ' HB3' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -81.65 12.93 3.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.99 -1.069 . . . . 0.0 110.812 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.73 4.87 28.23 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -121.33 163.48 18.58 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.183 -1.186 . . . . 0.0 109.397 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.614 ' O ' HG13 ' A' ' 76' ' ' VAL . 3.7 mp0 -113.1 -120.9 0.3 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.653 -1.279 . . . . 0.0 109.676 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 1.2 p -149.5 170.26 19.01 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.447 -0.783 . . . . 0.0 111.042 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.612 ' CB ' HG13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -144.81 139.94 28.11 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.173 ' CZ ' HG22 ' A' ' 51' ' ' THR . 25.8 m-85 -126.09 144.19 50.83 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.688 -1.258 . . . . 0.0 113.055 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -126.08 117.37 23.04 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.11 178.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 t -85.01 -64.06 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.534 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.57 -18.21 7.09 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.162 -0.961 . . . . 0.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.576 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -101.46 -31.57 10.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.654 -0.654 . . . . 0.0 110.073 179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.576 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 6.4 m-20 70.79 15.52 6.87 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.2 -0.938 . . . . 0.0 110.357 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 68' ' ' ASP . 25.5 ttm180 -113.64 129.54 56.55 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 121.406 -0.809 . . . . 0.0 109.829 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.74 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 2.0 m-30 -113.74 136.0 53.32 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.283 -0.886 . . . . 0.0 109.893 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.062 HD13 ' CD ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -129.02 148.51 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.205 -0.934 . . . . 0.0 110.61 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG13 ' O ' ' A' ' 64' ' ' GLN . 51.2 t -114.41 122.94 69.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.707 ' CB ' ' HB1' ' A' ' 63' ' ' ALA . 64.1 m-20 -50.02 142.69 8.98 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.364 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.6 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.96 140.0 9.53 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' ILE . 95.6 p -99.09 123.93 43.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -1.154 . . . . 0.0 109.863 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.6 ' CE1' ' O ' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -142.09 134.83 28.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.262 -0.899 . . . . 0.0 110.574 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.541 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 4.0 tt0 -85.32 158.94 20.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.401 -0.812 . . . . 0.0 109.418 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.541 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -51.24 -44.01 61.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.015 -1.053 . . . . 0.0 109.657 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.79 -33.08 75.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.166 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.496 ' CE ' ' HB3' ' A' ' 81' ' ' GLU . 0.6 OUTLIER -59.11 -35.79 74.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.669 -0.644 . . . . 0.0 110.324 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 85' ' ' LEU . 3.6 mm? -58.82 -38.78 79.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 0.0 109.924 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -68.57 -47.69 66.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.058 -1.026 . . . . 0.0 109.324 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 35.5 t0 -67.69 -36.04 79.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.339 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 25.3 ttp -57.75 -48.28 80.07 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 92' ' ' PHE . 0.4 OUTLIER -53.04 -30.68 37.14 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 178.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.666 ' HA ' HD12 ' A' ' 93' ' ' ILE . 0.8 OUTLIER -64.3 -46.24 84.46 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 95' ' ' LYS . . . -66.66 -32.03 80.23 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 60' ' ' GLU . 2.1 m-85 -55.17 -39.31 69.4 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.491 -1.005 . . . . 0.0 109.616 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.781 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . 17.3 mt -52.97 -47.94 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.2 -0.937 . . . . 0.0 109.733 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.722 ' O ' ' CD2' ' A' ' 98' ' ' LEU . 13.8 mptt -69.63 -25.17 63.8 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.534 -0.729 . . . . 0.0 110.755 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.522 ' HG3' ' HA ' ' A' ' 92' ' ' PHE . 18.6 mmtm -58.89 -29.42 67.01 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.421 -0.8 . . . . 0.0 111.985 -177.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.818 ' HB2' HD22 ' A' ' 137' ' ' LEU . 4.6 p90 -100.87 -19.12 16.07 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.491 -1.381 . . . . 0.0 110.223 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.879 HG13 HD21 ' A' ' 109' ' ' LEU . 6.9 t -71.23 -7.99 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.064 . . . . 0.0 109.495 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.963 HD13 ' HB2' ' A' ' 103' ' ' GLU . 2.3 mm? -37.75 106.07 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.476 -0.765 . . . . 0.0 109.905 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.534 ' N ' ' HB3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -64.14 155.13 80.31 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.457 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.62 -14.21 33.16 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.081 1.569 . . . . 0.0 110.767 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -66.68 0.81 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.136 -0.977 . . . . 0.0 109.754 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.59 ' O ' ' C ' ' A' ' 103' ' ' GLU . 14.3 p -160.38 10.22 0.1 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.847 . . . . 0.0 110.329 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.963 ' HB2' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 23.55 59.41 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.629 -0.67 . . . . 0.0 110.726 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.623 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 9.4 m-20 -101.44 -65.19 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 110.261 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 45.3 Cg_endo -72.12 150.07 53.28 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.715 1.376 . . . . 0.0 110.164 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.11 118.15 11.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 110.073 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.568 HG22 ' H ' ' A' ' 123' ' ' LYS . 4.0 p -110.13 166.06 11.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.199 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.7 p30 -113.92 159.4 19.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 110.123 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.879 HD21 HG13 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -106.03 139.47 40.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.93 . . . . 0.0 110.384 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.542 ' CE1' ' C ' ' A' ' 119' ' ' GLY . 1.5 p80 -123.58 131.31 53.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.349 -0.845 . . . . 0.0 110.07 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG21 HD23 ' A' ' 142' ' ' LEU . 2.0 p -117.95 129.68 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.292 -0.88 . . . . 0.0 110.289 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -98.27 122.48 53.82 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.48 -33.35 6.96 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 124.069 1.563 . . . . 0.0 110.456 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.525 ' CG ' ' N ' ' A' ' 115' ' ' LYS . 4.1 pttp -59.34 -42.23 91.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.291 -0.881 . . . . 0.0 110.278 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 114' ' ' LYS . 0.6 OUTLIER -100.46 0.53 39.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.229 -0.919 . . . . 0.0 110.194 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 52.65 42.05 31.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.192 -0.943 . . . . 0.0 110.109 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.474 ' OG1' ' HG2' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -134.96 179.52 6.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 110.167 -179.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.709 HD11 ' HG ' ' A' ' 142' ' ' LEU . 4.5 mt -137.1 139.91 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.935 . . . . 0.0 110.038 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 110' ' ' HIS . . . -116.66 163.81 12.42 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -135.39 129.82 33.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.366 -1.079 . . . . 0.0 109.681 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.556 ' CA ' ' HA ' ' A' ' 128' ' ' ARG . 1.1 p -117.44 152.7 34.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.519 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 1.8 t -106.28 126.27 52.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 109.978 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.568 ' H ' HG22 ' A' ' 107' ' ' THR . 1.1 ttmt -75.19 51.69 0.55 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.777 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.58 ' HB2' ' HG3' ' A' ' 105' ' ' PRO . . . -144.72 -34.38 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.412 -0.805 . . . . 0.0 110.012 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 14.0 p -137.83 2.16 2.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 110.689 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.669 ' O ' ' C ' ' A' ' 127' ' ' TYR . . . 85.44 -11.76 60.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.669 ' C ' ' O ' ' A' ' 126' ' ' GLY . 29.7 t80 -8.87 -64.16 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.83 -0.806 . . . . 0.0 111.237 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.571 ' N ' ' O ' ' A' ' 126' ' ' GLY . 9.9 ttt-85 35.88 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.589 -0.695 . . . . 0.0 110.578 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.27 -113.19 0.83 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.542 ' HA ' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -120.44 151.74 38.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.34 -1.094 . . . . 0.0 110.496 -179.706 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.884 HD22 ' SG ' ' A' ' 138' ' ' CYS . 2.6 tt -80.94 121.23 25.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.947 . . . . 0.0 110.024 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 133' ' ' THR . 10.4 m-20 -99.3 -97.24 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.201 -0.937 . . . . 0.0 110.348 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 96' ' ' PHE . 0.2 OUTLIER 66.52 -175.82 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 110.389 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -88.82 -91.49 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.324 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -51.41 173.45 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.188 -0.945 . . . . 0.0 110.236 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.59 81.96 2.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.818 HD22 ' HB2' ' A' ' 96' ' ' PHE . 0.7 OUTLIER -82.23 -4.05 56.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.86 . . . . 0.0 110.012 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.884 ' SG ' HD22 ' A' ' 131' ' ' LEU . 20.0 m -62.67 -45.33 93.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.401 -0.812 . . . . 0.0 110.392 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.31 -40.1 96.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.001 -1.062 . . . . 0.0 110.394 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.522 ' O ' ' CD ' ' A' ' 143' ' ' LYS . 0.2 OUTLIER -58.3 -48.5 80.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.016 -1.053 . . . . 0.0 109.389 179.624 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.737 HD11 ' HA ' ' A' ' 138' ' ' CYS . 16.8 pt -69.07 -41.34 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.489 -0.757 . . . . 0.0 109.545 178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.709 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.3 mt -52.91 -16.16 0.96 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.364 -0.835 . . . . 0.0 110.451 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -69.68 -5.36 24.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.923 . . . . 0.0 110.23 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.533 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 0.4 OUTLIER -59.27 170.21 1.03 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 109.985 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 144' ' ' ASN . 45.1 Cg_endo -72.99 156.96 51.82 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.872 1.459 . . . . 0.0 110.355 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.76 149.27 48.01 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.975 1.513 . . . . 0.0 110.433 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.51 65.55 0.93 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -140.6 122.06 15.06 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -0.884 . . . . 0.0 110.158 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.0 35.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 110.251 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.58 123.39 7.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.91 . . . . 0.0 110.222 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.3 t -174.41 154.55 2.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.22 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.25 89.4 1.58 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 153' ' ' THR . 11.3 t -137.09 64.04 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.254 -1.145 . . . . 0.0 110.317 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 156' ' ' LYS . . . 67.33 -174.83 26.33 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 52.0 tttt 45.88 -96.64 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -1.125 . . . . 0.0 110.25 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.253 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.165 0.507 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -170.63 147.95 2.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 4' ' ' ASN . 2.4 m -124.54 -103.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.328 -0.858 . . . . 0.0 110.22 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' H ' HG23 ' A' ' 3' ' ' VAL . 1.8 m-80 -73.29 105.85 4.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.122 -0.986 . . . . 0.0 110.219 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.98 -11.28 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 110.236 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -133.46 44.37 2.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.855 . . . . 0.0 110.176 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' HG3' ' N ' ' A' ' 8' ' ' SER . 7.3 ptt180 -65.69 -17.72 64.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 4.1 p -85.35 4.09 36.84 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG12 ' O ' ' A' ' 9' ' ' VAL . 30.0 t 55.29 85.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.239 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.404 ' C ' ' O ' ' A' ' 9' ' ' VAL . 1.9 tpt 44.41 88.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.71 141.69 35.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.235 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -58.85 -40.93 85.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.299 -0.876 . . . . 0.0 110.139 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.678 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -169.09 -103.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.316 -0.865 . . . . 0.0 110.222 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.487 ' OH ' ' HE3' ' A' ' 17' ' ' LYS . 61.0 t80 -177.29 -100.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.042 -1.036 . . . . 0.0 110.163 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 14' ' ' TYR . 2.5 mtm105 41.06 27.46 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.985 . . . . 0.0 110.184 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' N ' ' O ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -137.06 138.91 40.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.185 -0.947 . . . . 0.0 110.37 -179.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.487 ' HE3' ' OH ' ' A' ' 14' ' ' TYR . 8.9 mtpt -132.31 130.39 40.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.355 -0.841 . . . . 0.0 110.101 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.525 ' CE ' ' HB2' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -138.43 121.87 11.21 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.914 . . . . 0.0 110.269 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' ARG . 46.2 Cg_endo -73.24 -89.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.948 1.499 . . . . 0.0 110.395 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' HB2' ' CE ' ' A' ' 18' ' ' MET . 12.0 tpt85 60.77 72.39 0.52 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.212 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.906 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -96.37 143.49 27.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 110.649 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' A' ' 38' ' ' ASN . 19.9 mt -105.01 120.37 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.005 . . . . 0.0 110.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -125.66 152.32 45.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.907 . . . . 0.0 110.281 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.511 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 11.1 tttm -116.11 128.39 55.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 110.125 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 80' ' ' HIS . 15.5 m -105.59 135.19 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -0.923 . . . . 0.0 110.263 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE1' ' HE2' ' A' ' 33' ' ' LYS . 35.5 tt0 -112.67 134.42 54.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.26 69.89 0.3 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -116.72 139.03 51.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -1.143 . . . . 0.0 110.116 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 48.54 -150.62 3.35 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -99.66 12.44 36.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -1.122 . . . . 0.0 110.209 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 32' ' ' ILE . . . -70.01 -65.19 2.62 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.803 HG22 ' O ' ' A' ' 32' ' ' ILE . 2.1 mm 56.93 88.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -1.172 . . . . 0.0 110.107 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HE2' ' OE1' ' A' ' 26' ' ' GLU . 22.1 pttm -129.62 152.52 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 110.195 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.786 ' HB ' HG23 ' A' ' 76' ' ' VAL . 7.9 m -112.74 128.38 56.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.73 HG12 HD13 ' A' ' 75' ' ' ILE . 4.0 m -109.82 132.29 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 110.186 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 39' ' ' MET . 1.0 OUTLIER -80.56 129.3 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.948 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.57 -46.56 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 110.554 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.484 ' HB2' ' HB ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.64 -1.04 12.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.143 -0.973 . . . . 0.0 110.776 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.554 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 2.7 tmm? -60.38 -33.54 72.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.089 -1.007 . . . . 0.0 110.036 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.3 t -62.84 -42.84 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.905 . . . . 0.0 110.078 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -49.77 74.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 110.14 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -61.04 -40.73 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.056 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' ' HG3' ' A' ' 50' ' ' PRO . . . -62.81 -35.0 78.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 110.162 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -57.82 -40.37 79.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.865 . . . . 0.0 109.905 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.95 -15.9 62.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.0 110.041 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.832 ' O ' HD23 ' A' ' 46' ' ' LEU . 8.0 tt -82.56 1.02 40.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.344 -0.847 . . . . 0.0 110.176 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 46' ' ' LEU . 1.6 t30 71.57 -61.95 0.47 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.671 ' H ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -77.17 154.11 82.35 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 110.234 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' O ' ' CD ' ' A' ' 53' ' ' PRO . 46.5 Cg_endo -72.72 141.59 34.3 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.002 1.527 . . . . 0.0 110.52 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HG3' ' CB ' ' A' ' 43' ' ' ALA . 47.9 Cg_endo -73.55 -24.96 15.55 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.997 1.525 . . . . 0.0 110.393 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 1.026 HG22 ' CZ ' ' A' ' 67' ' ' PHE . 33.2 p -56.44 -21.75 27.49 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.875 . . . . 0.0 110.381 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.512 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -86.55 -57.46 0.33 Allowed Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 0.0 111.141 -179.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 52' ' ' TYR . 44.4 Cg_endo -70.83 -27.42 21.39 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.745 1.392 . . . . 0.0 111.197 -179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 50' ' ' PRO . 15.2 t -56.72 -15.12 4.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 0.0 110.399 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -72.81 -39.33 66.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.214 -0.929 . . . . 0.0 110.46 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 -50.84 72.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.147 -0.971 . . . . 0.0 110.443 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 23.9 m-85 -67.53 -31.7 71.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.213 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.814 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . -59.27 -48.46 85.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 56.3 m -58.97 -46.26 88.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.138 -1.213 . . . . 0.0 110.333 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -70.17 -28.72 65.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.95 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.844 ' O ' HD12 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -91.92 12.99 19.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 0.0 110.932 -179.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.13 12.51 44.35 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.712 ' CB ' HD11 ' A' ' 61' ' ' LEU . . . -131.59 163.2 28.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.211 -1.17 . . . . 0.0 109.52 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.523 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 0.1 OUTLIER -120.16 -125.31 0.27 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.722 -1.236 . . . . 0.0 109.187 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -150.8 170.36 19.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.34 -0.85 . . . . 0.0 111.985 -179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.552 ' CB ' ' O ' ' A' ' 75' ' ' ILE . 0.0 OUTLIER -151.0 139.53 20.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.302 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.026 ' CZ ' HG22 ' A' ' 51' ' ' THR . 19.3 m-85 -126.69 144.27 50.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.656 -1.278 . . . . 0.0 113.273 -178.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . 0.7 OUTLIER -118.7 117.27 28.46 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 t -86.79 -64.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 109.773 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -15.11 4.15 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.152 -0.968 . . . . 0.0 108.642 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -103.68 -31.28 9.95 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.662 . . . . 0.0 110.271 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' HB2' ' O ' ' A' ' 71' ' ' ASN . 5.9 m-20 72.15 15.32 5.48 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.222 -0.924 . . . . 0.0 109.986 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.535 ' C ' ' CD1' ' A' ' 74' ' ' TYR . 26.9 ttp180 -114.04 129.55 56.6 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.496 -0.752 . . . . 0.0 109.036 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.685 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . 5.3 m-30 -108.91 128.93 55.35 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.608 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.73 HD13 HG12 ' A' ' 35' ' ' VAL . 10.5 mt -128.51 149.95 33.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.786 HG23 ' HB ' ' A' ' 34' ' ' THR . 7.4 m -112.24 139.11 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.919 -1.113 . . . . 0.0 109.753 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.589 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -68.33 135.88 52.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.507 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.572 ' O ' ' CE1' ' A' ' 80' ' ' HIS . . . 106.2 158.42 22.08 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.528 ' HB3' HG23 ' A' ' 32' ' ' ILE . 91.8 p -97.22 123.78 41.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.119 -1.224 . . . . 0.0 110.317 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.629 ' CD2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -141.83 115.02 8.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.357 -0.84 . . . . 0.0 109.971 179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 82' ' ' ALA . 1.2 tt0 -89.92 155.32 19.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.139 -0.976 . . . . 0.0 109.935 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . -52.23 -43.59 64.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.223 -0.923 . . . . 0.0 109.934 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.15 -33.59 76.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.955 . . . . 0.0 109.611 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -70.88 -36.98 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.505 -0.747 . . . . 0.0 109.762 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.5 OUTLIER -60.15 -33.63 72.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.773 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -68.58 -37.12 79.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.829 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASP . 0.3 OUTLIER -61.62 -42.14 98.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.326 -0.859 . . . . 0.0 109.994 179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 61' ' ' LEU . 48.7 ttp -66.61 -48.69 68.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.816 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -53.37 -29.73 36.05 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 177.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 87' ' ' ASP . 1.3 t70 -56.13 -35.2 66.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.111 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 94' ' ' LYS . . . -60.97 -32.59 80.65 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -65.77 -39.8 91.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.329 -1.101 . . . . 0.0 109.346 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 1.116 HG23 ' CZ ' ' A' ' 96' ' ' PHE . 1.4 mp -53.37 -32.84 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.446 -0.784 . . . . 0.0 110.056 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.816 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -54.13 -25.84 24.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.471 -0.768 . . . . 0.0 109.763 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.527 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 24.1 mmtm -60.44 -25.95 66.37 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.688 -0.632 . . . . 0.0 111.706 -178.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 1.116 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 5.7 p90 -115.38 -19.72 10.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.537 -1.352 . . . . 0.0 111.725 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.671 ' CG2' ' HA ' ' A' ' 94' ' ' LYS . 30.1 m -62.24 -32.23 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.595 -1.315 . . . . 0.0 110.02 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.816 HD11 ' O ' ' A' ' 94' ' ' LYS . 1.2 mp -40.64 101.42 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.36 -0.837 . . . . 0.0 109.718 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 31.3 p -64.53 155.26 81.89 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.556 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.02 -0.68 8.33 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.112 1.585 . . . . 0.0 110.41 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.479 ' CB ' ' HB3' ' A' ' 127' ' ' TYR . 3.7 mm-40 -89.11 -11.29 44.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.353 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.614 ' O ' ' C ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -167.19 -38.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.547 -0.72 . . . . 0.0 109.795 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.617 ' CG ' ' HB3' ' A' ' 98' ' ' LEU . 0.8 OUTLIER 21.71 71.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.599 0.714 . . . . 0.0 110.306 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 6.1 m-80 -159.55 -64.02 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.651 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 104' ' ' ASN . 44.4 Cg_endo -70.89 149.29 59.4 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.841 1.443 . . . . 0.0 110.547 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.81 107.88 3.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.173 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 105' ' ' PRO . 12.7 p -112.09 163.03 14.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.193 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -114.2 137.95 51.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.174 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.485 ' HB3' ' OD1' ' A' ' 120' ' ' ASN . 0.4 OUTLIER -106.05 128.43 53.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.261 -0.899 . . . . 0.0 110.102 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -96.79 124.68 40.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 110.201 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 HG12 ' A' ' 118' ' ' ILE . 2.2 p -108.47 117.9 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -0.853 . . . . 0.0 110.18 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -93.55 123.6 59.65 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.134 -0.979 . . . . 0.0 110.182 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -73.17 -31.88 9.03 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.058 1.557 . . . . 0.0 110.461 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -40.77 67.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.879 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.655 ' O ' ' CG ' ' A' ' 116' ' ' GLN . 13.3 tttm -92.0 -3.73 55.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 110.229 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.655 ' CG ' ' O ' ' A' ' 115' ' ' LYS . 2.0 pt20 51.53 37.94 20.89 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 110.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.11 174.06 10.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 0.0 110.109 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.501 HG12 HG23 ' A' ' 111' ' ' VAL . 13.7 mt -141.72 139.3 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.175 -0.953 . . . . 0.0 110.268 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 130' ' ' MET . . . -117.84 163.79 12.79 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -142.44 127.57 18.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -1.173 . . . . 0.0 109.775 179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.696 ' HA ' ' HA ' ' A' ' 128' ' ' ARG . 1.3 p -117.0 124.7 49.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -0.972 . . . . 0.0 110.355 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 107' ' ' THR . 69.1 m -91.57 128.36 37.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.26 -23.33 0.53 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.25 -0.906 . . . . 0.0 110.166 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.505 ' O ' ' CB ' ' A' ' 125' ' ' CYS . . . -83.88 -5.54 59.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 110.152 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 126' ' ' GLY . 0.1 OUTLIER 70.54 2.79 4.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 0.0 110.23 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 125' ' ' CYS . . . -32.67 -71.72 0.09 OUTLIER Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.707 ' C ' ' CD1' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -135.55 1.68 2.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.27 -1.135 . . . . 0.0 110.316 -179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.696 ' HA ' ' HA ' ' A' ' 121' ' ' SER . 0.0 OUTLIER -10.9 120.48 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.788 -0.57 . . . . 0.0 111.403 -179.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.46 -93.52 0.11 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.52 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 0.0 OUTLIER -116.71 151.63 35.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.301 -1.117 . . . . 0.0 110.28 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.524 HD23 ' N ' ' A' ' 132' ' ' ASP . 1.2 tt -85.61 142.05 29.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.296 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.524 ' N ' HD23 ' A' ' 131' ' ' LEU . 75.2 m-20 -115.9 -91.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.231 -0.918 . . . . 0.0 110.193 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 132' ' ' ASP . 0.6 OUTLIER 56.93 161.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.188 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -75.68 -172.29 1.83 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.232 -0.917 . . . . 0.0 110.193 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' HIS . 15.6 m-70 42.54 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.219 -0.926 . . . . 0.0 110.111 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.0 ttmm -131.91 81.99 2.0 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.248 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.893 HD22 ' CD1' ' A' ' 96' ' ' PHE . 4.3 pp -82.29 -21.59 36.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.852 . . . . 0.0 110.101 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.73 ' HA ' HD11 ' A' ' 141' ' ' ILE . 56.5 m -56.69 -40.39 75.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.216 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 m -68.7 -42.64 77.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.259 -0.9 . . . . 0.0 110.247 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -57.08 -48.65 78.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.086 -1.009 . . . . 0.0 109.675 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.73 HD11 ' HA ' ' A' ' 138' ' ' CYS . 10.6 pt -69.17 -42.19 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 0.0 109.634 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.43 ' N ' HG13 ' A' ' 141' ' ' ILE . 57.7 tp -54.41 -28.76 45.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.434 -0.791 . . . . 0.0 110.302 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -70.3 -6.33 34.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 110.328 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 141' ' ' ILE . 8.0 m120 -73.4 117.29 59.26 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.221 -0.925 . . . . 0.0 110.237 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.96 115.21 4.27 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.92 1.484 . . . . 0.0 110.384 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.69 -89.75 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.904 1.476 . . . . 0.0 110.4 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.48 113.9 9.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.0 110.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.37 -156.86 0.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.224 -0.923 . . . . 0.0 110.176 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 p -169.94 137.1 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.36 -45.28 6.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 110.213 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 m 45.95 -153.77 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.169 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.43 ' O ' ' OG1' ' A' ' 153' ' ' THR . . . 46.64 79.12 0.07 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 152' ' ' GLY . 44.8 p 43.83 56.67 4.48 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.207 -1.172 . . . . 0.0 110.136 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.31 152.08 29.01 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.52 -163.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -1.193 . . . . 0.0 110.116 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 24.1 tttt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.214 179.988 . . . . . . . . 0 0 . 1 stop_ save_